umwelt-online-Demo: Archivdatei - 08_1272a_20_02_1 - Verordnung (EG) Nr. 1272/2008: Tabelle 3.1 Liste der harmonisierten Einstufung und Kennzeichnung gefährlicher Stoffe (1)

VO (EG) 1272/2008, Anhang VI, Teil 3
Tabelle 3 Die Liste der harmonisierten Einstufung und Kennzeichnung gefährlicher Stoffe ist in einem eigenen Band IIIa enthalten.¹⁷
~~Tabelle 3.1 Liste der harmonisierten Einstufung und Kennzeichnung gefährlicher Stoffe~~^{12 17}

Index-Nr.	Internationale chemische Bezeichnung	EG-Nr.	CAS-Nr.	Einstufung	Kennzeichnung	Spez. Konzentra-tionsgrenzen, M-Fakt.	Anm.
001-001-00-9	hydrogen	215-605-7	1333-74-0	Flam. Gas 1 Press. Gas	H220	GHS02 GHS04 Gef.	H220			U
001-002-00-4	aluminium lithium hydride	240-877-9	16853-85-3	Water-react. 1 Skin Corr. 1A	H260 H314	GHS02 GHS05 Gef.	H260 H314
001-003-00-X	sodium hydride	231-587-3	7646-69-7	Water-react. 1	H260	GHS02 Gef.	H260
001-004-00-5	calcium hydride	232-189-2	7789-78-8	Water-react. 1	H260	GHS02 Gef.	H260
003-001-00-4	lithium	231-102-5	7439-93-2	Water-react. 1 Skin Corr. 1B	H260 H314	GHS02 GHS05 Gef.	H260 H314	EUH014
003-002-00-X	n-hexyllithium	404-950-0	21369-64-2	Water-react. 1 Pyr. Sol. 1 Skin Corr. 1A	H260 H250 H314	GHS02 GHS05 Gef.	H260 H250 H314	EUH014
003-003-00-5	(2-methylpropyl)lithium; isobutyllithium	440-620-2	920-36-5	Water-react. 1 Pyr. Liq. 1 Skin Corr. 1a STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1	H260 H250 H314 H336 H400 H410	GHS02 GHS05 GHS07 GHS09 Gef.	H260 H250 H314 H336 H410	EUH014
004-001-00-7	beryllium	231-150-7	7440-41-7	Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1	H350i H330 H301 H372 ** H319 H335 H315 H317	GHS06 GHS08 Gef.	H350i H330 H301 H372 ** H319 H335 H315 H317
004-002-00-2	beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex	-	-	Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 2	H350i H330 H301 H372 ** H319 H335 H315 H317 H411	GHS06 GHS08 GHS09 Gef.	H350i H330 H301 H372 ** H319 H335 H315 H317 H411			A
004-003-00-8	beryllium oxide	215-133-1	1304-56-9	Carc. 1B Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1	H350i H330 H301 H372 ** H319 H335 H315 H317	GHS06 GHS08 Gef.	H350i H330 H301 H372 ** H319 H335 H315 H317
005-001-00-X	boron trifluoride	231-569-5	7637-07-2	Press. Gas Acute Tox. 2 * Skin Corr. 1A	H330 H314	GHS04 GHS06 GHS05 Gef.	H330 H314	EUH014		U
005-002-00-5	boron trichloride	233-658-4	10294-34-5	Press. Gas Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1B	H330 H300 H314	GHS04 GHS06 GHS05 Gef.	H330 H300 H314	EUH014		U
005-003-00-0	boron tribromide	233-657-9	10294-33-4	Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1A	H330 H300 H314	GHS06 GHS05 Gef.	H330 H300 H314	EUH014
005-004-00-6	trialkylboranes, solid	-	-	Pyr. Sol. 1 Skin Corr. 1B	H250 H314	GHS02 GHS05 Gef.	H250 H314			A
005-004-01-3	trialkylboranes, liquid	-	-	Pyr. Liq. 1 Skin Corr. 1B	H250 H314	GHS02 GHS05 Gef.	H250 H314			A
005-005-00-1	trimethyl borate	204-468-9	121-43-7	Flam. Liq. 3 Acute Tox. 4 *	H226 H312	GHS02 GHS07 Gef.	H226 H312
005-006-00-7	dibutyltin hydrogen borate	401-040-5	75113-37-0	Repr. 1B Muta. 2 STOT RE 1 Acute Tox. 4 * Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H360FD H341 H372** H312 H302 H318 H317 H400 H410	GHS05 GHS08 GHS07 GHS09 Gef.	H360FD H341 H372** H312 H302 H318 H317 H410
005-007-00-2	boric acid; [1] boric acid; [2]	233-139-2 [1] 234-343-4 [2]	10043-35-3 [1] 11113-50-1 [2]	Repr. 1B	H360FD	GHS08 Gef.	H360FD		Repr. 1B; H360FD: C> 5,5 %
005-008-00-8	diboron trioxide; boric oxide	215-125-8	1303-86-2	Repr. 1B	H360FD	GHS08 Gef.	H360FD		Repr. 1B; H360FD: C> 3,1 %
005-009-00-3	tetrabutylammonium butyltriphenylborate	418-080-4	120307-06-4	Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H317 H400 H410	GHS07 GHS09 Achtg.	H317 H410
005-010-00-9	N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate	422-050-6	118612-00-3	Carc. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1	H351 H302 H315 H318	GHS08 GHS05 GHS07 Gef.	H351 H302 H315 H318
005-011-00-4	disodium tetraborate, anhydrous; boric acid, disodium salt; [1] tetraboron disodium heptaoxide, hydrate; [2] orthoboric acid, sodium salt [3]	215-540-4 [1] 235-541-3 [2] 237-560-2 [3]	1330-43-4 [1] 12267-73-1 [2] 13840-56-7 [3]	Repr. 1B	H360FD	GHS08 Gef.	H360FD		Repr. 1B; H360FD: C> 4,5 %
005-011-01-1	disodium tetraborate decahydrate; borax decahydrate	215-540-4	1303-96-4	Repr. 1B	H360FD	GHS08 Gef.	H360FD		Repr. 1B; H360FD: C> 8,5 %
005-011-02-9	disodium tetraborate pentahydrate; borax pentahydrate	215-540-4	12179-04-3	Repr. 1B	H360FD	GHS08 Gef.	H360FD		Repr. 1B; H360FD: C> 6,5 %
005-012-00-X	diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate	418-070-1	141714-54-7	Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H317 H400 H410	GHS07 GHS09 Achtg.	H317 H410
005-013-00-5	diethylmethoxyborane	425-380-9	7397-46-8	Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4	H250 H332 H312 H302 H373** H314 H317 H413	GHS02 GHS05 GHS08 GHS07 Gef.	H250 H332 H312 H302 H373** H314 H317 H413
005-014-00-0	4-formylphenylboronic acid	438-670-5	87199-17-5	Skin Sens. 1	H317	GHS07 Achtg.	H317
005-015-00-6	1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)	414-380-4	140681-55-6	Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3	H302 H318 H317 H412	GHS05 GHS07 Gef.	H302 H318 H317 H412
005-016-00-1	tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate	431-370-5	-	Aquatic Chronic 4	H413	-	H413
005-017-00-7	sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]	239-172-9 [1] 231-556-4 [2]	15120-21-5 [1] 7632-04-4 [2]	Ox. Sol. 2 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1	H272 H360Df H302 H335 H318	GHS03 GHS05 GHS08 GHS07 Gef.	H272 H360Df H302 H335 H318		Repr. 1B; H360Df: C> 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C> 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-017-01-4	sodium perborate; [1] sodium peroxometaborate; [2] sodium peroxoborate; [containing> 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]	239-172-9 [1] 231-556-4 [2]	15120-21-5 [1] 7632-04-4 [2]	Ox. Sol. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1	H272 H360Df H331 H302 H335 H318	GHS03 GHS06 GHS05 GHS08 Gef.	H272 H360Df H331 H302 H335 H318		Repr. 1B; H360Df: C> 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C> 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-018-00-2	perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate [3] sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]	239-172-9 [1] 234-390-0 [2] 231-556-4 [3]	13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3]	Repr. 1B STOT SE 3 Eye Dam. 1	H360Df H335 H318	GHS05 GHS08 GHS07 Gef.	H360Df H335 H318		Repr. 1B; H360Df: C> 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C> 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 %
005-018-01-X	perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing> 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]	239-172-9 [1] 234-390-0 [2] 231-556-4 [3]	13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3]	Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1	H360Df H332 H335 H318	GHS05 GHS08 GHS07 Gef.	H360Df H332 H335 H318		Repr. 1B; H360Df: C> 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C> 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 %
005-019-00-8	perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate; [3] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]	234-390-0 [1] 234-390-0 [2] 231-556-4 [3]	11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3]	Ox. Sol. 3 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1	H272 H360Df H302 H335 H318	GHS03 GHS05 GHS08 GHS07 Gef.	H272 H360Df H302 H335 H318		Repr. 1B; H360Df: C> 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C> 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-019-01-5	perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate [3] sodium peroxoborate; [containing> 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]	234-390-0 [1] 234-390-0 [2] 231-556-4 [3]	11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3]	Ox. Sol. 3 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1	H272 H360Df H331 H302 H335 H318	GHS03 GHS06 GHS05 GHS08 Gef.	H272 H360Df H331 H302 H335 H318		Repr. 1B; H360Df: C> 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C> 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 %
005-020-00-3	Dinatriumoctaborat wasserfrei; [1] Dinatriumoctaborat Tetrahydrat [2]	234-541-0 [1] 234-541-0 [2]	12008-41-2 [1] 12280-03-4 [2]	Repr. 1B	H360FD	GHS08 Gef.	H360FD
006-001-00-2	carbon monoxide	211-128-3	630-08-0	Flam. Gas 1 Press. Gas Repr. 1a Acute Tox. 3 * STOT RE 1	H220 H360D * H331 H372	GHS02 GHS04 GHS06 GHS08 Gef.	H220 H360D * H331 H372			U
006-002-00-8	phosgene; carbonyl chloride	200-870-3	75-44-5	Press. Gas Acute Tox. 2 * Skin Corr. 1B	H330 H314	GHS04 GHS06 GHS05 Gef.	H330 H314			U
006-003-00-3	carbon disulphide	200-843-6	75-15-0	Flam. Liq. 2 Repr. 2 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2	H225 H361fd H372 ** H319 H315	GHS02 GHS08 GHS07 Gef.	H225 H361fd H372 ** H319 H315		Repr. 2; H361fd: C> 1 % STOT RE 1; H372: C> 1 % STOT RE 2; H373: 0.2 % ≤C < 1 %
006-004-00-9	calcium carbide	200-848-3	75-20-7	Water-react. 1	H260	GHS02 Gef.	H260			T
006-005-00-4	thiram (ISO); tetramethylthiuram disulphide	205-286-2	137-26-8	Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H332 H302 H373 ** H319 H315 H317 H400 H410	GHS08 GHS07 GHS09 Achtg.	H332 H302 H373 ** H319 H315 H317 H410		M=10
006-006-00-X	hydrogen cyanide; hydrocyanic acid	200-821-6	74-90-8	Flam. Liq. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H224 H330 H400 H410	GHS02 GHS06 GHS09 Gef.	H224 H330 H410
006-006-01-7	hydrogen cyanide ... %; hydrocyanic acid ... %	200-821-6	74-90-8	Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H330 H310 H300 H400 H410	GHS06 GHS09 Gef.	H330 H310 H300 H410			B
006-007-00-5	salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex	-	-	Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H330 H310 H300 H400 H410	GHS06 GHS09 Gef.	H330 H310 H300 H410	EUH032		A
006-008-00-0	antu (ISO); 1-(1-naphthyl)-2-thiourea	201-706-3	86-88-4	Acute Tox. 2 * Carc. 2	H300 H351	GHS06 GHS08 Gef.	H300 H351
006-009-00-6	1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate; isolan	204-318-2	119-38-0	Acute Tox. 1 Acute Tox. 2 *	H310 H300	GHS06 Gef.	H310 H300
006-010-00-1	5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate; dimetan	204-525-8	122-15-6	Acute Tox. 3 *	H301	GHS06 Gef.	H301
006-011-00-7	carbaryl (ISO); 1-naphthyl methylcarbamate	200-555-0	63-25-2	Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1	H351 H332 H302 H400	GHS08 GHS07 GHS09 Achtg.	H351 H332 H302 H400		M=100
006-012-00-2	ziram (ISO); zinc bis dimethyldithiocarbamate	205-288-3	137-30-4	Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H302 H373 ** H335 H318 H317 H400 H410	GHS06 GHS08 GHS05 GHS09 Gef.	H330 H302 H373 ** H335 H318 H317 H410		M=100
006-013-00-8	metam-sodium (ISO); sodium methyldithiocarbamate	205-293-0	137-42-8	Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H314 H317 H400 H410	GHS05 GHS07 GHS09 Gef.	H302 H314 H317 H410	EUH031
006-014-00-3	nabam (ISO); disodium ethylenebis(N, N'-dithiocarbamate)	205-547-0	142-59-6	Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H335 H317 H410	GHS07 GHS09 Gef.	H302 H335 H317 H410
006-015-00-9	diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea	206-354-4	330-54-1	Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1	H351 H302 H373** H400 H410	GHS08 GHS07 GHS09 Achtg.	H351 H302 H373** H410		M = 10
006-016-00-4	propoxur (ISO); 2-isopropyloxyphenylN-methylcarbamate; 2-isopropoxyphenyl methylcarbamate	204-043-8	114-26-1	Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H301 H400 H410	GHS06 GHS09 Gef.	H301 H410
006-017-00-X	aldicarb (ISO); 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime	204-123-2	116-06-3	Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H330 H300 H311 H400 H410	GHS06 GHS09 Gef.	H330 H300 H311 H410
006-018-00-5	aminocarb (ISO); 4-dimethylamino-3-tolyl methylcarbamate	217-990-7	2032-59-9	Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H311 H301 H400 H410	GHS06 GHS09 Gef.	H311 H301 H410
006-019-00-0	di-allate (ISO); S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate	218-961-1	2303-16-4	Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H351 H302 H400 H410	GHS08 GHS07 GHS09 Achtg.	H351 H302 H410
006-020-00-6	barban (ISO); 4-chlorbut-2-ynylN-(3-chlorophenyl)carbamate	202-930-4	101-27-9	Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H317 H400 H410	GHS07 GHS09 Achtg.	H302 H317 H410
006-021-00-1	linuron (ISO); 3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea	206-356-5	330-55-2	Repr. 1B Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1	H360Df H351 H302 H373 ** H400 H410	GHS08 GHS07 GHS09 Gef.	H360Df H351 H302 H373 ** H410
006-022-00-7	decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate	-	1563-67-3	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *	H331 H311 H301	GHS06 Gef.	H331 H311 H301
006-023-00-2	mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiophenylN-methylcarbamate	217-991-2	2032-65-7	Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H301 H400 H410	GHS06 GHS09 Gef.	H301 H410
006-024-00-8	proxan-sodium (ISO); sodiumO-isopropyldithiocarbonate	205-443-5	140-93-2	Acute Tox. 4 * Skin Irrit. 2 Aquatic Chronic 2	H302 H315 H411	GHS07 GHS09 Achtg.	H302 H315 H411
006-025-00-3	allethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; bioallethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1] S-bioallethrin; (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2] esbiothrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]	209-542-4 [1] 249-013-5 [2] - [3]	584-79-2 [1] 28434-00-6 [2] 84030-86-4 [3]	Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H332 H302 H400 H410	GHS07 GHS09 Achtg.	H332 H302 H410			C
006-026-00-9	carbofuran (ISO); 2,3-dihydro-2,2-dimethylbenzofuran-7-ylN-methylcarbamate	216-353-0	1563-66-2	Acute Tox. 2 * Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H330 H300 H400 H410	GHS06 GHS09 Gef.	H330 H300 H410
006-028-00-X	dinobuton (ISO); 2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate	213-546-1	973-21-7	Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H301 H400 H410	GHS06 GHS09 Gef.	H301 H410
006-029-00-5	dioxacarb (ISO); 2-(1,3-dioxolan-2-yl)phenylN-methylcarbamate	230-253-4	6988-21-2	Acute Tox. 3 * Aquatic Chronic 2	H301 H411	GHS06 GHS09 Gef.	H301 H411
006-030-00-0	EPTC (ISO); S-ethyl dipropylthiocarbamate	212-073-8	759-94-4	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
006-031-00-6	formetanate (ISO); 3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate	244-879-0	22259-30-9	Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H300 H317 H400 H410	GHS06 GHS09 Gef.	H330 H300 H317 H410
006-032-00-1	monolinuron (ISO); 3-(4-chlorophenyl)-1-methoxy-1-methylurea	217-129-5	1746-81-2	Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1	H302 H373 ** H400 H410	GHS08 GHS07 GHS09 Achtg.	H302 H373 ** H410
006-033-00-7	metoxuron (ISO); 3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea	243-433-2	19937-59-8	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Achtg.	H410
006-034-00-2	pebulate (ISO); N-butyl-N-ethyl-S-propylthiocarbamate	214-215-4	1114-71-2	Acute Tox. 4 * Aquatic Chronic 2	H302 H411	GHS07 GHS09 Achtg.	H302 H411
006-035-00-8	Pirimicarb (ISO); 2-(Dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamat	245-430-1	23103-98-2	Carc. 2 Acute Tox. 3 Acute Tox. 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H351 H331 H301 H317 H400 H410	GHS08 GHS06 GHS09 Gef.	H351 H331 H301 H317 H410		M = 10 M = 100
006-036-00-3	benzthiazuron (ISO); 1-benzothiazol-2-yl-3-methylurea	217-685-9	1929-88-0	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
006-037-00-9	promecarb (ISO); 3-isopropyl-5-methylphenylN-methylcarbamate	220-113-0	2631-37-0	Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H301 H400 H410	GHS06 GHS09 Gef.	H301 H410
006-038-00-4	sulfallate (ISO); 2-chloroallylN,N-dimethyldithiocarbamate	202-388-9	95-06-7	Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H350 H302 H400 H410	GHS08 GHS07 GHS09 Gef.	H350 H302 H410
006-039-00-X	tri-allate (ISO); S - 2,3,3-trichloroallyl diisopropylthiocarbamate	218-962-7	2303-17-5	Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H373 ** H317 H400 H410	GHS08 GHS07 GHS09 Achtg.	H302 H373 ** H317 H410
006-040-00-5	3-methylpyrazol-5-yl-dimethylcarbamate; monometilan	-	2532-43-6	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *	H331 H311 H301	GHS06 Gef.	H331 H311 H301
006-041-00-0	dimethylcarbamoyl chloride	201-208-6	79-44-7	Carc. 1B Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2	H350 H331 H302 H319 H335 H315	GHS06 GHS08 Gef.	H350 H331 H302 H319 H335 H315		Carc. 1B; H350: C> 0,001 %
006-042-00-6	monuron (ISO); 3-(4-chlorophenyl)-1,1-dimethylurea	205-766-1	150-68-5	Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H351 H302 H400 H410	GHS08 GHS07 GHS09 Achtg.	H351 H302 H410
006-043-00-1	3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA	-	140-41-0	Carc. 2 Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1	H351 H319 H315 H400 H410	GHS08 GHS07 GHS09 Achtg.	H351 H319 H315 H410
006-044-00-7	isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea	251-835-4	34123-59-6	Carc. 2 Aquatic Acute 1 Aquatic Chronic 1	H351 H400 H410	GHS08 GHS09 Achtg.	H351 H410		M=10
006-045-00-2	methomyl (ISO); 1-(methylthio)ethylideneaminoN-methylcarbamate	240-815-0	16752-77-5	Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H300 H400 H410	GHS06 GHS09 Gef.	H300 H410		M=100
006-046-00-8	Bendiocarb (ISO); 2,2-Dimethyl-1,3-benzodioxol-4-yl-N-methylcarbamat; 2,2-Dimethyl-1,3-benzodioxol-4-yl-methylcarbamat	245-216-8	22781-23-3	Acute Tox. 3 Acute Tox. 3 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1	H331 H311 H300 H400 H410	GHS06 GHS09 Gef.	H331 H311 H300 H410		M = 10 M = 100
006-047-00-3	bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenylN-methylcarbamate and 3-(1-ethylpropyl)phenylN-methylcarbamate	-	8065-36-9	Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H311 H301 H400 H410	GHS06 GHS09 Gef.	H311 H301 H410
006-048-00-9	ethiofencarb (ISO); 2-(ethylthiomethyl)phenylN-methylcarbamate	249-981-9	29973-13-5	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
006-049-00-4	dixanthogen; O,O-diethyl dithiobis(thioformate)	207-944-4	502-55-6	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
006-050-00-X	1,1-dimethyl-3-phenyluronium trichloroacetate; fenuron-TCA	-	4482-55-7	Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1	H315 H400 H410	GHS07 GHS09 Achtg.	H315 H410
006-051-00-5	ferbam (ISO); iron tris(dimethyldithiocarbamate)	238-484-2	14484-64-1	Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1	H319 H335 H315 H400 H410	GHS07 GHS09 Achtg.	H319 H335 H315 H410
006-052-00-0	formetanate hydrochloride; 3-(N,N-dimethylaminomethyleneamino)phenylN-methylcarbamate	245-656-0	23422-53-9	Acute Tox. 2 * Acute Tox. 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H300 H317 H400 H410	GHS06 GHS09 Gef.	H330 H300 H317 H410
006-053-00-6	isoprocarb (ISO); 2-isopropylphenylN-methylcarbamate	220-114-6	2631-40-5	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
006-054-00-1	mexacarbate (ISO); 3,5-dimethyl-4-dimethylaminophenylN-methylcarbamate	206-249-3	315-18-4	Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H300 H312 H400 H410	GHS06 GHS09 Gef.	H300 H312 H410
006-055-00-7	xylylcarb (ISO); 3,4-dimethylphenyl N-methylcarbamate; 3,4-xylyl methylcarbamate; MPMC	219-364-9	2425-10-7	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
006-056-00-2	metolcarb (ISO); m-tolyl methylcarbamate; MTMC	214-446-0	1129-41-5	Acute Tox. 4 * Aquatic Chronic 2	H302 H411	GHS07 GHS09 Achtg.	H302 H411
006-057-00-8	nitrapyrin (ISO); 2-chloro-6-trichloromethylpyridine	217-682-2	1929-82-4	Acute Tox. 4 * Aquatic Chronic 2	H302 H411	GHS07 GHS09 Achtg.	H302 H411
006-058-00-3	noruron (ISO); 1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea	-	2163-79-3	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
006-059-00-9	oxamyl (ISO); N',N'-dimethylcarbamoyl(methylthio)methylenamineN-methylcarbamate;	245-445-3	23135-22-0	Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 4 * Aquatic Chronic 2	H330 H300 H312 H411	GHS06 GHS09 Gef.	H330 H300 H312 H411
006-060-00-4	oxycarboxin (ISO); 2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide	226-066-2	5259-88-1	Acute Tox. 4 * Aquatic Chronic 3	H302 H412	GHS07 Achtg.	H302 H412
006-061-00-X	S-ethylN-(dimethylaminopropyl)thiocarbamatehydrochloride; prothiocarb hydrochloride	243-193-9	19622-19-6	Acute Tox. 4 * Aquatic Chronic 2	H302 H411	GHS07 GHS09 Achtg.	H302 H411
006-062-00-5	methyl 3,4-dichlorophenylcarbanilate; SWEP.	-	1918-18-9	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
006-063-00-0	thiobencarb (ISO); S-4-chlorobenzyl diethylthiocarbamate	248-924-5	28249-77-6	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
006-064-00-6	thiofanox (ISO); 3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime	254-346-4	39196-18-4	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410
006-065-00-1	3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime; triamid	-	15271-41-7	Acute Tox. 2 * Acute Tox. 3 * Aquatic Chronic 2	H300 H311 H411	GHS06 GHS09 Gef.	H300 H311 H411
006-066-00-7	vernolate (ISO); S-propyl dipropylthiocarbamate	217-681-7	1929-77-7	Acute Tox. 4 * Aquatic Chronic 2	H302 H411	GHS07 GHS09 Achtg.	H302 H411
006-067-00-2	XMC; 3,5-xylyl methylcarbamate	-	2655-14-3	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
006-068-00-8	diazomethane	206-382-7	334-88-3	Carc. 1B	H350	GHS08 Gef.	H350
006-069-00-3	thiophanate-methyl (ISO); 1,2-di-(3-methoxycarbonyl-2-thioureido)benzene	245-740-7	23564-05-8	Muta. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H341 H332 H317 H400 H410	GHS08 GHS07 GHS09 Achtg.	H341 H332 H317 H410
006-070-00-9	furmecyclox (ISO); N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide	262-302-0	60568-05-0	Carc. 2 Aquatic Acute 1 Aquatic Chronic 1	H351 H400 H410	GHS08 GHS09 Achtg.	H351 H410
006-071-00-4	cyclooct-4-en-1-yl methyl carbonate	401-620-8	87731-18-8	Skin Sens. 1	H317	GHS07 Achtg.	H317
006-072-00-X	prosulfocarb (ISO); S-benzylN,N-dipropylthiocarbamate	401-730-6	52888-80-9	Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2	H302 H317 H411	GHS07 GHS09 Achtg.	H302 H317 H411
006-073-00-5	3-(dimethylamino)propylurea	401-950-2	31506-43-1	Eye Dam. 1	H318	GHS05 Gef.	H318
006-074-00-0	2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate	402-440-2	2094-99-7	Acute Tox. 2 * Skin Corr. 1B STOT RE 2 * Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H314 H373 ** H334 H317 H400 H410	GHS06 GHS08 GHS05 GHS09 Gef.	H330 H314 H373 ** H334 H317 H410
006-076-00-1	mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt	-	8018-01-7	Repr. 2 Skin Sens. 1 Aquatic Acute 1	H361d*** H317 H400	GHS08 GHS07 GHS09 Achtg.	H361d*** H317 H400		M=10
006-077-00-7	maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric)	235-654-8	12427-38-2	Repr. 2 Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H361d*** H332 H319 H317 H400 H410	GHS08 GHS07 GHS09 Achtg.	H361d*** H332 H319 H317 H410		M=10
006-078-00-2	zineb (ISO); zinc ethylenebis(dithiocarbamate) (polymeric)	235-180-1	12122-67-7	STOT SE 3 Skin Sens. 1	H335 H317	GHS07 Achtg.	H335 H317
006-079-00-8	disulfiram; tetraethylthiuramdisulfide	202-607-8	97-77-8	Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H373 ** H317 H400 H410	GHS08 GHS07 GHS09 Achtg.	H302 H373 ** H317 H410
006-080-00-3	tetramethylthiuram monosulphide	202-605-7	97-74-5	Acute Tox. 4 * Skin Sens. 1 Aquatic Chronic 2	H302 H317 H411	GHS07 GHS09 Achtg.	H302 H317 H411
006-081-00-9	zinc bis(dibutyldithiocarbamate)	205-232-8	136-23-2	Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H319 H335 H315 H317 H400 H410	GHS07 GHS09 Achtg.	H319 H335 H315 H317 H410
006-082-00-4	zinc bis(diethyldithiocarbamate)	238-270-9	14324-55-1	Acute Tox. 4 * Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H319 H335 H315 H317 H400 H410	GHS07 GHS09 Achtg.	H302 H319 H335 H315 H317 H410
006-083-00-X	butocarboxim (ISO); 3-(methylthio)-2-butanoneO-[(methylamino)carbonyl]oxime	252-139-3	34681-10-2	Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Eye Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1	H226 H331 H311 H301 H319 H400 H410	GHS02 GHS06 GHS09 Gef.	H226 H331 H311 H301 H319 H410
006-084-00-5	carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate	259-565-9	55285-14-8	Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H301 H317 H400 H410	GHS06 GHS09 Gef.	H330 H301 H317 H410
006-085-00-0	fenobucarb (ISO); 2-butylphenyl methylcarbamate	223-188-8	3766-81-2	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
006-086-00-6	fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate	276-696-7	72490-01-8	Carc. 2 Aquatic Acute 1 Aquatic Chronic 1	H351 H400 H410	GHS08 GHS09 Achtg.	H351 H410		M = 1 M = 10 000
006-087-00-1	furathiocarb (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate	265-974-3	65907-30-4	Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H301 H373** H319 H315 H317 H400 H410	GHS06 GHS08 GHS09 Gef.	H330 H301 H373** H319 H315 H317 H410		M = 100
006-088-00-7	benfuracarb (ISO); ethylN-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- ß-alaninate	-	82560-54-1	Repr. 2 Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H361f*** H331 H302 H400 H410	GHS06 GHS08 GHS09 Gef.	H361f*** H331 H302 H410
006-090-00-8	2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate	408-010-0	88558-41-2	Acute Tox. 4 * Eye Dam. 1 Aquatic Chronic 3	H332 H318 H412	GHS05 GHS07 Gef.	H332 H318 H412
006-091-00-3	propineb (ISO); polymeric zinc propylenebis(dithiocarbamate)	-	9016-72-2	Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1	H332 H373** H317 H400	GHS08 GHS07 GHS09 Achtg.	H332 H373** H317 H400
006-092-00-9	tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate	425-420-5	98737-29-2	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Achtg.	H410
006-093-00-4	2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)	427-180-7	-	Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H317 H400 H410	GHS07 GHS09 Achtg.	H302 H317 H410
006-094-00-X	O-isobutyl-N-ethoxy carbonylthiocarbamate	434-350-4	103122-66-3	Flam. Liq. 3 Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2	H226 H350 H340 H302 H373** H317 H411	GHS02 GHS08 GHS07 GHS09 Gef.	H226 H350 H340 H302 H373** H317 H411
006-095-00-5	fosetyl-aluminium (ISO); aluminium triethyl triphosphonate	254-320-2	39148-24-8	Eye Dam. 1	H318	GHS05 Gef.	H318
006-096-00-0	chlorpropham (ISO); isopropyl 3-chlorocarbanilate	202-925-7	101-21-3	Carc. 2 STOT RE 2 * Aquatic Chronic 2	H351 H373** H411	GHS08 GHS09 Achtg.	H351 H373** H411
006-097-00-6	1-phenyl-3-(p-toluenesulfonyl)urea	424-620-1	13909-63-2	Acute Tox. 4 * STOT RE 2 * Aquatic Chronic 3	H302 H373** H412	GHS08 GHS07 Achtg.	H302 H373** H412
006-098-00-1	tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate	429-170-8	134575-17-0	Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Skin Sens. 1	H302 H373** H318 H317	GHS05 GHS08 GHS07 Gef.	H302 H373** H318 H317
006-099-00-7	N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate	432-520-2	232938-43-1	Aquatic Chronic 2	H411	GHS09	H411
006-101-00-6	reaction mass of:N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea; N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]	423-070-8	-	Aquatic Chronic 4	H413	-	H413
006-102-00-1	O-hexyl-N-ethoxycarbonylthiocarbamate	432-750-3	-	Carc. 1B Muta. 1B Acute Tox. 4 * STOT RE 2 * Skin Sens. 1 Aquatic Chronic 2	H350 H340 H302 H373** H317 H411	GHS08 GHS07 GHS09 Gef.	H350 H340 H302 H373** H317 H411
006-103-00-7	N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea	445-760-8	-	Eye Dam. 1 Resp. Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H318 H334 H400 H410	GHS05 GHS08 GHS09 Gef.	H318 H334 H410		M=100
007-001-00-5	ammonia, anhydrous	231-635-3	7664-41-7	Flam. Gas 2 Press. Gas Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1	H221 H331 H314 H400	GHS04 GHS06 GHS05 GHS09 Gef.	H221 H331 H314 H400			U
007-001-01-2	ammonia ....%	215-647-6	1336-21-6	Skin Corr. 1B Aquatic Acute 1	H314 H400	GHS05 GHS09 Gef.	H314 H400		STOT SE 3; H335: C> 5 %	B
007-002-00-0	nitrogen dioxide; [1] dinitrogen tetraoxide [2]	233-272-6 [1] 234-126-4 [2]	10102-44-0 [1] 10544-72-6 [2]	Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1B	H270 H330 H314	GHS04 GHS03 GHS06 GHS05 Gef.	H270 H330 H314		* STOT SE 3; H335: C> 0,5 %	5
007-003-00-6	chlormequat chloride (ISO); 2-chloroethyltrimethylammonium chloride	213-666-4	999-81-5	Acute Tox. 4 * Acute Tox. 4 *	H312 H302	GHS07 Achtg.	H312 H302
007-004-00-1	Salpetersäure ... %	231-714-2	7697-37-2	Ox. Liq. 2 Skin Corr. 1A	H272 H314	GHS03 GHS05 Gef.	H272 H314	EUH071	Skin Corr. 1A; H314: C> 20 % Skin Corr. 1B; H314: 5 % ≤ C < 20 % Ox. Liq. 2; H272: C> 99 % Ox. Liq. 3; H272: 99 %> C> 65 %	B
007-006-00-2	ethyl nitrite	203-722-6	109-95-5	Flam. Gas 1 Press. Gas Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *	H220 H332 H312 H302	GHS02 GHS04 GHS07 Gef.	H220 H332 H312 H302			U
007-007-00-8	ethyl nitrate	210-903-3	625-58-1	Unst. Expl.	H200	GHS01 Gef.	H200
007-008-00-3	hydrazine	206-114-9	302-01-2	Flam. Liq. 3 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H226 H350 H331 H311 H301 H314 H317 H400 H410	GHS02 GHS06 GHS08 GHS05 GHS09 Gef.	H226 H350 H331 H311 H301 H314 H317 H410		Skin Corr. 1B; H314: C> 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % Eye Irrit. 2; H319: 3 % ≤ C < 10 %
007-009-00-9	dicyclohexylammonium nitrite	221-515-9	3129-91-7	Acute Tox. 4 * Acute Tox. 4 *	H332 H302	GHS07 Achtg.	H332 H302		*
007-010-00-4	sodium nitrite	231-555-9	7632-00-0	Ox. Sol. 3 Acute Tox. 3 * Aquatic Acute 1	H272 H301 H400	GHS03 GHS06 GHS09 Gef.	H272 H301 H400		*
007-011-00-X	potassium nitrite	231-832-4	7758-09-0	Ox. Sol. 2 Acute Tox. 3 * Aquatic Acute 1	H272 H301 H400	GHS03 GHS06 GHS09 Gef.	H272 H301 H400		*
007-012-00-5	N,N-dimethylhydrazine	200-316-0	57-14-7	Flam. Liq. 2 Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Skin Corr. 1B Aquatic Chronic 2	H225 H350 H331 H301 H314 H411	GHS02 GHS06 GHS08 GHS05 GHS09 Gef.	H225 H350 H331 H301 H314 H411
007-013-00-0	1,2-dimethylhydrazine	-	540-73-8	Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2	H350 H331 H311 H301 H411	GHS06 GHS08 GHS09 Gef.	H350 H331 H311 H301 H411		Carc. 1B; H350: C> 0.01 %
007-014-00-6	salts of hydrazine	-	-	Carc. 1B Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H350 H331 H311 H301 H317 H400 H410	GHS06 GHS08 GHS09 Gef.	H350 H331 H311 H301 H317 H410			A
007-015-00-1	O-ethylhydroxylamine	402-030-3	624-86-2	Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1	H225 H331 H311 H301 H372 ** H319 H317 H400	GHS02 GHS06 GHS08 GHS09 Gef.	H225 H331 H311 H301 H372 ** H319 H317 H400
007-016-00-7	butyl nitrite	208-862-1	544-16-1	Flam. Liq. 2 Acute Tox. 3 * Acute Tox. 3 *	H225 H331 H301	GHS02 GHS06 Gef.	H225 H331 H301
007-017-00-2	isobutyl nitrite	208-819-7	542-56-3	Flam. Liq. 2 Carc. 1B Muta. 2 Acute Tox. 4 * Acute Tox. 4 *	H225 H350 H341 H332 H302	GHS02 GHS08 GHS07 Gef.	H225 H350 H341 H332 H302
007-018-00-8	sec-butyl nitrite	213-104-8	924-43-6	Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 *	H225 H332 H302	GHS02 GHS07 Gef.	H225 H332 H302
007-019-00-3	tert-butyl nitrite	208-757-0	540-80-7	Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 *	H225 H332 H302	GHS02 GHS07 Gef.	H225 H332 H302
007-020-00-9	pentyl nitrite; [1] ’amyl nitrite’, mixed isomers [2]	207-332-7 [1] 203-770-8 [2]	463-04-7 [1] 110-46-3 [2]	Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 *	H225 H332 H302	GHS02 GHS07 Gef.	H225 H332 H302
007-021-00-4	hydrazobenzene; 1,2-diphenylhydrazine	204-563-5	122-66-7	Carc. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H350 H302 H400 H410	GHS08 GHS07 GHS09 Gef.	H350 H302 H410
007-022-00-X	hydrazine bis(3-carboxy-4-hydroxybenzensulfonate)	405-030-1	-	Carc. 1B Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 3	H350 H302 H314 H317 H412	GHS08 GHS05 GHS07 Gef.	H350 H302 H314 H317 H412
007-023-00-5	sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate	405-510-0	-	Skin Irrit. 2 Skin Sens. 1	H315 H317	GHS07 Achtg.	H315 H317
007-024-00-0	2-(decylthio)ethylammonium chloride	405-640-8	36362-09-1	STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1	H373 ** H315 H318 H400 H410	GHS08 GHS05 GHS09 Gef.	H373 ** H315 H318 H410
007-025-00-6	(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride	406-090-1	81880-96-8	Muta. 2 Acute Tox. 3 * STOT RE 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H341 H301 H372 ** H317 H400 H410	GHS06 GHS08 GHS09 Gef.	H341 H301 H372 ** H317 H410
007-026-00-1	oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide	413-230-5	122035-71-6	Eye Dam. 1 Skin Sens. 1	H318 H317	GHS05 GHS07 Gef.	H318 H317
007-027-00-7	1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane	420-190-2	771478-66-1	Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H312 H302 H373 ** H314 H317 H400 H410	GHS08 GHS05 GHS07 GHS09 Gef.	H312 H302 H373 ** H314 H317 H410
007-028-00-2	hydroxylammonium nitrate	236-691-2	13465-08-2	Expl. 1.1 **** Carc. 2 Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1	H201 H351 H311 H302 H373** H319 H315 H317 H400	GHS01 GHS06 GHS08 GHS09 Gef.	H201 H351 H311 H302 H373** H319 H315 H317 H400
007-029-00-8	diethyldimethylammonium hydroxide	419-400-5	95500-19-9	Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A	H312 H302 H314	GHS05 GHS07 Gef.	H312 H302 H314
008-001-00-8	oxygen	231-956-9	7782-44-7	Ox. Gas 1 Press. Gas	H270	GHS03 GHS04 Gef.	H270			U
008-003-00-9	hydrogen peroxide solution ... %	231-765-0	7722-84-1	Ox. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A	H271 H332 H302 H314	GHS03 GHS05 GHS07 Gef.	H271 H332 H302 H314		Ox. Liq. 1; H271: C> 70 %^** Ox. Liq. 2; H272: 50 % ≤ C < 70 %^** * Skin Corr. 1A; H314: C> 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % Skin Irrit. 2; H315: 35 % ≤ C < 50 % Eye Dam. 1; H318: 8 % ≤ C < 50 % Eye Irrit. 2; H319: 5 % ≤ C < 8 % STOT SE 3; H335; C> 35 %	B
009-001-00-0	fluorine	231-954-8	7782-41-4	Press. Gas Ox. Gas 1 Acute Tox. 2 * Skin Corr. 1A	H270 H330 H314	GHS04 GHS03 GHS06 GHS05 Gef.	H270 H330 H314
009-002-00-6	hydrogen fluoride	231-634-8	7664-39-3	Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A	H330 H310 H300 H314	GHS06 GHS05 Gef.	H330 H310 H300 H314
009-003-00-1	hydrofluoric acid ... %	231-634-8	7664-39-3	Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Skin Corr. 1A	H330 H310 H300 H314	GHS06 GHS05 Gef.	H330 H310 H300 H314		Skin Corr. 1A; H314: C> 7 % Skin Corr. 1B; H314: 1 % ≤ C < 7 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %	B
009-004-00-7	sodium fluoride	231-667-8	7681-49-4	Acute Tox. 3 * Eye Irrit. 2 Skin Irrit. 2	H301 H319 H315	GHS06 Gef.	H301 H319 H315	EUH032
009-005-00-2	potassium fluoride	232-151-5	7789-23-3	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *	H331 H311 H301	GHS06 Gef.	H331 H311 H301
009-006-00-8	ammonium fluoride	235-185-9	12125-01-8	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *	H331 H311 H301	GHS06 Gef.	H331 H311 H301
009-007-00-3	sodium bifluoride; sodium hydrogen difluoride	215-608-3	1333-83-1	Acute Tox. 3 * Skin Corr. 1B	H301 H314	GHS06 GHS05 Gef.	H301 H314		* Skin Corr. 1B; H314: C> 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-008-00-9	potassium bifluoride; potassium hydrogen difluoride	232-156-2	7789-29-9	Acute Tox. 3 * Skin Corr. 1B	H301 H314	GHS06 GHS05 Gef.	H301 H314		* Skin Corr. 1B; H314: C> 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-009-00-4	ammonium bifluoride; ammonium hydrogen difluoride	215-676-4	1341-49-7	Acute Tox. 3 * Skin Corr. 1B	H301 H314	GHS06 GHS05 Gef.	H301 H314		* Skin Corr. 1B; H314: C> 1 % Skin Irrit. 2; H315: 0,1 % ≤ C < 1 % Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-010-00-X	fluoroboric acid ... %	240-898-3	16872-11-0	Skin Corr. 1B	H314	GHS05 Gef.	H314		Skin Corr. 1B; H314: C> 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 %	B
009-011-00-5	fluorosilicic acid ... %	241-034-8	16961-83-4	Skin Corr. 1B	H314	GHS05 Gef.	H314			B
009-012-00-0	alkali fluorosilicates(Na); [1] alkali fluorosilicates(K); [2] alkali fluorosilicates(NH4) [3]	240-934-8 [1] 240-896-2 [2] 240-968-3 [3]	16893-85-9 [1] 16871-90-2 [2] 16919-19-0 [3]	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *	H331 H311 H301	GHS06 Gef.	H331 H311 H301		*	A
009-013-00-6	fluorosilicates, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 4 *	H302	GHS07 Achtg.	H302		*	A
009-014-00-1	lead hexafluorosilicate	247-278-1	25808-74-6	Repr. 1a Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1	H360Df H332 H302 H373 ** H400 H410	GHS08 GHS07 GHS09 Gef.	H360Df H332 H302 H373 ** H410			1
009-015-00-7	sulphuryl difluoride	220-281-5	2699-79-8	Press. Gas Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1	H331 H373 ** H400	GHS04 GHS06 GHS08 GHS09 Gef.	H331 H373 ** H400			U
009-016-00-2	trisodium hexafluoroaluminate [1]	237-410-6 [1]	13775-53-6 [1]	STOT RE 1 Acute Tox. 4 Aquatic Chronic 2	H372 H332 H411	GHS07 GHS08 GHS09 Gef.	H372 H332 H411
trisodium hexafluoroaluminate (cryolite) [2]	239-148-8 [2]	15096-52-3 [2]
009-017-00-8	potassium mu-fluoro-bis(triethylaluminium)	400-040-2	12091-08-6	Flam. Sol. 1 Water-react. 1 Skin Corr. 1a Acute Tox. 4 *	H228 H270 H314 H332	GHS02 GHS05 GHS07 Gef.	H228 H270 H314 H332	EUH014		T
009-018-00-3	magnesium hexafluorosilicate	241-022-2	16949-65-8	Acute Tox. 3 *	H301	GHS06 Gef.	H301		*
011-001-00-0	sodium	231-132-9	7440-23-5	Water-react. 1 Skin Corr. 1B	H260 H314	GHS02 GHS05 Gef.	H260 H314	EUH014
011-002-00-6	sodium hydroxide; caustic soda	215-185-5	1310-73-2	Skin Corr. 1A	H314	GHS05 Gef.	H314		Skin Corr. 1A; H314: C> 5 % Skin Corr. 1B; H314: 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5 % ≤ C < 2 % Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
011-003-00-1	sodium peroxide	215-209-4	1313-60-6	Ox. Sol. 1 Skin Corr. 1A	H271 H314	GHS03 GHS05 Gef.	H271 H314
011-004-00-7	sodium azide	247-852-1	26628-22-8	Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H300 H400 H410	GHS06 GHS09 Gef.	H300 H400 H410	EUH032
011-005-00-2	sodium carbonate	207-838-8	497-19-8	Eye Irrit. 2	H319	GHS07 Achtg.	H319
011-006-00-8	sodium cyanate	213-030-6	917-61-3	Acute Tox. 4 * Aquatic Chronic 3	H302 H412	GHS07 Achtg.	H302 H412
011-007-00-3	propoxycarbazone-sodium	-	181274-15-7	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Achtg.	H410		M=10
012-001-00-3	magnesium powder (pyrophoric)	231-104-6	7439-95-4	Water-react. 1 Pyr. Sol. 1	H260 H250	GHS02 Gef.	H260 H250			T
012-002-00-9	magnesium, powder or turnings	231-104-6	-	Flam. Sol. 1 Water-react. 2 Self-heat. 1	H228 H261 H252	GHS02 Gef.	H228 H261 H252			T
012-003-00-4	magnesium alkyls	-	-	Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B	H250 H260 H314	GHS02 GHS05 Gef.	H250 H260 H314	EUH014		A
012-004-00-X	aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate	422-150-1	-	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Achtg.	H410
013-001-00-6	aluminium powder (pyrophoric)	231-072-3	7429-90-5	Water-react. 2 Pyr. Sol. 1	H261 H250	GHS02 Gef.	H261 H250			T
013-002-00-1	aluminium powder (stabilised)	231-072-3	7429-90-5	Water-react. 2 Flam. Sol. 1	H261 H228	GHS02 Gef.	H261 H228			T
013-003-00-7	aluminium chloride, anhydrous	231-208-1	7446-70-0	Skin Corr. 1B	H314	GHS05 Gef.	H314
013-004-00-2	aluminium alkyls	-	-	Pyr. Liq. 1 Water-react. 1 Skin Corr. 1B	H250 H260 H314	GHS02 GHS05 Gef.	H250 H260 H314	EUH014		A
013-005-00-8	diethyl(ethyldimethylsilanolato)aluminium	401-160-8	55426-95-4	Water-react. 1 Pyr. Liq. 1 Skin Corr. 1A	H260 H250 H314	GHS02 GHS05 Gef.	H260 H250 H314	EUH014
013-006-00-3	(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised	402-370-2	-	Flam. Liq. 3 Eye Dam. 1	H226 H318	GHS02 GHS05 Gef.	H226 H318
013-007-00-9	poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)	403-430-0	-	Eye Dam. 1	H318	GHS05 Gef.	H318
013-008-00-4	di-n-octylaluminium iodide	408-190-0	7585-14-0	Pyr. Liq. 1 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1	H250 H314 H400 H410	GHS02 GHS05 GHS09 Gef.	H250 H314 H410	EUH014
013-009-00-X	sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0.5 y = 1.5	418-720-2	-	Flam. Sol. 1 Water-react. 1 Pyr. Sol. 1 Acute Tox. 4 * Skin Corr. 1A	H228 H260 H250 H332 H314	GHS02 GHS05 GHS07 Gef.	H228 H260 H250 H332 H314	EUH014		T
013-010-00-5	hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)	430-650-4	151841-65-5	Aquatic Chronic 2	H411	GHS09	H411
014-001-00-9	trichlorosilane	233-042-5	10025-78-2	Flam. Liq. 1 Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A	H224 H250 H332 H302 H314	GHS02 GHS05 GHS07 Gef.	H224 H250 H332 H302 H314	EUH014 EUH029	* STOT SE 3; H335: C> 1 %	T
014-002-00-4	silicon tetrachloride	233-054-0	10026-04-7	Eye Irrit. 2 STOT SE 3 Skin Irrit. 2	H319 H335 H315	GHS07 Achtg.	H319 H335 H315	EUH014
014-003-00-X	dimethyldichlorosilane	200-901-0	75-78-5	Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2	H225 H319 H335 H315	GHS02 GHS07 Gef.	H225 H319 H335 H315
014-004-00-5	trichloro(methyl)silane; methyltrichlorosilane	200-902-6	75-79-6	Flam. Liq. 2 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2	H225 H319 H335 H315	GHS02 GHS07 Gef.	H225 H319 H335 H315	EUH014	Skin Irrit. 2; H315: C> 1 % Eye Irrit. 2; H319: C> 1 % STOT SE 3; H335: C> 1 %
014-005-00-0	tetraethyl silicate; ethyl silicate	201-083-8	78-10-4	Flam. Liq. 3 Acute Tox. 4 * Eye Irrit. 2 STOT SE 3	H226 H332 H319 H335	GHS02 GHS07 Achtg.	H226 H332 H319 H335
014-006-00-6	bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride	401-380-4	-	Eye Irrit. 2 Aquatic Chronic 2	H319 H411	GHS07 GHS09 Achtg.	H319 H411
014-007-00-1	triethoxyisobutylsilane	402-810-3	17980-47-1	Skin Irrit. 2	H315	GHS07 Achtg.	H315
014-008-00-7	(chloromethyl)bis(4-fluorophenyl)methylsilane	401-200-4	85491-26-5	Aquatic Chronic 2	H411	GHS09	H411
014-009-00-2	isobutylisopropyldimethoxysilane	402-580-4	111439-76-0	Flam. Liq. 3 Acute Tox. 4 * Skin Irrit. 2	H226 H332 H315	GHS02 GHS07 Achtg.	H226 H332 H315
014-010-00-8	disodium metasilicate	229-912-9	6834-92-0	Skin Corr. 1B STOT SE 3	H314 H335	GHS05 GHS07 Gef.	H314 H335
014-011-00-3	cyclohexyldimethoxymethylsilane	402-140-1	17865-32-6	Skin Irrit. 2 Aquatic Chronic 2	H315 H411	GHS07 GHS09 Achtg.	H315 H411
014-012-00-9	bis(3-(trimethoxysilyl)propyl)amine	403-480-3	-	Eye Dam. 1 Aquatic Chronic 2	H318 H411	GHS05 GHS09 Gef.	H318 H411
014-013-00-4	a-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)	404-920-7	-	Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2	H312 H302 H314 H411	GHS05 GHS07 GHS09 Gef.	H312 H302 H314 H411
014-014-00-X	etacelasil (ISO); 6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane	253-704-7	37894-46-5	Repr. 1B Acute Tox. 4 * STOT RE 2 *	H360D * H302 H373	GHS08 GHS07 Gef.	H360D * H302 H373
014-015-00-5	a-trimethylsilanyl-?-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane))	406-420-4	69430-40-6	Aquatic Chronic 4	H413	-	H413
014-016-00-0	reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane; 1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane	406-490-6	-	Aquatic Chronic 2	H411	GHS09	H411
014-017-00-6	flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H - 1,2,4-triazol-1-ylmethyl)silane	-	85509-19-9	Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2	H351 H360D *** H302 H411	GHS08 GHS07 GHS09 Gef.	H351 H360D *** H302 H411
014-018-00-1	octamethylcyclotetrasiloxane	209-136-7	556-67-2	Repr. 2 Aquatic Chronic 4	H361f *** H413	GHS08 Achtg.	H361f *** H413
014-019-00-7	reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H - 1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H - 1,2,4-triazole	403-250-2	-	Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2	H351 H360D *** H302 H411	GHS08 GHS07 GHS09 Gef.	H351 H360D *** H302 H411
014-020-00-2	bis(1,1-dimethyl-2-propynyloxy)dimethylsilane	414-960-7	53863-99-3	Acute Tox. 4 *	H332	GHS07 Achtg.	H332
014-021-00-8	tris(isopropenyloxy)phenyl silane	411-340-8	52301-18-5	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Achtg.	H400 H410
014-022-00-3	reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)	401-530-9	-	Flam. Sol. 1 STOT SE 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *	H228 H370 ** H332 H312 H302	GHS02 GHS08 GHS07 Gef.	H228 H370 ** H332 H312 H302			T
014-023-00-9	a, ?-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole	408-160-7	125613-45-8	Aquatic Chronic 2	H411	GHS09	H411
014-024-00-4	1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene	412-620-2	121626-74-2	Aquatic Chronic 2	H411	GHS09	H411
014-025-00-X	4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine	411-400-3	102089-33-8	Acute Tox. 4 * STOT RE 2 * Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3	H302 H373 ** H315 H318 H412	GHS08 GHS05 GHS07 Gef.	H302 H373 ** H315 H318 H412
014-026-00-5	dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane	407-180-3	770722-36-6	Skin Corr. 1A	H314	GHS05 Gef.	H314
014-027-00-0	chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane	410-270-5	770722-46-8	Skin Corr. 1A	H314	GHS05 Gef.	H314
014-028-00-6	a-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-?-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)	415-290-8	193159-06-7	Skin Sens. 1	H317	GHS07 Achtg.	H317
014-029-00-1	O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]	421-870-1	156145-66-3	Repr. 2 Acute Tox. 4 * STOT RE 2 *	H361f * H302 H373	GHS08 GHS07 Achtg.	H361f * H302 H373
014-030-00-7	[(dimethylsilylene)bis((1,2,3,3a,7a-?)-1H-inden-1-ylidene)dimethyl]hafnium	422-060-0	137390-08-0	Acute Tox. 2 *	H300	GHS06 Gef.	H300
014-031-00-2	bis(1-methylethyl)-dimethoxysilane	421-540-7	18230-61-0	Flam. Liq. 3 Skin Irrit. 2 Skin Sens. 1 Aquatic Chronic 3	H226 H315 H317 H412	GHS02 GHS07 Achtg.	H226 H315 H317 H412
014-032-00-8	dicyclopentyldimethoxysilane	404-370-8	126990-35-0	Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1	H315 H318 H400 H410	GHS05 GHS09 Gef.	H315 H318 H410
014-033-00-3	2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica	419-030-4	125804-20-8	Flam. Liq. 2 Eye Irrit. 2 STOT SE 3	H225 H319 H336	GHS02 GHS07 Gef.	H225 H319 H336
014-034-00-9	3-hexylheptamethyltrisiloxane	428-700-5	1873-90-1	Acute Tox. 4 * Aquatic Chronic 4	H332 H413	GHS07 Achtg.	H332 H413
014-035-00-4	2-(3,4-epoxycyclohexyl)ethyltriethoxy silane	425-050-4	10217-34-2	Skin Sens. 1 Aquatic Chronic 3	H317 H412	GHS07 Achtg.	H317 H412
014-036-00-X	(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane	405-020-7	105024-66-6	Repr. 1B Aquatic Acute 1 Aquatic Chronic 1	H360F*** H400 H410	GHS08 GHS09 Gef.	H360F*** H410		M=1000
014-037-00-5	2-butanone-O,O',O''-(phenylsilylidyne)trioxime	433-360-6	34036-80-1	STOT RE 2 * Skin Sens. 1 Aquatic Chronic 3	H373** H317 H412	GHS08 GHS07 Achtg.	H373** H317 H412
014-038-00-0	S-(3-(triethoxysilyl)propyl) octanethioate	436-690-9	220727-26-4	Skin Sens. 1	H317	GHS07 Achtg.	H317
014-039-00-6	(2,3-dimethylbut-2-yl)-trimethoxysilane	439-360-2	142877-45-0	Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3	H315 H318 H412	GHS05 Gef.	H315 H318 H412
014-041-00-7	N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane	445-890-5	201290-01-9	Acute Tox. 4 * Skin Sens. 1	H302 H317	GHS07 Achtg.	H302 H317
014-042-00-2	reaction mass of:O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)	423-010-0	-	Eye Dam. 1	H318	GHS05 Gef.	H318
014-043-00-8	reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)	432-200-2	-	STOT SE 3 Skin Irrit. 2 Eye Dam. 1 Aquatic Chronic 3	H335 H315 H318 H412	GHS05 GHS07 Gef.	H335 H315 H318 H412
014-044-00-3	3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane	433-050-0	-	Aquatic Chronic 2	H411	GHS09	H411
014-045-00-9	magnesium sodium fluoride silicate	442-650-1	-	STOT RE 2 *	H373**	GHS08 Achtg.	H373**
014-046-00-4	E-Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender repräsentativer Zusammensetzung (Angabe in % Massenanteil): SiO₂ 50,0-56,0 %, Al₂O₃ 13,0-16,0 %, B₂O₃ 5,8-10,0 %, Na₂O < 0,6 %, K₂O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe₂O₃ < 0,5 %, F₂ < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).]	-	-	Carc. 1B	H350i	GHS08 Gef.	H350i			A
014-047-00-X	Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender Zusammensetzung (Angabe in % Massenanteil): SiO₂ 55,0-60,0 %, Al₂O₃ 4,0-7,0 %, B₂O₃ 8,0-11,0 %, ZrO₂ 0,0-4,0 %, Na₂O 9,5-13,5 %, K₂O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe₂O₃ < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F₂ < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).]	-	-	Carc. 2	H351 (Einatmen)	GHS08 Achtg.	H351 (Einatmen)			A
015-001-00-1	white phosphorus	231-768-7	12185-10-3	Pyr. Sol. 1 Acute Tox. 2 * Acute Tox. 2 * Skin Corr. 1a Aquatic Acute 1	H250 H330 H300 H314 H400	GHS02 GHS06 GHS05 GHS09 Gef.	H250 H330 H300 H314 H400
015-002-00-7	red phosphorus	231-768-7	7723-14-0	Flam. Sol. 1 Aquatic Chronic 3	H228 H412	GHS02 Gef.	H228 H412
015-003-00-2	Calciumphosphid; Tricalciumdiphosphid	215-142-0	1305-99-3	Water-react. 1 Acute Tox. 2 Acute Tox. 3 Acute Tox. 1 Eye Dam. 1 Aquatic Acute 1	H260 H300 H311 H330 H318 H400	GHS02 GHS06 GHS05 GHS09 Gef.	H260 H300 H311 H330 H318 H400	EUH029 EUH032	M = 100
015-004-00-8	aluminium phosphide	244-088-0	20859-73-8	Water-react. 1	H260	GHS02	H260	EUH029	M = 100
Acute Tox. 2	H300	GHS06	H300	EUH032
Acute Tox. 3	H311	GHS09	H311
Acute Tox. 1	H330	Gef.	H330
Aquatic Acute 1	H400		H400
015-005-00-3	magnesium phosphide; trimagnesium diphosphide	235-023-7	12057-74-8	Water-react. 1	H260	GHS02	H260	EUH029	M = 100
Acute Tox. 2	H300	GHS06	H300	EUH032
Acute Tox. 3	H311	GHS09	H311
Acute Tox. 1	H330	Gef.	H330
Aquatic Acute 1	H400		H400
015-006-00-9	trizinc diphosphide; zinc phosphide	215-244-5	1314-84-7	Water-react. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H260 H300 H400 H410	GHS02 GHS06 GHS09 Gef.	H260 H300 H410	EUH029 EUH032	M=100	T
015-007-00-4	phosphorus trichloride	231-749-3	7719-12-2	Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Skin Corr. 1A	H330 H300 H373 ** H314	GHS06 GHS08 GHS05 Gef.	H330 H300 H373 ** H314	EUH014 EUH029
015-008-00-X	phosphorus pentachloride	233-060-3	10026-13-8	Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B	H330 H302 H373 ** H314	GHS06 GHS08 GHS05 Gef.	H330 H302 H373 ** H314	EUH014 EUH029
015-009-00-5	phosphoryl trichloride	233-046-7	10025-87-3	Acute Tox. 2 * STOT RE 1 Acute Tox. 4 * Skin Corr. 1A	H330 H372 ** H302 H314	GHS06 GHS08 GHS05 Gef.	H330 H372 ** H302 H314	EUH014 EUH029
015-010-00-0	phosphorus pentoxide	215-236-1	1314-56-3	Skin Corr. 1A	H314	GHS05 Gef.	H314
015-011-00-6	phosphoric acid ... %, orthophosphoric acid ... %	231-633-2	7664-38-2	Skin Corr. 1B	H314	GHS05 Gef.	H314		Skin Corr. 1B; H314: C> 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 %	B
015-012-00-1	tetraphosphorus trisulphide; phosphorus sesquisulphid	215-245-0	1314-85-8	Flam. Sol. 2 Water-react. 1 Acute Tox. 4 * Aquatic Acute 1	H228 H260 H302 H400	GHS02 GHS07 GHS09 Gef.	H228 H260 H302 H400			T
015-013-00-7	triethyl phosphate	201-114-5	78-40-0	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
015-014-00-2	tributyl phosphate	204-800-2	126-73-8	Carc. 2 Acute Tox. 4 * Skin Irrit. 2	H351 H302 H315	GHS08 GHS07 Achtg.	H351 H302 H315
015-015-00-8	tricresyl phosphate (o -o -o-,o -o -m-,o -o -p-,o -m -m-,o -m -p-,o -p -p-); tritolyl phosphate (o -o -o-,o -o -m-,o -o -p-,o -m -m-,o -m -p-,o -p -p-);	201-103-5	78-30-8	STOT SE 1 Aquatic Chronic 2	H370 ** H411	GHS08 GHS09 Gef.	H370 ** H411		STOT SE 1; H370: C> 1 % STOT SE 2; H371: 0,2 % ≤ C < 1 %	C
015-016-00-3	tricresyl phosphate (m -m -m-,m -m -p-,m -p -p-,p -p -p-); tritolyl phosphate (m -m -m-,m -m -p-,m -p -p-,p -p -p-);	201-105-6	78-32-0	Acute Tox. 4 * Acute Tox. 4 * Aquatic Chronic 2	H312 H302 H411	GHS07 GHS09 Achtg.	H312 H302 H411		*	C
015-019-00-X	dichlorvos (ISO); 2,2-dichlorovinyl dimethyl phosphate	200-547-7	62-73-7	Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1	H330 H311 H301 H317 H400	GHS06 GHS09 Gef.	H330 H311 H301 H317 H400		M=1000
015-020-00-5	mevinphos (ISO); 2-methoxycarbonyl-1-methylvinyl dimethyl phosphate	232-095-1	7786-34-7	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410		M=10000
015-021-00-0	trichlorfon (ISO); dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate	200-149-3	52-68-6	Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H317 H400 H410	GHS07 GHS09 Achtg.	H302 H317 H400 H410		M=1000
015-022-00-6	phosphamidon (ISO); 2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate	236-116-5	13171-21-6	Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H341 H300 H311 H400 H410	GHS06 GHS08 GHS09 Gef.	H341 H300 H311 H410
015-023-00-1	pyrazoxon; diethyl 3-methylpyrazol-5-yl phosphate	-	108-34-9	Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 *	H330 H310 H300	GHS06 Gef.	H330 H310 H300
015-024-00-7	triamiphos (ISO); 5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide	-	1031-47-6	Acute Tox. 1 Acute Tox. 2 *	H310 H300	GHS06 Gef.	H310 H300
015-025-00-2	TEPP (ISO); tetraethyl pyrophosphate	203-495-3	107-49-3	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1	H310 H300 H400	GHS06 GHS09 Gef.	H310 H300 H400
015-026-00-8	schradan (ISO); octamethylpyrophosphoramide	205-801-0	152-16-9	Acute Tox. 1 Acute Tox. 2 *	H310 H300	GHS06 Gef.	H310 H300
015-027-00-3	sulfotep (ISO); O,O,O,O-tetraethyl dithiopyrophosphate	222-995-2	3689-24-5	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410		M=1000
015-028-00-9	demeton-O (ISO); O,O-diethyl-O-2-ethylthioethyl phosphorothioate	206-053-8	298-03-3	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1	H310 H300 H400	GHS06 GHS09 Gef.	H310 H300 H400
015-029-00-4	demeton-S (ISO); diethyl-S-2-ethylthioethyl phosphorothioate	204-801-8	126-75-0	Acute Tox. 1 Acute Tox. 2 *	H310 H300	GHS06 Gef.	H310 H300
015-030-00-X	demeton-O-methyl (ISO); O-2-ethylthioethylO,O-dimethyl phosphorothioate	212-758-1	867-27-6	Acute Tox. 3 *	H301	GHS06 Gef.	H301
015-031-00-5	demeton-S-methyl (ISO); S-2-ethylthioethyl dimethyl phosphorothioate	213-052-6	919-86-8	Acute Tox. 3 * Acute Tox. 3 * Aquatic Chronic 2	H311 H301 H411	GHS06 GHS09 Gef.	H311 H301 H411
015-032-00-0	prothoate (ISO); O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate	218-893-2	2275-18-5	Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 3	H310 H300 H412	GHS06 Gef.	H310 H300 H412
015-033-00-6	phorate (ISO); O,O-diethyl ethylthiomethyl phosphorodithioate	206-052-2	298-02-2	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410		M=1000
015-034-00-1	parathion (ISO); O,O-diethylO-4-nitrophenyl phosphorothioate	200-271-7	56-38-2	Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H300 H311 H372 ** H400 H410	GHS06 GHS08 GHS09 Gef.	H330 H300 H311 H372 ** H410		M=100
015-035-00-7	parathion - methyl (ISO); O,O-dimethylO-4-nitrophenyl phosphorothioate	206-050-1	298-00-0	Flam. Liq. 3 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1	H226 H330 H300 H311 H373 ** H400 H410	GHS02 GHS06 GHS08 GHS09 Gef.	H226 H330 H300 H311 H373 ** H410		M=100
015-036-00-2	O-ethylO-4-nitrophenyl phenylphosphonothioate; EPN	218-276-8	2104-64-5	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410
015-037-00-8	phenkapton (ISO); S-(2,5-dichlorophenylthiomethyl)O,O-diethyl phosphorodithioate	218-892-7	2275-14-1	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H331 H311 H301 H400 H410	GHS06 GHS09 Gef.	H331 H311 H301 H410
015-038-00-3	coumaphos (ISO); O-3-chloro-4-methylcoumarin-7-ylO,O-diethyl phosphorothioate	200-285-3	56-72-4	Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H300 H312 H400 H410	GHS06 GHS09 Gef.	H300 H312 H410
015-039-00-9	azinphos-methyl (ISO); O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate	201-676-1	86-50-0	Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H300 H311 H317 H400 H410	GHS06 GHS09 Gef.	H330 H300 H311 H317 H410
015-040-00-4	diazinon (ISO); O,O-diethylO-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate	206-373-8	333-41-5	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H400 H410
015-041-00-X	malathion (ISO); 1,2-bis(ethoxycarbonyl)ethylO,O-dimethyl phosphorodithioate; [containing ≤ 0,03 % isomalathion]	204-497-7	121-75-5	Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H317 H400 H410	GHS07 GHS09 Achtg.	H302 H317 H410		M=1000
015-042-00-5	chlorthion O-(3-chloro-4-nitrophenyl)O,O-dimethyl phosphorothioate	207-902-5	500-28-7	Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H332 H312 H302 H400 H410	GHS07 GHS09 Achtg.	H332 H312 H302 H410		M=100
015-043-00-0	phosnichlor (ISO); O-4-chloro-3-nitrophenylO,O-dimethyl phosphorothioate	-	5826-76-6	Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 *	H332 H312 H302	GHS07 Achtg.	H332 H312 H302
015-044-00-6	carbophenothion (ISO); 4-chlorophenylthiomethylO,O-diethyl phosphorodithioate	212-324-1	786-19-6	Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H311 H301 H400 H410	GHS06 GHS09 Gef.	H311 H301 H410
015-045-00-1	mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethylO,O-diethyl phosphorodithioate	219-993-9	2595-54-2	Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H311 H301 H400 H410	GHS06 GHS09 Gef.	H311 H301 H400 H410
015-046-00-7	oxydemeton-methyl; S-2-(ethylsulphinyl)ethylO,O-dimethyl phosphorothioate	206-110-7	301-12-2	Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1	H311 H301 H400	GHS06 GHS09 Gef.	H311 H301 H400
015-047-00-2	ethion (ISO); O,O,O',O'-tetraethylS,S'-methylenedi (phosphorodithioate); diethion	209-242-3	563-12-2	Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H301 H312 H400 H410	GHS06 GHS09 Gef.	H301 H312 H410		M=10000
015-048-00-8	fenthion (ISO); O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate	200-231-9	55-38-9	Muta. 2 Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1	H341 H331 H312 H302 H372** H400 H410	GHS06 GHS08 GHS09 Gef.	H341 H331 H312 H302 H372** H410		M=100
015-049-00-3	endothion (ISO); S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate	220-472-3	2778-04-3	Acute Tox. 3 * Acute Tox. 3 *	H311 H301	GHS06 Gef.	H311 H301
015-050-00-9	thiometon (ISO); S-2-ethylthioethylO,O-dimethyl phosphorodithioate	211-362-6	640-15-3	Acute Tox. 3 * Acute Tox. 4 *	H301 H312	GHS06 Gef.	H301 H312
015-051-00-4	dimethoate (ISO); O,O-dimethyl methylcarbamoylmethyl phosphorodithioate	200-480-3	60-51-5	Acute Tox. 4 * Acute Tox. 4 *	H312 H302	GHS07 Achtg.	H312 H302
015-052-00-X	fenchlorphos (ISO); O,O-dimethylO - 2,4,5-trichlorophenyl phosphorothioate	206-082-6	299-84-3	Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H312 H302 H400 H410	GHS07 GHS09 Achtg.	H312 H302 H410
015-053-00-5	menazon (ISO); S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate	201-123-4	78-57-9	Acute Tox. 4 * Aquatic Chronic 3	H302 H412	GHS07 Achtg.	H302 H412
015-054-00-0	fenitrothion (ISO); O,O-dimethylO-4-nitro-m-tolyl phosphorothioate	204-524-2	122-14-5	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
015-055-00-6	naled (ISO); 1,2-dibromo-2,2-dichloroethyl dimethyl phosphate	206-098-3	300-76-5	Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1	H312 H302 H319 H315 H400	GHS07 GHS09 Achtg.	H312 H302 H319 H315 H400		M=1000
015-056-00-1	azinphos-ethyl (ISO); O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate	220-147-6	2642-71-9	Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H300 H311 H400 H410	GHS06 GHS09 Gef.	H300 H311 H410		M=100
015-057-00-7	formothion (ISO); N-formyl-N-methylcarbamoylmethylO,O-dimethyl phosphorodithioate	219-818-6	2540-82-1	Acute Tox. 4 * Acute Tox. 4 *	H312 H302	GHS07 Achtg.	H312 H302
015-058-00-2	morphothion (ISO); O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate	205-628-0	144-41-2	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H331 H311 H301 H400 H410	GHS06 GHS09 Gef.	H331 H311 H301 H410
015-059-00-8	vamidothion (ISO); O,O-dimethylS-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate	218-894-8	2275-23-2	Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1	H301 H312 H400	GHS06 GHS09 Gef.	H301 H312 H400
015-060-00-3	disulfoton (ISO); O,O-diethyl 2-ethylthioethyl phosphorodithioate	206-054-3	298-04-4	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410
015-061-00-9	dimefox (ISO); tetramethylphosphorodiamidic fluoride	204-076-8	115-26-4	Acute Tox. 1 Acute Tox. 2 *	H310 H300	GHS06 Gef.	H310 H300
015-062-00-4	mipafox (ISO); N,N'- di-isopropylphosphorodiamidic fluoride	206-742-3	371-86-8	STOT SE 1	H370 **	GHS08 Gef.	H370 **
015-063-00-X	dioxathion (ISO); 1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)	201-107-7	78-34-2	Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H330 H300 H311 H400 H410	GHS06 GHS09 Gef.	H330 H300 H311 H410		M=1000
015-064-00-5	bromophos-ethyl (ISO); O-4-bromo-2,5-dichlorophenylO,O-diethyl phosphorothioate	225-399-0	4824-78-6	Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H301 H312 H400 H410	GHS06 GHS09 Gef.	H301 H312 H410
015-065-00-0	S-[2-(ethylsulphinyl)ethyl]O,O-dimethyl phosphorodithioate	-	2703-37-9	Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2	H330 H310 H300 H411	GHS06 GHS09 Gef.	H330 H310 H300 H411
015-066-00-6	omethoate (ISO); O,O-dimethylS-methylcarbamoylmethyl phosphorothioate	214-197-8	1113-02-6	Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1	H301 H312 H400	GHS06 GHS09 Gef.	H301 H312 H400
015-067-00-1	phosalone (ISO); S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl)O,O-diethyl phosphorodithioate	218-996-2	2310-17-0	Acute Tox. 3 * Acute Tox. 4 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H301 H332 H312 H317 H400 H410	GHS06 GHS09 Gef.	H301 H332 H312 H317 H410		M=1000
015-068-00-7	dichlofenthion (ISO); O - 2,4-dichlorophenylO,O-diethyl phosphorothioate	202-564-5	97-17-6	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H400 H410
015-069-00-2	methidathion (ISO); 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate	213-449-4	950-37-8	Acute Tox. 2 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H300 H312 H400 H410	GHS06 GHS09 Gef.	H300 H312 H410
015-070-00-8	cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl)O,O-diethyl phosphorothioate	223-099-4	3734-95-0	Acute Tox. 2 * Acute Tox. 3 *	H300 H311	GHS06 Gef.	H300 H311
015-071-00-3	chlorfenvinphos (ISO); 2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate	207-432-0	470-90-6	Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H300 H311 H400 H410	GHS06 GHS09 Gef.	H300 H311 H410
015-072-00-9	monocrotophos (ISO); dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate	230-042-7	6923-22-4	Muta. 2 Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H341 H330 H300 H311 H400 H410	GHS06 GHS08 GHS09 Gef.	H341 H330 H300 H311 H410
015-073-00-4	dicrotophos (ISO); (Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate	205-494-3	141-66-2	Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H300 H311 H400 H410	GHS06 GHS09 Gef.	H300 H311 H410
015-074-00-X	crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate	206-083-1	299-86-5	Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H312 H302 H400 H410	GHS07 GHS09 Achtg.	H312 H302 H410
015-075-00-5	S-[2-(isopropylsulphinyl)ethyl]O,O-dimethyl phosphorothioate	-	2635-50-9	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *	H331 H311 H301	GHS06 Gef.	H331 H311 H301
015-076-00-0	potasan; O, O-diethylO-(4-methylcoumarin-7-yl) phosphorothioate	-	299-45-6	Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H330 H310 H300 H400 H410	GHS06 GHS09 Gef.	H330 H310 H300 H410		M=1000
015-077-00-6	2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate	-	7076-53-1	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 *	H331 H311 H301	GHS06 Gef.	H331 H311 H301
015-078-00-1	demeton-S-methylsulphon (ISO); S-2-ethylsulphonylethyl dimethyl phosphorothioate	241-109-5	17040-19-6	Acute Tox. 3 * Acute Tox. 4 * Aquatic Chronic 2	H301 H312 H411	GHS06 GHS09 Gef.	H301 H312 H411
015-079-00-7	acephate (ISO); O,S-dimethyl acetylphosphoramidothioate	250-241-2	30560-19-1	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
015-080-00-2	amidithion (ISO); 2-methoxyethylcarbamoylmethylO,O-dimethyl phosphorodithioate	-	919-76-6	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
015-081-00-8	O,O,O',O'-tetrapropyl dithiopyrophosphate	221-817-0	3244-90-4	Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H312 H302 H400 H410	GHS07 GHS09 Achtg.	H312 H302 H410
015-082-00-3	azothoate (ISO); O-4-(4-chlorophenylazo)phenylO,O-dimethyl phosphorothioate	227-419-3	5834-96-8	Acute Tox. 4 * Acute Tox. 4 *	H332 H302	GHS07 Achtg.	H332 H302
015-083-00-9	bensulide (ISO); O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate	212-010-4	741-58-2	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
015-084-00-4	chlorpyrifos (ISO); O,O-diethylO - 3,5,6-trichloro-2-pyridyl phosphorothioate	220-864-4	2921-88-2	Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H301 H400 H410	GHS06 GHS09 Gef.	H301 H400 H410		M=10000
015-085-00-X	chlorphonium chloride (ISO); tributyl (2,4-dichlorobenzyl) phosphonium chloride	204-105-4	115-78-6	Acute Tox. 3 * Acute Tox. 4 * Eye Irrit. 2 Skin Irrit. 2	H301 H312 H319 H315	GHS06 Gef.	H301 H312 H319 H315
015-086-00-5	coumithoate (ISO); O,O-diethylO - 7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate	-	572-48-5	Acute Tox. 3 *	H301	GHS06 Gef.	H301
015-087-00-0	cyanophos (ISO); O-4-cyanophenylO,O-dimethyl phosphorothioate	220-130-3	2636-26-2	Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H312 H302 H400 H410	GHS07 GHS09 Achtg.	H312 H302 H410
015-088-00-6	dialifos (ISO); 2-chloro-1-phthalimidoethylO,O-diethyl phosphorodithioate	233-689-3	10311-84-9	Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H300 H311 H400 H410	GHS06 GHS09 Gef.	H300 H311 H400 H410
015-089-00-1	ethoate-methyl (ISO); ethylcarbamoylmethylO,O-dimethyl phosphorodithioate	204-121-1	116-01-8	Acute Tox. 4 * Acute Tox. 4 *	H312 H302	GHS07 Achtg.	H312 H302
015-090-00-7	fensulfothion (ISO); O,O-diethylO-4-methylsulfinylphenyl phosphorothioate	204-114-3	115-90-2	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410
015-091-00-2	fonofos (ISO); O-ethyl phenyl ethylphosphonodithioate	213-408-0	944-22-9	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410
015-092-00-8	phosacetim (ISO); O,O-bis(4-chlorophenyl)N-acetimidoylphosphoramidothioate	223-874-7	4104-14-7	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410
015-093-00-3	leptophos (ISO); O-4-bromo-2,5-dichlorophenylO-methyl phenylphosphorothioate	244-472-8	21609-90-5	Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H301 H370 ** H312 H400 H410	GHS06 GHS08 GHS09 Gef.	H301 H370 ** H312 H410
015-094-00-9	mephosfolan (ISO); diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate	213-447-3	950-10-7	Acute Tox. 1 Acute Tox. 2 * Aquatic Chronic 2	H310 H300 H411	GHS06 GHS09 Gef.	H310 H300 H411
015-095-00-4	methamidophos (ISO); O,S-dimethyl phosphoramidothioate	233-606-0	10265-92-6	Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1	H330 H300 H311 H400	GHS06 GHS09 Gef.	H330 H300 H311 H400
015-096-00-X	oxydisulfoton (ISO); O, O-diethylS-2-ethylsulphinylethyl phosphorodithioate	219-679-1	2497-07-6	Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H300 H311 H400 H410	GHS06 GHS09 Gef.	H300 H311 H410		M=10
015-097-00-5	phenthoate (ISO); ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate	219-997-0	2597-03-7	Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H312 H302 H400 H410	GHS07 GHS09 Achtg.	H312 H302 H410		M=100
015-098-00-0	trichloronate (ISO); O-ethylO - 2,4,5-trichlorophenyl ethylphosphonothioate	206-326-1	327-98-0	Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H300 H311 H400 H410	GHS06 GHS09 Gef.	H300 H311 H410
015-099-00-6	pirimiphos-ethyl (ISO); O,O-diethylO-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate	245-704-0	23505-41-1	Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H301 H312 H400 H410	GHS06 GHS09 Gef.	H301 H312 H410
015-100-00-X	phoxim (ISO); a-(diethoxyphosphinothioylimino) phenylacetonitrile	238-887-3	14816-18-3	Repr. 2 Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H361f*** H302 H317 H400 H410	GHS08 GHS07 GHS09 Achtg.	H361f*** H302 H317 H410		M=1000
015-101-00-5	phosmet (ISO); O,O-dimethyl phthalimidomethylS-phosphorodithioate	211-987-4	732-11-6	Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H312 H302 H400 H410	GHS07 GHS09 Achtg.	H312 H302 H410		M=100
015-102-00-0	tris(2-chloroethyl)phosphate	204-118-5	115-96-8	Carc. 2 Repr. 1B Acute Tox. 4 * Aquatic Chronic 2	H351 H360F*** H302 H411	GHS08 GHS07 GHS09 Gef.	H351 H360F*** H302 H411
015-103-00-6	phosphorus tribromide	232-178-2	7789-60-8	Skin Corr. 1B STOT SE 3	H314 H335	GHS05 GHS07 Gef.	H314 H335	EUH014
015-104-00-1	diphosphorus pentasulphide; phosphorus pentasulphide	215-242-4	1314-80-3	Flam. Sol. 1 Water-react. 1 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1	H228 H260 H332 H302 H400	GHS02 GHS07 GHS09 Gef.	H228 H260 H332 H302 H400	EUH029		T
015-105-00-7	triphenyl phosphite	202-908-4	101-02-0	Eye Irrit. 2 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1	H319 H315 H400 H410	GHS07 GHS09 Achtg.	H319 H315 H410		Skin Irrit. 2; H315: C> 5 % Eye Irrit. 2; H319: C> 5 %
015-106-00-2	hexamethylphosphoric triamide; hexamethylphosphoramide	211-653-8	680-31-9	Carc. 1B Muta. 1B	H350 H340	GHS08 Gef.	H350 H340		Carc. 1B; H350: C> 0.01 %
015-107-00-8	ethoprophos (ISO); ethyl-S,S-dipropyl phosphorodithioate	236-152-1	13194-48-4	Acute Tox. 2 * Acute Tox. 1 Acute Tox. 3 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H310 H301 H317 H400 H410	GHS06 GHS09 Gef.	H330 H310 H301 H317 H410
015-108-00-3	bromophos (ISO); O-4-bromo-2,5-dichlorophenylO,O-dimethyl phosphorothioate	218-277-3	2104-96-3	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410		M=100
015-109-00-9	crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate	231-720-5	7700-17-6	Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H311 H301 H400 H410	GHS06 GHS09 Gef.	H311 H301 H410		M=10
015-110-00-4	cyanofenphos (ISO); O-4-cyanophenylO-ethyl phenylphosphonothioate	-	13067-93-1	Acute Tox. 3 * STOT SE 1 Acute Tox. 4 * Eye Irrit. 2 Aquatic Chronic 2	H301 H370 ** H312 H319 H411	GHS06 GHS08 GHS09 Gef.	H301 H370 ** H312 H319 H411
015-111-00-X	phosfolan (ISO); diethyl 1,3-dithiolan-2-ylidenephosphoramidate	213-423-2	947-02-4	Acute Tox. 1 Acute Tox. 2 *	H310 H300	GHS06 Gef.	H310 H300
015-112-00-5	thionazin (ISO); O,O-diethylO-pyrazin-2-yl phosphorothioate;	206-049-6	297-97-2	Acute Tox. 1 Acute Tox. 2 *	H310 H300	GHS06 Gef.	H310 H300
015-113-00-0	tolclofos-methyl (ISO); O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate	260-515-3	57018-04-9	Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H317 H400 H410	GHS07 GHS09 Achtg.	H317 H410
015-114-00-6	chlormephos (ISO); S-chloromethylO,O-diethyl phosphorodithioate	246-538-1	24934-91-6	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410		M = 10
015-115-00-1	chlorthiophos (ISO); [isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]	244-663-6	21923-23-9	Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H300 H311 H400 H410	GHS06 GHS09 Gef.	H300 H311 H410		M = 1000
015-116-00-7	demephion-O (ISO); O,O-dimethylO-2-methylthioethyl phosphorothioate	211-666-9	682-80-4	Acute Tox. 2 * Acute Tox. 3 *	H300 H311	GHS06 Gef.	H300 H311
015-117-00-2	demephion-S (ISO); O,O-dimethylS-2-methylthioethyl phosphorothioate	219-971-9	2587-90-8	Acute Tox. 2 * Acute Tox. 3 *	H300 H311	GHS06 Gef.	H300 H311
015-118-00-8	demeton	-	8065-48-3	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1	H310 H300 H400	GHS06 GHS09 Gef.	H310 H300 H400
015-119-00-3	dimethyl 4-(methylthio)phenyl phosphate	-	3254-63-5	Acute Tox. 1 Acute Tox. 2 *	H310 H300	GHS06 Gef.	H310 H300
015-120-00-9	ditalimfos (ISO); O,O-diethyl phthalimidophosphonothioate	225-875-8	5131-24-8	Skin Irrit. 2 Skin Sens. 1	H315 H317	GHS07 Achtg.	H315 H317
015-121-00-4	edifenphos (ISO); O-ethylS,S-diphenyl phosphorodithioate	241-178-1	17109-49-8	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H331 H301 H312 H317 H400 H410	GHS06 GHS09 Gef.	H331 H301 H312 H317 H410
015-122-00-X	etrimfos (ISO); O-6-ethoxy-2-ethylpyrimidin-4-ylO,O-dimethylphosphorothioate	253-855-9	38260-54-7	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410		M=10
015-123-00-5	fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate	244-848-1	22224-92-6	Acute Tox. 2	H300	GHS06	H300		M = 100
Acute Tox. 2	H310	GHS09	H310	M = 100
Acute Tox. 2	H330	Gef.	H330
Eye Irrit. 2	H319		H319
Aquatic Acute 1	H400
Aquatic Chronic 1	H410		H410
015-124-00-0	fosthietan (ISO); diethyl 1,3-dithietan-2-ylidenephosphoramidate	244-437-7	21548-32-3	Acute Tox. 1 Acute Tox. 2 *	H310 H300	GHS06 Gef.	H310 H300
015-125-00-6	glyphosine (ISO); N,N-bis(phosphonomethyl)glycine	219-468-4	2439-99-8	Eye Dam. 1	H318	GHS05 Gef.	H318
015-126-00-1	heptenophos (ISO); 7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate	245-737-0	23560-59-0	Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H301 H400 H410	GHS06 GHS09 Gef.	H301 H410		M=100
015-127-00-7	iprobenfos(ISO); S-benzyl diisopropyl phosphorothioate	247-449-0	26087-47-8	Acute Tox. 4 * Aquatic Chronic 2	H302 H411	GHS07 GHS09 Achtg.	H302 H411
015-128-00-2	IPSP; S-ethylsulphinylmethylO,O-diisopropylphosphorodithioate	-	5827-05-4	Acute Tox. 1 Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H310 H301 H400 H410	GHS06 GHS09 Gef.	H310 H301 H410		M=100
015-129-00-8	isofenphos (ISO); O-ethylO-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate	246-814-1	25311-71-1	Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H311 H301 H400 H410	GHS06 GHS09 Gef.	H311 H301 H410		M=100
015-130-00-3	isothioate (ISO); S-2-isopropylthioethylO,O-dimethyl phosphorodithioate;	-	36614-38-7	Acute Tox. 3 * Acute Tox. 3 *	H311 H301	GHS06 Gef.	H311 H301
015-131-00-9	isoxathion (ISO); O,O-diethylO-5-phenylisoxazol-3-ylphosphorothioate	242-624-8	18854-01-8	Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H311 H301 H400 H410	GHS06 GHS09 Gef.	H311 H301 H410
015-132-00-4	S-(chlorophenylthiomethyl)O,O-dimethylphosphorodithioate; methylcarbophenothione	-	953-17-3	Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H311 H301 H400 H410	GHS06 GHS09 Gef.	H311 H301 H410		M=1000
015-133-00-X	piperophos (ISO); S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate	-	24151-93-7	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410		M=10
015-134-00-5	pirimiphos-methyl (ISO); O-(2-diethylamino-6-methylpyrimidin-4-yl)O,O-dimethyl phosphorothioate	249-528-5	29232-93-7	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
015-135-00-0	profenofos (ISO) O-(4-bromo-2-chlorophenyl)O-ethylS-propyl phosphorothioate;	255-255-2	41198-08-7	Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H332 H312 H302 H400 H410	GHS07 GHS09 Achtg.	H332 H312 H302 H410		M=1000
015-136-00-6	trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate; isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate; propetamphos (ISO)	250-517-2	31218-83-4	Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H301 H400 H410	GHS06 GHS09 Gef.	H301 H410		M=100
015-137-00-1	pyrazophos (ISO); O,O-diethylO-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate	236-656-1	13457-18-6	Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H332 H302 H400 H410	GHS07 GHS09 Achtg.	H332 H302 H410
015-138-00-7	quinalphos (ISO); O,O-diethyl-O-quinoxalin-2-yl phosphorothioate	237-031-6	13593-03-8	Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H301 H312 H400 H410	GHS06 GHS09 Gef.	H301 H312 H410		M=1000
015-139-00-2	terbufos (ISO); S -tert-butylthiomethylO, O-diethylphosphorodithioate;	235-963-8	13071-79-9	Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1	H310 H300 H400 H410	GHS06 GHS09 Gef.	H310 H300 H410		M=1000
015-140-00-8	triazophos (ISO); O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate	245-986-5	24017-47-8	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H331 H301 H312 H400 H410	GHS06 GHS09 Gef.	H331 H301 H312 H410		M=100
015-141-00-3	ethylenediammoniumO,O-bis(octyl) phosphorodithioate, mixed isomers	400-520-1	-	Skin Corr. 1B Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H314 H302 H400 H410	GHS05 GHS07 GHS09 Gef.	H314 H302 H410
015-142-00-9	butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate	401-100-0	-	Flam. Liq. 2 Eye Irrit. 2 Aquatic Chronic 2	H225 H319 H411	GHS02 GHS07 GHS09 Gef.	H225 H319 H411			T
015-143-00-4	reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers	401-740-0	-	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
015-144-00-X	reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate	402-090-0	87025-52-3	Skin Corr. 1B	H314	GHS05 Gef.	H314
015-145-00-5	reaction mass of copper(I)O,O-diisopropyl phosphorodithioate and copper(I)O-isopropylO-(4-methylpent-2-yl) phosphorodithioate and copper(I)O,O-bis(4-methylpent-2-yl) phosphorodithioate	401-520-4	-	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Achtg.	H410
015-146-00-0	S-(tricyclo(5.2.1.0^2,6)deca-3-en-8(or 9)-ylO-(isopropyl or isobutyl or 2-ethylhexyl)O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate	401-850-9	-	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Achtg.	H410
015-147-00-6	reaction mass of C_12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)	400-930-0	-	Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2	H315 H318 H317 H411	GHS05 GHS07 GHS09 Gef.	H315 H318 H317 H411
015-148-00-1	2-(diphosphonomethyl)succinic acid	403-070-4	51395-42-7	Skin Corr. 1B Skin Sens. 1	H314 H317	GHS05 GHS07 Gef.	H314 H317
015-149-00-7	reaction mass of: hexyldioctylphosphineoxide; dihexyloctylphosphineoxide; trioctylphosphineoxide	403-470-9	-	Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1	H314 H400 H410	GHS05 GHS09 Gef.	H314 H410
015-150-00-2	(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide	404-940-6	86608-70-0	Acute Tox. 4 * Eye Dam. 1 STOT RE 2 * Aquatic Chronic 3	H302 H318 H373 ** H412	GHS08 GHS05 GHS07 Gef.	H302 H318 H373 ** H412
015-151-00-8	tris(isopropyl/tert-butylphenyl) phosphate	405-010-2	-	Aquatic Chronic 2	H411	GHS09	H411
015-152-00-3	dioxabenzofos (ISO); 2-methoxy-4H - 1,3,2-benzodioxaphosphorin 2-sulphide	223-292-3	3811-49-2	Acute Tox. 3 * Acute Tox. 3 * STOT SE 1 Aquatic Chronic 2	H311 H301 H370 ** H411	GHS06 GHS08 GHS09 Gef.	H311 H301 H370 ** H411
015-153-00-9	isazofos (ISO); O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl)O,O-diethyl phosphorothioate	255-863-8	42509-80-8	Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H311 H301 H373 ** H317 H400 H410	GHS06 GHS08 GHS09 Gef.	H330 H311 H301 H373 ** H317 H410
015-154-00-4	ethephon; 2-chloroethylphosphonic acid	240-718-3	16672-87-0	Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1C Aquatic Chronic 2	H311 H332 H302 H314 H411	GHS06 GHS05 GHS09 Gef.	H311 H332 H302 H314 H411	EUH071
015-155-00-X	glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate	278-636-5	77182-82-2	Repr. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 *	H360Fd H332 H312 H302 H373**	GHS08 GHS07 Gef.	H360Fd H332 H312 H302 H373**
015-156-00-5	methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1] methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]	250-366-9 [1] - [2]	30864-28-9 [1] 62610-77-9 [2]	Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H317 H400 H410	GHS07 GHS09 Achtg.	H302 H317 H410
015-157-00-0	phosphonic acid; [1] phosphorous acid [2]	237-066-7 [1] 233-663-1 [2]	13598-36-2 [1] 10294-56-1 [2]	Acute Tox. 4 * Skin Corr. 1A	H302 H314	GHS05 GHS07 Gef.	H302 H314
015-158-00-6	(?-cyclopentadienyl)(?-cumenyl)iron(1+)hexafluorophosphate(1-)	402-340-9	32760-80-8	Aquatic Chronic 3	H412	-	H412
015-159-00-1	hydroxyphosphonoacetic acid	405-710-8	23783-26-8	Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1	H302 H373 ** H314 H317	GHS08 GHS05 GHS07 Gef.	H302 H373 ** H314 H317
015-160-00-7	vanadyl pyrophosphate	406-260-5	58834-75-6	Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3	H319 H317 H412	GHS07 Achtg.	H319 H317 H412
015-161-00-2	divanadyl pyrophosphate	407-130-0	65232-89-5	Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 2	H302 H318 H317 H411	GHS05 GHS07 GHS09 Gef.	H302 H318 H317 H411
015-162-00-8	vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped	407-350-7	-	Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 Aquatic Chronic 2	H332 H373 ** H318 H411	GHS08 GHS05 GHS07 GHS09 Gef.	H332 H373 ** H318 H411
015-163-00-3	bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide	412-010-6	145052-34-2	Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H317 H400 H410	GHS07 GHS09 Achtg.	H317 H410
015-164-00-9	calciumP,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate	400-480-5	36669-85-9	Aquatic Chronic 3	H412	-	H412
015-165-00-4	reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate	404-986-7	-	Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1	H318 H400 H410	GHS05 GHS09 Gef.	H318 H410
015-166-00-X	3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane	410-290-4	80693-00-1	Aquatic Chronic 4	H413	-	H413
015-167-00-5	3-(hydroxyphenylphosphinyl)propanoic acid	411-200-6	14657-64-8	Eye Dam. 1	H318	GHS05 Gef.	H318
015-168-00-0	fosthiazate (ISO); (RS)-S -sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate	-	98886-44-3	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H331 H301 H312 H317 H400 H410	GHS06 GHS09 Gef.	H331 H301 H312 H317 H410	EUH070
015-169-00-6	tributyltetradecylphosphonium tetrafluoroborate	413-520-1	-	Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H302 H373 ** H314 H317 H400 H410	GHS08 GHS05 GHS07 GHS09 Gef.	H302 H373 ** H314 H317 H410
015-170-00-1	reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate; 1-octane-N,N,N-trimethylammonium di-octylphosphate; 1-octane-N,N,N-trimethylammonium octylphosphate	407-490-9	-	Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B	H312 H302 H314	GHS05 GHS07 Gef.	H312 H302 H314
015-171-00-7	O,O,O-tris(2(or 4)-C_9-10-isoalkylphenyl) phosphorothioate	406-940-1	-	Aquatic Chronic 2	H411	GHS09	H411
015-172-00-2	reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate; isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate	406-240-6	-	Flam. Liq. 3 Skin Corr. 1B Aquatic Chronic 2	H226 H314 H411	GHS02 GHS05 GHS09 Gef.	H226 H314 H411
015-173-00-8	methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate	414-080-3	117291-73-3	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
015-174-00-3	1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine	411-370-1	82857-68-9	Acute Tox. 3 * Eye Dam. 1 Aquatic Chronic 2	H301 H318 H411	GHS06 GHS05 GHS09 Gef.	H301 H318 H411
015-175-00-9	tert-butyl (triphenylphosphoranylidene) acetate	412-880-7	35000-38-5	Acute Tox. 3 * STOT RE 2 * Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 2	H301 H373 ** H319 H317 H411	GHS06 GHS08 GHS09 Gef.	H301 H373 ** H319 H317 H411
015-176-00-4	P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine	413-430-2	116163-96-3	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Achtg.	H410
015-177-00-X	((4-phenylbutyl)hydroxyphosphoryl)acetic acid	412-170-7	83623-61-4	STOT RE 2 * Eye Dam. 1 Skin Sens. 1	H373 ** H318 H317	GHS08 GHS05 Gef.	H373 ** H318 H317
015-178-00-5	(R)-a-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate	418-570-8	25383-07-7	Repr. 2 Aquatic Chronic 2	H361f *** H411	GHS08 GHS09 Achtg.	H361f *** H411
015-179-00-0	UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C_16-18 tallow alkylamine	422-720-8	166242-53-1	Carc. 2 Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H351 H302 H373 ** H314 H317 H400 H410	GHS08 GHS05 GHS07 GHS09 Gef.	H351 H302 H373 ** H314 H317 H410
015-180-00-6	[R-(R,S)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt	415-820-8	137590-32-0	Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3	H318 H317 H412	GHS05 GHS07 Gef.	H318 H317 H412
015-181-00-1	phosphine	232-260-8	7803-51-2	Flam. Gas 1 Press. Gas Acute Tox. 2 * Skin Corr. 1B Aquatic Acute 1	H220 H330 H314 H400	GHS02 GHS04 GHS06 GHS05 GHS09 Gef.	H220 H330 H314 H400			U
015-182-00-7	tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)	430-630-5	10596-22-2	Acute Tox. 4 * Eye Irrit. 2 Skin Sens. 1	H302 H319 H317	GHS07 Achtg.	H302 H319 H317
015-183-00-2	(1-hydroxydodecylidene)diphosphonic acid	425-230-2	16610-63-2	Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1	H314 H400 H410	GHS05 GHS09 Gef.	H314 H410
015-184-00-8	Salts of glyphosate, with the exception of those specified elsewhere in this Annex	-	-	Aquatic Chronic 2	H411	GHS09	H411			A
015-186-00-9	chlorpyrifos-methyl (ISO) O, O-dimethylO - 3,5,6-trichloro-2-pyridyl phosphorothioate	227-011-5	5598-13-0	Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H317 H400 H410	GHS07 GHS09 Achtg.	H317 H410		M=10000
015-187-00-4	reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate,N-oxide; trisodium ((tetrahydro-2-hydroxy-4H - 1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate,N-oxide,P-oxide	417-540-1	-	Eye Dam. 1 Aquatic Chronic 2	H318 H411	GHS05 GHS09 Gef.	H318 H411
015-189-00-5	phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide	423-340-5	162881-26-7	Skin Sens. 1 Aquatic Chronic 4	H317 H413	GHS07 Achtg.	H317 H413
015-190-00-0	bis(2,4-dicumylphenyl) neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane	421-920-2	154862-43-8	Aquatic Chronic 4	H413	-	H413
015-191-00-6	dodecyldiphenyl phosphate	431-760-5	27460-02-2	Skin Irrit. 2 Aquatic Chronic 3	H315 H412	GHS07 Achtg.	H315 H412
015-192-00-1	tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate	432-770-2	139189-30-3	Skin Sens. 1	H317	GHS07 Achtg.	H317
015-193-00-7	triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)	442-960-7	332350-93-3	Acute Tox. 3 * Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1	H301 H318 H400 H410	GHS05 GHS06 GHS09 Gef.	H301 H318 H410
015-194-00-2	tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate	444-440-5	220689-12-3	Acute Tox. 4 * Aquatic Chronic 3	H302 H412	GHS07 Achtg.	H302 H412
015-195-00-8	reaction mass of: potassiumo-toluenephosphonate; potassiumm-toluenephosphonate; potassiump-toluenephosphonate	433-860-4	-	Eye Irrit. 2 Skin Sens. 1 Aquatic Chronic 3	H319 H317 H412	GHS07 Achtg.	H319 H317 H412
015-196-00-3	reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate	435-960-3	-	Carc. 1B Muta. 1B Skin Sens. 1	H350 H340 H317	GHS08 GHS07 Gef.	H350 H340 H317
015-197-00-9	bis(2,4,4-trimethylpentyl)dithiophosphonic acid	420-160-9	107667-02-7	Flam. Liq. 3 Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Chronic 2	H226 H331 H302 H314 H411	GHS02 GHS06 GHS05 GHS09 Gef.	H226 H331 H302 H314 H411
015-198-00-4	(4-phenylbutyl)phosphinic acid	420-450-5	86552-32-1	Carc. 2 Eye Dam. 1	H351 H318	GHS05 GHS08 Gef.	H351 H318
015-199-00-X	tris[2-chloro-1-chloromethyl)ethyl] phosphate	237-159-2	13674-87-8	Carc. 2	H351	GSH08 Achtg.	H351
015-200-00-3	indium phosphide	244-959-5	22398-80-7	Carc. 1B Repr. 2 STOT RE 1	H350 H361f H372 (Lunge)	GHS08 Gef.	H350 H361f H372 (Lunge)		STOT RE 1; H372: C> 0,1 % Carc 1B; H350: C> 0,01 % STOT RE 2; H373: 0,01 % ≤ C < 0,1 %
015-201-00-9	trixylyl phosphate	246-677-8	25155-23-1	Repr. 1B	H360F	GHS08 Gef.	H360F
015-202-00-4	tris(nonylphenyl) phosphite	247-759-6	26523-78-4	Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H317 H400 H410	GHS07 GHS09 Achtg.	H317 H410
015-203-00-X	diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide	278-355-8	75980-60-8	Repr. 2	H361f (verursacht Hodenatrophie)	GHS08 Achtg.	H361f (verursacht Hodenatrophie)
016-001-00-4	hydrogen sulphide	231-977-3	7783-06-4	Flam. Gas 1 Press. Gas Acute Tox. 2 * Aquatic Acute 1	H220 H330 H400	GHS02 GHS04 GHS06 GHS09 Gef.	H220 H330 H400			U
016-002-00-X	barium sulphide	244-214-4	21109-95-5	Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1	H332 H302 H400	GHS07 GHS09 Achtg.	H332 H302 H400	EUH031
016-003-00-5	barium polysulphides	256-814-3	50864-67-0	Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1	H319 H335 H315 H400	GHS07 GHS09 Achtg.	H319 H335 H315 H400	EUH031
016-004-00-0	calcium sulphide	243-873-5	20548-54-3	Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1	H319 H335 H315 H400	GHS07 GHS09 Achtg.	H319 H335 H315 H400	EUH031
016-005-00-6	calcium polysulphides	215-709-2	1344-81-6	Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1	H319 H335 H315 H400	GHS07 GHS09 Achtg.	H319 H335 H315 H400	EUH031
016-006-00-1	dipotassium sulphide; potassium sulphide	215-197-0	1312-73-8	Skin Corr. 1B Aquatic Acute 1	H314 H400	GHS05 GHS09 Gef.	H314 H400	EUH031
016-007-00-7	potassium polysulphides	253-390-1	37199-66-9	Skin Corr. 1B Aquatic Acute 1	H314 H400	GHS05 GHS09 Gef.	H314 H400	EUH031
016-008-00-2	ammonium polysulphides	232-989-1	9080-17-5	Skin Corr. 1B Aquatic Acute 1	H314 H400	GHS05 GHS09 Gef.	H314 H400	EUH031	EUH031: C> 1 %
016-009-00-8	disodium sulfide; sodium sulfide	215-211-5	1313-82-2	Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1B Aquatic Acute 1	H311 H302 H314 H400	GHS06 GHS05 GHS09 Gef.	H311 H302 H314 H400
016-010-00-3	sodium polysulphides	215-686-9	1344-08-7	Acute Tox. 3 * Skin Corr. 1B Aquatic Acute 1	H301 H314 H400	GHS06 GHS05 GHS09 Gef.	H301 H314 H400	EUH031
016-011-00-9	sulphur dioxide	231-195-2	7446-09-5	Press. Gas Acute Tox. 3 * Skin Corr. 1B	H331 H314	GHS04 GHS06 GHS05 Gef.	H331 H314		*	U5
016-012-00-4	disulphur dichloride; sulfur monochloride	233-036-2	10025-67-9	Acute Tox. 3 * Acute Tox. 4 * Skin Corr. 1a Aquatic Acute 1	H301 H332 H314 H400	GHS06 GHS05 GHS09 Gef.	H301 H332 H314 H400	EUH014 EUH029	STOT SE 3; H335: C> 1 %
016-013-00-X	sulphur dichloride	234-129-0	10545-99-0	Skin Corr. 1B STOT SE 3 Aquatic Acute 1	H314 H335 H400	GHS05 GHS07 GHS09 Gef.	H314 H335 H400	EUH014	STOT SE 3; H335: C> 5 %
016-014-00-5	sulphur tetrachloride	-	13451-08-6	Skin Corr. 1B Aquatic Acute 1	H314 H400	GHS05 GHS09 Gef.	H314 H400	EUH014	STOT SE 3; H335: C> 5 %
016-015-00-0	thionyl dichloride; thionyl chloride	231-748-8	7719-09-7	Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1A	H332 H302 H314	GHS05 GHS07 Gef.	H332 H302 H314	EUH014 EUH029	STOT SE 3; H335: C> 1 %
016-016-00-6	sulphuryl chloride	232-245-6	7791-25-5	Skin Corr. 1B STOT SE 3	H314 H335	GHS05 GHS07 Gef.	H314 H335	EUH014
016-017-00-1	chlorosulphonic acid	232-234-6	7790-94-5	Skin Corr. 1a STOT SE 3	H314 H335	GHS05 GHS07 Gef.	H314 H335	EUH014
016-018-00-7	fluorosulphonic acid	232-149-4	7789-21-1	Acute Tox. 4 * Skin Corr. 1A	H332 H314	GHS05 GHS07 Gef.	H332 H314
016-019-00-2	oleum ... % SO₃	-	-	Skin Corr. 1a STOT SE 3	H314 H335	GHS05 GHS07 Gef.	H314 H335	EUH014		B
016-020-00-8	sulphuric acid ... %	231-639-5	7664-93-9	Skin Corr. 1A	H314	GHS05 Gef.	H314		Skin Corr. 1A; H314: C> 15 % Skin Irrit. 2; H315: 5 % ≤ C < 15 % Eye Irrit. 2; H319: 5 % ≤ C < 15 %	B
016-021-00-3	methanethiol; methyl mercaptan	200-822-1	74-93-1	Flam. Gas. 1 Press. Gas Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1	H220 H331 H400 H410	GHS02 GHS04 GHS06 GHS09 Gef.	H220 H331 H410			U
016-022-00-9	ethanethiol; ethyl mercaptan	200-837-3	75-08-1	Flam. Liq. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H225 H332 H400 H410	GHS02 GHS07 GHS09 Gef.	H225 H332 H410
016-023-00-4	dimethyl sulphate	201-058-1	77-78-1	Carc. 1B Muta. 2 Acute Tox. 2 * Acute Tox. 3 * Skin Corr. 1B Skin Sens. 1	H350 H341 H330 H301 H314 H317	GHS06 GHS08 GHS05 Gef.	H350 H341 H330 H301 H314 H317		Carc. 1B; H350: C> 0.01 % Muta. 2; H341: C> 0.01 % STOT SE 3; H335: C> 5 %
016-024-00-X	dimexano(ISO); bis(methoxythiocarbonyl) disulphide	215-993-8	1468-37-7	Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1	H302 H400 H410	GHS07 GHS09 Achtg.	H302 H410
016-025-00-5	disul (ISO); 2-(2,4-dichlorophenoxy)ethyl hydrogensulphate; 2,4-DES	205-259-5	149-26-8	Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1	H302 H315 H318	GHS05 GHS07 Gef.	H302 H315 H318
016-026-00-0	sulphamidic acid; sulphamic acid; sulfamic acid	226-218-8	5329-14-6	Eye Irrit. 2 Skin Irrit. 2 Aquatic Chronic 3	H319 H315 H412	GHS07 Achtg.	H319 H315 H412
016-027-00-6	diethyl sulphate	200-589-6	64-67-5	Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B	H350 H340 H332 H312 H302 H314	GHS05 GHS08 GHS07 Gef.	H350 H340 H332 H312 H302 H314
016-028-00-1	sodium dithionite; sodium hydrosulphite	231-890-0	7775-14-6	Self-heat. 1 Acute Tox. 4 *	H251 H302	GHS02 GHS07 Gef.	H251 H302	EUH031
016-029-00-7	p-toluenesulphonic acid, containing more than 5 % H₂SO₄	-	-	Skin Corr. 1B	H314	GHS05 Gef.	H314		Skin Corr. 1B; H314: C> 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 %
016-030-00-2	p-toluenesulphonic acid (containing a maximum of 5 % H₂SO₄)	203-180-0	104-15-4	Eye Irrit. 2 STOT SE 3 Skin Irrit. 2	H319 H335 H315	GHS07 Achtg.	H319 H335 H315		STOT SE 3; H335: C> 20 %
016-031-00-8	tetrahydrothiophene-1,1-dioxide; sulpholane	204-783-1	126-33-0	Acute Tox. 4 *	H302	GHS07 Achtg.	H302
016-032-00-3	1,3-propanesultone; 1,2-oxathiolane 2,2-dioxide	214-317-9	1120-71-4	Carc. 1B Acute Tox. 4 * Acute Tox. 4 *	H350 H312 H302	GHS08 GHS07 Gef.	H350 H312 H302		Carc. 1B; H350: C> 0,01 %
016-033-00-9	dimethylsulfamoylchloride	236-412-4	13360-57-1	Carc. 1B Acute Tox. 2 * Acute Tox. 4 * Acute Tox. 4 * Skin Corr. 1B	H350 H330 H312 H302 H314	GHS06 GHS05 GHS08 Gef.	H350 H330 H312 H302 H314
016-034-00-4	tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)	400-010-9	81898-60-4	Skin Sens. 1	H317	GHS07 Achtg.	H317
016-035-00-X	pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate	400-120-7	-	Eye Irrit. 2	H319	GHS07 Achtg.	H319

Index-Nr.

Internationale chemische Bezeichnung

EG-Nr.

CAS-Nr.

Einstufung

Kennzeichnung

Spez. Konzentra-tionsgrenzen, M-Fakt.

Anm.

Kodierung der Gefahrenklassen und -kategorien

Kodierung der Gef.-
hinweise

Piktogr., Kodierung der Signalw.

Kodierung der Gef.-
hinweise

Kodierung der erg. Gef.-
merkm.

001-001-00-9

hydrogen

215-605-7

1333-74-0

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04 Gef.

H220

001-002-00-4

aluminium lithium hydride

240-877-9

16853-85-3

Water-react. 1
Skin Corr. 1A

H260
H314

GHS02
GHS05
Gef.

H260
H314

001-003-00-X

sodium hydride

231-587-3

7646-69-7

Water-react. 1

H260

GHS02
Gef.

H260

001-004-00-5

calcium hydride

232-189-2

7789-78-8

Water-react. 1

H260

GHS02
Gef.

H260

003-001-00-4

lithium

231-102-5

7439-93-2

Water-react. 1
Skin Corr. 1B

H260
H314

GHS02
GHS05
Gef.

H260
H314

EUH014

003-002-00-X

n-hexyllithium

404-950-0

21369-64-2

Water-react. 1
Pyr. Sol. 1
Skin Corr. 1A

H260
H250
H314

GHS02
GHS05
Gef.

H260
H250
H314

EUH014

003-003-00-5

(2-methylpropyl)lithium;
isobutyllithium

440-620-2

920-36-5

Water-react. 1
Pyr. Liq. 1
Skin Corr. 1a
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H260
H250
H314
H336
H400
H410

GHS02
GHS05
GHS07
GHS09
Gef.

H260
H250
H314
H336
H410

EUH014

004-001-00-7

beryllium

231-150-7

7440-41-7

Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H350i
H330
H301
H372 **
H319
H335
H315
H317

GHS06
GHS08
Gef.

H350i
H330
H301
H372 **
H319
H335
H315
H317

004-002-00-2

beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex

Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H350i
H330
H301
H372 **
H319
H335
H315
H317
H411

GHS06
GHS08
GHS09
Gef.

H350i
H330
H301
H372 **
H319
H335
H315
H317
H411

004-003-00-8

beryllium oxide

215-133-1

1304-56-9

Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H350i
H330
H301
H372 **
H319
H335
H315
H317

GHS06
GHS08
Gef.

H350i
H330
H301
H372 **
H319
H335
H315
H317

005-001-00-X

boron trifluoride

231-569-5

7637-07-2

Press. Gas
Acute Tox. 2 *
Skin Corr. 1A

H330
H314

GHS04
GHS06
GHS05
Gef.

H330
H314

EUH014

005-002-00-5

boron trichloride

233-658-4

10294-34-5

Press. Gas
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1B

H330
H300
H314

GHS04
GHS06
GHS05
Gef.

H330
H300
H314

EUH014

005-003-00-0

boron tribromide

233-657-9

10294-33-4

Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1A

H330
H300
H314

GHS06
GHS05
Gef.

H330
H300
H314

EUH014

005-004-00-6

trialkylboranes, solid

Pyr. Sol. 1
Skin Corr. 1B

H250
H314

GHS02
GHS05
Gef.

H250
H314

005-004-01-3

trialkylboranes, liquid

Pyr. Liq. 1
Skin Corr. 1B

H250
H314

GHS02
GHS05
Gef.

H250
H314

005-005-00-1

trimethyl borate

204-468-9

121-43-7

Flam. Liq. 3
Acute Tox. 4 *

H226
H312

GHS02
GHS07
Gef.

H226
H312

005-006-00-7

dibutyltin hydrogen borate

401-040-5

75113-37-0

Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H360FD
H341
H372**
H312
H302
H318
H317
H400
H410

GHS05
GHS08
GHS07
GHS09
Gef.

H360FD
H341
H372**
H312
H302
H318
H317
H410

005-007-00-2

boric acid; [1]
boric acid; [2]

233-139-2 [1]
234-343-4 [2]

10043-35-3 [1]
11113-50-1 [2]

Repr. 1B

H360FD

GHS08
Gef.

H360FD

Repr. 1B; H360FD: C> 5,5 %

005-008-00-8

diboron trioxide;
boric oxide

215-125-8

1303-86-2

Repr. 1B

H360FD

GHS08
Gef.

H360FD

Repr. 1B; H360FD: C> 3,1 %

005-009-00-3

tetrabutylammonium butyltriphenylborate

418-080-4

120307-06-4

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

005-010-00-9

N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate

422-050-6

118612-00-3

Carc. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1

H351
H302
H315
H318

GHS08
GHS05
GHS07
Gef.

H351
H302
H315
H318

005-011-00-4

disodium tetraborate, anhydrous;
boric acid, disodium salt; [1]
tetraboron disodium heptaoxide, hydrate; [2]
orthoboric acid, sodium salt [3]

215-540-4 [1]
235-541-3 [2]
237-560-2 [3]

1330-43-4 [1]
12267-73-1 [2]
13840-56-7 [3]

Repr. 1B

H360FD

GHS08
Gef.

H360FD

Repr. 1B; H360FD: C> 4,5 %

005-011-01-1

disodium tetraborate decahydrate;
borax decahydrate

215-540-4

1303-96-4

Repr. 1B

H360FD

GHS08
Gef.

H360FD

Repr. 1B; H360FD: C> 8,5 %

005-011-02-9

disodium tetraborate pentahydrate;
borax pentahydrate

215-540-4

12179-04-3

Repr. 1B

H360FD

GHS08
Gef.

H360FD

Repr. 1B; H360FD: C> 6,5 %

005-012-00-X

diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate

418-070-1

141714-54-7

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

005-013-00-5

diethylmethoxyborane

425-380-9

7397-46-8

Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4

H250
H332
H312
H302
H373**
H314
H317
H413

GHS02
GHS05
GHS08
GHS07
Gef.

H250
H332
H312
H302
H373**
H314
H317
H413

005-014-00-0

4-formylphenylboronic acid

438-670-5

87199-17-5

Skin Sens. 1

H317

GHS07
Achtg.

H317

005-015-00-6

1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)

414-380-4

140681-55-6

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H302
H318
H317
H412

GHS05
GHS07
Gef.

H302
H318
H317
H412

005-016-00-1

tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate

431-370-5

Aquatic Chronic 4

H413

005-017-00-7

sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]

239-172-9 [1]
231-556-4 [2]

15120-21-5 [1]
7632-04-4 [2]

Ox. Sol. 2
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1

H272
H360Df
H302
H335
H318

GHS03
GHS05
GHS08
GHS07
Gef.

H272
H360Df
H302
H335
H318

Repr. 1B; H360Df: C> 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C> 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-017-01-4

sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing> 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]

239-172-9 [1]
231-556-4 [2]

15120-21-5 [1]
7632-04-4 [2]

Ox. Sol. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1

H272
H360Df
H331
H302
H335
H318

GHS03
GHS06
GHS05
GHS08
Gef.

H272
H360Df
H331
H302
H335
H318

Repr. 1B; H360Df: C> 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C> 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-018-00-2

perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]

239-172-9 [1]
234-390-0 [2]
231-556-4 [3]

13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]

Repr. 1B
STOT SE 3
Eye Dam. 1

H360Df
H335
H318

GHS05
GHS08
GHS07
Gef.

H360Df
H335
H318

Repr. 1B; H360Df: C> 14 %
Repr. 1B; H360D: 10 % ≤ C < 14 %
Eye Dam. 1; H318: C> 36 %
Eye Irrit. 2; H319: 22 % ≤ C < 36 %

005-018-01-X

perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing> 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]

239-172-9 [1]
234-390-0 [2]
231-556-4 [3]

13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]

Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1

H360Df
H332
H335
H318

GHS05
GHS08
GHS07
Gef.

H360Df
H332
H335
H318

Repr. 1B; H360Df: C> 14 %
Repr. 1B; H360D: 10 % ≤ C < 14 %
Eye Dam. 1; H318: C> 36 %
Eye Irrit. 2; H319: 22 % ≤ C < 36 %

005-019-00-8

perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]

234-390-0 [1]
234-390-0 [2]
231-556-4 [3]

11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]

Ox. Sol. 3
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1

H272
H360Df
H302
H335
H318

GHS03
GHS05
GHS08
GHS07
Gef.

H272
H360Df
H302
H335
H318

Repr. 1B; H360Df: C> 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C> 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-019-01-5

perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate [3]
sodium peroxoborate;
[containing> 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]

234-390-0 [1]
234-390-0 [2]
231-556-4 [3]

11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]

Ox. Sol. 3
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1

H272
H360Df
H331
H302
H335
H318

GHS03
GHS06
GHS05
GHS08
Gef.

H272
H360Df
H331
H302
H335
H318

Repr. 1B; H360Df: C> 9 %
Repr. 1B; H360D: 6,5 % ≤ C < 9 %
Eye Dam. 1; H318: C> 22 %
Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-020-00-3

Dinatriumoctaborat wasserfrei; [1]
Dinatriumoctaborat Tetrahydrat [2]

234-541-0 [1]
234-541-0 [2]

12008-41-2 [1]
12280-03-4 [2]

Repr. 1B

H360FD

GHS08
Gef.

H360FD

006-001-00-2

carbon monoxide

211-128-3

630-08-0

Flam. Gas 1
Press. Gas
Repr. 1a
Acute Tox. 3 *
STOT RE 1

H220
H360D ***
H331
H372 **

GHS02
GHS04
GHS06
GHS08
Gef.

H220
H360D ***
H331
H372 **

006-002-00-8

phosgene;
carbonyl chloride

200-870-3

75-44-5

Press. Gas
Acute Tox. 2 *
Skin Corr. 1B

H330
H314

GHS04
GHS06
GHS05
Gef.

H330
H314

006-003-00-3

carbon disulphide

200-843-6

75-15-0

Flam. Liq. 2
Repr. 2
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2

H225
H361fd
H372 **
H319
H315

GHS02
GHS08
GHS07
Gef.

H225
H361fd
H372 **
H319
H315

Repr. 2; H361fd: C> 1 %
STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0.2 % ≤C < 1 %

006-004-00-9

calcium carbide

200-848-3

75-20-7

Water-react. 1

H260

GHS02
Gef.

H260

006-005-00-4

thiram (ISO);
tetramethylthiuram disulphide

205-286-2

137-26-8

Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H373 **
H319
H315
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H332
H302
H373 **
H319
H315
H317
H410

M=10

006-006-00-X

hydrogen cyanide;
hydrocyanic acid

200-821-6

74-90-8

Flam. Liq. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H224
H330
H400
H410

GHS02
GHS06
GHS09
Gef.

H224
H330
H410

006-006-01-7

hydrogen cyanide ... %;
hydrocyanic acid ... %

200-821-6

74-90-8

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H400
H410

GHS06
GHS09
Gef.

H330
H310
H300
H410

006-007-00-5

salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H400
H410

GHS06
GHS09
Gef.

H330
H310
H300
H410

EUH032

006-008-00-0

antu (ISO);
1-(1-naphthyl)-2-thiourea

201-706-3

86-88-4

Acute Tox. 2 *
Carc. 2

H300
H351

GHS06
GHS08
Gef.

H300
H351

006-009-00-6

1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;
isolan

204-318-2

119-38-0

Acute Tox. 1
Acute Tox. 2 *

H310
H300

GHS06
Gef.

H310
H300

006-010-00-1

5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;
dimetan

204-525-8

122-15-6

Acute Tox. 3 *

H301

GHS06
Gef.

H301

006-011-00-7

carbaryl (ISO);
1-naphthyl methylcarbamate

200-555-0

63-25-2

Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1

H351
H332
H302
H400

GHS08
GHS07
GHS09
Achtg.

H351
H332
H302
H400

M=100

006-012-00-2

ziram (ISO);
zinc bis dimethyldithiocarbamate

205-288-3

137-30-4

Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H302
H373 **
H335
H318
H317
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H330
H302
H373 **
H335
H318
H317
H410

M=100

006-013-00-8

metam-sodium (ISO);
sodium methyldithiocarbamate

205-293-0

137-42-8

Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H314
H317
H410

EUH031

006-014-00-3

nabam (ISO);
disodium ethylenebis(N, N'-dithiocarbamate)

205-547-0

142-59-6

Acute Tox. 4 *
STOT SE 3
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H335
H317
H410

GHS07
GHS09
Gef.

H302
H335
H317
H410

006-015-00-9

diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea

206-354-4

330-54-1

Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H373**
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H302
H373**
H410

M = 10

006-016-00-4

propoxur (ISO);
2-isopropyloxyphenylN-methylcarbamate;
2-isopropoxyphenyl methylcarbamate

204-043-8

114-26-1

Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H400
H410

GHS06
GHS09
Gef.

H301
H410

006-017-00-X

aldicarb (ISO);
2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime

204-123-2

116-06-3

Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H311
H400
H410

GHS06
GHS09
Gef.

H330
H300
H311
H410

006-018-00-5

aminocarb (ISO);
4-dimethylamino-3-tolyl methylcarbamate

217-990-7

2032-59-9

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H311
H301
H400
H410

GHS06
GHS09
Gef.

H311
H301
H410

006-019-00-0

di-allate (ISO);
S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate

218-961-1

2303-16-4

Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H302
H410

006-020-00-6

barban (ISO);
4-chlorbut-2-ynylN-(3-chlorophenyl)carbamate

202-930-4

101-27-9

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

006-021-00-1

linuron (ISO);
3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea

206-356-5

330-55-2

Repr. 1B
Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H351
H302
H373 **
H400
H410

GHS08
GHS07
GHS09
Gef.

H360Df
H351
H302
H373 **
H410

006-022-00-7

decarbofuran (ISO);
2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate

1563-67-3

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H331
H311
H301

GHS06
Gef.

H331
H311
H301

006-023-00-2

mercaptodimethur (ISO);
methiocarb (ISO);
3,5-dimethyl-4-methylthiophenylN-methylcarbamate

217-991-2

2032-65-7

Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H400
H410

GHS06
GHS09
Gef.

H301
H410

006-024-00-8

proxan-sodium (ISO);
sodiumO-isopropyldithiocarbonate

205-443-5

140-93-2

Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2

H302
H315
H411

GHS07
GHS09
Achtg.

H302
H315
H411

006-025-00-3

allethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;
bioallethrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]
S-bioallethrin;
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]
esbiothrin;
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]

209-542-4 [1]
249-013-5 [2]
- [3]

584-79-2 [1]
28434-00-6 [2]
84030-86-4 [3]

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H302
H410

006-026-00-9

carbofuran (ISO);
2,3-dihydro-2,2-dimethylbenzofuran-7-ylN-methylcarbamate

216-353-0

1563-66-2

Acute Tox. 2 *
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H400
H410

GHS06
GHS09
Gef.

H330
H300
H410

006-028-00-X

dinobuton (ISO);
2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate

213-546-1

973-21-7

Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H400
H410

GHS06
GHS09
Gef.

H301
H410

006-029-00-5

dioxacarb (ISO);
2-(1,3-dioxolan-2-yl)phenylN-methylcarbamate

230-253-4

6988-21-2

Acute Tox. 3 *
Aquatic Chronic 2

H301
H411

GHS06
GHS09
Gef.

H301
H411

006-030-00-0

EPTC (ISO);
S-ethyl dipropylthiocarbamate

212-073-8

759-94-4

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

006-031-00-6

formetanate (ISO);
3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate

244-879-0

22259-30-9

Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H317
H400
H410

GHS06
GHS09
Gef.

H330
H300
H317
H410

006-032-00-1

monolinuron (ISO);
3-(4-chlorophenyl)-1-methoxy-1-methylurea

217-129-5

1746-81-2

Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H373 **
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373 **
H410

006-033-00-7

metoxuron (ISO);
3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea

243-433-2

19937-59-8

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

006-034-00-2

pebulate (ISO);
N-butyl-N-ethyl-S-propylthiocarbamate

214-215-4

1114-71-2

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

006-035-00-8

Pirimicarb (ISO); 2-(Dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamat

245-430-1

23103-98-2

Carc. 2
Acute Tox. 3
Acute Tox. 3
Skin Sens. 1
Aquatic Acute 1 Aquatic Chronic 1

H351
H331
H301
H317
H400
H410

GHS08
GHS06
GHS09
Gef.

H351
H331
H301
H317
H410

M = 10
M = 100

006-036-00-3

benzthiazuron (ISO);
1-benzothiazol-2-yl-3-methylurea

217-685-9

1929-88-0

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

006-037-00-9

promecarb (ISO);
3-isopropyl-5-methylphenylN-methylcarbamate

220-113-0

2631-37-0

Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H400
H410

GHS06
GHS09
Gef.

H301
H410

006-038-00-4

sulfallate (ISO);
2-chloroallylN,N-dimethyldithiocarbamate

202-388-9

95-06-7

Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H410

006-039-00-X

tri-allate (ISO);
S - 2,3,3-trichloroallyl diisopropylthiocarbamate

218-962-7

2303-17-5

Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373 **
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373 **
H317
H410

006-040-00-5

3-methylpyrazol-5-yl-dimethylcarbamate;
monometilan

2532-43-6

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H331
H311
H301

GHS06
Gef.

H331
H311
H301

006-041-00-0

dimethylcarbamoyl chloride

201-208-6

79-44-7

Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H350
H331
H302
H319
H335
H315

GHS06
GHS08
Gef.

H350
H331
H302
H319
H335
H315

Carc. 1B; H350: C> 0,001 %

006-042-00-6

monuron (ISO);
3-(4-chlorophenyl)-1,1-dimethylurea

205-766-1

150-68-5

Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H302
H410

006-043-00-1

3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;
monuron-TCA

140-41-0

Carc. 2
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H319
H315
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H319
H315
H410

006-044-00-7

isoproturon (ISO);
3-(4-isopropylphenyl)-1,1-dimethylurea

251-835-4

34123-59-6

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

M=10

006-045-00-2

methomyl (ISO);
1-(methylthio)ethylideneaminoN-methylcarbamate

240-815-0

16752-77-5

Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H400
H410

GHS06
GHS09
Gef.

H300
H410

M=100

006-046-00-8

Bendiocarb (ISO);
2,2-Dimethyl-1,3-benzodioxol-4-yl-N-methylcarbamat;
2,2-Dimethyl-1,3-benzodioxol-4-yl-methylcarbamat

245-216-8

22781-23-3

Acute Tox. 3
Acute Tox. 3
Acute Tox. 2
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H300
H400
H410

GHS06
GHS09
Gef.

H331
H311
H300
H410

M = 10
M = 100

006-047-00-3

bufencarb (ISO);
reaction mass of 3-(1-methylbutyl)phenylN-methylcarbamate and 3-(1-ethylpropyl)phenylN-methylcarbamate

8065-36-9

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H311
H301
H400
H410

GHS06
GHS09
Gef.

H311
H301
H410

006-048-00-9

ethiofencarb (ISO);
2-(ethylthiomethyl)phenylN-methylcarbamate

249-981-9

29973-13-5

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

006-049-00-4

dixanthogen;
O,O-diethyl dithiobis(thioformate)

207-944-4

502-55-6

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

006-050-00-X

1,1-dimethyl-3-phenyluronium trichloroacetate;
fenuron-TCA

4482-55-7

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

006-051-00-5

ferbam (ISO);
iron tris(dimethyldithiocarbamate)

238-484-2

14484-64-1

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H335
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H335
H315
H410

006-052-00-0

formetanate hydrochloride;
3-(N,N-dimethylaminomethyleneamino)phenylN-methylcarbamate

245-656-0

23422-53-9

Acute Tox. 2 *
Acute Tox. 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H317
H400
H410

GHS06
GHS09
Gef.

H330
H300
H317
H410

006-053-00-6

isoprocarb (ISO);
2-isopropylphenylN-methylcarbamate

220-114-6

2631-40-5

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

006-054-00-1

mexacarbate (ISO);
3,5-dimethyl-4-dimethylaminophenylN-methylcarbamate

206-249-3

315-18-4

Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H312
H400
H410

GHS06
GHS09
Gef.

H300
H312
H410

006-055-00-7

xylylcarb (ISO);
3,4-dimethylphenyl N-methylcarbamate;
3,4-xylyl methylcarbamate;
MPMC

219-364-9

2425-10-7

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

006-056-00-2

metolcarb (ISO);
m-tolyl methylcarbamate;
MTMC

214-446-0

1129-41-5

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

006-057-00-8

nitrapyrin (ISO);
2-chloro-6-trichloromethylpyridine

217-682-2

1929-82-4

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

006-058-00-3

noruron (ISO);
1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea

2163-79-3

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

006-059-00-9

oxamyl (ISO);
N',N'-dimethylcarbamoyl(methylthio)methylenamineN-methylcarbamate;

245-445-3

23135-22-0

Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Chronic 2

H330
H300
H312
H411

GHS06
GHS09
Gef.

H330
H300
H312
H411

006-060-00-4

oxycarboxin (ISO);
2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide

226-066-2

5259-88-1

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

006-061-00-X

S-ethylN-(dimethylaminopropyl)thiocarbamatehydrochloride;
prothiocarb hydrochloride

243-193-9

19622-19-6

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

006-062-00-5

methyl 3,4-dichlorophenylcarbanilate;
SWEP.

1918-18-9

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

006-063-00-0

thiobencarb (ISO);
S-4-chlorobenzyl diethylthiocarbamate

248-924-5

28249-77-6

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

006-064-00-6

thiofanox (ISO);
3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime

254-346-4

39196-18-4

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

006-065-00-1

3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;
triamid

15271-41-7

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Chronic 2

H300
H311
H411

GHS06
GHS09
Gef.

H300
H311
H411

006-066-00-7

vernolate (ISO);
S-propyl dipropylthiocarbamate

217-681-7

1929-77-7

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

006-067-00-2

XMC;
3,5-xylyl methylcarbamate

2655-14-3

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

006-068-00-8

diazomethane

206-382-7

334-88-3

Carc. 1B

H350

GHS08
Gef.

H350

006-069-00-3

thiophanate-methyl (ISO);
1,2-di-(3-methoxycarbonyl-2-thioureido)benzene

245-740-7

23564-05-8

Muta. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H341
H332
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H341
H332
H317
H410

006-070-00-9

furmecyclox (ISO);
N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide

262-302-0

60568-05-0

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

006-071-00-4

cyclooct-4-en-1-yl methyl carbonate

401-620-8

87731-18-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

006-072-00-X

prosulfocarb (ISO);
S-benzylN,N-dipropylthiocarbamate

401-730-6

52888-80-9

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

006-073-00-5

3-(dimethylamino)propylurea

401-950-2

31506-43-1

Eye Dam. 1

H318

GHS05
Gef.

H318

006-074-00-0

2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate

402-440-2

2094-99-7

Acute Tox. 2 *
Skin Corr. 1B
STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H314
H373 **
H334
H317
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H330
H314
H373 **
H334
H317
H410

006-076-00-1

mancozeb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt

8018-01-7

Repr. 2
Skin Sens. 1
Aquatic Acute 1

H361d***
H317
H400

GHS08
GHS07
GHS09
Achtg.

H361d***
H317
H400

M=10

006-077-00-7

maneb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric)

235-654-8

12427-38-2

Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d***
H332
H319
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361d***
H332
H319
H317
H410

M=10

006-078-00-2

zineb (ISO);
zinc ethylenebis(dithiocarbamate) (polymeric)

235-180-1

12122-67-7

STOT SE 3
Skin Sens. 1

H335
H317

GHS07
Achtg.

H335
H317

006-079-00-8

disulfiram;
tetraethylthiuramdisulfide

202-607-8

97-77-8

Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373 **
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373 **
H317
H410

006-080-00-3

tetramethylthiuram monosulphide

202-605-7

97-74-5

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

006-081-00-9

zinc bis(dibutyldithiocarbamate)

205-232-8

136-23-2

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H319
H335
H315
H317
H400
H410

GHS07
GHS09
Achtg.

H319
H335
H315
H317
H410

006-082-00-4

zinc bis(diethyldithiocarbamate)

238-270-9

14324-55-1

Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H335
H315
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H335
H315
H317
H410

006-083-00-X

butocarboxim (ISO);
3-(methylthio)-2-butanoneO-[(methylamino)carbonyl]oxime

252-139-3

34681-10-2

Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H226
H331
H311
H301
H319
H400
H410

GHS02
GHS06
GHS09
Gef.

H226
H331
H311
H301
H319
H410

006-084-00-5

carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate

259-565-9

55285-14-8

Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H301
H317
H400
H410

GHS06
GHS09
Gef.

H330
H301
H317
H410

006-085-00-0

fenobucarb (ISO);
2-butylphenyl methylcarbamate

223-188-8

3766-81-2

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

006-086-00-6

fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate

276-696-7

72490-01-8

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

M = 1
M = 10 000

006-087-00-1

furathiocarb (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate

265-974-3

65907-30-4

Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H301
H373**
H319
H315
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H301
H373**
H319
H315
H317
H410

M = 100

006-088-00-7

benfuracarb (ISO);
ethylN-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- ß-alaninate

82560-54-1

Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H361f***
H331
H302
H400
H410

GHS06
GHS08
GHS09
Gef.

H361f***
H331
H302
H410

006-090-00-8

2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate

408-010-0

88558-41-2

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H332
H318
H412

GHS05
GHS07
Gef.

H332
H318
H412

006-091-00-3

propineb (ISO);
polymeric zinc propylenebis(dithiocarbamate)

9016-72-2

Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1

H332
H373**
H317
H400

GHS08
GHS07
GHS09
Achtg.

H332
H373**
H317
H400

006-092-00-9

tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate

425-420-5

98737-29-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

006-093-00-4

2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)

427-180-7

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

006-094-00-X

O-isobutyl-N-ethoxy carbonylthiocarbamate

434-350-4

103122-66-3

Flam. Liq. 3
Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2

H226
H350
H340
H302
H373**
H317
H411

GHS02
GHS08
GHS07
GHS09
Gef.

H226
H350
H340
H302
H373**
H317
H411

006-095-00-5

fosetyl-aluminium (ISO);
aluminium triethyl triphosphonate

254-320-2

39148-24-8

Eye Dam. 1

H318

GHS05
Gef.

H318

006-096-00-0

chlorpropham (ISO);
isopropyl 3-chlorocarbanilate

202-925-7

101-21-3

Carc. 2
STOT RE 2 *
Aquatic Chronic 2

H351
H373**
H411

GHS08
GHS09
Achtg.

H351
H373**
H411

006-097-00-6

1-phenyl-3-(p-toluenesulfonyl)urea

424-620-1

13909-63-2

Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3

H302
H373**
H412

GHS08
GHS07
Achtg.

H302
H373**
H412

006-098-00-1

tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate

429-170-8

134575-17-0

Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1

H302
H373**
H318
H317

GHS05
GHS08
GHS07
Gef.

H302
H373**
H318
H317

006-099-00-7

N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;
3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate

432-520-2

232938-43-1

Aquatic Chronic 2

H411

GHS09

H411

006-101-00-6

reaction mass of:N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];
N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;
N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]

423-070-8

Aquatic Chronic 4

H413

006-102-00-1

O-hexyl-N-ethoxycarbonylthiocarbamate

432-750-3

Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2

H350
H340
H302
H373**
H317
H411

GHS08
GHS07
GHS09
Gef.

H350
H340
H302
H373**
H317
H411

006-103-00-7

N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea

445-760-8

Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H334
H400
H410

GHS05
GHS08
GHS09
Gef.

H318
H334
H410

M=100

007-001-00-5

ammonia, anhydrous

231-635-3

7664-41-7

Flam. Gas 2
Press. Gas
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1

H221
H331
H314
H400

GHS04
GHS06
GHS05
GHS09
Gef.

H221
H331
H314
H400

007-001-01-2

ammonia ....%

215-647-6

1336-21-6

Skin Corr. 1B
Aquatic Acute 1

H314
H400

GHS05
GHS09
Gef.

H314
H400

STOT SE 3; H335: C> 5 %

007-002-00-0

nitrogen dioxide; [1]
dinitrogen tetraoxide [2]

233-272-6 [1]
234-126-4 [2]

10102-44-0 [1]
10544-72-6 [2]

Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1B

H270
H330
H314

GHS04
GHS03
GHS06
GHS05
Gef.

H270
H330
H314

*
STOT SE 3; H335: C> 0,5 %

007-003-00-6

chlormequat chloride (ISO);
2-chloroethyltrimethylammonium chloride

213-666-4

999-81-5

Acute Tox. 4 *
Acute Tox. 4 *

H312
H302

GHS07
Achtg.

H312
H302

007-004-00-1

Salpetersäure ... %

231-714-2

7697-37-2

Ox. Liq. 2
Skin Corr. 1A

H272
H314

GHS03
GHS05
Gef.

H272
H314

EUH071

Skin Corr. 1A; H314: C> 20 %
Skin Corr. 1B; H314: 5 % ≤ C < 20 %
Ox. Liq. 2; H272: C> 99 %
Ox. Liq. 3; H272: 99 %> C> 65 %

007-006-00-2

ethyl nitrite

203-722-6

109-95-5

Flam. Gas 1
Press. Gas
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H220
H332
H312
H302

GHS02
GHS04
GHS07
Gef.

H220
H332
H312
H302

007-007-00-8

ethyl nitrate

210-903-3

625-58-1

Unst. Expl.

H200

GHS01
Gef.

H200

007-008-00-3

hydrazine

206-114-9

302-01-2

Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H226
H350
H331
H311
H301
H314
H317
H400
H410

GHS02
GHS06
GHS08
GHS05
GHS09
Gef.

H226
H350
H331
H311
H301
H314
H317
H410

Skin Corr. 1B; H314: C> 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 3 % ≤ C < 10 %

007-009-00-9

dicyclohexylammonium nitrite

221-515-9

3129-91-7

Acute Tox. 4 *
Acute Tox. 4 *

H332
H302

GHS07
Achtg.

H332
H302

007-010-00-4

sodium nitrite

231-555-9

7632-00-0

Ox. Sol. 3
Acute Tox. 3 *
Aquatic Acute 1

H272
H301
H400

GHS03
GHS06
GHS09
Gef.

H272
H301
H400

007-011-00-X

potassium nitrite

231-832-4

7758-09-0

Ox. Sol. 2
Acute Tox. 3 *
Aquatic Acute 1

H272
H301
H400

GHS03
GHS06
GHS09
Gef.

H272
H301
H400

007-012-00-5

N,N-dimethylhydrazine

200-316-0

57-14-7

Flam. Liq. 2
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2

H225
H350
H331
H301
H314
H411

GHS02
GHS06
GHS08
GHS05
GHS09
Gef.

H225
H350
H331
H301
H314
H411

007-013-00-0

1,2-dimethylhydrazine

540-73-8

Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2

H350
H331
H311
H301
H411

GHS06
GHS08
GHS09
Gef.

H350
H331
H311
H301
H411

Carc. 1B; H350: C> 0.01 %

007-014-00-6

salts of hydrazine

Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H331
H311
H301
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H331
H311
H301
H317
H410

007-015-00-1

O-ethylhydroxylamine

402-030-3

624-86-2

Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H225
H331
H311
H301
H372 **
H319
H317
H400

GHS02
GHS06
GHS08
GHS09
Gef.

H225
H331
H311
H301
H372 **
H319
H317
H400

007-016-00-7

butyl nitrite

208-862-1

544-16-1

Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *

H225
H331
H301

GHS02
GHS06
Gef.

H225
H331
H301

007-017-00-2

isobutyl nitrite

208-819-7

542-56-3

Flam. Liq. 2
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *

H225
H350
H341
H332
H302

GHS02
GHS08
GHS07
Gef.

H225
H350
H341
H332
H302

007-018-00-8

sec-butyl nitrite

213-104-8

924-43-6

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *

H225
H332
H302

GHS02
GHS07
Gef.

H225
H332
H302

007-019-00-3

tert-butyl nitrite

208-757-0

540-80-7

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *

H225
H332
H302

GHS02
GHS07
Gef.

H225
H332
H302

007-020-00-9

pentyl nitrite; [1]
’amyl nitrite’, mixed isomers [2]

207-332-7 [1]
203-770-8 [2]

463-04-7 [1]
110-46-3 [2]

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *

H225
H332
H302

GHS02
GHS07
Gef.

H225
H332
H302

007-021-00-4

hydrazobenzene;
1,2-diphenylhydrazine

204-563-5

122-66-7

Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H410

007-022-00-X

hydrazine bis(3-carboxy-4-hydroxybenzensulfonate)

405-030-1

Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3

H350
H302
H314
H317
H412

GHS08
GHS05
GHS07
Gef.

H350
H302
H314
H317
H412

007-023-00-5

sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate

405-510-0

Skin Irrit. 2
Skin Sens. 1

H315
H317

GHS07
Achtg.

H315
H317

007-024-00-0

2-(decylthio)ethylammonium chloride

405-640-8

36362-09-1

STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H373 **
H315
H318
H400
H410

GHS08
GHS05
GHS09
Gef.

H373 **
H315
H318
H410

007-025-00-6

(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride

406-090-1

81880-96-8

Muta. 2
Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H341
H301
H372 **
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H341
H301
H372 **
H317
H410

007-026-00-1

oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide

413-230-5

122035-71-6

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

007-027-00-7

1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane

420-190-2

771478-66-1

Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H373 **
H314
H317
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H312
H302
H373 **
H314
H317
H410

007-028-00-2

hydroxylammonium nitrate

236-691-2

13465-08-2

Expl. 1.1 ****
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H201
H351
H311
H302
H373**
H319
H315
H317
H400

GHS01
GHS06
GHS08
GHS09
Gef.

H201
H351
H311
H302
H373**
H319
H315
H317
H400

007-029-00-8

diethyldimethylammonium hydroxide

419-400-5

95500-19-9

Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A

H312
H302
H314

GHS05
GHS07
Gef.

H312
H302
H314

008-001-00-8

oxygen

231-956-9

7782-44-7

Ox. Gas 1
Press. Gas

H270

GHS03
GHS04
Gef.

H270

008-003-00-9

hydrogen peroxide solution ... %

231-765-0

7722-84-1

Ox. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A

H271
H332
H302
H314

GHS03
GHS05
GHS07
Gef.

H271
H332
H302
H314

Ox. Liq. 1; H271: C> 70 %^****
Ox. Liq. 2; H272: 50 % ≤ C < 70 %^****
*
Skin Corr. 1A; H314: C> 70 %
Skin Corr. 1B; H314: 50 % ≤ C < 70 %
Skin Irrit. 2; H315: 35 % ≤ C < 50 %
Eye Dam. 1; H318: 8 % ≤ C < 50 %
Eye Irrit. 2; H319: 5 % ≤ C < 8 %
STOT SE 3; H335; C> 35 %

009-001-00-0

fluorine

231-954-8

7782-41-4

Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1A

H270
H330
H314

GHS04
GHS03
GHS06
GHS05
Gef.

H270
H330
H314

009-002-00-6

hydrogen fluoride

231-634-8

7664-39-3

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A

H330
H310
H300
H314

GHS06
GHS05
Gef.

H330
H310
H300
H314

009-003-00-1

hydrofluoric acid ... %

231-634-8

7664-39-3

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1A

H330
H310
H300
H314

GHS06
GHS05
Gef.

H330
H310
H300
H314

Skin Corr. 1A; H314: C> 7 %
Skin Corr. 1B; H314: 1 % ≤ C < 7 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %

009-004-00-7

sodium fluoride

231-667-8

7681-49-4

Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2

H301
H319
H315

GHS06
Gef.

H301
H319
H315

EUH032

009-005-00-2

potassium fluoride

232-151-5

7789-23-3

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H331
H311
H301

GHS06
Gef.

H331
H311
H301

009-006-00-8

ammonium fluoride

235-185-9

12125-01-8

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H331
H311
H301

GHS06
Gef.

H331
H311
H301

009-007-00-3

sodium bifluoride;
sodium hydrogen difluoride

215-608-3

1333-83-1

Acute Tox. 3 *
Skin Corr. 1B

H301
H314

GHS06
GHS05
Gef.

H301
H314

*
Skin Corr. 1B; H314: C> 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %

009-008-00-9

potassium bifluoride;
potassium hydrogen difluoride

232-156-2

7789-29-9

Acute Tox. 3 *
Skin Corr. 1B

H301
H314

GHS06
GHS05
Gef.

H301
H314

*
Skin Corr. 1B; H314: C> 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %

009-009-00-4

ammonium bifluoride;
ammonium hydrogen difluoride

215-676-4

1341-49-7

Acute Tox. 3 *
Skin Corr. 1B

H301
H314

GHS06
GHS05
Gef.

H301
H314

*
Skin Corr. 1B; H314: C> 1 %
Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %
Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %

009-010-00-X

fluoroboric acid ... %

240-898-3

16872-11-0

Skin Corr. 1B

H314

GHS05
Gef.

H314

Skin Corr. 1B; H314: C> 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %

009-011-00-5

fluorosilicic acid ... %

241-034-8

16961-83-4

Skin Corr. 1B

H314

GHS05
Gef.

H314

009-012-00-0

alkali fluorosilicates(Na); [1]
alkali fluorosilicates(K); [2]
alkali fluorosilicates(NH4) [3]

240-934-8 [1]
240-896-2 [2]
240-968-3 [3]

16893-85-9 [1]
16871-90-2 [2]
16919-19-0 [3]

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H331
H311
H301

GHS06
Gef.

H331
H311
H301

009-013-00-6

fluorosilicates, with the exception of those specified elsewhere in this Annex

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

009-014-00-1

lead hexafluorosilicate

247-278-1

25808-74-6

Repr. 1a
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H332
H302
H373 **
H400
H410

GHS08
GHS07
GHS09
Gef.

H360Df
H332
H302
H373 **
H410

009-015-00-7

sulphuryl difluoride

220-281-5

2699-79-8

Press. Gas
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1

H331
H373 **
H400

GHS04
GHS06
GHS08
GHS09
Gef.

H331
H373 **
H400

009-016-00-2

trisodium hexafluoroaluminate [1]

237-410-6 [1]

13775-53-6 [1]

STOT RE 1
Acute Tox. 4
Aquatic Chronic 2

H372
H332
H411

GHS07
GHS08
GHS09
Gef.

H372
H332
H411

trisodium hexafluoroaluminate (cryolite) [2]

239-148-8 [2]

15096-52-3 [2]

009-017-00-8

potassium mu-fluoro-bis(triethylaluminium)

400-040-2

12091-08-6

Flam. Sol. 1
Water-react. 1
Skin Corr. 1a
Acute Tox. 4 *

H228
H270
H314
H332

GHS02
GHS05
GHS07
Gef.

H228
H270
H314
H332

EUH014

009-018-00-3

magnesium hexafluorosilicate

241-022-2

16949-65-8

Acute Tox. 3 *

H301

GHS06
Gef.

H301

011-001-00-0

sodium

231-132-9

7440-23-5

Water-react. 1
Skin Corr. 1B

H260
H314

GHS02
GHS05
Gef.

H260
H314

EUH014

011-002-00-6

sodium hydroxide;
caustic soda

215-185-5

1310-73-2

Skin Corr. 1A

H314

GHS05
Gef.

H314

Skin Corr. 1A; H314: C> 5 %
Skin Corr. 1B; H314: 2 % ≤ C < 5 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %

011-003-00-1

sodium peroxide

215-209-4

1313-60-6

Ox. Sol. 1
Skin Corr. 1A

H271
H314

GHS03
GHS05
Gef.

H271
H314

011-004-00-7

sodium azide

247-852-1

26628-22-8

Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H400
H410

GHS06
GHS09
Gef.

H300
H400
H410

EUH032

011-005-00-2

sodium carbonate

207-838-8

497-19-8

Eye Irrit. 2

H319

GHS07
Achtg.

H319

011-006-00-8

sodium cyanate

213-030-6

917-61-3

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

011-007-00-3

propoxycarbazone-sodium

181274-15-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M=10

012-001-00-3

magnesium powder (pyrophoric)

231-104-6

7439-95-4

Water-react. 1
Pyr. Sol. 1

H260
H250

GHS02
Gef.

H260
H250

012-002-00-9

magnesium, powder or turnings

231-104-6

Flam. Sol. 1
Water-react. 2
Self-heat. 1

H228
H261
H252

GHS02
Gef.

H228
H261
H252

012-003-00-4

magnesium alkyls

Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B

H250
H260
H314

GHS02
GHS05
Gef.

H250
H260
H314

EUH014

012-004-00-X

aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate

422-150-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

013-001-00-6

aluminium powder (pyrophoric)

231-072-3

7429-90-5

Water-react. 2
Pyr. Sol. 1

H261
H250

GHS02
Gef.

H261
H250

013-002-00-1

aluminium powder (stabilised)

231-072-3

7429-90-5

Water-react. 2
Flam. Sol. 1

H261
H228

GHS02
Gef.

H261
H228

013-003-00-7

aluminium chloride, anhydrous

231-208-1

7446-70-0

Skin Corr. 1B

H314

GHS05
Gef.

H314

013-004-00-2

aluminium alkyls

Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B

H250
H260
H314

GHS02
GHS05
Gef.

H250
H260
H314

EUH014

013-005-00-8

diethyl(ethyldimethylsilanolato)aluminium

401-160-8

55426-95-4

Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A

H260
H250
H314

GHS02
GHS05
Gef.

H260
H250
H314

EUH014

013-006-00-3

(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised

402-370-2

Flam. Liq. 3
Eye Dam. 1

H226
H318

GHS02
GHS05
Gef.

H226
H318

013-007-00-9

poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)

403-430-0

Eye Dam. 1

H318

GHS05
Gef.

H318

013-008-00-4

di-n-octylaluminium iodide

408-190-0

7585-14-0

Pyr. Liq. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H250
H314
H400
H410

GHS02
GHS05
GHS09
Gef.

H250
H314
H410

EUH014

013-009-00-X

sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0.5 y = 1.5

418-720-2

Flam. Sol. 1
Water-react. 1
Pyr. Sol. 1
Acute Tox. 4 *
Skin Corr. 1A

H228
H260
H250
H332
H314

GHS02
GHS05
GHS07
Gef.

H228
H260
H250
H332
H314

EUH014

013-010-00-5

hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)

430-650-4

151841-65-5

Aquatic Chronic 2

H411

GHS09

H411

014-001-00-9

trichlorosilane

233-042-5

10025-78-2

Flam. Liq. 1
Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A

H224
H250
H332
H302
H314

GHS02
GHS05
GHS07
Gef.

H224
H250
H332
H302
H314

EUH014
EUH029

*
STOT SE 3; H335: C> 1 %

014-002-00-4

silicon tetrachloride

233-054-0

10026-04-7

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H319
H335
H315

GHS07
Achtg.

H319
H335
H315

EUH014

014-003-00-X

dimethyldichlorosilane

200-901-0

75-78-5

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H225
H319
H335
H315

GHS02
GHS07
Gef.

H225
H319
H335
H315

014-004-00-5

trichloro(methyl)silane;
methyltrichlorosilane

200-902-6

75-79-6

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H225
H319
H335
H315

GHS02
GHS07
Gef.

H225
H319
H335
H315

EUH014

Skin Irrit. 2; H315: C> 1 %
Eye Irrit. 2; H319: C> 1 %
STOT SE 3; H335: C> 1 %

014-005-00-0

tetraethyl silicate;
ethyl silicate

201-083-8

78-10-4

Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3

H226
H332
H319
H335

GHS02
GHS07
Achtg.

H226
H332
H319
H335

014-006-00-6

bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride

401-380-4

Eye Irrit. 2
Aquatic Chronic 2

H319
H411

GHS07
GHS09
Achtg.

H319
H411

014-007-00-1

triethoxyisobutylsilane

402-810-3

17980-47-1

Skin Irrit. 2

H315

GHS07
Achtg.

H315

014-008-00-7

(chloromethyl)bis(4-fluorophenyl)methylsilane

401-200-4

85491-26-5

Aquatic Chronic 2

H411

GHS09

H411

014-009-00-2

isobutylisopropyldimethoxysilane

402-580-4

111439-76-0

Flam. Liq. 3
Acute Tox. 4 *
Skin Irrit. 2

H226
H332
H315

GHS02
GHS07
Achtg.

H226
H332
H315

014-010-00-8

disodium metasilicate

229-912-9

6834-92-0

Skin Corr. 1B
STOT SE 3

H314
H335

GHS05
GHS07
Gef.

H314
H335

014-011-00-3

cyclohexyldimethoxymethylsilane

402-140-1

17865-32-6

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

014-012-00-9

bis(3-(trimethoxysilyl)propyl)amine

403-480-3

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

014-013-00-4

a-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)

404-920-7

Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2

H312
H302
H314
H411

GHS05
GHS07
GHS09
Gef.

H312
H302
H314
H411

014-014-00-X

etacelasil (ISO);
6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane

253-704-7

37894-46-5

Repr. 1B
Acute Tox. 4 *
STOT RE 2 *

H360D ***
H302
H373 **

GHS08
GHS07
Gef.

H360D ***
H302
H373 **

014-015-00-5

a-trimethylsilanyl-?-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane))

406-420-4

69430-40-6

Aquatic Chronic 4

H413

014-016-00-0

reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;
1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane

406-490-6

Aquatic Chronic 2

H411

GHS09

H411

014-017-00-6

flusilazole (ISO);
bis(4-fluorophenyl)(methyl)(1H - 1,2,4-triazol-1-ylmethyl)silane

85509-19-9

Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2

H351
H360D ***
H302
H411

GHS08
GHS07
GHS09
Gef.

H351
H360D ***
H302
H411

014-018-00-1

octamethylcyclotetrasiloxane

209-136-7

556-67-2

Repr. 2
Aquatic Chronic 4

H361f ***
H413

GHS08
Achtg.

H361f ***
H413

014-019-00-7

reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H - 1,2,4-triazole;
1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H - 1,2,4-triazole

403-250-2

Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2

H351
H360D ***
H302
H411

GHS08
GHS07
GHS09
Gef.

H351
H360D ***
H302
H411

014-020-00-2

bis(1,1-dimethyl-2-propynyloxy)dimethylsilane

414-960-7

53863-99-3

Acute Tox. 4 *

H332

GHS07
Achtg.

H332

014-021-00-8

tris(isopropenyloxy)phenyl silane

411-340-8

52301-18-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H400
H410

014-022-00-3

reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)

401-530-9

Flam. Sol. 1
STOT SE 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H228
H370 **
H332
H312
H302

GHS02
GHS08
GHS07
Gef.

H228
H370 **
H332
H312
H302

014-023-00-9

a, ?-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole

408-160-7

125613-45-8

Aquatic Chronic 2

H411

GHS09

H411

014-024-00-4

1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene

412-620-2

121626-74-2

Aquatic Chronic 2

H411

GHS09

H411

014-025-00-X

4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine

411-400-3

102089-33-8

Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H302
H373 **
H315
H318
H412

GHS08
GHS05
GHS07
Gef.

H302
H373 **
H315
H318
H412

014-026-00-5

dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane

407-180-3

770722-36-6

Skin Corr. 1A

H314

GHS05
Gef.

H314

014-027-00-0

chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane

410-270-5

770722-46-8

Skin Corr. 1A

H314

GHS05
Gef.

H314

014-028-00-6

a-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-?-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)

415-290-8

193159-06-7

Skin Sens. 1

H317

GHS07
Achtg.

H317

014-029-00-1

O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]

421-870-1

156145-66-3

Repr. 2
Acute Tox. 4 *
STOT RE 2 *

H361f ***
H302
H373 **

GHS08
GHS07
Achtg.

H361f ***
H302
H373 **

014-030-00-7

[(dimethylsilylene)bis((1,2,3,3a,7a-?)-1H-inden-1-ylidene)dimethyl]hafnium

422-060-0

137390-08-0

Acute Tox. 2 *

H300

GHS06
Gef.

H300

014-031-00-2

bis(1-methylethyl)-dimethoxysilane

421-540-7

18230-61-0

Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H226
H315
H317
H412

GHS02
GHS07
Achtg.

H226
H315
H317
H412

014-032-00-8

dicyclopentyldimethoxysilane

404-370-8

126990-35-0

Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H400
H410

GHS05
GHS09
Gef.

H315
H318
H410

014-033-00-3

2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica

419-030-4

125804-20-8

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3

H225
H319
H336

GHS02
GHS07
Gef.

H225
H319
H336

014-034-00-9

3-hexylheptamethyltrisiloxane

428-700-5

1873-90-1

Acute Tox. 4 *
Aquatic Chronic 4

H332
H413

GHS07
Achtg.

H332
H413

014-035-00-4

2-(3,4-epoxycyclohexyl)ethyltriethoxy silane

425-050-4

10217-34-2

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

014-036-00-X

(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane

405-020-7

105024-66-6

Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H360F***
H400
H410

GHS08
GHS09
Gef.

H360F***
H410

M=1000

014-037-00-5

2-butanone-O,O',O''-(phenylsilylidyne)trioxime

433-360-6

34036-80-1

STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3

H373**
H317
H412

GHS08
GHS07
Achtg.

H373**
H317
H412

014-038-00-0

S-(3-(triethoxysilyl)propyl) octanethioate

436-690-9

220727-26-4

Skin Sens. 1

H317

GHS07
Achtg.

H317

014-039-00-6

(2,3-dimethylbut-2-yl)-trimethoxysilane

439-360-2

142877-45-0

Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H315
H318
H412

GHS05
Gef.

H315
H318
H412

014-041-00-7

N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane

445-890-5

201290-01-9

Acute Tox. 4 *
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

014-042-00-2

reaction mass of:O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)

423-010-0

Eye Dam. 1

H318

GHS05
Gef.

H318

014-043-00-8

reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)

432-200-2

STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H335
H315
H318
H412

GHS05
GHS07
Gef.

H335
H315
H318
H412

014-044-00-3

3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane

433-050-0

Aquatic Chronic 2

H411

GHS09

H411

014-045-00-9

magnesium sodium fluoride silicate

442-650-1

STOT RE 2 *

H373**

GHS08
Achtg.

H373**

014-046-00-4

E-Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender repräsentativer Zusammensetzung (Angabe in % Massenanteil): SiO₂ 50,0-56,0 %, Al₂O₃ 13,0-16,0 %, B₂O₃ 5,8-10,0 %, Na₂O < 0,6 %, K₂O < 0,4 %, CaO 15,0-24,0 %, MgO < 5,5 %, Fe₂O₃ < 0,5 %, F₂ < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).]

Carc. 1B

H350i

GHS08
Gef.

H350i

014-047-00-X

Glas-Mikrofasern in repräsentativer Zusammensetzung; [ungerichtete Calcium-Aluminium-Silicat-Fasern mit folgender Zusammensetzung (Angabe in % Massenanteil): SiO₂ 55,0-60,0 %, Al₂O₃ 4,0-7,0 %, B₂O₃ 8,0-11,0 %, ZrO₂ 0,0-4,0 %, Na₂O 9,5-13,5 %, K₂O 0,0-4,0 %, CaO 1,0-5,0 %, MgO 0,0-2,0 %, Fe₂O₃ < 0,2 %, ZnO 2,0-5,0 %, BaO 3,0-6,0 %, F₂ < 1,0 %. Verfahren: Herstellung typischerweise im Düsenblasverfahren oder im Schleuderverfahren. (Weitere Einzelelemente können in geringen Mengen vorhanden sein. Die Verfahrensliste schließt Innovationen nicht aus).]

Carc. 2

H351 (Einatmen)

GHS08
Achtg.

H351 (Einatmen)

015-001-00-1

white phosphorus

231-768-7

12185-10-3

Pyr. Sol. 1
Acute Tox. 2 *
Acute Tox. 2 *
Skin Corr. 1a
Aquatic Acute 1

H250
H330
H300
H314
H400

GHS02
GHS06
GHS05
GHS09
Gef.

H250
H330
H300
H314
H400

015-002-00-7

red phosphorus

231-768-7

7723-14-0

Flam. Sol. 1
Aquatic Chronic 3

H228
H412

GHS02
Gef.

H228
H412

015-003-00-2

Calciumphosphid; Tricalciumdiphosphid

215-142-0

1305-99-3

Water-react. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 1
Eye Dam. 1
Aquatic Acute 1

H260
H300
H311
H330
H318
H400

GHS02
GHS06
GHS05
GHS09
Gef.

H260
H300
H311
H330
H318
H400

EUH029
EUH032

M = 100

015-004-00-8

aluminium phosphide

244-088-0

20859-73-8

Water-react. 1

H260

GHS02

H260

EUH029

M = 100

Acute Tox. 2

H300

GHS06

H300

EUH032

Acute Tox. 3

H311

GHS09

H311

Acute Tox. 1

H330

Gef.

H330

Aquatic Acute 1

H400

015-005-00-3

magnesium phosphide;
trimagnesium
diphosphide

235-023-7

12057-74-8

Water-react. 1

H260

GHS02

H260

EUH029

M = 100

Acute Tox. 2

H300

GHS06

H300

EUH032

Acute Tox. 3

H311

GHS09

H311

Acute Tox. 1

H330

Gef.

H330

Aquatic Acute 1

H400

015-006-00-9

trizinc diphosphide;
zinc phosphide

215-244-5

1314-84-7

Water-react. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H260
H300
H400
H410

GHS02
GHS06
GHS09
Gef.

H260
H300
H410

EUH029
EUH032

M=100

015-007-00-4

phosphorus trichloride

231-749-3

7719-12-2

Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Skin Corr. 1A

H330
H300
H373 **
H314

GHS06
GHS08
GHS05
Gef.

H330
H300
H373 **
H314

EUH014
EUH029

015-008-00-X

phosphorus pentachloride

233-060-3

10026-13-8

Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B

H330
H302
H373 **
H314

GHS06
GHS08
GHS05
Gef.

H330
H302
H373 **
H314

EUH014
EUH029

015-009-00-5

phosphoryl trichloride

233-046-7

10025-87-3

Acute Tox. 2 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1A

H330
H372 **
H302
H314

GHS06
GHS08
GHS05
Gef.

H330
H372 **
H302
H314

EUH014
EUH029

015-010-00-0

phosphorus pentoxide

215-236-1

1314-56-3

Skin Corr. 1A

H314

GHS05
Gef.

H314

015-011-00-6

phosphoric acid ... %, orthophosphoric acid ... %

231-633-2

7664-38-2

Skin Corr. 1B

H314

GHS05
Gef.

H314

Skin Corr. 1B; H314: C> 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %

015-012-00-1

tetraphosphorus trisulphide;
phosphorus sesquisulphid

215-245-0

1314-85-8

Flam. Sol. 2
Water-react. 1
Acute Tox. 4 *
Aquatic Acute 1

H228
H260
H302
H400

GHS02
GHS07
GHS09
Gef.

H228
H260
H302
H400

015-013-00-7

triethyl phosphate

201-114-5

78-40-0

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

015-014-00-2

tributyl phosphate

204-800-2

126-73-8

Carc. 2
Acute Tox. 4 *
Skin Irrit. 2

H351
H302
H315

GHS08
GHS07
Achtg.

H351
H302
H315

015-015-00-8

tricresyl phosphate (o -o -o-,o -o -m-,o -o -p-,o -m -m-,o -m -p-,o -p -p-);
tritolyl phosphate (o -o -o-,o -o -m-,o -o -p-,o -m -m-,o -m -p-,o -p -p-);

201-103-5

78-30-8

STOT SE 1
Aquatic Chronic 2

H370 **
H411

GHS08
GHS09
Gef.

H370 **
H411

STOT SE 1; H370: C> 1 %
STOT SE 2; H371: 0,2 % ≤ C < 1 %

015-016-00-3

tricresyl phosphate (m -m -m-,m -m -p-,m -p -p-,p -p -p-);
tritolyl phosphate (m -m -m-,m -m -p-,m -p -p-,p -p -p-);

201-105-6

78-32-0

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2

H312
H302
H411

GHS07
GHS09
Achtg.

H312
H302
H411

015-019-00-X

dichlorvos (ISO);
2,2-dichlorovinyl dimethyl phosphate

200-547-7

62-73-7

Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1

H330
H311
H301
H317
H400

GHS06
GHS09
Gef.

H330
H311
H301
H317
H400

M=1000

015-020-00-5

mevinphos (ISO);
2-methoxycarbonyl-1-methylvinyl dimethyl phosphate

232-095-1

7786-34-7

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

M=10000

015-021-00-0

trichlorfon (ISO);
dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate

200-149-3

52-68-6

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H400
H410

M=1000

015-022-00-6

phosphamidon (ISO);
2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate

236-116-5

13171-21-6

Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H341
H300
H311
H400
H410

GHS06
GHS08
GHS09
Gef.

H341
H300
H311
H410

015-023-00-1

pyrazoxon;
diethyl 3-methylpyrazol-5-yl phosphate

108-34-9

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *

H330
H310
H300

GHS06
Gef.

H330
H310
H300

015-024-00-7

triamiphos (ISO);
5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide

1031-47-6

Acute Tox. 1
Acute Tox. 2 *

H310
H300

GHS06
Gef.

H310
H300

015-025-00-2

TEPP (ISO);
tetraethyl pyrophosphate

203-495-3

107-49-3

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1

H310
H300
H400

GHS06
GHS09
Gef.

H310
H300
H400

015-026-00-8

schradan (ISO);
octamethylpyrophosphoramide

205-801-0

152-16-9

Acute Tox. 1
Acute Tox. 2 *

H310
H300

GHS06
Gef.

H310
H300

015-027-00-3

sulfotep (ISO);
O,O,O,O-tetraethyl dithiopyrophosphate

222-995-2

3689-24-5

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

M=1000

015-028-00-9

demeton-O (ISO);
O,O-diethyl-O-2-ethylthioethyl phosphorothioate

206-053-8

298-03-3

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1

H310
H300
H400

GHS06
GHS09
Gef.

H310
H300
H400

015-029-00-4

demeton-S (ISO);
diethyl-S-2-ethylthioethyl phosphorothioate

204-801-8

126-75-0

Acute Tox. 1
Acute Tox. 2 *

H310
H300

GHS06
Gef.

H310
H300

015-030-00-X

demeton-O-methyl (ISO);
O-2-ethylthioethylO,O-dimethyl phosphorothioate

212-758-1

867-27-6

Acute Tox. 3 *

H301

GHS06
Gef.

H301

015-031-00-5

demeton-S-methyl (ISO);
S-2-ethylthioethyl dimethyl phosphorothioate

213-052-6

919-86-8

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2

H311
H301
H411

GHS06
GHS09
Gef.

H311
H301
H411

015-032-00-0

prothoate (ISO);
O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate

218-893-2

2275-18-5

Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 3

H310
H300
H412

GHS06
Gef.

H310
H300
H412

015-033-00-6

phorate (ISO);
O,O-diethyl ethylthiomethyl phosphorodithioate

206-052-2

298-02-2

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

M=1000

015-034-00-1

parathion (ISO);
O,O-diethylO-4-nitrophenyl phosphorothioate

200-271-7

56-38-2

Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H311
H372 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H300
H311
H372 **
H410

M=100

015-035-00-7

parathion - methyl (ISO);
O,O-dimethylO-4-nitrophenyl phosphorothioate

206-050-1

298-00-0

Flam. Liq. 3
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H226
H330
H300
H311
H373 **
H400
H410

GHS02
GHS06
GHS08
GHS09
Gef.

H226
H330
H300
H311
H373 **
H410

M=100

015-036-00-2

O-ethylO-4-nitrophenyl phenylphosphonothioate;
EPN

218-276-8

2104-64-5

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

015-037-00-8

phenkapton (ISO);
S-(2,5-dichlorophenylthiomethyl)O,O-diethyl phosphorodithioate

218-892-7

2275-14-1

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H410

015-038-00-3

coumaphos (ISO);
O-3-chloro-4-methylcoumarin-7-ylO,O-diethyl phosphorothioate

200-285-3

56-72-4

Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H312
H400
H410

GHS06
GHS09
Gef.

H300
H312
H410

015-039-00-9

azinphos-methyl (ISO);
O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate

201-676-1

86-50-0

Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H311
H317
H400
H410

GHS06
GHS09
Gef.

H330
H300
H311
H317
H410

015-040-00-4

diazinon (ISO);
O,O-diethylO-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate

206-373-8

333-41-5

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H400
H410

015-041-00-X

malathion (ISO);
1,2-bis(ethoxycarbonyl)ethylO,O-dimethyl phosphorodithioate;
[containing ≤ 0,03 % isomalathion]

204-497-7

121-75-5

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

M=1000

015-042-00-5

chlorthion
O-(3-chloro-4-nitrophenyl)O,O-dimethyl phosphorothioate

207-902-5

500-28-7

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

M=100

015-043-00-0

phosnichlor (ISO);
O-4-chloro-3-nitrophenylO,O-dimethyl phosphorothioate

5826-76-6

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H332
H312
H302

GHS07
Achtg.

H332
H312
H302

015-044-00-6

carbophenothion (ISO);
4-chlorophenylthiomethylO,O-diethyl phosphorodithioate

212-324-1

786-19-6

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H311
H301
H400
H410

GHS06
GHS09
Gef.

H311
H301
H410

015-045-00-1

mecarbam (ISO);
N-ethoxycarbonyl-N-methylcarbamoylmethylO,O-diethyl phosphorodithioate

219-993-9

2595-54-2

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H311
H301
H400
H410

GHS06
GHS09
Gef.

H311
H301
H400
H410

015-046-00-7

oxydemeton-methyl;
S-2-(ethylsulphinyl)ethylO,O-dimethyl phosphorothioate

206-110-7

301-12-2

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1

H311
H301
H400

GHS06
GHS09
Gef.

H311
H301
H400

015-047-00-2

ethion (ISO);
O,O,O',O'-tetraethylS,S'-methylenedi (phosphorodithioate);
diethion

209-242-3

563-12-2

Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H312
H400
H410

GHS06
GHS09
Gef.

H301
H312
H410

M=10000

015-048-00-8

fenthion (ISO);
O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate

200-231-9

55-38-9

Muta. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H341
H331
H312
H302
H372**
H400
H410

GHS06
GHS08
GHS09
Gef.

H341
H331
H312
H302
H372**
H410

M=100

015-049-00-3

endothion (ISO);
S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate

220-472-3

2778-04-3

Acute Tox. 3 *
Acute Tox. 3 *

H311
H301

GHS06
Gef.

H311
H301

015-050-00-9

thiometon (ISO);
S-2-ethylthioethylO,O-dimethyl phosphorodithioate

211-362-6

640-15-3

Acute Tox. 3 *
Acute Tox. 4 *

H301
H312

GHS06
Gef.

H301
H312

015-051-00-4

dimethoate (ISO);
O,O-dimethyl methylcarbamoylmethyl phosphorodithioate

200-480-3

60-51-5

Acute Tox. 4 *
Acute Tox. 4 *

H312
H302

GHS07
Achtg.

H312
H302

015-052-00-X

fenchlorphos (ISO);
O,O-dimethylO - 2,4,5-trichlorophenyl phosphorothioate

206-082-6

299-84-3

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

015-053-00-5

menazon (ISO);
S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate

201-123-4

78-57-9

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

015-054-00-0

fenitrothion (ISO);
O,O-dimethylO-4-nitro-m-tolyl phosphorothioate

204-524-2

122-14-5

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

015-055-00-6

naled (ISO);
1,2-dibromo-2,2-dichloroethyl dimethyl phosphate

206-098-3

300-76-5

Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1

H312
H302
H319
H315
H400

GHS07
GHS09
Achtg.

H312
H302
H319
H315
H400

M=1000

015-056-00-1

azinphos-ethyl (ISO);
O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate

220-147-6

2642-71-9

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H311
H400
H410

GHS06
GHS09
Gef.

H300
H311
H410

M=100

015-057-00-7

formothion (ISO);
N-formyl-N-methylcarbamoylmethylO,O-dimethyl phosphorodithioate

219-818-6

2540-82-1

Acute Tox. 4 *
Acute Tox. 4 *

H312
H302

GHS07
Achtg.

H312
H302

015-058-00-2

morphothion (ISO);
O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate

205-628-0

144-41-2

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H410

015-059-00-8

vamidothion (ISO);
O,O-dimethylS-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate

218-894-8

2275-23-2

Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1

H301
H312
H400

GHS06
GHS09
Gef.

H301
H312
H400

015-060-00-3

disulfoton (ISO);
O,O-diethyl 2-ethylthioethyl phosphorodithioate

206-054-3

298-04-4

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

015-061-00-9

dimefox (ISO);
tetramethylphosphorodiamidic fluoride

204-076-8

115-26-4

Acute Tox. 1
Acute Tox. 2 *

H310
H300

GHS06
Gef.

H310
H300

015-062-00-4

mipafox (ISO);
N,N'- di-isopropylphosphorodiamidic fluoride

206-742-3

371-86-8

STOT SE 1

H370 **

GHS08
Gef.

H370 **

015-063-00-X

dioxathion (ISO);
1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)

201-107-7

78-34-2

Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H311
H400
H410

GHS06
GHS09
Gef.

H330
H300
H311
H410

M=1000

015-064-00-5

bromophos-ethyl (ISO);
O-4-bromo-2,5-dichlorophenylO,O-diethyl phosphorothioate

225-399-0

4824-78-6

Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H312
H400
H410

GHS06
GHS09
Gef.

H301
H312
H410

015-065-00-0

S-[2-(ethylsulphinyl)ethyl]O,O-dimethyl phosphorodithioate

2703-37-9

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2

H330
H310
H300
H411

GHS06
GHS09
Gef.

H330
H310
H300
H411

015-066-00-6

omethoate (ISO);
O,O-dimethylS-methylcarbamoylmethyl phosphorothioate

214-197-8

1113-02-6

Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1

H301
H312
H400

GHS06
GHS09
Gef.

H301
H312
H400

015-067-00-1

phosalone (ISO);
S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl)O,O-diethyl phosphorodithioate

218-996-2

2310-17-0

Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H332
H312
H317
H400
H410

GHS06
GHS09
Gef.

H301
H332
H312
H317
H410

M=1000

015-068-00-7

dichlofenthion (ISO);
O - 2,4-dichlorophenylO,O-diethyl phosphorothioate

202-564-5

97-17-6

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H400
H410

015-069-00-2

methidathion (ISO);
2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate

213-449-4

950-37-8

Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H312
H400
H410

GHS06
GHS09
Gef.

H300
H312
H410

015-070-00-8

cyanthoate (ISO);
S-(N-(1-cyano-1-methylethyl)carbamoylmethyl)O,O-diethyl phosphorothioate

223-099-4

3734-95-0

Acute Tox. 2 *
Acute Tox. 3 *

H300
H311

GHS06
Gef.

H300
H311

015-071-00-3

chlorfenvinphos (ISO);
2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate

207-432-0

470-90-6

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H311
H400
H410

GHS06
GHS09
Gef.

H300
H311
H410

015-072-00-9

monocrotophos (ISO);
dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate

230-042-7

6923-22-4

Muta. 2
Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H341
H330
H300
H311
H400
H410

GHS06
GHS08
GHS09
Gef.

H341
H330
H300
H311
H410

015-073-00-4

dicrotophos (ISO);
(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate

205-494-3

141-66-2

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H311
H400
H410

GHS06
GHS09
Gef.

H300
H311
H410

015-074-00-X

crufomate (ISO);
4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate

206-083-1

299-86-5

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

015-075-00-5

S-[2-(isopropylsulphinyl)ethyl]O,O-dimethyl phosphorothioate

2635-50-9

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H331
H311
H301

GHS06
Gef.

H331
H311
H301

015-076-00-0

potasan;
O, O-diethylO-(4-methylcoumarin-7-yl) phosphorothioate

299-45-6

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H400
H410

GHS06
GHS09
Gef.

H330
H310
H300
H410

M=1000

015-077-00-6

2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate

7076-53-1

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H331
H311
H301

GHS06
Gef.

H331
H311
H301

015-078-00-1

demeton-S-methylsulphon (ISO);
S-2-ethylsulphonylethyl dimethyl phosphorothioate

241-109-5

17040-19-6

Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Chronic 2

H301
H312
H411

GHS06
GHS09
Gef.

H301
H312
H411

015-079-00-7

acephate (ISO);
O,S-dimethyl acetylphosphoramidothioate

250-241-2

30560-19-1

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

015-080-00-2

amidithion (ISO);
2-methoxyethylcarbamoylmethylO,O-dimethyl phosphorodithioate

919-76-6

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

015-081-00-8

O,O,O',O'-tetrapropyl dithiopyrophosphate

221-817-0

3244-90-4

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

015-082-00-3

azothoate (ISO);
O-4-(4-chlorophenylazo)phenylO,O-dimethyl phosphorothioate

227-419-3

5834-96-8

Acute Tox. 4 *
Acute Tox. 4 *

H332
H302

GHS07
Achtg.

H332
H302

015-083-00-9

bensulide (ISO);
O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate

212-010-4

741-58-2

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

015-084-00-4

chlorpyrifos (ISO);
O,O-diethylO - 3,5,6-trichloro-2-pyridyl phosphorothioate

220-864-4

2921-88-2

Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H400
H410

GHS06
GHS09
Gef.

H301
H400
H410

M=10000

015-085-00-X

chlorphonium chloride (ISO);
tributyl (2,4-dichlorobenzyl) phosphonium chloride

204-105-4

115-78-6

Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2

H301
H312
H319
H315

GHS06
Gef.

H301
H312
H319
H315

015-086-00-5

coumithoate (ISO);
O,O-diethylO - 7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate

572-48-5

Acute Tox. 3 *

H301

GHS06
Gef.

H301

015-087-00-0

cyanophos (ISO);
O-4-cyanophenylO,O-dimethyl phosphorothioate

220-130-3

2636-26-2

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

015-088-00-6

dialifos (ISO);
2-chloro-1-phthalimidoethylO,O-diethyl phosphorodithioate

233-689-3

10311-84-9

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H311
H400
H410

GHS06
GHS09
Gef.

H300
H311
H400
H410

015-089-00-1

ethoate-methyl (ISO);
ethylcarbamoylmethylO,O-dimethyl phosphorodithioate

204-121-1

116-01-8

Acute Tox. 4 *
Acute Tox. 4 *

H312
H302

GHS07
Achtg.

H312
H302

015-090-00-7

fensulfothion (ISO);
O,O-diethylO-4-methylsulfinylphenyl phosphorothioate

204-114-3

115-90-2

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

015-091-00-2

fonofos (ISO);
O-ethyl phenyl ethylphosphonodithioate

213-408-0

944-22-9

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

015-092-00-8

phosacetim (ISO);
O,O-bis(4-chlorophenyl)N-acetimidoylphosphoramidothioate

223-874-7

4104-14-7

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

015-093-00-3

leptophos (ISO);
O-4-bromo-2,5-dichlorophenylO-methyl phenylphosphorothioate

244-472-8

21609-90-5

Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H370 **
H312
H400
H410

GHS06
GHS08
GHS09
Gef.

H301
H370 **
H312
H410

015-094-00-9

mephosfolan (ISO);
diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate

213-447-3

950-10-7

Acute Tox. 1
Acute Tox. 2 *
Aquatic Chronic 2

H310
H300
H411

GHS06
GHS09
Gef.

H310
H300
H411

015-095-00-4

methamidophos (ISO);
O,S-dimethyl phosphoramidothioate

233-606-0

10265-92-6

Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1

H330
H300
H311
H400

GHS06
GHS09
Gef.

H330
H300
H311
H400

015-096-00-X

oxydisulfoton (ISO);
O, O-diethylS-2-ethylsulphinylethyl phosphorodithioate

219-679-1

2497-07-6

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H311
H400
H410

GHS06
GHS09
Gef.

H300
H311
H410

M=10

015-097-00-5

phenthoate (ISO);
ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate

219-997-0

2597-03-7

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

M=100

015-098-00-0

trichloronate (ISO);
O-ethylO - 2,4,5-trichlorophenyl ethylphosphonothioate

206-326-1

327-98-0

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H311
H400
H410

GHS06
GHS09
Gef.

H300
H311
H410

015-099-00-6

pirimiphos-ethyl (ISO);
O,O-diethylO-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate

245-704-0

23505-41-1

Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H312
H400
H410

GHS06
GHS09
Gef.

H301
H312
H410

015-100-00-X

phoxim (ISO);
a-(diethoxyphosphinothioylimino) phenylacetonitrile

238-887-3

14816-18-3

Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361f***
H302
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361f***
H302
H317
H410

M=1000

015-101-00-5

phosmet (ISO);
O,O-dimethyl phthalimidomethylS-phosphorodithioate

211-987-4

732-11-6

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

M=100

015-102-00-0

tris(2-chloroethyl)phosphate

204-118-5

115-96-8

Carc. 2
Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2

H351
H360F***
H302
H411

GHS08
GHS07
GHS09
Gef.

H351
H360F***
H302
H411

015-103-00-6

phosphorus tribromide

232-178-2

7789-60-8

Skin Corr. 1B
STOT SE 3

H314
H335

GHS05
GHS07
Gef.

H314
H335

EUH014

015-104-00-1

diphosphorus pentasulphide;
phosphorus pentasulphide

215-242-4

1314-80-3

Flam. Sol. 1
Water-react. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1

H228
H260
H332
H302
H400

GHS02
GHS07
GHS09
Gef.

H228
H260
H332
H302
H400

EUH029

015-105-00-7

triphenyl phosphite

202-908-4

101-02-0

Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H315
H410

Skin Irrit. 2; H315: C> 5 %
Eye Irrit. 2; H319: C> 5 %

015-106-00-2

hexamethylphosphoric triamide;
hexamethylphosphoramide

211-653-8

680-31-9

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

Carc. 1B; H350: C> 0.01 %

015-107-00-8

ethoprophos (ISO);
ethyl-S,S-dipropyl phosphorodithioate

236-152-1

13194-48-4

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H301
H317
H400
H410

GHS06
GHS09
Gef.

H330
H310
H301
H317
H410

015-108-00-3

bromophos (ISO);
O-4-bromo-2,5-dichlorophenylO,O-dimethyl phosphorothioate

218-277-3

2104-96-3

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M=100

015-109-00-9

crotoxyphos (ISO);
1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate

231-720-5

7700-17-6

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H311
H301
H400
H410

GHS06
GHS09
Gef.

H311
H301
H410

M=10

015-110-00-4

cyanofenphos (ISO);
O-4-cyanophenylO-ethyl phenylphosphonothioate

13067-93-1

Acute Tox. 3 *
STOT SE 1
Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2

H301
H370 **
H312
H319
H411

GHS06
GHS08
GHS09
Gef.

H301
H370 **
H312
H319
H411

015-111-00-X

phosfolan (ISO);
diethyl 1,3-dithiolan-2-ylidenephosphoramidate

213-423-2

947-02-4

Acute Tox. 1
Acute Tox. 2 *

H310
H300

GHS06
Gef.

H310
H300

015-112-00-5

thionazin (ISO);
O,O-diethylO-pyrazin-2-yl phosphorothioate;

206-049-6

297-97-2

Acute Tox. 1
Acute Tox. 2 *

H310
H300

GHS06
Gef.

H310
H300

015-113-00-0

tolclofos-methyl (ISO);
O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate

260-515-3

57018-04-9

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

015-114-00-6

chlormephos (ISO);
S-chloromethylO,O-diethyl phosphorodithioate

246-538-1

24934-91-6

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

M = 10

015-115-00-1

chlorthiophos (ISO);
[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]

244-663-6

21923-23-9

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H311
H400
H410

GHS06
GHS09
Gef.

H300
H311
H410

M = 1000

015-116-00-7

demephion-O (ISO);
O,O-dimethylO-2-methylthioethyl phosphorothioate

211-666-9

682-80-4

Acute Tox. 2 *
Acute Tox. 3 *

H300
H311

GHS06
Gef.

H300
H311

015-117-00-2

demephion-S (ISO);
O,O-dimethylS-2-methylthioethyl phosphorothioate

219-971-9

2587-90-8

Acute Tox. 2 *
Acute Tox. 3 *

H300
H311

GHS06
Gef.

H300
H311

015-118-00-8

demeton

8065-48-3

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1

H310
H300
H400

GHS06
GHS09
Gef.

H310
H300
H400

015-119-00-3

dimethyl 4-(methylthio)phenyl phosphate

3254-63-5

Acute Tox. 1
Acute Tox. 2 *

H310
H300

GHS06
Gef.

H310
H300

015-120-00-9

ditalimfos (ISO);
O,O-diethyl phthalimidophosphonothioate

225-875-8

5131-24-8

Skin Irrit. 2
Skin Sens. 1

H315
H317

GHS07
Achtg.

H315
H317

015-121-00-4

edifenphos (ISO);
O-ethylS,S-diphenyl phosphorodithioate

241-178-1

17109-49-8

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H312
H317
H400
H410

GHS06
GHS09
Gef.

H331
H301
H312
H317
H410

015-122-00-X

etrimfos (ISO);
O-6-ethoxy-2-ethylpyrimidin-4-ylO,O-dimethylphosphorothioate

253-855-9

38260-54-7

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M=10

015-123-00-5

fenamiphos (ISO);
ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate

244-848-1

22224-92-6

Acute Tox. 2

H300

GHS06

H300

M = 100

Acute Tox. 2

H310

GHS09

H310

M = 100

Acute Tox. 2

H330

Gef.

H330

Eye Irrit. 2

H319

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

015-124-00-0

fosthietan (ISO);
diethyl 1,3-dithietan-2-ylidenephosphoramidate

244-437-7

21548-32-3

Acute Tox. 1
Acute Tox. 2 *

H310
H300

GHS06
Gef.

H310
H300

015-125-00-6

glyphosine (ISO);
N,N-bis(phosphonomethyl)glycine

219-468-4

2439-99-8

Eye Dam. 1

H318

GHS05
Gef.

H318

015-126-00-1

heptenophos (ISO);
7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate

245-737-0

23560-59-0

Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H400
H410

GHS06
GHS09
Gef.

H301
H410

M=100

015-127-00-7

iprobenfos(ISO);
S-benzyl diisopropyl phosphorothioate

247-449-0

26087-47-8

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

015-128-00-2

IPSP;
S-ethylsulphinylmethylO,O-diisopropylphosphorodithioate

5827-05-4

Acute Tox. 1
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H301
H400
H410

GHS06
GHS09
Gef.

H310
H301
H410

M=100

015-129-00-8

isofenphos (ISO);
O-ethylO-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate

246-814-1

25311-71-1

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H311
H301
H400
H410

GHS06
GHS09
Gef.

H311
H301
H410

M=100

015-130-00-3

isothioate (ISO);
S-2-isopropylthioethylO,O-dimethyl phosphorodithioate;

36614-38-7

Acute Tox. 3 *
Acute Tox. 3 *

H311
H301

GHS06
Gef.

H311
H301

015-131-00-9

isoxathion (ISO);
O,O-diethylO-5-phenylisoxazol-3-ylphosphorothioate

242-624-8

18854-01-8

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H311
H301
H400
H410

GHS06
GHS09
Gef.

H311
H301
H410

015-132-00-4

S-(chlorophenylthiomethyl)O,O-dimethylphosphorodithioate;
methylcarbophenothione

953-17-3

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H311
H301
H400
H410

GHS06
GHS09
Gef.

H311
H301
H410

M=1000

015-133-00-X

piperophos (ISO);
S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate

24151-93-7

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M=10

015-134-00-5

pirimiphos-methyl (ISO);
O-(2-diethylamino-6-methylpyrimidin-4-yl)O,O-dimethyl phosphorothioate

249-528-5

29232-93-7

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

015-135-00-0

profenofos (ISO)
O-(4-bromo-2-chlorophenyl)O-ethylS-propyl phosphorothioate;

255-255-2

41198-08-7

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

M=1000

015-136-00-6

trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;
isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;
propetamphos (ISO)

250-517-2

31218-83-4

Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H400
H410

GHS06
GHS09
Gef.

H301
H410

M=100

015-137-00-1

pyrazophos (ISO);
O,O-diethylO-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate

236-656-1

13457-18-6

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H302
H410

015-138-00-7

quinalphos (ISO);
O,O-diethyl-O-quinoxalin-2-yl phosphorothioate

237-031-6

13593-03-8

Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H312
H400
H410

GHS06
GHS09
Gef.

H301
H312
H410

M=1000

015-139-00-2

terbufos (ISO);
S -tert-butylthiomethylO, O-diethylphosphorodithioate;

235-963-8

13071-79-9

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

M=1000

015-140-00-8

triazophos (ISO);
O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate

245-986-5

24017-47-8

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H312
H400
H410

GHS06
GHS09
Gef.

H331
H301
H312
H410

M=100

015-141-00-3

ethylenediammoniumO,O-bis(octyl) phosphorodithioate, mixed isomers

400-520-1

Skin Corr. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H314
H302
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H302
H410

015-142-00-9

butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate

401-100-0

Flam. Liq. 2
Eye Irrit. 2
Aquatic Chronic 2

H225
H319
H411

GHS02
GHS07
GHS09
Gef.

H225
H319
H411

015-143-00-4

reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate,
reaction mass of isomers

401-740-0

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

015-144-00-X

reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate

402-090-0

87025-52-3

Skin Corr. 1B

H314

GHS05
Gef.

H314

015-145-00-5

reaction mass of copper(I)O,O-diisopropyl phosphorodithioate and copper(I)O-isopropylO-(4-methylpent-2-yl) phosphorodithioate and copper(I)O,O-bis(4-methylpent-2-yl) phosphorodithioate

401-520-4

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

015-146-00-0

S-(tricyclo(5.2.1.0^2,6)deca-3-en-8(or 9)-ylO-(isopropyl or isobutyl or 2-ethylhexyl)O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate

401-850-9

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

015-147-00-6

reaction mass of C_12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)

400-930-0

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H315
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H411

015-148-00-1

2-(diphosphonomethyl)succinic acid

403-070-4

51395-42-7

Skin Corr. 1B
Skin Sens. 1

H314
H317

GHS05
GHS07
Gef.

H314
H317

015-149-00-7

reaction mass of: hexyldioctylphosphineoxide;
dihexyloctylphosphineoxide;
trioctylphosphineoxide

403-470-9

Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H314
H400
H410

GHS05
GHS09
Gef.

H314
H410

015-150-00-2

(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide

404-940-6

86608-70-0

Acute Tox. 4 *
Eye Dam. 1
STOT RE 2 *
Aquatic Chronic 3

H302
H318
H373 **
H412

GHS08
GHS05
GHS07
Gef.

H302
H318
H373 **
H412

015-151-00-8

tris(isopropyl/tert-butylphenyl) phosphate

405-010-2

Aquatic Chronic 2

H411

GHS09

H411

015-152-00-3

dioxabenzofos (ISO);
2-methoxy-4H - 1,3,2-benzodioxaphosphorin 2-sulphide

223-292-3

3811-49-2

Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1
Aquatic Chronic 2

H311
H301
H370 **
H411

GHS06
GHS08
GHS09
Gef.

H311
H301
H370 **
H411

015-153-00-9

isazofos (ISO);
O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl)O,O-diethyl phosphorothioate

255-863-8

42509-80-8

Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H311
H301
H373 **
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H311
H301
H373 **
H317
H410

015-154-00-4

ethephon; 2-chloroethylphosphonic acid

240-718-3

16672-87-0

Acute Tox. 3
Acute Tox. 4
Acute Tox. 4
Skin Corr. 1C
Aquatic Chronic 2

H311
H332
H302
H314
H411

GHS06
GHS05
GHS09
Gef.

H311
H332
H302
H314
H411

EUH071

015-155-00-X

glufosinate ammonium (ISO);
ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate

278-636-5

77182-82-2

Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *

H360Fd
H332
H312
H302
H373**

GHS08
GHS07
Gef.

H360Fd
H332
H312
H302
H373**

015-156-00-5

methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]
methacrifos (ISO);
methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]

250-366-9 [1]
- [2]

30864-28-9 [1]
62610-77-9 [2]

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

015-157-00-0

phosphonic acid; [1]
phosphorous acid [2]

237-066-7 [1]
233-663-1
[2]

13598-36-2 [1]
10294-56-1 [2]

Acute Tox. 4 *
Skin Corr. 1A

H302
H314

GHS05
GHS07
Gef.

H302
H314

015-158-00-6

(?-cyclopentadienyl)(?-cumenyl)iron(1+)hexafluorophosphate(1-)

402-340-9

32760-80-8

Aquatic Chronic 3

H412

015-159-00-1

hydroxyphosphonoacetic acid

405-710-8

23783-26-8

Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1

H302
H373 **
H314
H317

GHS08
GHS05
GHS07
Gef.

H302
H373 **
H314
H317

015-160-00-7

vanadyl pyrophosphate

406-260-5

58834-75-6

Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H319
H317
H412

GHS07
Achtg.

H319
H317
H412

015-161-00-2

divanadyl pyrophosphate

407-130-0

65232-89-5

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H317
H411

015-162-00-8

vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped

407-350-7

Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2

H332
H373 **
H318
H411

GHS08
GHS05
GHS07
GHS09
Gef.

H332
H373 **
H318
H411

015-163-00-3

bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide

412-010-6

145052-34-2

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

015-164-00-9

calciumP,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate

400-480-5

36669-85-9

Aquatic Chronic 3

H412

015-165-00-4

reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate

404-986-7

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

015-166-00-X

3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane

410-290-4

80693-00-1

Aquatic Chronic 4

H413

015-167-00-5

3-(hydroxyphenylphosphinyl)propanoic acid

411-200-6

14657-64-8

Eye Dam. 1

H318

GHS05
Gef.

H318

015-168-00-0

fosthiazate (ISO);
(RS)-S -sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate

98886-44-3

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H312
H317
H400
H410

GHS06
GHS09
Gef.

H331
H301
H312
H317
H410

EUH070

015-169-00-6

tributyltetradecylphosphonium tetrafluoroborate

413-520-1

Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373 **
H314
H317
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H302
H373 **
H314
H317
H410

015-170-00-1

reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;
1-octane-N,N,N-trimethylammonium di-octylphosphate;
1-octane-N,N,N-trimethylammonium octylphosphate

407-490-9

Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H312
H302
H314

GHS05
GHS07
Gef.

H312
H302
H314

015-171-00-7

O,O,O-tris(2(or 4)-C_9-10-isoalkylphenyl) phosphorothioate

406-940-1

Aquatic Chronic 2

H411

GHS09

H411

015-172-00-2

reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;
isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate

406-240-6

Flam. Liq. 3
Skin Corr. 1B
Aquatic Chronic 2

H226
H314
H411

GHS02
GHS05
GHS09
Gef.

H226
H314
H411

015-173-00-8

methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate

414-080-3

117291-73-3

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

015-174-00-3

1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine

411-370-1

82857-68-9

Acute Tox. 3 *
Eye Dam. 1
Aquatic Chronic 2

H301
H318
H411

GHS06
GHS05
GHS09
Gef.

H301
H318
H411

015-175-00-9

tert-butyl (triphenylphosphoranylidene) acetate

412-880-7

35000-38-5

Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H301
H373 **
H319
H317
H411

GHS06
GHS08
GHS09
Gef.

H301
H373 **
H319
H317
H411

015-176-00-4

P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine

413-430-2

116163-96-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

015-177-00-X

((4-phenylbutyl)hydroxyphosphoryl)acetic acid

412-170-7

83623-61-4

STOT RE 2 *
Eye Dam. 1
Skin Sens. 1

H373 **
H318
H317

GHS08
GHS05
Gef.

H373 **
H318
H317

015-178-00-5

(R)-a-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate

418-570-8

25383-07-7

Repr. 2
Aquatic Chronic 2

H361f ***
H411

GHS08
GHS09
Achtg.

H361f ***
H411

015-179-00-0

UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C_16-18 tallow alkylamine

422-720-8

166242-53-1

Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H373 **
H314
H317
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H351
H302
H373 **
H314
H317
H410

015-180-00-6

[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt

415-820-8

137590-32-0

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

015-181-00-1

phosphine

232-260-8

7803-51-2

Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1

H220
H330
H314
H400

GHS02
GHS04
GHS06
GHS05
GHS09
Gef.

H220
H330
H314
H400

015-182-00-7

tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)

430-630-5

10596-22-2

Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1

H302
H319
H317

GHS07
Achtg.

H302
H319
H317

015-183-00-2

(1-hydroxydodecylidene)diphosphonic acid

425-230-2

16610-63-2

Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H314
H400
H410

GHS05
GHS09
Gef.

H314
H410

015-184-00-8

Salts of glyphosate, with the exception of those specified elsewhere in this Annex

Aquatic Chronic 2

H411

GHS09

H411

015-186-00-9

chlorpyrifos-methyl (ISO)
O, O-dimethylO - 3,5,6-trichloro-2-pyridyl phosphorothioate

227-011-5

5598-13-0

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

M=10000

015-187-00-4

reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate,N-oxide;
trisodium ((tetrahydro-2-hydroxy-4H - 1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate,N-oxide,P-oxide

417-540-1

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

015-189-00-5

phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide

423-340-5

162881-26-7

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

015-190-00-0

bis(2,4-dicumylphenyl) neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane

421-920-2

154862-43-8

Aquatic Chronic 4

H413

015-191-00-6

dodecyldiphenyl phosphate

431-760-5

27460-02-2

Skin Irrit. 2
Aquatic Chronic 3

H315
H412

GHS07
Achtg.

H315
H412

015-192-00-1

tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate

432-770-2

139189-30-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

015-193-00-7

triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)

442-960-7

332350-93-3

Acute Tox. 3 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H318
H400
H410

GHS05
GHS06
GHS09
Gef.

H301
H318
H410

015-194-00-2

tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate

444-440-5

220689-12-3

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

015-195-00-8

reaction mass of: potassiumo-toluenephosphonate;
potassiumm-toluenephosphonate;
potassiump-toluenephosphonate

433-860-4

Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H319
H317
H412

GHS07
Achtg.

H319
H317
H412

015-196-00-3

reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate

435-960-3

Carc. 1B
Muta. 1B
Skin Sens. 1

H350
H340
H317

GHS08
GHS07
Gef.

H350
H340
H317

015-197-00-9

bis(2,4,4-trimethylpentyl)dithiophosphonic acid

420-160-9

107667-02-7

Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2

H226
H331
H302
H314
H411

GHS02
GHS06
GHS05
GHS09
Gef.

H226
H331
H302
H314
H411

015-198-00-4

(4-phenylbutyl)phosphinic acid

420-450-5

86552-32-1

Carc. 2
Eye Dam. 1

H351
H318

GHS05
GHS08
Gef.

H351
H318

015-199-00-X

tris[2-chloro-1-chloromethyl)ethyl] phosphate

237-159-2

13674-87-8

Carc. 2

H351

GSH08
Achtg.

H351

015-200-00-3

indium phosphide

244-959-5

22398-80-7

Carc. 1B
Repr. 2
STOT RE 1

H350
H361f
H372 (Lunge)

GHS08
Gef.

H350
H361f
H372 (Lunge)

STOT RE 1;
H372: C> 0,1 %
Carc 1B;
H350: C> 0,01 %
STOT RE 2;
H373: 0,01 % ≤ C < 0,1 %

015-201-00-9

trixylyl phosphate

246-677-8

25155-23-1

Repr. 1B

H360F

GHS08
Gef.

H360F

015-202-00-4

tris(nonylphenyl) phosphite

247-759-6

26523-78-4

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

015-203-00-X

diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide

278-355-8

75980-60-8

Repr. 2

H361f (verursacht Hodenatrophie)

GHS08
Achtg.

H361f (verursacht Hodenatrophie)

016-001-00-4

hydrogen sulphide

231-977-3

7783-06-4

Flam. Gas 1
Press. Gas
Acute Tox. 2 *
Aquatic Acute 1

H220
H330
H400

GHS02
GHS04
GHS06
GHS09
Gef.

H220
H330
H400

016-002-00-X

barium sulphide

244-214-4

21109-95-5

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1

H332
H302
H400

GHS07
GHS09
Achtg.

H332
H302
H400

EUH031

016-003-00-5

barium polysulphides

256-814-3

50864-67-0

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1

H319
H335
H315
H400

GHS07
GHS09
Achtg.

H319
H335
H315
H400

EUH031

016-004-00-0

calcium sulphide

243-873-5

20548-54-3

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1

H319
H335
H315
H400

GHS07
GHS09
Achtg.

H319
H335
H315
H400

EUH031

016-005-00-6

calcium polysulphides

215-709-2

1344-81-6

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1

H319
H335
H315
H400

GHS07
GHS09
Achtg.

H319
H335
H315
H400

EUH031

016-006-00-1

dipotassium sulphide;
potassium sulphide

215-197-0

1312-73-8

Skin Corr. 1B
Aquatic Acute 1

H314
H400

GHS05
GHS09
Gef.

H314
H400

EUH031

016-007-00-7

potassium polysulphides

253-390-1

37199-66-9

Skin Corr. 1B
Aquatic Acute 1

H314
H400

GHS05
GHS09
Gef.

H314
H400

EUH031

016-008-00-2

ammonium polysulphides

232-989-1

9080-17-5

Skin Corr. 1B
Aquatic Acute 1

H314
H400

GHS05
GHS09
Gef.

H314
H400

EUH031

EUH031: C> 1 %

016-009-00-8

disodium sulfide;
sodium sulfide

215-211-5

1313-82-2

Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1

H311
H302
H314
H400

GHS06
GHS05
GHS09
Gef.

H311
H302
H314
H400

016-010-00-3

sodium polysulphides

215-686-9

1344-08-7

Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1

H301
H314
H400

GHS06
GHS05
GHS09
Gef.

H301
H314
H400

EUH031

016-011-00-9

sulphur dioxide

231-195-2

7446-09-5

Press. Gas
Acute Tox. 3 *
Skin Corr. 1B

H331
H314

GHS04
GHS06
GHS05
Gef.

H331
H314

016-012-00-4

disulphur dichloride;
sulfur monochloride

233-036-2

10025-67-9

Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1a
Aquatic Acute 1

H301
H332
H314
H400

GHS06
GHS05
GHS09
Gef.

H301
H332
H314
H400

EUH014
EUH029

STOT SE 3; H335: C> 1 %

016-013-00-X

sulphur dichloride

234-129-0

10545-99-0

Skin Corr. 1B
STOT SE 3
Aquatic Acute 1

H314
H335
H400

GHS05
GHS07
GHS09
Gef.

H314
H335
H400

EUH014

STOT SE 3; H335: C> 5 %

016-014-00-5

sulphur tetrachloride

13451-08-6

Skin Corr. 1B
Aquatic Acute 1

H314
H400

GHS05
GHS09
Gef.

H314
H400

EUH014

STOT SE 3; H335: C> 5 %

016-015-00-0

thionyl dichloride;
thionyl chloride

231-748-8

7719-09-7

Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A

H332
H302
H314

GHS05
GHS07
Gef.

H332
H302
H314

EUH014
EUH029

STOT SE 3; H335: C> 1 %

016-016-00-6

sulphuryl chloride

232-245-6

7791-25-5

Skin Corr. 1B
STOT SE 3

H314
H335

GHS05
GHS07
Gef.

H314
H335

EUH014

016-017-00-1

chlorosulphonic acid

232-234-6

7790-94-5

Skin Corr. 1a
STOT SE 3

H314
H335

GHS05
GHS07
Gef.

H314
H335

EUH014

016-018-00-7

fluorosulphonic acid

232-149-4

7789-21-1

Acute Tox. 4 *
Skin Corr. 1A

H332
H314

GHS05
GHS07
Gef.

H332
H314

016-019-00-2

oleum ... % SO₃

Skin Corr. 1a
STOT SE 3

H314
H335

GHS05
GHS07
Gef.

H314
H335

EUH014

016-020-00-8

sulphuric acid ... %

231-639-5

7664-93-9

Skin Corr. 1A

H314

GHS05
Gef.

H314

Skin Corr. 1A; H314: C> 15 %
Skin Irrit. 2; H315: 5 % ≤ C < 15 %
Eye Irrit. 2; H319: 5 % ≤ C < 15 %

016-021-00-3

methanethiol;
methyl mercaptan

200-822-1

74-93-1

Flam. Gas. 1
Press. Gas
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H220
H331
H400
H410

GHS02
GHS04
GHS06
GHS09
Gef.

H220
H331
H410

016-022-00-9

ethanethiol;
ethyl mercaptan

200-837-3

75-08-1

Flam. Liq. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H225
H332
H400
H410

GHS02
GHS07
GHS09
Gef.

H225
H332
H410

016-023-00-4

dimethyl sulphate

201-058-1

77-78-1

Carc. 1B
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1

H350
H341
H330
H301
H314
H317

GHS06
GHS08
GHS05
Gef.

H350
H341
H330
H301
H314
H317

Carc. 1B; H350: C> 0.01 %
Muta. 2; H341: C> 0.01 %
STOT SE 3; H335: C> 5 %

016-024-00-X

dimexano(ISO);
bis(methoxythiocarbonyl) disulphide

215-993-8

1468-37-7

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

016-025-00-5

disul (ISO);
2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;
2,4-DES

205-259-5

149-26-8

Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1

H302
H315
H318

GHS05
GHS07
Gef.

H302
H315
H318

016-026-00-0

sulphamidic acid;
sulphamic acid;
sulfamic acid

226-218-8

5329-14-6

Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3

H319
H315
H412

GHS07
Achtg.

H319
H315
H412

016-027-00-6

diethyl sulphate

200-589-6

64-67-5

Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H350
H340
H332
H312
H302
H314

GHS05
GHS08
GHS07
Gef.

H350
H340
H332
H312
H302
H314

016-028-00-1

sodium dithionite;
sodium hydrosulphite

231-890-0

7775-14-6

Self-heat. 1
Acute Tox. 4 *

H251
H302

GHS02
GHS07
Gef.

H251
H302

EUH031

016-029-00-7

p-toluenesulphonic acid, containing more than 5 % H₂SO₄

Skin Corr. 1B

H314

GHS05
Gef.

H314

Skin Corr. 1B; H314: C> 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %

016-030-00-2

p-toluenesulphonic acid (containing a maximum of 5 % H₂SO₄)

203-180-0

104-15-4

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H319
H335
H315

GHS07
Achtg.

H319
H335
H315

STOT SE 3; H335: C> 20 %

016-031-00-8

tetrahydrothiophene-1,1-dioxide;
sulpholane

204-783-1

126-33-0

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

016-032-00-3

1,3-propanesultone;
1,2-oxathiolane 2,2-dioxide

214-317-9

1120-71-4

Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *

H350
H312
H302

GHS08
GHS07
Gef.

H350
H312
H302

Carc. 1B; H350: C> 0,01 %

016-033-00-9

dimethylsulfamoylchloride

236-412-4

13360-57-1

Carc. 1B
Acute Tox. 2 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H350
H330
H312
H302
H314

GHS06
GHS05
GHS08
Gef.

H350
H330
H312
H302
H314

016-034-00-4

tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)

400-010-9

81898-60-4

Skin Sens. 1

H317

GHS07
Achtg.

H317

016-035-00-X

pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate

400-120-7

Eye Irrit. 2

H319

GHS07
Achtg.

H319

016-036-00-5

tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate

400-130-1

Resp. Sens. 1
Aquatic Chronic 2

H334
H411

GHS08
GHS09
Gef.

H334
H411

016-037-00-0

disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate

400-350-8

85153-93-1

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

016-038-00-6

disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate

400-380-1

86393-35-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

016-039-00-1

tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate

400-430-2

Skin Sens. 1

H317

GHS07
Achtg.

H317

016-040-00-7

reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate

400-570-4

Eye Irrit. 2

H319

GHS07
Achtg.

H319

016-041-00-2

calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate

400-710-4

Acute Tox. 4 *

H332

GHS07
Achtg.

H332

016-042-00-8

tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate

400-790-0

85665-97-0

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

016-043-00-3

dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate

401-010-1

Skin Sens. 1

H317

GHS07
Achtg.

H317

016-044-00-9

disodiumS,S-hexane-1,6-diyldi(thiosulphate) dihydrate

401-320-7

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

016-045-00-4

lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate

401-560-2

108624-00-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

016-046-00-X

sodium hydrogensulphate

231-665-7

7681-38-1

Eye Dam. 1

H318

GHS05
Gef.

H318

016-047-00-5

hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate

401-650-1

85665-96-9

Skin Sens. 1

H317

GHS07
Achtg.

H317

016-048-00-0

sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate

401-870-8

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

016-049-00-6

calcium octadecylxylenesulphonate

402-040-8

Skin Corr. 1B
Aquatic Chronic 2

H314
H411

GHS05
GHS09
Gef.

H314
H411

016-050-00-1

potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat

402-150-6

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

016-051-00-7

trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate

402-170-5

106359-91-5

Skin Sens. 1

H317

GHS07
Achtg.

H317

016-052-00-2

benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate

402-240-5

102561-46-6

Acute Tox. 4 *
Aquatic Chronic 2

H332
H411

GHS07
GHS09
Achtg.

H332
H411

016-053-00-8

(C₁₆ or C₁₈-n-alkyl)(C₁₆ or C₁₈-n-alkyl)ammonium 2-((C₁₆ or C₁₈-n-alkyl)(C₁₆ or C₁₈-n-alkyl)carbamoyl)benzenesulphonate

402-460-1

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4

H315
H317
H413

GHS07
Achtg.

H315
H317
H413

016-054-00-3

sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate

400-030-8

Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Sens. 1

H331
H372 **
H302
H319
H335
H317

GHS06
GHS08
Gef.

H331
H372 **
H302
H319
H335
H317

016-055-00-9

tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing> 35 % sodium chloride and sodium acetate)

400-510-7

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

016-056-00-4

potassium hydrogensulphate

231-594-1

7646-93-7

Skin Corr. 1B
STOT SE 3

H314
H335

GHS05
GHS07
Gef.

H314
H335

016-057-00-X

styrene-4-sulfonyl chloride

404-770-2

2633-67-2

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H315
H318
H317

GHS05
GHS07
Gef.

H315
H318
H317

016-058-00-5

thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol,tert-nonanethiol and C_12-14 -tert-alkylamine

404-820-3

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H315
H317
H412

GHS07
Achtg.

H315
H317
H412

016-059-00-0

N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride

405-300-9

17339-60-5

Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H317
H410

016-060-00-6

diammonium peroxodisulphate;
ammonium persulphate

231-786-5

7727-54-0

Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1

H272
H302
H319
H335
H315
H334
H317

GHS03
GHS08
GHS07
Gef.

H272
H302
H319
H335
H315
H334
H317

016-061-00-1

dipotassium peroxodisulphate;
potassium persulphate

231-781-8

7727-21-1

Ox. Sol. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1

H272
H302
H319
H335
H315
H334
H317

GHS03
GHS08
GHS07
Gef.

H272
H302
H319
H335
H315
H334
H317

016-062-00-7

bensultap (ISO);
1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane

17606-31-4

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

016-063-00-2

sodium metabisulphite

231-673-0

7681-57-4

Acute Tox. 4 *
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

EUH031

016-064-00-8

sodium hydrogensulphite . . . %;
sodium bisulphite . . . %

231-548-0

7631-90-5

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

EUH031

016-065-00-3

sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate

400-100-8

84057-97-6

Aquatic Chronic 2

H411

GHS09

H411

016-066-00-9

tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)

404-070-7

116912-62-0

Aquatic Chronic 3

H412

016-067-00-4

(4-methylphenyl)mesitylene sulfonate

407-530-5

67811-06-7

Aquatic Chronic 4

H413

016-068-00-X

sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate

407-720-8

155160-86-4

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

016-069-00-5

3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid

407-990-7

141915-64-2

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

016-070-00-0

4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone

408-220-2

Aquatic Chronic 4

H413

016-071-00-6

trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate

410-130-3

136248-03-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

016-072-00-1

3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide

411-520-6

112195-27-4

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

016-073-00-7

tetrakis(phenylmethyl)thioperoxydi(carbothioamide)

404-310-0

10591-85-2

Aquatic Chronic 4

H413

016-074-00-2

6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene

405-410-7

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H315
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H411

016-075-00-8

2,2'-diallyl-4,4'-sulfonyldiphenol

411-570-9

41481-66-7

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

016-076-00-3

2,3-bis((2-mercaptoethyl)thio)-1-propanethiol

411-290-7

131538-00-6

Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H373 **
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373 **
H410

016-077-00-9

2-chloro-p-toluenesulfochloride

412-890-1

42413-03-6

Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3

H314
H317
H412

GHS05
GHS07
Gef.

H314
H317
H412

016-078-00-4

4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide

413-300-5

56187-04-3

Aquatic Chronic 4

H413

016-079-00-X

N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide

412-920-3

16695-22-0

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

016-080-00-5

sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate

412-320-1

31361-99-6

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

016-081-00-0

hexahydrocyclopenta[c]pyrrole-1-(1H)-ammoniumN-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide

418-350-1

Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H341
H302
H319
H317
H411

GHS08
GHS07
GHS09
Achtg.

H341
H302
H319
H317
H411

016-082-00-6

ethoxysulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea

126801-58-9

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

016-083-00-1

acibenzolar-S-methyl;
benzo[1,2,3]thiadiazole-7-carbothioic acidS-methyl ester

420-050-0

135158-54-2

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H319
H335
H315
H317
H400
H410

GHS07
GHS09
Achtg.

H319
H335
H315
H317
H410

016-084-00-7

prosulfuron (ISO);
1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea

94125-34-5

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M=100

016-085-00-2

flazasulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea

104040-78-0

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

016-086-00-8

tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate

402-590-9

109125-56-6

Eye Dam. 1

H318

GHS05
Gef.

H318

016-087-00-3

reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;
diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;
propylene carbonate

403-490-8

104558-95-4

Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H319
H317
H400
H410

GHS07
GHS09
Achtg.

H319
H317
H410

016-088-00-9

4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid

407-280-7

71297-11-5

Aquatic Chronic 3

H412

016-089-00-4

reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene

413-840-1

Self-react. C ****
Aquatic Chronic 4

H242
H413

GHS02
Gef.

H242
H413

016-090-00-X

4-methyl-N-(methylsulfonyl)benzenesulfonamide

415-040-8

14653-91-9

Acute Tox. 4 *
STOT SE 3
Eye Dam. 1

H302
H335
H318

GHS05
GHS07
Gef.

H302
H335
H318

016-091-00-5

C_12-14 -tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate

414-110-5

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

016-092-00-0

reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol

427-050-1

Repr. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361f
H315
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361f
H315
H317
H410

016-093-00-6

reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);
4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)

414-770-4

140698-96-0

Self-react. C****
Carc. 2

H242
H351

GHS02
GHS08
Gef.

H242
H351

016-094-00-1

sulfur

231-722-6

7704-34-9

Skin Irrit. 2

H315

GHS07
Achtg.

H315

016-095-00-7

reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);
Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)

417-980-4

Self-react. C****
Carc. 2

H242
H351

GHS02
GHS08
Gef.

H242
H351

016-096-00-2

thifensulfuron-methyl (ISO);
methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate

79277-27-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

016-097-00-8

1-amino-2-methyl-2-propanethiol hydrochloride

434-480-1

32047-53-3

Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3

H302
H314
H317
H412

GHS05
GHS07
Gef.

H302
H314
H317
H412

017-001-00-7

chlorine

231-959-5

7782-50-5

Ox. Gas 1
Press. Gas
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1

H270
H331
H319
H335
H315
H400

GHS03
GHS04
GHS06
GHS09
Gef.

H270
H331
H319
H335
H315
H400

M = 100

017-002-00-2

hydrogen chloride

231-595-7

7647-01-0

Press. Gas
Acute Tox. 3 *
Skin Corr. 1A

H331
H314

GHS04
GHS06
GHS05
Gef.

H331
H314

017-002-01-X

hydrochloric acid ... %

231-595-7

Skin Corr. 1B
STOT SE 3

H314
H335

GHS05
GHS07
Gef.

H314
H335

Skin Corr. 1B; H314: C> 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
STOT SE 3; H335: C> 10 %

017-003-00-8

barium chlorate

236-760-7

13477-00-4

Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2

H271
H332
H302
H411

GHS03
GHS07
GHS09
Gef.

H271
H332
H302
H411

017-004-00-3

potassium chlorate

223-289-7

3811-04-9

Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2

H271
H332
H302
H411

GHS03
GHS07
GHS09
Gef.

H271
H332
H302
H411

017-005-00-9

sodium chlorate

231-887-4

7775-09-9

Ox. Sol. 1
Acute Tox. 4 *
Aquatic Chronic 2

H271
H302
H411

GHS03
GHS07
GHS09
Gef.

H271
H302
H411

017-006-00-4

perchloric acid ... %

231-512-4

7601-90-3

Ox. Liq. 1
Skin Corr. 1A

H271
H314

GHS03
GHS05
Gef.

H271
H314

Skin Corr. 1A; H314: C> 50 %
Skin Corr. 1B; H314: 10 % ≤ C < 50 %
Skin Irrit. 2; H315: 1 % ≤ C < 10 %
Eye Irrit. 2; H319: 1 % ≤ C < 10 %
Ox. Liq. 1; H271: C> 50 %:
Ox. Liq. 2; H272: C ≤ 50 %:

017-007-00-X

barium perchlorate

236-710-4

13465-95-7

Ox. Sol. 1
Acute Tox. 4 *
Acute Tox. 4 *

H271
H332
H302

GHS03
GHS07
Gef.

H271
H332
H302

017-008-00-5

potassium perchlorate

231-912-9

7778-74-7

Ox. Sol. 1
Acute Tox. 4 *

H271
H302

GHS03
GHS07
Gef.

H271
H302

017-009-00-0

ammonium perchlorate

232-235-1

7790-98-9

Expl. 1,1
Ox. Sol. 1

H201
H271

GHS01
Gef.

H201
H271

017-010-00-6

sodium perchlorate

231-511-9

7601-89-0

Ox. Sol. 1
Acute Tox. 4 *

H271
H302

GHS03
GHS07
Gef.

H271
H302

017-011-00-1

sodium hypochlorite, solution ... % Cl active

231-668-3

7681-52-9

Skin Corr. 1B
Aquatic Acute 1

H314
H400

GHS05
GHS09
Gef.

H314
H400

EUH031

EUH031: C> 5 %

017-012-00-7

calcium hypochlorite

231-908-7

7778-54-3

Ox. Sol. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1

H272
H302
H314
H400

GHS03
GHS05
GHS07
GHS09
Gef.

H272
H302
H314
H400

EUH031

Skin Corr. 1B; H314: C> 5 %
Skin Irrit. 2; H315: 1 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 3 %
M = 10

017-013-00-2

calcium chloride

233-140-8

10043-52-4

Eye Irrit. 2

H319

GHS07
Achtg.

H319

017-014-00-8

ammonium chloride

235-186-4

12125-02-9

Acute Tox. 4 *
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

017-015-00-3

(2-(aminomethyl)phenyl)acetylchloride hydrochloride

417-410-4

61807-67-8

Acute Tox. 4 *
Skin Corr. 1a
Skin Sens. 1

H302
H314
H317

GHS05
GHS07
Gef.

H302
H314
H317

017-016-00-9

methyltriphenylphosphonium chloride

418-400-2

1031-15-8

Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2

H312
H302
H315
H318
H411

GHS05
GHS07
GHS09
Gef.

H312
H302
H315
H318
H411

017-017-00-4

(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride

426-210-6

120086-58-0

Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H314
H400
H410

GHS05
GHS09
Gef.

H314
H410

017-018-00-X

N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride

405-660-7

Aquatic Chronic 2

H411

GHS09

H411

017-019-00-5

(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride

415-110-8

54417-53-7

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

017-020-00-0

ethyl propoxy aluminium chloride

421-790-7

13014-29-4

Water-react. 1
Skin Corr. 1A

H260
H314

GHS02
GHS05
Gef.

H260
H314

EUH014

017-021-00-6

behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride

423-420-1

136920-10-0

Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H318
H317
H410

017-023-00-7

[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C_6-18)-alkyl] trichlorides

425-520-9

197179-61-6

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

017-026-00-3

chlorine dioxide

233-162-8

10049-04-4

Press. Gas
Ox. Gas 1
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1

H270
H330
H314
H400

GHS04
GHS03
GHS06
GHS05
GHS09
Gef.

H270
H330
H314
H400

M = 10

017-026-01-0

chlorine dioxide ... %

233-162-8

10049-04-4

Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1

H301
H314
H400

GHS06
GHS05
GHS09
Gef.

H301
H314
H400

Skin Corr. 1B; H314: C> 5 %
Skin Irrit. 2; H315: 1 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,3 % ≤ C < 3 %
STOT SE 3; H335: C> 3 %
M = 10

019-001-00-2

potassium

231-119-8

7440-09-7

Water-react. 1
Skin Corr. 1B

H260
H314

GHS02
GHS05
Gef.

H260
H314

EUH014

019-002-00-8

potassium hydroxide;
caustic potash

215-181-3

1310-58-3

Acute Tox. 4 *
Skin Corr. 1A

H302
H314

GHS05
GHS07
Gef.

H302
H314

Skin Corr. 1A; H314: C> 5 %
Skin Corr. 1B; H314: 2 % ≤ C < 5 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %

019-003-00-3

Kalium-(E,E)-hexa-2,4-dienoat

246-376-1

24634-61-5

Eye Irrit. 2

H319

GSH07
Achtg.

H319

020-001-00-X

calcium

231-179-5

7440-70-2

Water-react. 2

H261

GHS02
Gef.

H261

020-002-00-5

calcium cyanide

209-740-0

592-01-8

Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H400
H410

GHS06
GHS09
Gef.

H300
H410

EUH032

020-003-00-0

reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;
tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;
poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]

420-470-4

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

022-001-00-5

titanium tetrachloride

231-441-9

7550-45-0

Skin Corr. 1B

H314

GHS05
Gef.

H314

EUH014

022-002-00-0

titanium(4+) oxalate

403-260-7

Eye Dam. 1

H318

GHS05
Gef.

H318

022-003-00-6

bis(?⁵-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium

412-000-1

125051-32-3

Flam. Sol. 1
Repr. 2
STOT RE 2 *
Aquatic Chronic 2

H228
H361f ***
H373 **
H411

GHS02
GHS08
GHS09
Gef.

H228
H361f ***
H373 **
H411

022-004-00-1

potassium titanium oxide (K₂Ti₆O₁₃)

432-240-0

12056-51-8

Carc. 2

H351

GHS08
Achtg.

H351

022-005-00-7

[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-?)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-?N][(1,2,3,4-?)-1,3-pentadiene]-titanium

419-840-8

169104-71-6

Flam. Sol. 1****
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4

H228
H314
H317
H413

GHS02
GHS05
GHS07
Gef.

H228
H314
H317
H413

023-001-00-8

divanadium pentaoxide;
vanadium pentoxide

215-239-8

1314-62-1

Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Aquatic Chronic 2

H341
H361d ***
H372 **
H332
H302
H335
H411

GHS08
GHS07
GHS09
Gef.

H341
H361d ***
H372 **
H332
H302
H335
H411

024-001-00-0

chromium (VI) trioxide

215-607-8

1333-82-0

Ox. Sol. 1
Carc. 1a
Muta. 1B
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1a
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H400
H410

GHS03
GHS06
GHS08
GHS05
GHS09
Gef.

H271
H350
H340
H361f ***
H330
H311
H301
H372 **
H314
H334
H317
H410

STOT SE 3; H335: C> 1 %

024-002-00-6

potassium dichromate

231-906-6

7778-50-9

Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410

GHS03
GHS06
GHS08
GHS05
GHS09
Gef.

H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410

STOT SE 3; H335: C> 5 %

024-003-00-1

ammonium dichromate

232-143-1

7789-09-5

Ox. Sol. 2 ****
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410

GHS03
GHS06
GHS08
GHS05
GHS09
Gef.

H272
H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410

STOT SE 3; H335: C> 5 %
Resp. Sens.; H334: C> 0,2 %
Skin Sens.; H317: C> 0,2 %

024-004-00-7

sodium dichromate

234-190-3

10588-01-9

Ox. Sol. 2
Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H400
H410

GHS03
GHS06
GHS05
GHS08
GHS09
Gef.

H272
H350
H340
H360FD
H330
H301
H312
H372**
H314
H334
H317
H410

Resp. Sens. 1; H334: C> 0,2 %
Skin Sens. 1; H317: C> 0,2 %
STOT SE 3; H335: C> 5 %

024-005-00-2

chromyl dichloride;
chromic oxychloride

239-056-8

14977-61-8

Ox. Liq. 1
Carc. 1B
Muta. 1B
Skin Corr. 1a
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H271
H350i
H340
H314
H317
H400
H410

GHS03
GHS08
GHS05
GHS07
GHS09
Gef.

H271
H350i
H340
H314
H317
H410

Skin Corr. 1A; H314: C> 10 %
Skin Corr. 1B; H314: 5 % ≤ C < 10 %
Skin Irrit. 2; H315: 0,5 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %
STOT SE 3; H335: 0,5 % ≤ C < 5 %
Skin Sens. 1; H317: C> 0,5 %

024-006-00-8

potassium chromate

232-140-5

7789-00-6

Carc. 1B
Muta. 1B
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H340
H319
H335
H315
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H340
H319
H335
H315
H317
H410

Skin Sens. 1; H317: C> 0.5 %

024-007-00-3

zinc chromates including zinc potassium chromate

Carc. 1a
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H317
H410

024-008-00-9

calcium chromate

237-366-8

13765-19-0

Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H410

024-009-00-4

strontium chromate

232-142-6

7789-06-2

Carc. 1B
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H400
H410

024-010-00-X

dichromium tris(chromate);
chromium III chromate;
chromic chromate

246-356-2

24613-89-6

Ox. Sol. 1
Carc. 1B
Skin Corr. 1a
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H271
H350
H314
H317
H400
H410

GHS03
GHS08
GHS05
GHS07
GHS09
Gef.

H271
H350
H314
H317
H410

024-011-00-5

ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)

400-110-2

109125-51-1

Self-react. C ****
Aquatic Acute 1
Aquatic Chronic 1

H242
H400
H410

GHS02
GHS09
Gef.

H242
H410

024-012-00-0

trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)

400-810-8

Muta. 2

H341

GHS08
Achtg.

H341

024-013-00-6

trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)

402-500-8

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

024-014-00-1

trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)

402-870-0

93952-24-0

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

024-015-00-7

disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)

404-930-1

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H332
H318
H411

GHS05
GHS07
GHS09
Gef.

H332
H318
H411

024-016-00-2

tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)

405-110-6

88377-66-6

STOT RE 2 *
Aquatic Chronic 4

H373 **
H413

GHS08
Achtg.

H373 **
H413

024-017-00-8

Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex

Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H317
H410

024-018-00-3

sodium chromate

231-889-5

7775-11-3

Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Acute Tox. 4 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H350
H340
H360FD
H330
H301
H372 **
H312
H314
H334
H317
H410

Resp. Sens.; H334: C> 0,2 %
Skin Sens.; H317: C> 0,2 %

024-019-00-9

Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);
by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);
by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)

419-230-1

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

024-020-00-4

trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III)

418-220-4

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

024-021-00-X

potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)

425-830-4

Eye Dam. 1

H318

GHS05
Gef.

H318

025-001-00-3

manganese dioxide

215-202-6

1313-13-9

Acute Tox. 4 *
Acute Tox. 4 *

H332
H302

GHS07
Achtg.

H332
H302

025-002-00-9

potassium permanganate

231-760-3

7722-64-7

Ox. Sol. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H272
H302
H400
H410

GHS03
GHS07
GHS09
Gef.

H272
H302
H410

025-003-00-4

manganese sulphate

232-089-9

7785-87-7

STOT RE 2 *
Aquatic Chronic 2

H373 **
H411

GHS08
GHS09
Achtg.

H373 **
H411

025-004-00-X

bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate

411-760-1

116633-53-5

Aquatic Chronic 2

H411

GHS09

H411

025-005-00-5

reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);
tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);
pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)

417-660-4

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

026-001-00-6

(?-cumene)-(?-cyclopentadienyl)iron(II) hexafluoroantimonate

407-840-0

100011-37-8

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

026-002-00-1

(?-cumene)-(?-cyclopentadienyl)iron(II) trifluoromethane-sulfonate

407-880-9

117549-13-0

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

026-003-00-7

iron(II) sulfate

231-753-5

7720-78-7

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2

H302
H319
H315

GHS07
Achtg.

H302
H319
H315

026-003-01-4

iron (II) sulfate (1:1) heptahydrate;
sulfuric acid, iron(II) salt (1:1), heptahydrate;
ferrous sulfate heptahydrate

231-753-5

7782-63-0

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2

H302
H319
H315

GHS07
Achtg.

H302
H319
H315

Skin Irrit. 2; H315: C> 25 %

026-004-00-2

potassium ferrite

430-010-4

12160-44-0

Skin Corr. 1B
Skin Sens. 1

H314
H317

GHS05
GHS07
Gef.

H314
H317

027-001-00-9

cobalt

231-158-0

7440-48-4

Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4

H334
H317
H413

GHS08
Gef.

H334
H317
H413

027-002-00-4

cobalt oxide

215-154-6

1307-96-6

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

M=10

027-003-00-X

cobalt sulfide

215-273-3

1317-42-6

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

M=10

027-004-00-5

cobalt dichloride

231-589-4

7646-79-9

Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360F***
H302
H334
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H341
H360F***
H302
H334
H317
H410

Carc. 1B; H350i: C> 0,01 %
M=10

027-005-00-0

cobalt sulfate

233-334-2

10124-43-3

Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360F***
H302
H334
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H341
H360F***
H302
H334
H317
H410

Carc. 1B; H350i: C> 0,01 %
M=10

027-006-00-6

cobalt di(acetate)

200-755-8

71-48-7

Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360F***
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360F***
H334
H317
H410

Carc. 1B; H350i: C> 0,01 %
M = 10

027-007-00-1

zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex

425-240-7

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

027-008-00-7

complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H₂O, 2 < n < 3)

427-390-9

Skin Sens. 1

H317

GHS07
Achtg.

H317

027-009-00-2

cobalt dinitrate

233-402-1

10141-05-6

Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360F***
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360F***
H334
H317
H410

Carc. 1B; H350i: C> 0,01 %
M = 10

027-010-00-8

cobalt carbonate

208-169-4

513-79-1

Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360F***
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360F***
H334
H317
H410

Carc. 1B; H350i: C> 0,01 %
M=10

028-001-00-1

tetracarbonylnickel;
nickel tetracarbonyl

236-669-2

13463-39-3

Flam. Liq. 2
Carc. 2
Repr. 1B
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H225
H351
H360D ***
H330
H400
H410

GHS02
GHS06
GHS08
GHS09
Gef.

H225
H351
H360D ***
H330
H410

028-002-00-7

nickel

231-111-4

7440-02-0

Carc. 2
STOT RE 1
Skin Sens. 1

H351
H372**
H317

GHS08
GHS07
Gef.

H351
H372**
H317

028-002-01-4

nickel powder;
[particle diameter < 1 mm]

231-111-4

7440-02-0

Carc. 2
STOT RE 1
Skin Sens. 1
Aquatic Chronic 3

H351
H372**
H317
H412

GHS08
GHS07
Gef.

H351
H372**
H317
H412

028-003-00-2

nickel monoxide; [1]
nickel oxide; [2]
bunsenite [3]

215-215-7 [1]
234-323-5 [2]
- [3]

1313-99-1 [1]
11099-02-8 [2]
34492-97-2 [3]

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4

H350i
H372**
H317
H413

GHS08
GHS07
Gef.

H350i
H372**
H317
H413

028-004-00-8

nickel dioxide

234-823-3

12035-36-8

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4

H350i
H372**
H317
H413

GHS08
GHS07
Gef.

H350i
H372**
H317
H413

028-005-00-3

dinickel trioxide

215-217-8

1314-06-3

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Chronic 4

H350i
H372**
H317
H413

GHS08
GHS07
Gef.

H350i
H372**
H317
H413

028-006-00-9

nickel (II) sulfide; [1]
nickel sulfide; [2]
millerite [3]

240-841-2 [1]
234-349-7 [2]
- [3]

16812-54-7 [1]
11113-75-0 [2]
1314-04-1 [3]

Carc. 1a
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H341
H372**
H317
H410

028-007-00-4

trinickel disulfide;
nickel subsulfide; [1]
heazlewoodite [2]

234-829-6 [1]
- [2]

12035-72-2 [1]
12035-71-1 [2]

Carc. 1a
Muta. 2
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H341
H372**
H317
H410

028-008-00-X

nickel dihydroxide; [1]
nickel hydroxide [2]

235-008-5 [1]
234-348-1 [2]

12054-48-7 [1]
11113-74-9 [2]

Carc. 1a
Repr. 1B
Muta. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H360D***
H341
H372**
H332
H302
H315
H334
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H360D***
H341
H372**
H332
H302
H315
H334
H317
H410

028-009-00-5

nickel sulfate

232-104-9

7786-81-4

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Irrit. 2; H315: C> 20 %
Skin Sens. 1; H317: C> 0,01 %
M = 1

028-010-00-0

nickel carbonate;
basic nickel carbonate;
carbonic acid, nickel (2+) salt; [1]
carbonic acid, nickel salt; [2]
[µ-[carbonato(2-)-O:O']] dihydroxy trinickel; [3]
[carbonato(2-)] tetrahydroxytrinickel [4]

222-068-2 [1]
240-408-8 [2]
265-748-4 [3]
235-715-9 [4]

3333-67-3 [1]
16337-84-1 [2]
65405-96-1 [3]
12607-70-4 [4]

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410

028-011-00-6

nickel dichloride

231-743-0

7718-54-9

Carc. 1a
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C> 20 %
Skin Sens. 1; H317: C> 0,01 %
M = 1

028-012-00-1

nickel dinitrate; [1]
nitric acid, nickel salt [2]

236-068-5 [1]
238-076-4 [2]

13138-45-9 [1]
14216-75-2 [2]

Ox. Sol. 2
Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H272
H350i
H341
H360D***
H372**
H332
H302
H315
H318
H334
H317
H400
H410

GHS03
GHS05
GHS08
GHS07
GHS09
Gef.

H272
H350i
H341
H360D***
H372**
H332
H302
H315
H318
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C> 20 %
Skin Sens. 1; H317: C> 0,01 %
M = 1

028-013-00-7

nickel matte

273-749-6

69012-50-6

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-014-00-2

slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate

295-859-3

92129-57-2

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-015-00-8

slimes and sludges, copper electrolyte refining, decopperised

305-433-1

94551-87-8

Carc. 1a
Muta. 2
Repr. 1a
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

028-016-00-3

nickel diperchlorate;
perchloric acid, nickel(II) salt

237-124-1

13637-71-3

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410

GHS05
GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H314
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-017-00-9

nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]

237-563-9 [1]
239-793-2 [2]

13842-46-1 [1]
15699-18-0 [2]

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-018-00-4

nickel bis(sulfamidate);
nickel sulfamate

237-396-1

13770-89-3

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-019-00-X

nickel bis(tetrafluoroborate)

238-753-4

14708-14-6

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-021-00-0

nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]

222-101-0 [1]
239-946-6 [2]
268-755-0 [3]

3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-022-00-6

nickel di(acetate); [1]
nickel acetate [2]

206-761-7 [1]
239-086-1 [2]

373-02-4 [1]
14998-37-9 [2]

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M = 1

028-024-00-7

nickel dibenzoate

209-046-8

553-71-9

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-025-00-2

nickel bis(4-cyclohexylbutyrate)

223-463-2

3906-55-6

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-026-00-8

nickel(II) stearate;
nickel(II) octadecanoate

218-744-1

2223-95-2

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-027-00-3

nickel dilactate

16039-61-5

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-028-00-9

nickel(II) octanoate

225-656-7

4995-91-9

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1a
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410

GHS05
GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H314
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-029-00-4

nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]

233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4]

10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-030-00-X

nickel hexafluorosilicate

247-430-7

26043-11-8

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-031-00-5

nickel selenate

239-125-2

15060-62-5

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-032-00-0

nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8]

238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8]

14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]

Carc. 1a
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H372**
H334
H317
H410

028-033-00-6

diammonium nickel hexacyanoferrate

74195-78-1

Carc. 1a
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H372**
H334
H317
H410

028-034-00-1

nickel dicyanide

209-160-8

557-19-7

Carc. 1a
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H372**
H334
H317
H410

EUH032

028-035-00-7

nickel chromate

238-766-5

14721-18-7

Carc. 1a
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H372**
H334
H317
H410

028-036-00-2

nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]

244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]

21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-037-00-8

dinickel hexacyanoferrate

238-946-3

14874-78-3

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-038-00-3

trinickel bis(arsenate);
nickel(II) arsenate

236-771-7

13477-70-8

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H372**
H317
H410

028-039-00-9

nickel oxalate; [1]
oxalic acid, nickel salt [2]

208-933-7 [1]
243-867-2 [2]

547-67-1 [1]
20543-06-0 [2]

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-040-00-4

nickel telluride

235-260-6

12142-88-0

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-041-00-X

trinickel tetrasulfide

12137-12-1

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-042-00-5

trinickel bis(arsenite)

74646-29-0

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-043-00-0

cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]

269-051-6 [1]
261-346-8 [2]
- [3]

68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]

Carc. 1a
STOT RE 1
Skin Sens. 1

H350i
H372**
H317

GHS08
GHS07
Gef.

H350i
H372**
H317

028-044-00-6

nickel tin trioxide;
nickel stannate

234-824-9

12035-38-0

Carc. 1a
STOT RE 1
Skin Sens. 1

H350i
H372**
H317

GHS08
GHS07
Gef.

H350i
H372**
H317

028-045-00-1

nickel triuranium decaoxide

239-876-6

15780-33-3

Carc. 1a
STOT RE 1
Skin Sens. 1

H350i
H372**
H317

GHS08
GHS07
Gef.

H350i
H372**
H317

028-046-00-7

nickel dithiocyanate

237-205-1

13689-92-4

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

EUH032

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-047-00-2

nickel dichromate

239-646-5

15586-38-6

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-048-00-8

nickel(II) selenite

233-263-7

10101-96-9

Carc. 1a
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H372**
H334
H317
H410

028-049-00-3

nickel selenide

215-216-2

1314-05-2

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-050-00-9

silicic acid, lead nickel salt

68130-19-8

Carc. 1a
Repr. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H360Df
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H360Df
H372**
H317
H410

028-051-00-4

nickel diarsenide; [1]
nickel arsenide [2]

235-103-1 [1]
248-169-1 [2]

12068-61-0 [1]
27016-75-7 [2]

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-052-00-X

nickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900

271-853-6

68610-24-2

Carc. 1a
STOT RE 1
Skin Sens. 1

H350i
H372**
H317

GHS08
GHS07
Gef.

H350i
H372**
H317

028-053-00-5

nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]

267-897-0 [1]
238-596-1 [2]
275-897-7 [3]

67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-054-00-0

nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(d-gluconato-O¹,O²)nickel; [18]
nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]
(isononanoato-O)(isooctanoato-O)nickel; [22]
(isooctanoato-O)(neodecanoato-O)nickel; [23]
(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]
(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]
(isodecanoato-O)(isooctanoato-O)nickel; [26]
(isodecanoato-O)(isononanoato-O)nickel; [27]
(isononanoato-O)(neodecanoato-O)nickel; [28]
fatty acids, C_6-19-branched, nickel salts; [29]
fatty acids, C_8-18 and C₁₈-unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]

240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31]

16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]

Carc. 1a
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H341
H360D***
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H341
H360D***
H372**
H334
H317
H410

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,1 % ≤ C < 1 %
Skin Sens. 1; H317: C> 0,01 %
M=1

028-055-00-6

nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide phosphate [4]

231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]

7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]

Carc. 1a
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H334
H317
H400
H410

GHS08
GHS09
Gef.

H350i
H372**
H334
H317
H410

028-056-00-1

nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]

234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8]

12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]

Carc. 1a
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H372**
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350i
H372**
H317
H410

028-057-00-7

dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]

234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11]

12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11]

Carc. 1a
STOT RE 1
Skin Sens. 1

H350i
H372**
H317

GHS08
GHS07
Gef.

H350i
H372**
H317

028-058-00-2

cobalt lithium nickel oxide

442-750-5

Carc. 1a
Acute Tox. 2 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350i
H330
H372**
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H350i
H330
H372**
H317
H410

029-001-00-4

copper chloride;
copper (I) chloride;
cuprous chloride

231-842-9

7758-89-6

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H400
H410

029-002-00-X

Dikupferoxid;
Kupfer(I)-oxid

215-270-7

1317-39-1

Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H318
H400
H410

GHS07
GHS05
GHS09
Gef.

H332
H302
H318
H410

M = 100

029-003-00-5

Naphthenic acids, copper salts;
copper naphthenate

215-657-0

1338-02-9

Flam. Liq. 3
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H226
H302
H400
H410

GHS02
GHS07
GHS09
Achtg.

H226
H302
H410

029-004-00-0

copper sulphate

231-847-6

7758-98-7

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H315
H410

029-005-00-6

(tris(chloromethyl)phthalocyaninato)copper(II), reaction products withN-methylpiperazine and methoxyacetic acid

401-260-1

Eye Irrit. 2

H319

GHS07
Achtg.

H319

029-006-00-1

tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II)

403-210-4

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

029-007-00-7

(trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide

404-670-9

89797-01-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

029-008-00-2

copper(II) methanesulfonate

405-400-2

54253-62-2

Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H318
H410

029-009-00-8

phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex

413-650-9

93971-95-0

Aquatic Chronic 3

H412

029-010-00-3

reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II)

407-700-9

101408-30-4

Skin Sens. 1

H317

GHS07
Achtg.

H317

029-011-00-9

sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex

412-730-0

150522-10-4

Skin Corr. 1B

H314

GHS05
Gef.

H314

029-012-00-4

sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)

407-340-2

124719-24-0

Eye Dam. 1

H318

GHS05
Gef.

H318

029-013-00-X

trisodium(2-(a-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)

407-580-8

130201-51-3

Eye Dam. 1

H318

GHS05
Gef.

H318

029-014-00-5

reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex;
2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex

419-610-7

171866-24-3

STOT RE 2 *
Aquatic Chronic 2

H373**
H411

GHS08
GHS09
Achtg.

H373**
H411

029-015-00-0

Kupferthiocyanat

214-183-1

1111-67-7

Aquatic Acute 1 Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

EUH032

M = 10

029-016-00-6

Kupfer(II)-oxid

215-269-1

1317-38-0

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M = 100

029-017-00-1

Dikupferchloridtrihydroxid

215-572-9

1332-65-6

Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1

H332
H301
H400
H410

GHS06
GHS09
Gef.

H332
H301
H410

M = 10

029-018-00-7

Tetrakupferhexahydroxidsulfat; [1]
Tetrakupferhexahydroxidsulfathydrat; [2]

215-582-3 [1]
215-582-3 [2]

1333-22-8 [1]
12527-76-3 [2]

Acute Tox. 4
Aquatic Acute 1 Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M = 10

029-019-01-X

Kupferflocken (mit einem Überzug aus aliphatischer Säure)

Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H331
H302
H319
H400
H410

GHS06
GHS09
Gef.

H331
H302
H319
H410

M = 10

029-020-00-8

Kupfer(II)-carbonat - Kupfer(II)-hydroxid (1:1)

235-113-6

12069-69-1

Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H319
H400
H410

GHS07
GHS09
Achtg.

H332
H302
H319
H410

M = 10

029-021-00-3

Kupferdihydroxid;
Kupfer(II)-hydroxid

243-815-9

20427-59-2

Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H302
H318
H400
H410

GHS06
GHS05
GHS09
Gef.

H330
H302
H318
H410

M = 10

029-022-00-9

Kupferkalkbrühe (Bordeauxbrühe);
Reaktionsprodukte von Kupfersulfat mit Calciumdihydroxid

8011-63-0

Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H332
H318
H400
H410

GHS07
GHS05
GHS09
Gef.

H332
H318
H410

M = 10

029-023-00-4

Kupfersulfat-Pentahydrat

231-847-6

7758-99-8

Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H318
H400
H410

GHS07
GHS05
GHS09
Gef.

H302
H318
H410

M = 10

030-001-00-1

zinc powder - zinc dust (pyrophoric)

231-175-3

7440-66-6

Water-react. 1
Pyr. Sol. 1
Aquatic Acute 1
Aquatic Chronic 1

H260
H250
H400
H410

GHS02
GHS09
Gef.

H260
H250
H410

030-001-01-9

zinc powder - zinc dust (stabilised)

231-175-3

7440-66-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

030-003-00-2

zinc chloride

231-592-0

7646-85-7

Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H302
H314
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H314
H410

STOT SE 3; H335: C> 5 %

030-004-00-8

dimethylzinc; [1]
diethylzinc [2]

208-884-1 [1]
209-161-3 [2]

544-97-8 [1]
557-20-0 [2]

Pyr. Liq. 1
Water-react. 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H250
H260
H314
H400
H410

GHS02
GHS05
GHS09
Gef.

H250
H260
H314
H410

EUH014

030-005-00-3

diamminediisocyanatozinc

401-610-3

Acute Tox. 4 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1

H302
H318
H334
H317
H400

GHS05
GHS08
GHS07
GHS09
Gef.

H302
H318
H334
H317
H400

030-006-00-9

zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]
zinc sulphate (anhydrous) [2]

231-793-3 [1]
231-793-3 [2]

7446-19-7 [1]
7733-02-0 [2]

Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H318
H410

030-007-00-4

bis(3,5-di-tert-butylsalicylato-O¹,O²)zinc

403-360-0

42405-40-3

Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H228
H302
H400
H410

GHS02
GHS07
GHS09
Gef.

H228
H302
H410

030-008-00-X

hydroxo(2-(benzenesulfonamido)benzoato)zinc(II)

403-750-0

113036-91-2

Acute Tox. 4 *
Aquatic Chronic 2

H332
H411

GHS07
GHS09
Achtg.

H332
H411

030-009-00-5

zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate

417-130-2

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

030-010-00-0

2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt

430-740-3

Aquatic Chronic 2

H411

GHS09

H411

030-011-00-6

trizinc bis(orthophosphate)

231-944-3

7779-90-0

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

030-012-00-1

aluminium-magnesium-zinc-carbonate-hydroxide

423-570-6

169314-88-9

Aquatic Chronic 4

H413

030-013-00-7

zinc oxide

215-222-5

1314-13-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

030-015-00-8

tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate

440-060-9

Aquatic Chronic 2

H411

GHS09

H411

031-001-00-4

Galliumarsenid

215-114-8

1303-00-0

Repr. 1B
Carc. 1B
STOT RE 1

H360F
H350
H372 (Atmungssystem und hämatopoetisches System)

GHS08
Gef.

H360F
H350
H372 (Atmungssystem und hämatopoetisches System)

033-001-00-X

arsenic

231-148-6

7440-38-2

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H400
H410

GHS06
GHS09
Gef.

H331
H301
H410

033-002-00-5

arsenic compounds, with the exception of those specified elsewhere in this Annex

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H400
H410

GHS06
GHS09
Gef.

H331
H301
H410

033-003-00-0

diarsenic trioxide;
arsenic trioxide

215-481-4

1327-53-3

Carc. 1a
Acute Tox. 2 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H300
H314
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H350
H300
H314
H410

033-004-00-6

diarsenic pentaoxide;
arsenic pentoxide;
arsenic oxide

215-116-9

1303-28-2

Carc. 1a
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H350
H331
H301
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H331
H301
H410

033-005-00-1

arsenic acid and its salts with the exception of those specified elsewhere in this Annex

Carc. 1a
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H350
H331
H301
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H331
H301
H410

033-006-00-7

arsine

232-066-3

7784-42-1

Flam. Gas 1
Press. Gas
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H220
H330
H373 **
H400
H410

GHS02
GHS04
GHS06
GHS08
GHS09
Gef.

H220
H330
H373 **
H410

033-007-00-2

tert-butylarsine

423-320-6

4262-43-5

Pyr. Liq. 1
Acute Tox. 2 *

H250
H330

GHS02
GHS06
Gef.

H250
H330

034-001-00-2

selenium

231-957-4

7782-49-2

Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 4

H331
H301
H373 **
H413

GHS06
GHS08
Gef.

H331
H301
H373 **
H413

034-002-00-8

selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex

Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H373**
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H301
H373**
H410

034-003-00-3

sodium selenite

233-267-9

10102-18-8

Acute Tox. 2 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Chronic 2

H300
H331
H317
H411

GHS06
GHS09
Gef.

H300
H331
H317
H411

EUH031

035-001-00-5

bromine

231-778-1

7726-95-6

Acute Tox. 2 *
Skin Corr. 1a
Aquatic Acute 1

H330
H314
H400

GHS06
GHS05
GHS09
Gef.

H330
H314
H400

035-002-00-0

hydrogen bromide

233-113-0

10035-10-6

Press. Gas
Skin Corr. 1a
STOT SE 3

H314
H335

GHS04
GHS05
GHS07
Gef.

H314
H335

035-002-01-8

hydrobromic acid ... %

Skin Corr. 1B
STOT SE 3

H314
H335

GHS05
GHS07
Gef.

H314
H335

Skin Corr. 1B; H314: C> 40 %
Skin Irrit. 2; H315: 10 % ≤ C < 40 %
Eye Irrit. 2; H319: 10 % ≤ C < 40 %
STOT SE 3; H335: C> 10 %

035-003-00-6

potassium bromate

231-829-8

7758-01-2

Ox. Sol. 1
Carc. 1B
Acute Tox. 3 *

H271
H350
H301

GHS03
GHS06
GHS08
Gef.

H271
H350
H301

035-004-00-1

2-hydroxyethylammonium perbromide

407-440-6

Ox. Sol. 2 ****
Acute Tox. 4 *
Skin Corr. 1a
Skin Sens. 1
Aquatic Acute 1

H272
H302
H314
H317
H400

GHS03
GHS05
GHS07
GHS09
Gef.

H272
H302
H314
H317
H400

040-001-00-3

zirconium powder (pyrophoric)

231-176-9

7440-67-7

Water-react. 1
Pyr. Sol. 1

H260
H250

GHS02
Gef.

H260
H250

040-002-00-9

zirconium powder, dry (non pyrophoric)

Self-heat. 1

H251

GHS02
Gef.

H251

040-003-00-4

reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS = 1,0: 1,0 to 1,0: 1,5

430-610-6

226996-19-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

042-001-00-9

molybdenum trioxide

215-204-7

1313-27-5

Carc. 2
Eye Irrit. 2
STOT SE 3

H351
H319
H335

GHS08
GHS07
Achtg.

H351
H319
H335

042-002-00-4

tetrakis(dimethylditetradecylammonium) hexa-µ-oxotetra-µ3-oxodi-µ5-oxotetradecaoxooctamolybdate(4-)

404-760-8

117342-25-3

Acute Tox. 3 *
Eye Dam. 1

H331
H318

GHS06
GHS05
Gef.

H331
H318

042-003-00-X

tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-)

404-860-1

116810-46-9

Flam. Sol. 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H228
H318
H400
H410

GHS02
GHS05
GHS09
Gef.

H228
H318
H410

042-004-00-5

Reaction product of ammonium molybdate and C₁₂-C₂₄-diethoxylated alkylamine (1:5-1:3)

412-780-3

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H315
H317
H411

GHS07
GHS09
Achtg.

H315
H317
H411

042-005-00-0

reaction mass of: mono- and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];
N,N-diorgano dithiocarbamate molybdenum complex

434-240-6

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

046-001-00-X

tetraammine palladium(II) hydrogen carbonate

425-270-0

134620-00-1

Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373**
H318
H317
H400
H410

GHS05
GHS08
GHS07
GHS09
Gef.

H302
H373**
H318
H317
H410

047-001-00-2

silver nitrate

231-853-9

7761-88-8

Ox. Sol. 2
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H272
H314
H400
H410

GHS03
GHS05
GHS09
Gef.

H272
H314
H410

047-002-00-8

polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt

416-850-4

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

047-003-00-3

Silber-Zink-Zeolith (Zeolith, Linde Typ A, Oberfläche mit Silber- und Zinkionen modifiziert)
[Dieser Eintrag betrifft Zeolith vom Typ LTa (Linde Typ A), dessen Oberfläche mit Silber- und Zinkionen mit einem Gehalt von Ag⁺ 0,5 %-6 %, Zn₂⁺ 5 %-16 % und möglicherweise Phospor, NH₄⁺, Mg₂⁺ und/oder Ca₂+ jeweils < 3 % modifiziert wurde.]

130328-20-0

Repr. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d
H315
H318
H400
H410

GHS08
GHS05
GHS09
Gef.

H361d
H315
H318
H410

M = 100
M = 100

048-001-00-5

cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe),
reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

048-002-00-0

cadmium (non-pyrophoric); [1]
cadmium oxide (non-pyrophoric) [2]

231-152-8 [1]
215-146-2 [2]

7440-43-9 [1]
1306-19-0 [2]

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H341
H361fd
H330
H372 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H341
H361fd
H330
H372 **
H410

048-003-00-6

cadmium diformate;
cadmiumformate

224-729-0

4464-23-7

Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H351
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H301
H351
H373 **
H410

*
STOT RE 2; H373: C> 0,25 %

048-004-00-1

cadmium cyanide

208-829-1

542-83-6

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H351
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H310
H300
H351
H373 **
H410

EUH032

STOT RE 2; H373: C> 0,1 %
EUH032: C> 1 %

048-005-00-7

cadmiumhexafluorosilicate(2-);
cadmium fluorosilica

241-084-0

17010-21-8

Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H351
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H301
H351
H373 **
H410

*
STOT RE 2; H373: C> 0,1 %

048-006-00-2

cadmium fluoride

232-222-0

7790-79-6

Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H340
H360FD
H330
H301
H372 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H340
H360FD
H330
H301
H372 **
H410

Carc. 1B; H350: C> 0,01 %
* oral
STOT RE 1; H372: C> 7 %
STOT RE 2: 0,1 % ≤ C < 7 %

048-007-00-8

cadmium iodide

232-223-6

7790-80-9

Acute Tox. 3 *
Acute Tox. 3 *
Carc. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H351
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H301
H351
H373 **
H410

*
STOT RE 2; H373: C> 0,1 %

048-008-00-3

cadmium chloride

233-296-7

10108-64-2

Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H340
H360FD
H330
H301
H372 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H340
H360FD
H330
H301
H372 **
H410

Carc. 1B; H350: C> 0,01 %
* oral
STOT RE 1; H372: C> 7 %
STOT RE 2; H373: 0,1 % ≤ C < 7 %

048-009-00-9

cadmium sulphate

233-331-6

10124-36-4

Carc. 1B
Muta. 1B
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H340
H360FD
H330
H301
H372 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H340
H360FD
H330
H301
H372 **
H410

Carc. 1B; H350: C> 0,01 %
* oral
STOT RE 1; H372: C> 7 %
STOT RE 2; H373: 0,1 % ≤ C < 7 %

048-010-00-4

cadmium sulphide

215-147-8

1306-23-6

Carc. 1B
Muta. 2
Repr. 2
STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 4

H350
H341
H361fd
H372 **
H302
H413

GHS08
GHS07
Gef.

H350
H341
H361fd
H372 **
H302
H413

*
STOT RE 1; H372: C> 10 %
STOT RE 2; H373: 0,1 % ≤ C < 10 %

048-011-00-X

cadmium (pyrophoric)

231-152-8

7440-43-9

Pyr. Sol. 1
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H250
H350
H341
H361fd
H330
H372 **
H400
H410

GHS02
GHS06
GHS08
GHS09
Gef.

H250
H350
H341
H361fd
H330
H372 **
H410

048-012-00-5

Cadmiumcarbonat

208-168-9

513-78-0

Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H410

048-013-00-0

Cadmiumhydroxid;
Cadmiumdihydroxid

244-168-5

21041-95-2

Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H410

048-014-00-6

Cadmiumnitrat;
Cadmiumdinitrat

233-710-6

10325-94-7

Carc. 1B
Muta. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H340
H332
H312
H302
H372 (Nieren, Knochen)
H410

Carc. 1B;
H350:
C> 0,01 %

050-001-00-5

tin tetrachloride;
stannic chloride

231-588-9

7646-78-8

Skin Corr. 1B
Aquatic Chronic 3

H314
H412

GHS05
Gef.

H314
H412

STOT SE 3; H335: C> 5 %

050-002-00-0

cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide

236-049-1

13121-70-5

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

M=1000

050-003-00-6

fentin acetate (ISO);
triphenyltin acetate

212-984-0

900-95-8

Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H400
H410

GHS06
GHS05
GHS08
GHS09
Gef.

H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H410

M=10

050-004-00-1

fentin hydroxide (ISO);
triphenyltin hydroxide

200-990-6

76-87-9

Carc. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H400
H410

GHS06
GHS05
GHS08
GHS09
Gef.

H351
H361d***
H330
H311
H301
H372**
H335
H315
H318
H410

M=10

050-005-00-7

trimethyltin compounds, with the exception of those specified elsewhere in this Annex

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H400
H410

GHS06
GHS09
Gef.

H330
H310
H300
H410

050-006-00-2

triethyltin compounds, with the exception of those specified elsewhere in this Annex

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H400
H410

GHS06
GHS09
Gef.

H330
H310
H300
H410

050-007-00-8

tripropyltin compounds, with the exception of those specified elsewhere in this Annex

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H410

050-008-00-3

Tributyl-Zinnverbindungen, soweit in diesem Anhang nicht gesondert aufgeführt

Repr. 1B
Acute Tox. 3
Acute Tox. 4*
STOT RE 1
Skin Irrit. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H360FD
H301
H312
H372**
H315
H319
H400
H410

GHS08
GHS06
GHS09
Gef.

H360FD
H301
H312
H372**
H315
H319
H410

*
STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,25 % ≤ C < 1 %
Skin Irrit. 2; H315:C> 1 %
Eye Irrit. 2; H319:C> 1 %
M = 10

a
1

050-009-00-9

fluorotripentylstannane; [1]
hexapentyldistannoxane [2]

243-546-7 [1]
247-143-7 [2]

20153-49-5 [1]
25637-27-8 [2]

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

050-010-00-4

fluorotrihexylstannane

243-547-2

20153-50-8

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

050-011-00-X

triphenyltin compounds, with the exception of those specified elsewhere in this Annex

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H410

*
M=100

050-012-00-5

tetracyclohexylstannane; [1]
chlorotricyclohexylstannane; [2]
butyltricyclohexylstannane [3]

215-910-5 [1]
221-437-5 [2]
230-358-5 [3]

1449-55-4 [1]
3091-32-5 [2]
7067-44-9 [3]

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

050-013-00-0

trioctyltin compounds, with the exception of those specified elsewhere in this Annex

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 4

H319
H335
H315
H413

GHS07
Achtg.

H319
H335
H315
H413

Skin Irrit. 2; H315: C> 1 %
Eye Irrit. 2; H319: C> 1 %
STOT SE 3; H335: C> 1 %

050-017-00-2

fenbutatin oxide (ISO);
bis(tris(2-methyl-2-phenylpropyl)tin)oxide

236-407-7

13356-08-6

Acute Tox. 2 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H330
H319
H315
H400
H410

GHS06
GHS09
Gef.

H330
H319
H315
H410

050-018-00-8

tin(II) methanesulphonate

401-640-7

53408-94-9

Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H314
H302
H317
H411

GHS05
GHS07
GHS09
Gef.

H314
H302
H317
H411

050-019-00-3

azocyclotin (ISO);
1-(tricyclohexylstannyl)-1H - 1,2,4-triazole

255-209-1

41083-11-8

Acute Tox. 2 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H301
H335
H315
H318
H400
H410

GHS06
GHS05
GHS09
Gef.

H330
H301
H335
H315
H318
H410

050-020-00-9

trioctylstannane

413-320-4

869-59-0

STOT RE 1
Skin Irrit. 2
Aquatic Chronic 4

H372 **
H315
H413

GHS08
GHS07
Gef.

H372 **
H315
H413

050-021-00-4

dichlorodioctyl stannane

222-583-2

3542-36-7

Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3

H331
H372**
H412

GHS06
GHS08
Gef.

H331
H372**
H412

050-022-00-X

dibutyltin dichloride;
(DBTC)

211-670-0

683-18-1

Muta. 2
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H341
H360FD
H330
H301
H312
H372**
H314
H400
H410

GHS06
GHS05
GHS08
GHS09
Gef.

H341
H360FD
H330
H301
H312
H372**
H314
H410

Skin Corr. 1B; H314: C> 5 %
Skin Irrit. 2; H315: 0,01 % ≤ C < 5 %
Eye Dam. 1; H318: 3 % ≤ C < 5 %
Eye Irrit. 2; H319: 0,01 % ≤ C < 3 %
M=10

050-023-00-5

reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane

422-920-5

STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H373**
H400
H410

GHS08
GHS09
Achtg.

H373**
H410

M=10

050-024-00-0

reaction mass of: tri-p-tolyltin hydroxide;
hexa-p-tolyl-distannoxane

432-230-6

STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H372**
H302
H315
H318
H317
H400
H410

GHS05
GHS08
GHS07
GHS09
Gef.

H372**
H302
H315
H318
H317
H410

050-025-00-6

trichloromethylstannane

213-608-8

993-16-8

Repr. 2

H361d

GHS08
Achtg.

H361d

050-026-00-1

2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

260-828-5

57583-34-3

Repr. 2

H361d

GHS08
Achtg.

H361d

050-027-00-7

2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

239-622-4

15571-58-1

Repr. 1B

H360D

GHS08
Gef.

H360D

050-028-00-2

2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate

260-829-0

57583-35-4

Repr. 2
Acute Tox. 4
STOT RE 1
Skin Sens. 1A

H361d
H302
H372 (Nervensystem, Immunsystem)
H317

GHS08
GHS07
Gef.

H361d
H302
H372 (Nervensystem, Immunsystem)
H317

050-029-00-8

dimethyltin dichloride

212-039-2

753-73-1

Repr. 2
Acute Tox. 2
Acute Tox. 3
Acute Tox. 3
STOT RE 1
Skin Corr. 1B

H361d
H330
H301
H311
H372 (Nervensystem, Immunsystem)
H314

GHS08
GHS06
GHS05
Gef.

H361d
H330
H301
H311
H372 (Nervensystem, Immunsystem)
H314

EUH071

050-030-00-3

Dibutylzinndilaurat; Dibutyl[bis(dodecanoyloxy)]-stannan

201-039-8

77-58-7

Muta. 2
Repr. 1B
STOT RE 1

H341
H360FD
H372 (Immunsystem)

GHS08
Gef.

H341
H360FD
H372 (Immunsystem)

051-001-00-8

antimony trichloride

233-047-2

10025-91-9

Skin Corr. 1B
Aquatic Chronic 2

H314
H411

GHS05
GHS09
Gef.

H314
H411

STOT SE 3; H335: C> 5 %

051-002-00-3

antimony pentachloride

231-601-8

7647-18-9

Skin Corr. 1B
Aquatic Chronic 2

H314
H411

GHS05
GHS09
Gef.

H314
H411

STOT SE 3; H335: C> 5 %

051-003-00-9

antimony compounds, with the exception of the tetroxide (Sb₂O₄), pentoxide (Sb₂O₅), trisulphide (Sb₂S₃), pentasulphide (Sb₂S₅) and those specified elsewhere in this Annex

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2

H332
H302
H411

GHS07
GHS09
Achtg.

H332
H302
H411

051-004-00-4

antimony trifluoride

232-009-2

7783-56-4

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Chronic 2

H331
H311
H301
H411

GHS06
GHS09
Gef.

H331
H311
H301
H411

051-005-00-X

antimony trioxide

215-175-0

1309-64-4

Carc. 2

H351

GHS08
Achtg.

H351

051-006-00-5

diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate

403-500-0

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

051-007-00-0

bis(4-dodecylphenyl)iodonium hexafluoroantimonate

404-420-9

71786-70-4

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

053-001-00-3

iodine

231-442-4

7553-56-2

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1

H332
H312
H400

GHS07
GHS09
Achtg.

H332
H312
H400

053-002-00-9

hydrogen iodide

233-109-9

10034-85-2

Press. Gas
Skin Corr. 1A

H314

GHS04
GHS05
Gef.

H314

Skin Corr. 1A; H314: C> 10 %
Skin Corr. 1B; H314: 0,2 % ≤ C < 10 %
Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 %
Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 %
STOT SE 3; H335: C> 0,02 %

053-002-01-6

hydriodic acid ... %

Skin Corr. 1B

H314

GHS05
Gef.

Skin Corr. 1B; H314: C> 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %

053-003-00-4

iodoxybenzene

696-33-3

Expl. ****

****

053-004-00-X

calcium iodoxybenzoate

Expl. ****

****

053-005-00-5

(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-)

422-960-3

178233-72-2

Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H373 **
H400
H410

GHS08
GHS07
GHS09
Achtg.

H312
H302
H373 **
H410

056-001-00-1

barium peroxide

215-128-4

1304-29-6

Ox. Sol. 2
Acute Tox. 4 *
Acute Tox. 4 *

H272
H332
H302

GHS03
GHS07
Gef.

H272
H332
H302

056-002-00-7

barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex

Acute Tox. 4 *
Acute Tox. 4 *

H332
H302

GHS07
Achtg.

H332
H302

056-003-00-2

barium carbonate

208-167-3

513-77-9

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

056-004-00-8

barium chloride

233-788-1

10361-37-2

Acute Tox. 3 *
Acute Tox. 4 *

H301
H332

GHS06
Gef.

H301
H332

064-001-00-8

gadolinium(III)sulfite trihydrate

456-900-2

51285-81-5

Aquatic Chronic 2

H411

GHS09

H411

072-001-00-4

hafnium tetra-n-butoxide

411-740-2

22411-22-9

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

074-001-00-X

hexasodium tungstate hydrate

412-770-9

12141-67-2

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

074-002-00-5

Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione

408-250-6

Flam. Liq. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H225
H332
H314
H317
H400
H410

GHS02
GHS05
GHS07
GHS09
Gef.

H225
H332
H314
H317
H410

076-001-00-5

osmium tetraoxide;
osmic acid

244-058-7

20816-12-0

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Skin Corr. 1B

H330
H310
H300
H314

GHS06
GHS05
Gef.

H330
H310
H300
H314

078-001-00-0

tetrachloroplatinates with the exception of those specified elsewhere in this Annex

Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H301
H318
H334
H317

GHS06
GHS05
GHS08
Gef.

H301
H318
H334
H317

078-002-00-6

diammonium tetrachloroplatinate

237-499-1

13820-41-2

Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H301
H315
H318
H334
H317

GHS06
GHS05
GHS08
Gef.

H301
H315
H318
H334
H317

078-003-00-1

disodium tetrachloroplatinate

233-051-4

10026-00-3

Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H301
H315
H318
H334
H317

GHS06
GHS05
GHS08
Gef.

H301
H315
H318
H334
H317

078-004-00-7

dipotassium tetrachloroplatinate

233-050-9

10025-99-7

Acute Tox. 3 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H301
H315
H318
H334
H317

GHS06
GHS05
GHS08
Gef.

H301
H315
H318
H334
H317

078-005-00-2

hexachloroplatinates with the exception of those specified elsewhere in this Annex

Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H301
H318
H334
H317

GHS06
GHS05
GHS08
Gef.

H301
H318
H334
H317

078-006-00-8

disodium hexachloroplatinate

240-983-5

16923-58-3

Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H301
H318
H334
H317

GHS06
GHS05
GHS08
Gef.

H301
H318
H334
H317

078-007-00-3

dipotassium hexachloroplatinate

240-979-3

16921-30-5

Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H301
H318
H334
H317

GHS06
GHS05
GHS08
Gef.

H301
H318
H334
H317

078-008-00-9

diammonium hexachloroplatinate

240-973-0

16919-58-7

Acute Tox. 3 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H301
H318
H334
H317

GHS06
GHS05
GHS08
Gef.

H301
H318
H334
H317

078-009-00-4

hexachloroplatinic acid

241-010-7

16941-12-1

Acute Tox. 3 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1

H301
H314
H334
H317

GHS06
GHS05
GHS08
Gef.

H301
H314
H334
H317

078-010-00-X

tetraammine platinum(II) hydrogen carbonate

426-730-3

123439-82-7

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

078-011-00-5

hydroxydisulfito platinum(II) acid

423-310-1

61420-92-6

Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1a
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3

H302
H373
H314
H334
H317
H412

GHS05
GHS08
GHS07
Gef.

H302
H373
H314
H334
H317
H412

078-012-00-0

platinum(IV) nitrate/nitric acid solution

432-400-1

Skin Corr. 1a
Aquatic Acute 1
Aquatic Chronic 1

H314
H400
H410

GHS05
GHS09
Gef.

H314
H410

080-001-00-0

mercury

231-106-7

7439-97-6

Repr. 1B
Acute Tox. 2 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H360D***
H330
H372**
H400
H410

GHS06
GHS08
GHS09
Gef.

H360D***
H330
H372**
H410

080-002-00-6

inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H310
H300
H373 **
H410

*
STOT RE 2; H373: C> 0,1 %

080-003-00-1

dimercury dichloride;
mercurous chloride;
calomel

233-307-5

10112-91-1

Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H335
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H335
H315
H410

080-004-00-7

organic compounds of mercury with the exception of those specified elsewhere in this Annex

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H310
H300
H373 **
H410

*
STOT RE 2; H373: C> 0,1 %

080-005-00-2

mercury difulminate;
mercuric fulminate;
fulminate of mercury

211-057-8

628-86-4

Unst. Expl.
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H200
H331
H311
H301
H373 **
H400
H410

GHS01
GHS06
GHS08
GHS09
Gef.

H200
H331
H311
H301
H373 **
H400
H410

080-005-01-X

mercury difulminate;
mercuric fulminate;
fulminate of mercury [> 20 % phlegmatiser]

211-057-8

628-86-4

Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H201
H331
H311
H301
H373 **
H400
H410

GHS01
GHS06
GHS08
GHS09
Gef.

H201
H331
H311
H301
H373 **
H400
H410

080-006-00-8

dimercury dicyanide oxide;
mercuric oxycyanide

215-629-8

1335-31-5

Expl. 1,1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H201
H331
H311
H301
H373**
H400
H410

GHS01
GHS06
GHS08
GHS09
Gef.

H201
H331
H311
H301
H373**
H410

080-007-00-3

dimethylmercury; [1]
diethylmercury [2]

209-805-3 [1]
211-000-7 [2]

593-74-8 [1]
627-44-1 [2]

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H310
H300
H373 **
H410

*
STOT RE 2; H373: C> 0,05 %

080-008-00-9

phenylmercury nitrate; [1]
phenylmercury hydroxide; [2]
basic phenylmercury nitrate [3]

200-242-9 [1]
202-866-7 [2]
- [3]

55-68-5 [1]
100-57-2 [2]
8003-05-2 [3]

Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H301
H372 **
H314
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H301
H372 **
H314
H410

080-009-00-4

2-methoxyethylmercury chloride

204-659-7

123-88-6

Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H301
H372 **
H314
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H301
H372 **
H314
H410

080-010-00-X

mercury dichloride;
mercuric chloride

231-299-8

7487-94-7

Muta. 2
Repr. 2
Acute Tox. 2 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H341
H361f***
H300
H372**
H314
H400
H410

GHS06
GHS05
GHS08
GHS09
Gef.

H341
H361f***
H300
H372**
H314
H410

080-011-00-5

phenylmercury acetate

200-532-5

62-38-4

Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H301
H372 **
H314
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H301
H372 **
H314
H410

081-001-00-3

thallium

231-138-1

7440-28-0

Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4

H330
H300
H373 **
H413

GHS06
GHS08
Gef.

H330
H300
H373 **
H413

081-002-00-9

thallium compounds, with the exception of those specified elsewhere in this Annex

Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2

H330
H300
H373 **
H411

GHS06
GHS08
GHS09
Gef.

H330
H300
H373 **
H411

081-003-00-4

dithallium sulphate;
thallic sulphate

231-201-3

7446-18-6

Acute Tox. 2 *
STOT RE 1
Skin Irrit. 2
Aquatic Chronic 2

H300
H372 **
H315
H411

GHS06
GHS08
GHS09
Gef.

H300
H372 **
H315
H411

082-001-00-6

lead compounds with the exception of those specified elsewhere in this Annex

Repr. 1a
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H332
H302
H373 **
H400
H410

GHS08
GHS07
GHS09
Gef.

H360Df
H332
H302
H373 **
H410

Repr. 2; H361f: C> 2,5 %
*
STOT RE 2; H373: C> 0,5 %

082-002-00-1

lead alkyls

Repr. 1a
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H330
H310
H300
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H360Df
H330
H310
H300
H373 **
H410

Repr. 1A; H360D: C> 0,1 %
*
STOT RE 2; H373: C> 0,05 %

082-003-00-7

lead diazide;
lead azide

236-542-1

13424-46-9

Unst. Expl.
Repr. 1a
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H200
H360Df
H332
H302
H373 **
H400
H410

GHS01
GHS08
GHS07
GHS09
Gef.

H200
H360Df
H332
H302
H373 **
H410

082-003-01-4

lead diazide;
lead azide [> 20 % phlegmatiser]

236-542-1

13424-46-9

Expl. 1.1
Repr. 1a
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H201
H360Df
H332
H302
H373 **
H400
H410

GHS01
GHS08
GHS07
GHS09
Gef.

H201
H360Df
H332
H302
H373 **
H410

082-004-00-2

lead chromate

231-846-0

7758-97-6

Carc. 1B
Repr. 1a
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H350
H360Df
H373**
H400
H410

GHS08
GHS09
Gef.

H350
H360Df
H373**
H410

082-005-00-8

lead di(acetate)

206-104-4

301-04-2

Repr. 1a
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H373 **
H400
H410

GHS08
GHS09
Gef.

H360Df
H373 **
H410

082-006-00-3

trilead bis(orthophosphate)

231-205-5

7446-27-7

Repr. 1a
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H373 **
H400
H410

GHS08
GHS09
Gef.

H360Df
H373 **
H410

082-007-00-9

lead acetate, basic

215-630-3

1335-32-6

Carc. 2
Repr. 1a
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H360Df
H373 **
H400
H410

GHS08
GHS09
Gef.

H351
H360Df
H373 **
H410

082-008-00-4

lead(II) methanesulphonate

401-750-5

17570-76-2

Repr. 1a
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1

H360Df
H332
H302
H373 **
H315
H318

GHS08
GHS05
GHS07
Gef.

H360Df
H332
H302
H373 **
H315
H318

082-009-00-X

lead sulfochromate yellow;
C.I. Pigment Yellow 34;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.]

215-693-7

1344-37-2

Carc. 1B
Repr. 1a
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H350
H360Df
H373**
H400
H410

GHS08
GHS09
Gef.

H350
H360Df
H373**
H410

082-010-00-5

lead chromate molybdate sulfate red;
C.I. Pigment Red 104;
[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.]

235-759-9

12656-85-8

Carc. 1B
Repr. 1a
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H350
H360Df
H373**
H400
H410

GHS08
GHS09
Gef.

H350
H360Df
H373**
H410

082-011-00-0

lead hydrogen arsenate

232-064-2

7784-40-9

Carc. 1a
Repr. 1a
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H350
H360Df
H331
H301
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H360Df
H331
H301
H373 **
H410

082-012-00-6

barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped

431-780-4

199876-46-5

Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2

H302
H373**
H411

GHS08
GHS07
GHS09
Achtg.

H302
H373**
H411

082-013-00-1

Bleipulver;
[Partikeldurchmesser < 1 mm]

231-100-4

7439-92-1

Repr. 1 a
Lakt.

H360FD
H362

GHS08
Gef.

H360FD
H362

Repr. 1 A; H360D: C> 0,03 %

082-014-00-7

Blei, massiv:
[Partikeldurchmesser> 1 mm]

231-100-4

7439-92-1

Repr. 1 a
Lakt.

H360FD
H362

GHS08
Gef.

H360FD
H362

092-001-00-8

uranium

231-170-6

7440-61-1

Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 4

H330
H300
H373 **
H413

GHS06
GHS08
Gef.

H330
H300
H373 **
H413

092-002-00-3

uranium compounds with the exception of those specified elsewhere in this Annex

Acute Tox. 2 *
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2

H330
H300
H373**
H411

GHS06
GHS08
GHS09
Gef.

H330
H300
H373**
H411

601-001-00-4

methane

200-812-7

74-82-8

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

601-002-00-X

ethane

200-814-8

74-84-0

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

601-003-00-5

propane

200-827-9

74-98-6

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

601-004-00-0

butane; [1]
and isobutane [2]

203-448-7 [1]
200-857-2 [2]

106-97-8 [1]
75-28-5 [2]

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

C U

601-004-01-8

butane (containing> 0.1 % butadiene (203-450-8)); [1]
isobutane (containing> 0.1 % butadiene (203-450-8)) [2]

203-448-7 [1]
200-857-2 [2]

106-97-8 [1]
75-28-5 [2]

Flam. Gas 1
Press. Gas
Carc. 1a
Muta. 1B

H220
H350
H340

GHS02
GHS04
GHS08
Gef.

H220
H350
H340

C S U

601-005-00-6

2,2-dimethylpropane;
neopentane

207-343-7

463-82-1

Flam. Gas 1
Press. Gas
Aquatic Chronic 2

H220
H411

GHS02
GHS04
GHS09
Gef.

H220
H411

601-006-00-1

pentane

203-692-4

109-66-0

Flam. Liq. 2
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2

H225
H304
H336
H411

GHS02
GHS08
GHS07
GHS09
Gef.

H225
H304
H336
H411

EUH066

601-007-00-7

hexane (containing < 5 %n-hexane (203-777-6));
2-methylpentane; [1]
3-methylpentane; [2]
2,2-dimethylbutane; [3]
2,3-dimethylbutane [4]

203-523-4 [1]
202-481-4 [2]
200-906-8 [3]
201-193-6 [4]

107-83-5 [1]
96-14-0 [2]
75-83-2 [3]
79-29-8 [4]

Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2

H225
H304
H315
H336
H411

GHS02
GHS08
GHS07
GHS09
Gef.

H225
H304
H315
H336
H411

601-008-00-2

heptane;
n-heptane; [1]
2,4-dimethylpentane; [2]
2,2,3-trimethylbutane; [3]
3,3-dimethylpentane; [4]
2,3-dimethylpentane; [5]
3-methylhexane; [6]
2,2-dimethylpentane; [7]
2-methylhexane; [8]
3-ethylpentane; [9]
isoheptane; [10]

205-563-8 [1]
203-548-0 [2]
207-346-3 [3]
209-230-8 [4]
209-280-0 [5]
209-643-3 [6]
209-680-5 [7]
209-730-6 [8]
210-529-0 [9]
250-610-8 [10]

142-82-5 [1]
108-08-7 [2]
464-06-2 [3]
562-49-2 [4]
565-59-3 [5]
589-34-4 [6]
590-35-2 [7]
591-76-4 [8]
617-78-7 [9]
31394-54-4 [10]

Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H225
H304
H315
H336
H400
H410

GHS02
GHS08
GHS07
GHS09
Gef.

H225
H304
H315
H336
H410

601-009-00-8

octane;
n-octane; [1]
2,2,4-trimethylpentane; [2]
2,3,3-trimethylpentane; [3]
3,3-dimethylhexane; [4]
2,2,3-trimethylpentane; [5]
2,3,4-trimethylpentane; [6]
3,4-dimethylhexane; [7]
2,3-dimethylhexane; [8]
2,4-dimethylhexane; [9]
4-methylheptane; [10]
3-methylheptane; [11]
2,2-dimethylhexane; [12]
2,5-dimethylhexane; [13]
2-methylheptane; [14]
2,2,3,3-tetramethylbutane; [15]
3-ethyl-2-methylpentane; [16]
3-ethylhexane; [17]
3-ethyl-3-methylpentane; [18]
isooctane; [19]

203-892-1 [1]
208-759-1 [2]
209-207-2 [3]
209-243-9 [4]
209-266-4 [5]
209-292-6 [6]
209-504-7 [7]
209-547-1 [8]
209-649-6 [9]
209-650-1 [10]
209-660-6 [11]
209-689-4 [12]
209-745-8 [13]
209-747-9 [14]
209-855-6 [15]
210-187-2 [16]
210-621-0 [17]
213-923-0 [18]
247-861-0 [19]

111-65-9 [1]
540-84-1 [2]
560-21-4 [3]
563-16-6 [4]
564-02-3 [5]
565-75-3 [6]
583-48-2 [7]
584-94-1 [8]
589-43-5 [9]
589-53-7 [10]
589-81-1 [11]
590-73-8 [12]
592-13-2 [13]
592-27-8 [14]
594-82-1 [15]
609-26-7 [16]
619-99-8 [17]
1067-08-9 [18]
26635-64-3 [19]

Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H225
H304
H315
H336
H400
H410

GHS02
GHS08
GHS07
GHS09
Gef.

H225
H304
H315
H336
H410

601-010-00-3

ethylene

200-815-3

74-85-1

Flam. Gas 1
Press. Gas
STOT SE 3

H220
H336

GHS02
GHS04
GHS07
Gef.

H220
H336

601-011-00-9

propene;
propylene

204-062-1

115-07-1

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

601-012-00-4

but-1-ene; [1]
butene, mixed-1-and-2-isomers; [2]
2-methylpropene; [3]
(Z)-but-2-ene; [4]
(E)-but-2-ene [5]

203-449-2 [1]
203-452-9 [2]
204-066-3 [3]
209-673-7 [4]
210-855-3 [5]

106-98-9 [1]
107-01-7 [2]
115-11-7 [3]
590-18-1 [4]
624-64-6 [5]

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

C U

601-013-00-X

1,3-butadiene;
buta-1,3-diene

203-450-8

106-99-0

Flam. Gas 1
Press. Gas
Carc. 1a
Muta. 1B

H220
H350
H340

GHS02
GHS04
GHS08
Gef.

H220
H350
H340

D U

601-014-00-5

isoprene (stabilised)
2-methyl-1,3-butadiene

201-143-3

78-79-5

Flam. Liq. 1
Carc. 1B
Muta. 2
Aquatic Chronic 3

H224
H350
H341
H412

GHS02
GHS08
Gef.

H224
H350
H341
H412

601-015-00-0

acetylene;
ethyne

200-816-9

74-86-2

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

EUH006

601-016-00-6

cyclopropane

200-847-8

75-19-4

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

601-017-00-1

cyclohexane

203-806-2

110-82-7

Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H225
H304
H315
H336
H400
H410

GHS02
GHS08
GHS07
GHS09
Gef.

H225
H304
H315
H336
H410

601-018-00-7

methylcyclohexane

203-624-3

108-87-2

Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2

H225
H304
H315
H336
H411

GHS02
GHS08
GHS07
GHS09
Gef.

H225
H304
H315
H336
H411

601-019-00-2

1,4-dimethylcyclohexane

209-663-2

589-90-2

Flam. Liq. 2
Asp. Tox. 1
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2

H225
H304
H315
H336
H411

GHS02
GHS08
GHS07
GHS09
Gef.

H225
H304
H315
H336
H411

601-020-00-8

benzene

200-753-7

71-43-2

Flam. Liq. 2
Carc. 1a
Muta. 1B
STOT RE 1
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2

H225
H350
H340
H372 **
H304
H319
H315

GHS02
GHS08
GHS07
Gef.

H225
H350
H340
H372 **
H304
H319
H315

601-021-00-3

toluene

203-625-9

108-88-3

Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3

H225
H361d ***
H304
H373 **
H315
H336

GHS02
GHS08
GHS07
Gef.

H225
H361d ***
H304
H373 **
H315
H336

601-022-00-9

o-xylene; [1]
p-xylene; [2]
m-xylene; [3]
xylene [4]

202-422-2 [1]
203-396-5 [2]
203-576-3 [3]
215-535-7 [4]

95-47-6 [1]
106-42-3 [2]
108-38-3 [3]
1330-20-7 [4]

Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2

H226
H332
H312
H315

GHS02
GHS07
Achtg.

H226
H332
H312
H315

601-023-00-4

ethylbenzene

202-849-4

100-41-4

Flam. Liq. 2
Acute Tox. 4*
STOT RE 2
Asp. Tox. 1

H225
H332
H373 (Hörorgane)
H304

GHS02
GHS07
GHS08
Gef.

H225
H332
H373 (Hörorgane)
H304

601-024-00-X

cumene; [1]
propylbenzene [2]

202-704-5 [1]
203-132-9 [2]

98-82-8 [1]
103-65-1 [2]

Flam. Liq. 3
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2

H226
H304
H335
H411

GHS02
GHS08
GHS07
GHS09
Gef.

H226
H304
H335
H411

601-025-00-5

mesitylene;
1,3,5-trimethylbenzene

203-604-4

108-67-8

Flam. Liq. 3
STOT SE 3
Aquatic Chronic 2

H226
H335
H411

GHS02
GHS07
GHS09
Achtg.

H226
H335
H411

STOT SE 3; H335: C> 25 %

601-026-00-0

styrene

202-851-5

100-42-5

Flam. Liq. 3
Repr. 2
Acute Tox. 4*
STOT RE 1
Skin Irrit. 2
Eye Irrit. 2

H226
H361d
H332
H372 (Hörorgane)
H315
H319

GHS02
GHS08
GHS07
Gef.

H226
H361d
H332
H372 (Hörorgane)
H315
H319

601-027-00-6

2-phenylpropene;
a-methylstyrene

202-705-0

98-83-9

Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 2

H226
H319
H335
H411

GHS02
GHS07
GHS09
Achtg.

H226
H319
H335
H411

STOT SE 3; H335: C> 25 %

601-028-00-1

2-methylstyrene;
2-vinyltoluene

210-256-7

611-15-4

Acute Tox. 4 *
Aquatic Chronic 2

H332
H411

GHS07
GHS09
Achtg.

H332
H411

601-029-00-7

dipentene;
limonene; [1]
(R)-p-mentha-1,8-diene;
d-limonene; [2]
(S)-p-mentha-1,8-diene;
l-limonene; [3]
trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]
(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5]

205-341-0 [1]
227-813-5 [2]
227-815-6 [3]
229-977-3 [4]
231-732-0 [5]

138-86-3 [1]
5989-27-5 [2]
5989-54-8 [3]
6876-12-6 [4]
7705-14-8 [5]

Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H226
H315
H317
H400
H410

GHS02
GHS07
GHS09
Achtg.

H226
H315
H317
H410

601-030-00-2

cyclopentane

206-016-6

287-92-3

Flam. Liq. 2
Aquatic Chronic 3

H225
H412

GHS02
Gef.

H225
H412

601-031-00-8

2,4,4-trimethylpent-1-ene

203-486-4

107-39-1

Flam. Liq. 2
Aquatic Chronic 2

H225
H411

GHS02
GHS09
Gef.

H225
H411

601-032-00-3

benzo[a]pyrene;
benzo[def]chrysene

200-028-5

50-32-8

Carc. 1B
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H340
H360FD
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H340
H360FD
H317
H410

Carc. 1B; H350: C> 0,01 %

601-033-00-9

benz[a]anthracene

200-280-6

56-55-3

Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H400
H410

GHS08
GHS09
Gef.

H350
H410

M=100

601-034-00-4

benz[e]acephenanthrylene

205-911-9

205-99-2

Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H400
H410

GHS08
GHS09
Gef.

H350
H410

601-035-00-X

benzo[j]fluoranthene

205-910-3

205-82-3

Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H400
H410

GHS08
GHS09
Gef.

H350
H410

601-036-00-5

benzo[k]fluoranthene

205-916-6

207-08-9

Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H400
H410

GHS08
GHS09
Gef.

H350
H410

601-037-00-0

n-hexane

203-777-6

110-54-3

Flam. Liq. 2
Repr. 2
Asp. Tox. 1
STOT RE 2 *
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 2

H225
H361f ***
H304
H373 **
H315
H336
H411

GHS02
GHS08
GHS07
GHS09
Gef.

H225
H361f ***
H304
H373 **
H315
H336
H411

STOT RE 2; H373: C> 5 %

601-041-00-2

dibenz[a,h]anthracene

200-181-8

53-70-3

Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H400
H410

GHS08
GHS09
Gef.

H350
H410

Carc. 1B; H350: C> 0,01 %
M=100

601-042-00-8

biphenyl;
diphenyl

202-163-5

92-52-4

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H335
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H335
H315
H410

601-043-00-3

1,2,4-trimethylbenzene

202-436-9

95-63-6

Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2

H226
H332
H319
H335
H315
H411

GHS02
GHS07
GHS09
Achtg.

H226
H332
H319
H335
H315
H411

601-044-00-9

3a,4,7,7a-tetrahydro-4,7-methanoindene

201-052-9

77-73-6

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2

H225
H332
H302
H319
H335
H315
H411

GHS02
GHS07
GHS09
Gef.

H225
H332
H302
H319
H335
H315
H411

601-045-00-4

1,2,3,4-tetrahydronaphthalene

204-340-2

119-64-2

Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H319
H315
H411

GHS07
GHS09
Achtg.

H319
H315
H411

EUH019

601-046-00-X

7-methylocta-1,6-diene

404-210-7

42152-47-6

Flam. Liq. 3
Aquatic Acute 1
Aquatic Chronic 1

H226
H400
H410

GHS02
GHS09
Achtg.

H226
H410

601-047-00-5

m-mentha-1,3(8)-diene

404-150-1

17092-80-7

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

601-048-00-0

chrysene

205-923-4

218-01-9

Carc. 1B
Muta. 2
Aquatic Acute 1
Aquatic Chronic 1

H350
H341
H400
H410

GHS08
GHS09
Gef.

H350
H341
H410

601-049-00-6

benzo[e]pyrene

205-892-7

192-97-2

Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H400
H410

GHS08
GHS09
Gef.

H350
H410

601-051-00-7

4-phenylbut-1-ene

405-980-7

768-56-9

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

601-052-00-2

naphthalene

202-049-5

91-20-3

Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H400
H410

GHS07
GHS08
GHS09
Achtg.

H351
H302
H410

601-053-00-8

nonylphenol; [1]
4-nonylphenol, branched [2]

246-672-0 [1]
284-325-5 [2]

25154-52-3 [1]
84852-15-3 [2]

Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H361fd
H302
H314
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H361fd
H302
H314
H410

601-054-00-3

reaction mass of isomers of: dibenzylbenzene;
dibenzyl(methyl)benzene;
dibenzyl(dimethyl)benzene;
dibenzyl(trimethyl)benzene

405-570-8

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

601-055-00-9

reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;
di-(2-tetradecyl)naphthalenes;
tri-(2-tetradecyl)naphthalenes

410-190-0

132983-41-6

Eye Irrit. 2
Aquatic Chronic 4

H319
H413

GHS07
Achtg.

H319
H413

601-056-00-4

reaction mass of isomers of: methyldiphenylmethane;
dimethyldiphenylmethane

405-470-4

73807-39-3

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

601-057-00-X

N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate

421-130-8

156679-41-3

Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H318
H317
H410

601-058-00-5

di-L-para-menthene

417-870-6

83648-84-4

Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H317
H400
H410

GHS07
GHS09
Achtg.

H315
H317
H410

601-059-00-0

methyl 2-benzylidene-3-oxobutyrate

420-940-9

15768-07-7

Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H319
H315
H411

GHS07
GHS09
Achtg.

H319
H315
H411

601-060-00-6

1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245

417-610-1

155522-09-1

Skin Sens. 1

H317

GHS07
Achtg.

H317

601-061-00-1

(ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]?-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl)

418-960-8

Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H314
H317
H411

GHS05
GHS07
GHS09
Gef.

H314
H317
H411

601-062-00-7

reaction mass of: branched triacontane;
branched dotriacontane;
branched tetratriacontane;
branched hexatriacontane

417-030-9

151006-59-6

Aquatic Chronic 4

H413

601-063-00-2

reaction mass of isomers of branched tetracosane

417-060-2

151006-61-0

Acute Tox. 4 *
Aquatic Chronic 4

H332
H413

GHS07
Achtg.

H332
H413

601-064-00-8

branched hexatriacontane

417-070-7

151006-62-1

Aquatic Chronic 4

H413

601-065-00-3

reaction mass of: (1'a,3'a,6'a)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);
(1'a,3'ß,6'a)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)

416-930-9

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

601-066-00-9

1-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone

426-820-2

78531-60-9

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

601-067-00-4

triethyl arsenate

427-700-2

15606-95-8

Carc. 1a
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H350
H331
H301
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H331
H301
H410

601-068-00-X

1,2-diacetoxybut-3-ene

421-720-5

18085-02-4

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

601-069-00-5

2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide

422-680-1

287933-44-2

Aquatic Chronic 3

H412

601-070-00-0

reaction mass of: branched icosane;
branched docosane;
branched tetracosane

417-050-8

151006-58-5

Acute Tox. 4 *
Aquatic Chronic 4

H332
H413

GHS07
Achtg.

H332
H413

601-071-00-6

1-dimethoxymethyl-2-nitro-benzene

423-830-9

20627-73-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

601-072-00-1

reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane;
1-(3-isopropylphenyl)-1-phenylethane;
1-(2-isopropylphenyl)-1-phenylethane

430-690-2

52783-21-8

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

601-073-00-7

1-bromo-3,5-difluorobenzene

416-710-2

461-96-1

Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H226
H302
H373 **
H315
H317
H400
H410

GHS02
GHS08
GHS07
GHS09
Achtg.

H226
H302
H373 **
H315
H317
H410

601-074-00-2

reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;
1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;
spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];
spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]

422-040-1

Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H319
H315
H411

GHS07
GHS09
Achtg.

H319
H315
H411

601-075-00-8

4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane

418-770-5

151882-81-4

Carc. 2

H351

GHS08
Achtg.

H351

601-076-00-3

ethynyl cyclopropane

425-430-1

6746-94-7

Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H225
H315
H318
H412

GHS02
GHS05
Gef.

H225
H315
H318
H412

601-077-00-9

reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;
1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane

426-510-7

196965-91-0

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

601-078-00-4

reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane;
2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane

427-040-5

Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H314
H400
H410

GHS05
GHS09
Gef.

H314
H410

601-079-00-X

reaction mass of:trans-trans-cyclohexadeca-1,9-diene;
cis-trans-cyclohexadeca-1,9-diene

429-620-3

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4

H315
H317
H413

GHS07
Achtg.

H315
H317
H413

601-080-00-5

reaction mass of:sec-butylphenyl(phenyl)methane, mixed isomers;
1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-(sec-butylphenyl-1-phenylethane, mixed isomers

431-100-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

601-081-00-0

cyclohexadeca-1,9-diene

431-730-1

4277-06-9

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4

H315
H317
H413

GHS07
Achtg.

H315
H317
H413

601-082-00-6

reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane

434-420-4

Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H400
H410

GHS05
GHS09
Gef.

H315
H318
H410

601-083-00-1

5-endo-hexyl-bicyclo[2.2.1]hept-2-ene

435-000-3

22094-83-3

Asp. Tox. 1
Skin Irrit. 2
Aquatic Chronic 4

H304
H315
H413

GHS08
GHS07
Gef.

H304
H315
H413

601-084-00-7

reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)

435-180-3

Asp. Tox. 1
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H304
H315
H400
H410

GHS08
GHS07
GHS09
Gef.

H304
H315
H410

601-085-00-2

isopentane;
2-methylbutane

201-142-8

78-78-4

Flam. Liq. 1
Asp. Tox. 1
STOT SE 3
Aquatic Chronic 2

H224
H304
H336
H411

GHS02
GHS08
GHS07
GHS09
Gef.

H224
H304
H336
H411

EUH066

601-087-00-3

2,4,4-trimethylpentene

246-690-9

25167-70-8

Flam. Liq. 2

H225

GHS02

H225

Asp. Tox. 1

H304

GHS07

H304

STOT SE 3

H336

GHS08
Gef.

H336

601-088-00-9

4-vinylcyclohexene

202-848-9

100-40-3

Carc. 2

H351

GHS08
Achtg.

H351

601-089-00-4

muscalure; cis-tricos-9-ene

248-505-7

27519-02-4

Skin Sens. 1B

H317

GHS07
Achtg.

H317

602-001-00-7

chloromethane;
methyl chloride

200-817-4

74-87-3

Flam. Gas 1
Press. Gas
Carc. 2
STOT RE 2 *

H220
H351
H373 **

GHS02
GHS04
GHS08
Gef.

H220
H351
H373 **

602-002-00-2

bromomethane;
methylbromide

200-813-2

74-83-9

Press. Gas
Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Ozone 1

H341
H331
H301
H373
**
H319
H335
H315
H400
H420

GHS04
GHS06
GHS08
GHS09
Gef.

H341
H331
H301
H373 **
H319
H335
H315
H400
H420

602-003-00-8

dibromomethane

200-824-2

74-95-3

Acute Tox. 4 *
Aquatic Chronic 3

H332
H412

GHS07
Achtg.

H332
H412

602-004-00-3

dichloromethane;
methylene chloride

200-838-9

75-09-2

Carc. 2

H351

GHS08
Achtg.

H351

602-005-00-9

methyl iodide;
iodomethane

200-819-5

74-88-4

Carc. 2
Acute Tox. 4 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 3
Skin Irrit. 2

H351
H312
H331
H301
H335
H315

GHS06
GHS08
Gef.

H351
H312
H331
H301
H335
H315

602-006-00-4

chloroform;
trichloromethane

200-663-8

67-66-3

Carc. 2

H351

GHS06

H351

Repr. 2

H361d

GHS08

H361d

Acute Tox. 3

H331

Gef.

H331

Acute Tox. 4

H302

STOT RE 1

H372

Eye Irrit. 2

H319

Skin Irrit. 2

H315

602-007-00-X

bromoform;
tribromomethane

200-854-6

75-25-2

Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H331
H302
H319
H315
H411

GHS06
GHS09
Gef.

H331
H302
H319
H315
H411

602-008-00-5

carbon tetrachloride;
tetrachloromethane

200-262-8

56-23-5

Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic
Chronic 3
Ozone 1

H351
H331
H311
H301
H372
**
H412
H420

GHS06
GHS08
Gef.

H351
H331
H311
H301
H372 **
H412
H420

*
STOT RE 1;
H372: C> 1 %
STOT RE 2;
H373: 0,2 % ≤ C
< 1 %

602-009-00-0

chloroethane

200-830-5

75-00-3

Flam. Gas 1
Press. Gas
Carc. 2
Aquatic Chronic 3

H220
H351
H412

GHS02
GHS04
GHS08
Gef.

H220
H351
H412

602-010-00-6

1,2-dibromoethane

203-444-5

106-93-4

Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2

H350
H331
H311
H301
H319
H335
H315
H411

GHS06
GHS08
GHS09
Gef.

H350
H331
H311
H301
H319
H335
H315
H411

602-011-00-1

1,1-dichloroethane

200-863-5

75-34-3

Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3

H225
H302
H319
H335
H412

GHS02
GHS07
Gef.

H225
H302
H319
H335
H412

602-012-00-7

1,2-dichloroethane;
ethylene dichloride

203-458-1

107-06-2

Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H225
H350
H302
H319
H335
H315

GHS02
GHS08
GHS07
Gef.

H225
H350
H302
H319
H335
H315

602-013-00-2

1,1,1-trichloroethane;
methyl chloroform

200-756-3

71-55-6

Acute Tox. 4 *
Ozone 1

H332
H420

GHS07
Achtg.

H332
H420

602-014-00-8

1,1,2-trichloroethane

201-166-9

79-00-5

Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H351
H332
H312
H302

GHS08
GHS07
Achtg.

H351
H332
H312
H302

EUH066

602-015-00-3

1,1,2,2-tetrachloroethane

201-197-8

79-34-5

Acute Tox. 2 *
Acute Tox. 1
Aquatic Chronic 2

H330
H310
H411

GHS06
GHS09
Gef.

H330
H310
H411

602-016-00-9

1,1,2,2-tetrabromoethane

201-191-5

79-27-6

Acute Tox. 2 *
Eye Irrit. 2
Aquatic Chronic 3

H330
H319
H412

GHS06
Gef.

H330
H319
H412

602-017-00-4

pentachloroethane

200-925-1

76-01-7

Carc. 2
STOT RE 1
Aquatic Chronic 2

H351
H372 **
H411

GHS08
GHS09
Gef.

H351
H372 **
H411

STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 %

602-018-00-X

1-chloropropane; [1]
2-chloropropane [2]

208-749-7 [1]
200-858-8 [2]

540-54-5 [1]
75-29-6 [2]

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H225
H332
H312
H302

GHS02
GHS07
Gef.

H225
H332
H312
H302

602-019-00-5

1-bromopropane;
n-propyl bromide

203-445-0

106-94-5

Flam. Liq. 2
Repr. 1B
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
STOT SE 3

H225
H360FD
H373 **
H319
H335
H315
H336

GHS02
GHS08
GHS07
Gef.

H225
H360FD
H373 **
H319
H335
H315
H336

602-020-00-0

1,2-Dichlorpropan;
Propylendichlorid

201-152-2

78-87-5

Flam. Liq. 2
Carc. 1B
Acute Tox. 4*
Acute Tox. 4*

H225
H350
H332
H302

GHS02
GHS08
GHS07
Gef.

H225
H350
H332
H302

602-021-00-6

1,2-dibromo-3-chloropropane

202-479-3

96-12-8

Carc. 1B
Muta. 1B
Repr. 1a
Acute Tox. 3 *
STOT RE 2 *
Aquatic Chronic 3

H350
H340
H360F ***
H301
H373 **
H412

GHS06
GHS08
Gef.

H350
H340
H360F ***
H301
H373 **
H412

602-022-00-1

1-chloropentane; [1]
2-chloropentane; [2]
3-chloropentane [3]

208-846-4 [1]
210-885-7 [2]
210-467-4 [3]

543-59-9 [1]
625-29-6 [2]
616-20-6 [3]

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H225
H332
H312
H302

GHS02
GHS07
Gef.

H225
H332
H312
H302

602-023-00-7

vinyl chloride;
chloroethylene

200-831-0

75-01-4

Press. Gas
Flam. Gas 1
Carc. 1A

H220
H350

GHS02
GHS08
Gef.

H220
H350

D U

602-024-00-2

bromoethylene

209-800-6

593-60-2

Press. Gas
Flam. Gas 1
Carc. 1B

H220
H350

GHS02
GHS08
Gef.

H220
H350

602-025-00-8

1,1-dichloroethylene;
vinylidene chloride

200-864-0

75-35-4

Flam. Liq. 1
Carc. 2
Acute Tox. 4 *

H224
H351
H332

GHS02
GHS08
GHS07
Gef.

H224
H351
H332

602-026-00-3

1,2-dichloroethylene; [1]
cis-dichloroethylene; [2]
trans-dichloroethylene [3]

208-750-2 [1]
205-859-7 [2]
205-860-2 [3]

540-59-0 [1]
156-59-2 [2]
156-60-5 [3]

Flam. Liq. 2
Acute Tox. 4 *
Aquatic Chronic 3

H225
H332
H412

GHS02
GHS07
Gef.

H225
H332
H412

602-027-00-9

trichloroethylene;
trichloroethene

201-167-4

79-01-6

Carc. 1B
Muta. 2
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3
Aquatic Chronic 3

H350
H341
H319
H315
H336
H412

GHS08
GHS07
Gef.

H350
H341
H319
H315
H336
H412

602-028-00-4

tetrachloroethylene

204-825-9

127-18-4

Carc. 2
Aquatic Chronic 2

H351
H411

GHS08
GHS09
Achtg.

H351
H411

602-029-00-X

3-chloropropene;
allyl chloride

203-457-6

107-05-1

Flam. Liq. 2
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1

H225
H351
H341
H332
H312
H302
H373 **
H319
H335
H315
H400

GHS02
GHS08
GHS07
GHS09
Gef.

H225
H351
H341
H332
H312
H302
H373 **
H319
H335
H315
H400

602-030-00-5

1,3-dichloropropene; [1]
(Z)-1,3-dichloropropene [2]

208-826-5 [1]
233-195-8 [2]

542-75-6 [1]
10061-01-5 [2]

Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Asp. Tox. 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H226
H311
H301
H332
H304
H319
H335
H315
H317
H400
H410

GHS02
GHS06
GHS08
GHS09
Gef.

H226
H311
H301
H332
H304
H319
H335
H315
H317
H410

C D

602-031-00-0

1,1-dichloropropene

209-253-3

563-58-6

Flam. Liq. 2
Acute Tox. 3 *
Aquatic Chronic 3

H225
H301
H412

GHS02
GHS06
Gef.

H225
H301
H412

602-032-00-6

3-chloro-2-methylpropene

209-251-2

563-47-3

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H225
H332
H302
H314
H317
H411

GHS02
GHS05
GHS07
GHS09
Gef.

H225
H332
H302
H314
H317
H411

602-033-00-1

Chlorbenzol

203-628-5

108-90-7

Flam. Liq. 3
Acute Tox. 4
Skin Irrit. 2
Aquatic Chronic 2

H226
H332
H315
H411

GHS02
GHS07
GHS09
Achtg.

H226
H332
H315
H411

602-034-00-7

1,2-dichlorobenzene;
o-dichlorobenzene

202-425-9

95-50-1

Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H335
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H335
H315
H410

602-035-00-2

1,4-dichlorobenzene;
p-dichlorobenzene

203-400-5

106-46-7

Carc. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H319
H400
H410

GHS08
GHS09
Achtg.

H351
H319
H410

602-036-00-8

chloroprene (stabilised);
2-chlorobuta-1,3-diene (stabilised)

204-818-0

126-99-8

Flam. Liq. 2
Carc. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H225
H350
H332
H302
H373 **
H319
H335
H315

GHS02
GHS08
GHS07
Gef.

H225
H350
H332
H302
H373 **
H319
H335
H315

602-037-00-3

a-chlorotoluene;
benzyl chloride

202-853-6

100-44-7

Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1

H350
H331
H302
H373 **
H335
H315
H318

GHS06
GHS08
GHS05
Gef.

H350
H331
H302
H373 **
H335
H315
H318

602-038-00-9

a, a,a-trichlorotoluene;
benzotrichloride

202-634-5

98-07-7

Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1

H350
H331
H302
H335
H315
H318

GHS06
GHS08
GHS05
Gef.

H350
H331
H302
H335
H315
H318

602-039-00-4

polychlorobiphenyls;
PCB

215-648-1

1336-36-3

STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H373 **
H400
H410

GHS08
GHS09
Achtg.

H373 **
H410

STOT RE 2; H373: C> 0,005 %

602-040-00-X

2-chlorotoluene; [1]
3-chlorotoluene; [2]
4-chlorotoluene; [3]
chlorotoluene [4]

202-424-3 [1]
203-580-5 [2]
203-397-0 [3]
246-698-2 [4]

95-49-8 [1]
108-41-8 [2]
106-43-4 [3]
25168-05-2 [4]

Acute Tox. 4 *
Aquatic Chronic 2

H332
H411

GHS07
GHS09
Achtg.

H332
H411

602-041-00-5

penthachloronaphthalene

215-320-8

1321-64-8

Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H319
H315
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H319
H315
H410

602-042-00-0

1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex

Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H301
H312
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H301
H312
H410

a C

602-043-00-6

lindane (ISO);
?-HCH or ?-BHC;
?-1,2,3,4,5,6-hexachlorocyclohexane

200-401-2

58-89-9

Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1

H301
H332
H312
H373 **
H362
H400
H410

GHS06
GHS08
GHS09
Gef.

H301
H332
H312
H373 **
H362
H410

M=10

602-044-00-1

camphechlor (ISO);
toxaphene;

232-283-3

8001-35-2

Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H301
H312
H335
H315
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H301
H312
H335
H315
H410

602-045-00-7

DDT (ISO);
clofenotane (INN);
dicophane;
1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;
dichlorodiphenyltrichloroethane

200-024-3

50-29-3

Carc. 2
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H301
H372 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H301
H372 **
H410

602-046-00-2

heptachlor (ISO);
1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene

200-962-3

76-44-8

Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H311
H301
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H311
H301
H373 **
H410

602-047-00-8

chlordane (ISO);
1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan

200-349-0

57-74-9

Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H312
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H312
H302
H410

602-048-00-3

aldrin (ISO)

206-215-8

309-00-2

Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H311
H301
H372 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H311
H301
H372 **
H410

602-049-00-9

dieldrin (ISO)

200-484-5

60-57-1

Carc. 2
Acute Tox. 1
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H310
H301
H372 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H310
H301
H372 **
H410

602-050-00-4

isodrin;
(1a,4a,4aß,5ß,8ß,8aß)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene

207-366-2

465-73-6

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H400
H410

GHS06
GHS09
Gef.

H330
H310
H300
H410

M=100

602-051-00-X

endrin (ISO);
1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene

200-775-7

72-20-8

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H311
H400
H410

GHS06
GHS09
Gef.

H300
H311
H410

602-052-00-5

endosulfan (ISO);
1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite;
1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite

204-079-4

115-29-7

Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H312
H400
H410

GHS06
GHS09
Gef.

H330
H300
H312
H410

602-053-00-0

isobenzan (ISO);
1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran

206-045-4

297-78-9

Acute Tox. 1
Acute Tox. 2 *
Aquatic Acute 1

H310
H300
H400

GHS06
GHS09
Gef.

H310
H300
H400

602-054-00-6

3-iodpropene;
allyl iodide

209-130-4

556-56-9

Flam. Liq. 2
Skin Corr. 1B

H225
H314

GHS02
GHS05
Gef.

H225
H314

602-055-00-1

bromoethane;
ethyl bromide

200-825-8

74-96-4

Flam. Liq. 2
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *

H225
H351
H332
H302

GHS02
GHS08
GHS07
Gef.

H225
H351
H332
H302

602-056-00-7

a, a,a-trifluorotoluene;
benzotrifluoride

202-635-0

98-08-8

Flam. Liq. 2
Aquatic Chronic 2

H225
H411

GHS02
GHS09
Gef.

H225
H411

602-057-00-2

a-bromotoluene;
benzyl bromide

202-847-3

100-39-0

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H319
H335
H315

GHS07
Achtg.

H319
H335
H315

602-058-00-8

a, a-dichlorotoluene;
benzylidene chloride;
benzal chloride

202-709-2

98-87-3

Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1

H351
H331
H302
H335
H315
H318

GHS06
GHS08
GHS05
Gef.

H351
H331
H302
H335
H315
H318

602-059-00-3

1-chlorobutane;
butyl chloride

203-696-6

109-69-3

Flam. Liq. 2

H225

GHS02
Gef.

H225

602-060-00-9

bromobenzene

203-623-8

108-86-1

Flam. Liq. 3
Skin Irrit. 2
Aquatic Chronic 2

H226
H315
H411

GHS02
GHS07
GHS09
Achtg.

H226
H315
H411

602-061-00-4

hexafluoropropene;
hexafluoropropylene

204-127-4

116-15-4

Press. Gas
Acute Tox. 4 *
STOT SE 3

H332
H335

GHS07
Achtg.

H332
H335

602-062-00-X

1,2,3-trichloropropane

202-486-1

96-18-4

Carc. 1B
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H350
H360F ***
H332
H312
H302

GHS08
GHS07
Gef.

H350
H360F ***
H332
H312
H302

602-063-00-5

heptachlor epoxide;
2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane

213-831-0

1024-57-3

Carc. 2
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H301
H373 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H301
H373 **
H410

602-064-00-0

1,3-dichloro-2-propanol

202-491-9

96-23-1

Carc. 1B
Acute Tox. 3 *
Acute Tox. 4 *

H350
H301
H312

GHS06
GHS08
Gef.

H350
H301
H312

602-065-00-6

hexachlorobenzene

204-273-9

118-74-1

Carc. 1B
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H372 **
H400
H410

GHS08
GHS09
Gef.

H350
H372 **
H410

602-066-00-1

tetrachloro-p-benzoquinone

204-274-4

118-75-2

Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H315
H410

602-067-00-7

1,3-dichlorbenzene

208-792-1

541-73-1

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

602-068-00-2

ethylene bis(trichloroacetate)

219-732-9

2514-53-6

Skin Irrit. 2

H315

GHS07
Achtg.

H315

602-069-00-8

dichloroacetylene

7572-29-4

Unst. Expl.
Carc. 2
STOT RE 2 *

H200
H351
H373 **

GHS01
GHS08
Achtg.

H200
H351
H373 **

602-070-00-3

3-chloro-4,5,a, a,a-pentafluorotoluene

401-930-3

77227-99-7

Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1

H226
H332
H302
H400

GHS02
GHS07
GHS09
Achtg.

H226
H332
H302
H400

602-071-00-9

bromobenzylbromotoluene, reaction mass of isomers

402-210-1

99688-47-8

STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373 **
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H373 **
H317
H410

602-072-00-4

dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;
(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)

278-404-3

76253-60-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

602-073-00-X

1,4-dichlorobut-2-ene

212-121-8

764-41-0

Carc. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H330
H311
H301
H314
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H350
H330
H311
H301
H314
H410

Carc. 1B; H350: C> 0,01 %
STOT SE 3; H335: C> 5 %

602-074-00-5

pentachlorobenzene

210-172-0

608-93-5

Flam. Sol. 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H228
H302
H400
H410

GHS02
GHS07
GHS09
Gef.

H228
H302
H410

602-075-00-0

4,4,5,5-tetrachloro-1,3-dioxolan-2-one

404-060-2

22432-68-4

Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B

H330
H302
H314

GHS06
GHS05
Gef.

H330
H302
H314

602-076-00-6

2,3,4-trichlorobut-1-ene

219-397-9

2431-50-7

Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H331
H302
H319
H335
H315
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H331
H302
H319
H335
H315
H410

Carc. 2; H351: C> 0,1 %

602-077-00-1

dodecachloropentacyclo[5.2.1.0^2,6.0^3,9.0^5,8]decane;
mirex

219-196-6

2385-85-5

Carc. 2
Repr. 2
Lact.
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H361fd
H362
H312
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H361fd
H362
H312
H302
H410

602-078-00-7

hexachlorocyclopentadiene

201-029-3

77-47-4

Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H330
H311
H302
H314
H400
H410

GHS06
GHS05
GHS09
Gef.

H330
H311
H302
H314
H410

602-079-00-2

2,3-dichloropropene;
2,3-dichloropropylene

201-153-8

78-88-6

Flam. Liq. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H225
H341
H332
H312
H302
H335
H315
H318
H412

GHS02
GHS08
GHS05
GHS07
Gef.

H225
H341
H332
H312
H302
H335
H315
H318
H412

602-080-00-8

alkanes, C_10-13, chloro;
chlorinated paraffins, C_10-13

287-476-5

85535-84-8

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

EUH066

602-081-00-3

2-chloro-4,5-difluorobenzoic acid

405-380-5

Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1

H312
H302
H318
H317

GHS05
GHS07
Gef.

H312
H302
H318
H317

602-082-00-9

2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol

408-020-5

109678-33-3

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

602-083-00-4

diphenyl ether, pentabromo derivative pentabromodiphenyl ether

251-084-2

32534-81-9

STOT RE 2 *
Lact.
Aquatic Acute 1
Aquatic Chronic 1

H373 **
H362
H400
H410

GHS08
GHS09
Achtg.

H373 **
H362
H410

602-084-00-X

1,1-dichloro-1-fluoroethane

404-080-1

1717-00-6

Aquatic
Chronic 3
Ozone 1

H412
H420

GHS07
Achtg.

H412
H420

602-085-00-5

2-bromopropane

200-855-1

75-26-3

Flam. Liq. 2
Repr. 1a
STOT RE 2 *

H225
H360F ***
H373 **

GHS02
GHS08
Gef.

H225
H360F ***
H373 **

EUH066

602-086-00-0

trifluoroiodomethane;
trifluoromethyl iodide

219-014-5

2314-97-8

Muta. 2

H341

GHS08
Achtg.

H341

602-087-00-6

1,2,4-trichlorobenzene

204-428-0

120-82-1

Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H315
H410

602-088-00-1

2,3-dibromopropan-1-ol;
2,3-dibromo-1-propanol

202-480-9

96-13-9

Carc. 1B
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3

H350
H361f ***
H311
H332
H302
H412

GHS08
GHS07
Gef.

H350
H361f ***
H311
H332
H302
H412

602-089-00-7

4-bromo-2-chlorofluorobenzene

405-580-2

60811-21-4

Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H315
H410

602-090-00-2

1-allyl-3-chloro-4-fluorobenzene

406-630-6

121626-73-1

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

602-091-00-8

1,3-dichloro-4-fluorobenzene

406-160-1

1435-48-9

Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2

H302
H373 **
H315
H411

GHS08
GHS07
Achtg.

H302
H373 **
H315
H411

602-092-00-3

1-bromo-3,4,5-trifluorobenzene

418-480-9

138526-69-9

Flam. Liq. 3
Carc. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2

H226
H351
H315
H318
H411

GHS02
GHS08
GHS05
GHS09
Gef.

H226
H351
H315
H318
H411

602-093-00-9

a, a,a,4-tetrachlorotoluene;
p-chlorobenzotrichloride

226-009-1

5216-25-1

Carc. 1B
Repr. 2
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2

H350
H361f ***
H372 **
H312
H302
H335
H315

GHS08
GHS07
Gef.

H350
H361f ***
H372 **
H312
H302
H335
H315

602-094-00-4

diphenylether; octabromo derivate

251-087-9

32536-52-0

Repr. 1B

H360Df

GHS08
Gef.

H360Df

602-095-00-X

alkanes, C_14-17, chloro;
chlorinated paraffins, C_14-17

287-477-0

85535-85-9

Lact.
Aquatic Acute 1
Aquatic Chronic 1

H362
H400
H410

GHS09
Achtg.

H362
H410

EUH066

602-096-00-5

malachite green hydrochloride; [1]
malachite green oxalate [2]

209-322-8 [1]
219-441-7 [2]

569-64-2 [1]
2437-29-8 [2]

Repr. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d ***
H302
H318
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H361d ***
H302
H318
H410

602-097-00-0

1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane

422-850-5

148757-89-5

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

602-098-00-6

2-(3-bromophenoxy)tetrahydro-2H-pyran

429-030-6

57999-49-2

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

602-099-00-1

3-(4-fluorophenyl)-2-methylpropionylchloride

426-370-7

Skin Corr. 1a
Acute Tox. 4 *
Aquatic Chronic 3

H314
H302
H412

GHS05
GHS07
Gef.

H314
H302
H412

EUH014
EUH029

602-100-00-5

reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane;
(S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane

420-640-8

Aquatic Chronic 3

H412

602-101-00-0

2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate

427-020-6

141772-37-4

STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373**
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H373**
H317
H410

602-102-00-6

1,1,1,3,3-pentafluorobutane

430-250-1

406-58-6

Flam. Liq. 2

H225

GHS02
Gef.

H225

602-103-00-1

1-(chlorophenylmethyl)-2-methylbenzene

431-450-1

41870-52-4

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

602-104-00-7

1,1,2,2,3,3,4-heptafluorocyclopentane

430-710-1

15290-77-4

Aquatic Chronic 3

H412

602-105-00-2

sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate

422-100-7

102061-82-5

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

602-106-00-8

2-bromo-4,6-difluoroaniline

429-430-0

444-14-4

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

602-107-00-3

3,3,4,4-tetrafluoro-4-iodo-1-butene

439-500-2

33831-83-3

Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2

H302
H315
H411

GHS07
GHS09
Achtg.

H302
H315
H411

602-108-00-9

(2,3,5,6-tetrafluorophenyl)methanol

443-840-7

4084-38-2

Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1

H302
H319
H317

GHS07
Achtg.

H302
H319
H317

602-109-00-4

Hexabromocyclododecane [1]

247-148-4 [1]

25637-99-4[1]

Repr. 2
Lact.

H361
H362

GHS08
Achtg.

H361
H362

1,2,5,6,9,10-hexabromocyclododecane [2]

221-695-9[2]

3194-55-6[2]

603-001-00-X

methanol

200-659-6

67-56-1

Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT SE 1

H225
H331
H311
H301
H370 **

GHS02
GHS06
GHS08
Gef.

H225
H331
H311
H301
H370 **

*
STOT SE 1; H370: C> 10 %
STOT SE 2; H371: 3 % ≤ C < 10 %

603-002-00-5

ethanol;
ethyl alcohol

200-578-6

64-17-5

Flam. Liq. 2

H225

GHS02
Gef.

H225

603-003-00-0

propan-1-ol;
n-propanol

200-746-9

71-23-8

Flam. Liq. 2
Eye Dam. 1
STOT SE 3

H225
H318
H336

GHS02
GHS05
GHS07
Gef.

H225
H318
H336

603-004-00-6

butan-1-ol;
n-butanol

200-751-6

71-36-3

Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3

H226
H302
H335
H315
H318
H336

GHS02
GHS05
GHS07
Gef.

H226
H302
H335
H315
H318
H336

603-005-00-1

2-methylpropan-2-ol;
tert-butyl alcohol

200-889-7

75-65-0

Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3

H225
H332
H319
H335

GHS02
GHS07
Gef.

H225
H332
H319
H335

603-006-00-7

pentanol isomers, with the exception fo those specified elsewhere in this Annex

250-378-8

Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3

H226
H332
H335

GHS02
GHS07
Achtg.

H226
H332
H335

EUH066

603-007-00-2

2-methylbutan-2-ol;
tert-pentanol

200-908-9

75-85-4

Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2

H225
H332
H335
H315

GHS02
GHS07
Gef.

H225
H332
H335
H315

603-008-00-8

4-methylpentan-2-ol;
methyl isobutyl carbinol

203-551-7

108-11-2

Flam. Liq. 3
STOT SE 3

H226
H335

GHS02
GHS07
Achtg.

H226
H335

STOT SE 3; H335: C> 25 %

603-009-00-3

cyclohexanol

203-630-6

108-93-0

Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2

H332
H302
H335
H315

GHS07
Achtg.

H332
H302
H335
H315

603-010-00-9

2-methylcyclohexanol, mixed isomers; [1]
cis-2-methylcyclohexanol; [2]
trans-2-methylcyclohexanol [3]

209-512-0 [1]
231-187-9 [2]
231-186-3 [3]

583-59-5 [1]
7443-70-1 [2]
7443-52-9 [3]

Acute Tox. 4 *

H332

GHS07
Achtg.

H332

603-011-00-4

2-methoxyethanol;
ethylene glycol monomethyl ether

203-713-7

109-86-4

Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H226
H360FD
H332
H312
H302

GHS02
GHS08
GHS07
Gef.

H226
H360FD
H332
H312
H302

603-012-00-X

2-ethoxyethanol;
ethylene glycol monoethyl ether

203-804-1

110-80-5

Flam. Liq. 3
Repr. 1B
Acute Tox. 3
Acute Tox. 4

H226
H360FD
H331
H302

GHS02
GHS08
GHS06
Gef.

H226
H360FD
H331
H302

603-013-00-5

2-isopropoxyethanol;
ethylene glycol monoisopropyl ether

203-685-6

109-59-1

Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2

H332
H312
H319

GHS07
Achtg.

H332
H312
H319

603-014-00-0

2-butoxyethanol;
ethylene glycol monobutyl ether;
butyl cellosolve

203-905-0

111-76-2

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2

H332
H312
H302
H319
H315

GHS07
Achtg.

H332
H312
H302
H319
H315

603-015-00-6

allyl alcohol

203-470-7

107-18-6

Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1

H225
H331
H311
H301
H319
H335
H315
H400

GHS02
GHS06
GHS09
Gef.

H225
H331
H311
H301
H319
H335
H315
H400

603-016-00-1

4-hydroxy-4-methylpentan-2-one;
diacetone alcohol

204-626-7

123-42-2

Eye Irrit. 2

H319

GHS07
Achtg.

H319

Eye Irrit. 2; H319: C> 10 %

603-018-00-2

furfuryl alcohol

202-626-1

98-00-0

Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3

H351
H331
H312
H302
H373**
H319
H335

GHS06
GHS08
Gef.

H351
H331
H312
H302
H373**
H319
H335

603-019-00-8

dimethyl ether

204-065-8

115-10-6

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

603-020-00-3

ethyl methyl ether

540-67-0

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

603-021-00-9

methyl vinyl ether

203-475-4

107-25-5

Flam. Gas 1
Press. Gas

H220

GHS02
GHS04
Gef.

H220

D U

603-022-00-4

diethyl ether;
ether

200-467-2

60-29-7

Flam. Liq. 1
Acute Tox. 4 *
STOT SE 3

H224
H302
H336

GHS02
GHS07
Gef.

H224
H302
H336

EUH019
EUH066

603-023-00-X

ethylene oxide;
oxirane

200-849-9

75-21-8

Press. Gas
Flam. Gas 1
Carc. 1B
Muta. 1B
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H220
H350
H340
H331
H319
H335
H315

GHS02
GHS04
GHS06
GHS08
Gef.

H220
H350
H340
H331
H319
H335
H315

603-024-00-5

1,4-dioxane

204-661-8

123-91-1

Flam. Liq. 2
Carc. 2
Eye Irrit. 2
STOT SE 3

H225
H351
H319
H335

GHS02
GHS08
GHS07
Gef.

H225
H351
H319
H335

EUH019
EUH066

603-025-00-0

tetrahydrofuran

203-726-8

109-99-9

Flam. Liq. 2
Carc. 2
Eye Irrit. 2
STOT SE 3

H225
H351
H319
H335

GHS02
GHS07
GHS08
Gef.

H225
H351
H319
H335

EUH019

STOT SE 3;
H335: C> 25 %
Eye Irrit.2;
H319: C> 25 %

603-026-00-6

1-chloro-2,3-epoxypropane;
epichlorhydrin

203-439-8

106-89-8

Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1

H226
H350
H331
H311
H301
H314
H317

GHS02
GHS06
GHS08
GHS05
Gef.

H226
H350
H331
H311
H301
H314
H317

603-027-00-1

ethanediol;
ethylene glycol

203-473-3

107-21-1

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

603-028-00-7

2-chloroethanol;
ethylene chlorohydrin

203-459-7

107-07-3

Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *

H330
H310
H300

GHS06
Gef.

H330
H310
H300

603-029-00-2

bis(2-chloroethyl) ether

203-870-1

111-44-4

Carc. 2
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *

H351
H330
H310
H300

GHS06
GHS08
Gef.

H351
H330
H310
H300

603-030-00-8

2-aminoethanol;
ethanolamine

205-483-3

141-43-5

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H332
H312
H302
H314

GHS05
GHS07
Gef.

H332
H312
H302
H314

STOT SE 3; H335: C> 5 %

603-031-00-3

1,2-dimethoxyethane;
ethylene glycol dimethyl ether;
EGDME

203-794-9

110-71-4

Flam. Liq. 2
Repr. 1B
Acute Tox. 4 *

H225
H360FD
H332

GHS02
GHS08
GHS07
Gef.

H225
H360FD
H332

EUH019

603-032-00-9

ethylene dinitrate;
ethylene glycol dinitrate

211-063-0

628-96-6

Unst. Expl.
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2

H200
H330
H310
H300
H373**

GHS01
GHS06
GHS08
Gef.

H200
H330
H310
H300
H373**

603-033-00-4

oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate

211-745-8

693-21-0

Unst. Expl
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3

H200
H330
H310
H300
H373 **
H412

GHS01
GHS06
GHS08
Gef.

H200
H330
H310
H300
H373 **
H412

603-033-01-1

oxydiethylene dinitrate;
diethylene glycol dinitrate;
digol dinitrate;
[>25 % phlegmatiser]

211-745-8

693-21-0

Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 3

H201
H330
H310
H300
H373 **
H412

GHS01
GHS06
GHS08
Gef.

H201
H330
H310
H300
H373 **
H412

603-034-00-X

glycerol trinitrate;
nitroglycerine

200-240-8

55-63-0

Unst. Expl.
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2

H200
H330
H310
H300
H373 **
H411

GHS01
GHS06
GHS08
GHS09
Gef.

H200
H330
H310
H300
H373 **
H411

603-034-01-7

glycerol trinitrate;
nitroglycerine;
[>40 % phlegmatiser]

200-240-8

55-63-0

Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2 *
Aquatic Chronic 2

H201
H330
H310
H300
H373 **
H411

GHS01
GHS06
GHS08
GHS09
Gef.

H201
H330
H310
H300
H373 **
H411

603-035-00-5

pentaerythritol tetranitrate; pentaerythrite tetranitrate;
P.E.T.N.

201-084-3

78-11-5

Unst. Expl.

H200

GHS01
Gef.

H200

603-035-01-2

pentaerythritol tetranitrate; pentaerythrite tetranitrate;
P.E.T.N.;
[>20 % phlegmatiser]

201-084-3

78-11-5

Expl. 1.1

H201

GHS01
Gef.

H201

603-036-00-0

mannitol hexanitrate;
nitromannite

239-924-6

15825-70-4

Unst. Expl.

H200

GHS01
Gef.

H200

603-036-01-8

mannitol hexanitrate;
nitromannite;
[>40 % phlegmatiser]

239-924-6

15825-70-4

Expl. 1.1

H201

GHS01
Gef.

H201

603-037-00-6

cellulose nitrate;
nitrocellulose

Expl. 1.1

H201

GHS01
Gef.

H201

603-038-00-1

allyl glycidyl ether;
allyl 2,3-epoxypropyl ether;
prop-2-en-1-yl 2,3-epoxypropyl ether

203-442-4

106-92-3

Flam. Liq. 3
Carc. 2
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H226
H351
H341
H361f ***
H332
H302
H335
H315
H318
H317
H412

GHS02
GHS08
GHS05
GHS07
Gef.

H226
H351
H341
H361f ***
H332
H302
H335
H315
H318
H317
H412

603-039-00-7

butyl glycidyl ether;
butyl 2,3-epoxypropyl ether

219-376-4

2426-08-6

Flam. Liq. 3
Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Sens. 1
Aquatic Chronic 3

H226
H351
H341
H332
H302
H335
H317
H412

GHS02
GHS08
GHS07
Achtg.

H226
H351
H341
H332
H302
H335
H317
H412

603-040-00-2

sodium methanolate;
sodium methoxide; [1]
potassium methanolate;
potassium methoxide; [2]
lithium methanolate;
lithium methoxide [3]

204-699-5 [1]
212-736-1 [2]
212-737-7 [3]

124-41-4 [1]
865-33-8 [2]
865-34-9 [3]

Self-heat 1
Skin Corr. 1B

H251
H314

GHS02
GHS05
Gef.

H251
H314

EUH014

603-041-00-8

potassium ethanolate;
potassium ethoxide; [1]
sodium ethanolate;
sodium ethoxide [2]

213-029-0 [1]
205-487-5 [2]

917-58-8 [1]
141-52-6 [2]

Self-heat 1
Skin Corr. 1B

H251
H314

GHS02
GHS05
Gef.

H251
H314

EUH014

603-042-00-3

aluminium-tri-isopropoxide

209-090-8

555-31-7

Flam. Sol. 1

H228

GHS02
Gef.

H228

603-043-00-9

triarimol (ISO);
2,4-dichloro-a-(pyrimidin-5-yl) benzhydryl alcohol

26766-27-8

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

603-044-00-4

dicofol (ISO);
2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol

204-082-0

115-32-2

Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H315
H317
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H315
H317
H410

603-045-00-X

diisopropyl ether; [1]
dipropyl ether [2]

203-560-6 [1]
203-869-6 [2]

108-20-3 [1]
111-43-3 [2]

Flam. Liq. 2
STOT SE 3

H225
H336

GHS02
GHS07
Gef.

H225
H336

EUH019
EUH066

603-046-00-5

bis(chloromethyl) ether;
oxybis(chloromethane)

208-832-8

542-88-1

Flam. Liq. 2
Carc. 1a
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *

H225
H350
H330
H311
H302

GHS02
GHS06
GHS08
Gef.

H225
H350
H330
H311
H302

Carc. 1A; H350: C> 0,001 %

603-047-00-0

2-dimethylaminoethanol;
N,N-dimethylethanolamine

203-542-8

108-01-0

Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H226
H332
H312
H302
H314

GHS02
GHS05
GHS07
Gef.

H226
H332
H312
H302
H314

STOT SE 3; H335: C> 5 %

603-048-00-6

2-diethylaminoethanol;
N,N-diethylethanolamine

202-845-2

100-37-8

Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H226
H332
H312
H302
H314

GHS02
GHS05
GHS07 GHS09
Gef.

H226
H332
H312
H302
H314

STOT SE 3; H335: C> 5 %

603-049-00-1

chlorfenethol (ISO);
1,1-bis (4-chlorophenyl) ethanol

201-246-3

80-06-8

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

603-050-00-7

1-(2-butoxypropoxy)propan-2-ol

246-011-6

24083-03-2

Acute Tox. 4 *
Acute Tox. 4 *

H312
H302

GHS07
Achtg.

H312
H302

603-051-00-2

2-ethylbutan-1-ol

202-621-4

97-95-0

Acute Tox. 4 *
Acute Tox. 4 *

H312
H302

GHS07
Achtg.

H312
H302

603-052-00-8

3-butoxypropan-2-ol;
propylene glycol monobutyl ether

225-878-4

5131-66-8

Eye Irrit. 2
Skin Irrit. 2

H319
H315

GHS07
Achtg.

H319
H315

603-053-00-3

2-methylpentane-2,4-diol

203-489-0

107-41-5

Eye Irrit. 2
Skin Irrit. 2

H319
H315

GHS07
Achtg.

H319
H315

603-054-00-9

di-n-butyl ether;
dibutyl ether

205-575-3

142-96-1

Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3

H226
H319
H335
H315
H412

GHS02
GHS07
Achtg.

H226
H319
H335
H315
H412

STOT SE 3; H335: C> 10 %

603-055-00-4

Propylenoxid;
1,2-Epoxypropan; Methyloxiran

200-879-2

75-56-9

Flam. Liq. 1
Carc. 1B
Muta. 1B
Acute Tox. 3
Acute Tox. 3
Acute Tox. 4
STOT SE 3
Eye Irrit. 2

H224
H350
H340
H331
H311
H302
H335
H319

GHS02
GHS08
GHS06
Gef.

H224
H350
H340
H331
H311
H302
H335
H319

603-056-00-X

[(p-tolyloxy)methyl]oxirane; [1]
[(m-tolyloxy)methyl]oxirane; [2]
2,3-epoxypropylo-tolyl ether; [3]
[(tolyloxy)methyl]oxirane;
cresyl glycidyl ether [4]

218-574-8 [1]
218-575-3 [2]
218-645-3 [3]
247-711-4 [4]

2186-24-5 [1]
2186-25-6 [2]
2210-79-9 [3]
26447-14-3 [4]

Muta. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H341
H315
H317
H411

GHS08
GHS07
GHS09
Achtg.

H341
H315
H317
H411

603-057-00-5

benzyl alcohol

202-859-9

100-51-6

Acute Tox. 4 *
Acute Tox. 4 *

H332
H302

GHS07
Achtg.

H332
H302

603-058-00-0

1,3-propylene oxide

207-964-3

503-30-0

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H225
H332
H312
H302

GHS02
GHS07
Gef.

H225
H332
H312
H302

603-059-00-6

hexan-1-ol

203-852-3

111-27-3

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

603-060-00-1

2,2'-bioxirane;
1,2:3,4-diepoxybutane

215-979-1

1464-53-5

Carc. 1B
Muta. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B

H350
H340
H330
H311
H301
H314

GHS06
GHS08
GHS05
Gef.

H350
H340
H330
H311
H301
H314

603-061-00-7

tetrahydro-2-furylmethanol;
tetrahydrofurfuryl alcohol

202-625-6

97-99-4

Repr. 1B
Eye Irrit. 2

H360Df
H319

GHS08
GHS07
Gef.

H360Df
H319

603-062-00-2

tetrahydrofuran-2,5-diyldimethanol

203-239-0

104-80-3

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H319
H335
H315

GHS07
Achtg.

H319
H335
H315

STOT SE 3; H335: C> 10 %

603-063-00-8

2,3-epoxypropan-1-ol;
glycidol;
oxiranemethanol

209-128-3

556-52-5

Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H350
H341
H360F ***
H331
H312
H302
H319
H335
H315

GHS06
GHS08
Gef.

H350
H341
H360F ***
H331
H312
H302
H319
H335
H315

603-064-00-3

1-methoxy-2-propanol;
monopropylene glycol methyl ether

203-539-1

107-98-2

Flam. Liq. 3
STOT SE 3

H226
H336

GHS02
GHS07
Achtg.

H226
H336

603-065-00-9

resorcinol diglycidyl ether;
1,3-bis(2,3-epoxypropoxy)benzene

202-987-5

101-90-6

Carc. 2
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H351
H341
H312
H302
H319
H315
H317
H412

GHS08
GHS07
Achtg.

H351
H341
H312
H302
H319
H315
H317
H412

603-066-00-4

1,2-epoxy-4-epoxyethylcyclohexane;
4-vinylcyclohexene diepoxide

203-437-7

106-87-6

Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H351
H331
H311
H301

GHS06
GHS08
Gef.

H351
H331
H311
H301

603-067-00-X

phenyl glycidyl ether;
2,3-epoxypropyl phenyl ether;
1,2-epoxy-3-phenoxypropane

204-557-2

122-60-1

Carc. 1B
Muta. 2
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H350
H341
H332
H335
H315
H317
H412

GHS08
GHS07
Gef.

H350
H341
H332
H335
H315
H317
H412

603-068-00-5

2,3-epoxypropyl-2-ethylcyclohexyl ether;
ethylcyclohexylglycidyl ether

130014-35-6

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

603-069-00-0

2,4,6-tris(dimethylaminomethyl)phenol

202-013-9

90-72-2

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2

H302
H319
H315

GHS07
Achtg.

H302
H319
H315

603-070-00-6

2-amino-2-methylpropanol

204-709-8

124-68-5

Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3

H319
H315
H412

GHS07
Achtg.

H319
H315
H412

603-071-00-1

2,2'-iminodiethanol;
diethanolamine

203-868-0

111-42-2

Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1

H302
H373 **
H315
H318

GHS08
GHS05
GHS07
Gef.

H302
H373 **
H315
H318

603-072-00-7

1,4-bis(2,3 epoxypropoxy)butane;
butanedioldiglycidyl ether

219-371-7

2425-79-8

Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H332
H312
H319
H315
H317

GHS07
Achtg.

H332
H312
H319
H315
H317

603-073-00-2

bis-[4-(2,3-epoxipropoxi)phenyl]propane

216-823-5

1675-54-3

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

Eye Irrit. 2; H319: C> 5 %
Skin Irrit. 2; H315: C> 5 %

603-074-00-8

reaction product: bisphenol-A-(epichlorhydrin);
epoxy resin (number average molecular weight ≤ 700)

500-033-5

25068-38-6

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H319
H315
H317
H411

GHS07
GHS09
Achtg.

H319
H315
H317
H411

Eye Irrit. 2; H319: C> 5 %
Skin Irrit. 2; H315: C> 5 %

603-075-00-3

chlormethyl methyl ether;
chlorodimethyl ether

203-480-1

107-30-2

Flam. Liq. 2
Carc. 1a
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H225
H350
H332
H312
H302

GHS02
GHS08
GHS07
Gef.

H225
H350
H332
H312
H302

603-076-00-9

but-2-yne-1,4-diol;
2-butyne-1,4-diol

203-788-6

110-65-6

Skin Corr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1

H314
H331
H301
H312
H373 **
H317

GHS06
GHS05
GHS08
Gef.

H314
H331
H301
H312
H373 **
H317

Skin Corr. 1B; H314: C> 50 %
Skin Irrit. 2; H315: 25 % ≤ C < 50 %
Eye Irrit. 2; H319: 25 % ≤ C < 50 %

603-077-00-4

1-dimethylaminopropan-2-ol;
dimepranol (INN)

203-556-4

108-16-7

Flam. Liq. 3
Acute Tox. 4 *
Skin Corr. 1B

H226
H302
H314

GHS02
GHS05
GHS07
Gef.

H226
H302
H314

603-078-00-X

prop-2-yn-1-ol;
propargyl alcohol

203-471-2

107-19-7

Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2

H226
H331
H311
H301
H314
H411

GHS02
GHS06
GHS05
GHS09
Gef.

H226
H331
H311
H301
H314
H411

603-079-00-5

2,2'-(methylimino)diethanol;
N-methyldiethanolamine

203-312-7

105-59-9

Eye Irrit. 2

H319

GHS07
Achtg.

H319

603-080-00-0

2-methylaminoethanol;
N-methylethanolamine;
N-methyl-2-ethanolamine;
N-methyl-2-amino ethanol;
2-(methylamino)ethanol

203-710-0

109-83-1

Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H312
H302
H314

GHS05 GHS07
Gef.

H312
H302
H314

STOT SE 3; H335: C> 5 %

603-081-00-6

2,2'-thiodiethanol;
thiodiglycol

203-874-3

111-48-8

Eye Irrit. 2

H319

GHS07
Achtg.

H319

603-082-00-1

1-aminopropan-2-ol;
isopropanolamine

201-162-7

78-96-6

Skin Corr. 1B

H314

GHS05
Gef.

H314

603-083-00-7

1,1'-iminodipropan-2-ol;
di-isopropanolamine

203-820-9

110-97-4

Eye Irrit. 2

H319

GHS07
Achtg.

H319

603-084-00-2

styrene oxide;
(epoxyethyl)benzene;
phenyloxirane

202-476-7

96-09-3

Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2

H350
H312
H319

GHS08
GHS07
Gef.

H350
H312
H319

603-085-00-8

bronopol (INN);
2-bromo-2-nitropropane-1,3-diol

200-143-0

52-51-7

Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1

H312
H302
H335
H315
H318
H400

GHS05
GHS07
GHS09
Gef.

H312
H302
H335
H315
H318
H400

M=10

603-086-00-3

ethirimol (ISO);
5-butyl-2-ethylamino-6-methylpyrimidin-4-ol

245-949-3

23947-60-6

Acute Tox. 4 *

H312

GHS07
Achtg.

H312

603-087-00-9

2-ethylhexane-1,3-diol;
octylene glycol;
ethoexadiol

202-377-9

94-96-2

Eye Dam. 1

H318

GHS05
Gef.

H318

603-088-00-4

2-(octylthio)ethanol;
2-hydroxyethyl octyl sulphide

222-598-4

3547-33-9

Eye Dam. 1

H318

GHS05
Gef.

H318

603-089-00-X

7,7-dimethyl-3-oxa-6-azaoctan-1-ol

400-390-6

Skin Corr. 1a
Acute Tox. 4 *

H314
H302

GHS05
GHS07
Gef.

H314
H302

603-090-00-5

2-(2-bromoethoxy)anisole

402-010-4

4463-59-6

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

603-091-00-0

exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol

402-470-6

87172-89-2

Acute Tox. 4 *
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

603-092-00-6

2-methyl-4-phenylpentanol

402-770-7

92585-24-5

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

603-093-00-1

cinmethylin (ISO);
exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane

402-410-9

87818-31-3

Acute Tox. 4 *
Aquatic Chronic 2

H332
H411

GHS07
GHS09
Gef.

H332
H411

603-094-00-7

1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane

241-536-7

17557-23-2

Skin Irrit. 2
Skin Sens. 1

H315
H317

GHS07
Achtg.

H315
H317

603-095-00-2

2-(propyloxy)ethanol;
EGPE

220-548-6

2807-30-9

Acute Tox. 4 *
Eye Irrit. 2

H312
H319

GHS07
Achtg.

H312
H319

603-096-00-8

2-(2-butoxyethoxy)ethanol;
diethylene glycol monobutyl ether

203-961-6

112-34-5

Eye Irrit. 2

H319

GHS07
Achtg.

H319

603-097-00-3

1,1',1?-nitrilotripropan-2-ol;
triisopropanolamine

204-528-4

122-20-3

Eye Irrit. 2

H319

GHS07
Achtg.

H319

603-098-00-9

2-phenoxyethanol

204-589-7

122-99-6

Acute Tox. 4 *
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

603-099-00-4

3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride

403-440-5

93633-79-5

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

603-100-00-8

1,2-dimethoxypropane

404-630-0

7778-85-0

Flam. Liq. 2

H225

GHS02
Gef.

H225

EUH019

603-101-00-3

tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis andtrans)

405-040-6

Eye Irrit. 2

H319

GHS07
Achtg.

H319

603-102-00-9

1,2-Epoxybutan

203-438-2

106-88-7

Flam. Liq. 2
Carc. 2
Acute Tox. 4*
Acute Tox. 4*
Acute Tox. 4*
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2

H225
H351
H302
H312
H332
H335
H315
H319

GHS02
GHS08
GHS07
Gef.

H225
H351
H302
H312
H332
H335
H315
H319

603-103-00-4

oxirane, mono[(C_12-14-alkyloxy)methyl] derivs.

271-846-8

68609-97-2

Skin Irrit. 2
Skin Sens. 1

H315
H317

GHS07
Achtg.

H315
H317

603-104-00-X

fenarimol (ISO);
2,4'-dichloro-a-(pyrimidin-5-yl)benzhydryl alcohol

262-095-7

60168-88-9

Repr. 2
Lact.
Aquatic Chronic 2

H361fd
H362
H411

GHS08 GHS09
Achtg.

H361fd
H362
H411

603-105-00-5

furan

203-727-3

110-00-9

Flam. Liq. 1
Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Aquatic Chronic 3

H224
H350
H341
H332
H302
H373 **
H315
H412

GHS02
GHS08
GHS07
Gef.

H224
H350
H341
H332
H302
H373 **
H315
H412

EUH019

603-106-00-0

2-methoxypropanol

216-455-5

1589-47-5

Flam. Liq. 3
Repr. 1B
STOT SE 3
Skin Irrit. 2
Eye Dam. 1

H226
H360D ***
H335
H315
H318

GHS02
GHS08
GHS05
GHS07
Gef.

H226
H360D ***
H335
H315
H318

603-107-00-6

2-(2-methoxyethoxy)ethanol;
diethylene glycol monomethyl ether

203-906-6

111-77-3

Repr. 2

H361d ***

GHS08
Achtg.

H361d ***

603-108-00-1

2-methylpropan-1-ol;
iso-butanol

201-148-0

78-83-1

Flam. Liq. 3
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
STOT SE 3

H226
H335
H315
H318
H336

GHS02
GHS05
GHS07
Gef.

H226
H335
H315
H318
H336

603-109-00-7

reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;
1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane

425-340-0

Aquatic Chronic 4

H413

603-110-00-2

reaction mass of:cis-2-isobutyl-5-methyl 1,3-dioxane;
trans-2-isobutyl-5-methyl 1,3-dioxane

426-130-1

166301-21-9

Skin Irrit. 2
Aquatic Chronic 3

H315
H412

GHS07
Achtg.

H315
H412

603-111-00-8

reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;
1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane

426-530-6

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

603-112-00-3

cyclopentyl 2-phenylethyl ether

428-340-9

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

603-113-00-9

6-glycidyloxynapht-1-yl oxymethyloxirane

429-960-2

27610-48-6

Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H341
H312
H315
H317
H412

GHS08
GHS07
Achtg.

H341
H312
H315
H317
H412

603-114-00-4

9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene

430-830-2

26912-64-1

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

603-115-00-X

reaction mass of:O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)

423-580-0

STOT RE 2 *
Aquatic Chronic 4

H373**
H413

GHS08
Achtg.

H373**
H413

603-116-00-5

(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride

424-740-2

138271-16-6

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

603-117-00-0

propan-2-ol;
isopropyl alcohol;
isopropanol

200-661-7

67-63-0

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3

H225
H319
H336

GHS02
GHS07
Gef.

H225
H319
H336

603-118-00-6

6-dimethylaminohexan-1-ol

404-680-3

1862-07-3

Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3

H302
H314
H412

GHS05
GHS07
Gef.

H302
H314
H412

603-119-00-1

1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)

405-840-5

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

603-120-00-7

2-methyl-5-phenylpentanol

405-890-8

25634-93-9

Eye Irrit. 2
Skin Irrit. 2

H319
H315

GHS07
Achtg.

H319
H315

603-121-00-2

4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone

406-057-1

114565-66-1

Carc. 2
Skin Sens. 1
Aquatic Chronic 4

H351
H317
H413

GHS08
GHS07
Achtg.

H351
H317
H413

603-122-00-8

sodium 2-ethylhexanolate

406-150-7

38411-13-1

Flam. Sol. 1
Skin Corr. 1B
Aquatic Chronic 3

H228
H314
H412

GHS02
GHS05
Gef.

H228
H314
H412

603-123-00-3

4-methyl-8-methylenetricyclo[3.3.1.1^3,7]decan-2-ol

406-330-5

122760-84-3

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H315
H317
H411

GHS07
GHS09
Achtg.

H315
H317
H411

603-124-00-9

1,4-bis[2-(vinyloxy)ethoxy]benzene

406-900-3

84563-49-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

603-125-00-4

2-(2,4-dichlorophenyl)-1-(1H - 1,2,4-triazol-1-yl)pent-4-en-2-ol

407-850-5

89544-40-1

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

603-126-00-X

2-((4-methyl-2-nitrophenyl)amino)ethanol

408-090-7

100418-33-5

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3

H302
H317
H412

GHS07
Achtg.

H302
H317
H412

603-127-00-5

butan-2-ol; [1]
(S)-butan-2-ol; [2]
(R)-butan-2-ol; [3]
(±)-butan-2-ol [4]

201-158-5 [1]
224-168-1 [2]
238-967-8 [3]
240-029-8 [4]

78-92-2 [1]
4221-99-2 [2]
14898-79-4 [3]
15892-23-6 [4]

Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
STOT SE 3

H226
H319
H335
H336

GHS02
GHS07
Achtg.

H226
H319
H335
H336

603-128-00-0

2-(phenylmethoxy)naphthalene

405-490-3

613-62-7

Aquatic Chronic 4

H413

603-129-00-6

1-tert-butoxypropan-2-ol

406-180-0

57018-52-7

Flam. Liq. 3
Eye Dam. 1

H226
H318

GHS02
GHS05
Gef.

H226
H318

603-130-00-1

reaction mass of isomers of: a-((dimethyl)biphenyl)-?-hydroxypoly(oxyethylene)

406-325-8

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

603-131-00-7

reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)

407-290-1

Eye Dam. 1

H318

GHS05
Gef.

H318

603-132-00-2

2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane

408-200-3

63187-91-7

Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H315
H318
H412

GHS05
Gef.

H315
H318
H412

603-133-00-8

reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;
3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)

408-240-1

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

603-134-00-3

reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C₁-C₁₀ alkyl groups. The alkyl groups are bonded randomly between C₁ and C₆. Linear C₁₂ and C₁₄, 50/50 used.

410-450-3

Aquatic Chronic 4

H413

603-135-00-9

bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium

410-500-4

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

603-136-00-4

3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol

410-910-3

104226-19-9

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

603-137-00-X

reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;
1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol

411-130-6

Eye Dam. 1

H318

GHS05
Gef.

H318

603-138-00-5

3-(2,2-dimethyl-3-hydroxypropyl)toluene;
(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol

403-140-4

103694-68-4

Aquatic Chronic 3

H412

603-139-00-0

bis(2-methoxyethyl) ether

203-924-4

111-96-6

Flam. Liq. 3
Repr. 1B

H226
H360FD

GHS02
GHS08
Gef.

H226
H360FD

EUH019

603-140-00-6

2,2' -oxybisethanol;
diethylene glycol

203-872-2

111-46-6

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

603-141-00-1

reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;
dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane

413-780-6

Aquatic Chronic 3

H412

603-142-00-7

2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane

407-360-1

116230-20-7

Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1

H312
H302
H373 **
H315
H318

GHS06
GHS08
GHS05
Gef.

H312
H302
H373 **
H315
H318

603-143-00-2

R - 2,3-epoxy-1-propanol

404-660-4

57044-25-4

Self-react. C ****
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H242
H350
H341
H360F ***
H331
H312
H302
H314

GHS02
GHS06
GHS08
GHS05
Gef.

H242
H350
H341
H360F ***
H331
H312
H302
H314

603-144-00-8

reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;
6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol

413-530-6

111850-00-1

Aquatic Chronic 2

H411

GHS09

H411

603-145-00-3

2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane

406-970-5

129228-11-1

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

603-146-00-9

2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol

406-080-7

83016-70-0

Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3

H302
H314
H412

GHS05
GHS07
Gef.

H302
H314
H412

603-147-00-4

(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine

406-030-4

105812-81-5

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

603-148-00-X

1,4-bis[(vinyloxy)methyl]cyclohexane

413-370-7

17351-75-6

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07 GHS09
Achtg.

H317
H411

603-149-00-5

reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane

407-640-3

63767-86-2

Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H319
H315
H411

GHS07 GHS09
Achtg.

H319
H315
H411

603-150-00-0

(±)trans - 3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol

411-580-3

107898-54-4

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

603-151-00-6

(±)-2-(2,4-dichlorophenyl)-3-(1H - 1,2,4-triazol-1-yl)propan-1-ol

413-570-4

Aquatic Chronic 3

H412

603-152-00-1

2-(4-tert-butylphenyl)ethanol

410-020-5

5406-86-0

Repr. 2
STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2

H361f ***
H373 **
H318
H411

GHS08
GHS05
GHS09
Gef.

H361f ***
H373 **
H318
H411

603-153-00-7

3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol

410-010-0

104333-00-8

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

603-154-00-2

1-[(2-tert-butyl)cyclohexyloxy]-2-butanol

412-300-2

139504-68-0

Aquatic Chronic 2

H411

GHS09

H411

603-156-00-3

2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane

411-210-0

89544-48-9

Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H317
H400
H410

GHS07
GHS09
Achtg.

H315
H317
H410

603-157-00-9

6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol

411-450-6

143747-72-2

Aquatic Chronic 4

H413

603-158-00-4

reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene

412-460-3

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07 GHS09
Achtg.

H315
H411

603-159-00-X

2-cyclododecylpropan-1-ol

411-410-8

118562-73-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

603-160-00-5

1,2-diethoxypropane

412-180-1

10221-57-5

Flam. Liq. 2

H225

GHS02
Gef.

H225

EUH019

603-161-00-0

1,3-diethoxypropane

413-140-6

3459-83-4

Flam. Liq. 3

H226

GHS02
Achtg.

H226

603-162-00-6

a[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ? nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]

413-420-8

144736-29-8

Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H314
H317
H411

GHS05
GHS07
GHS09
Gef.

H314
H317
H411

603-163-00-1

2-phenyl-1,3-propanediol

411-810-2

1570-95-2

Eye Dam. 1

H318

GHS05
Gef.

H318

603-164-00-7

2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole

412-420-5

133909-99-6

Aquatic Chronic 4

H413

603-165-00-2

reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;
4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol

417-470-1

Muta. 2
Skin Sens. 1

H341
H317

GHS08
GHS07
Achtg.

H341
H317

603-166-00-8

R-1-chloro-2,3-epoxypropane

424-280-2

51594-55-9

Flam. Liq. 3
Carc. 1B
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1

H226
H350
H331
H311
H301
H314
H317

GHS02
GHS06
GHS08
GHS05
Gef.

H226
H350
H331
H311
H301
H314
H317

603-167-00-3

3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol

407-920-5

6390-69-8

Aquatic Chronic 4

H413

GHS05
Gef.

H413

603-168-00-9

3-(2-ethylhexyloxy)propane-1,2-diol

408-080-2

70445-33-9

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

603-169-00-4

(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine

415-550-0

109887-53-8

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

603-170-00-X

reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;
2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;
2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol

415-990-3

67739-11-1

Eye Irrit. 2
Aquatic Chronic 2

H319
H411

GHS07
GHS09
Achtg.

H319
H411

603-171-00-5

5-thiazolylmethanol

414-780-9

38585-74-9

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

603-172-00-0

mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanoltrans-butenedioate

415-180-1

773058-82-5

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

603-173-00-6

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane

421-750-9

57280-22-5

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

603-174-00-1

4-cyclohexyl-2-methyl-2-butanol

420-630-3

83926-73-2

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

603-175-00-7

2-(2-hexyloxyethoxy)ethanol;
DEGHE;
diethylene glycol monohexyl ether;
3,6-dioxa-1-dodecanol;
hexyl carbitol;
3,6-dioxadodecan-1-ol

203-988-3

112-59-4

Acute Tox. 4 *
Eye Dam. 1

H312
H318

GHS05
GHS07
Gef.

H312
H318

603-176-00-2

1,2-bis(2-methoxyethoxy)ethane;
TEGDME;
triethylene glycol dimethyl ether;
triglyme

203-977-3

112-49-2

Repr. 1B

H360Df

GHS08
Gef.

H360Df

EUH019

603-177-00-8

1-ethoxypropan-2-ol;
2PG1EE;
1-ethoxy-2-propanol;
propylene glycol monoethyl ether; [1]
2-ethoxy-1-methylethyl acetate;
2PG1EEa [2]

216-374-5 [1]
259-370-9 [2]

1569-02-4 [1]
54839-24-6 [2]

Flam. Liq. 3
STOT SE 3

H226
H336

GHS02
GHS07
Achtg.

H226
H336

603-178-00-3

2-hexyloxyethanol;
ethylene glycol monohexyl ether;
n-hexylglycol

203-951-1

112-25-4

Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H312
H302
H314

GHS05
GHS07
Gef.

H312
H302
H314

603-179-00-9

ergocalciferol (ISO);
Vitamin D2

200-014-9

50-14-6

Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1

H330
H311
H301
H372 **

GHS06
GHS08
Gef.

H330
H311
H301
H372 **

603-180-00-4

colecalciferol;
Vitamin D3

200-673-2

67-97-0

Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1

H330
H311
H301
H372 **

GHS06
GHS08
Gef.

H330
H311
H301
H372 **

603-181-00-X

tert-butyl methyl ether;
MTBE;
2-methoxy-2-methylpropane

216-653-1

1634-04-4

Flam. Liq. 2
Skin Irrit. 2

H225
H315

GHS02
GHS07
Gef.

H225
H315

603-182-00-5

reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L.,Brassica rapa L.,Helianthus annuus L.,Glycine hispida,Gossypium hirsutumL.,Cocos nucifera L.,Elaeis guineensis) withO,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide

428-630-5

Skin Sens. 1

H317

GHS07
Achtg.

H317

603-183-00-0

2-[2-(2-butoxyethoxy)ethoxy]ethanol;
TEGBE;
triethylene glycol monobutyl ether;
butoxytriethylene glycol

205-592-6

143-22-6

Eye Dam. 1

H318

GHS05
Gef.

H318

Eye Dam. 1; H318: C> 30 %
Eye Irrit. 2; H319: 20 % ≤ C < 30 %

603-184-00-6

2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol

416-380-1

146925-83-9

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

603-185-00-1

2,4-dichloro-3-ethyl-6-nitrophenol

420-740-1

99817-36-4

Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H318
H317
H400
H410

GHS06
GHS05
GHS09
Gef.

H301
H318
H317
H410

603-186-00-7

trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol

419-050-3

79944-37-9

Skin Sens. 1

H317

GHS07
Achtg.

H317

603-187-00-2

2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride

419-360-9

163661-77-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

603-188-00-8

reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene;
7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene

426-970-9

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

603-189-00-3

reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol

405-250-8

Aquatic Chronic 2

H411

GHS09

H411

603-190-00-9

8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane

424-030-2

62406-73-9

Skin Irrit. 2
Aquatic Chronic 3

H315
H412

GHS07
Achtg.

H315
H412

603-191-00-4

2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol

419-740-4

137658-79-8

Aquatic Chronic 4

H413

603-192-00-X

(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol

423-240-1

125474-34-2

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H410

603-193-00-5

disodium 9,10-anthracenedioxide

426-030-8

46492-07-3

Skin Corr. 1A

H314

GHS05
Gef.

H314

603-194-00-0

2-(2-aminoethylamino)ethanol;
(AEEA)

203-867-5

111-41-1

Repr. 1B
Skin Corr. 1B
Skin Sens. 1

H360Df
H314
H317

GHS05
GHS08
GHS07
Gef.

H360Df
H314
H317

STOT SE 3; H335: C> 5 %

603-195-00-6

2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol

430-810-3

154825-62-4

Aquatic Chronic 3

H412

603-196-00-1

2-(7-ethyl-1H-indol-3-yl)ethanol

431-020-1

41340-36-7

Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2

H302
H373 **
H411

GHS08
GHS07
GHS09
Achtg.

H302
H373 **
H411

603-197-00-7

Tebuconazol (ISO); 1-(4-Chlorphenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol

403-640-2

107534-96-3

Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1

H361d***
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361d***
H302
H410

M = 1
M = 10

603-199-00-8

etoxazol (ISO);
(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole

153233-91-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M=100

603-200-00-1

1-pentanol; [1]
3-pentanol [2]

200-752-1 [1]
209-526-7 [2]

71-41-0 [1]
584-02-1 [2]

Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2

H226
H332
H335
H315

GHS02
GHS07
Achtg.

H226
H332
H335
H315

603-201-00-7

(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol

416-120-5

Skin Irrit. 2
Aquatic Chronic 4

H315
H413

GHS07
Achtg.

H315
H413

603-202-00-2

4,4,5,5,5-pentafluoropentan-1-ol

421-360-9

148043-73-6

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

603-203-00-8

(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.0^1,10.0^3,7]tetradecane

427-580-1

Skin Irrit. 2

H315

GHS07
Achtg.

H315

603-204-00-3

reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;
2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane

428-110-8

Aquatic Chronic 3

H412

603-205-00-9

(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride

426-200-1

172015-79-1

STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H372**
H302
H318
H317
H412

GHS05
GHS08
GHS07
Gef.

H372**
H302
H318
H317
H412

603-206-00-4

2,2-dichloro-1,3-benzodioxol

426-850-6

2032-75-9

Flam. Liq. 3
Skin Corr. 1a
Acute Tox. 4 *
Skin Sens. 1

H226
H314
H302
H317

GHS02
GHS05
GHS07
Gef.

H226
H314
H302
H317

EUH014

603-207-00-X

2-isobutyl-2-isopropyl-1,3-dimethoxypropane

430-800-9

129228-21-3

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

603-208-00-5

1,2-diethoxyethane

211-076-1

629-14-1

Flam. Liq. 2
Repr. 1a
Eye Irrit. 2

H225
H360Df
H319

GHS02
GHS08
GHS07
Gef.

H225
H360Df
H319

EUH019

603-209-00-0

spinosad (ISO) (reaction mass of spinosyn a and spinosyn D in ratios between 95:5 to 50:50);
reaction mass of 50-95 % of (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-a-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-ß-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-a-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-ß-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]
spinosyn A; [2]
spinosyn D [3]

- [1]
- [2]
- [3]

- [1]
131929-60-7 [2]
131929-63-0 [3]

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M=10

603-210-00-6

2,4-diethyl-1,5-pentanediol

429-310-8

57987-55-0

Eye Dam. 1

H318

GHS05
Gef.

H318

603-211-00-1

2,3-epoxypropyltrimethylammonium chloride ... %;
glycidyl trimethylammonium chloride ... %

221-221-0

3033-77-0

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H350
H341
H361f***
H312
H302
H373**
H318
H317
H412

GHS05
GHS08
GHS07
Gef.

H350
H341
H361f***
H312
H302
H373**
H318
H317
H412

603-212-00-7

1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;
galaxolide;
(HHCB)

214-946-9

1222-05-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

603-213-00-2

2-methoxy-2-methylbutane;
tert-amyl methyl ether

213-611-4

994-05-8

Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3

H225
H302
H336

GHS02
GHS07
Gef.

H225
H302
H336

603-214-00-8

1,1-diisopropoxycyclohexane

413-740-8

1132-95-2

Skin Corr. 1B

H314

GHS05
Gef.

H314

603-215-00-3

1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)

418-330-2

162241-33-0

Expl. 1.1****
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H201
H302
H373**
H318
H317
H400
H410

GHS01
GHS05
GHS08
GHS07
GHS09
Gef.

H201
H302
H373**
H318
H317
H410

603-216-00-9

cis-1-amino-2,3-dihydro-1H-inden-2-ol

422-660-2

7480-35-5

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

603-217-00-4

2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite

423-560-1

161717-32-4

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

603-220-00-0

1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol

432-890-5

72955-94-3

Aquatic Chronic 4

H413

603-221-00-6

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]

433-580-2

214353-17-0

Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2

H302
H314
H411

GHS05
GHS07
GHS09
Gef.

H302
H314
H411

603-221-01-3

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing> 0,1 % 4-chloroaniline (EC No 203-401-0)]

433-580-2

214353-17-0

Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2

H350
H302
H314
H411

GHS05
GHS08
GHS07
GHS09
Gef.

H350
H302
H314
H411

603-222-00-1

(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane

433-820-6

118058-74-5

Eye Irrit. 2

H319

GHS07
Achtg.

H319

603-223-00-7

2-cyclopentylidene cyclopentanol;
1,1'-bi(cyclopentyliden)-2-ol

434-270-1

6261-30-9

Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H315
H318
H412

GHS05
Gef.

H315
H318
H412

603-224-00-2

3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane

435-790-1

297730-93-9

Aquatic Chronic 4

H413

603-225-00-8

erythromycin A9-oxime (E);
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-ß-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)

437-070-0

13127-18-9

Aquatic Chronic 2

H411

GHS09

H411

603-226-00-3

4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol

444-500-0

1440-00-2

Aquatic Chronic 3

H412

603-227-00-9

a-hydro-?-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
reaction product of: a-hydro-?-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate

445-060-2

203574-04-3

****
Aquatic Acute 1
Aquatic Chronic 1

****
H400
H410

****
GHS09
Achtg.

****
H410

603-228-00-4

(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
6-fluoro-2-(2-oxiranyl)chromane

419-620-1

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

603-229-00-X

sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate

420-800-7

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H410

603-230-00-5

2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan

440-030-5

Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 4

H315
H318
H413

GHS05
Gef.

H315
H318
H413

603-231-00-0

(S)-1,1-diphenyl-1,2-propanediol

443-220-6

Aquatic Chronic 3

H412

603-232-00-6

3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane

444-420-6

Aquatic Chronic 4

H413

603-233-00-1

reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol

444-430-0

Aquatic Chronic 2

H411

GHS09

H411

603-234-00-7

(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene

444-480-3

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

603-235-00-2

Linalool: 3,7-Dimethyl-1,6-octadien-3-ol; DL-Linalool; [1]
Coriandrol; (S)-3,7-Dimethyl-1,6-octadien-3-ol; D- Linalool; [2]
Licareol; (R)-3,7-Dimethyl-1,6-octadien-3-ol; L- Linalool [3]

201-134-4 [1]
204-810-7 [2]
204-811-2 [3]

78-70-6 [1]
126-90-9 [2]
126-91-0 [3]

Skin Sens. 1B

H317

GHS07 Achtg.

H317

604-001-00-2

phenol;
carbolic acid;
monohydroxybenzene;
phenylalcohol

203-632-7

108-95-2

Muta. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Corr. 1B

H341
H331
H311
H301
H373 **
H314

GHS06
GHS08 GHS05
Gef.

H341
H331
H311
H301
H373 **
H314

*
Skin Corr. 1B; H314: C> 3 %
Skin Irrit. 2; H315: 1 % ≤ C < 3 %
Eye Irrit. 2; H319: 1 % ≤ C < 3 %

604-002-00-8

pentachlorophenol

201-778-6

87-86-5

Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H330
H311
H301
H319
H335
H315
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H330
H311
H301
H319
H335
H315
H410

604-003-00-3

sodium pentachlorophenolate; [1]
potassium pentachlorophenolate [2]

205-025-2 [1]
231-911-3 [2]

131-52-2 [1]
7778-73-6 [2]

Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H330
H311
H301
H319
H335
H315
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H330
H311
H301
H319
H335
H315
H410

604-004-00-9

m-cresol; [1]
o-cresol; [2]
p-cresol; [3]
mix-cresol [4]

203-577-9 [1]
202-423-8 [2]
203-398-6 [3]
215-293-2 [4]

108-39-4 [1]
95-48-7 [2]
106-44-5 [3]
1319-77-3 [4]

Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B

H311
H301
H314

GHS06
GHS05
Gef.

H311
H301
H314

604-005-00-4

1,4-dihydroxybenzene;
hydroquinone;
quinol

204-617-8

123-31-9

Carc. 2
Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1

H351
H341
H302
H318
H317
H400

GHS05
GHS08
GHS07
GHS09
Gef.

H351
H341
H302
H318
H317
H400

M=10

604-006-00-X

3,4-xylenol; [1]
2,5-xylenol; [2]
2,4-xylenol; [3]
2,3-xylenol; [4]
2,6-xylenol; [5]
xylenol; [6]
2,4(or 2,5)-xylenol [7]

202-439-5 [1]
202-461-5 [2]
203-321-6 [3]
208-395-3 [4]
209-400-1 [5]
215-089-3 [6]
276-245-4 [7]

95-65-8 [1]
95-87-4 [2]
105-67-9 [3]
526-75-0 [4]
576-26-1 [5]
1300-71-6 [6]
71975-58-1 [7]

Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Chronic 2

H311
H301
H314
H411

GHS06
GHS05
GHS09
Gef.

H311
H301
H314
H411

604-007-00-5

2-naphthol

205-182-7

135-19-3

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1

H332
H302
H400

GHS07
GHS09
Achtg.

H332
H302
H400

604-008-00-0

2-chlorophenol; [1]
4-chlorophenol; [2]
3-chlorophenol; [3]
chlorophenol [4]

202-433-2 [1]
203-402-6 [2]
203-582-6 [3]
246-691-4 [4]

95-57-8 [1]
106-48-9 [2]
108-43-0 [3]
25167-80-0 [4]

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2

H332
H312
H302
H411

GHS07 GHS09
Achtg.

H332
H312
H302
H411

604-009-00-6

pyrogallol;
1,2,3-trihydroxybenzene

201-762-9

87-66-1

Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3

H341
H332
H312
H302
H412

GHS08
GHS07
Achtg.

H341
H332
H312
H302
H412

604-010-00-1

resorcinol;
1,3-benzenediol

203-585-2

108-46-3

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1

H302
H319
H315
H400

GHS07
GHS09
Achtg.

H302
H319
H315
H400

604-011-00-7

2,4-dichlorophenol

204-429-6

120-83-2

Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2

H311
H302
H314
H411

GHS06
GHS05
GHS09
Gef.

H311
H302
H314
H411

604-012-00-2

4-chloro-o-cresol;
4-chloro-2-methyl phenol

216-381-3

1570-64-5

Acute Tox. 3 *
Skin Corr. 1a
Aquatic Acute 1

H331
H314
H400

GHS06
GHS05
GHS09
Gef.

H331
H314
H400

STOT SE 3; H335: C> 1 %

604-013-00-8

2,3,4,6-tetrachlorophenol

200-402-8

58-90-2

Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H301
H319
H315
H400
H410

GHS06
GHS09
Gef.

H301
H319
H315
H410

*
Eye Irrit. 2; H319: C> 5 %
Skin Irrit. 2; H315: C> 5 %

604-014-00-3

chlorocresol;
4-chloro-m-cresol;
4-chloro-3-methylphenol

200-431-6

59-50-7

Acute Tox. 4 *
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1

H312
H302
H318
H317
H400

GHS05
GHS07
GHS09
Gef.

H312
H302
H318
H317
H400

604-015-00-9

2,2'-methylenebis-(3,4,6-trichlorophenol);
hexachlorophene

200-733-8

70-30-4

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H311
H301
H400
H410

GHS06
GHS09
Gef.

H311
H301
H410

604-016-00-4

1,2-dihydroxybenzene;
pyrocatechol

204-427-5

120-80-9

Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2

H312
H302
H319
H315

GHS07
Achtg.

H312
H302
H319
H315

604-017-00-X

2,4,5-trichlorophenol

202-467-8

95-95-4

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H315
H410

*
Eye Irrit. 2; H319: C> 5 %
Skin Irrit. 2; H315: C> 5 %

604-018-00-5

2,4,6-trichlorophenol

201-795-9

88-06-2

Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H319
H315
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H302
H319
H315
H410

604-019-00-0

dichlorophen (ISO)

202-567-1

97-23-4

Acute Tox. 4 *
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H410

604-020-00-6

2-phenylphenol (ISO)
biphenyl-2-ol;
2-hydroxybiphenyl;

201-993-5

90-43-7

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1

H319
H335
H315
H400

GHS07
GHS09
Achtg.

H319
H335
H315
H400

604-021-00-1

sodium 2-biphenylate;
2-phenylphenol, sodium salt

205-055-6

132-27-4

Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1

H302
H335
H315
H318
H400

GHS05
GHS07
GHS09
Achtg.

H302
H335
H315
H318
H400

604-022-00-7

2,2-dimethyl-1,3-benzodioxol-4-ol

400-900-7

22961-82-6

Eye Dam. 1

H318

GHS05
Gef.

H318

604-023-00-2

2,4-dichloro-3-ethylphenol

401-060-4

Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H314
H400
H410

GHS05
GHS09
Gef.

H314
H410

604-024-00-8

4,4-isobutylethylidenediphenol

401-720-1

6807-17-6

Repr. 1B
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H360F ***
H319
H400
H410

GHS08
GHS09
Gef.

H360F ***
H319
H410

604-025-00-3

2,5-bis(1,1-dimethylbutyl)hydroquinone

400-220-0

Aquatic Chronic 2

H411

GHS09

H411

604-026-00-9

2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)

400-270-3

Aquatic Chronic 2

H411

GHS09

H411

604-027-00-4

2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone

400-530-6

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

604-028-00-X

4-amino-3-fluorophenol

402-230-0

399-95-1

Carc. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H350
H302
H317
H411

GHS08
GHS07
GHS09
Gef.

H350
H302
H317
H411

604-029-00-5

1-naphtol

201-969-4

90-15-3

Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1

H312
H302
H335
H315
H318

GHS05
GHS07
Gef.

H312
H302
H335
H315
H318

604-030-00-0

Bisphenol A;
4,4'-Isopropylidendiphenol

201-245-8

80-05-7

Repr. 1B
STOT SE 3
Eye Dam. 1
Skin Sens. 1

H360F
H335
H318
H317

GHS08
GHS05 GHS07
Gef.

H360F
H335
H318
H317

604-031-00-6

guaiacol

201-964-7

90-05-1

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2

H302
H319
H315

GHS07
Achtg.

H302
H319
H315

604-032-00-1

thymol

201-944-8

89-83-8

Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2

H302
H314
H411

GHS05
GHS07
GHS09
Gef.

H302
H314
H411

604-033-00-7

isobutyl but-3-enoate

401-170-2

24342-03-8

Flam. Liq. 3

H226

GHS02
Achtg.

H226

604-034-00-2

4,4'-thiodi-o-cresol

403-330-7

24197-34-0

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

604-035-00-8

4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol

404-160-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

604-036-00-3

4,4'-oxybis(ethylenethio)diphenol

404-590-4

90884-29-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

604-037-00-9

3,5-xylenol;
3,5-dimethylphenol

203-606-5

108-68-9

Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B

H311
H301
H314

GHS06
GHS05
Gef.

H311
H301
H314

604-038-00-4

4-chloro-3,5-dimethylphenol; [1]
chloroxylenol [2]

201-793-8 [1]
215-316-6 [2]

88-04-0 [1]
1321-23-9 [2]

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H302
H319
H315
H317

GHS07
Achtg.

H302
H319
H315
H317

604-039-00-X

ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;
fenoxaprop-ethyl

266-362-9

66441-23-4

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

604-040-00-5

fomesafen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide

276-439-9

72178-02-0

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

604-041-00-0

acifluorfen (ISO);
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]
sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;
acifluorfen-sodium [2]

256-634-5 [1]
263-560-7 [2]

50594-66-6 [1]
62476-59-9 [2]

Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H315
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H315
H318
H410

604-042-00-6

4-nitrosophenol

203-251-6

104-91-6

Muta. 2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H341
H302
H318
H411

GHS08
GHS05
GHS07
GHS09
Gef.

H341
H302
H318
H411

604-043-00-1

monobenzone;
4-hydroxyphenyl benzyl ether;
hydroquinone monobenzyl ether

203-083-3

103-16-2

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

604-044-00-7

mequinol;
4-methoxyphenol;
hydroquinone monomethyl ether

205-769-8

150-76-5

Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1

H302
H319
H317

GHS07
Achtg.

H302
H319
H317

604-045-00-2

2,3,5-trimethylhydroquinone

211-838-3

700-13-0

Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H332
H335
H315
H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H332
H335
H315
H318
H317
H410

604-046-00-8

4-(4-isopropoxyphenylsulfonyl)phenol

405-520-5

95235-30-6

Aquatic Chronic 2

H411

GHS09

H411

604-047-00-3

4-(4-tolyloxy)biphenyl

405-730-7

51601-57-1

STOT RE 2 *
Aquatic Chronic 4

H373 **
H413

GHS08
Achtg.

H373 **
H413

604-048-00-9

4,4',4''-(ethan-1,1,1-triyl)triphenol

405-800-7

27955-94-8

Aquatic Chronic 2

H411

GHS09

H411

604-049-00-4

4-4'-methylenebis(oxyethylenethio)diphenol

407-480-4

93589-69-6

Aquatic Chronic 2

H411

GHS09

H411

604-051-00-5

3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol

401-110-5

87113-78-8

Aquatic Chronic 3

H412

604-052-00-0

2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)

403-800-1

103597-45-1

Aquatic Chronic 4

H413

604-053-00-6

2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol

410-760-9

157661-93-3

Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H317
H400
H410

GHS07
GHS09
Achtg.

H315
H317
H410

604-054-00-1

reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;
4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol

412-020-0

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

604-055-00-7

2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane

413-900-7

85954-11-6

Carc. 2
Skin Sens. 1

H351
H317

GHS08
GHS07
Achtg.

H351
H317

604-056-00-2

2-(2-hydroxy-3,5-dinitroanilino)ethanol

412-520-9

99610-72-7

Flam. Sol. 2
Repr. 2
Acute Tox. 4 *

H228
H361f ***
H302

GHS02
GHS07
GHS08
Gef.

H228
H361f ***
H302

604-057-00-8

Reaktionsmasse aus Isomeren von 2-(2 H-Benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol; Isomeren von 2-(2 H-Benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol; Isomeren von 2-(2 H-Benzotriazol-2-yl)-4-methyl-5,6-didodecylphenol; n = 5 oder 6

401-680-5

Aquatic Chronic 4

H413

604-058-00-3

1,2-bis(3-methylphenoxy)ethane

402-730-9

54914-85-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

604-059-00-9

2-n-hexadecylhydroquinone

406-400-5

STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4

H373 **
H315
H317
H413

GHS08
GHS07
Achtg.

H373 **
H315
H317
H413

604-060-00-4

9,9-bis(4-hydroxyphenyl)fluorene

406-950-6

3236-71-3

Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H315
H410

604-061-00-X

reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones wheresec-tetradecyl= 1-methyltridecyl;
1-ethyldodecyl;
1-propylundecyl;
1-butyldecyl;
1-pentylnonyl;
1-hexyloctyl

407-740-7

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H315
H317
H412

GHS07
Achtg.

H315
H317
H412

604-062-00-5

2,4-dimethyl-6-(1-methyl-pentadecyl)phenol

411-220-5

Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H317
H400
H410

GHS07
GHS09
Achtg.

H315
H317
H410

604-063-00-0

5,6-dihydroxyindole

412-130-9

3131-52-0

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05 GHS07
GHS09
Gef.

H302
H318
H411

604-064-00-6

2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol

411-380-6

147315-50-2

Aquatic Chronic 4

H413

604-065-00-1

4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)

407-460-5

111850-25-0

Aquatic Chronic 2

H411

GHS09

H411

604-066-00-7

reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C₄₁-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C₄₅-compound);
2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;
2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol

414-550-8

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

604-067-00-2

reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);
formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)

414-520-4

Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H400
H410

GHS05
GHS09
Gef.

H315
H318
H410

604-068-00-8

(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride

415-170-5

90274-24-1

Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1

H332
H302
H317

GHS07
Achtg.

H332
H302
H317

604-069-00-3

2-(1-methylpropyl)-4-tert-butylphenol

421-740-4

51390-14-8

Skin Corr. 1B
Aquatic Chronic 2

H314
H411

GHS05
GHS09
Gef.

H314
H411

604-070-00-9

triclosan;
2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;
5-chloro-2-(2,4-dichlorophenoxy)phenol

222-182-2

3380-34-5

Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H315
H410

M=100

604-071-00-4

4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol

425-600-3

110726-28-8

Aquatic Chronic 4

H413

604-072-00-X

1,2-bis(phenoxymethyl)benzene

428-620-0

10403-74-4

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

604-073-00-5

(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol

428-010-4

82413-20-5

Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H360F***
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H351
H360F***
H317
H410

604-074-00-0

tetrabromobisphenol-A;
2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol

201-236-9

79-94-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

604-075-00-6

4-(1,1,3,3-tetramethylbutyl)phenol;
4-tert-octylphenol

205-426-2

140-66-9

Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H400
H410

GHS05
GHS09
Gef.

H315
H318
H410

M=10

604-076-00-1

phenolphthalein

201-004-7

77-09-8

Carc. 1B
Muta. 2
Repr. 2

H350
H341
H361f***

GHS08
Gef.

H350
H341
H361f***

Carc. 1B; H350: C> 1 %

604-077-00-7

2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol

419-750-9

98809-58-6

Aquatic Chronic 4

H413

604-079-00-8

4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol

428-970-4

13595-25-0

Repr. 2
Skin Sens. 1
Aquatic Chronic 2

H361f***
H317
H411

GHS08
GHS07
GHS09
Achtg.

H361f***
H317
H411

604-080-00-3

4-fluoro-3-trifluoromethylphenol

432-560-0

61721-07-1

Acute Tox. 4 *
Skin Corr. 1a
Skin Sens. 1
Aquatic Chronic 2

H332
H314
H317
H411

GHS05
GHS07
GHS09
Gef.

H332
H314
H317
H411

604-081-00-9

1,1-bis(4-hydroxyphenyl)-1-phenylethane

433-130-5

1571-75-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

604-082-00-4

2-chloro-6-fluoro-phenol

433-890-8

2040-90-6

Muta. 1B
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H340
H361f***
H302
H314
H317
H411

GHS05
GHS08
GHS07
GHS09
Gef.

H340
H361f***
H302
H314
H317
H411

604-083-00-X

4,4'-sulfonylbisphenol, polymer with ammonium chloride (NH₄Cl), pentachlorophosphorane and phenol

439-270-3

260408-02-4

Aquatic Chronic 4

H413

604-084-00-5

1-ethoxy-2,3-difluorobenzene

441-000-4

121219-07-6

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

604-087-00-1

reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol

433-640-8

Pyr. Sol. 1
Aquatic Chronic 4

H250
H413

GHS02
Gef.

H250
H413

EUH044

604-089-00-2

2-methyl-5-tert-butylthiophenol

444-970-7

Flam. Liq. 3
Repr. 2
STOT RE 2 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H226
H361d***
H373**
H304
H319
H315
H317
H336
H400
H410

GHS02
GHS08
GHS07
GHS09
Gef.

H226
H361d***
H373**
H304
H319
H315
H317
H336
H410

604-090-00-8

4-tert-butylphenol

202-679-0

98-54-4

Repr. 2
Skin Irrit. 2
Eye Dam. 1

H361f
H315
H318

GHS08
GHS05
Gef.

H361f
H315
H318

604-091-00-3

etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether

407-980-2

80844-07-1

Lact.
Aquatic Acute 1
Aquatic Chronic 1

H362
H400
H410

GHS09
Achtg.

H362
H410

M = 100
M = 1 000

604-092-00-9

Phenol, dodecyl-, verzweigt; [1]
Phenol, 2-dodecyl-, verzweigt; [2]
Phenol, 3-dodecyl-, verzweigt; [3]
Phenol, 4-dodecyl-, verzweigt; [4]
Phenol, (tetrapropenyl) Derivate [5]

310-154-3 [1]
[2]
[3]
[4]
[5]

121158-58-5 [1]
[2]
[3]
210555-94-5 [4]
74499-35-7 [5]

Repr. 1B
Skin Corr. 1C
Eye Dam. 1
Aquatic Acute 1 Aquatic Chronic 1

H360F
H314
H318
H400
H410

GHS08
GHS05
GHS09
Gef.

H360F
H314
H410

M = 10
M = 10

604-093-00-4

Clorofen;
Chlorophen;
2-Benzyl-4-chlorphenol

204-385-8

120-32-1

Carc. 2
Repr. 2
Acute Tox. 4
Skin Irrit. 2
Skin Sens. 1
Eye Dam. 1
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H361f
H332
H315
H317
H318
H373 (Nieren)
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H351
H361f
H332
H315
H317
H318
H373 (Nieren)
H410

M = 1
M = 100

605-001-00-5

formaldehyde ...%

200-001-8

50-00-0

Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Skin Sens. 1

H351
H331
H311
H301
H314
H317

GHS06
GHS08
GHS05
Gef.

H351
H331
H311
H301
H314
H317

*
Skin Corr. 1B; H314: C>25 %
Skin Irrit. 2; H315: 5 % ≤ C < 25 %
Eye Irrit. 2; H319: 5 % ≤ C < 25 %
STOT SE 3; H335: C> 5 %
Skin Sens. 1; H317: C> 0,2 %

B D

605-002-00-0

1,3,5-trioxan;
trioxymethylene

203-812-5

110-88-3

Flam. Sol. 1
Repr. 2
STOT SE 3

H228
H361d ***
H335

GHS02
GHS08
GHS07
Gef.

H228
H361d ***
H335

605-003-00-6

acetaldehyde;
ethanal

200-836-8

75-07-0

Flam. Liq. 1
Carc. 2
Eye Irrit. 2
STOT SE 3

H224
H351
H319
H335

GHS02
GHS08
GHS07
Gef.

H224
H351
H319
H335

605-004-00-1

2,4,6-trimethyl-1,3,5-trioxane;
paraldehyde

204-639-8

123-63-7

Flam. Liq. 3

H226

GHS02
Achtg.

H226

605-005-00-7

2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde

203-600-2

108-62-3

Flam. Sol. 2
Acute Tox. 4 *

H228
H302

GHS02
GHS07
Achtg.

H228
H302

605-006-00-2

butyraldehyde

204-646-6

123-72-8

Flam. Liq. 2

H225

GHS02
Gef.

H225

605-007-00-8

1,1-dimethoxyethane;
dimethyl acetal

208-589-8

534-15-6

Flam. Liq. 2

H225

GHS02
Gef.

H225

605-008-00-3

acrolein;
prop-2-enal;
acrylaldehyde

203-453-4

107-02-8

Flam. Liq. 2
Acute Tox. 1
Acute Tox. 2
Acute Tox. 3
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H225
H330
H300
H311
H314
H400
H410

GHS02
GHS06
GHS05
GHS09
Gef.

H225
H330
H300
H311
H314
H410

EUH071

Skin Corr. 1B;
H314: C> 0,1 %
M = 100
M = 1

605-009-00-9

crotonaldehyde;
2-butenal; [1]
(E)-2-butenal;
(E)-crotonaldehyde [2]

224-030-0 [1]
204-647-1 [2]

4170-30-3 [1]
123-73-9 [2]

Flam. Liq. 2
Muta. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1

H225
H341
H330
H311
H301
H373 **
H335
H315
H318
H400

GHS02
GHS06
GHS08
GHS05
GHS09
Gef.

H225
H341
H330
H311
H301
H373 **
H335
H315
H318
H400

605-010-00-4

2-furaldehyde

202-627-7

98-01-1

Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H351
H331
H301
H312
H319
H335
H315

GHS06
GHS08
Gef.

H351
H331
H301
H312
H319
H335
H315

605-011-00-X

2-chlorobenzaldehyde;
o-chlorobenzaldehyde

201-956-3

89-98-5

Skin Corr. 1B

H314

GHS05
Gef.

H314

605-012-00-5

benzaldehyde

202-860-4

100-52-7

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

605-013-00-0

Chloralose (INN);
(R)-1,2-O-(2,2,2-Trichlorethyliden)-a-D-glucofuranose; Glucochloralose; Anhydroglucochloral

240-016-7

15879-93-3

Acute Tox. 4*
Acute Tox. 3
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H332
H301
H336
H400
H410

GHS06
GHS09
Gef.

H332
H301
H336
H410

M = 10
M = 10

605-014-00-6

chloral hydrate;
2,2,2-trichloroethane-1,1-diol

206-117-5

302-17-0

Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2

H301
H319
H315

GHS06
Gef.

H301
H319
H315

605-015-00-1

1,1-diethoxyethane;
acetal

203-310-6

105-57-7

Flam. Liq. 2
Eye Irrit. 2
Skin Irrit. 2

H225
H319
H315

GHS02
GHS07
Gef.

H225
H319
H315

605-016-00-7

glyoxal...%;
ethandial...%

203-474-9

107-22-2

Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H341
H332
H319
H315
H317

GHS07
GHS08
Achtg.

H341
H332
H319
H315
H317

605-017-00-2

1,3-dioxolane

211-463-5

646-06-0

Flam. Liq. 2

H225

GHS02
Gef.

H225

605-018-00-8

propanal;
propionaldehyde

204-623-0

123-38-6

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H225
H319
H335
H315

GHS02
GHS07
Gef.

H225
H319
H335
H315

605-019-00-3

citral

226-394-6

5392-40-5

Skin Irrit. 2
Skin Sens. 1

H315
H317

GHS07
Achtg.

H315
H317

605-020-00-9

safrole;
5-allyl-1,3-benzodioxole

202-345-4

94-59-7

Carc. 1B
Muta. 2
Acute Tox. 4 *

H350
H341
H302

GHS08
GHS07
Gef.

H350
H341
H302

605-021-00-4

formaldehyde, reaction products with butylphenol

294-145-9

91673-30-2

Skin Sens. 1

H317

GHS07
Achtg.

H317

605-022-00-X

Glutaral; Glutaraldehyd;
1,5-Pentandial

203-856-5

111-30-8

Acute Tox. 2
Acute Tox. 3
STOT SE 3
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1 a
Aquatic Acute 1
Aquatic Chronic 2

H330
H301
H335
H314
H334
H317
H400
H411

GHS06
GHS05
GHS08
GHS09
Gef.

H330
H301
H335
H314
H334
H317
H410

EUH071

STOT SE 3; H335: 0,5 % ≤ C < 5 %
M = 1

605-023-00-5

5-Chlor-2-(4-chlorphenoxy)phenol;
[DCPP]

429-290-0

3380-30-1

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

M = 10
M = 10

605-024-00-0

2-bromo-5-hydroxy-4-methoxybenzaldehyde

426-540-0

2973-59-3

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

605-025-00-6

chloroacetaldehyde

203-472-8

107-20-0

Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1

H351
H330
H311
H301
H314
H400

GHS06
GHS08
GHS05
GHS09
Gef.

H351
H330
H311
H301
H314
H400

STOT SE 3; H335: C> 5 %

605-026-00-1

2,5,7,7-tetramethyloctanal

405-690-0

114119-97-0

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H315
H317
H411

GHS07 GHS09
Achtg.

H315
H317
H411

605-027-00-7

reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;
3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde

410-480-7

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

605-028-00-2

ß-methyl-3-(1-methylethyl)-benzenepropanal

412-050-4

125109-85-5

Aquatic Chronic 2

H411

GHS09

H411

605-029-00-8

2-cyclohexylpropanal

412-270-0

2109-22-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

605-030-00-3

1-(p-methoxyphenyl)acetaldehyde oxime

411-510-1

3353-51-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

605-031-00-9

reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate;
water(Including free water and water in hydrated 2,2-dimethoxyethanal)]

421-890-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

605-032-00-4

3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal

425-370-4

93957-50-7

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

605-033-00-X

reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;
3,7,11-trimethyl-trans-6,10-dodecadienal

425-910-9

32480-08-3

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

605-034-00-5

reaction mass of: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;
(1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde

429-860-9

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

605-035-00-0

(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal

426-330-9

177964-68-0

Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 4

H319
H317
H413

GHS07
Achtg.

H319
H317
H413

605-036-00-6

2-bromomalonaldehyde

430-470-6

2065-75-0

Acute Tox. 4 *
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

605-037-00-1

trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde

421-800-1

120578-03-2

Aquatic Chronic 4

H413

605-038-00-7

3-methyl-5-phenylpentan-1-al

433-900-0

55066-49-4

Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H302
H315
H317
H411

GHS07
GHS09
Achtg.

H302
H315
H317
H411

605-039-00-2

3,4-dihydroxy-5-nitrobenzaldehyde

441-810-8

116313-85-0

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1

H302
H318
H317

GHS05
GHS07
Gef.

H302
H318
H317

605-040-00-8

Hydroxyisohexyl-3-cyclohexencarboxaldehyd (INCI); Reaktionsmasse von 4-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd und 3-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [1]
4-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [2]
3-(4-Hydroxy-4-methylpentyl)cyclohex-3-en-1-carbaldehyd; [3]

- [1]
250-863-4 [2]
257-187-9 [3]

130066-44-3 [1]
31906-04-4 [2]
51414-25-6 [3]

Skin Sens. 1 A

H317

GHS07
Achtg.

H317

606-001-00-8

acetone;
propan-2-one;
propanone

200-662-2

67-64-1

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3

H225
H319
H336

GHS02
GHS07
Gef.

H225
H319
H336

EUH066

606-002-00-3

butanone;
ethyl methyl ketone

201-159-0

78-93-3

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3

H225
H319
H336

GHS02
GHS07
Gef.

H225
H319
H336

EUH066

606-003-00-9

heptan-3-one;
butyl ethyl ketone

203-388-1

106-35-4

Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2

H226
H332
H319

GHS02
GHS07
Achtg.

H226
H332
H319

606-004-00-4

4-methylpentan-2-one;
isobutyl methyl ketone

203-550-1

108-10-1

Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3

H225
H332
H319
H335

GHS02
GHS07
Gef.

H225
H332
H319
H335

EUH066

606-005-00-X

2,6-dimethylheptan-4-one;
di-isobutyl ketone

203-620-1

108-83-8

Flam. Liq. 3
STOT SE 3

H226
H335

GHS02
GHS07
Achtg.

H226
H335

STOT SE 3; H335: C> 10 %

606-006-00-5

pentan-3-one;
diethyl ketone

202-490-3

96-22-0

Flam. Liq. 2
STOT SE 3
STOT SE 3

H225
H335
H336

GHS02
GHS07
Gef.

H225
H335
H336

EUH066

606-007-00-0

3-methylbutan-2-one;
methyl isopropyl ketone

209-264-3

563-80-4

Flam. Liq. 2

H225

GHS02
Gef.

H225

606-009-00-1

4-methylpent-3-en-2-one;
mesityl oxide

205-502-5

141-79-7

Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H226
H332
H312
H302

GHS02
GHS07
Achtg.

H226
H332
H312
H302

606-010-00-7

cyclohexanone

203-631-1

108-94-1

Flam. Liq. 3
Acute Tox. 4 *

H226
H332

GHS02
GHS07
Achtg.

H226
H332

606-011-00-2

2-methylcyclohexanone

209-513-6

583-60-8

Flam. Liq. 3
Acute Tox. 4 *

H226
H332

GHS02
GHS07
Achtg.

H226
H332

606-012-00-8

3,5,5-trimethylcyclohex-2-enone;
isophorone

201-126-0

78-59-1

Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3

H351
H312
H302
H319
H335

GHS08
GHS07
Achtg.

H351
H312
H302
H319
H335

STOT SE 3; H335: C> 10 %

606-013-00-3

p-benzoquinone;
quinone

203-405-2

106-51-4

Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1

H331
H301
H319
H335
H315
H400

GHS06
GHS09
Gef.

H331
H301
H319
H335
H315
H400

M=10

606-014-00-9

Chlorphacinon (ISO);
2-[(4-Chlorphenyl)(phenyl)acetyl]-1H-inden-1,3(2H)-dion

223-003-0

3691-35-8

Repr. 1B
Acute Tox. 1
Acute Tox. 1
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H360D
H330
H310
H300
H372 (Blut)
H400
H410

GHS08
GHS06
GHS09
Gef.

H360D
H330
H310
H300
H372 (Blut)
H410

Repr. 1B; H360D:
C> 0,003 %
STOT RE 1; H372 (Blut): C> 0,1 %
STOT RE 2; H373 (Blut):
0,01 % ≤ C < 0,1 %
M = 1
M = 1

606-016-00-X

pindone (ISO);
2-pivaloylindan-1,3-dione

201-462-8

83-26-1

Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H372 **
H400
H410

GHS06
GHS08
GHS09
Gef.

H301
H372 **
H410

606-017-00-5

diketene;
diketen

211-617-1

674-82-8

Flam. Liq. 3
Acute Tox. 4 *

H226
H332

GHS02
GHS07
Achtg.

H226
H332

606-018-00-0

dichlone (ISO);
2,3-dichloro-1,4-naphthoquinone

204-210-5

117-80-6

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H315
H410

606-019-00-6

chlordecone (ISO);
perchloropentacyclo[5,3,0,0^2,6,0^3,9,0^4,8]decan-5-one;
decachloropentacyclo[5,2,1,0^2,6,0^3,9,0^5,8]decan-4-one

205-601-3

143-50-0

Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H311
H301
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H311
H301
H410

606-020-00-1

5-methylheptan-3-one

208-793-7

541-85-5

Flam. Liq. 3
Eye Irrit. 2
STOT SE 3

H226
H319
H335

GHS02
GHS07
Achtg.

H226
H319
H335

STOT SE 3; H335: C> 10 %

606-021-00-7

N-Methyl-2-pyrrolidon; 1-Methyl-2-pyrrolidon

212-828-1

872-50-4

Repr. 1B
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2

H360D***
H335
H315
H319

GHS08
GHS07
Gef.

H360D***
H335
H315
H319

STOT SE 3; H335: C> 10 %

606-022-00-2

1-phenyl-3-pyrazolidone

202-155-1

92-43-3

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

606-023-00-8

4-methoxy-4-methylpentan-2-one

203-512-4

107-70-0

Flam. Liq. 3
Acute Tox. 4 ((*))

H226
H332

GHS02
GHS07
Achtg.

H226
H332

606-024-00-3

heptan-2-one;
methyl amyl ketone

203-767-1

110-43-0

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H226
H332
H302

GHS02
GHS07
Achtg.

H226
H332
H302

606-025-00-9

cyclopentanone

204-435-9

120-92-3

Flam. Liq. 3
Eye Irrit. 2
Skin Irrit. 2

H226
H319
H315

GHS02
GHS07
Achtg.

H226
H319
H315

606-026-00-4

5-methylhexan-2-one;
isoamyl methyl ketone

203-737-8

110-12-3

Flam. Liq. 3
Acute Tox. 4 (*)

H226
H332

GHS02
GHS07
Achtg.

H226
H332

606-027-00-X

heptan-4-one;
di-n-propyl ketone

204-608-9

123-19-3

Flam. Liq. 3
Acute Tox. 4 (*)

H226
H332

GHS02
GHS07
Achtg.

H226
H332

606-028-00-5

2,4-dimethylpentan-3-one;
di-isopropyl ketone

209-294-7

565-80-0

Flam. Liq. 2
Acute Tox. 4 (*)

H225
H332

GHS02
GHS07
Gef.

H225
H332

606-029-00-0

pentane-2,4-dione;
acetylacetone

204-634-0

123-54-6

Flam. Liq. 3
Acute Tox. 4 (*)

H226
H302

GHS02
GHS07
Achtg.

H226
H302

606-030-00-6

hexan-2-one;
methyl butyl ketone;
butyl methyl ketone;
methyl-n-butyl ketone

209-731-1

591-78-6

Flam. Liq. 3
Repr. 2
STOT RE 1
STOT SE 3

H226
H361f (*)(*)(*)
H372 (*)(*)
H336

GHS02
GHS08
GHS07
Gef.

H226
H361f (*)(*)(*)
H372 (*)(*)
H336

606-031-00-1

3-propanolide;
1,3-propiolactone

200-340-1

57-57-8

Carc. 1B
Acute Tox. 2 (*)
Eye Irrit. 2
Skin Irrit. 2

H350
H330
H319
H315

GHS06
GHS08
Gef.

H350
H330
H319
H315

606-032-00-7

hexachloroacetone

204-129-5

116-16-5

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

606-033-00-2

2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;
methazole

243-761-6

20354-26-1

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H312
H302
H319
H315
H411

GHS07
GHS09
Achtg.

H312
H302
H319
H315
H411

606-034-00-8

metribuzin (ISO);
4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;
4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one

244-209-7

21087-64-9

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M=10

606-035-00-3

chloridazon (ISO);
5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;
pyrazon

216-920-2

1698-60-8

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

606-036-00-9

quinomethionate;
chinomethionat (ISO);
6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one

219-455-3

2439-01-2

Repr. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361f (*)(*)(*)
H332
H312
H302
H373 (*)(*)
H319
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361f (*)(*)(*)
H332
H312
H302
H373 (*)(*)
H319
H317
H410

606-037-00-4

triadimefon (ISO);
1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone

256-103-8

43121-43-3

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

606-038-00-X

diphacinone (ISO);
2-diphenylacetylindan-1,3-dione

201-434-5

82-66-6

Acute Tox. 2 (*)
STOT RE 1

H300
H372 (*)(*)

GHS06
GHS08
Gef.

H300
H372 (*)(*)

606-039-00-5

5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one

400-680-2

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H332
H400
H410

GHS07
GHS09
Achtg.

H332
H410

606-040-00-0

(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride

401-840-4

55845-90-4

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

606-041-00-6

2-Methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-on

400-600-6

71868-10-5

Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2

H360FD
H302
H411

GHS08
GHS07
GHS09
Gef.

H360FD
H302
H411“

606-042-00-1

acetophenone

202-708-7

98-86-2

Acute Tox. 4 (*)
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

606-043-00-7

2,4-di-tert-butylcyclohexanone

405-340-7

13019-04-0

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

606-044-00-2

2,4,6-trimethylbenzophenone

403-150-9

954-16-5

Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H410

606-045-00-8

oxadiazon (ISO);
3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one

243-215-7

19666-30-9

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-046-00-3

reaction mass ofcis- andtrans-cyclohexadec-8-en-1-one

401-700-2

3100-36-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-047-00-9

2-benzyl-2-dimethylamino-4-morpholinobutyrophenone

404-360-3

119313-12-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-048-00-4

2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one

406-480-1

Aquatic Chronic 4

H413

606-049-00-X

4-(trans-4-propylcyclohexyl)acetophenone

406-700-6

78531-61-0

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

606-050-00-5

6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione

412-480-2

72453-58-8

Aquatic Chronic 2

H411

GHS09

H411

606-051-00-0

4-pentylcyclohexanone

406-670-4

61203-83-6

Aquatic Chronic 2

H411

GHS09

H411

606-052-00-6

4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone

410-410-5

54574-82-2

Aquatic Chronic 3

H412

606-053-00-1

flurtamone (ISO);
(RS)-5-methylamino-2-phenyl-4-(a, a,a-trifluoro-m-tolyl)furan-3(2H)-one

96525-23-4

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-054-00-7

Isoxaflutol (ISO); 5-Cyclopropyl-1,2-oxazol-4-yl a,a,a-trifluor-2-mesyl-p-tolyl keton

141112-29-0

Repr. 2
Aquatic Acute 1
Aquatic Chronic 1

H361d***
H400
H410

GHS08
GHS09
Achtg.

H361d***
H410

M = 10
M = 100

606-055-00-2

1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone

411-180-9

92836-10-7

Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H302
H373 (*)(*)
H411

GHS08
GHS07
GHS09
Achtg.

H302
H373 (*)(*)
H411

606-056-00-8

4-chloro-3',4'-dimethoxybenzophenone

404-610-1

116412-83-0

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-057-00-3

4-propylcyclohexanone

406-810-4

40649-36-3

Skin Irrit. 2
Aquatic Chronic 3

H315
H412

GHS07
Achtg.

H315
H412

606-058-00-9

4'-fluoro-2,2-dimethoxyacetophenone

407-500-1

21983-80-2

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

606-059-00-4

2,4-difluoro-a-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride

412-390-3

86386-75-6

Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1

H302
H318
H317

GHS05
GHS07
Gef.

H302
H318
H317

606-060-00-X

reaction mass of:trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;
cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane

412-950-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-061-00-5

(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone

423-290-4

66938-41-8

Muta. 2
Aquatic Acute 1
Aquatic Chronic 1

H341
H400
H410

GHS08
GHS09
Achtg.

H341
H410

606-062-00-0

tetrahydrothiopyran-3-carboxaldehyde

407-330-8

61571-06-0

Repr. 1B
Eye Dam. 1
Aquatic Chronic 3

H360D (*)(*)(*)
H318
H412

GHS08
GHS05
Gef.

H360D (*)(*)(*)
H318
H412

606-063-00-6

(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal

410-980-5

112704-51-5

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

606-064-00-1

pregn-5-ene-3,20-dione bis(ethylene ketal)

407-450-0

7093-55-2

Aquatic Chronic 4

H413

606-065-00-7

1-(4-morpholinophenyl)butan-1-one

413-790-0

Aquatic Chronic 2

H411

GHS09

H411

606-066-00-2

(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone

410-440-9

164058-20-2

Aquatic Chronic 2

H411

GHS09

H411

606-067-00-8

reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;
1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone

414-870-8

96792-67-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-068-00-3

2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al

415-770-7

1638-05-7

STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 3

H373 (*)(*)
H317
H412

GHS08
GHS07
Achtg.

H373 (*)(*)
H317
H412

606-069-00-9

spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]

415-460-1

154171-76-3

Aquatic Chronic 2

H411

GHS09

H411

606-070-00-4

butroxydim (ISO);
5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one

414-790-3

138164-12-2

Repr. 2
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H361fd
H302
H315
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361fd
H302
H315
H410

606-071-00-X

17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one

421-050-3

13258-43-0

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-072-00-5

3-acetyl-1-phenyl-pyrrolidine-2,4-dione

421-600-2

719-86-8

STOT RE 2 (*)
Aquatic Chronic 2

H373 (*)(*)
H411

GHS08
GHS09
Achtg.

H373 (*)(*)
H411

606-073-00-0

4,4'-bis(dimethylamino)benzophenone;
Michler's ketone

202-027-5

90-94-8

Carc. 1B
Muta. 2
Eye Dam. 1

H350
H341
H318

GHS08
GHS05
Gef.

H350
H341
H318

606-074-00-6

reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;
(2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene

425-570-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-075-00-1

1-benzyl-5-ethoxyimidazolidine-2,4-dione

417-340-4

65855-02-9

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

606-076-00-7

1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione

418-630-3

136465-99-1

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

606-077-00-2

(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone

418-650-2

104872-06-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-078-00-8

1-octylazepin-2-one

420-040-6

59227-88-2

Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H314
H317
H411

GHS05
GHS07
GHS09
Gef.

H314
H317
H411

606-079-00-3

2-n-butyl-benzo[d]isothiazol-3-one

420-590-7

4299-07-4

Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H317
H410

606-081-00-4

(3ß, 5a, 6ß)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one

419-790-7

4229-69-0

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

606-082-00-X

reaction mass of: butan-2-one oxime;
syn-O,O'-di(butan-2-one oxime)diethoxysilane

406-930-7

STOT RE 1
Skin Sens. 1
Aquatic Chronic 3

H372 (*)(*)
H317
H412

GHS08
GHS07
Gef.

H372 (*)(*)
H317
H412

606-083-00-5

2-chloro-5-sec-hexadecylhydroquinone

407-750-1

137193-60-3

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H319
H315
H317
H412

GHS07
Achtg.

H319
H315
H317
H412

606-084-00-0

1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione

414-540-3

484-33-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-085-00-6

(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one

418-530-1

79200-56-9

Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1

H302
H318
H317

GHS05
GHS07
Gef.

H302
H318
H317

606-086-00-1

1-(3,3-dimethylcyclohexyl)pent-4-en-1-one

422-330-8

56973-87-6

Aquatic Chronic 2

H411

GHS09

H411

606-087-00-7

6-ethyl-5-fluoro-4(3H)-pyrimidone

422-460-5

137234-87-8

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

606-088-00-2

2,4,4,7-tetramethyl-6-octen-3-one

422-520-0

74338-72-0

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

606-089-00-8

reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;
1,4-diamino-2,3-bis-phenoxyanthraquinone

423-220-2

12223-77-7

Aquatic Chronic 4

H413

606-090-00-3

1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone

430-920-1

73096-98-7

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

606-091-00-9

6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one

421-320-0

118289-55-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-092-00-4

reaction mass of: (E)-oxacyclohexadec-12-en-2-one;
(E)-oxacyclohexadec-13-en-2-one;
a)(Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one

422-320-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-093-00-X

5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one

414-470-3

95885-13-5

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

606-094-00-5

N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one

417-460-7

Aquatic Chronic 4

H413

606-095-00-0

(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one

421-830-3

49805-30-3

Acute Tox. 4 *
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

606-096-00-6

3-(6-O-(6-desoxy-a-l-mannopyranosyl-O-(a-d-glucopyranosyl)-(ß-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one

424-170-4

130603-71-3

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

606-097-00-1

2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone

424-210-0

23911-85-5

Aquatic Chronic 4

H413

606-098-00-7

1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione

431-220-9

158574-65-3

Aquatic Chronic 4

H413

606-099-00-2

5-methoxy-4'-(trifluoromethyl)valerophenone

425-000-1

61718-80-7

Aquatic Chronic 2

H411

GHS09

H411

606-100-00-6

2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one

425-150-8

94723-86-1

Repr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3

H360F***
H302
H317
H412

GHS08
GHS07
Gef.

H360F***
H302
H317
H412

606-101-00-1

reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;
1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione;
1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione

426-050-7

165038-51-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

606-102-00-7

4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone

431-490-8

79876-59-8

Aquatic Chronic 2

H411

GHS09

H411

606-103-00-2

1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone

426-460-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

606-104-00-8

1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone

426-830-7

78531-59-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

606-105-00-3

3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione

431-500-0

226065-73-2

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

606-106-00-9

1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone

427-320-7

83626-30-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

606-107-00-4

8-azaspiro[4.5]decane-7,9-dione

427-770-4

1075-89-4

Acute Tox. 3 *
Aquatic Chronic 2

H301
H411

GHS06
GHS09
Gef.

H301
H411

606-108-00-X

1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone

436-710-6

756-13-8

Aquatic Chronic 3

H412

606-109-00-5

2-(4-methyl-3-pentenyl)anthraquinone

428-320-1

71308-16-2

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 4

H302
H317
H413

GHS07
Achtg.

H302
H317
H413

606-110-00-0

5-ethoxy-5H-furan-2-one

428-330-4

2833-30-9

Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1

H314
H312
H302
H373**
H317

GHS05
GHS08
GHS07
Gef.

H314
H312
H302
H373**
H317

606-111-00-6

5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one

428-410-9

67014-36-2

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

606-112-00-1

(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one

428-690-2

1668-86-6

Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3

H302
H319
H412

GHS07
Achtg.

H302
H319
H412

606-113-00-7

1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one

429-040-0

272460-97-6

Eye Dam. 1
Aquatic Chronic 4

H318
H413

GHS05
Gef.

H318
H413

606-114-00-2

4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone

429-150-9

67887-47-2

Aquatic Chronic 4

H413

606-115-00-8

profoxydim (ISO);
2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one

139001-49-3

Carc. 2
Repr. 2
Skin Sens. 1

H351
H361d
H317

GHS08
GHS07
Achtg.

H351
H361d
H317

606-116-00-3

tepraloxydim (ISO);
(RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one

149979-41-9

Carc. 2
Repr. 2

H351
H361fd

GHS08
Achtg.

H351
H361fd

606-117-00-9

2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one

429-460-4

7078-98-0

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

606-118-00-4

N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine

429-640-2

52870-46-9

Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H400
H410

GHS07
GHS09
Achtg.

H319
H410

606-119-00-X

(E)-3-methyl-5-cyclopentadecen-1-one

429-900-5

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

606-120-00-5

2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one

430-170-5

114625-74-0

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

606-121-00-0

(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)

430-460-1

133636-82-5

Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H317
H410

606-122-00-6

3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one

430-820-8

114341-88-7

Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373**
H315
H318
H317
H400
H410

GHS05
GHS08
GHS07
GHS09
Gef.

H302
H373**
H315
H318
H317
H410

606-123-00-1

4-hexadecyl-1-phenylpyrazolidin-3-one

430-840-7

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

606-124-00-7

1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione

421-080-7

161462-35-7

STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H373**
H400
H410

GHS08
GHS09
Achtg.

H373**
H410

606-125-00-2

1-benzylimidazolidine-2,4-dione

421-340-1

6777-05-5

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

606-126-00-8

1,4-bis(2,3-dihydroxypropylamino)anthraquinone

421-470-7

99788-75-7

Aquatic Chronic 2

H411

GHS09

H411

606-128-00-9

2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione

422-650-8

148935-94-8

Aquatic Chronic 4

H413

606-129-00-4

5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;
(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one

423-090-7

156732-13-7

Aquatic Chronic 4

H413

606-130-00-X

4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone

423-860-2

56309-94-5

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

606-131-00-5

cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione

427-230-8

5571-36-8

Repr. 1B
STOT RE 2 *
Aquatic Chronic 2

H360F***
H373**
H411

GHS08
GHS09
Gef.

H360F***
H373**
H411

606-132-00-0

(6ß)-6,19-epoxyandrost-4-ene-3,17-dione

433-490-3

6563-83-3

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

606-134-00-1

androsta-1,4,9(11)-triene-3,17-dione

433-560-3

15375-21-0

Repr. 2

H361f***

GHS08
Achtg.

H361f***

606-135-00-7

cyclohexadecanone

438-930-8

2550-52-9

Aquatic Chronic 4

H413

606-136-00-2

(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone

444-350-6

133413-70-4

Eye Irrit. 2
Aquatic Chronic 4

H319
H413

GHS07
Achtg.

H319
H413

606-137-00-8

trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione

444-750-0

211387-26-7

Aquatic Chronic 4

H413

606-138-00-3

(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone

444-800-1

141645-23-0

Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H226
H302
H373**
H315
H318
H317
H400
H410

GHS02
GHS05
GHS08
GHS07
GHS09
Gef.

H226
H302
H373**
H315
H318
H317
H410

M=10

606-139-00-9

(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one

444-830-5

124379-29-9

Aquatic Chronic 4

H413

606-140-00-4

2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one

444-860-9

474510-57-1

STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H373**
H400
H410

GHS08
GHS09
Achtg.

H373**
H410

606-141-00-X

sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate

418-410-7

Eye Irrit. 2

H319

GHS07
Achtg.

H319

606-142-00-5

reaction mass of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(^2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(^2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(^2,7)]undecan-4-one

434-290-9

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

606-143-00-0

abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]

_ [1]

71751-41-2 [1]

Repr. 2
Acute Tox. 2
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H361d
H300
H330
H372 (Nervensystem)
H400
H410

GHS06
GHS08
GHS09
Gef.

H361d
H300
H330
H372 (Nervensystem)
H410

STOT RE 1;
H372: C> 5 %
STOT RE 2;
H373: 0,5 % ≤ C < 5 %
M = 10 000

avermectin B1a (purity> 80 %); [2]

265-610-3 [2]

65195-55-3 [2]

606-144-00-6

acequinocyl (ISO);
3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate

57960-19-7

Skin Sens. 1
STOT SE 1
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H317
H370 (Lunge)
(Einatmung)
H373 (Blutkreislauf)
H400
H410

GHS07
GHS08
GHS09
Gef.

H317
H370 (Lunge)
(Einatmung)
H373 (Blutkreislauf)
H410

M = 1 000

606-145-00-1

sulcotrione (ISO);
2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

99105-77-8

Repr. 2

H361d

GHS08

H361d

M = 1
M = 10

STOT RE 2

H373 (Nieren)

GHS07

H373 (Nieren)

Skin Sens. 1A

H317

HS09

H317

Aquatic Acute 1

H400

Achtg.

Aquatic Chronic 1

H410

606-146-00-7

tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one

87820-88-0

Carc. 2
Acute Tox. 4
Aquatic Chronic 2

H351
H302
H411

GHS08
GHS07
GHS09
Achtg.

H351
H302
H411

606-147-00-2

cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one

405-230-9

101205-02-1

Repr. 2

H361d

GHS08
Achtg.

H361d

606-148-00-8

Carvon (ISO);
2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [1]
d-Carvon; (5S)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on; [2]
l-Carvon; (5R)-2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-on [3]

202-759-5 [1]
218-827-2 [2]
229-352-5 [3]

99-49-0 [1]
2244-16-8 [2]
6485-40-1 [3]

Skin Sens. 1

H317

GHS07
Achtg.

H317

606-149-00-3

Tembotrion (ISO); 2-{2-Chlor-4-(methylsulfonyl)-3-[(2,2,2-trifluorethoxy)methyl]benzoyl}cyclohexan-1,3-dion

335104-84-2

Repr. 2
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d
H373 (Augen, Nieren, Leber)
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361d
H373 (Augen, Nieren, Leber)
H317
H410

M = 100
M = 10

606-150-00-9

Clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-Chlorallyloxyimino]propyl}-5-[(2RS)- 2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-on

99129-21-2

Acute Tox. 4
Skin Sens. 1
Aquatic Chronic 3

H302
H317
H412

GHS07
Achtg.

H302
H317
H412

EUH066

606-151-00-4

Anthrachinon

201-549-0

84-65-1

Carc. 1B

H350

GHS08
Gef.

H350

607-001-00-0

formic acid ... %

200-579-1

64-18-6

Skin Corr. 1A

H314

GHS05 Gef.

H314

Skin Corr. 1A; H314: C> 90 %
Skin Corr. 1B; H314: 10 % ≤ C < 90 %
Skin Irrit. 2; H315: 2 % ≤ C < 10 %
Eye Irrit. 2; H319: 2 % ≤ C < 10 %

607-002-00-6

acetic acid ... %

200-580-7

64-19-7

Flam. Liq. 3
Skin Corr. 1A

H226
H314

GHS02
GHS05 Gef.

H226
H314

Skin Corr. 1A; H314: C> 90 %
Skin Corr. 1B; H314: 25 % ≤ C < 90 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %

607-003-00-1

chloroacetic acid

201-178-4

79-11-8

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1

H331
H311
H301
H314
H400

GHS06
GHS05
GHS09
Gef.

H331
H311
H301
H314
H400

STOT SE 3; H335: C> 5 %

607-004-00-7

TCa (ISO);
trichloroacetic acid

200-927-2

76-03-9

Skin Corr. 1a
Aquatic Acute 1
Aquatic Chronic 1

H314
H400
H410

GHS05
GHS09
Gef.

H314
H410

STOT SE 3; H335: C> 1 %

607-005-00-2

TCA-sodium (ISO);
sodium trichloroacetate

211-479-2

650-51-1

STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H335
H400
H410

GHS07
GHS09
Achtg.

H335
H410

607-006-00-8

oxalic acid

205-634-3

144-62-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)

H312
H302

GHS07
Achtg.

H312
H302

(*)

607-007-00-3

salts of oxalic acid with the exception of those specified elsewhere in this Annex

Acute Tox. 4 *
Acute Tox. 4 *

H312
H302

GHS07
Achtg.

H312
H302

607-008-00-9

acetic anhydride

203-564-8

108-24-7

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H226
H332
H302
H314

GHS02
GHS05
GHS07
Gef.

H226
H332
H302
H314

Skin Corr. 1B; H314: C> 25 %
Skin Irrit. 2; H315: 5 % ≤ C < 25 %
Eye Dam. 1; H318: 5 % ≤ C < 25 %
Eye Irrit. 2; H319: 1 % ≤ C < 5 %
STOT SE 3; H335: C> 5 %

607-009-00-4

phthalic anhydride

201-607-5

85-44-9

Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H302
H335
H315
H318
H334
H317

GHS08
GHS05
GHS07
Gef.

H302
H335
H315
H318
H334
H317

607-010-00-X

propionic anhydride

204-638-2

123-62-6

Skin Corr. 1B

H314

GHS05
Gef.

H314

Skin Corr. 1B; H314: C> 25 %
Skin Irrit. 2; H315: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %

607-011-00-5

acetyl chloride

200-865-6

75-36-5

Flam. Liq. 2
Skin Corr. 1B

H225
H314

GHS02
GHS05
Gef.

H225
H314

EUH014

607-012-00-0

benzoyl chloride

202-710-8

98-88-4

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1

H332
H312
H302
H314
H317

GHS05
GHS07
Gef.

H332
H312
H302
H314
H317

607-013-00-6

dimethyl carbonate

210-478-4

616-38-6

Flam. Liq. 2

H225

GHS02
Gef.

H225

607-014-00-1

methyl formate

203-481-7

107-31-3

Flam. Liq. 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3

H224
H332
H302
H319
H335

GHS02
GHS07
Gef.

H224
H332
H302
H319
H335

607-015-00-7

ethyl formate

203-721-0

109-94-4

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3

H225
H332
H302
H319
H335

GHS02
GHS07
Gef.

H225
H332
H302
H319
H335

607-016-00-2

propyl formate; [1]
isopropyl formate [2]

203-798-0 [1]
210-901-2 [2]

110-74-7 [1]
625-55-8 [2]

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
STOT SE 3

H225
H319
H335
H336

GHS02
GHS07
Gef.

H225
H319
H335
H336

607-017-00-8

butyl formate; [1]
tert-butyl formate; [2]
isobutyl formate [3]

209-772-5 [1]
212-105-0 [2]
208-818-1 [3]

592-84-7 [1]
762-75-4 [2]
542-55-2 [3]

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3

H225
H319
H335

GHS02
GHS07
Gef.

H225
H319
H335

607-018-00-3

isopentyl formate; [1]
2-methylbutyl formate [2]

203-769-2 [1]
252-343-2 [2]

110-45-2 [1]
35073-27-9 [2]

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3

H225
H319
H335

GHS02
GHS07
Gef.

H225
H319
H335

607-019-00-9

methyl chloroformate

201-187-3

79-22-1

Flam. Liq. 2
Acute Tox. 2 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H225
H330
H312
H302
H314

GHS02
GHS06
GHS05
Gef.

H225
H330
H312
H302
H314

607-020-00-4

ethyl chloroformate

208-778-5

541-41-3

Flam. Liq. 2
Acute Tox. 2 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H225
H330
H302
H314

GHS02
GHS06
GHS05
Gef.

H225
H330
H302
H314

607-021-00-X

methyl acetate

201-185-2

79-20-9

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3

H225
H319
H336

GHS02
GHS07
Gef.

H225
H319
H336

EUH066

607-022-00-5

ethyl acetate

205-500-4

141-78-6

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3

H225
H319
H336

GHS02
GHS07
Gef.

H225
H319
H336

EUH066

607-023-00-0

vinyl acetate

203-545-4

108-05-4

Flam. Liq. 2

H225

GHS02

H225

Carc. 2

H351

GHS08

H351

Acute Tox. 4

H332

GHS07

H332

STOT SE 3

H335

Gef.

H335

607-024-00-6

propyl acetate; [1]
isopropyl acetate [2]

203-686-1 [1]
203-561-1 [2]

109-60-4 [1]
108-21-4 [2]

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3

H225
H319
H336

GHS02
GHS07
Gef.

H225
H319
H336

EUH066

607-025-00-1

n-butyl acetate

204-658-1

123-86-4

Flam. Liq. 3
STOT SE 3

H226
H336

GHS02
GHS07
Achtg.

H226
H336

EUH066

607-026-00-7

sec-butyl acetate; [1]
isobutyl acetate; [2]
tert-butyl acetate [3]

203-300-1 [1]
203-745-1 [2]
208-760-7 [3]

105-46-4 [1]
110-19-0 [2]
540-88-5 [3]

Flam. Liq. 2

H225

GHS02
Gef.

H225

EUH066

607-027-00-2

methyl propionate

209-060-4

554-12-1

Flam. Liq. 2
Acute Tox. 4 (*)

H225
H332

GHS02
GHS07
Gef.

H225
H332

607-028-00-8

ethyl propionate

203-291-4

105-37-3

Flam. Liq. 2

H225

GHS02
Gef.

H225

607-029-00-3

n-butyl propionate; [1]
sec-butyl propionate; [2]
iso-butyl propionate [3]

209-669-5 [1]
[2]
208-746-0 [3]

590-01-2 [1]
591-34-4 [2]
540-42-1 [3]

Flam. Liq. 3

H226

GHS02
Achtg.

H226

607-030-00-9

propyl propionate

203-389-7

106-36-5

Flam. Liq. 3
Acute Tox. 4 (*)

H226
H332

GHS02
GHS07
Achtg.

H226
H332

607-031-00-4

butyl butyrate

203-656-8

109-21-7

Flam. Liq. 3

H226

GHS02
Achtg.

H226

607-032-00-X

ethyl acrylate

205-438-8

140-88-5

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H225
H332
H312
H302
H319
H335
H315
H317

GHS02
GHS07
Gef.

H225
H332
H312
H302
H319
H335
H315
H317

Skin Irrit. 2; H315: C> 5 %
Eye Irrit. 2; H319: C> 5 %
STOT SE 3; H335: C> 5 %

607-033-00-5

n-butyl methacrylate

202-615-1

97-88-1

Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H226
H319
H335
H315
H317

GHS02
GHS07
Achtg.

H226
H319
H335
H315
H317

607-034-00-0

methyl acrylate;
methyl propenoate

202-500-6

96-33-3

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H225
H332
H312
H302
H319
H335
H315
H317

GHS02
GHS07
Gef.

H225
H332
H312
H302
H319
H335
H315
H317

607-035-00-6

methyl methacrylate;
methyl 2-methylprop-2-enoate;
methyl 2-methylpropenoate

201-297-1

80-62-6

Flam. Liq. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H225
H335
H315
H317

GHS02
GHS07
Gef.

H225
H335
H315
H317

607-036-00-1

2-methoxyethyl acetate;
methylglycol acetate

203-772-9

110-49-6

Repr. 1B
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H360FD
H332
H312
H302

GHS08
GHS07
Gef.

H360FD
H332
H312
H302

607-037-00-7

2-ethoxyethyl acetate;
ethylglycol acetate

203-839-2

111-15-9

Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H226
H360FD
H332
H312
H302

GHS02
GHS08
GHS07
Gef.

H226
H360FD
H332
H312
H302

607-038-00-2

2-butoxyethyl acetate;
butylglycol acetate

203-933-3

112-07-2

Acute Tox. 4 (*)
Acute Tox. 4 (*)

H332
H312

GHS07
Achtg.

H332
H312

607-039-00-8

2,4-D (ISO);
2,4-dichlorophenoxyacetic acid

202-361-1

94-75-7

Acute Tox. 4 (*)
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H302
H335
H318
H317
H412

GHS05
GHS07
Gef.

H302
H335
H318
H317
H412

607-040-00-3

salts of 2,4-D

Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H317
H411

607-041-00-9

2,4,5-T (ISO);
2,4,5-trichlorophenoxy acetic acid

202-273-3

93-76-5

Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H335
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H335
H315
H410

607-042-00-4

salts and esters of 2,4,5-T;
salts and esters of 2,4,5-trichlorophenoxy acetic acid

Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H335
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H335
H315
H410

607-043-00-X

dicamba (ISO);
2,5-dichloro-6-methoxybenzoic acid;
3,6-dichloro-2-methoxybenzoic acid

217-635-6

1918-00-9

Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

607-044-00-5

3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]
potassium 3,6-dichloro-o-anisate [2]

218-951-7 [1]
233-002-7 [2]

2300-66-5 [1]
10007-85-9 [2]

Eye Irrit. 2
Aquatic Chronic 3

H319
H412

GHS07
Achtg.

H319
H412

607-045-00-0

dichlorprop (ISO);
2-(2,4-dichlorophenoxy) propionic acid

204-390-5

120-36-5

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1

H312
H302
H315
H318

GHS05
GHS07
Gef.

H312
H302
H315
H318

607-046-00-6

salts of dichlorprop

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H332
H312
H302

GHS07
Achtg.

H332
H312
H302

607-047-00-1

fenoprop (ISO);
2-(2,4,5-trichlorophenoxy)propionic acid

202-271-2

93-72-1

Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H315
H410

607-048-00-7

salts of fenoprop;
salts of 2-(2,4,5-trichlorophenoxy)propionic acid

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

607-049-00-2

mecoprop (ISO);
2-(4-chloro-o-tolyloxy) propionic acid;
(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]
2-(4-chloro-2-methylphenoxy)propionic acid [2]

230-386-8 [1]
202-264-4 [2]

7085-19-0 [1]
708519-0 [2]

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H315
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H315
H318
H410

M=100

607-050-00-8

salts of mecoprop

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H315
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H315
H318
H410

607-051-00-3

MCPa (ISO);
4-chloro-o-tolyloxyacetic acid

202-360-6

94-74-6

Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H315
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H315
H318
H410

607-052-00-9

salts and esters of MCPA

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

607-053-00-4

MCPB (ISO);
4-(4-chloro-o-tolyloxy) butyric acid

202-365-3

94-81-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-054-00-X

salts and esters of MCPB

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

607-055-00-5

endothal-sodium (ISO);
disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate

204-959-8

129-67-9

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H301
H312
H319
H335
H315

GHS06
Gef.

H301
H312
H319
H335
H315

607-056-00-0

Warfarin (ISO);
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-on; [1]
(S)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron; [2]
(R)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyron; [3]

201-377-6
[1]
226-907-3
[2]
226-908-9
[3]

81-81-2 [1]
5543-57-7
[2]
5543-58-8
[3]

Repr. 1 a
Acute Tox. 1
Acute Tox. 1
Acute Tox. 2
STOT RE 1
Aquatic Chronic 2

H360D
H330
H310
H300
H372 (Blut)
H411

GHS08
GHS06
GHS09
Gef.

H360D
H330
H310
H300
H372 (Blut)
H411

Repr. 1 A; H360D:
C> 0,003 %
STOT RE 1; H372 (Blut): C> 0,5 %
STOT RE 2; H373 (Blut): 0,05 % ≤ C < 0,5 %

607-057-00-6

coumachlor (ISO);
3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin

201-378-1

81-82-3

STOT RE 2 (*)
Aquatic Chronic 3

H373 (*)(*)
H412

GHS08
Achtg.

H373 (*)(*)
H412

607-058-00-1

coumafuryl (ISO);
fumarin;
(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;
4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin

204-195-5

117-52-2

Acute Tox. 3 (*)
STOT RE 1
Aquatic Chronic 3

H301
H372 (*)(*)
H412

GHS06
GHS08
Gef.

H301
H372 (*)(*)
H412

607-059-00-7

Coumatetralyl (ISO); 4-Hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)cumarin

227-424-0

5836-29-3

Repr. 1B
Acute Tox. 2
Acute Tox. 3
Acute Tox. 2
STOT RE 1
Aquatic Chronic 1

H360D
H330
H311
H300
H372 (Blut)
H410

GHS08
GHS06
GHS09
Gef.

H360D
H330
H311
H300
H372 (Blut)
H410

Repr. 1B; H360D: C> 0,003 %
STOT RE 1; H372 (Blut): C> 1,0 %
STOT RE 2; H373 (Blut) 0,1 % ≤ C < 1,0 %
M = 10

607-060-00-2

dicoumarol;
4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)

200-632-9

66-76-2

STOT RE 1
Acute Tox. 4 (*)
Aquatic Chronic 2

H372 (*)(*)
H302
H411

GHS08
GHS07
GHS09
Gef.

H372 (*)(*)
H302
H411

607-061-00-8

acrylic acid;
prop-2-enoic acid

201-177-9

79-10-7

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1a
Aquatic Acute 1

H226
H332
H312
H302
H314
H400

GHS02
GHS05
GHS07
GHS09
Gef.

H226
H332
H312
H302
H314
H400

STOT SE 3; H335: C> 1 %

607-062-00-3

n-butyl acrylate

205-480-7

141-32-2

Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H226
H319
H335
H315
H317

GHS02
GHS07
Achtg.

H226
H319
H335
H315
H317

607-063-00-9

isobutyric acid

201-195-7

79-31-2

Acute Tox. 4 (*)
Acute Tox. 4 (*)

H312
H302

GHS07
Achtg.

H312
H302

607-064-00-4

benzyl chloroformate

207-925-0

501-53-1

Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H314
H400
H410

GHS05
GHS09
Gef.

H314
H410

STOT SE 3; H335: C> 5 %

607-065-00-X

bromoacetic acid

201-175-8

79-08-3

Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1a
Skin Sens. 1
Aquatic Acute 1

H331
H311
H301
H314
H317
H400

GHS06
GHS05
GHS09
Gef.

H331
H311
H301
H314
H317
H400

607-066-00-5

dichloroacetic acid

201-207-0

79-43-6

Skin Corr. 1a
Aquatic Acute 1

H314
H400

GHS05
GHS09
Gef.

H314
H400

607-067-00-0

dichloroacetyl chloride

201-199-9

79-36-7

Skin Corr. 1a
Aquatic Acute 1

H314
H400

GHS05
GHS09
Gef.

H314
H400

607-068-00-6

iodoacetic acid

200-590-1

64-69-7

Acute Tox. 3 (*)
Skin Corr. 1A

H301
H314

GHS06
GHS05
Gef.

H301
H314

607-069-00-1

ethyl bromoacetate

203-290-9

105-36-2

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)

H330
H310
H300

GHS06
Gef.

H330
H310
H300

607-070-00-7

ethyl chloroacetate

203-294-0

105-39-5

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1

H331
H311
H301
H400

GHS06
GHS09
Gef.

H331
H311
H301
H400

607-071-00-2

ethyl methacrylate

202-597-5

97-63-2

Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H225
H319
H335
H315
H317

GHS02
GHS07
Gef.

H225
H319
H335
H315
H317

607-072-00-8

2-hydroxyethyl acrylate

212-454-9

818-61-1

Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1

H311
H314
H317
H400

GHS06
GHS05
GHS09
Gef.

H311
H314
H317
H400

(*)
Skin Sens. 1; H317: C> 0,2 %

607-073-00-3

4-CPa (ISO);
4-chlorophenoxyacetic acid

204-581-3

122-88-3

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

607-074-00-9

chlorfenac(ISO);
2,3,6-trichlorophenylacetic acid

201-599-3

85-34-7

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-075-00-4

chlorfenprop-methyl;
methyl 2-chloro-3-(4-chlorophenyl)propionate

238-413-5

14437-17-3

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

607-076-00-X

dodine(ISO);
dodecylguanidinium acetate

219-459-5

2439-10-3

Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H315
H410

607-077-00-5

erbon (ISO);
2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate

136-25-4

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-078-00-0

fluenetil (ISO);
2-fluoroethyl biphenyl-4-ylacetate

4301-50-2

Acute Tox. 1
Acute Tox. 2 (*)

H310
H300

GHS06
Gef.

H310
H300

607-079-00-6

kelevan (ISO);
ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,0^2,6,0^3,9,0^4,8]decan-5-yl)-4-oxopentanoate;
ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,0^2,6,0^3,9,0^5,8)dec-4-yl)-4-oxovalerate

4234-79-1

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Chronic 2

H311
H302
H411

GHS06
GHS09
Gef.

H311
H302
H411

607-080-00-1

chloroacetyl chloride

201-171-6

79-04-9

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Skin Corr. 1a
Aquatic Acute 1

H331
H311
H301
H372 (*)(*)
H314
H400

GHS06
GHS08
GHS05
GHS09
Gef.

H331
H311
H301
H372 (*)(*)
H314
H400

EUH014
EUH029

607-081-00-7

fluoroacetic acid

205-631-7

144-49-0

Acute Tox. 2 (*)
Aquatic Acute 1

H300
H400

GHS06
GHS09
Gef.

H300
H400

607-082-00-2

fluoroacetates, soluble

Acute Tox. 2 (*)
Aquatic Acute 1

H300
H400

GHS06
GHS09
Gef.

H300
H400

607-083-00-8

2,4-DB (ISO);
4-(2,4-dichlorophenoxy)butyric acid

202-366-9

94-82-6

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-084-00-3

salts of 2,4-DB

Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

607-085-00-9

benzyl benzoate

204-402-9

120-51-4

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-086-00-4

diallyl phthalate

205-016-3

131-17-9

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

607-088-00-5

methacrylic acid;
2-methylpropenoic acid

201-204-4

79-41-4

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A

H312
H302
H314

GHS05
GHS07
Gef.

H312
H302
H314

STOT SE 3; H335: C> 1 %

607-089-00-0

propionic acid ... %

201-176-3

79-09-4

Skin Corr. 1B

H314

GHS05
Gef.

H314

Skin Corr. 1B; H314: C> 25 %
Skin Irrit. 2; H319: 10 % ≤ C < 25 %
Eye Irrit. 2; H319: 10 % ≤ C < 25 %
STOT SE 3; H335: C> 10 %

607-090-00-6

thioglycolic acid

200-677-4

68-11-1

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B

H331
H311
H301
H314

GHS06
GHS05
Gef.

H331
H311
H301
H314

(*)

607-091-00-1

trifluoroacetic acid . . . %

200-929-3

76-05-1

Acute Tox. 4 (*)

H332

GHS05

H332

Skin Corr. 1a
Aquatic Chronic 3

H314
H412

GHS07
Gef.

H314
H412

607-092-00-7

methyl lactate; [1]
methyl (±)-lactate; [2]
methyl (R)-lactate; [3]
methyl (S)-(-)-lactate [4]

208-930-0 [1]
218-449-8 [2]
241-420-6 [3]
248-704-9 [4]

547-64-8 [1]
2155-30-8 [2]
17392-83-5 [3]
27871-49-4 [4]

Flam. Liq. 3
Eye Irrit. 2
STOT SE 3

H226
H319
H335

GHS02
GHS07
Achtg.

H226
H319
H335

607-093-00-2

propionyl chloride

201-170-0

79-03-8

Flam. Liq. 2
Skin Corr. 1B

H225
H314

GHS02
GHS05
Gef.

H225
H314

EUH014

B D

607-094-00-8

peracetic acid . . . %

201-186-8

79-21-0

Flam. Liq. 3
Org. Perox. D (*)(*)(*)(*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1a
Aquatic Acute 1

H226
H242
H332
H312
H302
H314
H400

GHS02
GHS05
GHS07
GHS09
Gef.

H226
H242
H332
H312
H302
H314
H400

(*)
STOT SE 3; H335: C> 1 %

B D

607-095-00-3

maleic acid

203-742-5

110-16-7

Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H302
H319
H335
H315
H317

GHS07
Achtg.

H302
H319
H335
H315
H317

Skin Sens. 1; H317: C> 0,1 %

607-096-00-9

maleic anhydride

203-571-6

108-31-6

Acute Tox. 4 (*)
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1

H302
H314
H334
H317

GHS08
GHS05
GHS07
Gef.

H302
H314
H334
H317

607-097-00-4

benzene-1,2,4-tricarboxylic acid 1,2-anhydride;
trimellitic anhydride

209-008-0

552-30-7

STOT SE 3
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H335
H318
H334
H317

GHS08
GHS05
GHS07
Gef.

H335
H318
H334
H317

607-098-00-X

benzene-1,2:4,5-tetracarboxylic dianhydride;
benzene-1,2:4,5-tetracarboxylic dianhydride;
pyromellitic dianhydride

201-898-9

89-32-7

Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H318
H334
H317

GHS08
GHS05
Gef.

H318
H334
H317

607-099-00-5

1,2,3,6-tetrahydrophthalic anhydride; [1]
cis-1,2,3,6-tetrahydrophthalic anhydride; [2]
3,4,5,6-tetrahydrophthalic anhydride; [3]
tetrahydrophthalic anhydride [4]

201-605-4 [1]
213-308-7 [2]
219-374-3 [3]
247-570-9 [4]

85-43-8 [1]
935-79-5 [2]
2426-02-0 [3]
26266-63-7 [4]

Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H334
H317
H412

GHS08
GHS05
Gef.

H318
H334
H317
H412

607-100-00-9

benzophenone-3,3',4,4'-tetracarboxylic dianhydride;
4,4'-carbonyldi(phthalic anhydride)

219-348-1

2421-28-5

Eye Irrit. 2
STOT SE 3

H319
H335

GHS07
Achtg.

H319
H335

Eye Irrit. 2; H319: C> 1 %
STOT SE 3; H335: C> 1 %

607-101-00-4

1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride

204-077-3

115-27-5

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H319
H335
H315

GHS07
Achtg.

H319
H335
H315

Skin Irrit. 2; H315: C> 1 %
Eye Irrit. 2; H319: C> 1 %
STOT SE 3; H335: C> 1 %

607-102-00-X

cyclohexane-1,2-dicarboxylic anhydride; [1]
cis-cyclohexane-1,2-dicarboxylic anhydride; [2]
trans-cyclohexane-1,2-dicarboxylic anhydride [3]

201-604-9 [1]
236-086-3 [2]
238-009-9 [3]

85-42-7 [1]
13149-00-3 [2]
14166-21-3 [3]

Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H318
H334
H317

GHS08
GHS05
Gef.

H318
H334
H317

607-103-00-5

succinic anhydride

203-570-0

108-30-5

Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3

H302
H319
H335

GHS07
Achtg.

H302
H319
H335

*
Eye Irrit. 2; H319: C> 1 %
STOT SE 3; H335: C> 1 %

607-104-00-0

cyclopentane-1,2,3,4-tetracarboxylic dianhydride

227-964-7

6053-68-5

Eye Irrit. 2
STOT SE 3

H319
H335

GHS07
Achtg.

H319
H335

Eye Irrit. 2; H319: C> 1 %
STOT SE 3; H335: C> 1 %

607-105-00-6

8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]
1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2]
(1a,2a,3ß,6ß)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3]

204-957-7 [1]
212-557-9 [2]
220-384-5 [3]

129-64-6 [1]
826-62-0 [2]
2746-19-2 [3]

Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H318
H334
H317

GHS08
GHS05
Gef.

H318
H334
H317

607-106-00-1

8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride

123748-85-6

Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H302
H319
H335
H315
H334

GHS08
GHS07
Gef.

H302
H319
H335
H315
H334

STOT SE 3; H335: C> 10 %

607-107-00-7

2-ethylhexyl acrylate

203-080-7

103-11-7

STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H335
H315
H317

GHS07
Achtg.

H335
H315
H317

607-108-00-2

2-hydroxy-1-methylethylacrylate; [1]
2-hydroxypropylacrylate; [2]
acrylic acid, monoester with propane-1,2-diol [3]

220-852-9 [1]
213-663-8 [2]
247-118-0 [3]

2918-23-2 [1]
999-61-1 [2]
25584-83-2 [3]

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1

H331
H311
H301
H314
H317

GHS06
GHS05
Gef.

H331
H311
H301
H314
H317

(*)
Skin Sens. 1; H317: C> 0,2 %

C D

607-109-00-8

hexamethylene diacrylate;
hexane-1,6-diol diacrylate

235-921-9

13048-33-4

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

607-110-00-3

pentaerythritol triacrylate

222-540-8

3524-68-3

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

607-111-00-9

2,2-bis(acryloyloxymethyl)butyl acrylate;
trimethylolpropane triacrylate

239-701-3

15625-89-5

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

607-112-00-4

2,2-dimethyltrimethylene diacrylate;
neopentyl glycol diacrylate

218-741-5

2223-82-7

Acute Tox. 3 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H311
H319
H315
H317

GHS06
Gef.

H311
H319
H315
H317

(*)

607-113-00-X

isobutyl methacrylate

202-613-0

97-86-9

Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H226
H319
H335
H315
H317
H400

GHS02
GHS07
GHS09
Achtg.

H226
H319
H335
H315
H317
H400

607-114-00-5

ethylene dimethacrylate

202-617-2

97-90-5

STOT SE 3
Skin Sens. 1

H335
H317

GHS07
Achtg.

H335
H317

STOT SE 3; H335: C> 10 %

607-115-00-0

isobutyl acrylate

203-417-8

106-63-8

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Skin Sens. 1

H226
H332
H312
H315
H317

GHS02
GHS07
Achtg.

H226
H332
H312
H315
H317

607-116-00-6

cyclohexyl acrylate

221-319-3

3066-71-5

STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2

H335
H315
H411

GHS07
GHS09
Achtg.

H335
H315
H411

STOT SE 3; H335: C> 10 %

607-117-00-1

2,3-epoxypropyl acrylate;
glycidyl acrylate

203-440-3

106-90-1

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1

H331
H311
H301
H314
H317

GHS06
GHS05
Gef.

H331
H311
H301
H314
H317

(*)
Skin Sens. 1; H317: C> 0,2 %

607-118-00-7

1-methyltrimethylene diacrylate;
1,3-butylene glycol diacrylate

243-105-9

19485-03-1

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1

H312
H314
H317

GHS05
GHS07
Gef.

H312
H314
H317

607-119-00-2

tetramethylene diacrylate;
1,4-butyleneglycol diacrylate

213-979-6

1070-70-8

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1

H312
H314
H317

GHS05
GHS07
Gef.

H312
H314
H317

607-120-00-8

2,2'-oxydiethyl diacrylate;
diethylene glycol diacrylate

223-791-6

4074-88-8

Acute Tox. 3 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H311
H319
H315
H317

GHS06
Gef.

H311
H319
H315
H317

(*)
Skin Sens. 1; H317: C> 0,2 %

607-121-00-3

8,9,10-trinorborn-2-yl acrylate

10027-06-2

Acute Tox. 4 (*)
Skin Irrit. 2
Skin Sens. 1

H312
H315
H317

GHS07
Achtg.

H312
H315
H317

607-122-00-9

pentaerythritol tetraacrylate

225-644-1

4986-89-4

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

607-123-00-4

2,3-Epoxypropylmethacrylat;
Glycidylmethacrylat

203-441-9

106-91-2

Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3
Acute Tox. 4
STOT SE 3
STOT RE 1
Eye Dam. 1
Skin Corr. 1C
Skin Sens. 1

H350
H341
H360F
H311
H302
H335
H372 (Atemwege) (Einatmung)
H318
H314
H317

GHS08
GHS06
GHS05
Gef.

H350
H341
H360F
H311
H302
H335
H372 (Atemwege) (Einatmung)
H314
H317

607-124-00-X

2-hydroxyethyl methacrylate

212-782-2

868-77-9

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

607-125-00-5

2-hydroxypropyl methacrylate; [1]
3-hydroxypropyl methacrylate [2]

213-090-3 [1]
220-426-2 [2]

923-26-2 [1]
2761-09-3 [2]

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

C D

607-126-00-0

2,2'-(ethylenedioxy)diethyl diacrylate;
triethylene glycol diacrylate

216-853-9

1680-21-3

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

607-127-00-6

2-diethylaminoethyl methacrylate

203-275-7

105-16-8

Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H332
H319
H315
H317

GHS07
Achtg.

H332
H319
H315
H317

607-128-00-1

2-tert-butylaminoethyl methacrylate

223-228-4

3775-90-4

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

607-129-00-7

ethyl lactate;
ethyl DL-lactate; [1]
ethyl (S)-2-hydroxypropionate;
ethyl L-lactate;
ethyl-(S)-lactate [2]

202-598-0 [1]
211-694-1 [2]

97-64-3 [1]
687-47-8 [2]

Flam. Liq. 3
STOT SE 3
Eye Dam. 1

H226
H335
H318

GHS02
GHS05
GHS07
Gef.

H226
H335
H318

607-130-00-2

pentyl acetate; [1]
isopentyl acetate; [2]
1-methylbutyl acetate; [3]
2-methylbutyl acetat; [4]
2(or 3)-methylbutyl acetate [5]

211-047-3 [1]
204-662-3 [2]
210-946-8 [3]
210-843-8 [4]
282-263-3 [5]

628-63-7 [1]
123-92-2 [2]
626-38-0 [3]
624-41-9 [4]
84145-37-9 [5]

Flam. Liq. 3

H226

GHS02

H226

EUH066

607-131-00-8

isopentyl propionate; [1]
pentyl propionate; [2]
2-methylbutyl propionate [3]

203-322-1 [1]
210-852-7 [2]
219-449-0 [3]

105-68-0 [1]
624-54-4 [2]
2438-20-2 [3]

Flam. Liq. 3

H226

GHS02
Achtg.

H226

607-132-00-3

2-dimethylaminoethyl methacrylate

220-688-8

2867-47-2

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H312
H302
H319
H315
H317

GHS07
Achtg.

H312
H302
H319
H315
H317

607-133-00-9

monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2

H319
H335
H315
H411

GHS07
GHS09
Achtg.

H319
H335
H315
H411

STOT SE 3; H335: C> 10 %

607-134-00-4

monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H319
H335
H315

GHS07
Achtg.

H319
H335
H315

STOT SE 3; H335: C> 10 %

607-135-00-X

butyric acid

203-532-3

107-92-6

Skin Corr. 1B

H314

GHS05
Gef.

H314

607-136-00-5

butyryl chloride

205-498-5

141-75-3

Flam. Liq. 2
Skin Corr. 1B

H225
H314

GHS02
GHS05
Gef.

H225
H314

607-137-00-0

methyl acetoacetate

203-299-8

105-45-3

Eye Irrit. 2

H319

GHS07
Achtg.

H319

607-138-00-6

butyl chloroformate;
chloroformic acid butyl ester

209-750-5

592-34-7

Flam. Liq. 3
Acute Tox. 3 (*)
Skin Corr. 1B

H226
H331
H314

GHS02
GHS06
GHS05
Gef.

H226
H331
H314

607-139-00-1

2-chloropropionic acid

209-952-3

598-78-7

Acute Tox. 4 (*)
Skin Corr. 1A

H302
H314

GHS05
GHS07
Gef.

H302
H314

607-140-00-7

isobutyryl chloride

201-194-1

79-30-1

Flam. Liq. 2
Skin Corr. 1A

H225
H314

GHS02
GHS05
Gef.

H225
H314

607-141-00-2

oxydiethylene bis(chloroformate)

203-430-9

106-75-2

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2

H302
H315
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H315
H318
H411

607-142-00-8

propyl chloroformate;
chloroformic acid propylester;
n-propyl chloroformate

203-687-7

109-61-5

Flam. Liq. 2
Acute Tox. 3 *
Skin Corr. 1B

H225
H331
H314

GHS02
GHS06
GHS05
Gef.

H225
H331
H314

607-143-00-3

valeric acid

203-677-2

109-52-4

Skin Corr. 1B
Aquatic Chronic 3

H314
H412

GHS05
Gef.

H314
H412

607-144-00-9

adipic acid

204-673-3

124-04-9

Eye Irrit. 2

H319

GHS07
Achtg.

H319

607-145-00-4

methanesulphonic acid

200-898-6

75-75-2

Skin Corr. 1B

H314

GHS05
Gef.

H314

607-146-00-X

fumaric acid

203-743-0

110-17-8

Eye Irrit. 2

H319

GHS07
Achtg.

H319

607-147-00-5

oxalic acid diethylester;
diethyl oxalate

202-464-1

95-92-1

Acute Tox. 4 (*)
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

607-148-00-0

guanidinium chloride;
guanadine hydrochloride

200-002-3

50-01-1

Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2

H302
H319
H315

GHS07
Achtg.

H302
H319
H315

607-149-00-6

urethane (INN);
ethyl carbamate

200-123-1

51-79-6

Carc. 1B

H350

GHS08
Gef.

H350

607-150-00-1

endothal (ISO);
7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid

205-660-5

145-73-3

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H301
H312
H319
H335
H315

GHS06
Gef.

H301
H312
H319
H335
H315

607-151-00-7

propargite (ISO);
2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite

219-006-1

2312-35-8

Carc. 2
Acute Tox. 3 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H331
H315
H318
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H351
H331
H315
H318
H410

M=10

607-152-00-2

2,3,6-TBa (ISO);
2,3,6-trichlorobenzoic acid

200-026-4

50-31-7

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-153-00-8

benazolin (ISO);
4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid

223-297-0

3813-05-6

Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3

H319
H315
H412

GHS07
Achtg.

H319
H315
H412

607-154-00-3

ethylN-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;
benzoylprop-ethyl (ISO)

244-845-5

22212-55-1

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

607-155-00-9

3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;
blasticidin-s

2079-00-7

Acute Tox. 2 (*)

H300

GHS06
Gef.

H300

607-156-00-4

chlorfenson (ISO);
4-chlorophenyl 4-chlorobenzenesulfonate

201-270-4

80-33-1

Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H315
H410

607-157-00-X

Difenacoum (ISO); 3-(3-Biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycumarin

259-978-4

56073-07-5

Repr. 1B
Acute Tox. 1
Acute Tox. 1
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H360D
H330
H310
H300
H372 (Blut)
H400
H410

GHS08
GHS06
GHS09
Gef.

H360D
H330
H310
H300
H372 (Blut)
H410

Repr. 1B; H360D:
C> 0,003 %
STOT RE 1; H372 (Blut): C> 0,02 % STOT RE 2; H373 (Blut):
0,002 % ≤ C < 0,02 %
M = 10
M = 10

607-158-00-5

sodium salt of chloroacetic acid;
sodium chloroacetate

223-498-3

3926-62-3

Acute Tox. 3 (*)
Skin Irrit. 2
Aquatic Acute 1

H301
H315
H400

GHS06
GHS09
Gef.

H301
H315
H400

607-159-00-0

chlorobenzilate (ISO);
ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;
ethyl 4,4'-dichlorobenzilate

208-110-2

510-15-6

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

607-160-00-6

isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;
clofop-isobutyl (ISO)

51337-71-4

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

607-161-00-1

diethanolamine salt of 4-CPA

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

607-162-00-7

dalapon;
2,2-dichloropropionic acid; [1]
dalapon-sodium;
sodium 2,2-dichloropropionate [2]

200-923-0 [1]
204-828-5 [2]

75-99-0 [1]
127-20-8 [2]

Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H315
H318
H412

GHS05
Gef.

H315
H318
H412

607-163-00-2

3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;
dehydracetic acid

208-293-9

520-45-6

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

607-164-00-8

sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;
sodium dehydracetate

224-580-1

4418-26-2

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

607-165-00-3

diclofop-methyl (ISO)
methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;
methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate;

257-141-8

51338-27-3

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

607-166-00-9

medinoterb acetate (ISO);
6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate

219-634-6

2487-01-6

Acute Tox. 3 (*)
Acute Tox. 4 (*)

H301
H312

GHS06
Gef.

H301
H312

607-167-00-4

sodium 3-chloroacrylate

4312-97-4

Acute Tox. 4 (*)
Acute Tox. 4 (*)

H312
H302

GHS07
Achtg.

H312
H302

607-168-00-X

dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;
propylisome

83-59-0

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H311
H302
H400
H410

GHS06
GHS09
Gef.

H311
H302
H410

607-169-00-5

sodium fluoroacetate

200-548-2

62-74-8

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Aquatic Acute 1

H330
H310
H300
H400

GHS06
GHS09
Gef.

H330
H310
H300
H400

607-170-00-0

bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;
thiocyclam-oxalate

250-859-2

31895-22-4

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

607-172-00-1

Brodifacoum (ISO);
4-Hydroxy-3-(3-(4'-brom-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)cumarin

259-980-5

56073-10-0

Repr. 1 a
Acute Tox. 1
Acute Tox. 1
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H360D
H330
H310
H300
H372 (Blut)
H400
H410

GHS08
GHS06
GHS09
Gef.

H360D
H330
H310
H300
H372 (Blut)
H410

Repr. 1 A; H360D:
C> 0,003 %
STOT RE 1; H372 (Blut): C> 0,02 % STOT RE 2; H373 (Blut):
0,002 % ≤ C < 0,02 %
M = 10
M = 10

607-173-00-7

dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate

400-460-6

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-174-00-2

reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate

400-580-9

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

607-175-00-8

methyl 2-(2-nitrobenzylidene)acetoacetate

400-650-9

39562-27-1

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-176-00-3

reaction mass of a-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-?-hydroxypoly(oxyethylene) and a-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-?-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)

400-830-7

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-177-00-9

tribenuron-methyl (ISO);
methyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate

401-190-1

101200-48-0

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

M = 100

607-178-00-4

methyl a-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate

401-340-6

83055-99-6

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-179-00-X

(benzothiazol-2-ylthio)succinic acid

401-450-4

95154-01-1

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-180-00-5

potassium 2-hydroxycarbazole-1-carboxylate

401-630-2

96566-70-0

Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Aquatic Chronic 3

H302
H319
H335
H412

GHS07
Achtg.

H302
H319
H335
H412

607-181-00-0

3,5-dichloro-2,4-difluorobenzoyl fluoride

401-800-6

101513-70-6

Acute Tox. 3 (*)
Skin Corr. 1B
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 3

H331
H314
H302
H317
H412

GHS06
GHS05
Gef.

H331
H314
H302
H317
H412

EUH029

607-182-00-6

methyl 3-sulphamoyl-2-thenoate

402-050-2

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-183-00-1

zinc 2-hydroxy-5-C13-18alkylbenzoate

402-280-3

Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H319
H315
H411

GHS07
GHS09
Achtg.

H319
H315
H411

607-184-00-7

S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate

402-290-8

85702-90-5

Flam. Liq. 3
Resp. Sens. 1
Skin Sens. 1

H226
H334
H317

GHS02
GHS08
Gef.

H226
H334
H317

607-185-00-2

ethyltrans-3-dimethylaminoacrylate

402-650-4

1117-37-9

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-186-00-8

quinclorac (ISO);
3,7-dichloroquinoline-8-carboxylic acid

402-780-1

84087-01-4

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-187-00-3

bis(2,2,6,6-tetramethyl-4-piperidyl) succinate

402-940-0

62782-03-0

Eye Irrit. 2
Aquatic Chronic 3

H319
H412

GHS07
Achtg.

H319
H412

607-188-00-9

hydrogen sodiumN-carboxylatoethyl-N-octadec-9-enylmaleamate

402-970-4

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-189-00-4

trimethylenediaminetetraacetic acid

400-400-9

1939-36-2

Acute Tox. 4 *
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

607-190-00-X

methyl acrylamidomethoxyacetate (containing> 0,1 % acrylamid)

401-890-7

77402-03-0

Carc. 1B
Muta. 1B
Acute Tox. 4 (*)
Eye Irrit. 2

H350
H340
H302
H319

GHS08
GHS07
Gef.

H350
H340
H302
H319

607-191-00-5

isobutyl 3,4-epoxybutyrate

401-920-9

100181-71-3

Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H317
H400
H410

GHS07
GHS09
Achtg.

H315
H317
H410

607-192-00-0

disodiumN-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate

402-360-8

92511-22-3

Eye Dam. 1

H318

GHS05
Gef.

H318

607-194-00-1

propylene carbonate

203-572-1

108-32-7

Eye Irrit. 2

H319

GHS07
Achtg.

H319

607-195-00-7

2-methoxy-1-methylethyl acetate

203-603-9

108-65-6

Flam. Liq. 3

H226

GHS02
Achtg.

H226

607-196-00-2

heptanoic acid

203-838-7

111-14-8

Skin Corr. 1B

H314

GHS05
Gef.

H314

607-197-00-8

Nonansäure

203-931-2

112-05-0

Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic 3

H315
H319
H412

GHS07
Achtg.

H315
H319
H412

607-198-00-3

propyl 3,4,5-trihydroxybenzoate

204-498-2

121-79-9

Acute Tox. 4 (*)
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

607-199-00-9

octyl 3,4,5-trihydroxybenzoate

213-853-0

1034-01-1

Acute Tox. 4 (*)
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

607-200-00-2

dodecyl 3,4,5-trihydroxybenzoate

214-620-6

1166-52-5

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-201-00-8

thiocarbonyl chloride

207-341-6

463-71-8

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H331
H302
H319
H335
H315

GHS06
Gef.

H331
H302
H319
H335
H315

607-203-00-9

2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate

279-452-8

80387-97-9

Repr. 1B
Skin Sens. 1
Aquatic Chronic 3

H360D (*)(*)(*)
H317
H412

GHS08
GHS07
Gef.

H360D (*)(*)(*)
H317
H412

607-204-00-4

(chlorophenyl)(chlorotolyl)methane, mixed isomers

400-140-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-205-00-X

methyl chloroacetate

202-501-1

96-34-4

Flam. Liq. 3
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT SE 3
Skin Irrit. 2
Eye Dam. 1

H226
H331
H301
H335
H315
H318

GHS02
GHS06
GHS05
Gef.

H226
H331
H301
H335
H315
H318

607-206-00-5

isopropyl chloroacetate

203-301-7

105-48-6

Flam. Liq. 3
Acute Tox. 3 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H226
H301
H319
H335
H315

GHS02
GHS06
Gef.

H226
H301
H319
H335
H315

607-207-00-0

haloxyfop-etotyl (ISO);
2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;
haloxyfop-(2-ethoxyethyl)

402-560-5

87237-48-7

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

607-208-00-6

4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers

403-000-2

91853-67-7

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

607-209-00-1

reaction mass ofO,O'-diisopropyl (pentathio)dithioformate andO,O'-diisopropyl (trithio)dithioformate andO,O'-diisopropyl (tetrathio)dithioformate

403-030-6

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

607-210-00-7

methyl acrylamidoglycolate (containing> 0,1 % acrylamide)

403-230-3

77402-05-2

Carc. 1B
Muta. 1B
Skin Corr. 1B
Skin Sens. 1

H350
H340
H314
H317

GHS08
GHS05
GHS07
Gef.

H350
H340
H314
H317

607-211-00-2

methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate

403-270-1

6386-39-6

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-212-00-8

poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate

403-300-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-213-00-3

ethyl 3,3-bis(tert-pentylperoxy)butyrate

403-320-2

67567-23-1

Org. Perox. D****
Flam. Liq. 3
Aquatic Chronic 2

H242
H226
H411

GHS02
GHS09
Gef.

H242
H226
H411

607-214-00-9

N,N-hydrazinodiacetic acid

403-510-5

19247-05-3

Acute Tox. 3 (*)
STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 3

H301
H373 (*)(*)
H317
H412

GHS06
GHS08
Gef.

H301
H373 (*)(*)
H317
H412

607-215-00-4

3-(3-tert-butyl-4-hydroxyphenyl)propionic acid

403-920-4

107551-67-7

Acute Tox. 4 (*)
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

607-216-00-X

glutamic acid, reaction products withN-(C_12-14-alkyl)propylenediamine

403-950-8

Acute Tox. 2 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Acute 1

H330
H302
H314
H400

GHS06
GHS05
GHS09
Gef.

H330
H302
H314
H400

607-217-00-5

2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate

403-960-2

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

607-218-00-0

dichlorprop-P (ISO);
(+)-R-2-(2,4-dichlorophenoxy)propionic acid

403-980-1

15165-67-0

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H302
H315
H318
H317

GHS05
GHS07
Gef.

H302
H315
H318
H317

607-219-00-6

bis(2-ethylhexyl) dithiodiacetate

404-510-8

62268-47-7

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

607-221-00-7

6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid

404-550-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

607-222-00-2

6-(2,3-dimethylmaleimido)hexyl methacrylate

404-870-6

63740-41-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-223-00-8

transfluthrin (ISO);
2,3,5,6-tetrafluorobenzyltrans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate

405-060-5

118712-89-3

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

607-224-00-3

methyl 2-(3-nitrobenzylidene)acetoacetate

405-270-7

39562-17-9

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

607-225-00-9

3-azidosulfonylbenzoic acid

405-310-3

15980-11-7

Self-React. C (*)(*)(*)(*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1

H241
H373 (*)(*)
H318
H317

GHS02
GHS08
GHS05
GHS07
Gef.

H241
H373 (*)(*)
H318
H317

607-226-00-4

reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate

405-360-6

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H315
H318
H317
H412

GHS05
GHS07
Gef.

H315
H318
H317
H412

607-227-00-X

potassium 2-amino-2-methylpropionate octahydrate

405-560-3

120447-91-8

Acute Tox. 4 (*)
Skin Corr. 1A

H302
H314

GHS05
GHS07
Gef.

H302
H314

607-228-00-5

bis(2-methoxyethyl) phthalate

204-212-6

117-82-8

Repr. 1B

H360Df

GHS08
Gef.

H360Df

607-229-00-0

diethylcarbamoyl chloride

201-798-5

88-10-8

Carc. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H351
H332
H302
H319
H335
H315

GHS08
GHS07
Achtg.

H351
H332
H302
H319
H335
H315

607-230-00-6

2-ethylhexanoic acid

205-743-6

149-57-5

Repr. 2

H361d (*)(*)(*)

GHS08
Achtg.

H361d (*)(*)(*)

607-231-00-1

clopyralid (ISO);
3,6-dichloropyridine-2-carboxylic acid

216-935-4

1702-17-6

Eye Dam. 1

H318

GHS05
Gef.

H318

607-232-00-7

pyridate (ISO);
O-(6-chloro-3-phenylpyridazin-4-yl)S-octyl thiocarbonate

259-686-7

55512-33-9

Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H317
H400
H410

GHS07
GHS09
Achtg.

H315
H317
H410

607-233-00-2

hexyl acrylate

219-698-5

2499-95-8

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H319
H335
H315
H317
H411

GHS07
GHS09
Achtg.

H319
H335
H315
H317
H411

607-234-00-8

flurenol (ISO);
9-hydroxy-9H-fluorene-9-carboxylic acid

207-397-1

467-69-6

Aquatic Chronic 2

H411

GHS09

H411

607-235-00-3

mecrilate;
methyl 2-cyanoacrylate

205-275-2

137-05-3

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H319
H335
H315

GHS07
Achtg.

H319
H335
H315

STOT SE 3; H335: C> 10 %

607-236-00-9

ethyl 2-cyanoacrylate

230-391-5

7085-85-0

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H319
H335
H315

GHS07
Achtg.

H319
H335
H315

STOT SE 3; H335: C> 10 %

607-237-00-4

benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;
flurazole

276-942-3

72850-64-7

Aquatic Chronic 2

H411

GHS09

H411

607-238-00-X

tau-fluvalinate (ISO);
cyano-(3-phenoxyphenyl)methylN-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate

102851-06-9

Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H315
H400
H410

GHS07
GHS09
Achtg.

H302
H315
H410

607-239-00-5

fenpropathrin (ISO);
a-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate

254-485-0

39515-41-8

Acute Tox. 2 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H330
H301
H312
H400
H410

GHS06
GHS09
Gef.

H330
H301
H312
H410

607-240-00-0

cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]
1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]
1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]
tetrahydromethylphthalic anhydride; [4]
1,2,3,6-tetrahydromethylphthalic anhydride; [5]
tetrahydro-4-methylphthalic anhydride; [6]
2,3,5,6-tetrahydro-2-methylphthalic anhydride [7]

216-906-6 [1]
222-323-8 [2]
226-247-6 [3]
234-290-7 [4]
247-830-1 [5]
251-823-9 [6]
255-853-3 [7]

1694-82-2 [1]
3425-89-6 [2]
5333-84-6 [3]
11070-44-3 [4]
26590-20-5 [5]
34090-76-1 [6]
42498-58-8 [7]

Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H318
H334
H317

GHS08
GHS05
Gef.

H318
H334
H317

607-241-00-6

hexahydro-4-methylphthalic anhydride; [1]
hexahydromethylphthalic anhydride; [2]
hexahydro-1-methylphthalic anhydride; [3]
hexahydro-3-methylphthalic anhydride [4]

243-072-0 [1]
247-094-1 [2]
256-356-4 [3]
260-566-1 [4]

19438-60-9 [1]
25550-51-0 [2]
48122-14-1 [3]
57110-29-9 [4]

Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H318
H334
H317

GHS08
GHS05
Gef.

H318
H334
H317

607-242-00-1

tetrachlorophthalic anhydride

204-171-4

117-08-8

Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H334
H317
H400
H410

GHS08
GHS05
GHS09
Gef.

H318
H334
H317
H410

607-243-00-7

sodium 3,6-dichloro-o-anisate; [1]
3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]
3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3]

217-846-3 [1]
246-590-5 [2]
258-527-9 [3]

1982-69-0 [1]
25059-78-3 [2]
53404-28-7 [3]

Aquatic Chronic 3

H412

607-244-00-2

isooctyl acrylate

249-707-8

29590-42-9

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H335
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H335
H315
H410

STOT SE 3; H335: C> 10 %

607-245-00-8

tert-butyl acrylate

216-768-7

1663-39-4

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H225
H332
H312
H302
H335
H315
H317
H411

GHS02
GHS07
GHS09
Gef.

H225
H332
H312
H302
H335
H315
H317
H411

607-246-00-3

allyl methacrylate;
2-methyl-2-propenoic acid 2-propenyl ester

202-473-0

96-05-9

Flam. Liq. 3
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1

H226
H331
H312
H302
H400

GHS02
GHS06
GHS09
Gef.

H226
H331
H312
H302
H400

607-247-00-9

dodecyl methacrylate

205-570-6

142-90-5

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H335
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H335
H315
H410

STOT SE 3; H335: C> 10 %

607-248-00-4

naptalam-sodium (ISO);
sodiumN-naphth-1-ylphthalamate

205-073-4

132-67-2

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

607-249-00-X

(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate

256-032-2

42978-66-5

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H319
H335
H315
H317
H411

GHS07
GHS09
Achtg.

H319
H335
H315
H317
H411

STOT SE 3; H335: C> 10 %

607-250-00-5

4H-3,1-benzoxazine-2,4(1H)-dione

204-255-0

118-48-9

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

607-251-00-0

2-methoxypropyl acetate

274-724-2

70657-70-4

Flam. Liq. 3
Repr. 1B
STOT SE 3

H226
H360D (*)(*)(*)
H335

GHS02
GHS08
GHS07
Gef.

H226
H360D (*)(*)(*)
H335

607-252-00-6

lambda-cyhalothrin (ISO);
reaction mass of (S)-a-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-a-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)

415-130-7

91465-08-6

Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H330
H301
H312
H400
H410

GHS06
GHS09
Gef.

H330
H301
H312
H410

M=10000

607-253-00-1

cyfluthrin (ISO);
a-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate

269-855-7

68359-37-5

Acute Tox. 2 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H300
H331
H400
H410

GHS06
GHS09
Gef.

H300
H331
H410

M=1000

607-254-00-7

a-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
beta-cyfluthrin

269-855-7

68359-37-5

Acute Tox. 2 (*)
Acute Tox. 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H400
H410

GHS06
GHS09
Gef.

H330
H300
H410

607-255-00-2

fluroxypyr (ISO);
4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid

69377-81-7

Aquatic Chronic 3

H412

607-256-00-8

azoxystrobin (ISO);
methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate

131860-33-8

Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H400
H410

GHS06
GHS09
Gef.

H331
H410

607-257-00-3

isopropyl propionate

211-300-8

637-78-5

Flam. Liq. 2

H225

GHS02
Gef.

H225

607-258-00-9

dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate

403-990-6

70950-45-7

Aquatic Chronic 4

H413

607-259-00-4

methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate

404-130-2

105560-93-8

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

607-260-00-X

ethyl 2-(3-nitrobenzylidene)acetoacetate

404-490-0

39562-16-8

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

607-261-00-5

iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate

404-800-4

118832-72-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-262-00-0

7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid

405-050-0

86393-33-1

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

607-263-00-6

potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate

405-680-6

Self-heat. 2 (*)(*)(*)(*)
Aquatic Chronic 2

H252
H411

GHS02
GHS09
Achtg.

H252
H411

607-264-00-1

2-chloro-4-(methylsulfonyl)benzoic acid

406-520-8

53250-83-2

Eye Dam. 1

H318

GHS05
Gef.

H318

607-265-00-7

ethyl-2-chloro-2,2-diphenylacetate

406-580-5

52460-86-3

Skin Irrit. 2
Aquatic Chronic 3

H315
H412

GHS07
Achtg.

H315
H412

607-266-00-2

reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];
3,5-di-tert-butyl-salicylic acid

406-890-0

130296-87-6

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

607-267-00-8

tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate

407-620-4

33610-13-8

Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3

H334
H317
H412

GHS08
Gef.

H334
H317
H412

607-268-00-3

2-methylpropyl (R)-2-hydroxypropanoate

407-770-0

61597-96-4

Eye Irrit. 2

H319

GHS07
Achtg.

H319

607-269-00-9

(R)-2-(4-hydroxyphenoxy)propanoic acid

407-960-3

94050-90-5

Eye Dam. 1

H318

GHS05
Gef.

H318

607-270-00-4

3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane

410-730-5

90498-90-1

Acute Tox. 4 (*)

H312

GHS07
Achtg.

H312

607-271-00-X

2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane

417-420-9

156324-82-2

Eye Irrit. 2
Aquatic Chronic 2

H319
H411

GHS07
GHS09
Achtg.

H319
H411

607-272-00-5

fluroxypyr-meptyl (ISO);
methylheptyl,O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]
fluroxypyr-butometyl (ISO);
2-butoxy-1-methylethyl,O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2]

279-752-9 [1]
[2]

81406-37-3 [1]
154486-27-8 [2]

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-273-00-0

ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate

404-520-2

Aquatic Chronic 3

H412

607-274-00-6

2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate

405-350-1

54527-73-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-275-00-1

sodium benzoyloxybenzene-4-sulfonate

405-450-5

66531-87-1

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-276-00-7

bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex

405-635-0

Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H400
H410

GHS05
GHS09
Gef.

H315
H318
H410

607-277-00-2

reaction mass of: 2-(hexylthio)ethylamine hydrochloride;
sodium propionate

405-720-2

Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H317
H411

607-278-00-8

reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;
sodium naphthylethylbenzenesulfonate

405-760-0

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

607-279-00-3

reaction mass ofn-octadecylaminodiethyl bis(hydrogen maleate);
n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate

405-960-8

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-280-00-9

sodium 4-chloro-1-hydroxybutane-1-sulfonate

406-190-5

54322-20-2

Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1

H302
H319
H317

GHS07
Achtg.

H302
H319
H317

607-281-00-4

reaction mass of branched and linear C7-C₉ alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates

407-000-3

127519-17-9

Aquatic Chronic 2

H411

GHS09

H411

607-282-00-X

2-acetoxymethyl-4-benzyloxybut-1-yl acetate

407-140-5

131266-10-9

Aquatic Chronic 3

H412

607-283-00-5

E-ethyl-4-oxo-4-phenylcrotonate

408-040-4

15121-89-8

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H315
H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H312
H302
H315
H318
H317
H410

607-284-00-0

reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);
lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)

410-040-4

136213-76-8

Aquatic Chronic 2

H411

GHS09

H411

607-285-00-6

reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;
sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;
potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate

410-065-0

Skin Sens. 1

H317

GHS07
Achtg.

607-286-00-1

reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate

410-070-8

141880-36-6

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-287-00-7

O'-methylO-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate

410-140-8

Aquatic Chronic 3

H412

607-288-00-2

tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, wherea is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18,d is 22 or 23 or 24 or 25 and wheree andf together are 2 and 4 or 4 and 2 respectively

410-160-7

148732-74-5

Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H319
H317
H412

GHS07
Achtg.

H319
H317
H412

607-289-00-8

3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid

410-370-9

105488-33-3

Aquatic Chronic 4

H413

607-290-00-3

reaction mass (ratio not known) of: ammonium 1-C14-C₁₈-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;
ammonium 2-C14-C₁₈-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate

410-540-2

Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H317
H400
H410

GHS07
GHS09
Achtg.

H315
H317
H410

607-291-00-9

dodecyl-?-(C5/C6-cycloalkyl)alkyl carboxylate

410-630-1

104051-92-5

Aquatic Chronic 4

H413

607-292-00-4

reaction mass of: [1-(methoxymethyl)-2-(C₁₂-alkoxy)-ethoxy]acetic acid;
[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid

410-640-6

Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H400
H410

GHS05
GHS09
Gef.

H315
H318
H410

607-293-00-X

reaction mass of:N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;
N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate

410-650-0

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

607-294-00-5

sodium 2-benzoyloxy-1-hydroxyethane-sulfonate

410-680-4

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-295-00-0

reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;
hexasodium phosphonobutane-1,2,3,4-tetracarboxylate

410-800-5

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-296-00-6

reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid

410-830-9

Aquatic Chronic 4

H413

607-297-00-1

(E -E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)

410-960-6

92761-26-7

Eye Dam. 1

H318

GHS05
Gef.

H318

607-298-00-7

2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate

411-010-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-299-00-2

methyl 3-(acetylthio)-2-methyl-propanoate

411-040-7

97101-46-7

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

607-300-00-6

trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) wherea=1,2,3,4b=8,9,10,11c=15,16,17,18d=22,23,24,25

411-430-7

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-301-00-1

reaction mass of: dodecanoic acid;
poly(1-7)lactate esters of dodecanoic acid

411-860-5

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-302-00-7

reaction mass of: tetradecanoic acid;
poly(1-7)lactate esters of tetradecanoic acid

411-910-6

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H315
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H411

607-303-00-2

1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid

413-760-7

93107-30-3

Repr. 2
Aquatic Chronic 3

H361f (*)(*)(*)
H412

GHS08
Achtg.

H361f (*)(*)(*)
H412

607-304-00-8

fluazifop-butyl (ISO);
butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate

274-125-6

69806-50-4

Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H360D (*)(*)(*)
H400
H410

GHS08
GHS09
Gef.

H360D (*)(*)(*)
H410

607-305-00-3

fluazifop-P-butyl (ISO);
butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate

79241-46-6

Repr. 2
Aquatic Acute 1
Aquatic Chronic 1

H361d (*)(*)(*)
H400
H410

GHS08
GHS09
Achtg.

H361d (*)(*)(*)
H410

607-306-00-9

chlozolinate (ISO);
ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate

282-714-4

84332-86-5

Carc. 2
Aquatic Chronic 2

H351
H411

GHS08
GHS09
Achtg.

H351
H411

607-307-00-4

vinclozolin (ISO);
N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione

256-599-6

50471-44-8

Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Chronic 2

H351
H360FD
H317
H411

GHS08
GHS07
GHS09
Gef.

H351
H360FD
H317
H411

607-308-00-X

esters of 2,4-D

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

607-309-00-5

carfentrazone-ethyl (ISO);
ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate

128639-02-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-310-00-0

kresoxim-methyl (ISO);
methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate

143390-89-0

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

607-311-00-6

benazolin-ethyl;
ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate

246-591-0

25059-80-7

Aquatic Chronic 2

H411

GHS09

H411

607-312-00-1

methoxyacetic acid

210-894-6

625-45-6

Repr. 1B
Acute Tox. 4 (*)
Skin Corr. 1B

H360FD
H302
H314

GHS08
GHS05
GHS07
Gef.

H360FD
H302
H314

STOT SE 3; H335: C> 5 %

607-313-00-7

neodecanoyl chloride

254-875-0

40292-82-8

Acute Tox. 2 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H330
H302
H314

GHS06
GHS06
Gef.

H330
H302
H314

STOT SE 3; H335: C> 5 %

607-314-00-2

ethofumesate (ISO);
(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate

247-525-3

26225-79-6

Aquatic Chronic 2

H411

GHS09

H411

607-315-00-8

glyphosate (ISO);
N-(phosphonomethyl)glycine

213-997-4

1071-83-6

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

607-316-00-3

glyphosate-trimesium;
glyphosate-trimethylsulfonium

81591-81-3

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07 GHS09
Achtg.

H302
H411

607-317-00-9

bis(2-ethylhexyl) phthalate;
di-(2-ethylhexyl) phthalate;
DEHP

204-211-0

117-81-7

Repr. 1B

H360FD

GHS08
Gef.

H360FD

607-318-00-4

dibutyl phthalate;
DBP

201-557-4

84-74-2

Repr. 1B
Aquatic Acute 1

H360Df
H400

GHS08
GHS09
Gef.

H360Df
H400

607-319-00-X

deltamethrin (ISO);
(S)-a-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate

258-256-6

52918-63-5

Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H400
H410

GHS06
GHS09
Gef.

H331
H301
H410

M=1000000

607-320-00-5

bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate

413-930-0

130066-57-8

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

607-321-00-0

(S)-methyl-2-chloropropionate

412-470-8

73246-45-4

Flam. Liq. 3
STOT RE 2 (*)
Eye Irrit. 2

H226
H373 (*)(*)
H319

GHS02
GHS08
Achtg.

H226
H373 (*)(*)
H319

607-322-00-6

4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid

413-120-7

107144-30-9

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-323-00-1

2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate

413-850-6

123968-25-2

Aquatic Chronic 4

H413

607-324-00-7

reaction mass of:N,N-di(hydrogenated alkyl C14-C₁₈)phtalamic acid;
dihydrogenated alkyl (C14-C₁₈)amine

413-800-3

Aquatic Chronic 4

H413

607-325-00-2

(S)-2-chloropropionic acid

411-150-5

29617-66-1

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A

H312
H302
H314

GHS05
GHS07
Gef.

H312
H302
H314

607-326-00-8

reaction mass of: isobutyl hydrogen 2-(a-2,4,6-trimethylnon-2-enyl)succinate;
isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate

410-720-0

141847-13-4

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

607-327-00-3

2-(2-iodoethyl)-1,3-propanediol diacetate

411-780-0

127047-77-2

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-328-00-9

methyl 4-bromomethyl-3-methoxybenzoate

410-310-1

70264-94-7

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H410

607-329-00-4

reaction mass of: sodium 2-(C12-18 -n-alkyl)amino-1,4-butandioate;
sodium 2-octadecenyl-amino-1,4-butandioate

411-250-9

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-330-00-X

(S)-2,3-dihydro-1H-indole-2-carboxylic acid

410-860-2

79815-20-6

Repr. 2
STOT RE 2 (*)
Skin Sens. 1

H361f (*)(*)(*)
H373 (*)(*)
H317

GHS08
GHS07
Achtg.

H361f (*)(*)(*)
H373 (*)(*)
H317

~~607-331-00-5~~gestrichen

607-332-00-0

cyclopentyl chloroformate

411-460-0

50715-28-1

Flam. Liq. 3
Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1

H226
H331
H302
H373 (*)(*)
H318
H317

GHS02
GHS06
GHS08
GHS05
Gef.

H226
H331
H302
H373 (*)(*)
H318
H317

607-333-00-6

reaction mass of: dodecylN-(2,2,6,6-tetramethylpiperidin-4-yl)-ß-alaninate;
tetradecylN-(2,2,6,6-tetramethylpiperidin-4-yl)-ß-alaninate

405-670-1

Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H302
H373 (*)(*)
H314
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H302
H373 (*)(*)
H314
H410

607-334-00-1

ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate

405-880-3

100501-62-0

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-335-00-7

methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate

406-250-0

72619-32-0

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

607-336-00-2

4-methyl-8-methylenetricyclo[3.3.1.1^3,7]dec-2-yl acetate

406-560-6

122760-85-4

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H315
H317
H411

GHS07
GHS09
Achtg.

H315
H317
H411

607-337-00-8

di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate

406-052-4

125078-60-6

Flam. Liq. 3
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2

H226
H302
H315
H318
H411

GHS02
GHS05
GHS07
GHS09
Gef.

H226
H302
H315
H318
H411

607-338-00-3

2-methylpropyl 2-hydroxy-2-methylbut-3-enoate

406-235-9

72531-53-4

Eye Irrit. 2
Skin Irrit. 2

H319
H315

GHS07
Achtg.

H319
H315

607-339-00-9

2,3,4,5-tetrachlorobenzoylchloride

406-760-3

42221-52-3

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1

H302
H314
H317

GHS05
GHS07
Gef.

H302
H314
H317

607-340-00-4

1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate

406-990-4

Aquatic Chronic 2

H411

GHS09

H411

607-341-00-X

(9S)-9-amino-9-deoxyerythromycin

406-790-7

26116-56-3

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

607-342-00-5

4-chlorobutyl veratrate

410-950-1

69788-75-6

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-343-00-0

4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)

407-410-2

Aquatic Chronic 4

H413

607-344-00-6

reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C_4-8)perfluoroalkylsulfonamido)propionic acid;
N-[dimethyl-3-(C_4-8-perfluoroalkylsulfonamido)propylammonium propionate;
3-(N-(3-dimethyl-propylammonium)-(C_4-8)perfluoroalkylsulfonamido)propionic acid propionate

407-810-7

STOT RE 2 (*)

H373 (*)(*)

GHS08
Achtg.

H373 (*)(*)

607-345-00-1

potassium 2-(2,4-dichlorophenoxy)-(R)-propionate

413-580-9

113963-87-4

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H302
H315
H318
H317

GHS05
GHS07
Gef.

H302
H315
H318
H317

607-346-00-7

3-icosyl-4-henicosylidene-2-oxetanone

401-210-9

83708-14-9

Aquatic Chronic 4

H413

607-347-00-2

sodium (R)-2-(2,4-dichlorophenoxy)propionate

413-340-3

119299-10-4

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H302
H315
H318
H317

GHS05
GHS07
Gef.

H302
H315
H318
H317

607-348-00-8

magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)

413-360-2

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H302
H315
H318
H317

GHS05
GHS07
Gef.

H302
H315
H318
H317

607-349-00-3

mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate

411-270-8

Aquatic Chronic 3

H412

607-350-00-9

bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane

412-060-9

136210-32-7

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-351-00-4

methylO-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate

407-550-4

69184-17-4

Aquatic Chronic 2

H411

GHS09

H411

607-352-00-X

4,4'-oxydiphthalic anhydride

412-830-4

1823-59-2

Aquatic Chronic 3

H412

607-353-00-5

reaction mass of: ethylexo-tricyclo[5.2.1.0^2,6]decane-endo-2-carboxylate;
ethylendo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate

407-520-0

80657-64-3

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

607-354-00-0

ethyl 2-cyclohexylpropionate

412-280-5

2511-00-4

Aquatic Chronic 2

H411

GHS09

H411

607-355-00-6

p-tolyl 4-chlorobenzoate

411-530-0

15024-10-9

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

607-356-00-1

ethyltrans-2,2,6-trimethylcyclohexanecarboxylate

412-540-8

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

607-357-00-7

reaction mass of:trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;
cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran

412-450-9

131766-73-9

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-358-00-2

(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate

412-670-5

54275-93-3

Resp. Sens. 1

H334

GHS08
Gef.

H334

607-359-00-8

(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate

412-800-0

76109-32-5

Resp. Sens. 1

H334

GHS08
Gef.

H334

607-360-00-3

sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate

411-680-7

133167-77-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-361-00-9

methyl (R)-2-(4-hydroxyphenoxy)propionate

411-950-4

96562-58-2

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-362-00-4

reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;
(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate

413-500-2

Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2

H315
H318
H411

GHS05
GHS09
Gef.

H315
H318
H411

607-363-00-X

methyl-3-methoxyacrylate

412-900-4

5788-17-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-364-00-5

3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione

413-330-9

134724-55-3

Aquatic Chronic 4

H413

607-365-00-0

2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride

410-620-7

119154-86-8

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1

H302
H314
H317

GHS05
GHS07
Gef.

H302
H314
H317

607-366-00-6

3,5-dimethylbenzoyl chloride

413-010-9

6613-44-1

Skin Corr. 1B
Skin Sens. 1

H314
H317

GHS05
GHS07
Gef.

H314
H317

607-367-00-1

potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate

411-640-9

153352-59-1

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

607-368-00-7

1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole

411-650-3

110895-43-7

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H400
H410

GHS06
GHS09
Gef.

H331
H301
H410

607-369-00-2

reaction mass of:trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;
cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid

411-660-8

147027-04-1

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H302
H315
H318
H317

GHS05
GHS07
Gef.

H302
H315
H318
H317

607-370-00-8

2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol

412-210-3

41620-33-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-371-00-3

3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate

413-410-3

88150-62-3

Aquatic Chronic 4

H413

607-372-00-9

ethoxylated bis phenol a di-(norbornene carboxylate)

412-410-0

Aquatic Chronic 3

H412

607-373-00-4

(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate

414-200-4

119738-06-6

Muta. 2
Repr. 1B
Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H341
H360Df
H302
H373 (*)(*)
H400
H410

GHS08
GHS07
GHS09
Gef.

H341
H360Df
H302
H373 (*)(*)
H410

607-374-00-X

5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride

417-220-1

37441-29-5

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-375-00-5

Flocoumafen (ISO); Reaktionsmasse aus: cis-4-Hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)phenyl)-1-naphthyl)cumarin und trans-4-Hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluormethylbenzyloxy)phenyl)-1-naphthyl)cumarin

421-960-0

90035-08-8

Repr. 1B
Acute Tox. 1
Acute Tox. 1
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H360D
H330
H310
H300
H372 (Blut)
H400
H410

GHS08
GHS06
GHS09
Gef.

H360D
H330
H310
H300
H372 (Blut)
H410

Repr. 1B; H360D:
C> 0,003 %
STOT RE 1; H372 (Blut): C> 0,05 %
STOT RE 2; H373 (Blut):
0,005 % ≤ C < 0,05 %
M = 10
M = 10

607-376-00-0

benzyl 2,4-dibromobutanoate

420-710-8

23085-60-1

Repr. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361f (*)(*)(*)
H315
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361f (*)(*)(*)
H315
H317
H410

607-377-00-6

trans-4-cyclohexyl-L-proline monohydrochloride

419-160-1

90657-55-9

Repr. 2
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H361f (*)(*)(*)
H302
H315
H318
H317

GHS08
GHS05
GHS07
Gef.

H361f (*)(*)(*)
H302
H315
H318
H317

607-378-00-1

ammonium (Z)-a-methoxyimino-2-furylacetate

405-990-1

97148-39-5

Flam. Sol. 2

H228

GHS02
Gef.

H228

607-379-00-7

reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;
sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;
sodium [bis(2-hydroxyethyl)amino]methylsulfonate;
N,N-bis(2-hydroxyethyl)stearamide

401-230-8

Aquatic Chronic 3

H412

607-380-00-2

reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;
ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;
ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate

407-320-3

Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H315
H318
H412

GHS05
Gef.

H315
H318
H412

607-381-00-8

reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C₇-alkanoic acids and 2-ethylhexanoic acid

413-710-4

Aquatic Chronic 4

H413

607-382-00-3

2-((4-amino-2-nitrophenyl)amino)benzoic acid

411-260-3

117907-43-4

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

607-383-00-9

reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;
2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate

415-430-8

86403-32-9

Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H318
H317
H410

607-384-00-4

reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;
C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;
C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate

413-750-2

171090-93-0

Aquatic Chronic 4

H413

607-385-00-X

Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate

414-590-6

125229-74-5

Aquatic Chronic 2

H411

GHS09

H411

607-386-00-5

reaction mass of: tetradecanoic acid (42,5 -47,5 %);
poly(1-7)lactate esters of tetradecanoic acid (52,5 - 57,5 %)

412-580-6

174591-51-6

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H410

607-387-00-0

reaction mass of: dodecanoic acid (35-40 %);
poly(1-7)lactate esters of dodecanoic acid (60-65 %)

412-590-0

58856-63-6

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H410

607-388-00-6

4-ethylamino-3-nitrobenzoic acid

412-090-2

2788-74-1

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 3

H302
H317
H412

GHS07
Achtg.

H302
H317
H412

607-389-00-1

trisodiumN,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate

414-130-4

119710-96-2

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

607-390-00-7

1,2,3,4-tetrahydro-6-nitro-quinoxaline

414-270-6

41959-35-7

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-391-00-2

dimethylcyclopropane-1,1-dicarboxylate

414-240-2

6914-71-2

Aquatic Chronic 3

H412

607-392-00-8

2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate

414-260-1

88938-37-8

Aquatic Chronic 4

H413

607-393-00-3

3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

415-750-8

106447-44-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-394-00-9

5-methylpyrazine-2-carboxylic acid

413-260-9

5521-55-1

Eye Dam. 1

H318

GHS05
Gef.

H318

607-395-00-4

reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;
sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate

410-230-7

Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H314
H317
H411

GHS05
GHS07
GHS09
Gef.

H314
H317
H411

607-396-00-X

bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate

414-840-4

147783-69-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-397-00-5

reaction mass of: Ca salicylates (branched C_10-14 and C_18-30 alkylated);
Ca phenates (branched C_10-14 and C_18-30 alkylated);
Ca sulfurised phenates (branched C_10-14 and C_18-30 alkylated)

415-930-6

Repr. 2
Skin Sens. 1

H361f***
H317

GHS08
GHS07
Achtg.

H361f***
H317

607-398-00-0

ethylN-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate

414-820-5

125630-94-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-399-00-6

2,2-dimethyl 3-methyl-3-butenyl propanoate

415-610-6

104468-21-5

Skin Irrit. 2
Aquatic Chronic 3

H315
H412

GHS07
Achtg.

H315
H412

607-400-00-X

methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate

414-400-1

32750-89-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-401-00-5

ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate

414-450-4

88805-65-6

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H315
H318
H317

GHS05
GHS07
Gef.

H315
H318
H317

607-402-00-0

methylN-(phenoxycarbonyl)-L-valinate

414-500-5

153441-77-1

Aquatic Chronic 3

H412

607-403-00-6

reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;
isopropyl alcohol

414-810-0

STOT RE 2 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H318
H400
H410

GHS08
GHS05
GHS09
Gef.

H373 (*)(*)
H318
H410

607-404-00-1

reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;
di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;
di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;
(Z)-3,7-dimethyl-2,6-octadienyl butandioate;
((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid

415-190-4

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-405-00-7

2-hexyldecyl-p-hydroxybenzoate

415-380-7

148348-12-3

Aquatic Chronic 2

H411

GHS09

H411

607-406-00-2

potassium 2,5-dichlorobenzoate

415-700-5

184637-62-5

Acute Tox. 4 (*)
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

607-407-00-8

ethyl 2-carboxy-3-(2-thienyl)propionate

415-680-8

143468-96-6

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H315
H318
H317

GHS05
GHS07
Gef.

H315
H318
H317

607-408-00-3

potassiumN-(4-fluorophenyl)glycinate

415-710-1

184637-63-6

STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H373 (*)(*)
H318
H317
H412

GHS08
GHS05
GHS07
Gef.

H373 (*)(*)
H318
H317
H412

607-409-00-9

reaction mass of: (3R)-[1S-(1a, 2a, 6ß-((2S)-2-methyl-1-oxo-butoxy)-8a?)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;
inert biomass fromAspergillus terreus

415-840-7

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-410-00-4

mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate

415-880-5

779343-34-9

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H410

607-411-00-X

oxiranemethanol, 4-methylbenzene-sulfonate, (S)-

417-210-7

70987-78-9

Carc. 1B
Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H350
H341
H318
H317
H411

GHS08
GHS05
GHS07
GHS09
Gef.

H350
H341
H318
H317
H411

607-412-00-5

ethyl 2-(1-cyanocyclohexyl)acetate

415-970-4

133481-10-4

Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Chronic 3

H302
H373 (*)(*)
H412

GHS08
GHS07
Achtg.

H302
H373 (*)(*)
H412

607-413-00-0

trans-4-phenyl-L-proline

416-020-1

96314-26-0

Repr. 2
Skin Sens. 1

H361f (*)(*)(*)
H317

GHS08
GHS07
Achtg.

H361f (*)(*)(*)
H317

607-414-00-6

tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate

402-070-1

88122-99-0

Aquatic Chronic 4

H413

607-415-00-1

poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-a, a-dimethylbenzyl carbamate)-co-(maleicanhydride)

419-590-1

Flam. Sol. 1
Skin Sens. 1

H228
H317

GHS02
GHS07
Gef.

H228
H317

607-416-00-7

4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide

420-730-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-417-00-2

3-chloropropyl chloroformiate

425-770-9

628-11-5

Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H331
H302
H373**
H315
H318
H317

GHS06
GHS05
GHS08
Gef.

H331
H302
H373**
H315
H318
H317

607-418-00-8

2-ethylhexyl 4-aminobenzoate

420-170-3

26218-04-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-419-00-3

(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid

422-240-9

166596-68-5

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-420-00-9

2,2-bis(hydroxymethyl)butanoic acid

424-090-1

10097-02-6

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-421-00-4

cypermethrincis/trans +/- 40/60;
(RS)-a-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate

257-842-9

52315-07-8

Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H335
H400
H410

GHS07
GHS09
Achtg.

H332
H302
H335
H410

607-422-00-X

a-cypermethrin (ISO);
racemate comprising (R)-a-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
(S)-a-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate

257-842-9

67375-30-8

Acute Tox. 3 *
STOT RE 2 *
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H301
H373**
H335
H400
H410

GHS06
GHS08
GHS09
Gef.

H301
H373**
H335
H410

M=1000

607-423-00-5

esters of mecoprop and of mecoprop-P

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

607-424-00-0

trifloxystrobin (ISO);
(E,E)-a-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester

141517-21-7

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

607-425-00-6

metalaxyl (ISO);
methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate

260-979-7

57837-19-1

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 3

H302
H317
H412

GHS07
Achtg.

H302
H317
H412

607-426-00-1

1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]
n-pentyl-isopentylphthalate; [2]
di-n-pentyl phthalate; [3]
diisopentylphthalate [4]

284-032-2 [1]
[2]
205-017-9 [3]
210-088-4 [4]

84777-06-0 [1]
[2]
131-18-0 [3]
605-50-5 [4]

Repr. 1B
Aquatic Acute 1

H360FD
H400

GHS08
GHS09
Gef.

H360FD
H400

607-427-00-7

bromoxynil heptanoate (ISO);
2,6-dibromo-4-cyanophenyl heptanoate

260-300-4

56634-95-8

Repr. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d (*)(*)(*)
H332
H302
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361d (*)(*)(*)
H332
H302
H317
H410

607-428-00-2

tetrasodium ethylene diamine tetraacetate

200-573-9

64-02-8

Acute Tox. 4 *
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

607-429-00-8

edetic acid;
(EDTA)

200-449-4

60-00-4

Eye Irrit. 2

H319

GHS07
Achtg.

H319

607-430-00-3

BBP;
benzyl butyl phthalate e

201-622-7

85-68-7

Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H400
H410

GHS08
GHS09
Gef.

H360Df
H410

607-431-00-9

prallethrin (ISO);
ETOC;
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate

245-387-9

23031-36-9

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H302
H400
H410

GHS06
GHS09
Gef.

H331
H302
H410

607-432-00-4

S-metolachlor;
reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2]

[1]
[2]

87392-12-9 [1]
178961-20-1 [2]

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

607-433-00-X

cypermethrincis/trans +/- 80/20;
(RS)-a-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate

257-842-9

52315-07-8

Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H335
H315
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H335
H315
H317
H410

607-434-00-5

mecoprop-P [1] and its salts;
(R)-2-(4-chloro-2-methylphenoxy)propionic acid

240-539-0

16484-77-8

Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

607-435-00-0

2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate

416-810-6

111969-64-3

STOT RE 2 (*)
Eye Dam. 1
Aquatic Chronic 2

H373 (*)(*)
H318
H411

GHS08
GHS05
GHS09
Gef.

H373 (*)(*)
H318
H411

607-436-00-6

2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate

417-350-9

Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H400
H410

GHS05
GHS09
Gef.

H315
H318
H410

607-437-00-1

3-(4-aminophenyl)-2-cyano-2-propenoic acid

417-480-6

252977-62-1

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-438-00-7

methyl-2-[(aminosulfonyl)methyl]benzoate

419-010-5

112941-26-1

Acute Tox. 4 (*)
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

607-439-00-2

methyl tetrahydro-2-furancarboxylate

420-670-1

37443-42-8

Eye Dam. 1

H318

GHS05
Gef.

H318

607-440-00-8

methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate

421-220-7

144740-59-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-441-00-3

3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid

421-490-6

167684-63-1

Aquatic Chronic 4

H413

607-442-00-9

benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate

416-050-5

87460-09-1

Eye Dam. 1

H318

GHS05
Gef.

H318

607-444-00-X

reaction mass of:cis-1,4-dimethylcyclohexyl dibenzoate;
trans-1,4-dimethylcyclohexyl dibenzoate

416-230-3

35541-81-2

Aquatic Chronic 4

H413

607-445-00-5

Iron (III) tris(4-methylbenzenesulfonate)

420-960-8

77214-82-5

Eye Dam. 1

H318

GHS05
Gef.

H318

607-446-00-0

methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate

416-240-8

155522-12-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

607-447-00-6

sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate

416-370-5

156738-27-1

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-448-00-1

2,3,5,6-tetrafluorobenzoic acid

416-800-1

652-18-6

Skin Irrit. 2
Eye Dam. 1

H315
H318

GHS05
Gef.

H315
H318

607-449-00-7

reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];
4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]

417-080-1

Self-react. D (*)(*)(*)(*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H242
H317
H400
H410

GHS02
GHS07
GHS09
Gef.

H242
H317
H410

607-450-00-2

2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate

419-040-9

89604-92-2

Aquatic Chronic 4

H413

607-451-00-8

4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt

417-640-5

161935-19-9

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-453-00-9

4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate)

418-100-1

172964-15-7

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

607-454-00-4

reaction mass of:trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;
cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid

418-170-3

116193-72-7

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-455-00-X

1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt

419-520-8

172890-93-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-456-00-5

3-amino-4-chlorobenzoic acid, hexadecyl ester

419-700-6

143269-74-3

Aquatic Chronic 2

H411

GHS09

H411

607-457-00-0

tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)

420-350-1

172277-97-3

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

607-458-00-6

reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;
2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;
2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]

420-850-1

Aquatic Chronic 2

H411

GHS09

H411

607-459-00-1

isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate

418-930-4

Aquatic Chronic 4

H413

607-460-00-7

3-tridecyloxy-propyl-ammonium 9-octadecenoate

418-990-1

778577-53-0

STOT RE 2 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H319
H315
H400
H410

GHS08
GHS07
GHS09
Achtg.

H373 (*)(*)
H319
H315
H410

607-461-00-2

reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;
pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate

421-160-1

Aquatic Chronic 3

H412

607-462-00-8

reaction mass of: 1-hexyl acetate;
2-methyl-1-pentyl acetate;
3-methyl-1-pentyl acetate;
4-methyl-1-pentyl acetate;
other mixed linear and branched C6-alkyl acetates

421-230-1

88230-35-7

Aquatic Chronic 2

H411

GHS09

H411

607-463-00-3

3-(phenothiazin-10-yl)propionic acid

421-260-5

362-03-8

Aquatic Chronic 2

H411

GHS09

H411

607-464-00-9

reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;
5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid

421-280-4

Aquatic Chronic 3

H412

607-465-00-4

tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate

421-440-3

778583-04-3

Aquatic Chronic 3

H412

607-466-00-X

reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;
phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate

421-480-1

Aquatic Chronic 2

H411

GHS09

H411

607-467-00-5

1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate

419-430-9

56533-00-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H373 (*)(*)
H314
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H312
H302
H373 (*)(*)
H314
H410

607-468-00-0

reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;
tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate

419-450-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-469-00-6

disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate

419-460-2

120029-06-3

Aquatic Chronic 3

H412

607-470-00-1

potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate

414-100-0

154336-20-6

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-471-00-7

1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane

429-280-6

151900-44-6

Aquatic Chronic 4

H413

607-473-00-8

pentaerythritol, dipentaerythritol, fatty acids, C_6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid

426-590-3

187412-41-5

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-474-00-3

(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid

410-430-4

117573-89-4

Aquatic Chronic 4

H413

607-475-00-9

reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)

412-940-2

148878-18-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-476-00-4

trisodiumN,N-bis(carboxymethyl)-ß-alanine

414-070-9

129050-62-0

Skin Corr. 1B
Aquatic Chronic 3

H314
H412

GHS05
Gef.

H314
H412

607-477-00-X

(1a5a6a)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt

426-740-8

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

607-478-00-5

tetramethylammonium hydrogen phthalate

416-900-5

79723-02-7

Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1

H301
H373 (*)(*)
H400

GHS06
GHS08
GHS09
Gef.

H301
H373 (*)(*)
H400

607-479-00-0

hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate

418-550-9

168689-49-4

Aquatic Chronic 4

H413

607-480-00-6

1,2-benzenedicarboxylic acid;
di-C7-11-branched and linear alkylesters

271-084-6

68515-42-4

Repr. 1B

H360Df

GHS08
Gef.

H360Df

607-481-00-1

reaction mass of: trihexyl citrate;
dihexyloctyl citrate;
dioctylhexyl citrate;
dihexyldecyl citrate

430-290-8

Aquatic Chronic 4

H413

607-482-00-7

N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride

430-360-8

84793-24-8

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-483-00-2

1,2-benzenedicarboxylic acid;
di-C_6-8-branched alkylesters, C₇-rich

276-158-1

71888-89-6

Repr. 1B

H360D***

GHS08
Gef.

H360D***

607-484-00-8

ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl]ethylamino}propionate

430-480-0

221452-67-1

Aquatic Chronic 4

H413

607-485-00-3

(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate

430-510-2

Aquatic Chronic 4

H413

607-486-00-9

potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'-disulfonate

402-110-8

110081-40-8

Aquatic Chronic 3

H412

607-487-00-4

reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;
trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate

402-660-9

Repr. 1B
Aquatic Chronic 3

H360D (*)(*)(*)
H412

GHS08
Gef.

H360D (*)(*)(*)
H412

607-488-00-X

ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate

414-210-9

147379-38-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-489-00-5

reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;
2-ethylhexyl epoxyoleate;
2-ethylhexyl diepoxylinoleate;
2-ethylhexyl triepoxylinolenate

414-890-7

71302-79-9

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-490-00-0

N-[2-hydroxy-3-(C_12-16-alkyloxy)propyl]-N-methyl glycinate

415-060-7

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-491-00-6

reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2);
triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)

427-140-9

Carc. 2

H351

GHS08
Achtg.

H351

607-492-00-1

2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate

415-490-5

141773-73-1

Aquatic Chronic 2

H411

GHS09

H411

607-493-00-7

methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate

415-670-3

78850-37-0

Eye Dam. 1

H318

GHS05
Gef.

H318

607-494-00-2

bis(2-ethylhexyl)octylphosphonate

417-170-0

52894-02-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-495-00-8

sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate

417-550-6

168151-92-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-496-00-3

2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite

418-310-3

126050-54-2

Aquatic Chronic 4

H413

607-497-00-9

cerium oxide isostearate

419-760-3

Aquatic Chronic 4

H413

607-498-00-4

(E)-3,7-dimethyl-2,6-octadienylhexadecanoate

421-370-3

3681-73-0

Skin Irrit. 2
Aquatic Chronic 4

H315
H413

GHS07
Achtg.

H315
H413

607-499-00-X

bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)

421-660-1

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

607-500-00-3

calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate

421-670-4

Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H315
H400
H410

GHS07
GHS09
Achtg.

H315
H410

607-501-00-9

reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives

421-820-9

192268-65-8

Aquatic Chronic 4

H413

607-502-00-4

(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate

422-200-0

178277-55-9

Skin Corr. 1B
Acute Tox. 4 (*)
Aquatic Chronic 2

H314
H302
H411

GHS05
GHS07
GHS09
Gef.

H314
H302
H411

607-503-00-X

2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane

422-210-5

68957-94-8

Skin Corr. 1B

H314

GHS05
Gef.

H314

607-504-00-5

diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate

422-670-7

Repr. 2
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H361f
H301
H373**
H400
H410

GHS06
GHS08
GHS09
Gef.

H361f
H301
H373**
H410

607-505-00-0

pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate

422-930-1

Aquatic Chronic 3

H412

607-506-00-6

reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;
disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate

422-970-8

Aquatic Chronic 2

H411

GHS09

H411

607-507-00-1

potassium, sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate

422-980-2

187026-95-5

Eye Dam. 1

H318

GHS05
Gef.

H318

607-508-00-7

disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]

423-110-4

Eye Dam. 1

H318

GHS05
Gef.

H318

607-509-00-2

2-phenoxyethyl 4-aminobenzoate

430-880-5

88938-23-2

Aquatic Chronic 2

H411

GHS09

H411

607-510-00-8

(2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide

427-200-4

76646-91-8

Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H302
H315
H318
H317

GHS05
GHS07
Gef.

H302
H315
H318
H317

607-511-00-3

reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid;
4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid

423-750-4

Eye Irrit. 2
Aquatic Chronic 2

H319
H411

GHS07
GHS09
Achtg.

H319
H411

607-512-00-9

trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate

423-970-0

182926-43-8

Aquatic Chronic 3

H412

607-513-00-4

reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;
5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid

423-200-3

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

607-514-00-X

potassiumN-(1-methoxy-1-oxobut-2-en-3-yl)valinate

427-240-2

134841-35-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-515-00-5

reaction mass of: disodium hexyldiphenyl ether disulphonate;
disodium dihexyldiphenyl ether disulphonate

429-650-7

147732-60-3

Eye Irrit. 2
Aquatic Chronic 2

H319
H411

GHS07
GHS09
Achtg.

H319
H411

607-516-00-0

N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine

429-670-6

105996-54-1

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-517-00-6

(S)-a-(acetylthio)benzenepropanoic acid

430-300-0

76932-17-7

Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1

H302
H318
H317

GHS05
GHS07
Gef.

H302
H318
H317

607-518-00-1

3-oxoandrost-4-ene-17-ß-carboxylic acid

414-990-0

302-97-6

Repr. 2
Aquatic Chronic 4

H361f
H413

GHS08
Achtg.

H361f
H413

607-519-00-7

poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]

427-280-0

176429-27-9

STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H335
H315
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H335
H315
H318
H410

607-520-00-2

reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C_6-18)alkyl]-3H-imidazolium-N-ethylphosphate;
disodium 4,5-dihydro-2-[(dipropionato)(C_6-18)alkyl]-3H-imidazolium-N-ethylphosphate

427-740-0

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-521-00-8

tetraethylN,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate

429-270-1

136210-30-5

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-522-00-3

sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate

429-720-7

184246-86-4

Aquatic Chronic 3

H412

607-523-00-9

reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10’-diamino-6,6',13,13’-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10’[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate

430-200-7

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-524-00-4

tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters

430-310-5

Aquatic Chronic 4

H413

607-525-00-X

(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid

431-520-1

64485-90-1

Flam. Sol. 1****
Carc. 2
Aquatic Chronic 3

H228
H351
H412

GHS02
GHS08
Gef.

H228
H351
H412

607-526-00-5

cartap (ISO);
1,3-bis(carbamoylthio)-2-(dimethylamino)propane

15263-53-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-527-00-0

reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;
1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate

423-180-6

STOT RE 2 (*)

H373 (*)(*)

GHS08
Achtg.

H373 (*)(*)

607-528-00-6

(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid

430-900-2

192725-50-1

Eye Dam. 1

H318

GHS05
Gef.

H318

607-529-00-1

benzylcis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate

426-070-6

67299-45-0

Aquatic Chronic 3

H412

607-530-00-7

reaction mass of isomers of: C_7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate

406-040-9

125643-61-0

Aquatic Chronic 4

H413

607-531-00-2

methyl 3-amino-4,6-dibromo-2-methyl-benzoate

425-190-6

119916-05-1

STOT RE 2 *
Aquatic Chronic 2

H373**
H411

GHS08
GHS09
Achtg.

H373**
H411

607-532-00-8

(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt

425-510-4

167944-94-7

Aquatic Chronic 3

H412

607-533-00-3

pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate

414-910-4

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-534-00-9

ethyl 2-(3-benzoylphenyl)propanoate

414-920-9

60658-04-0

Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Chronic 2

H301
H372**
H317
H411

GHS06
GHS08
GHS09
Gef.

H301
H372**
H317
H411

607-535-00-4

potassium 4-iodo-2-sulfonato-benzoic acid

426-620-5

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-536-00-X

(2,6-xylyloxy) acetic acid

430-910-7

13335-71-2

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

607-537-00-5

isopropylammonium 2-(3-benzoylphenyl)propionate

417-970-1

Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H312
H372**
H318
H400
H410

GHS06
GHS05
GHS08
GHS09
Gef.

H301
H312
H372**
H318
H410

607-539-00-6

propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate

431-000-2

198705-81-6

Aquatic Chronic 4

H413

607-540-00-1

1-(mercaptomethyl)cyclopropylacetic acid

420-240-3

162515-68-6

Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H314
H312
H302
H317
H411

GHS05
GHS07
GHS09
Gef.

H314
H312
H302
H317
H411

607-541-00-7

[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)

421-940-1

28698-31-9

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

607-542-00-2

methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate

422-110-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-543-00-8

poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]

427-480-8

176429-22-4

STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H335
H315
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H335
H315
H318
H410

607-544-00-3

ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate

427-490-2

158585-86-5

Aquatic Chronic 3

H412

607-545-00-9

1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate

424-070-0

94346-09-5

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

607-546-00-4

reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate;
methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate

424-290-7

188070-47-5

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-547-00-X

18-methylnonadecyl 2,2-dimethylpropanoate

424-370-1

125496-22-2

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4

H315
H317
H413

GHS07
Achtg.

H315
H317
H413

607-548-00-5

1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate

431-010-7

154486-26-7

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

607-549-00-0

methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate

424-430-7

125778-19-0

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-550-00-6

2-amino-4-bromo-5-chlorobenzoic acid

424-700-4

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-551-00-1

tetrabutylammonium 2-amino-6-iodopurinate

424-710-9

156126-48-6

Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H312
H302
H373**
H315
H318
H317
H411

GHS05
GHS08
GHS07
GHS09
Gef.

H312
H302
H373**
H315
H318
H317
H411

607-552-00-7

hexadecyl 3-amino-4-isopropoxybenzoate

424-830-1

Aquatic Chronic 4

H413

607-553-00-2

7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6 (or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt

424-850-0

Eye Dam. 1

H318

GHS05
Gef.

H318

607-554-00-8

2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid

424-870-1

27624-67-5

Expl. 1.1
Eye Dam. 1
Aquatic Chronic 3

H201
H318
H412

GHS01
GHS05
Gef.

H201
H318
H412

607-555-00-3

1,1,3,3-tetramethylbutylperoxypivalate

424-980-8

22288-41-1

Flam. Liq. 2
Org. Perox. D
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H225
H242
H315
H317
H411

GHS02
GHS07
GHS09
Gef.

H225
H242
H315
H317
H411

607-556-00-9

2-acetoxymethylene-4-acetylphenylacetate

425-160-2

24085-06-1

Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373**
H318
H317
H400
H410

GHS05 GHS08 GHS07 GHS09 Gef.

H302
H373**
H318
H317
H410

607-557-00-4

salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid

425-210-3

169939-84-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-558-00-X

2S-isopropyl-5R-methyl-1R-cyclohexyl (2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]-oxathiolane-2-carboxylate

425-250-1

147027-10-9

Aquatic Chronic 2

H411

GHS09

H411

607-559-00-5

coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid

425-400-6

179986-09-5

Aquatic Chronic 4

H413

607-560-00-0

(R,S)-2-butyloctanedioic acid

431-210-4

50905-10-7

Eye Dam. 1

H318

GHS05
Gef.

H318

607-561-00-6

sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate

425-460-3

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-562-00-1

reaction mass of: (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;
(2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate

425-530-3

98769-75-6

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

607-563-00-7

5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid

431-250-2

171850-30-9

Aquatic Chronic 2

H411

GHS09

H411

607-564-00-2

1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate

425-730-0

51178-75-7

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-565-00-8

3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate

425-820-1

88150-42-9

Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H373**
H318
H400
H410

GHS06
GHS05
GHS08
GHS09
Gef.

H301
H373**
H318
H410

607-566-00-3

reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate;
bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate

426-140-6

Aquatic Chronic 4

H413

607-567-00-9

potassium 3-iodo-6-methylbenzenesulfonate

426-300-5

Eye Dam. 1

H318

GHS05
Gef.

H318

607-568-00-4

potassium 2-chloro-3-(benzyloxy)propionate

426-350-8

138666-92-9

Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1

H302
H373**
H318
H317

GHS05
GHS08
GHS07
Gef.

H302
H373**
H318
H317

607-569-00-X

reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate;
sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate

426-470-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-570-00-5

sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate

426-520-1

71420-85-4

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-571-00-0

2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate

431-400-7

57374-49-9

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-572-00-6

diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate

426-790-0

162208-27-7

Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H373**
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H312
H302
H373**
H317
H410

607-573-00-1

reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate;
disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate

426-840-1

Eye Dam. 1

H318

GHS05
Gef.

H318

607-574-00-7

[1R-(1-a,2ß,5a)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate

426-890-4

77341-67-4

Eye Dam. 1

H318

GHS05
Gef.

H318

607-575-00-2

4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt

426-900-7

STOT SE 3
Aquatic Chronic 3

H335
H412

GHS07
Achtg.

H335
H412

607-576-00-8

branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate

427-030-0

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-577-00-3

(2R*,3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate

427-100-0

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H302
H318
H317
H412

GHS05
GHS07
Gef.

H302
H318
H317
H412

607-578-00-9

ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate

427-110-5

Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 4

H302
H373**
H413

GHS08
GHS07
Achtg.

H302
H373**
H413

607-579-00-4

diethyl[(p-ethoxyanilino)methylene]malonate

431-430-0

103976-28-9

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

607-580-00-X

ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate

422-360-1

100491-29-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-581-00-5

ethyl 2-ethoxy-4-carboxymethylbenzoate

427-630-2

99469-99-5

Eye Dam. 1

H318

GHS05
Gef.

H318

607-582-00-0

reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate

427-650-1

Aquatic Chronic 3

H412

607-583-00-6

4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid

427-680-5

188907-52-0

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

607-584-00-1

trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate

427-710-7

215612-56-9

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

607-585-00-7

strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate

427-930-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-586-00-2

dodecyl 3-amino-4-chlorobenzoate

428-020-9

6195-20-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

607-587-00-8

ethylcis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate

428-030-3

67914-69-6

Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H373**
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373**
H410

607-588-00-3

reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate;
bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate

428-050-2

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

607-589-00-9

tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate

428-070-1

91788-83-9

STOT RE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H372**
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H372**
H302
H410

607-590-00-4

hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate

428-140-1

210706-50-6

Aquatic Chronic 4

H413

607-591-00-X

reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;
disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate

428-400-4

Eye Dam. 1

H318

GHS05
Gef.

H318

607-592-00-5

di(C_9-11-alkyl) cyclohexane-1,4-dicarboxylate

428-870-0

Aquatic Chronic 4

H413

607-593-00-0

4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate

429-000-2

159235-16-2

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-594-00-6

ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate

429-020-1

204254-96-6

STOT RE 2 *
Skin Sens. 1

H373**
H317

GHS08
GHS07
Achtg.

H373**
H317

607-595-00-1

N-amidino-N-methylglycine-2-oxopropionate

429-120-5

208535-04-0

Eye Dam. 1

H318

GHS05
Gef.

H318

607-596-00-7

ethyl 2-(4-phenoxyphenyl)lactate

429-220-9

132584-17-9

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

607-597-00-2

tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate

429-230-3

Eye Dam. 1

H318

GHS05
Gef.

H318

607-598-00-8

trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate

429-240-8

212652-59-0

Eye Dam. 1

H318

GHS05
Gef.

H318

607-599-00-3

1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate

431-610-9

68860-54-8

Org. Perox. D
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H242
H317
H400
H410

GHS02
GHS07
GHS09
Gef.

H242
H317
H410

607-600-00-7

(1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate

431-700-8

Aquatic Chronic 2

H411

GHS09

H411

607-601-00-2

1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate

429-370-5

220410-74-2

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

607-602-00-8

ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate

429-680-0

122665-86-5

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-603-00-3

lithium sodium 4,4',4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate

429-730-1

193562-37-7

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-604-00-9

guanidinium benzoate

429-820-0

26739-54-8

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

607-605-00-4

methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate

429-890-2

144550-06-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-606-00-X

(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid

430-100-3

86978-24-7

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

607-607-00-5

reaction mass of: calcium bis(C_10-14 branched alkyl salicylate);
calcium bis(C_18-30-alkyl salicylate);
calcium C_10-14 branched alkylsalicylato-C_18-30-alkyl salicylate;
calcium bis (C_10-14 branched alkyl phenolate);
calcium bis (C_18-30-alkyl phenolate);
calcium C_10-14 branched alkylphenolato-C_18-30-alkyl phenolate;
C_10-14 branched alkyl phenol;
C_18-30-alkyl phenol

430-180-1

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

607-608-00-0

pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate

430-210-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-609-00-6

ethyl (3R)-4-cyano-3-hydroxybutanoate

430-220-6

141942-85-0

Eye Irrit. 2

H319

GHS07
Achtg.

H319

607-610-00-1

trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate

430-280-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-611-00-7

methyl 3-amino-2,2,3-trimethylbutyrate

431-720-7

90886-53-6

Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 3

H314
H302
H412

GHS05
GHS07
Gef.

H314
H302
H412

607-612-00-2

reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid;
ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate

432-190-1

182176-52-9

Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1

H302
H373**
H318

GHS05
GHS08
GHS07
Gef.

H302
H373**
H318

607-613-00-8

reaction mass of:
succinic acid
monopersuccinic acid
dipersuccinic acid
monomethyl ester of succinic acid
monomethyl ester of persuccinic acid
dimethyl succinate
glutaric acid
monoperglutaric acid
diperglutaric acid
monomethyl ester of glutaric acid
monomethyl ester of perglutaric acid
dimethyl glutarate
adipic acid
monoperadipic acid
diperadipic acid
monomethyl ester of adipic acid
monomethyl ester of peradipic acid
dimethyl adipate
hydrogen peroxide
methanol
water

432-790-1

Acute Tox. 4*

H332

GHS07

H332

Acute Tox. 4*

H312

GHS05

H312

Acute Tox. 4*

H302

GHS08

H302

Skin Corr. 1B

H314

Gef.

H314

STOT SE 2

H371 (Augen)

607-614-00-3

2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid

426-480-5

63562-33-4

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

607-615-00-9

reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance

431-120-5

Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1

H331
H302
H319
H317

GHS06
Gef.

H331
H302
H319
H317

607-616-00-4

2,4-dichloro-5-fluorobenzoylchloride

428-390-1

86393-34-2

STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H335
H315
H318
H317
H412

GHS05
GHS07
Gef.

H335
H315
H318
H317
H412

607-617-00-X

bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate

430-700-5

10138-36-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-618-00-5

menadione sodium bisulfite;
2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt

204-987-0

130-37-0

Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H315
H410

607-619-00-0

menadione nicotinamide bisulfite;
1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)

277-543-7

73581-79-0

Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H315
H410

607-620-00-6

trisodium nitrilotriacetate

225-768-6

5064-31-3

Carc. 2
Acute Tox. 4 *
Eye Irrit. 2

H351
H302
H319

GHS08
GHS07
Achtg.

H351
H302
H319

Carc. 2; H351: C> 5 %

607-621-00-1

milbemectin (ISO);
[reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H302
H410

M=100

607-622-00-7

2-ethylhexyl-2-ethylhexanoate

231-057-1

7425-14-1

Repr. 2

H361d***

GHS08
Achtg.

H361d***

607-623-00-2

Diisobutylphthalat

201-553-2

84-69-5

Repr. 1B

H360Df

GHS08
Gef.

H360Df

607-624-00-8

perfluorooctane sulfonic acid;
heptadecafluorooctane-1-sulfonic acid; [1]
potassium perfluorooctanesulfonate;
potassium heptadecafluorooctane-1-sulfonate; [2]
diethanolamine perfluorooctane sulfonate; [3]
ammonium perfluorooctane sulfonate;
ammonium heptadecafluorooctanesulfonate; [4]
lithium perfluorooctane sulfonate;
lithium heptadecafluorooctanesulfonate [5]

217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5]

1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5]

Carc. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Lact.
Aquatic Chronic 2

H351
H360D***
H372**
H332
H302
H362
H411

GHS08
GHS07
GHS09
Gef.

H351
H360D***
H372**
H332
H302
H362
H411

607-625-00-3

clodinafop-propargyl (ISO)

105512-06-9

Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373**
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373**
H317
H410

Skin Sens. 1; H317: C> 0,001 %
M=1

607-626-00-9

ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate

401-290-5

103112-35-2

Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H400
H410

GHS08
GHS09
Gef.

H350
H410

607-627-00-4

[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate

416-360-0

162221-28-5

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-628-00-X

4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine

419-240-6

171054-89-0

Eye Dam. 1

H318

GHS05
Gef.

H318

607-629-00-5

[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid

419-270-1

123599-82-6

Eye Irrit. 2

H319

GHS07
Achtg.

H319

607-630-00-0

acrylic acid, 3-(trimethoxysilyl)propyl ester

419-560-6

4369-14-6

Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3

H332
H314
H317
H412

GHS05
GHS07
Gef.

H332
H314
H317
H412

607-631-00-6

reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;
(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate

442-300-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-632-00-1

N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide

420-210-1

111244-14-5

Aquatic Chronic 4

H413

607-633-00-7

trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate

440-480-2

341026-59-3

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-634-00-2

(S)-(-)-2-acetoxypropionylchloride;
(1S)-2-chloro-1-methyl-2-oxoethyl acetate

420-610-4

36394-75-9

Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1

H302
H314
H317

GHS05
GHS07
Gef.

H302
H314
H317

607-635-00-8

trisodiumN-(3-propionato)-l-aspartate

422-090-4

172737-80-3

Eye Dam. 1

H318

GHS05
Gef.

H318

607-636-00-3

1-bromo-2-methylpropyl propionate

422-900-6

158894-67-8

Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Skin Sens. 1

H226
H351
H314
H317

GHS02
GHS05
GHS08
GHS07
Gef.

H226
H351
H314
H317

607-637-00-9

disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate

423-730-5

250688-43-8

Eye Dam. 1

H318

GHS05
Gef.

H318

607-638-00-4

2-hydroxybenzoic acid 2-butyloctyl ester

431-090-3

190085-41-7

Aquatic Chronic 4

H413

607-639-00-X

2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate

431-770-1

216698-07-6

Aquatic Chronic 4

H413

607-641-00-0

2-(formylamino)-3-thiophenecarboxylic acid;
2-formamido-3-thiophenecarboxylic acid

431-930-9

43028-69-9

Acute Tox. 4 *
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

607-642-00-6

3,6,9-trithiaundecamethylene-1,11-dimethacrylate

432-210-7

141631-22-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

607-643-00-1

dimethyl (2S)-2-hydroxysuccinate

432-310-0

617-55-0

Flam. Liq. 3
Eye Dam. 1
Skin Sens. 1

H226
H318
H317

GHS02
GHS05
GHS07
Gef.

H226
H318
H317

607-644-00-7

methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate

432-350-9

81752-87-6

Skin Irrit. 2

H315

GHS07
Achtg.

H315

607-645-00-2

tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate

432-550-6

243858-01-7

Eye Dam. 1

H318

GHS05
Gef.

H318

607-646-00-8

d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;
tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate

432-960-5

124655-09-0

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

607-647-00-3

5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane

433-530-1

143446-73-5

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1

H302
H317
H400

GHS07
GHS09
Achtg.

H302
H317
H400

607-649-00-4

[3-(chlorocarbonyl)-2-methylphenyl]acetate

433-690-0

167678-46-8

Skin Corr. 1a
Skin Sens. 1

H314
H317

GHS05
GHS07
Gef.

H314
H317

607-650-00-X

2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate

433-910-5

145153-52-2

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-651-00-5

sodium 2-(nonanoyloxy)benzenesulfonate

434-360-9

91125-43-8

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-652-00-0

ethylN²-dodecanoyl-l-argininate hydrochloride

434-630-6

60372-77-2

Eye Dam. 1
Aquatic Acute 1

H318
H400

GHS05
GHS09
Gef.

H318
H400

607-653-00-6

tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate

434-840-8

225786-91-4

Aquatic Chronic 2

H411

GHS09

H411

607-654-00-1

(S)-3-hydroxy-?-butyrolactone

434-990-4

7331-52-4

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-655-00-7

ethyl 6,8-dichlorooctanoate

435-080-1

1070-64-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-656-00-2

sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid

435-350-7

141250-43-3

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-657-00-8

pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate

436-920-8

172399-10-9

Eye Dam. 1

H318

GHS05
Gef.

H318

607-658-00-3

3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt

440-770-9

371921-63-0

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-659-00-9

pentasodiumN-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid

442-030-0

321912-47-4

Eye Dam. 1

H318

GHS05
Gef.

H318

607-660-00-4

2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt

442-230-8

321679-52-1

Eye Dam. 1

H318

GHS05
Gef.

H318

607-661-00-X

1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate

442-850-9

114772-40-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

607-662-00-5

methyl 2-(acetylamino)-3-chloropropionate

442-860-3

87333-22-0

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

607-663-00-0

bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate

442-980-6

127474-91-3

Aquatic Chronic 4

H413

607-664-00-6

methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate

443-120-2

393509-79-0

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

607-665-00-1

trans-methyl-2-ethyl-but-2-enoate

443-150-6

101226-85-1

Flam. Liq. 3

H226

GHS02
Achtg.

H226

607-666-00-7

(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid

443-560-5

88784-33-2

Eye Irrit. 2

H319

GHS07
Achtg.

H319

607-667-00-2

chloro-1-ethylcyclohexyl carbonate

444-950-8

99464-83-2

Muta. 2
Skin Sens. 1

H341
H317

GHS08
GHS07
Achtg.

H341
H317

607-668-00-8

trans-2-isopropyl-5-carboxy-1,3-dioxane

445-770-2

42031-28-7

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

607-669-00-3

methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate

445-990-9

376588-17-9

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

607-670-00-9

dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;
(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate

448-700-9

500791-70-8

STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373**
H318
H317
H400
H410

GHS05
GHS08
GHS07
GHS09
Gef.

H373**
H318
H317
H410

M=10

607-671-00-4

diethyl 1,4-cyclohexanedicarboxylate

417-310-0

72903-27-6

Aquatic Chronic 2

H411

GHS09

H411

607-672-00-X

reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;
1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;
x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate

419-000-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-673-00-5

1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate

419-570-0

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

607-675-00-6

reaction mass of:cis-9-octadecenedioic acid;
cis-9-cis-12-octadecadienedioic acid;
hexadecanedioic acid;
octadecanedioic acid

422-260-8

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

607-676-00-1

reaction mass of: 2-methylnonanedioic acid;
2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;
8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid

423-670-1

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

607-677-00-7

2,5-dioxopyrrolidin-1-ylN-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-l-valinate

424-660-8

STOT RE 2 *
Eye Dam. 1
Skin Sens. 1

H373**
H318
H317

GHS05
GHS08
GHS07
Gef.

H373**
H318
H317

607-678-00-2

reaction mass of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;
ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate

427-090-8

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-679-00-8

reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);
3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);
3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)

431-440-5

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

607-680-00-3

tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate

432-810-9

Aquatic Chronic 4

H413

607-681-00-9

reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;
9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;
dihexadecyl 9-nonyl-10-octylnonadecandioate;
1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;
dioctadecyl 9-nonyl-10-octylnonadecandioate

432-910-2

Aquatic Chronic 4

H413

607-682-00-4

complex reaction mass of Chinese gum rosin post reacted with acrylic acid

434-230-1

144413-22-9

Aquatic Chronic 4

H413

607-683-00-X

reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)

435-450-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

607-684-00-5

alkenes, C_12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts

435-660-2

243662-67-1

Skin Irrit. 2
Skin Sens. 1

H315
H317

GHS07
Achtg.

H315
H317

607-685-00-0

ammonium 2-cocoyloxyethanesulfonate

441-050-7

Skin Irrit. 2
Eye Dam. 1

H315
H318

GHS05
Gef.

H315
H318

607-686-00-6

6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)

441-550-5

Self-react. C ****
Carc. 2

H242
H351

GHS02
GHS08
Gef.

H242
H351

607-687-00-1

reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)

442-800-6

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

607-688-00-7

(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride

444-320-2

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

607-689-00-2

reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate ("para-isomer" includingcis- andtrans- isomers);
methyl 1,3-dimethylcyclohexanecarboxylate ("meta-isomer" includingcis- andtrans-isomers)

444-920-4

Aquatic Chronic 3

H412

607-690-00-8

dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoate

432-860-1

255387-46-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

607-691-00-3

magnesium salts, fatty acids, C_16-18 and C₁₈ unsaturated, branched and linear

448-690-6

Aquatic Chronic 4

H413

607-692-00-9

zinc salts, fatty acids, C_16-18 and C₁₈ unsaturated, branched and linear

446-470-4

Aquatic Chronic 4

H413

607-693-00-4

hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate

443-860-6

302776-68-7

Aquatic Chronic 4

H413

607-694-00-X

ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate

443-870-0

163520-33-0

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

607-696-00-0

pentyl formate

211-340-6

638-49-3

Flam. Liq. 3
Eye Irrit. 2
STOT SE 3

H226
H319
H335

GHS02
GHS07
Gef.

H226
H319
H335

607-697-00-6

tert-butyl propionate

20487-40-5

Flam. Liq. 2

H225

GHS02
Gef.

H225

607-698-00-1

4-tert-butylbenzoic acid

202-696-3

98-73-7

Repr. 1B
STOT RE 1
Acute Tox. 4

H360F
H372
H302

GHS07
GHS08
Gef.

H360F
H372
H302

607-699-00-7

bifenthrin (ISO);
(2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

82657-04-3

Carc. 2

H351

GHS06

H351

M = 10000
M = 100000

Acute Tox. 3

H331

GHS08

H331

Acute Tox. 2

H300

GHS09

H300

STOT RE 1

H372 (Nerven-system)

Gef.

H372 (Nerven-system)

Skin Sens. 1B

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

607-700-00-0

indoxacarb (ISO);
methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]

173584-44-6 [1]

Acute Tox. 3

H301

GHS06

H301

M = 1
M = 1

Acute Tox. 4

H332

GHS08

H332

STOT RE 1

H372 (Blut, Nervensystem, Herz)

GHS09

H372 (Blut, Nervensystem, Herz)

Skin Sens. 1B

H317

Gef.

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]

144171-61-9 [2]

607-702-00-1

dihexyl phthalate

201-559-5

84-75-3

Repr. 1B

H360FD

GHS08
Gef.

H360FD

607-703-00-7

ammoniumpentadeca-fluorooctanoate

223-320-4

3825-26-1

Carc. 2

H351

GHS08

H351

Repr. 1B

H360D

GHS07

H360D

Lact.

H362

GHS05

H362

Acute Tox. 4

H332

Gef.

H332

Acute Tox. 4

H302

STOT RE 1

H372 (Leber)

Eye Dam.1

H318

607-704-00-2

perfluorooctanoic acid

206-397-9

335-67-1

Carc. 2

H351

GHS08

H351

Repr. 1B

H360D

GHS07

H360D

Lact.

H362

GHS05

H362

Acute Tox. 4

H332

Gef.

H332

Acute Tox. 4

H302

STOT RE 1

H372 (Leber)

Eye Dam. 1

H318

607-705-00-8

benzoic acid

200-618-2

65-85-0

STOT RE 1
Skin Irrit. 2
Eye Dam. 1

H372 (Lunge) (Einatmen)
H315
H318

GHS08
GHS05
Gef.

H372 (Lunge) (Einatmen)
H315
H318

607-706-00-3

methyl 2,5-dichlorobenzoate

220-815-7

2905-69-3

Acute Tox. 4
STOT SE 3
Aquatic Chronic 2

H302
H336
H411

GHS07
GHS09
Achtg.

H302
H336
H411

607-707-00-9

Fenoxaprop-P-ethyl (ISO); Ethyl (2R)-2-{4-[(6-chlor-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoat

71283-80-2

STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373 (Nieren)
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H373 (Nieren)
H317
H410

M = 1
M = 1

607-708-00-4

Octansäure

204-677-5

124-07-2

Skin Corr. 1C
Aquatic Chronic 3

H314
H412

GHS05
Gef.

H314
H412

607-709-00-X

Decansäure

206-376-4

334-48-5

Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic 3

H315
H319
H412

GHS07
Achtg.

H315
H319
H412

607-710-00-5

1,2-Benzoldicarbonsäure, Dihexylester, verzweigt und linear

271-093-5

68515-50-4

Repr. 1B

H360FD

GHS08
Gef.

H360FD

607-711-00-0

Spirotetramat (ISO); (5s,8s)-3-(2,5-Dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-ylethylcarbonat

203313-25-1

Repr. 2
STOT SE 3
Eye Irrit. 2
Skin Sens. 1a
Aquatic Acute 1
Aquatic Chronic 1

H361fd
H335
H319
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361fd
H335
H319
H317
H410

M = 1
M = 1

607-712-00-6

Dodemorphacetat; 4-Cyclododecyl-2,6-dimethylmorpholin-4-ium acetat

250-778-2

31717-87-0

Repr. 2
STOT RE 2
Skin Corr. 1C
Skin Sens. 1a
Aquatic Chronic 1

H361d
H373 (Leber)
H314
H317
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H361d
H373 (Leber)
H314
H317
H410

EUH071

M = 1

607-713-00-1

Fenpyroximat (ISO); Tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylen]amino}oxy)methyl]benzoat

134098-61-6

Acute Tox. 3
Acute Tox. 2
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1

H301
H330
H317
H400
H410

GHS06 GHS09
Gef.

H301
H330
H317
H410

M = 100
M = 1 000

607-714-00-7

Triflusulfuron-methyl; Methyl 2-({[4-(dimethylamino)-6-(2,2,2-trifluorethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoat

126535-15-7

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

M = 100
M = 10

607-715-00-2

Bifenazat (ISO); Isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazincarboxylat

442-820-5

149877-41-8

STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H373
H317
H410

M = 1
M = 1

607-716-00-8

Bromadiolon (ISO); 3-[3-(4'-Brombiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2H-chromen-2-on

249-205-9

28772-56-7

Repr. 1B
Acute Tox. 1
Acute Tox. 1
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H360D
H330
H310
H300
H372 (Blut)
H400
H410

GHS08
GHS06
GHS09
Gef.

H360D
H330
H310
H300
H372 (Blut)
H410

Repr. 1B; H360D:
C> 0,003 %
STOT RE 1; H372 (Blut): C> 0,005 % STOT RE 2; H373 (Blut):
0,0005 % ≤ C < 0,005 %
M = 1
M = 1

607-717-00-3

Difethialon (ISO);
3-[3-(4'-Brombiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-1-benzothiopyran-2-on

104653-34-1

Repr. 1B
Acute Tox. 1
Acute Tox. 1
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H360D
H330
H310
H300
H372 (Blut)
H400
H410

GHS08
GHS06
GHS09
Gef.

H360D
H330
H310
H300
H372 (Blut)
H410

EUH070

Repr. 1B; H360D:
C> 0,003 %
STOT RE 1; H372 (Blut): C> 0,02 % STOT RE 2; H373 (Blut):
0,002 % ≤ C < 0,02 %
M = 100
M = 100

607-718-00-9

Perfluornonan-1-säure [1] und ihre Natrium- [2] und Ammoniumsalze [3]

206-801-3 [1]
[2]
[3]

375-95-1 [1]
21049-39-8 [2]
4149-60-4 [3]

Carc. 2
Repr. 1B
Lakt.
Acute Tox. 4
Acute Tox. 4
STOT RE 1
Eye Dam. 1

H351
H360Df
H362
H332
H302
H372 (Leber, Thymus, Milz)
H318

GSH08
GSH07
GHS05
Gef.

H351
H360Df
H362
H332
H302
H372 (Leber, Thymus, Milz)
H318

607-719-00-4

Dicyclohexylphthalat

201-545-9

84-61-7

Repr. 1B
Skin Sens. 1

H360D
H317

GHS08
GHS07
Gef.

H360D
H317

607-720-00-X

Nonadecafluordecansäure; [1]
Ammoniumnonadecafluordecanoat; [2]
Natriumnonadecafluordecanoat [3]

206-400-3 [1]
221-470-5 [2]
[3]

335-76-2 [1]
3108-42-7 [2]
3830-45-3 [3]

Carc. 2
Repr. 1B
Lact.

H351
H360Df
H362

GHS08
Gef.

H351
H360Df
H362

607-721-00-5

N,N'-Methylendimorpholin;
N,N'-Methylenbismorpholin;
[aus N,N2-Methylenbismorpholin freigesetztes Formaldehyd];
[MBM]

227-062-3

5625-90-1

Carc. 1B
Muta. 2
Acute Tox. 4
Acute Tox. 4
Acute Tox. 4
STOT RE 2
Skin Corr. 1B
Skin Sens. 1
Eye Dam.1

H350
H341
H332
H312
H302
H373 (Magen-Darm-Trakt, Atemwege)
H314
H317
H318

GHS08
GHS07
GHS05
Gef.

H350
H341
H332
H312
H302
H373 (Magen-Darm-Trakt, Atemwege)
H314
H317

EUH071

8
9

607-722-00-0

2,3,5,6-Tetrafluor-4-(methoxymethyl)benzyl-(Z)-(1R,3R)-3-(2-cyanoprop- 1-enyl)-2,2-dimethylcyclopropancarboxylat;
Epsilon-momfluorothrin

1065124-65-3

Acute Tox. 4
STOT SE 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H371
(Nervensystem)
H400
H410

GHS07
GHS08
GHS09
Achtg.

H302
H371
(Nervensystem)
H410

M = 100
M = 100

607-723-00-6

Tefluthrin (ISO);
2,3,5,6-Tetrafluor-4-methylbenzyl-(1RS,3RS)-3- [(Z)-2-chlor-3,3,3-trifluorprop-1-enyl]-2,2-dimethylcyclopropancarboxylat

79538-32-2

Acute Tox. 1
Acute Tox. 2
Acute Tox. 2
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H400
H410

GHS06
GHS09
Gef.

H330
H310
H300
H410

M = 10.000
M = 10.000

608-001-00-3

acetonitrile;
cyanomethane

200-835-2

75-05-8

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2

H225
H332
H312
H302
H319

GHS02
GHS07
Gef.

H225
H332
H312
H302
H319

608-002-00-9

trichloroacetonitrile

208-885-7

545-06-2

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2

H331
H311
H301
H411

GHS06
GHS09
Gef.

H331
H311
H301
H411

608-003-00-4

acrylonitrile

203-466-5

107-13-1

Flam. Liq. 2
Carc. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H225
H350
H331
H311
H301
H335
H315
H318
H317
H411

GHS02
GHS06
GHS08
GHS05
GHS09
Gef.

H225
H350
H331
H311
H301
H335
H315
H318
H317
H411

(*)

608-004-00-X

2-hydroxy-2-methylpropionitrile;
2-cyanopropan-2-ol;
acetone cyanohydrin

200-909-4

75-86-5

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H400
H410

GHS06
GHS09
Gef.

H330
H310
H300
H410

608-005-00-5

n-butyronitrile

203-700-6

109-74-0

Flam. Liq. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H225
H331
H311
H301

GHS02
GHS06
Gef.

H225
H331
H311
H301

608-006-00-0

bromoxynil (ISO)
3,5-dibromo-4-hydroxybenzonitrile;
bromoxynil phenol

216-882-7

1689-84-5

Repr. 2
Acute Tox. 2 (*)
Acute Tox. 3 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d (*)(*)(*)
H330
H301
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H361d (*)(*)(*)
H330
H301
H317
H410

M=10

608-007-00-6

ioxynil (ISO)
4-hydroxy-3,5-diiodobenzonitrile

216-881-1

1689-83-4

Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H361d (*)(*)(*)
H331
H301
H312
H373 (*)(*)
H319
H400
H410

GHS06
GHS08
GHS09
Gef.

H361d (*)(*)(*)
H331
H301
H312
H373 (*)(*)
H319
H410

M=10

608-008-00-1

chloroacetonitrile

203-467-0

107-14-2

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2

H331
H311
H301
H411

GHS06
GHS09
Gef.

H331
H311
H301
H411

608-009-00-7

malononitrile

203-703-2

109-77-3

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H410

608-010-00-2

methacrylonitrile;
2-methyl-2-propene nitrile

204-817-5

126-98-7

Flam. Liq. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Sens. 1

H225
H331
H311
H301
H317

GHS02
GHS06
Gef.

H225
H331
H311
H301
H317

(*)
Skin Sens. 1; H317: C> 0,2 %

608-011-00-8

oxalonitrile;
cyanogen

207-306-5

460-19-5

Press. Gas
Flam. Gas 1
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H220
H331
H400
H410

GHS02
GHS04
GHS06
GHS09
Gef.

H220
H331
H410

608-012-00-3

benzonitrile

202-855-7

100-47-0

Acute Tox. 4 (*)
Acute Tox. 4 (*)

H312
H302

GHS07
Achtg.

H312
H302

608-013-00-9

2-chlorobenzonitrile

212-836-5

873-32-5

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2

H312
H302
H319

GHS07
Achtg.

H312
H302
H319

608-014-00-4

chlorothalonil (ISO);
tetrachloroisophthalonitrile

217-588-1

1897-45-6

Carc. 2
Acute Tox. 2 *
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H330
H335
H318
H317
H400
H410

GHS06
GHS05
GHS08
GHS09
Gef.

H351
H330
H335
H318
H317
H410

M=10

608-015-00-X

dichlobenil (ISO);
2,6-dichlorobenzonitrile

214-787-5

1194-65-6

Acute Tox. 4 (*)
Aquatic Chronic 2

H312
H411

GHS07
GHS09
Achtg.

H312
H411

608-016-00-5

1,4-Dicyano-2,3,5,6-tetra-chloro-benzene

401-550-8

1897-41-2

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

608-017-00-0

bromoxynil octanoate (ISO);
2,6-dibromo-4-cyanophenyl octanoate

216-885-3

1689-99-2

Repr. 2
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d (*)(*)(*)
H331
H302
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H361d (*)(*)(*)
H331
H302
H317
H410

M=10

608-018-00-6

ioxynil octanoate (ISO);
4-cyano-2,6-diiodophenyl octanoate

223-375-4

3861-47-0

Repr. 2
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d (*)(*)(*)
H301
H319
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H361d (*)(*)(*)
H301
H319
H317
H410

M=10

608-019-00-1

2,2'-dimethyl-2,2'-azodipropiononitrile;
ADZN

201-132-3

78-67-1

Self-react. C
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Chronic 3

H242
H332
H302
H412

GHS02
GHS07
Gef.

H242
H332
H302
H412

608-020-00-7

diphenoxymethylenecyanamide

427-300-8

79463-77-7

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

608-021-00-2

3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile

403-710-2

76823-93-3

Acute Tox. 4 (*)
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

608-022-00-8

3,7-dimethyloctanenitrile

403-620-3

40188-41-8

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H315
H317
H411

GHS07
GHS09
Achtg.

H315
H317
H411

608-023-00-3

fenbuconazole (ISO);
4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile

406-140-2

114369-43-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

608-024-00-9

2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile

407-650-8

97460-76-9

Aquatic Chronic 4

H413

608-025-00-4

2-nitro-4,5-bis(benzyloxy)phenylacetonitrile

410-970-0

117568-27-1

Aquatic Chronic 4

H413

608-026-00-X

3-cyano-3,5,5-trimethylcyclohexanone

411-490-4

7027-11-4

Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 3

H302
H373 (*)(*)
H317
H412

GHS08
GHS07
Achtg.

H302
H373 (*)(*)
H317
H412

608-027-00-5

reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;
3-(3-ethylphenyl)-2,2-dimethylpropanenitrile

412-660-0

Aquatic Chronic 2

H411

GHS09

H411

608-028-00-0

4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate

413-510-7

147374-67-2

STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2

H373 (*)(*)
H317
H411

GHS08
GHS09
Achtg.

H373 (*)(*)
H317
H411

608-029-00-6

1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile

411-990-2

68612-94-2

Skin Sens. 1

H317

GHS07
Achtg.

H317

608-030-00-1

N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide

412-340-0

147741-93-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

608-031-00-7

2-benzyl-2-methyl-3-butenitrile

407-870-4

97384-48-0

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

608-032-00-2

acetamiprid (ISO);
(E)-N¹-[(6-chloro-3-pyridyl)methyl]-N²-cyano-N¹-methylacetamidine

135410-20-7

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

608-033-00-8

N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide

407-970-8

75511-91-0

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

608-034-00-3

chlorfenapyr (ISO);
4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile

122453-73-0

Acute Tox. 3 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H331
H302
H400
H410

GHS06
GHS09
Gef.

H331
H302
H410

M=100

608-035-00-9

(±)-a-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile

419-290-9

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

608-036-00-4

3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile

419-060-8

79026-02-1

Aquatic Chronic 4

H413

608-037-00-X

reaction mass of: (E)-2,12-tridecadiennitrile;
(E)-3,12-tridecadiennitrile;
(Z)-3,12-tridecadiennitrile

422-190-8

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

608-038-00-5

2,2,4-trimethyl-4-phenyl-butane-nitrile

422-580-8

75490-39-0

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

608-039-00-0

2-phenylhexanenitrile

423-460-8

3508-98-3

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

608-040-00-6

4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)

423-490-1

130755-46-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

608-041-00-1

4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile

423-500-4

138401-24-8

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

608-042-00-7

(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide

421-810-4

194602-27-2

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H317
H411

608-043-00-2

3-(cis-3-hexenyloxy)propanenitril

415-220-6

142653-61-0

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H302
H400
H410

GHS06
GHS09
Gef.

H331
H302
H410

608-044-00-8

2-cyclohexylidene-2-phenylacetonitrile

423-740-1

10461-98-0

Acute Tox. 4 *
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

608-046-00-9

5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile

425-310-7

77889-90-8

Aquatic Chronic 4

H413

608-047-00-4

2-piperidin-1-yl-benzonitrile

427-330-1

72752-52-4

Aquatic Chronic 2

H411

GHS09

H411

608-048-00-X

1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile

427-450-4

152630-47-2

Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2

H302
H373**
H317
H411

GHS08
GHS07
GHS09
Achtg.

H302
H373**
H317
H411

608-049-00-5

2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile

429-180-2

157362-53-3

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

608-050-00-0

reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile;
5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile

429-760-5

Aquatic Chronic 4

H413

608-051-00-6

(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile

430-760-2

219861-18-4

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

608-052-00-1

(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile

430-770-7

128173-52-4

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

608-053-00-7

(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile

430-780-1

103146-25-4

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

608-054-00-2

(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate

430-790-6

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H317
H411

608-055-00-8

Fipronil (ISO);
(±)-5-Amino-1-(2,6-dichlor-a,a,a-trifluor-p-tolyl)-4-trifluormethylsulfinylpyrazol-3-carbonitril

424-610-5

120068-37-3

Acute Tox. 3*
Acute Tox. 3*
Acute Tox. 3*
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H311
H331
H372*
H400
H410

GHS06
GHS08
GHS09
Gef.

H301
H311
H331
H372*
H410

M = 1 000
M = 10 000

608-056-00-3

N-methyl-N-cyanomethylmorpholiniummethylsulfate

429-340-1

Acute Tox. 4 *
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

608-057-00-9

4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate

431-200-1

208538-34-5

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1

H302
H318
H317

GHS05
GHS07
Gef.

H302
H318
H317

608-058-00-4

esfenvalerate (ISO);
(S)-a-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate

66230-04-4

Acute Tox. 3 *
Acute Tox. 3 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H317
H400
H410

GHS06
GHS09
Gef.

H331
H301
H317
H410

M = 10000

608-059-00-X

5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile

421-240-6

120068-79-3

Aquatic Chronic 2

H411

GHS09

H411

608-060-00-5

5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile

421-300-1

138564-59-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

608-062-00-6

2-fluoro-4-hydroxybenzonitrile

422-810-7

82380-18-5

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

608-063-00-1

(S)-a-hydroxy-3-phenoxy-benzeneacetonitrile

441-070-6

61826-76-4

Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H318
H317
H400
H410

GHS06
GHS05
GHS09
Gef.

H301
H318
H317
H410

608-064-00-7

cyanomethyltrimethylammoniummethylsulfate

433-720-2

Aquatic Chronic 3

H412

608-065-00-2

salts of bromoxynil with the exception of those specified elsewhere in this Annex

Repr. 2
Acute Tox. 2 (*)
Acute Tox. 3 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d (*)(*)(*)
H330
H301
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H361d (*)(*)(*)
H330
H301
H317
H410

M=10

608-066-00-8

salts of ioxynil with the exception of those specified elsewhere in this Annex

Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H361d (*)(*)(*)
H331
H301
H312
H373 (*)(*)
H319
H400
H410

GHS06
GHS08
GHS09
Gef.

H361d (*)(*)(*)
H331
H301
H312
H373 (*)(*)
H319
H410

M=10

608-067-00-3

3,7-Dimethylocta-2,6-diennitril

225-918-0

5146-66-7

Muta. 1B

H340

GHS08
Gef.

H340

609-001-00-6

1-nitropropane

203-544-9

108-03-2

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H226
H332
H312
H302

GHS02
GHS07
Achtg.

H226
H332
H312
H302

(*)

609-002-00-1

2-nitropropane

201-209-1

79-46-9

Flam. Liq. 3
Carc. 1B
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H226
H350
H332
H302

GHS02
GHS08
GHS07
Gef.

H226
H350
H332
H302

609-003-00-7

nitrobenzene

202-716-0

98-95-3

Carc. 2.

H351

GHS06

H351

Repr. 1B

H360F

GHS08

H360F

Acute Tox. 3

H301

Gef.

H301

Acute Tox. 3

H331

Acute Tox. 3

H311

STOT RE 1

H372 (Blut)

Aquatic Chronic 3

H412

609-004-00-2

dinitrobenzene; [1]
1,4-dinitrobenzene; [2]
1,3-dinitrobenzene; [3]
1,2-dinitrobenzene [4]

246-673-6 [1]
202-833-7 [2]
202-776-8 [3]
208-431-8 [4]

25154-54-5 [1]
100-25-4 [2]
99-65-0 [3]
528-29-0 [4]

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H373 (*)(*)
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H310
H300
H373 (*)(*)
H410

609-005-00-8

1,3,5-trinitrobenzene

202-752-7

99-35-4

Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H201
H330
H310
H300
H373**
H400
H410

GHS01
GHS06
GHS08
GHS09
Gef.

H201
H330
H310
H300
H373**
H410

609-006-00-3

4-nitrotoluene

202-808-0

99-99-0

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H331
H311
H301
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H411

609-007-00-9

2,4-dinitrotoluene; [1]
dinitrotoluene [2]

204-450-0 [1]
246-836-1 [2]

121-14-2 [1]
25321-14-6 [2]

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H350
H341
H361f***
H331
H311
H301
H373**
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H341
H361f***
H331
H311
H301
H373**
H410

609-008-00-4

2,4,6-trinitrotoluene;
TNT

204-289-6

118-96-7

Expl. 1.1
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H201
H331
H311
H301
H373 (*)(*)
H411

GHS01
GHS06
GHS08
GHS09
Gef.

H201
H331
H311
H301
H373 (*)(*)
H411

609-009-00-X

2,4,6-trinitrophenol;
picric acid

201-865-9

88-89-1

Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *

H201
H331
H311
H301

GHS01
GHS06
Gef.

H201
H331
H311
H301

609-010-00-5

salts of picric acid

Unst. Expl
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)

H201
H331
H311
H301

GHS01
GHS06
Gef.

H201
H331
H311
H301

609-011-00-0

2,4,6-trinitroanisole

606-35-9

Expl. 1.1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Chronic 2

H201
H332
H312
H302
H411

GHS01
GHS07
GHS09
Achtg.

H201
H332
H312
H302
H411

609-012-00-6

2,4,6-trinitro-m-cresol

210-027-1

602-99-3

Expl. 1.1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H201
H332
H312
H302

GHS01
GHS07
Achtg.

H201
H332
H312
H302

609-013-00-1

2,4,6-trinitro-m-xylene

211-187-5

632-92-8

Expl. 1.1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)

H201
H332
H312
H302
H373 (*)(*)

GHS01
GHS08
GHS07
Achtg.

H201
H332
H312
H302
H373 (*)(*)

609-015-00-2

4-nitrophenol;
p-nitrophenol

202-811-7

100-02-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)

H332
H312
H302
H373 (*)(*)

GHS08
GHS07
Achtg.

H332
H312
H302
H373 (*)(*)

609-016-00-8

dinitrophenol (reaction mass of isomers); [1]
2,4(or 2,6)-dinitrophenol [2]

247-096-2 [1]
275-732-9 [2]

25550-58-7 [1]
71629-74-8 [2]

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H373 (*)(*)
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H410

609-018-00-9

2,4,6-trinitroresorcinol;
styphnic acid

201-436-6

82-71-3

Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H201
H332
H312
H302

GHS01
GHS07
Gef.

H201
H332
H312
H302

609-019-00-4

lead 2,4,6-trinitro-m-phenylene dioxide;
lead 2,4,6-trinitroresorcinoxide;
lead styphnate

239-290-0

15245-44-0

Unst. Expl
Repr. 1a
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H200
H360Df
H332
H302
H373 (*)(*)
H400
H410

GHS01
GHS08
GHS07
GHS09
Gef.

H200
H360Df
H332
H302
H373 (*)(*)
H410

609-019-01-1

lead 2,4,6-trinitro-m-phenylene dioxide;
lead 2,4,6-trinitroresorcinoxide;
lead styphnate (> 20 % phlegmatiser)

239-290-0

15245-44-0

Expl. 1.1
Repr. 1a
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H201
H360Df
H332
H302
H373 (*)(*)
H400
H410

GHS01
GHS08
GHS07
GHS09
Gef.

H201
H360Df
H332
H302
H373 (*)(*)
H410

609-020-00-X

DNOC (ISO);
4,6-dinitro-o-cresol

208-601-1

534-52-1

Muta. 2
Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H341
H330
H310
H300
H315
H318
H317
H400
H410

GHS06
GHS08
GHS05
GHS07
GHS09
Gef.

H341
H330
H310
H300
H315
H318
H317
H410

EUH044

609-021-00-5

sodium salt of DNOC;
sodium 4,6-dinitro-o-cresolate; [1]
potassium salt of DNOC;
potassium 4,6-dinitro-o-cresolate [2]

219-007-7 [1]
[2]

2312-76-7 [1]
5787-96-2 [2]

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H373 (*)(*)
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H410

609-022-00-0

ammonium salt of DNOC;
ammonium 4,6-dinitro-o-tolyl oxide

221-037-0

2980-64-5

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H330
H310
H300
H373 (*)(*)
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H310
H300
H373 (*)(*)
H410

609-023-00-6

dinocap (ISO);
(RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which "octyl" is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups

254-408-0

39300-45-3

Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H360D***
H332
H302
H373**
H315
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H360D***
H332
H302
H373**
H315
H317
H410

M=100

609-024-00-1

binapacryl (ISO);
2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate

207-612-9

485-31-4

Repr. 1B
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H360D (*)(*)(*)
H312
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H360D (*)(*)(*)
H312
H302
H410

609-025-00-7

dinoseb(ISO);
6-sec-butyl-2,4-dinitrophenol

201-861-7

88-85-7

Repr. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H311
H301
H319
H400
H410

GHS06
GHS08
GHS09
Gef.

H360Df
H311
H301
H319
H410

EUH044

609-026-00-2

salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex

Repr. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H311
H301
H319
H400
H410

GHS06
GHS08
GHS09
Gef.

H360Df
H311
H301
H319
H410

EUH044

609-027-00-8

dinocton;
reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate

63919-26-6

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

609-028-00-3

dinex (ISO);
2-cyclohexyl-4,6-dinitrophenol

205-042-5

131-89-5

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H410

609-029-00-9

salts and esters of dinex

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H410

609-030-00-4

dinoterb (ISO);
2-tert-butyl-4,6-dinitrophenol

215-813-8

1420-07-1

Repr. 1B
Acute Tox. 2 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H360D (*)(*)(*)
H300
H311
H400
H410

GHS06
GHS08
GHS09
Gef.

H360D (*)(*)(*)
H300
H311
H410

EUH044

609-031-00-X

salts and esters of dinoterb

Repr. 1B
Acute Tox. 2 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H360D (*)(*)(*)
H300
H311
H400
H410

GHS06
GHS08
GHS09
Gef.

H360D (*)(*)(*)
H300
H311
H410

609-032-00-5

bromofenoxim (ISO);
3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime

236-129-6

13181-17-4

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

609-033-00-0

dinosam (ISO);
2-(1-methylbutyl)-4,6-dinitrophenol

4097-36-3

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H410

609-034-00-6

salts and esters of dinosam

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H410

609-035-00-1

nitroethane

201-188-9

79-24-3

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H226
H332
H302

GHS02
GHS07
Achtg.

H226
H332
H302

(*)

609-036-00-7

nitromethane

200-876-6

75-52-5

Flam. Liq. 3
Acute Tox. 4 (*)

H226
H302

GHS02
GHS07
Achtg.

H226
H302

(*)

609-037-00-2

5-nitroacenaphthene

210-025-0

602-87-9

Carc. 1B

H350

GHS08
Gef.

H350

609-038-00-8

2-nitronaphthalene

209-474-5

581-89-5

Carc. 1B
Aquatic Chronic 2

H350
H411

GHS08
GHS09
Gef.

H350
H411

609-039-00-3

4-nitrobiphenyl

202-204-7

92-93-3

Carc. 1B
Aquatic Chronic 2

H350
H411

GHS08
GHS09
Gef.

H350
H411

609-040-00-9

nitrofen (ISO);
2,4-dichlorophenyl 4-nitrophenyl ether

217-406-0

1836-75-5

Carc. 1B
Repr. 1B
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H350
H360D (*)(*)(*)
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H360D (*)(*)(*)
H302
H410

609-041-00-4

2,4-dinitrophenol

200-087-7

51-28-5

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1

H331
H311
H301
H373 (*)(*)
H400

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H400

609-042-00-X

pendimethalin (ISO);
N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine

254-938-2

40487-42-1

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

609-043-00-5

quintozene (ISO);
pentachloronitrobenzene

201-435-0

82-68-8

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

609-044-00-0

tecnazene (ISO);
1,2,4,5-tetrachloro-3-nitrobenzene

204-178-2

117-18-0

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

609-045-00-6

reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;
dinocton-6

8069-76-9

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

609-046-00-1

trifluralin (ISO) (containing < 0,5 ppm NPDA);
a,a,a-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA);
2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA);
N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0,5 ppm NPDA)

216-428-8

1582-09-8

Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H317
H410

M=10

609-047-00-7

2-nitroanisole

202-052-1

91-23-6

Carc. 1B
Acute Tox. 4 (*)

H350
H302

GHS08
GHS07
Gef.

H350
H302

609-048-00-2

sodium 3-nitrobenzenesulphonate

204-857-3

127-68-4

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

609-049-00-8

2,6-dinitrotoluene

210-106-0

606-20-2

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 3

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H412

GHS06
GHS08
Gef.

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H412

609-050-00-3

2,3-dinitrotoluene

210-013-5

602-01-7

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H410

609-051-00-9

3,4-dinitrotoluene

210-222-1

610-39-9

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H411

609-052-00-4

3,5-dinitrotoluene

210-566-2

618-85-9

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 3

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H412

GHS06
GHS08
Gef.

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H412

609-053-00-X

hydrazine-trinitromethane

414-850-9

Expl. 1.1 (*)(*)(*)(*)
Self-react. a
Carc. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Sens. 1

H201
H240
H350
H331
H301
H317

GHS01
GHS06
GHS08
Gef.

H201
H240
H350
H331
H301
H317

609-054-00-5

2,3-dinitrophenol; [1]
2,5-dinitrophenol; [2]
2,6-dinitrophenol; [3]
3,4-dinitrophenol; [4]
salts of dinitrophenol [5]

200-628-7 [1]
206-348-1 [2]
209-357-9 [3]
209-415-3 [4]
[5]

66-56-8 [1]
329-71-5 [2]
573-56-8 [3]
577-71-9 [4]
[5]

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H331
H311
H301
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H411

609-055-00-0

2,5-dinitrotoluene

210-581-4

619-15-8

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H350
H341
H361f (*)(*)(*)
H331
H311
H301
H373 (*)(*)
H411

609-056-00-6

2,2-dibromo-2-nitroethanol

412-380-9

69094-18-4

Expl. 1.1
Carc. 2
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1a
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H201
H351
H302
H373 (*)(*)
H314
H317
H400
H410

GHS01
GHS08
GHS05
GHS07
GHS09
Gef.

H201
H351
H302
H373 (*)(*)
H314
H317
H410

(*)
STOT SE 3; H335: C> 1 %

609-057-00-1

3-chloro-2,4-difluoronitrobenzene

411-980-8

3847-58-3

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H314
H317
H410

609-058-00-7

2-nitro-2-phenyl-1,3-propanediol

410-360-4

5428-02-4

STOT RE 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2

H372 (*)(*)
H312
H302
H317
H411

GHS08
GHS07
GHS09
Gef.

H372 (*)(*)
H312
H302
H317
H411

EUH070

609-059-00-2

2-chloro-6-(ethylamino)-4-nitrophenol

411-440-1

131657-78-8

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

609-060-00-8

4-[(3-hydroxypropyl)amino]-3-nitrophenol

406-305-9

92952-81-3

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

609-061-00-3

(E,Z)-4-chlorophenyl(cyclopropyl)ketoneO-(4-nitrophenylmethyl)oxime

406-100-4

94097-88-8

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

609-062-00-9

2-bromo-2-nitropropanol

407-030-7

24403-04-1

Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H311
H302
H373 (*)(*)
H314
H317
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H311
H302
H373 (*)(*)
H314
H317
H410

609-063-00-4

2-[(4-chloro-2-nitrophenyl)amino]ethanol

413-280-8

59320-13-7

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

609-064-00-X

mesotrione(ISO);
2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione

104206-82-8

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

609-065-00-5

2-nitrotoluene

201-853-3

88-72-2

Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 4 (*)
Aquatic Chronic 2

H350
H340
H361f (*)(*)(*)
H302
H411

GHS08
GHS07
GHS09
Gef.

H350
H340
H361f (*)(*)(*)
H302
H411

~~609-066-00-0~~gestrichen

609-067-00-6

sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine

416-280-6

156769-97-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

609-068-00-1

musk xylene;
5-tert-butyl-2,4,6-trinitro-m-xylene

201-329-4

81-15-2

Expl. 1.1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H201
H351
H400
H410

GHS01
GHS08
GHS09
Achtg.

H201
H351
H410

609-069-00-7

musk ketone;
3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;
4'-tert-butyl-2',6'-dimethyl-3',5'-dinitroacetophenone

201-328-9

81-14-1

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

609-070-00-2

1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene

415-580-4

130841-23-5

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

609-071-00-8

reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;
2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol

423-520-3

156137-33-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

609-072-00-3

4-mesyl-2-nitrotoluene

430-550-0

1671-49-4

Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3

H361f***
H302
H317
H412

GHS08
GHS07
Achtg.

H361f***
H302
H317
H412

609-073-00-9

lithium potassium sodiumN,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato]}-N'-(2-aminoethyl)piperazine

427-850-9

Skin Sens. 1

H317

GHS07
Achtg.

H317

610-001-00-3

trichloronitromethane;
chloropicrin

200-930-9

76-06-2

Acute Tox. 2 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H330
H302
H319
H335
H315

GHS06
Gef.

H330
H302
H319
H335
H315

610-002-00-9

1,1-dichloro-1-nitroethane

209-854-0

594-72-9

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)

H331
H311
H301

GHS06
Gef.

H331
H311
H301

610-003-00-4

chlorodinitrobenzene

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H373 (*)(*)
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H410

610-004-00-X

2-chloro-1,3,5-trinitrobenzene

201-864-3

88-88-0

Expl. 1.1
Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H201
H330
H310
H300
H400
H410

GHS01
GHS06
GHS09
Gef.

H201
H330
H310
H300
H410

610-005-00-5

1-chloro-4-nitrobenzene

202-809-6

100-00-5

Carc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H351
H341
H331
H311
H301
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H351
H341
H331
H311
H301
H373 (*)(*)
H411

610-006-00-0

chloronitroanilines with the exception of those specified elsewhere in this Annex

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H330
H310
H300
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H330
H310
H300
H373 (*)(*)
H411

a C

610-007-00-6

1-chloro-1-nitropropane

209-990-0

600-25-9

Acute Tox. 4 (*)
Acute Tox. 4 (*)

H332
H302

GHS07
Achtg.

H332
H302

(*)

610-008-00-1

2,6-dichloro-4-nitroanisole

403-350-6

17742-69-7

Acute Tox. 3 (*)
Aquatic Chronic 2

H301
H411

GHS06
GHS09
Gef.

H301
H411

610-009-00-7

2-chloro-4-nitroaniline

204-502-2

121-87-9

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

610-010-00-2

2-bromo-1-(2-furyl)-2-nitroethylene

406-110-9

35950-52-8

Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373 (*)(*)
H314
H317
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H302
H373 (*)(*)
H314
H317
H410

611-001-00-6

azobenzene

203-102-5

103-33-3

Carc. 1B
Muta. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H350
H341
H332
H302
H373 (*)(*)
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H341
H332
H302
H373 (*)(*)
H410

611-002-00-1

azoxybenzene

207-802-1

495-48-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)

H332
H302

GHS07
Achtg.

H332
H302

611-003-00-7

fenaminosulf (ISO);
sodium 4-dimethylaminobenzenediazosulphonate

205-419-4

140-56-7

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Chronic 3

H301
H312
H412

GHS06
Gef.

H301
H312
H412

611-004-00-2

methyl-ONN-azoxymethyl acetate;
methyl azoxy methyl acetate

209-765-7

592-62-1

Carc. 1B
Repr. 1B

H350
H360D (*)(*)(*)

GHS08
Gef.

H350
H360D (*)(*)(*)

611-005-00-8

disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);
CI Direct Brown 95

240-221-1

16071-86-6

Carc. 1B

H350

GHS08
Gef.

H350

611-006-00-3

4-o-tolylazo-o-toluidine;
4-amino-2',3-dimethylazobenzene;
fast garnet GBC base;
AAT;
o-aminoazotoluene

202-591-2

97-56-3

Carc. 1B
Skin Sens. 1

H350
H317

GHS08
Gef.

H350
H317

611-007-00-9

tricyclazole (ISO);
5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole;

255-559-5

41814-78-2

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

611-008-00-4

4-aminoazobenzene;
4-phenylazoaniline

200-453-6

60-09-3

Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H400
H410

GHS08
GHS09
Gef.

H350
H410

611-009-00-X

sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)

401-220-3

Acute Tox. 4 (*)
Aquatic Chronic 3

H332
H412

GHS07
Achtg.

H332
H412

611-010-00-5

2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide

403-010-7

106359-94-8

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

611-011-00-0

N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate

403-340-1

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Dg

H318
H411

611-012-00-6

reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate andN,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate

403-410-1

114565-65-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-013-00-1

trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate

403-650-7

117409-78-6

Expl. 1.3 (*)(*)(*)(*)
Aquatic Chronic 2

H203
H411

GHS01
GHS09
Gef.

H203
H411

611-014-00-7

(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide

404-250-5

115099-55-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-015-00-2

tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate

404-320-5

116889-78-2

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-016-00-8

reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride

404-540-1

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-017-00-3

2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide

404-910-2

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

611-018-00-9

tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate

405-130-5

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-019-00-4

tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate

405-150-4

106028-58-4

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-020-00-X

tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate

405-170-3

116340-05-7

Acute Tox. 3 (*)
Skin Sens. 1
Aquatic Chronic 3

H301
H317
H412

GHS06
Gef.

H301
H317
H412

611-021-00-5

2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate

405-480-9

Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Irrit. 2
Aquatic Chronic 4

H302
H373 (*)(*)
H315
H413

GHS08
GHS07
Achtg.

H302
H373 (*)(*)
H315
H413

611-022-00-0

4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate

404-980-4

Self-react. C
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H242
H331
H301
H312
H373 (*)(*)
H318
H317
H400
H410

GHS02
GHS06
GHS08
GHS05
GHS09
Gef.

H242
H331
H301
H312
H373 (*)(*)
H318
H317
H410

611-023-00-6

disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate

404-600-7

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-024-00-1

Benzidine based azo dyes;
4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex

Carc. 1B

H350

GHS08
Gef.

H350

611-025-00-7

disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;
C.I. Direct Black 38

217-710-3

1937-37-7

Carc. 1B
Repr. 2

H350
H361d (*)(*)(*)

GHS08
Gef.

H350
H361d (*)(*)(*)

611-026-00-2

tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];
C.I. Direct Blue 6

220-012-1

2602-46-2

Carc. 1B
Repr. 2

H350
H361d (*)(*)(*)

GHS08
Gef.

H350
H361d (*)(*)(*)

611-027-00-8

disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);
C.I. Direct Red 28

209-358-4

573-58-0

Carc. 1B
Repr. 2

H350
H361d (*)(*)(*)

GHS08
Gef.

H350
H361d (*)(*)(*)

611-028-00-3

C,C'-azodi(formamide)

204-650-8

123-77-3

Resp. Sens. 1

H334

GHS08
Gef.

H334

611-029-00-9

o-dianisidine based azo dyes;
4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex

Carc. 1B

H350

GHS08
Gef.

H350

611-030-00-4

o-tolidine based dyes;
4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex

Carc. 1B

H350

GHS08
Gef.

H350

611-031-00-X

4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;
C.I. Basic Red 9

209-321-2

569-61-9

Carc. 1B

H350

GHS08
Gef.

H350

611-032-00-5

1,4,5,8-tetraaminoanthraquinone;
C.I. Disperse Blue 1

219-603-7

2475-45-8

Carc. 1B
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1

H350
H315
H318
H317

GHS08
GHS05
GHS07
Gef.

H350
H315
H318
H317

611-033-00-0

hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II)

400-020-3

82027-60-9

Aquatic Chronic 2

H411

GHS09

H411

611-034-00-6

N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide

402-430-8

105076-77-5

Aquatic Chronic 4

H413

611-035-00-1

tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate

403-660-1

107246-80-0

Aquatic Chronic 2

H411

GHS09

H411

611-036-00-7

2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate

405-440-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-037-00-2

3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate

406-055-0

124584-00-5

Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H317
H411

611-038-00-8

trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate

406-820-9

Eye Irrit. 2

H319

GHS07
Achtg.

H319

611-039-00-3

7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid

407-050-6

117715-57-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-040-00-9

3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid

407-670-7

115099-58-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

611-041-00-4

2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide

407-680-1

98809-11-1

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

611-042-00-X

trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate

411-770-6

136213-71-3

Aquatic Chronic 3

H412

611-043-00-5

reaction mass of: trisodiumN(1')-N(2):N(1''')-N(2'')-?-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodiumN(1')-N(2):N(1''')-N(2'')-?-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;
trisodiumN(1')-N(2):N(1''')-N(2'')-?-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)

402-850-1

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-044-00-0

reaction mass of:tert-alkyl(C₁₂-C₁₄)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C₁₂-C₁₄)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C₁₂-C₁₄)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);
tert-alkyl(C₁₂-C₁₄)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C₁₂-C₁₄)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);
tert-alkyl(C₁₂-C₁₄)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)

403-720-7

117527-94-3

Aquatic Chronic 2

H411

GHS09

H411

611-045-00-6

2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene

404-830-8

Aquatic Chronic 4

H413

611-046-00-1

4,4'-diamino-2-methylazobenzene

407-590-2

43151-99-1

Acute Tox. 3 (*)
STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H373 (*)(*)
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H301
H373 (*)(*)
H317
H410

611-047-00-7

reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)

407-890-3

111381-11-4

Aquatic Chronic 4

H413

611-048-00-2

reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;
2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)

407-900-6

111381-12-5

Aquatic Chronic 4

H413

611-049-00-8

reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)

408-000-6

118658-98-3

STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 3

H373 (*)(*)
H317
H412

GHS08
Achtg.

H373 (*)(*)
H317
H412

611-050-00-3

reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate

415-350-3

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-051-00-9

2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride

411-110-7

136213-74-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

611-052-00-4

monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex

400-720-9

Aquatic Chronic 3

H412

611-053-00-X

2,2'-azobis[2-methylpropionamidine] dihydrochloride

221-070-0

2997-92-4

Acute Tox. 4 (*)
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

611-055-00-0

C.I. Disperse Yellow 3;
N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide

220-600-8

2832-40-8

Carc. 2
Skin Sens. 1

H351
H317

GHS08
GHS07
Achtg.

H351
H317

611-056-00-6

C.I. Solvent Yellow 14;
1-phenylazo-2-naphthol

212-668-2

842-07-9

Carc. 2
Muta. 2
Skin Sens. 1
Aquatic Chronic 4

H351
H341
H317
H413

GHS08
GHS07
Achtg.

H351
H341
H317
H413

611-057-00-1

6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile

400-340-3

85136-74-9

Carc. 1B
Aquatic Chronic 4

H350
H413

GHS08
Achtg.

H350
H413

611-058-00-7

(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate

402-060-7

108225-03-2

Carc. 1B
Eye Dam. 1
Aquatic Chronic 2

H350
H318
H411

GHS08
GHS05
GHS09
Gef.

H350
H318
H411

611-059-00-2

octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate

412-960-1

148878-21-1

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

611-060-00-8

reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;
5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid

413-180-4

187285-15-0

Eye Dam. 1

H318

GHS05
Gef.

H318

611-061-00-3

disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate

412-530-3

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

611-062-00-9

octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate

413-550-5

Skin Irrit. 2
Eye Dam. 1

H315
H318

GHS05
Gef.

H315
H318

611-063-00-4

trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)

413-590-3

164058-22-4

Carc. 1B

H350

GHS08
Gef.

H350

611-064-00-X

4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol

410-600-8

124719-26-2

STOT RE 2 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H315
H400
H410

GHS08
GHS07
GHS09
Achtg.

H373 (*)(*)
H315
H410

611-065-00-5

4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol

410-610-2

111850-24-9

STOT RE 2 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H319
H315
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H373 (*)(*)
H319
H315
H317
H410

611-066-00-0

tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate

411-540-5

130201-57-9

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

611-067-00-6

reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;
bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate

406-910-8

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

611-068-00-1

tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate

400-690-7

85665-98-1

Aquatic Chronic 2

H411

GHS09

H411

611-069-00-7

N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline

413-380-1

Aquatic Chronic 2

H411

GHS09

H411

611-070-00-2

reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);
trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)

405-665-4

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

611-071-00-8

tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate

406-073-9

131013-81-5

Acute Tox. 3 (*)
Aquatic Chronic 3

H301
H412

GHS06
Gef.

H301
H412

611-072-00-3

2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride

407-010-8

118208-02-9

Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

611-073-00-9

dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate

407-310-9

122630-55-1

Aquatic Chronic 4

H413

611-074-00-4

reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);
sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)

407-100-7

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-075-00-X

reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;
tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)

406-000-0

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

611-076-00-5

3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole

406-280-4

117584-16-4

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

611-077-00-0

dilithium disodium (5,5'-diamino-(µ-4,4'-dihydroxy-1:2-?-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-?-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-?:N3',N4'-?)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)

407-230-4

126637-70-5

Acute Tox. 4 (*)
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

611-078-00-6

(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate

407-240-9

159604-94-1

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

611-079-00-1

disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate

410-390-8

147703-64-8

Eye Dam. 1

H318

GHS05
Gef.

H318

611-080-00-7

sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate

410-150-2

147703-65-9

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-081-00-2

tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II)

411-470-5

141048-13-7

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

611-082-00-8

reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);
pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)

407-570-3

Aquatic Chronic 2

H411

GHS09

H411

611-083-00-3

reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;
2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)

411-560-4

STOT RE 1
Skin Sens. 1
Aquatic Chronic 2

H372 (*)(*)
H317
H411

GHS08
GHS07
GHS09
Gef.

H372 (*)(*)
H317
H411

611-085-00-4

reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;
3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine

411-880-4

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

611-086-00-X

monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate

411-360-7

Aquatic Chronic 3

H412

611-087-00-5

reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;
3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)

411-710-9

Aquatic Chronic 4

H413

611-088-00-0

reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;
trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate

411-890-9

Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

611-089-00-6

2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate

411-100-2

136213-73-5

STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H373 (*)(*)
H317
H410

611-090-00-1

2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate

413-290-2

93672-52-7

Self-react. C
Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H242
H302
H318
H317
H412

GHS02
GHS05
GHS07
Gef.

H242
H302
H318
H317
H412

611-091-00-7

sodium (1,0 -1,95 )/lithium (0,05 -1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate

413-470-0

134595-59-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-092-00-2

tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate

413-210-6

Aquatic Chronic 2

H411

GHS09

H411

611-093-00-8

sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate

410-770-3

146177-84-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-094-00-3

reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;
2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)

411-600-0

143145-93-1

Aquatic Chronic 4

H413

611-095-00-9

hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide

412-240-7

89797-03-5

Aquatic Chronic 2

H411

GHS09

H411

611-096-00-4

methylN-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate

413-040-2

149850-30-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-097-00-X

reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)

414-150-3

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

611-098-00-5

tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate

405-950-3

131013-83-7

Acute Tox. 3 (*)
Aquatic Chronic 3

H301
H412

GHS06
Gef.

H301
H412

611-099-00-0

(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride

401-500-5

118658-99-4

Carc. 1B
Aquatic Chronic 2

H350
H411

GHS08
GHS09
Gef.

H350
H411

611-100-00-4

potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate

403-810-6

140876-13-7

Eye Dam. 1

H318

GHS05
Gef.

H318

611-101-00-X

2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide

405-200-5

104366-25-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-102-00-5

reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid;
disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzen-diazoniumchlorid

424-500-7

Aquatic Chronic 3

H412

611-103-00-0

trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)

407-110-1

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

611-104-00-6

reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);
trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);
trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);
disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate

406-870-1

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

611-105-00-1

sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate

407-800-2

136213-75-7

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

611-106-00-7

hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate

410-180-6

157627-99-1

Eye Dam. 1

H318

GHS05
Gef.

H318

611-107-00-2

potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate

412-490-7

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-108-00-8

disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate

413-600-6

6527-62-4

Aquatic Chronic 3

H412

611-109-00-3

reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)

407-710-3

Aquatic Chronic 2

H411

GHS09

H411

611-110-00-9

tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene

408-210-8

124605-82-9

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

611-111-00-4

disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)

414-230-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-112-00-X

tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate

413-070-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-113-00-5

lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)

414-280-0

149626-00-6

Aquatic Chronic 2

H411

GHS09

H411

611-114-00-0

lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)

414-250-7

149564-66-9

Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

611-115-00-6

trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)

414-290-5

149564-65-8

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

611-116-00-1

reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate

414-620-8

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

611-117-00-7

1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt

415-100-3

149850-29-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-118-00-2

sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt

413-990-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

611-119-00-8

tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate

415-400-4

148878-22-2

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

611-120-00-3

5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt

418-340-7

157707-94-3

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-121-00-9

main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;
main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol

417-280-9

30785-74-1

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

611-122-00-4

hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel

417-250-5

151436-99-6

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

611-123-00-X

3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate

424-310-4

178452-66-9

Eye Dam. 1

H318

GHS05
Gef.

H318

611-124-00-5

reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;
pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;
tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate

424-320-9

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

611-125-00-0

reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;
Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex

423-940-7

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

611-126-00-6

2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride

424-120-1

174514-06-8

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

611-127-00-1

pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate

423-790-2

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

611-128-00-7

N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt

419-500-9

171599-85-2

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

611-129-00-2

reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;
5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid

418-230-9

163879-69-4

Expl. 1.3 (*)(*)(*)(*)
Repr. 2
STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2

H203
H361f (*)(*)(*)
H373 (*)(*)
H317
H411

GHS01
GHS08
GHS07
GHS09
Gef.

H203
H361f (*)(*)(*)
H373 (*)(*)
H317
H411

611-130-00-8

tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate

418-520-5

183130-96-3

Eye Irrit. 2
Aquatic Chronic 3

H319
H412

GHS07
Achtg.

H319
H412

611-131-00-3

2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one

420-580-2

151798-26-4

Repr. 1B
Aquatic Chronic 4

H360D (*)(*)(*)
H413

GHS08
Gef.

H360D (*)(*)(*)
H413

611-132-00-9

pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)

419-210-2

178452-71-6

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-133-00-4

Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt

419-260-5

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

611-134-00-X

trisodium 2-{a[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex

423-770-3

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

611-135-00-5

reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt

424-250-9

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-136-00-0

2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate

424-260-3

Repr. 2
Eye Dam. 1
Aquatic Chronic 2

H361f (*)(*)(*)
H318
H411

GHS05
GHS08
GHS09
Gef.

H361f (*)(*)(*)
H318
H411

611-137-00-6

6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole

419-870-1

159038-16-1

Aquatic Chronic 4

H413

611-138-00-1

2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole

415-910-7

152828-25-6

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

611-139-00-7

reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride

424-510-1

Eye Dam. 1
Aquatic Chronic 2

H318
H411

GHS05
GHS09
Gef.

H318
H411

611-140-00-2

azafenidin (ISO);
2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one

68049-83-2

Repr. 1B
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H360Df
H373 (*)(*)
H400
H410

GHS08
GHS09
Gef.

H360Df
H373 (*)(*)
H410

M=1000

611-141-00-8

5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt

414-410-6

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

611-142-00-3

product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;
sodium chloride

425-740-5

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-143-00-9

reaction mass of: trisodium 2-(2-[a-(2-carboxylato-?-O-4-sulfonatophenylazo)benzylidene]hydrazino-?-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II);
trisodium 2-(2-[a-(2-carboxylato-?-O-4-sulfonatophenylazo)benzylidene]hydrazino-?-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)

428-260-4

Eye Dam. 1

H318

GHS05
Gef.

H318

611-144-00-4

reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;
7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt

429-070-4

214362-06-8

Eye Dam. 1

H318

GHS05
Gef.

H318

611-145-00-X

reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate;
3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt

429-440-5

Eye Dam. 1

H318

GHS05
Gef.

H318

611-146-00-5

reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate;
hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate

430-070-1

Aquatic Chronic 2

H411

GHS09

H411

611-147-00-0

sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate

430-090-0

205764-96-1

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

611-148-00-6

reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;
2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol;
3-(2,6-dichloro-4-nitrophenylazo)carbazol

429-590-1

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

611-149-00-1

2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate

427-570-7

193486-83-8

Aquatic Chronic 2

H411

GHS09

H411

611-150-00-7

tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate

440-460-3

Eye Irrit. 2
Aquatic Chronic 3

H319
H412

GHS07
Achtg.

H319
H412

611-151-00-2

chrysoidine;
4-(phenylazo)benzene-1,3-diamine

207-803-7

495-54-5

Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H341
H302
H315
H400
H410

GHS08
GHS07
GHS09
Achtg.

H341
H302
H315
H410

611-152-00-8

chrysoidine monohydrochloride;
4-phenylazophenylene-1,3-diamine monohydrochloride; [1]
chrysoidine monoacetate;
4-(phenylazo)benzene-1,3-diamine monoacetate; [2]
chrysoidine acetate;
4-(phenylazo)benzene-1,3-diamine acetate; [3]
chrysoidine-p-dodecylbenzenesulfonate;
dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4]
chrysoidine dihydrochloride;
4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5]
chrysoidine sulfate;
bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6]

208-545-8 [1]
278-290-5 [2]
279-116-0 [3]
264-409-8 [4]
281-549-5 [5]
282-432-1 [6]

532-82-1 [1]
75660-25-2 [2]
79234-33-6 [3]
63681-54-9 [4]
83968-67-6 [5]
84196-22-5 [6]

Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H341
H302
H315
H318
H400
H410

GHS05
GHS08
GHS07
GHS09
Gef.

H341
H302
H315
H318
H410

611-153-00-3

chrysoidine C_10-14-alkyl derivatives;
benzenesulfonic acid, mono-C_10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1]
chrysoidine compound with dibutylnaphthalene sulfonic acid;
dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2]

286-946-7 [1]
304-236-8 [2]

85407-90-5 [1]
94247-67-3 [2]

Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1

H341
H302
H315
H318

GHS05
GHS08
GHS07
Gef.

H341
H302
H315
H318

611-154-00-9

trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate

403-670-6

92408-46-3

Aquatic Chronic 3

H412

611-155-00-4

4,4'-oxybis(benzenesulfonylazide)

431-850-4

7456-68-0

Expl. 1.1****
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H201
H373**
H400
H410

GHS01
GHS08
GHS09
Gef.

H201
H373**
H410

611-156-00-X

triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate

432-270-4

221354-37-6

Repr. 2
STOT RE 2 *
Aquatic Chronic 2

H361f***
H373**
H411

GHS08
GHS09
Achtg.

H361f***
H373**
H411

611-157-00-5

benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;
potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate

432-590-4

243869-48-9

Eye Irrit. 2
Aquatic Chronic 3

H319
H412

GHS07
Achtg.

H319
H412

611-158-00-0

reaction product of: 2,3,4,2',3',4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride

421-520-8

****
Aquatic Chronic 4

****
H413

****

****
H413

611-159-00-6

disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate

421-880-6

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-160-00-1

reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane;
1,1,1-tris(phenyl-4'-(6''-diazo-5'',6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane;
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)

422-760-6

****
Aquatic Chronic 4

****
H413

****

****
H413

611-161-00-7

trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)

423-100-1

Eye Dam. 1

H318

GHS05
Gef.

H318

611-162-00-2

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)

429-600-4

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

611-163-00-8

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate

429-610-9

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2

H302
H318
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H411

611-164-00-3

reaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile;
2-methylpentanenitrile-2-azo-2’-(2’-methylpropanenitrile);
2,2’-dimethyl-2,2’-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2’-(2’-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2’-(2’-methylbutanenitrile)

429-710-2

Self-react. D
Acute Tox. 4 *
Aquatic Chronic 2

H242
H302
H411

GHS02
GHS07
GHS09
Gef.

H242
H302
H411

611-165-00-9

reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;
tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate

431-830-5

Aquatic Chronic 3

H412

611-166-00-4

432-100-9

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-167-00-X

sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)

435-240-9

Aquatic Chronic 3

H412

611-168-00-5

reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid

435-440-6

Eye Dam. 1

H318

GHS05
Gef.

H318

611-169-00-0

sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate

435-800-2

Aquatic Chronic 3

H412

611-170-00-6

reaction mass of: trisodium 2-((1-(2-hydroxy-?-O-5-(2-sulfonatoethansulfonyl)phenylazo-?-N² )-1-phenylmethyl)azo-?-N¹ )-4-sulfonatobenzoate(5-)-?-O)cuprate(II);
disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-?-O-phenylazo-?-N² )-1-phenylmethyl)azo-?-N¹ )-4-sulfonatobenzoate-?-O-(5-))cuprate(II)

435-880-9

Aquatic Chronic 3

H412

611-171-00-1

reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;
trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate

436-890-6

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-172-00-7

reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate

438-310-7

Self-react. C****
Repr. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3

H242
H361f***
H302
H373**
H412

GHS02
GHS08
GHS07
Gef.

H242
H361f***
H302
H373**
H412

611-173-00-2

reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;
3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt

440-510-4

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

611-174-00-8

reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt

442-290-5

457624-86-1

Eye Dam. 1

H318

GHS05
Gef.

H318

611-175-00-3

reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate

444-050-5

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

611-176-00-9

2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate

444-250-2

Self-react. C****
Aquatic Chronic 2

H242
H411

GHS02
GHS09
Gef.

H242
H411

611-177-00-4

reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)

444-290-0

508202-43-5

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

611-178-00-X

reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

445-280-9

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

611-179-00-5

reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate

450-010-8

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

611-180-00-0

iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts

417-850-7

Aquatic Chronic 2

H411

GHS09

H411

612-001-00-9

mono-methylamine; [1]
di-methylamine; [2]
tri-methylamine [3]

200-820-0 [1]
204-697-4 [2]
200-875-0 [3]

74-89-5 [1]
124-40-3 [2]
75-50-3 [3]

Flam. Gas 1
Press. Gas
Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Eye Dam. 1

H220
H332
H335
H315
H318

GHS02
GHS04
GHS05
GHS07
Gef.

H220
H332
H335
H315
H318

(*)
Skin Irrit. 2; H315: C> 5 %
Eye Dam. 1; H318: C> 5 %
Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %
STOT SE 3; H335: C> 5 %

612-001-01-6

mono-methylamine ...%; [1]
di-methylamine ...%; [2]
tri-methylamine ...% [3]

200-820-0 [1]
204-697-4 [2]
200-875-0 [3]

74-89-5 [1]
124-40-3 [2]
75-50-3 [3]

Flam. Liq. 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H224
H332
H302
H314

GHS02
GHS05
GHS07
Gef.

H224
H332
H302
H314

(*)
STOT SE 3; H335: C> 5 %

612-002-00-4

ethylamine

200-834-7

75-04-7

Flam. Gas 1
Press. Gas
Eye Irrit. 2
STOT SE 3

H220
H319
H335

GHS02
GHS04
GHS07
Gef.

H220
H319
H335

612-003-00-X

diethylamine

203-716-3

109-89-7

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A

H225
H332
H312
H302
H314

GHS02
GHS05
GHS07
Gef.

H225
H332
H312
H302
H314

STOT SE 3; H335: C> 1 %

612-004-00-5

triethylamine

204-469-4

121-44-8

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A

H225
H332
H312
H302
H314

GHS02
GHS05
GHS07
Gef.

H225
H332
H312
H302
H314

STOT SE 3; H335: C> 1 %

612-005-00-0

butylamine

203-699-2

109-73-9

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A

H225
H332
H312
H302
H314

GHS02
GHS05
GHS07
Gef.

H225
H332
H312
H302
H314

STOT SE 3; H335: C> 1 %

612-006-00-6

ethylenediamine;
1,2-diaminoethane

203-468-6

107-15-3

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1

H226
H312
H302
H314
H334
H317

GHS02
GHS08
GHS05
GHS07
Gef.

H226
H312
H302
H314
H334
H317

612-007-00-1

2-aminopropane;
isopropylamine

200-860-9

75-31-0

Flam. Liq. 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H224
H319
H335
H315

GHS02
GHS07
Gef.

H224
H319
H335
H315

612-008-00-7

aniline

200-539-3

62-53-3

Carc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1

H351
H341
H331
H311
H301
H372 (*)(*)
H318
H317
H400

GHS06
GHS08
GHS05
GHS09
Gef.

H351
H341
H331
H311
H301
H372 (*)(*)
H318
H317
H400

(*)
STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 %

612-009-00-2

salts of aniline

Carc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1

H351
H341
H331
H311
H301
H372 (*)(*)
H318
H317
H400

GHS06
GHS08
GHS05
GHS09
Gef.

H351
H341
H331
H311
H301
H372 (*)(*)
H318
H317
H400

(*)
STOT RE 1; H372: C> 1 %
STOT RE 2; H373: 0,2 % ≤ C < 1 %

612-010-00-8

chloroanilines (with exception of those specified elsewhere in this Annex)

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H373 (*)(*)
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H410

612-011-00-3

4-nitrosoaniline

211-535-6

659-49-4

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H332
H312
H302

GHS07
Achtg.

H332
H312
H302

612-012-00-9

o-nitroaniline; [1]
m-nitroaniline; [2]
p-nitroaniline [3]

201-855-4 [1]
202-729-1 [2]
202-810-1 [3]

88-74-4 [1]
99-09-2 [2]
100-01-6 [3]

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 3

H331
H311
H301
H373 (*)(*)
H412

GHS06
GHS08
Gef.

H331
H311
H301
H373 (*)(*)
H412

612-013-00-4

3-aminobenzene sulphonic acid;
metanilic acid

204-473-6

121-47-1

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H332
H312
H302

GHS07
Achtg.

H332
H312
H302

612-014-00-X

sulphanilic acid;
4-aminobenzenesulphonic acid

204-482-5

121-57-3

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H319
H315
H317

GHS07
Achtg.

H319
H315
H317

612-015-00-5

N-methylaniline

202-870-9

100-61-8

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H373 (*)(*)
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H410

612-016-00-0

N,N-dimethylaniline

204-493-5

121-69-7

Carc. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2

H351
H331
H311
H301
H411

GHS06
GHS08
GHS09
Gef.

H351
H331
H311
H301
H411

612-017-00-6

N-methyl-N-2,4,6-tetranitroaniline;
tetryl

207-531-9

479-45-8

Expl. 1.1
Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2

H201
H331
H311
H301
H373**

GHS01
GHS06
GHS08
Gef.

H201
H331
H311
H301
H373**

612-018-00-1

bis(2,4,6-trinitrophenyl)amine;
hexyl

205-037-8

131-73-7

Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2

H201
H330
H310
H300
H373**
H411

GHS01
GHS06
GHS08
GHS09
Gef.

H201
H330
H310
H300
H373**
H411

612-019-00-7

dipicrylamine, ammonium salt

220-639-0

2844-92-0

Expl. 1.1
Acute Tox. 2 *
Acute Tox. 1
Acute Tox. 2 *
STOT RE 2
Aquatic Chronic 2

H201
H330
H310
H300
H373**
H411

GHS01
GHS06
GHS08
GHS09
Gef.

H201
H330
H310
H300
H373**
H411

612-020-00-2

1-naphthylamine

205-138-7

134-32-7

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

612-022-00-3

2-naphthylamine

202-080-4

91-59-8

Carc. 1a
Acute Tox. 4 (*)
Aquatic Chronic 2

H350
H302
H411

GHS08
GHS07
GHS09
Gef.

H350
H302
H411

Carc. 1A; H350: C> 0,01 %

612-023-00-9

phenylhydrazine; [1]
phenylhydrazinium chloride; [2]
phenylhydrazine hydrochloride; [3]
phenylhydrazinium sulphate (2:1) [4]

202-873-5 [1]
200-444-7 [2]
248-259-0 [3]
257-622-2 [4]

100-63-0 [1]
59-88-1 [2]
27140-08-5 [3]
52033-74-6 [4]

Carc. 1B
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H350
H341
H331
H311
H301
H372 (*)(*)
H319
H315
H317
H400

GHS06
GHS08
GHS09
Gef.

H350
H341
H331
H311
H301
H372 (*)(*)
H319
H315
H317
H400

612-024-00-4

m-toluidine;
3-aminotoluene

203-583-1

108-44-1

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1

H331
H311
H301
H373 (*)(*)
H400

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H400

612-025-00-X

nitrotoluidines, with the exception of those specified elsewhere in this Annex

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H331
H311
H301
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H411

612-026-00-5

diphenylamine

204-539-4

122-39-4

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H373 (*)(*)
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H410

612-027-00-0

xylidines with the exception of those specified elsewhere in this Annex;
dimethyl anilines with the exception of those specified elsewhere in this Annex

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H331
H311
H301
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H411

612-028-00-6

p-phenylenediamine

203-404-7

106-50-3

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H319
H317
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H319
H317
H410

612-029-00-1

benzene-1,4-diamine dihydrochloride;
p-phenylenediamine dihydrochloride

210-834-9

624-18-0

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H319
H317
H400
H410

GHS06
GHS09
Gef.

H331
H311
H301
H319
H317
H410

612-030-00-7

2-methyl-p-phenylenediamine sulphate [1]

210-431-8 [1]
228-871-4 [2]

615-50-9 [1]
6369-59-1 [2]

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2

H301
H332
H312
H317
H411

GHS06
GHS09
Gef.

H301
H332
H312
H317
H411

612-031-00-2

N,N-dimethylbenzene-1,3-diamine; [1]
4-amino-N,N-dimethylaniline;
3-amino-N,N'-dimethylaniline [2]

220-623-3 [1]
202-807-5 [2]

2836-04-6 [1]
99-98-9 [2]

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)

H331
H311
H301

GHS06
Gef.

H331
H311
H301

612-032-00-8

N,N,N',N'-tetramethyl-p-phenylenediamine

202-831-6

100-22-1

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H332
H312
H302

GHS07
Achtg.

H332
H312
H302

612-033-00-3

2-aminophenol

202-431-1

95-55-6

Muta. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H341
H332
H302

GHS08
GHS07
Achtg.

H341
H332
H302

612-034-00-9

2-amino-4,6-dinitrophenol;
picramic acid

202-544-6

96-91-3

Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3

H201
H332
H312
H302
H412

GHS01
GHS07
Gef.

H201
H332
H312
H302
H412

612-034-01-6

2-amino-4,6-dinitrophenol;
picramic acid;
[> 20 % water]

202-544-6

96-91-3

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Chronic 3

H332
H312
H302
H412

GHS07
Achtg.

H332
H312
H302
H412

612-035-00-4

2-methoxyaniline;
o-anisidine

201-963-1

90-04-0

Carc. 1B
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)

H350
H341
H331
H311
H301

GHS06
GHS08
Gef.

H350
H341
H331
H311
H301

612-036-00-X

3,3'-dimethoxybenzidine;
o-dianisidine

204-355-4

119-90-4

Carc. 1B
Acute Tox. 4 (*)

H350
H302

GHS08
GHS07
Gef.

H350
H302

612-037-00-5

salts of 3,3'-dimethoxybenzidine;
salts ofo-dianisidine

Carc. 1B
Acute Tox. 4 (*)

H350
H302

GHS08
GHS07
Gef.

H350
H302

612-038-00-0

2-nitro-p-anisidine;
4-methoxy-2-nitroaniline

202-547-2

96-96-8

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 2 (*)
Aquatic Chronic 3

H330
H310
H300
H373 (*)(*)
H412

GHS06
GHS08
Gef.

H330
H310
H300
H373 (*)(*)
H412

612-039-00-6

2-ethoxyaniline;
o-phenetidine

202-356-4

94-70-2

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)

H331
H311
H301
H373 (*)(*)

GHS06
GHS08
Gef.

H331
H311
H301
H373 (*)(*)

612-040-00-1

2,4-dinitroaniline

202-553-5

97-02-9

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H330
H310
H300
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H330
H310
H300
H373 (*)(*)
H411

612-041-00-7

4,4'-bi-o-toluidine

204-358-0

119-93-7

Carc. 1B
Acute Tox. 4 (*)
Aquatic Chronic 2

H350
H302
H411

GHS08
GHS07
GHS09
Gef.

H350
H302
H411

612-042-00-2

benzidine;
1,1'-biphenyl-4,4'-diamine;
4,4'-diaminobiphenyl;
biphenyl-4,4'-ylenediamine

202-199-1

92-87-5

Carc. 1a
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H410

Carc. 1A; H350: C> 0,01 %

612-043-00-8

N,N'-dimethylbenzidine

2810-74-4

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H332
H312
H302

GHS07
Achtg.

H332
H312
H302

612-044-00-3

N,N'-diacetylbenzidine

210-338-2

613-35-4

Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H350
H341
H332
H312
H302

GHS08
GHS07
Gef.

H350
H341
H332
H312
H302

612-046-00-4

allylamine

203-463-9

107-11-9

Flam. Liq. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2

H225
H331
H311
H301
H411

GHS02
GHS06
GHS09
Gef.

H225
H331
H311
H301
H411

612-047-00-X

benzylamine

202-854-1

100-46-9

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H312
H302
H314

GHS05
GHS07
Gef.

H312
H302
H314

612-048-00-5

dipropylamine

205-565-9

142-84-7

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A

H225
H332
H312
H302
H314

GHS02
GHS05
GHS07
Gef.

H225
H332
H312
H302
H314

STOT SE 3; H335: C> 1 %

612-049-00-0

di-n-butylamine; [1]
di-sec-butylamine [2]

203-921-8 [1]
210-937-9 [2]

111-92-2 [1]
626-23-3 [2]

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H226
H332
H312
H302

GHS02
GHS07
Achtg.

H226
H332
H312
H302

612-050-00-6

cyclohexylamine

203-629-0

108-91-8

Flam. Liq. 3
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H226
H361f***
H312
H302
H314

GHS02
GHS05
GHS08
GHS07
Gef.

H226
H361f***
H312
H302
H314

612-051-00-1

4,4'-diaminodiphenylmethane;
4,4'-methylenedianiline

202-974-4

101-77-9

Carc. 1B
Muta. 2
STOT SE 1
STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2

H350
H341
H370 (*)(*)
H373 (*)(*)
H317
H411

GHS08
GHS07
GHS09
Gef.

H350
H341
H370 (*)(*)
H373 (*)(*)
H317
H411

612-052-00-7

(S)-sec-butylamine;
(S)-2-aminobutane; [1]
(R)-sec-butylamine;
(R)-2-aminobutane; [2]
sec-butylamine;
2-aminobutane [3]

208-164-7 [1]
236-232-6 [2]
237-732-7 [3]

513-49-5 [1]
13250-12-9 [2]
13952-84-6 [3]

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1a
Aquatic Acute 1

H225
H332
H302
H314
H400

GHS02
GHS05
GHS07
GHS09
Gef.

H225
H332
H302
H314
H400

612-053-00-2

N-ethylaniline

203-135-5

103-69-5

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)

H331
H311
H301
H373 (*)(*)

GHS06
GHS08
Gef.

H331
H311
H301
H373 (*)(*)

612-054-00-8

N,N-diethylaniline

202-088-8

91-66-7

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H331
H311
H301
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H411

(*)

612-055-00-3

N-methyl-o-toluidine; [1]
N-methyl-m-toluidine; [2]
N-methyl-p-toluidine [3]

210-260-9 [1]
211-795-0 [2]
210-769-6 [3]

611-21-2 [1]
696-44-6 [2]
623-08-5 [3]

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 3

H331
H311
H301
H373 (*)(*)
H412

GHS06
GHS08
Gef.

H331
H311
H301
H373 (*)(*)
H412

612-056-00-9

N,N-dimethyl-p-toluidine; [1]
N,N-dimethyl-m-toluidine; [2]
N,N-dimethyl-o-toluidine [3]

202-805-4 [1]
204-495-6 [2]
210-199-8 [3]

99-97-8 [1]
121-72-2 [2]
609-72-3 [3]

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 3

H331
H311
H301
H373 (*)(*)
H412

GHS06
GHS08
Gef.

H331
H311
H301
H373 (*)(*)
H412

(*)

612-057-00-4

piperazine;
[solid]

203-808-3

110-85-0

Repr. 2
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1

H361fd
H314
H334
H317

GHS05
GHS08
Gef.

H361fd
H314
H334
H317

612-057-01-1

piperazine;
[liquid]

203-808-3

110-85-0

Repr. 2
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1

H361fd
H314
H334
H317

GHS05
GHS08
Gef.

H361fd
H314
H334
H317

612-058-00-X

2,2'-iminodiethylamine;
diethylenetriamine

203-865-4

111-40-0

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1

H312
H302
H314
H317

GHS05
GHS07
Gef.

H312
H302
H314
H317

612-059-00-5

3,6-diazaoctanethylenediamin;
triethylenetetramine

203-950-6

112-24-3

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3

H312
H314
H317
H412

GHS05
GHS07
Gef.

H312
H314
H317
H412

612-060-00-0

3,6,9-triazaundecamethylenediamine;
tetraethylenepentamine

203-986-2

112-57-2

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H312
H302
H314
H317
H411

GHS05
GHS07
GHS09
Gef.

H312
H302
H314
H317
H411

612-061-00-6

3-aminopropyldimethylamine;
N,N-dimethyl-1,3-diaminopropane

203-680-9

109-55-7

Flam. Liq. 3
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1

H226
H302
H314
H317

GHS02
GHS05
GHS07
Gef.

H226
H302
H314
H317

612-062-00-1

3-aminopropyldiethylamine;
N,N-diethyl-1,3-diaminopropane

203-236-4

104-78-9

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1

H226
H312
H302
H314
H317

GHS02
GHS05
GHS07
Gef.

H226
H312
H302
H314
H317

612-063-00-7

3,3'-iminodi(propylamine);
dipropylenetriamine

200-261-2

56-18-8

Acute Tox. 2 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Skin Corr. 1a
Skin Sens. 1

H330
H311
H302
H314
H317

GHS06
GHS05
Gef.

H330
H311
H302
H314
H317

612-064-00-2

3,6,9,12-tetra-azatetradecamethylenediamine;
pentacthylenehexamine

223-775-9

4067-16-7

Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H317
H410

612-065-00-8

polyethlyenepolyamines with the exception of those specified elsewhere in this Annex

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H312
H302
H314
H317
H410

612-066-00-3

dicyclohexylamine

202-980-7

101-83-7

Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H302
H314
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H314
H410

612-067-00-9

3-aminomethyl-3,5,5-trimethylcyclohexylamine

220-666-8

2855-13-2

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3

H312
H302
H314
H317
H412

GHS05
GHS07
Gef.

H312
H302
H314
H317
H412

612-068-00-4

3,3'-dichlorobenzidine;
3,3'-dichlorobiphenyl-4,4'-ylenediamine

202-109-0

91-94-1

Carc. 1B
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H312
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H312
H317
H410

612-069-00-X

salts of 3,3'-dichlorobenzidine;
salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine

Carc. 1B
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H312
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H312
H317
H410

612-070-00-5

salts of benzidine

208-519-6
208-520-1
244-236-4
252-984-8

531-85-1
531-86-2
21136-70-9
36341-27-2

Carc. 1a
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H410

612-071-00-0

salts of 2-naphthylamine

209-030-0
210-313-6

553-00-4
612-52-2

Carc. 1a
Acute Tox. 4 (*)
Aquatic Chronic 2

H350
H302
H411

GHS08
GHS07
GHS09
Gef.

H350
H302
H411

612-072-00-6

biphenyl-4-ylamine;
xenylamine;
4-aminobiphenyl

202-177-1

92-67-1

Carc. 1a
Acute Tox. 4 (*)

H350
H302

GHS08
GHS07
Gef.

H350
H302

612-073-00-1

salts of biphenyl-4-ylamine;
salts of xenylamine;
salts of 4-aminobiphenyl

Carc. 1a
Acute Tox. 4 (*)

H350
H302

GHS08
GHS07
Gef.

H350
H302

612-074-00-7

benzyldimethylamine

203-149-1

103-83-3

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Chronic 3

H226
H332
H312
H302
H314
H412

GHS02
GHS05
GHS07
Gef.

H226
H332
H312
H302
H314
H412

612-075-00-2

2-aminoethyldimethylamine;
2-dimethylaminoethylamine

203-541-2

108-00-9

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A

H225
H312
H302
H314

GHS02
GHS05
GHS07
Gef.

H225
H312
H302
H314

612-076-00-8

ethyldimethylamine

209-940-8

598-56-1

Flam. Liq. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B

H225
H332
H302
H314

GHS02
GHS05
GHS07
Gef.

H225
H332
H302
H314

612-077-00-3

dimethylnitrosoamine;
N-nitrosodimethylamine

200-549-8

62-75-9

Carc. 1B
Acute Tox. 2 (*)
Acute Tox. 3 (*)
STOT RE 1
Aquatic Chronic 2

H350
H330
H301
H372 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H350
H330
H301
H372 (*)(*)
H411

Carc. 1B; H350: C> 0,001 %

612-078-00-9

2,2'-dichloro-4,4'-methylenedianiline;
4,4'-methylene bis(2-chloroaniline)

202-918-9

101-14-4

Carc. 1B
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H410

612-079-00-4

salts of 2,2'-dichloro-4,4'-methylenedianiline;
salts of 4,4'-methylenebis(2-chloroaniline)

Carc. 1B
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H410

612-080-00-X

4-amino-N,N-diethylaniline;
N,N-diethyl-p-phenylendiamine

202-214-1

93-05-0

Acute Tox. 3 (*)
Skin Corr. 1B

H301
H314

GHS06
GHS05
Gef.

H301
H314

612-081-00-5

salts of 4,4'-bi-o-toluidine;
salts of 3,3'-dimethylbenzidine;
salts ofo-tolidine

210-322-5
265-294-7
277-985-0

612-82-8
64969-36-4
74753-18-7

Carc. 1B
Acute Tox. 4 (*)
Aquatic Chronic 2

H350
H302
H411

GHS08
GHS07
GHS09
Gef.

H350
H302
H411

612-082-00-0

thiourea;
thiocarbamide

200-543-5

62-56-6

Carc. 2
Repr. 2
Acute Tox. 4 (*)
Aquatic Chronic 2

H351
H361d (*)(*)(*)
H302
H411

GHS08
GHS07
GHS09
Achtg.

H351
H361d (*)(*)(*)
H302
H411

612-083-00-6

1-methyl-3-nitro-1-nitrosoguanidine

200-730-1

70-25-7

Carc. 1B
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H350
H332
H319
H315
H411

GHS08
GHS07
GHS09
Gef.

H350
H332
H319
H315
H411

Carc. 1B; H350: C> 0,01 %

612-084-00-1

dapsone;
4,4'-diamino diphenyl sulfone

201-248-4

80-08-0

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

612-085-00-7

4,4'-methylenedi-o-toluidine

212-658-8

838-88-0

Carc. 1B
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H350
H302
H317
H410

612-086-00-2

amitraz (ISO);
N,N-bis(2,4-xylyliminomethyl) methylamine

251-375-4

33089-61-1

Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373 (*)(*)
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373 (*)(*)
H317
H410

M=10

612-087-00-8

guazatine (ISO)

108173-90-6

Acute Tox. 2 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H312
H302
H335
H315
H318
H400
H410

GHS06
GHS05
GHS09
Gef.

H330
H312
H302
H335
H315
H318
H410

612-088-00-3

simazine (ISO);
6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine

204-535-2

122-34-9

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

612-089-00-9

1,5-naphthylenediamine

218-817-8

2243-62-1

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

612-090-00-4

2,2'-(nitrosoimino)bisethanol

214-237-4

1116-54-7

Carc. 1B

H350

GHS08
Gef.

H350

612-091-00-X

o-toluidine;
2-aminotoluene

202-429-0

95-53-4

Carc. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Aquatic Acute 1

H350
H331
H301
H319
H400

GHS06
GHS08
GHS09
Gef.

H350
H331
H301
H319
H400

612-092-00-5

N,N'-(2,2-dimethylpropylidene)hexamethylenediamine

401-660-6

1000-78-8

Skin Irrit. 2
Skin Sens. 1

H315
H317

GHS07
Achtg.

H315
H317

612-093-00-0

3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline

401-790-3

104147-32-2

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

612-094-00-6

4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride

402-190-4

113674-95-6

STOT RE 1
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H372**
H302
H373**
H318
H317
H400
H410

GHS05
GHS08
GHS07
GHS09
Gef.

H372**
H302
H373**
H318
H317
H410

612-095-00-1

benzyl-2-hydroxydodecyldimethylammonium benzoate

402-610-6

113694-52-3

Skin Corr. 1B
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H314
H302
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H302
H410

612-096-00-7

4,4'-carbonimidoylbis[N,N-dimethylaniline]

207-762-5

492-80-8

Carc. 2
Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Chronic 2

H351
H302
H319
H411

GHS08
GHS07
GHS09
Achtg.

H351
H302
H319
H411

612-097-00-2

salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline]

Carc. 2
Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Chronic 2

H351
H302
H319
H411

GHS08
GHS07
GHS09
Achtg.

H351
H302
H319
H411

612-098-00-8

nitrosodipropylamine

210-698-0

621-64-7

Carc. 1B
Acute Tox. 4 *
Aquatic Chronic 2

H350
H302
H411

GHS08
GHS07
GHS09
Gef.

H350
H302
H411

Carc. 1B; H350: C> 0,001 %

612-099-00-3

4-methyl-m-phenylenediamine;
2,4-toluenediamine

202-453-1

95-80-7

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2

H350
H341
H361f***
H301
H312
H373**
H317
H411

GHS06
GHS08
GHS09
Gef.

H350
H341
H361f***
H301
H312
H373**
H317
H411

612-100-00-7

propylenediamine

201-155-9

78-90-0

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A

H226
H312
H302
H314

GHS02
GHS05
GHS07
Gef.

H226
H312
H302
H314

612-101-00-2

methenamine;
hexamethylenetetramine

202-905-8

100-97-0

Flam. Sol. 2
Skin Sens. 1

H228
H317

GHS02
GHS07
Achtg.

H228
H317

612-102-00-8

N,N-bis(3-aminopropyl)methylamine

203-336-8

105-83-9

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H331
H311
H302
H314

GHS06
GHS05
Gef.

H331
H311
H302
H314

612-103-00-3

N,N,N',N'-tetramethylethylenediamine

203-744-6

110-18-9

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H225
H332
H302
H314

GHS02
GHS05
GHS07
Gef.

H225
H332
H302
H314

612-104-00-9

hexamethylenediamine

204-679-6

124-09-4

Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT SE 3
Skin Corr. 1B

H312
H302
H335
H314

GHS05
GHS07
Gef.

H312
H302
H335
H314

612-105-00-4

2-piperazin-1-ylethylamine

205-411-0

140-31-8

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3

H312
H302
H314
H317
H412

GHS05
GHS07
Gef.

H312
H302
H314
H317
H412

612-106-00-X

2,6-diethylaniline

209-445-7

579-66-8

Acute Tox. 4 (*)

H302

612-107-00-5

1-phenylethylamine; [1]
DL-a-methylbenzylamine [2]

202-706-6 [1]
210-545-8 [2]

98-84-0 [1]
618-36-0 [2]

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H312
H302
H314

GHS05
GHS07
Gef.

H312
H302
H314

612-108-00-0

3-aminopropyltriethoxysilane

213-048-4

919-30-2

Acute Tox. 4 (*)
Skin Corr. 1B

H302
H314

GHS05
GHS07
Gef.

H302
H314

612-109-00-6

bis(2-dimethylaminoethyl)(methyl)amine

221-201-1

3030-47-5

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H311
H302
H314

GHS06
GHS05
Gef.

H311
H302
H314

612-110-00-1

2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)

229-962-1

6864-37-5

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Skin Corr. 1a
Aquatic Chronic 2

H331
H311
H302
H314
H411

GHS06
GHS05
GHS09
Gef.

H331
H311
H302
H314
H411

612-111-00-7

2-methyl-m-phenylenediamine;
2,6-toluenediamine

212-513-9

823-40-5

Muta. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2

H341
H312
H302
H317
H411

GHS08
GHS07
GHS09
Achtg.

H341
H312
H302
H317
H411

612-112-00-2

p-anisidine;
4-methoxyaniline

203-254-2

104-94-9

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 2 (*)
Aquatic Acute 1

H330
H310
H300
H373 (*)(*)
H400

GHS06
GHS08
GHS09
Gef.

H330
H310
H300
H373 (*)(*)
H400

612-113-00-8

6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine

403-240-8

106264-79-3

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

612-114-00-3

R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate

404-390-7

Flam. Sol. 1
Skin Sens. 1
Aquatic Chronic 3

H228
H317
H412

GHS02
GHS07
Achtg.

H228
H317
H412

612-115-00-9

dimethyldioctadecylammonium hydrogen sulfate

404-050-8

123312-54-9

Eye Irrit. 2
Aquatic Chronic 4

H319
H413

GHS07
Achtg.

H319
H413

612-116-00-4

C_8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate

404-690-8

68132-19-4

Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H314
H317
H400
H410

GHS06
GHS05
GHS09
Gef.

H331
H314
H317
H410

612-117-00-X

C_12-14 -tert-alkylamine, methylphosphonic acid salt

404-750-3

119415-07-5

Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Chronic 2

H302
H314
H411

GHS05
GHS07
GHS09
Gef.

H302
H314
H411

612-118-00-5

a reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate;
(1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide

405-080-4

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

612-119-00-0

benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate

405-330-2

Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H400
H410

GHS05
GHS09
Gef.

H315
H318
H410

612-120-00-6

aclonifen (ISO);
2-chloro-6-nitro-3-phenoxyaniline

277-704-1

74070-46-5

Carc. 2

H351

GHS08

H351

M = 100
M = 10

Skin Sens. 1A

H317

GHS07

H317

Aquatic Acute 1

H400

GHS09

Aquatic Chronic 1

H410

Achtg.

H410

612-121-00-1

amines, polyethylenepoly-;
HEPA

268-626-9

68131-73-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H312
H302
H314
H317
H410

612-122-00-7

hydroxylamine ... %
[> 55 % in aqueous solution]

232-259-2

7803-49-8

Unst. Expl.
Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1

H200
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400

GHS01
GHS05
GHS08
GHS07
GHS09
Gef.

H200
H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400

612-122-01-4

hydroxylamine ... % [≤ 55 % in aqueous solution]

232-259-2

7803-49-8

Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1

H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400

GHS05
GHS08
GHS07
GHS09
Gef.

H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400

612-123-00-2

hydroxylammonium chloride;
hydroxylamine hydrochloride; [1]
bis(hydroxylammonium) sulfate;
hydroxylamine sulfate (2:1) [2]

226-798-2 [1]
233-118-8 [2]

5470-11-1 [1]
10039-54-0 [2]

Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H290
H351
H312
H302
H373**
H319
H315
H317
H400

GHS05
GHS08
GHS07
GHS09
Achtg.

H290
H351
H312
H302
H373**
H319
H315
H317
H400

612-124-00-8

N,N,N-trimethylanilinium chloride

205-319-0

138-24-9

Acute Tox. 3 (*)
Acute Tox. 3 (*)

H311
H301

GHS06
Gef.

H311
H301

612-125-00-3

2-methyl-p-phenylenediamine;
2,5-toluenediamine

202-442-1

95-70-5

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2

H301
H332
H312
H317
H411

GHS06
GHS09
Gef.

H301
H332
H312
H317
H411

612-126-00-9

toluene-2,4-diammonium sulphate;
4-methyl-m-phenylenediamine sulfate

265-697-8

65321-67-7

Carc. 1B
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H350
H301
H312
H319
H317
H411

GHS06
GHS08
GHS09
Gef.

H350
H301
H312
H319
H317
H411

612-127-00-4

3-aminophenol

209-711-2

591-27-5

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Chronic 2

H332
H302
H411

GHS07
GHS09
Achtg.

H332
H302
H411

612-128-00-X

4-aminophenol

204-616-2

123-30-8

Muta. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H341
H332
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H341
H332
H302
H410

612-129-00-5

diisopropylamine

203-558-5

108-18-9

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H225
H332
H302
H314

GHS02
GHS05
GHS07
Gef.

H225
H332
H302
H314

STOT SE 3; H335: C> 5 %

612-130-00-0

2,6-diamino-3,5-diethyltoluene;
4,6-diethyl-2-methyl-1,3-benzenediamine; [1]
2,4-diamino-3,5-diethyltoluene;
2,4-diethyl-6-methyl-1,3-benzenediamine; [2]
diethylmethylbenzenediamine [3]

218-255-3 [1]
218-256-9 [2]
270-877-4 [3]

2095-01-4 [1]
2095-02-5 [2]
68479-98-1 [3]

Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H373 (*)(*)
H319
H400
H410

GHS08
GHS07
GHS09
Achtg.

H312
H302
H373 (*)(*)
H319
H410

612-131-00-6

didecyldimethylammonium chloride

230-525-2

7173-51-5

Acute Tox. 4 (*)
Skin Corr. 1B

H302
H314

GHS05
GHS07
Gef.

H302
H314

612-132-00-1

N,N'-diphenyl-p-phenylenediamine;
N,N'-diphenyl-1,4-benzenediamine

200-806-4

74-31-7

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

612-133-00-7

(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;
4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate

247-162-0

25646-77-9

Acute Tox. 3 (*)
STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H373 (*)(*)
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H301
H373 (*)(*)
H317
H410

612-134-00-2

N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;
4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate

247-161-5

25646-71-3

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

612-135-00-8

N-2-naphthylaniline;
N-phenyl-2-naphthylamine

205-223-9

135-88-6

Carc. 2
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H351
H319
H315
H317
H411

GHS08
GHS07
GHS09
Achtg.

H351
H319
H315
H317
H411

612-136-00-3

N-isopropyl-N'-phenyl-p-phenylenediamine

202-969-7

101-72-4

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

Skin Sens. 1; H317: C> 0,1 %

612-137-00-9

4-chloroaniline

203-401-0

106-47-8

Carc. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H331
H311
H301
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H331
H311
H301
H317
H410

612-138-00-4

furalaxyl (ISO);
methylN-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate

260-875-1

57646-30-7

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

612-139-00-X

mefenacet (ISO);
2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide

277-328-8

73250-68-7

Aquatic Chronic 2

H411

GHS09

H411

612-140-00-5

quaternary ammonium compounds, benzyl-C_8-18-alkyldimethyl, chlorides

264-151-6

63449-41-2

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Acute 1

H312
H302
H314
H400

GHS05
GHS07
GHS09
Gef.

H312
H302
H314
H400

612-141-00-0

4,4'-methylenebis(2-ethylaniline);
4,4'-methylenebis(2-ethylbenzeneamine)

243-420-1

19900-65-3

Carc. 2
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H302
H410

612-142-00-6

biphenyl-2-ylamine

201-990-9

90-41-5

Carc. 2
Acute Tox. 4 (*)
Aquatic Chronic 3

H351
H302
H412

GHS08
GHS07
Achtg.

H351
H302
H412

612-143-00-1

N⁵,N⁵-diethyltoluene-2,5-diamine monohydrochloride;
4-diethylamino-2-methylaniline monohydrochloride

218-130-3

2051-79-8

Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H319
H317
H400
H410

GHS06
GHS09
Gef.

H301
H319
H317
H410

612-144-00-7

flumetralin (ISO);
N-(2-chloro-6-fluorobenzyl)-N-ethyl-a, a,a-trifluoro-2,6-dinitro-p-toluidine

62924-70-3

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H319
H315
H317
H400
H410

GHS07
GHS09
Achtg.

H319
H315
H317
H410

612-145-00-2

o-phenylenediamine

202-430-6

95-54-5

Carc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H341
H301
H332
H312
H319
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H341
H301
H332
H312
H319
H317
H410

612-146-00-8

o-phenylenediamine dihydrochloride

210-418-7

615-28-1

Carc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H341
H301
H332
H312
H319
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H351
H341
H301
H332
H312
H319
H317
H410

612-147-00-3

m-phenylenediamine

203-584-7

108-45-2

Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H341
H331
H311
H301
H319
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H341
H331
H311
H301
H319
H317
H410

612-148-00-9

m-phenylenediamine dihydrochloride

208-790-0

541-69-5

Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H341
H331
H311
H301
H319
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H341
H331
H311
H301
H319
H317
H410

612-149-00-4

1,3-diphenylguanidine

203-002-1

102-06-7

Repr. 2
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2

H361f (*)(*)(*)
H302
H319
H335
H315
H411

GHS08
GHS07
GHS09
Achtg.

H361f (*)(*)(*)
H302
H319
H335
H315
H411

612-150-00-X

Spiroxamin (ISO);
8-tert-Butyl-1,4-dioxa-spiro[4.5]dec-2-ylmethyl-ethylpropylamin

118134-30-8

Repr. 2
Acute Tox. 4
Acute Tox. 4
Acute Tox. 4
STOT RE 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361d
H332
H312
H302
H373 (Augen)
H315
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361d
H332
H312
H302
H373 (Augen)
H315
H317
H410

M = 100
M = 100

612-151-00-5

methyl-phenylene diamine;
diaminotoluene;
[technical product - reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]

Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H350
H341
H361f***
H301
H312
H373**
H319
H317
H411

GHS06
GHS08
GHS09
Gef.

H350
H341
H361f***
H301
H312
H373**
H319
H317
H411

612-152-00-0

N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine

406-610-7

62478-82-4

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1a
Aquatic Chronic 3

H226
H332
H302
H373 (*)(*)
H314
H412

GHS02
GHS08
GHS05
GHS07
Gef.

H226
H332
H302
H373 (*)(*)
H314
H412

612-153-00-6

4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride

407-020-2

132885-85-9

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 3

H302
H317
H412

GHS07
Achtg.

H302
H317
H412

612-154-00-1

6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]

410-890-6

95235-29-3

Aquatic Chronic 4

H413

612-155-00-7

2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene

411-730-8

93071-94-4

Aquatic Chronic 4

H413

612-156-00-2

reaction mass of: trihexadecylmethylammonium chloride;
dihexadecyldimethylammonium chloride

405-620-9

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

612-157-00-8

(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride

410-780-8

Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H373 (*)(*)
H318
H317
H411

GHS08
GHS05
GHS07
GHS09
Gef.

H302
H373 (*)(*)
H318
H317
H411

612-158-00-3

reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C₁₂-alkyl group is branched;
4-dodecylsalicylaldoxime

410-820-4

Aquatic Chronic 4

H413

612-159-00-9

Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C₁₀-C₁₆-alkyloxy)methyl]oxirane derivatives) andp-toluene-sulfonic acid

410-880-1

Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H302
H314
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H314
H410

612-160-00-4

p-toluidine;
4-aminotoluene; [1]
toluidinium chloride; [2]
toluidine sulphate (1:1) [3]

203-403-1 [1]
208-740-8 [2]
208-741-3 [3]

106-49-0 [1]
540-23-8 [2]
540-25-0 [3]

Carc. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H351
H331
H311
H301
H319
H317
H400

GHS06
GHS08
GHS09
Gef.

H351
H331
H311
H301
H319
H317
H400

612-161-00-X

2,6-xylidine;
2,6-dimethylaniline

201-758-7

87-62-7

Carc. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2

H351
H332
H312
H302
H335
H315
H411

GHS08
GHS07
GHS09
Achtg.

H351
H332
H312
H302
H335
H315
H411

612-162-00-5

dimethyldioctadecylammonium chloride;
DODMAC

203-508-2

107-64-2

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

612-163-00-0

metalaxyl-M (ISO);
mefenoxam;
(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester

70630-17-0

Acute Tox. 4 (*)
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

612-164-00-6

2-butyl-2-ethyl-1,5-diaminopentane

412-700-7

137605-95-9

Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3

H312
H302
H373 (*)(*)
H314
H317
H412

GHS08
GHS05
GHS07
Gef.

H312
H302
H373 (*)(*)
H314
H317
H412

612-165-00-1

N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine

413-810-8

65181-78-4

Aquatic Chronic 2

H411

GHS09

H411

612-166-00-7

reaction mass of:cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);
trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)

411-830-1

114765-88-7

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

612-167-00-2

5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride

410-490-1

Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H373 (*)(*)
H318
H317
H411

GHS08
GHS05
GHS07
GHS09
Gef.

H302
H373 (*)(*)
H318
H317
H411

612-168-00-8

3,5-dichloro-2,6-difluoropyrdine-4-amine

220-630-1

2840-00-8

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Chronic 2

H312
H302
H411

GHS07
GHS09
Achtg.

H312
H302
H411

612-169-00-3

bis(N-methyl-N-phenylhydrazine)sulfate

423-170-1

618-26-8

Flam. Liq. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H225
H372**
H302
H318
H317
H400
H410

GHS02
GHS05
GHS08
GHS07
GHS09
Gef.

H225
H372**
H302
H318
H317
H410

612-170-00-9

4-chlorophenyl cyclopropyl ketoneO-(4-aminobenzyl)oxime

405-260-2

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

612-171-00-4

N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane

410-060-3

130728-76-6

Muta. 2
Skin Sens. 1
Aquatic Chronic 2

H341
H317
H411

GHS08
GHS09
Achtg.

H341
H317
H411

612-172-00-X

4,4'-methylenebis(N,N'-dimethylcyclohexanamine

412-840-9

13474-64-1

Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1a
Aquatic Chronic 3

H302
H373 (*)(*)
H314
H412

GHS08
GHS05
GHS07
Gef.

H302
H373 (*)(*)
H314
H412

612-173-00-5

lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate

411-140-0

125328-86-1

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

612-174-00-0

4,4-dimethoxybutylamine

407-690-6

19060-15-2

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3

H302
H314
H317
H412

GHS05
GHS07
Gef.

H302
H314
H317
H412

612-175-00-6

2-(O-aminooxy)ethylamine dihydrochloride

412-310-7

37866-45-8

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

612-176-00-1

polymer of 1,3-dibromopropane andN,N-diethyl-N',N'-dimethyl-1,3-propanediamine

410-570-6

143747-73-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

612-177-00-7

2-naphthylamino-6-sulfomethylamide

412-120-4

104295-55-8

STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2

H373 (*)(*)
H317
H411

GHS08
GHS09
Achtg.

H373 (*)(*)
H317
H411

612-178-00-2

1,4,7,10-tetraazacyclododecane disulfate

412-080-8

112193-77-8

Acute Tox. 4 (*)
STOT SE 3
Eye Dam. 1
Aquatic Chronic 3

H302
H335
H318
H412

GHS05
GHS07
Gef.

H302
H335
H318
H412

612-179-00-8

1-(2-propenyl)pyridinium chloride

412-740-5

25965-81-5

Acute Tox. 4 (*)
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

612-180-00-3

3-aminobenzylamine

412-230-2

4403-70-7

Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Chronic 2

H302
H314
H411

GHS05
GHS07
GHS09
Gef.

H302
H314
H411

612-181-00-9

2-phenylthioaniline

413-030-8

1134-94-7

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

612-182-00-4

1-ethyl-1-methylmorpholinium bromide

418-210-1

65756-41-4

Muta. 2

H341

GHS08
Achtg.

H341

612-183-00-X

1-ethyl-1-methylpyrrolidinium bromide

418-200-5

69227-51-6

Muta. 2

H341

GHS08
Achtg.

H341

612-184-00-5

6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one

403-830-5

89331-94-2

Aquatic Chronic 3

H412

612-185-00-0

1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide

407-400-8

59493-72-0

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

612-186-00-6

bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate

406-770-8

149057-64-7

STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H318
H317
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H373 (*)(*)
H318
H317
H410

612-187-00-1

2,3,4-trifluoroaniline

407-170-9

3862-73-5

Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2

H312
H302
H373 (*)(*)
H315
H318
H411

GHS08
GHS05
GHS07
GHS09
Gef.

H312
H302
H373 (*)(*)
H315
H318
H411

612-188-00-7

4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)

407-560-9

107934-68-9

Aquatic Chronic 2

H411

GHS09

H411

612-189-00-2

4-amino-2-(aminomethyl)phenol dihydrochloride

412-510-4

135043-64-0

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

612-190-00-8

4,4'-methylenebis(2-isopropyl-6-methylaniline)

415-150-6

16298-38-7

STOT RE 2 (*)
Aquatic Chronic 2

H373 (*)(*)
H411

GHS08
GHS09
Achtg.

H373 (*)(*)
H411

612-191-00-3

polymer of allylamine hydrochloride

415-050-2

71550-12-4

Acute Tox. 4 (*)
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

612-192-00-9

2-isopropyl-4-(N-methyl)aminomethylthiazole

414-800-6

154212-60-9

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2

H312
H302
H315
H318
H411

GHS05
GHS07
GHS09
Gef.

H312
H302
H315
H318
H411

612-193-00-4

3-methylaminomethylphenylamine

414-570-7

18759-96-1

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H312
H302
H314
H317
H410

612-194-00-X

2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride

414-670-0

141890-30-4

Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H318
H410

612-195-00-5

bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate

415-210-1

160236-81-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H332
H302
H318
H410

612-196-00-0

4-chloro-o-toluidine; [1]
4-chloro-o-toluidine hydrochloride [2]

202-441-6 [1]
221-627-8 [2]

95-69-2 [1]
3165-93-3 [2]

Carc. 1B
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H350
H341
H331
H311
H301
H400
H410

GHS06
GHS08
GHS09
Gef.

H350
H341
H331
H311
H301
H410

612-197-00-6

2,4,5-trimethylaniline; [1]
2,4,5-trimethylaniline hydrochloride [2]

205-282-0 [1]
[2]

137-17-7 [1]
21436-97-5 [2]

Carc. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2

H350
H331
H311
H301
H411

GHS06
GHS08
GHS09
Gef.

H350
H331
H311
H301
H411

612-198-00-1

4,4'-thiodianiline and its salts

205-370-9

139-65-1

Carc. 1B
Acute Tox. 4 (*)
Aquatic Chronic 2

H350
H302
H411

GHS08
GHS07
GHS09
Gef.

H350
H302
H411

612-199-00-7

4,4'-oxydianiline and its salts;
p-aminophenyl ether

202-977-0

101-80-4

Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2

H350
H340
H361f (*)(*)(*)
H331
H311
H301
H411

GHS06
GHS08
GHS09
Gef.

H350
H340
H361f (*)(*)(*)
H331
H311
H301
H411

612-200-00-0

2,4-diaminoanisole;
4-methoxy-m-phenylenediamine; [1]
2,4-diaminoanisole sulphate [2]

210-406-1 [1]
254-323-9 [2]

615-05-4 [1]
39156-41-7 [2]

Carc. 1B
Muta. 2
Acute Tox. 4 (*)
Aquatic Chronic 2

H350
H341
H302
H411

GHS08
GHS07
GHS09
Gef.

H350
H341
H302
H411

612-201-00-6

N,N,N',N'-tetramethyl-4,4'-methylendianiline

202-959-2

101-61-1

Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1

H350
H400
H410

GHS08
GHS09
Gef.

H350
H410

612-202-00-1

3,4-dichloroaniline

202-448-4

95-76-1

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H318
H317
H400
H410

GHS06
GHS05
GHS09
Gef.

H331
H311
H301
H318
H317
H410

612-203-00-7

C_8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C₈: < 3 %, chain = C₈: 15 %-70 %, chain = C₁₀: 30 %-85 %, chain> C₁₀: < 3 %)

417-360-3

Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2

H312
H302
H315

GHS07
Achtg.

H312
H302
H315

612-204-00-2

C.I. Basic Violet 3;
4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride

208-953-6

548-62-9

Carc. 2
Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H318
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H351
H302
H318
H410

612-205-00-8

C.I. Basic Violet 3 with> 0,1 % of Michler's ketone (EC no. 202-027-5)

208-953-6

548-62-9

Carc. 1B
Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H302
H318
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H350
H302
H318
H410

612-206-00-3

famoxadone (ISO);
3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione

131807-57-3

STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H400
H410

GHS08
GHS09
Achtg.

H373 (*)(*)
H410

612-207-00-9

4-ethoxyaniline;
p-phenetidine

205-855-5

156-43-4

Muta. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1

H341
H332
H312
H302
H319
H317

GHS08
GHS07
Achtg.

H341
H332
H312
H302
H319
H317

612-208-00-4

N-methylbenzene-1,2-diammonium hydrogen phosphate

424-460-0

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

612-209-00-X

6-methoxy-m-toluidine;
p-cresidine

204-419-1

120-71-8

Carc. 1B
Acute Tox. 4 (*)

H350
H302

GHS08
GHS07
Gef.

H350
H302

612-210-00-5

5-nitro-o-toluidine; [1]
5-nitro-o-toluidine hydrochloride [2]

202-765-8 [1]
256-960-8 [2]

99-55-8 [1]
51085-52-0 [2]

Carc. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 3

H351
H331
H311
H301
H412

GHS06
GHS08
Gef.

H351
H331
H311
H301
H412

612-211-00-0

N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide

416-470-9

170292-97-4

Eye Irrit. 2
Aquatic Chronic 2

H319
H411

GHS07
GHS09
Achtg.

H319
H411

612-212-00-6

2,6-dichloro-4-trifluoromethylaniline

416-430-0

24279-39-8

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H315
H317
H400
H410

GHS07
GHS09
Achtg.

H332
H302
H315
H317
H410

612-213-00-1

isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine

419-850-2

148348-13-4

Skin Corr. 1B
Aquatic Chronic 3

H314
H412

GHS05
Gef.

H314
H412

612-214-00-7

4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine

421-390-2

89114-90-9

Aquatic Chronic 4

H413

612-215-00-2

3-chloro-2-(isopropylthio)aniline

421-700-6

179104-32-6

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

612-216-00-8

1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt

425-870-2

19450-38-5

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

612-217-00-3

1-methoxy-2-propylamine

422-550-4

37143-54-7

Flam. Liq. 2
Skin Corr. 1B
Acute Tox. 4 (*)
Aquatic Chronic 3

H225
H314
H302
H412

GHS02
GHS05
GHS07
Gef.

H225
H314
H302
H412

612-219-00-4

(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride

402-200-7

Aquatic Chronic 3

H412

612-220-00-X

N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine

431-060-1

153719-38-1

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3

H302
H317
H412

GHS07
Achtg.

H302
H317
H412

612-221-00-5

2-amino-4-(trifluoromethyl)benzenethiol hydrochloride

429-560-8

4274-38-8

Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1

H314
H332
H312
H302
H373**
H317
H400

GHS05
GHS08
GHS07
GHS09
Gef.

H314
H332
H312
H302
H373**
H317
H400

612-222-00-0

cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine

425-080-8

104860-26-6

Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H373**
H318
H400
H410

GHS05
GHS08
GHS07
GHS09
Gef.

H312
H302
H373**
H318
H410

612-223-00-6

N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine

425-300-2

186450-73-7

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

612-224-00-1

N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine

426-150-0

121246-28-4

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

612-225-00-7

1,4,7,10-tetraazacyclododecane

425-450-9

294-90-6

Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H314
H312
H302
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H312
H302
H410

612-226-00-2

3-(2'-phenoxyethoxy)propylamine

427-870-8

6903-18-0

Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H302
H315
H318
H412

GHS05
GHS07
Gef.

H302
H315
H318
H412

612-227-00-8

benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride

428-290-8

120606-08-8

Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H318
H410

612-228-00-3

reaction mass of:N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine

414-340-6

Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H226
H332
H312
H302
H371
H318
H317
H412

GHS02
GHS05
GHS08
GHS07
Gef.

H226
H332
H312
H302
H371
H318
H317
H412

612-229-00-9

mepanipyrim;
4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine

110235-47-7

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

612-230-00-4

N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide

431-530-4

Skin Corr. 1a
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H317
H410

612-231-00-X

3-((C_12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride

427-370-1

164288-56-6

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

612-232-00-5

reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;
triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid

430-410-9

186148-38-9

Aquatic Chronic 3

H412

612-237-00-2

hydroxylammonium hydrogensulfate;
hydroxylamine sulfate(1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphosphate; [3]
hydroxylamine 4-methylbenzenesulfonate [4]

233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]

10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]

Expl. 1.1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H201
H351
H312
H302
H373**
H319
H315
H317
H400

GHS01
GHS08
GHS07
GHS09
Gef.

H201
H351
H312
H302
H373**
H319
H315
H317
H400

612-238-00-8

(3-chloro-2-hydroxypropyl) trimethylammonium chloride ... %

222-048-3

3327-22-8

Carc. 2
Aquatic Chronic 3

H351
H412

GHS08
Achtg.

H351
H412

612-239-00-3

biphenyl-3,3',4,4'-tetrayltetraamine;
diaminobenzidine

202-110-6

91-95-2

Carc. 1B
Muta. 2

H350
H341

GHS08
Gef.

H350
H341

612-240-00-9

pyrimethanil (ISO);
N-(4,6-dimethylpyrimidin-2-yl)aniline

53112-28-0

Aquatic Chronic 2

H411

GHS09

H411

612-241-00-4

piperazine hydrochloride; [1]
piperazine dihydrochloride; [2]
piperazine phosphate [3]

228-042-7 [1]
205-551-2 [2]
217-775-8 [3]

6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3]

Repr. 2
Eye Irrit. 2
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3

H361fd
H319
H315
H334
H317
H412

GHS08
Gef.

H361fd
H319
H315
H334
H317
H412

612-242-00-X

cyprodinil (ISO);
4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine

121552-61-2

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

M=10

612-243-00-5

(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate

420-560-3

79617-97-3

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

M=10

612-244-00-0

3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride

421-310-6

87691-88-1

Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361f***
H302
H319
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361f***
H302
H319
H317
H410

612-245-00-6

2-ethylphenylhydrazine hydrochloride

421-460-2

19398-06-2

Carc. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H372**
H302
H318
H317
H400
H410

GHS05
GHS08
GHS07
GHS09
Gef.

H351
H372**
H302
H318
H317
H410

M=10

612-246-00-1

(2-chloroethyl)(3-hydroxypropyl)ammonium chloride

429-740-6

40722-80-3

Carc. 1B
Muta. 1B
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3

H350
H340
H373**
H317
H412

GHS08
GHS07
Gef.

H350
H340
H373**
H317
H412

612-247-00-7

N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide

423-530-8

152828-23-4

STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 3

H372**
H302
H412

GHS08
GHS07
Gef.

H372**
H302
H412

612-248-00-2

reaction product of diphenylamine, phenothiazine, and alkenes, branched (C_8-10, C₉-rich)

439-540-0

Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4

H315
H317
H413

GHS07
Achtg.

H315
H317
H413

612-249-00-8

4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride

425-030-5

159939-85-2

Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H361f***
H302
H314
H317
H411

GHS05
GHS08
GHS07
GHS09
Gef.

H361f***
H302
H314
H317
H411

612-250-00-3

chloro-N,N-dimethylformiminium chloride

425-970-6

3724-43-4

Repr. 1B
Acute Tox. 4 *
Skin Corr. 1A

H360D***
H302
H314

GHS05
GHS08
GHS07
Gef.

H360D***
H302
H314

EUH014

612-251-00-9

cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride

426-020-3

51229-78-8

Flam. Sol. 2
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H228
H361d***
H302
H315
H317
H411

GHS02
GHS08
GHS07
GHS09
Achtg.

H228
H361d***
H302
H315
H317
H411

612-252-00-4

imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine

428-040-8

138261-41-3

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

612-253-00-X

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing < 0,5 % formamide (EC No 200-842-0)]

429-400-7

199327-61-2

Aquatic Chronic 3

H412

612-253-01-7

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing> 0,5 % formamide (EC No 200-842-0)]

429-400-7

199327-61-2

Repr. 1B
Aquatic Chronic 3

H360D***
H412

GHS08
Gef.

H360D***
H412

612-254-00-5

reaction products of diisopropanolamine with formaldehyde (1:4)

432-440-8

220444-73-5

Carc. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H351
H302
H314
H317
H411

GHS05
GHS08
GHS07
GHS09
Gef.

H351
H302
H314
H317
H411

612-255-00-0

1-(3-methoxypropyl)-4-piperidinamine

431-950-8

179474-79-4

Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3

H312
H302
H314
H412

GHS05
GHS07
Gef.

H312
H302
H314
H412

612-256-00-6

benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate

427-470-3

137864-22-3

Acute Tox. 4 *
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

612-257-00-1

tripropylammonium dihydrogenphosphate

433-700-3

35687-90-2

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

612-259-00-2

N-ethyl-3-trimethoxysilyl-2-methyl-propanamine

437-720-3

227085-51-0

Eye Dam. 1

H318

GHS05
Gef.

H318

612-261-00-3

3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline

441-190-9

121451-05-6

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

M=10

612-265-00-5

bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate

444-360-0

191617-13-7

Aquatic Chronic 3

H412

612-266-00-0

3-chloro-4-(3-fluorobenzyloxy)aniline

445-590-4

202197-26-0

Muta. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H341
H302
H373**
H400
H410

GHS08
GHS07
GHS09
Achtg.

H341
H302
H373**
H410

612-267-00-6

bis(hydrogenated tallow C_16-18-alkyl)hydroxylamine

418-370-0

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

612-269-00-7

reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;
1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;
reaction mass of:N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;
N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline

420-720-2

Aquatic Chronic 4

H413

612-270-00-2

(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride

433-010-2

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3

H302
H317
H412

GHS07
Achtg.

H302
H317
H412

612-271-00-8

reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;
ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate

434-970-5

160987-57-5

Aquatic Chronic 4

H413

612-272-00-3

ammonium (?-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate

435-210-5

Aquatic Chronic 2

H411

GHS09

H411

612-273-00-9

alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride

435-650-8

Acute Tox. 4 *
Skin Corr. 1a
Aquatic Acute 1
Aquatic Chronic 1

H302
H314
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H314
H410

612-274-00-4

(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate

445-750-3

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H302
H318
H317
H412

GHS05
GHS07
Gef.

H302
H318
H317
H412

612-275-00-X

fatty acids, C₁₈-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil

447-880-6

206565-89-1

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H315
H318
H317
H410

M=10

612-276-00-5

1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts

451-430-4

500717-36-2

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

612-277-00-0

reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium

451-440-9

586372-44-3

Eye Dam. 1

H318

GHS05
Gef.

H318

612-278-00-6

ethidium bromide;
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide

214-984-6

1239-45-8

Muta. 2
Acute Tox. 2 *
Acute Tox. 4 *

H341
H330
H302

GHS06
GHS08
Gef.

H341
H330
H302

612-279-00-1

(R,S)-2-amino-3,3-dimethylbutane amide

447-860-7

144177-62-8

Repr. 2
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H361f***
H373**
H319
H315
H317

GHS08
GHS07
Achtg.

H361f***
H373**
H319
H315
H317

612-280-00-7

3-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine

205-057-7

132-32-1

Carc. 1B

H350

GHS08
Gef.

H350

612-281-00-2

leucomalachite green;
N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline

204-961-9

129-73-7

Carc. 2
Muta. 2

H351
H341

GHS08
Achtg.

H351
H341

612-282-00-8

octadecylamine

204-695-3

124-30-1

Asp. Tox. 1

H304

GHS05

H304

M = 10
M = 10

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS08

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Irrit. 2

H315

GHS09

H315

Eye Dam. 1

H318

Gef.

H318

Aquatic Acute 1

H400

H410

Aquatic Chronic 1

H410

612-283-00-3

(Z)-octadec-9-enylamine

204-015-5

112-90-3

Acute Tox. 4

H302

GHS05

H302

M = 10
M = 10

Asp Tox. 1

H304

GHS07

H304

STOT SE 3

H335

GHS08

H335

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS09

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Corr. 1B

H314

Gef.

H314

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

612-284-00-9

amines, hydrogenated tallow alkyl

262-976-6

61788-45-2

Asp Tox. 1

H304

GHS08

H304

M = 10
M = 10

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS05

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Irrit. 2

H315

GHS09

H315

Eye Dam. 1

H318

Gef.

H318

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

612-285-00-4

amines, coco alkyl

262-977-1

61788-46-3

Acute Tox. 4

H302

GHS05

H302

M = 10
M = 10

Asp. Tox. 1

H304

GHS07

H304

STOT SE 3

H335

GHS08

H335

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS09

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Corr. 1B

H314

Gef.

H314

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

612-286-00-X

amines, tallow alkyl

263-125-1

61790-33-8

Acute Tox. 4

H302

GHS05

H302

M = 10
M = 10

Asp. Tox. 1

H304

GHS07

H304

STOT RE 2

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

GHS08

H373 (Magen-Darm-Trakt, Leber, Immunsystem)

Skin Corr. 1B

H314

GHS09

H314

Aquatic Acute 1

H400

Gef.

Aquatic Chronic 1

H410

612-287-00-5

fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine

79622-59-6

Repr. 2
Acute Tox. 4
Eye Dam. 1
Skin Sens. 1a
Aquatic Acute 1
Aquatic Chronic 1

H361d
H332
H318
H317
H400
H410

GHS08
GHS07
GHS05
GHS09
Gef.

H361d
H332
H318
H317
H410

M = 10
M = 10

612-288-00-0

Bupirimat (ISO);
5-Butyl-2-ethylamino-6-methylpyrimidin-4-yl dimethylsulfamat

255-391-2

41483-43-6

Carc. 2
Skin Sens. 1B
Aquatic Chronic 1

H351
H317
H410

GHS08
GHS07
GHS09
Achtg.

H351
H317
H410

M = 1

612-289-00-6

Triflumizol (ISO);
(1E)-N-[4-Chlor-2-(trifluormethyl)phenyl]-1-(1H-imidazol-1-yl)-2-propoxyethanimin

68694-11-1

Repr. 1B
Acute Tox. 4
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H360D
H302
H373 (Leber)
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H360D
H302
H373 (Leber)
H317
H410

M = 1
M = 1

612-290-00-1

Reaktionsprodukte von Paraformaldehyd und 2-Hydroxypropylamin (Verhältnis 3:2);
[aus 3,3'-Methylenbis[5-methyloxazolidin freigesetztes Formaldehyd]
[aus Oxazolidin freigesetztes Formaldehyd];
[MBO]

Carc. 1B
Muta. 2
Acute Tox. 4
Acute Tox. 3
Acute Tox. 4
STOT RE 2
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1A
Aquatic Chronic 2

H350
H341
H332
H311
H302
H373 (Magen-Darm-Trakt, Atemwege)
H314
H318
H317
H411

GHS08
GHS06
GHS05
GHS09
Gef.

H350
H341
H332
H311
H302
H373 (Magen-Darm-Trakt, Atemwege)
H314
H317
H411

EUH071

8
9

612-291-00-7

Reaktionsprodukte von Paraformaldehyd und 2-Hydroxypropylamin (Verhältnis 1: 1);
[aus a,a,a-Trimethyl-1,3,5-triazin-1,3,5 (2H,4H,6H)-triethanol freigesetztes Formaldehyd];
[HPT]

Carc. 1B
Muta. 2
Acute Tox. 4
Acute Tox. 4
STOT RE 2
Skin Corr. 1C
Eye Dam. 1
Skin Sens. 1A
Aquatic Chronic 2

H350
H341
H332
H302
H373 (Magen-Darm-Trakt, Atemwege)
H314
H318
H317
H411

GHS08
GHS07
GHS05
GHS09
Gef.

H350
H341
H332
H302
H373 (Magen-Darm-Trakt, Atemwege)
H314
H317
H411

EUH071

8
9

612-292-00-2

Methylhydrazin

200-471-4

60-34-4

Carc. 1B

H350

GHS08
Gef.

H350

613-001-00-1

ethyleneimine;
aziridine

205-793-9

151-56-4

Flam. Liq. 2
Carc. 1B
Muta. 1B
Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Skin Corr. 1B
Aquatic Chronic 2

H225
H350
H340
H330
H310
H300
H314
H411

GHS02
GHS06
GHS08
GHS05
GHS09
Gef.

H225
H350
H340
H330
H310
H300
H314
H411

613-002-00-7

pyridine

203-809-9

110-86-1

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)

H225
H332
H312
H302

GHS02
GHS07
Gef.

H225
H332
H312
H302

(*)

613-003-00-2

1,2,3,4-tetranitrocarbazole

6202-15-9

Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *

H201
H332
H312
H302

GHS01
GHS07
Gef.

H201
H332
H312
H302

613-004-00-8

crimidine (ISO);
2-chloro-6-methylpyrimidin-4-yldimethylamine

208-622-6

535-89-7

Acute Tox. 2 (*)

H300

GHS06
Gef.

H300

613-007-00-4

desmetryne (ISO);
6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine

213-800-1

1014-69-3

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

613-008-00-X

dazomet (ISO);
tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione

208-576-7

533-74-4

Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H410

613-009-00-5

2,4,6-trichloro-1,3,5-triazine;
cyanuric chloride

203-614-9

108-77-0

Acute Tox. 2 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1

H330
H302
H314
H317

GHS06
GHS05
Gef.

H330
H302
H314
H317

EUH014

STOT SE 3; H335: C> 5 %

613-010-00-0

ametryn (ISO);
N-ethyl-N'-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine

212-634-7

834-12-8

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M = 100

613-011-00-6

amitrole (ISO);
1,2,4-triazol-3-ylamine

200-521-5

61-82-5

Repr. 2
STOT RE 2 (*)
Aquatic Chronic 2

H361d (*)(*)(*)
H373 (*)(*)
H411

GHS08
GHS09
Achtg.

H361d (*)(*)(*)
H373 (*)(*)
H411

613-012-00-1

bentazone (ISO);
3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide

246-585-8

25057-89-0

Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H302
H319
H317
H412

GHS07
Achtg.

H302
H319
H317
H412

613-013-00-7

cyanazine (ISO);
2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile

244-544-9

21725-46-2

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-014-00-2

ethoxyquin(ISO);
6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline

202-075-7

91-53-2

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

613-015-00-8

fenazaflor (ISO);
phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate

238-134-9

14255-88-0

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

613-016-00-3

fuberidazole (ISO);
2-(2-furyl)-1H-benzimidazole

223-404-0

3878-19-1

Carc. 2
Acute Tox. 4
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H373 (Herz)
H317
H400
H410

GHS07
GHS08
GHS09
Achtg.

H351
H302
H373 (Herz)
H317
H410

M=1

613-017-00-9

bis (8-hydroxyquinolinium) sulphate

205-137-1

134-31-6

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

613-018-00-4

morfamquat (ISO);
1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion

7411-47-4

Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3

H302
H319
H335
H315
H412

GHS07
Achtg.

H302
H319
H335
H315
H412

613-019-00-X

thioquinox(ISO);
2-thio-1,3-dithiolo(4,5,b)quinoxaline

202-272-8

93-75-4

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

613-020-00-5

tridemorph (ISO);
2,6-dimethyl-4-tridecylmorpholine

246-347-3

24602-86-6

Repr. 1B
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H360D (*)(*)(*)
H332
H302
H315
H400
H410

GHS08
GHS07
GHS09
Gef.

H360D (*)(*)(*)
H332
H302
H315
H410

613-021-00-0

dithianon (ISO);
5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile

222-098-6

3347-22-6

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-022-00-6

pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

613-023-00-1

2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1a[S(*)(Z)],3ß]]-chrysanthemate;
pyrethrin I

204-455-8

121-21-1

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

613-024-00-7

2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1a[S(*)(Z)](3ß)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
pyrethrin II

204-462-6

121-29-9

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

613-025-00-2

cinerin I;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate

246-948-0

25402-06-6

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-026-00-8

cinerin II;
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate

204-454-2

121-20-0

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-027-00-3

piperidine

203-813-0

110-89-4

Flam. Liq. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B

H225
H331
H311
H314

GHS02
GHS06
GHS05
Gef.

H225
H331
H311
H314

(*)

613-028-00-9

morpholine

203-815-1

110-91-8

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H226
H332
H312
H302
H314

GHS02
GHS05
GHS07
Dg

H226
H332
H312
H302
H314

613-029-00-4

dichloro-1,3,5-triazinetrione;
dichloroisocyanuric acid

220-487-5

2782-57-2

Ox. Sol. 2
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H272
H302
H319
H335
H400
H410

GHS03
GHS07
GHS09
Gef.

H272
H302
H319
H335
H410

EUH031

613-030-00-X

troclosene potassium; [1]
troclosene sodium [2]

218-828-8 [1]
220-767-7 [2]

2244-21-5 [1]
2893-78-9 [2]

Ox. Sol. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H272
H302
H319
H335
H400
H410

GHS03
GHS07
GHS09
Gef.

H272
H302
H319
H335
H410

EUH031

*
STOT SE 3; H335: C> 10 %
EUH031: C> 10 %

613-030-01-7

troclosene sodium, dihydrate

220-767-7

51580-86-0

Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H335
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H335
H410

EUH031

613-031-00-5

symclosene;
trichloroisocyanuric acid;
trichloro-1,3,5-triazinetrion

201-782-8

87-90-1

Ox. Sol. 2
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H272
H302
H319
H335
H400
H410

GHS03
GHS07
GHS09
Gef.

H272
H302
H319
H335
H410

EUH031

613-032-00-0

methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine

236-035-5

13108-52-6

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1

H312
H302
H319
H317

GHS07
Achtg.

H312
H302
H319
H317

613-033-00-6

2-methylaziridine;
propyleneimine

200-878-7

75-55-8

Flam. Liq. 2
Carc. 1B
Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Eye Dam. 1
Aquatic Chronic 2

H225
H350
H330
H310
H300
H318
H411

GHS02
GHS06
GHS08
GHS05
GHS09
Gef.

H225
H350
H330
H310
H300
H318
H411

Carc. 1B; H350: C> 0,01 %

613-034-00-1

1,2-dimethylimidazole

217-101-2

1739-84-0

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1

H302
H315
H318

GHS05
GHS07
Gef.

H302
H315
H318

613-035-00-7

1-methylimidazole

210-484-7

616-47-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B

H312
H302
H314

GHS05
GHS07
Gef.

H312
H302
H314

613-036-00-2

2-methylpyridine;
2-picoline

203-643-7

109-06-8

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3

H226
H332
H312
H302
H319
H335

GHS02
GHS07
Achtg.

H226
H332
H312
H302
H319
H335

613-037-00-8

4-methylpyridine;
4-picoline

203-626-4

108-89-4

Flam. Liq. 3
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H226
H311
H332
H302
H319
H335
H315

GHS02
GHS06
Gef.

H226
H311
H332
H302
H319
H335
H315

613-038-00-3

6-phenyl-1,3,5-triazine-2,4-diyldiamine;
6-phenyl-1,3,5-triazine-2,4-diamine;
benzoguanamine

202-095-6

91-76-9

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

613-039-00-9

ethylene thiourea;
imidazolidine-2-thione;
2-imidazoline-2-thiol

202-506-9

96-45-7

Repr. 1B
Acute Tox. 4 (*)

H360D (*)(*)(*)
H302

GHS08
GHS07
Gef.

H360D (*)(*)(*)
H302

613-040-00-4

azaconazole (ISO);
1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole

262-102-3

60207-31-0

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

613-041-00-X

morpholine-4-carbonyl chloride

239-213-0

15159-40-7

Carc. 2
Eye Irrit. 2
Skin Irrit. 2

H351
H319
H315

GHS08
Achtg.

H351
H319
H315

EUH014

613-042-00-5

Imazalil (ISO); 1-[2-(Allyloxy)-2-(2,4-dichlorphenyl)ethyl]-1H-imidazol

252-615-0

35554-44-0

Carc. 2
Acute Tox. 3
Acute Tox. 4
Eye Dam. 1
Aquatic Chronic 1

H351
H301
H332
H318
H410

GHS08
GHS06
GHS05
GHS09
Gef.

H351
H301
H332
H318
H410

M = 10

613-043-00-0

imazalil sulphate (ISO) powder;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]

261-351-5 [1]
281-291-3 [2]

58594-72-2 [1]
83918-57-4 [2]

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

613-043-01-8

imazalil sulphate (ISO), aqueous solution;
1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]

261-351-5 [1]
281-291-3 [2]

58594-72-2 [1]
83918-57-4 [2]

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H314
H317
H400
H410

GHS05
GHS07
GHS09
Achtg.

H302
H314
H317
H410

Skin Corr. 1B; H314: C> 50 %
Skin Irrit. 2; H315: 30 % ≤ C < 50 %
Eye Dam. 1; H318: 15 % ≤ C < 50 %
Eye Irrit. 2; H319: 5 % ≤ C < 15 %

613-044-00-6

captan (ISO);
1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide

205-087-0

133-06-2

Carc. 2
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1

H351
H331
H318
H317
H400

GHS06
GHS05
GHS08
GHS09
Gef.

H351
H331
H318
H317
H400

M=10

613-045-00-1

folpet (ISO);
N-(trichloromethylthio)phthalimide

205-088-6

133-07-3

Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H351
H332
H319
H317
H400

GHS08
GHS07
GHS09
Achtg.

H351
H332
H319
H317
H400

M=10

613-046-00-7

captafol (ISO);
1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide

219-363-3

2425-06-1

Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H350
H317
H400
H410

GHS08
GHS09
Gef.

H350
H317
H410

613-047-00-2

1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;
dimetilan (ISO)

211-420-0

644-64-4

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H301
H312
H400
H410

GHS06
GHS09
Gef.

H301
H312
H410

613-048-00-8

carbendazim (ISO);
methyl benzimidazol-2-ylcarbamate

234-232-0

10605-21-7

Muta. 1B
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H340
H360FD
H400
H410

GHS08
GHS09
Gef.

H340
H360FD
H410

613-049-00-3

benomyl (ISO);
methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate

241-775-7

17804-35-2

Muta. 1B
Repr. 1B
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H340
H360FD
H335
H315
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H340
H360FD
H335
H315
H317
H410

M=10

613-050-00-9

carbadox (INN);
methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;
2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide

229-879-0

6804-07-5

Flam. Sol. 1
Carc. 1B
Acute Tox. 4 (*)

H228
H350
H302

GHS02
GHS08
GHS07
Gef.

H228
H350
H302

613-051-00-4

molinate (ISO);
S-ethyl 1-perhydroazepinecarbothioate;
S-ethyl perhydroazepine-1-carbothioate

218-661-0

2212-67-1

Carc. 2
Repr. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H361f (*)(*)(*)
H332
H302
H373 (*)(*)
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H361f (*)(*)(*)
H332
H302
H373 (*)(*)
H317
H410

M=100

613-052-00-X

trifenmorph (ISO);
4-tritylmorpholine

215-812-2

1420-06-0

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-053-00-5

anilazine (ISO);
2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline

202-910-5

101-05-3

Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H315
H400
H410

GHS07
GHS09
Achtg.

H319
H315
H410

613-054-00-0

thiabendazol (ISO);
2-(thiazole-4-yl)benzimidazole

205-725-8

148-79-8

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-056-00-1

1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;
difenzoquat methyl sulfate

256-152-5

43222-48-6

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS09
Achtg.

H302
H410

613-057-00-7

Dodemorph (ISO); 4-Cyclododecyl-2,6-dimethylmorpholin

216-474-9

1593-77-7

Repr. 2
STOT RE 2
Skin Corr. 1C
Skin Sens. 1a
Aquatic Acute 1
Aquatic Chronic 1

H361d
H373 (Leber)
H314
H317
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H361d
H373 (Leber)
H314
H317
H410

EUH071

M = 1
M = 1

613-058-00-2

permethrin (ISO);
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate

258-067-9

52645-53-1

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H317
H400
H410

GHS07
GHS09
Achtg.

H332
H302
H317
H410

M=1000

613-059-00-8

profluralin (ISO);
N-(cyclopropylmethyl)-a, a,a-trifluoro-2,6-dinitro-N-propyl-p-toluidine

247-656-6

26399-36-0

Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H400
H410

GHS07
GHS09
Achtg.

H319
H410

613-060-00-3

resmethrin (ISO);
5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate

233-940-7

10453-86-8

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M=1000

613-061-00-9

6-(1a,5aß,8aß,9-pentahydroxy-7ß-isopropyl-2ß,5ß,8ß-trimethylperhydro-8ba,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;
ryania

239-732-2

15662-33-6

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

613-062-00-4

sabadilla (ISO);
veratrine

8051-02-3

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H319
H335
H315

GHS07
Achtg.

H319
H335
H315

613-063-00-X

secbumeton (ISO);
2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine

247-554-1

26259-45-0

Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H410

613-064-00-5

5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;
sesamex

51-14-9

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

613-065-00-0

simetryn (ISO);
2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine

213-801-7

1014-70-6

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-066-00-6

terbumeton (ISO);
2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine

251-637-8

33693-04-8

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-067-00-1

propazine(ISO);
2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine

205-359-9

139-40-2

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

613-068-00-7

atrazine (ISO);
2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine

217-617-8

1912-24-9

STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H317
H400
H410

GHS08
GHS09
Achtg.

H373 (*)(*)
H317
H410

613-069-00-2

e-caprolactam

203-313-2

105-60-2

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2

H332
H302
H319
H335
H315

GHS07
Achtg.

H332
H302
H319
H335
H315

613-070-00-8

propylenethiourea

2122-19-2

Repr. 2
Acute Tox. 4 (*)
Aquatic Chronic 3

H361d (*)(*)(*)
H302
H412

GHS08
GHS07
Achtg.

H361d (*)(*)(*)
H302
H412

613-071-00-3

2-fluoro-5-trifluoromethylpyridine

400-290-2

69045-82-5

Flam. Liq. 3
Skin Sens. 1
Aquatic Chronic 3

H226
H317
H412

GHS02
GHS07
Achtg.

H226
H317
H412

613-072-00-9

N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine

401-280-0

91273-04-0

Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H314
H317
H411

GHS05
GHS07
GHS09
Gef.

H314
H317
H411

613-073-00-4

N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine

401-410-6

10357-99-0

STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2

H373 (*)(*)
H317
H411

GHS08
GHS09
Achtg.

H373 (*)(*)
H317
H411

613-074-00-X

3-(3-methylpent-3-yl)isoxazol-5-ylamine

401-460-9

82560-06-3

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Dam. 1
Aquatic Chronic 3

H331
H301
H318
H412

GHS06
GHS05
Gef.

H331
H301
H318
H412

613-075-00-5

1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione

401-570-7

89415-87-2

Ox. Sol. 1 (*)(*)(*)(*)
Acute Tox. 3 (*)
Skin Corr. 1B
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1

H271
H331
H314
H302
H317
H400

GHS03
GHS06
GHS05
GHS09
Gef.

H271
H331
H314
H302
H317
H400

613-076-00-0

3-chloro-5-trifluoromethyl-2-pyridylamine

401-670-0

79456-26-1

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

613-077-00-6

reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine

401-940-8

Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Chronic 2

H302
H319
H411

GHS07
GHS09
Achtg.

H302
H319
H411

613-078-00-1

N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine

401-990-0

106990-43-6

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

613-079-00-7

4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers

402-520-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H315
H317
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H315
H317
H410

613-080-00-2

3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione

402-540-6

105254-85-1

Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H317
H410

613-081-00-8

1-butyl-2-methylpyridinium bromide

402-680-8

26576-84-1

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

613-082-00-3

2-methyl-1-pentylpyridinium bromide

402-690-2

Acute Tox. 4 ((*))
Acute Tox. 4 ((*))
Aquatic Chronic 3

H312
H302
H412

GHS07
Achtg.

H312
H302
H412

613-083-00-9

2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate

402-120-2

Skin Corr. 1B
STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H314
H373 (*)(*)
H317
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H314
H373 (*)(*)
H317
H410

613-084-00-4

2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate

402-490-5

106359-93-7

Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H400
H410

GHS07
GHS09
Achtg.

H319
H410

613-085-00-X

reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione andN-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione

401-970-1

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

613-086-00-5

caffeine

200-362-1

58-08-2

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

613-087-00-0

tetrahydrothiophene

203-728-9

110-01-0

Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3

H225
H332
H312
H302
H319
H315
H412

GHS02
GHS07
Gef.

H225
H332
H312
H302
H319
H315
H412

613-088-00-6

1,2-benzisothiazol-3(2H)-one;
1,2-benzisothiazolin-3-one

220-120-9

2634-33-5

Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1

H302
H315
H318
H317
H400

GHS05
GHS07
GHS09
Gef.

H302
H315
H318
H317
H400

Skin Sens. 1; H317: C> 0,05 %

613-089-00-1

diquat dibromide; [1]
diquat dichloride; [2]
6,7-dihydrodipyrido[1,2-a:2',1'-c]pyrazinediylium dihydroxide [3]

201-579-4 [1]
223-714-6 [2]
301-467-6 [3]

85-00-7 [1]
4032-26-2 [2]
94021-76-8 [3]

Acute Tox. 2 (*)
STOT RE 1
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H372 (*)(*)
H302
H319
H335
H315
H317
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H372 (*)(*)
H302
H319
H335
H315
H317
H410

613-090-00-7

paraquat dichloride;
1,1-dimethyl-4,4'-bipyridinium dichloride; [1]
paraquat dimethylsulfate;
1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]

217-615-7 [1]
218-196-3 [2]

1910-42-5 [1]
2074-50-2 [2]

Acute Tox. 2 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H330
H311
H301
H372 (*)(*)
H319
H335
H315
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H311
H301
H372 (*)(*)
H319
H335
H315
H410

613-091-00-2

morfamquat dichloride; [1]
morfamquat sulfate [2]

225-062-8 [1]
-[2]

4636-83-3 [1]
29873-36-7 [2]

Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3

H302
H319
H335
H315
H412

GHS07
Achtg.

H302
H319
H335
H315
H412

613-092-00-8

1,10-phenanthroline

200-629-2

66-71-7

Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1

H301
H400
H410

GHS06
GHS09
Gef.

H301
H410

613-093-00-3

hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate

400-050-7

85153-92-0

Resp. Sens. 1
Skin Sens. 1

H334
H317

GHS08
Gef.

H334
H317

613-094-00-9

4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine

401-360-5

5248-39-5

Acute Tox. 4 (*)
STOT RE 2 (*)

H302
H373 (*)(*)

GHS08
GHS07
Achtg.

H302
H373 (*)(*)

613-095-00-4

sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate

403-080-9

92484-48-5

Eye Dam. 1

H318

GHS05
Gef.

H318

613-096-00-X

2-amino-6-ethoxy-4-methylamino-1,3,5-triazine

403-580-7

62096-63-3

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

613-097-00-5

7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid

403-690-5

111298-82-9

Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3

H334
H317
H412

GHS08
Gef.

H334
H317
H412

613-098-00-0

N-(n-octyl)-2-pyrrolidone

403-700-8

2687-94-7

Skin Corr. 1B
Aquatic Chronic 2

H314
H411

GHS05
GHS09
Gef.

H314
H411

613-099-00-6

1-dodecyl-2-pyrrolidone

403-730-1

2687-96-9

Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H317
H410

613-100-00-X

2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione

404-230-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

613-101-00-5

N -tert-pentyl-2-benzothiazolesulfenamide

404-380-2

110799-28-5

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

613-102-00-0

dimethomorph (ISO);
4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine

404-200-2

110488-70-5

Aquatic Chronic 2

H411

GHS09

H411

613-103-00-6

sodium 5-n-butylbenzotriazole

404-450-2

118685-34-0

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H302
H314
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H314
H317
H411

613-104-00-1

5-tert-butyl-3-isoxazolylamine hydrochloride

404-840-2

Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Aquatic Chronic 3

H302
H373 (*)(*)
H318
H412

GHS08
GHS05
GHS07
Gef.

H302
H373 (*)(*)
H318
H412

613-105-00-7

hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)

405-160-9

124537-30-0

Acute Tox. 3 (*)
Skin Sens. 1
Aquatic Chronic 3

H301
H317
H412

GHS06
Gef.

H301
H317
H412

613-106-00-2

tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate

405-240-3

Skin Sens. 1

H317

GHS07
Achtg.

H317

613-107-00-8

hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate

405-280-1

76508-02-6

Eye Irrit. 2

H319

GHS07
Achtg.

H319

613-108-00-3

benzothiazole-2-thiol

205-736-8

149-30-4

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

613-109-00-9

bis(piperidinothiocarbonyl) disulphide

202-328-1

94-37-1

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1

H319
H335
H315
H317

GHS07
Achtg.

H319
H335
H315
H317

613-110-00-4

dimepiperate (ISO);
S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate

262-784-2

61432-55-1

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

613-111-00-X

1,2,4-triazole

206-022-9

288-88-0

Repr. 2
Acute Tox. 4 (*)
Eye Irrit. 2

H361d (*)(*)(*)
H302
H319

GHS08
GHS07
Achtg.

H361d (*)(*)(*)
H302
H319

613-112-00-5

octhilinone (ISO);
2-octyl-2H-isothiazol-3-one

247-761-7

26530-20-1

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H302
H314
H317
H400
H410

GHS06
GHS05
GHS09
Gef.

H331
H311
H302
H314
H317
H410

Skin Sens. 1; H317: C> 0,05 %

613-113-00-0

2-(morpholinothio)benzothiazole

203-052-4

102-77-2

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H319
H315
H317
H411

GHS07
GHS09
Achtg.

H319
H315
H317
H411

613-114-00-6

2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;
1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine

225-208-0

4719-04-4

Acute Tox. 4 (*)
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

Skin Sens. 1; H317: C> 0,1 %

613-115-00-1

hymexazol (ISO);
3-hydroxy-5-methylisoxazole

233-000-6

10004-44-1

Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

613-116-00-7

tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing> 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]

211-986-9

731-27-1

Acute Tox. 2*
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H330
H372**
H319
H335
H315
H317
H400

GHS06
GHS08
GHS09
Gef.

H330
H372**
H319
H335
H315
H317
H400

M=10

613-116-01-4

tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]

211-986-9

731-27-1

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H319
H335
H315
H317
H400

GHS07
GHS09
Achtg.

H319
H335
H315
H317
H400

M=10

613-117-00-2

diniconazole (ISO);
(E)-ß-[(2,4-dichlorophenyl)methylene]-a-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;
(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol

76714-88-0

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-118-00-8

flubenzimine (ISO);
N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline

253-703-1

37893-02-0

Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H319
H400
H410

GHS07
GHS09
Achtg.

H319
H410

613-119-00-3

(benzothiazol-2-ylthio)methyl thiocyanate;
TCMTB

244-445-0

21564-17-0

Acute Tox. 2 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H302
H319
H315
H317
H400
H410

GHS06
GHS09
Gef.

H330
H302
H319
H315
H317
H410

613-120-00-9

bioresmethrin (ISO);
(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate

249-014-0

28434-01-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M = 1000

613-121-00-4

Chlorsulfuron (ISO); 2-Chlor-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2- yl)amino]carbonyl]benzolsulfonamid

265-268-5

64902-72-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M = 1 000
M = 100

613-122-00-X

diclobutrazole (ISO);
(R^(*),R^(*))-(±)-ß-[(2,4-dichlorophenyl)methyl]-a-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;
(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol

75736-33-3

Eye Irrit. 2
Aquatic Chronic 2

H319
H411

GHS07
GHS09
Achtg.

H319
H411

613-123-00-5

5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;
etem

251-684-4

33813-20-6

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-124-00-0

fenpropimorph (ISO);
cis-4-[3-(p -tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine

266-719-9

67564-91-4

Repr. 2
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Chronic 2

H361d (*)(*)(*)
H302
H315
H411

GHS08
GHS07
GHS09
Achtg.

H361d (*)(*)(*)
H302
H315
H411

613-125-00-6

hexythiazox(ISO);
trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide

78587-05-0

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-126-00-1

imazapyr (ISO);
2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate

81334-34-1

Eye Irrit. 2
Aquatic Chronic 3

H319
H412

GHS07
Achtg.

H319
H412

613-127-00-7

1,1-dimethylpiperidinium chloride;
mepiquat chloride

246-147-6

24307-26-4

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

613-128-00-2

prochloraz (ISO);
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide

266-994-5

67747-09-5

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-129-00-8

metamitron (ISO);
4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one

255-349-3

41394-05-2

Acute Tox. 4 (*)
Aquatic Acute 1

H302
H400

GHS07
GHS09
Achtg.

H302
H400

613-131-00-9

pyroquilon (ISO);
1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one

57369-32-1

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

613-132-00-4

hexazinone (ISO);
3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione

257-074-4

51235-04-2

Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H410

613-133-00-X

Etridiazol (ISO); 5-Ethoxy-3-trichlormethyl-1,2,4-thiadiazol

219-991-8

2593-15-9

Carc. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H302
H317
H410

M = 1
M = 1

613-134-00-5

myclobutanil(ISO);
2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile

88671-89-0

Repr. 2
Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Chronic 2

H361d (*)(*)(*)
H302
H319
H411

GHS08
GHS07
GHS09
Achtg.

H361d (*)(*)(*)
H302
H319
H411

613-135-00-0

di(benzothiazol-2-yl) disulphide

204-424-9

120-78-5

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

EUH031

613-136-00-6

N-cyclohexylbenzothiazole-2-sulphenamide

202-411-2

95-33-0

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

613-137-00-1

methabenzthiazuron (ISO);
1-(1,3-benzothiazol-2-yl)1,3-dimethylurea

242-505-0

18691-97-9

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-138-00-7

quinoxyfen (ISO);
5,7-dichloro-4-(4-fluorophenoxy)quinoline

124495-18-7

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

613-139-00-2

metsulfuron-methyl (ISO);
methyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate

74223-64-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M = 1000

613-140-00-8

cycloheximide (ISO);
4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione

200-636-0

66-81-9

Muta. 2
Repr. 1B
Acute Tox. 2 (*)
Aquatic Chronic 2

H341
H360D (*)(*)(*)
H300
H411

GHS06
GHS08
GHS09
Gef.

H341
H360D (*)(*)(*)
H300
H411

613-141-00-3

1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone

401-470-3

93686-63-6

Aquatic Chronic 4

H413

613-142-00-9

trans -N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate

405-860-4

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

613-143-00-4

1-(3-phenylpropyl)-2-methylpyridinium bromide

405-930-4

10551-42-5

Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Chronic 3

H302
H319
H412

GHS07
Achtg.

H302
H319
H412

613-144-00-X

reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate

406-460-2

125139-08-4

Aquatic Chronic 3

H412

613-145-00-5

(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate

406-960-0

77497-97-3

Aquatic Chronic 2

H411

GHS09

H411

613-146-00-0

N-ethyl-N-methylpiperidinium iodide

407-780-5

4186-71-4

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

613-147-00-6

4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine

407-940-4

111681-72-2

Eye Dam. 1

H318

GHS05
Gef.

H318

613-148-00-1

tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane

411-240-4

143683-23-2

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

613-149-00-7

Pyridaben (ISO); 2-tert-Butyl-5-(4-tert-butylbenzylthio)-4-chlorpyridazin-3(2H)-on

405-700-3

96489-71-3

Acute Tox. 3
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H400
H410

GHS06
GHS09
Gef.

H331
H301
H410

M = 1 000
M = 1 000

613-150-00-2

2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione

406-295-6

Aquatic Chronic 4

H413

613-151-00-8

1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine

406-360-9

104218-44-2

Aquatic Chronic 4

H413

613-152-00-3

phenylN-(4,6-dimethoxypyrimidin-2-yl)carbamate

406-600-2

89392-03-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

613-153-00-9

2,3,5-trichloropyridine

407-270-2

16063-70-0

Aquatic Chronic 3

H412

613-154-00-4

2-amino-4-chloro-6-methoxypyrimidine

410-050-9

5734-64-5

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

613-155-00-X

5-chloro-2,3-difluoropyridine

410-090-7

89402-43-7

Flam. Liq. 3
Acute Tox. 4 (*)
Aquatic Chronic 3

H226
H302
H412

GHS02
GHS07
Achtg.

H226
H302
H412

613-156-00-5

2-butyl-4-chloro-5-formylimidazole

410-260-0

83857-96-9

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

613-157-00-0

2,4-diamino-5-methoxymethylpyrimidine

410-330-0

54236-98-5

Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Irrit. 2

H302
H373 (*)(*)
H319

GHS08
GHS07
Achtg.

H302
H373 (*)(*)
H319

613-158-00-6

2,3-dichloro-5-trifluoromethyl-pyridine

410-340-5

69045-84-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H332
H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H332
H302
H318
H317
H411

613-159-00-1

fenazaquin (ISO);
4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline

410-580-0

120928-09-8

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H301
H332
H400
H410

GHS06
GHS09
Gef.

H301
H332
H410

613-160-00-7

(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide

411-000-9

125224-62-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

613-161-00-2

(2,4-diaminopteridin-6-yl)methanol hydrobromide

430-620-0

76145-91-0

STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3

H373**
H317
H412

GHS08
GHS07
Achtg.

H373**
H317
H412

613-162-00-8

(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide

423-260-0

100988-63-4

Muta. 2
Skin Sens. 1
Aquatic Chronic 2

H341
H317
H411

GHS08
GHS07
GHS09
Achtg.

H341
H317
H411

613-163-00-3

azimsulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea

120162-55-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M=1000

613-164-00-9

flufenacet (ISO);
N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide

142459-58-3

Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373**
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373**
H317
H410

M=100

613-165-00-4

flupyrsulfuron-methyl-sodium (ISO);
methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt

144740-54-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M=100

613-166-00-X

Flumioxazin (ISO);
2-[7-Fluor-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindol-1,3(2H)-dion

103361-09-7

Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H360D
H400
H410

GHS08
GHS09
Gef.

H360D
H410

M = 1 000
M = 1 000

613-167-00-5

reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);
reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]
and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)

55965-84-9

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H311
H301
H314
H317
H400
H410

GHS06
GHS05
GHS09
Gef.

H331
H311
H301
H314
H317
H410

Skin Corr. 1B; H314: C> 0,6 %
Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %
Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %
Skin Sens. 1; H317: C> 0,0015 %

613-168-00-0

1-vinyl-2-pyrrolidone

201-800-4

88-12-0

Carc. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
STOT SE 3
Eye Dam. 1

H351
H332
H312
H302
H373 (*)(*)
H335
H318

GHS06
GHS05
GHS09
Gef.

H351
H332
H312
H302
H373 (*)(*)
H335
H318

613-169-00-6

9-vinylcarbazole

216-055-0

1484-13-5

Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H341
H312
H302
H315
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H341
H312
H302
H315
H317
H410

M=100

613-170-00-1

2,2-ethylmethylthiazolidine

404-500-3

694-64-4

Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H317
H411

613-171-00-7

hexaconazole (ISO);
(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol

413-050-7

79983-71-4

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

613-172-00-2

5-chloro-1,3-dihydro-2H-indol-2-one

412-200-9

17630-75-0

Repr. 2
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 3

H361f (*)(*)(*)
H302
H317
H412

GHS08
GHS07
Achtg.

H361f (*)(*)(*)
H302
H317
H412

613-173-00-8

fluquinconazole (ISO);
3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one

411-960-9

136426-54-5

Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H372 (*)(*)
H312
H315
H400
H410

GHS06
GHS08
GHS09
Gef.

H331
H301
H372 (*)(*)
H312
H315
H410

613-174-00-3

tetraconazole (ISO);
(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether

407-760-6

112281-77-3

Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 2

H332
H302
H411

GHS07
GHS09
Achtg.

H332
H302
H411

613-175-00-9

epoxiconazole (ISO);
(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane

406-850-2

133855-98-8

Carc. 2

H351

GHS08

H351

Repr. 1B

H360Df

GHS09

H360Df

Aquatic Chronic 2

H411

Gef.

H411

613-176-00-4

2-methyl-2-azabicyclo[2.2.1]heptane

404-810-9

4524-95-2

Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B

H226
H312
H302
H373 (*)(*)
H314

GHS02
GHS08
GHS05
GHS07
Gef.

H226
H312
H302
H373 (*)(*)
H314

613-177-00-X

8-amino-7-methylquinoline

412-760-4

5470-82-6

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2

H312
H302
H317
H411

GHS07
GHS09
Achtg.

H312
H302
H317
H411

613-178-00-5

4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine

410-470-2

137796-06-6

Skin Corr. 1B
Skin Sens. 1

H314
H317

GHS05
GHS07
Gef.

H314
H317

STOT SE 3; H335: C> 5 %

613-179-00-0

lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide

411-690-1

111337-53-2

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H302
H314
H317
H411

GHS05
GHS07
Gef.

H302
H314
H317
H411

613-180-00-6

N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide

407-430-1

3741-80-8

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-181-00-1

5,5-dimethyl-perhydro-pyrimidin-2-one a-(4-trifluoromethylstyryl)-a-(4-trifluoromethyl)cinnamylidenehydrazone

405-090-9

67485-29-4

STOT RE 1
Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H372 (*)(*)
H302
H319
H400
H410

GHS08
GHS07
GHS09
Gef.

H372 (*)(*)
H302
H319
H410

613-182-00-7

1-(1-naphthylmethyl)quinolinium chloride

406-220-7

65322-65-8

Carc. 2
Muta. 2
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H351
H341
H302
H315
H318
H412

GHS08
GHS05
GHS07
Gef.

H351
H341
H302
H315
H318
H412

613-183-00-2

reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;
5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one

413-640-4

STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H400
H410

GHS08
GHS09
Achtg.

H373 (*)(*)
H410

613-184-00-8

nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate

413-670-8

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

613-185-00-3

2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one

407-630-9

82633-79-2

Acute Tox. 3 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H301
H318
H317
H400
H410

GHS06
GHS05
GHS09
Gef.

H301
H318
H317
H410

613-186-00-9

(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate

408-050-9

76855-69-1

Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H319
H317
H411

GHS07
GHS09
Achtg.

H319
H317
H411

613-187-00-4

5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene

410-530-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

613-188-00-X

1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone

411-500-7

116256-11-2

Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H317
H411

613-189-00-5

1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane

414-030-0

52667-88-6

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

613-190-00-0

disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate

414-040-5

149530-93-8

Acute Tox. 4 (*)
Skin Sens. 1

H302
H317

GHS07
Achtg.

H302
H317

613-191-00-6

3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine

421-150-7

143860-04-2

Repr. 1B
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H360F (*)(*)(*)
H314
H400
H410

GHS08
GHS05
GHS09
Gef.

H360F (*)(*)(*)
H314
H410

613-192-00-1

3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane

426-750-2

151860-15-0

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

613-193-00-7

pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate

414-930-3

Aquatic Chronic 2

H411

GHS09

H411

613-194-00-2

6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt

418-000-8

163062-28-0

Eye Dam. 1

H318

GHS05
Gef.

H318

613-195-00-8

2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one)

418-280-1

18600-59-4

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

613-196-00-3

5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt

418-380-5

168113-78-8

Eye Dam. 1

H318

GHS05
Gef.

H318

613-197-00-9

reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;
2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;
[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;
[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine

420-390-1

187547-46-2

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

613-198-00-4

2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine

415-500-8

145963-84-4

Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3

H302
H373**
H412

GHS08
GHS07
Achtg.

H302
H373**
H412

613-199-00-X

reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;
reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione

421-550-1

Carc. 1B
Repr. 1B
Skin Sens. 1
Aquatic Chronic 3

H350
H360D (*)(*)(*)
H317
H412

GHS08
Gef.

H350
H360D (*)(*)(*)
H317
H412

613-200-00-3

Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts

420-980-7

Eye Dam. 1

H318

GHS05
Gef.

H318

613-201-00-9

(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole

422-390-5

143322-57-0

Repr. 2
STOT RE 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361f (*)(*)(*)
H372 (*)(*)
H332
H302
H317
H400
H410

GHS08
GHS07
GHS09
Gef.

H361f (*)(*)(*)
H372 (*)(*)
H332
H302
H317
H410

EUH070

613-202-00-4

pymetrozine (ISO);
(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one

123312-89-0

Carc. 2
Aquatic Chronic 3

H351
H412

GHS08
Achtg.

H351
H412

613-203-00-X

pyraflufen-ethyl (ISO);
2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1]
pyraflufen (ISO);
2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2]

- [1]
- [2]

129630-19-9 [1]
129630-17-7 [2]

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M=1000

613-204-00-5

oxadiargyl (ISO);
3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one

254-637-6

39807-15-3

Repr. 2
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H361d***
H373**
H400
H410

GHS08
GHS09
Achtg.

H361d***
H373**
H410

M = 1000

613-205-00-0

propiconazole(ISO);
(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole

262-104-4

60207-90-1

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

613-206-00-6

fenamidone (ISO);
(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one

161326-34-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-208-00-7

imazamox (ISO);
(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid

114311-32-9

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-209-00-2

cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride

417-430-3

63645-17-0

Acute Tox. 3 (*)
STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2

H301
H373 (*)(*)
H317
H411

GHS06
GHS08
GHS09
Gef.

H301
H373 (*)(*)
H317
H411

613-210-00-8

2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane

417-650-1

88128-57-8

STOT RE 2 (*)
Aquatic Chronic 3

H373 (*)(*)
H412

GHS08
Achtg.

H373 (*)(*)
H412

613-211-00-3

N-methyl-4-(p-formylstyryl)pyridinium methylsulfate

418-240-3

74401-04-0

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

613-212-00-9

4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)

418-320-8

133467-41-1

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-213-00-4

cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline

416-040-0

120807-02-5

Aquatic Chronic 3

H412

613-214-00-X

N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide

416-260-7

147613-95-4

Aquatic Chronic 4

H413

613-215-00-5

2-chloromethyl-3,4-dimethoxypyridinium chloride

416-440-5

72830-09-2

Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H312
H302
H373 (*)(*)
H315
H318
H317
H411

GHS08
GHS05
GHS07
GHS09
Gef.

H312
H302
H373 (*)(*)
H315
H318
H317
H411

613-216-00-0

6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole

416-490-8

162208-01-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-217-00-6

4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine

416-770-1

73754-27-5

Aquatic Chronic 4

H413

613-218-00-1

6-hydroxyindole

417-020-4

2380-86-1

Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H302
H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H302
H318
H317
H411

613-219-00-7

7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole

417-140-7

79185-77-6

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

613-220-00-2

trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide

417-290-3

147086-81-5

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

613-221-00-8

2-chloro-5-methyl-pyridine

418-050-0

18368-64-4

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Chronic 3

H312
H302
H315
H412

GHS07
Achtg.

H312
H302
H315
H412

613-222-00-3

4-(1-oxo-2-propenyl)-morpholine

418-140-1

5117-12-4

Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1

H302
H373 (*)(*)
H318
H317

GHS08
GHS05
GHS07
Gef.

H302
H373 (*)(*)
H318
H317

613-223-00-9

N-isopropyl-3-(4-fluorophenyl)-1H-indole

418-790-4

93957-49-4

Aquatic Chronic 4

H413

613-224-00-4

2,5-dimercaptomethyl-1,4-dithiane

419-770-8

136122-15-1

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H314
H317
H410

613-225-00-X

reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;
2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.

421-290-9

STOT RE 2 (*)
Aquatic Chronic 4

H373 (*)(*)
H413

GHS08
Achtg.

H373 (*)(*)
H413

613-226-00-5

1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride

420-950-3

163831-67-2

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

613-227-00-0

(±)-[(R^(*),R^(*)) and (R^(*),S^(*))]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran

419-600-2

99199-90-3

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

613-228-00-6

(±)-(R^(*),S^(*))-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran

419-630-6

793669-26-8

Aquatic Chronic 2

H411

GHS09

H411

613-229-00-1

1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine

411-930-5

106917-31-1

Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H317
H400
H410

GHS07
GHS09
Achtg.

H315
H317
H410

613-230-00-7

florasulam (ISO);
2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];
pyrimidine-2-sulfonanilide

145701-23-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-231-00-2

2,6-diamino-3-((pyridine-3-yl)azo)pyridine

421-430-9

28365-08-4

Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2

H302
H373**
H411

GHS08
GHS07
GHS09
Achtg.

H302
H373**
H411

613-232-00-8

3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide

431-030-6

163269-30-5

Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H373**
H318
H400
H410

GHS06
GHS05
GHS08
GHS09
Gef.

H331
H373**
H318
H410

613-233-00-3

4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane

423-230-7

56552-15-9

Eye Dam. 1

H318

GHS05
Gef.

H318

613-234-00-9

imidazo[1,2-b]pyridazin hydrochloride

431-510-5

18087-70-2

Acute Tox. 4 *
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

613-235-00-4

2,3-dihydro-2,2-dimethyl-1H-perimidine

424-060-6

6364-17-6

Acute Tox. 4*
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373**
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373**
H317
H410

613-236-00-X

2-chloro-3-trifluoromethylpyridine

424-520-6

65753-47-1

Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Chronic 3

H311
H301
H372**
H314
H412

GHS06
GHS05
GHS08
Gef.

H311
H301
H372**
H314
H412

613-237-00-5

6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine

424-950-4

133949-92-5

Aquatic Chronic 4

H413

613-238-00-0

sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate

430-890-1

81992-66-7

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

613-239-00-6

2-[3-(methylamino)propyl]-1H-benzimidazole

425-760-4

64137-52-6

Eye Dam. 1
Aquatic Chronic 3

H318
H412

GHS05
Gef.

H318
H412

613-241-00-7

3-(2H-tetrazol-5-yl)pyridine

426-810-8

3250-74-6

Eye Dam. 1

H318

GHS05
Gef.

H318

613-242-00-2

reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts

426-860-0

191877-09-5

Eye Dam. 1

H318

GHS05
Gef.

H318

613-243-00-8

4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)

427-350-0

182235-14-9

Aquatic Chronic 2

H411

GHS09

H411

613-244-00-3

5,7-dichloro-4-hydroxyquinoline

427-420-0

21873-52-9

Aquatic Chronic 2

H411

GHS09

H411

613-245-00-9

2-fluoro-6-trifluoromethylpyridine

428-100-3

94239-04-0

Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3

H226
H332
H302
H412

GHS02
GHS07
Achtg.

H226
H332
H302
H412

613-246-00-4

2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine

428-200-7

103577-66-8

Aquatic Chronic 3

H412

613-247-00-X

3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole

428-910-7

107786-36-7

Aquatic Chronic 4

H413

613-248-00-5

3,4-dimethyl-1H-pyrazole

429-130-1

2820-37-3

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

613-249-00-0

1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate

429-300-3

155601-30-2

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

613-250-00-6

reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;
methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;
2-isopropyl-N-hydroxyethyl 1,3-oxazolidine

429-990-6

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H318
H317
H412

GHS05
GHS07
Gef.

H318
H317
H412

613-251-00-1

(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole

430-560-5

180637-89-2

Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1

H302
H373**
H318
H317

GHS05
GHS08
GHS07
Gef.

H302
H373**
H318
H317

613-253-00-2

2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;
reaction products with ethylene oxide (alkyl is C_1-12 and the sum to C₁₃, average degree of ethoxylation is 3,5)

430-580-4

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

EUH019

613-254-00-8

forchlorfenuron (ISO);
1-(2-chloro-4-pyridyl)-3-phenylurea

68157-60-8

Carc. 2
Aquatic Chronic 2

H351
H411

GHS08
GHS09
Achtg.

H351
H411

613-255-00-3

reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl](sulfamoyl)}(sulfonatophthalocyaninato)]copper(II)

424-270-8

Eye Dam. 1

H318

GHS05
Gef.

H318

613-256-00-9

3'5'-anhydro thymidine

425-810-5

38313-48-3

Aquatic Chronic 3

H412

613-257-00-4

2-phthalimidoethylN-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-ß-alaninate

426-400-9

170222-39-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

613-258-00-X

reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;
4-chloro-5-methylbenzotriazole sodium salt;
5-chloro-4-methylbenzotriazole sodium salt

427-730-6

202420-04-0

Skin Corr. 1B
Aquatic Chronic 3

H314
H412

GHS05
Gef.

H314
H412

613-259-00-5

reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;
[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate

428-790-6

72963-72-5

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

613-260-00-0

(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin

430-730-9

Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H400
H410

GHS05
GHS09
Gef.

H318
H410

613-261-00-6

pyrazole-1-carboxamidine monohydrochloride

429-520-1

4023-02-3

Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H302
H373**
H318
H317
H412

GHS05
GHS08
GHS07
Gef.

H302
H373**
H318
H317
H412

613-262-00-1

disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene

427-310-2

180850-95-7

Eye Dam. 1

H318

GHS05
Gef.

H318

613-263-00-7

monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate

429-570-2

Skin Sens. 1

H317

GHS07
Achtg.

H317

613-266-00-3

2-chloro-5-chloromethylthiazole

429-830-5

105827-91-6

Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H311
H314
H302
H317
H411

GHS06
GHS05
GHS09
Gef.

H311
H314
H302
H317
H411

613-267-00-9

thiamethoxam (ISO);
3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine

428-650-4

153719-23-4

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M=10

613-268-00-4

(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine

425-930-8

151213-39-7

Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2

H314
H332
H302
H373**
H411

GHS05
GHS08
GHS07
GHS09
Gef.

H314
H332
H302
H373**
H411

613-269-00-X

2-thiazolidinylidenecyanamide

427-720-1

26364-65-8

Acute Tox. 4*
STOT RE 2 *
Aquatic Chronic 3

H302
H373**
H412

GHS08
GHS07
Achtg.

H302
H373**
H412

613-270-00-5

5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide

428-150-6

113171-13-4

Aquatic Chronic 3

H412

613-271-00-0

tritosulfuron (ISO) (containing ≤ 0,02 % AMTT);
1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)

142469-14-5

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

M=10

613-272-00-6

pyraclostrobin (ISO);
methylN-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate

Acute Tox. 3 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H331
H315
H400
H410

GHS06
GHS09
Gef.

H331
H315
H410

M=100

613-273-00-1

tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine

427-600-9

192439-46-6

Aquatic Chronic 2

H411

GHS09

H411

613-274-00-7

2,6-dichloro-1-fluoropyridiniumtetrafluoroborate

427-400-1

140623-89-8

Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H314
H302
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H314
H302
H317
H410

613-275-00-2

3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride

424-530-0

93076-03-0

Acute Tox. 3 *
STOT SE 2
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H301
H371**
H373**
H318
H317
H411

GHS06
GHS05
GHS08
GHS09
Gef.

H301
H371**
H373**
H318
H317
H411

613-276-00-8

1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one

426-110-2

98377-35-6

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

613-277-00-3

(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one

427-070-9

Aquatic Chronic 4

H413

613-278-00-9

(3-aminophenyl)pyridin-3-ylmethanone

428-230-0

79568-06-2

STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H373**
H400
H410

GHS08
GHS09
Achtg.

H373**
H410

613-279-00-4

2-ethyl-2,3-dihydro-2-methyl-1H-perimidine

424-380-6

43057-68-7

Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H373**
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373**
H410

613-280-00-X

tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;
dimethyl propyleneurea

230-625-6

7226-23-5

Repr. 2
Acute Tox. 4 *
Eye Dam. 1

H361f***
H302
H318

GHS05
GHS08
GHS07
Gef.

H361f***
H302
H318

613-281-00-5

quinoline

202-051-6

91-22-5

Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H350
H341
H312
H302
H319
H315
H411

GHS08
GHS07
GHS09
Gef.

H350
H341
H312
H302
H319
H315
H411

613-282-00-0

triticonazole (ISO);
(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol

131983-72-7

Aquatic Chronic 2

H411

GHS09

H411

613-283-00-6

ketoconazole;
1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone

265-667-4

65277-42-1

Repr. 1B
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H360F***
H301
H373**
H400
H410

GHS06
GHS08
GHS09
Gef.

H360F***
H301
H373**
H410

613-284-00-1

metconazole (ISO);
(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

125116-23-6

Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2

H361d***
H302
H411

GHS08
GHS07
GHS09
Achtg.

H361d***
H302
H411

613-285-00-7

1-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2]

219-989-7 [1]
219-989-7 [2]

2592-95-2 [1]
123333-53-9 [2]

Expl. 1.3

H203

GHS01
Gef.

H203

613-286-00-2

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing < 0,5 %N,N-dimethylformamide (EC No 200-679-5)]

418-260-2

183196-57-8

Skin Sens. 1

H317

GHS07
Achtg.

H317

613-286-01-X

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing> 0,5 %N,N-dimethylformamide (EC No 200-679-5)]

418-260-2

183196-57-8

Repr. 1B
Skin Sens. 1

H360D***
H317

GHS08
GHS07
Gef.

H360D***
H317

613-287-00-8

1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole

419-540-7

160194-26-3

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

613-288-00-3

1,3-bis(dimethylcarbamoyl)-imidazolium chloride

420-930-4

135756-61-5

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

613-289-00-9

3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole

432-020-4

142623-48-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-290-00-4

4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride

432-470-1

189012-93-9

Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H318
H317
H410

613-291-00-X

2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one

434-820-9

106461-41-0

STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H373**
H400
H410

GHS08
GHS09
Achtg.

H373**
H410

613-292-00-5

N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine

435-010-8

26157-73-3

Muta. 2
Aquatic Chronic 3

H341
H412

GHS08
Achtg.

H341
H412

613-293-00-0

2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester

448-050-6

444065-11-6

Aquatic Chronic 4

H413

613-294-00-6

2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester

448-260-8

379268-96-9

Aquatic Chronic 4

H413

613-295-00-1

11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride

448-720-8

363138-44-7

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

613-296-00-7

pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate

418-270-7

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

613-297-00-2

5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole

420-820-6

Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 2

H226
H302
H411

GHS02
GHS07
GHS09
Achtg.

H226
H302
H411

613-298-00-8

bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate

421-560-6

STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2

H373**
H318
H411

GHS05
GHS08
GHS09
Gef.

H373**
H318
H411

613-299-00-3

main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt

422-610-1

Eye Dam. 1

H318

GHS05
Gef.

H318

613-300-00-7

1-imidazol-1-yl-octadecan-2-ol

434-120-3

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

613-301-00-2

dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate

443-910-7

Aquatic Chronic 4

H413

613-302-00-8

disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate

432-980-4

243858-60-8

Eye Dam. 1

H318

GHS05
Gef.

H318

613-303-00-3

2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine

429-800-1

95737-68-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-304-00-9

5,6-dihydroxy-2,3-dihydro-1H-indolium bromide

421-170-6

138937-28-7

Acute Tox. 4 *
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

613-305-00-4

2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole

448-630-9

3147-77-1

Aquatic Chronic 4

H413

613-306-00-X

(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate

433-520-5

82911-69-1

Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2

H302
H317
H411

GHS07
GHS09
Achtg.

H302
H317
H411

613-307-00-5

clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine

210880-92-5

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M=10

613-308-00-0

2-amino-5-methylthiazole

423-800-5

7305-71-7

Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H373**
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373**
H410

613-309-00-6

1-methyl-3-phenyl-1-piperazine

431-180-2

5271-27-2

Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3

H312
H302
H315
H318
H412

GHS05
GHS07
Gef.

H312
H302
H315
H318
H412

613-310-00-1

(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride

432-360-3

105813-13-6

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

613-311-00-7

methyl-5-nitrophenyl-guanidine

435-500-1

152460-07-6

Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H302
H319
H317
H412

GHS07
Achtg.

H302
H319
H317
H412

613-312-00-2

2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride

420-200-5

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H302
H318
H317
H412

GHS05
GHS07
Gef.

H302
H318
H317
H412

613-313-00-8

2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione

442-780-9

173838-67-0

Aquatic Chronic 3

H412

613-314-00-3

4-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one

443-770-7

7693-82-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

613-315-00-9

tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate

430-390-1

Acute Tox. 4 *
Aquatic Chronic 3

H332
H412

GHS07
Achtg.

H332
H412

613-316-00-4

trimethylopropane tri(3-aziridinylpropanoate);
(TAZ)

257-765-0

52234-82-9

Muta. 2
Eye Dam. 1
Skin Sens. 1

H341
H318
H317

GHS05
GHS08
GHS07
Gef.

H341
H318
H317

613-317-00-X

penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole

266-275-6

66246-88-6

Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1

H361d
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361d
H302
H410

M = 1
M = 1

613-318-00-5

Fenpyrazamin (ISO);
S-Allyl-5-amino-2,3-dihydro-2-isopropyl-3-oxo-4-(o-tolyl)pyrazol-1-carbothioat;
S-Allyl-5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydropyrazol-1-carbothioat

473798-59-3

Aquatic Acute 1 Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M = 10
M = 1

613-319-00-0

Imidazol

206-019-2

288-32-4

Repr. 1B
Acute Tox. 4
Skin Corr. 1C

H360D
H302
H314

GHS08
GHS07
GHS05
Gef.

H360D
H302
H314

613-320-00-6

Lenacil (ISO); 3-Cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidin-2,4(3H,5H)-dion

218-499-0

2164-08-1

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

M = 10
M = 10

613-321-00-1

(RS)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazol;
Medetomidin

86347-14-0

Acute Tox. 2
Acute Tox. 2
STOT SE 3
STOT SE 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H336
H370 (Augen)
H372
H400
H410

GHS06
GHS08
GHS09
Gef.

H330
H300
H336
H370 (Augen)
H372
H410

M = 1
M = 100

613-322-00-7

Triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-Chlorphenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;
α-tert-Butyl-β-(4-chlorphenoxy)-1H-1,2,4-triazol-1-ethanol

259-537-6

55219-65-3

Repr. 1B
Lact.
Acute Tox. 4
Aquatic Chronic 2

H360
H362
H302
H411

GHS08
GHS07
GHS09
Gef.

H360
H362
H302
H411

613-323-00-2

Terbuthylazin (ISO);
N-tert-Butyl-6-chlor-N'-ethyl-1,3,5-triazin-2,4-diamin

227-637-9

5915-41-3

Acute Tox. 4
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H302
H373
H400
H410

GHS07
GHS08
GHS09
Achtg.

H302
H373
H410

M = 10
M = 10

613-324-00-8

Chinolin-8-ol
8-Hydroxychinolin

205-711-1

148-24-3

Repr. 1B
Acute Tox. 3
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H360D
H301
H318
H317
H400
H410

GHS08
GHS06
GHS05
GHS09
Gef.

H360D
H301
H318
H317
H410

M = 1
M = 1

613-325-00-3

Thiacloprid (ISO);
(Z)-3-(6-Chlor-3-pyridyl-methyl)-1,3-thiazolidin-2-ylidencyanamid;
{(2Z)-3-[(6-Chlorpyridin-3-yl)methyl]-1,3-thiazolidin-2-yliden}cyanamid

111988-49-9

Carc. 2
Repr. 1B
Acute Tox. 4
Acute Tox. 3
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1

H351
H360FD
H332
H301
H336
H400
H410

GHS08
GHS06
GHS09
Gef.

H351
H360FD
H332
H301
H336
H410

M = 100
M = 100

614-001-00-4

Nicotin (ISO);
3-[(2S)-1-Methylpyrrolidin-2-yl]pyridin

200-193-3

54-11-5

Acute Tox. 2
Acute Tox. 2
Acute Tox. 2
Aquatic Chronic 2

H330
H310
H300
H411

GHS06
GHS09
Gef.

H330
H310
H300
H411

Einatmung:
ATE = 0,19 mg/L (Stäube oder Nebel)
Dermal:
ATE = 70 mg/kg
Oral:
ATE = 5 mg/kg

614-002-00-X

salts of nicotine

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Aquatic Chronic 2

H330
H310
H300
H411

GHS06
GHS09
Gef.

H330
H310
H300
H411

614-003-00-5

strychnine

200-319-7

57-24-9

Acute Tox. 1
Acute Tox. 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H310
H300
H400
H410

GHS06
GHS09
Gef.

H310
H300
H410

614-004-00-0

salts of strychnine

Acute Tox. 2 (*)
Acute Tox. 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H330
H300
H400
H410

GHS06
GHS09
Gef.

H330
H300
H410

614-005-00-6

colchicine

200-598-5

64-86-8

Muta. 1B
Acute Tox. 2 *

H340
H300

GHS06
GHS08
Gef.

H340
H300

614-006-00-1

brucine;
2,3-dimethoxystrychnine

206-614-7

357-57-3

Acute Tox. 2 (*)
Acute Tox. 2 (*)
Aquatic Chronic 3

H330
H300
H412

GHS06
Gef.

H330
H300
H412

614-007-00-7

brucine sulphate; [1]
brucine nitrate; [2]
strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]
strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]

225-432-9 [1]
227-317-9 [2]
269-439-5 [3]
269-710-8 [4]

4845-99-2 [1]
5786-97-0 [2]
68239-26-9 [3]
68310-42-9 [4]

Acute Tox. 2 (*)
Acute Tox. 2 (*)
Aquatic Chronic 3

H330
H300
H412

GHS06
Gef.

H330
H300
H412

614-008-00-2

aconitine

206-121-7

302-27-2

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-009-00-8

salts of aconitine

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-010-00-3

atropine

200-104-8

51-55-8

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-011-00-9

salts of atropine

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-012-00-4

hyoscyamine

202-933-0

101-31-5

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-013-00-X

salts of hyoscyamine

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-014-00-5

hyoscine

200-090-3

51-34-3

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)

H330
H310
H300

GHS06
Gef.

H330
H310
H300

614-015-00-0

salts of hyoscine

Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)

H330
H310
H300

GHS06
Gef.

H330
H310
H300

614-016-00-6

pilocarpine

202-128-4

92-13-7

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-017-00-1

salts of pilocarpine

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-018-00-7

papaverine

200-397-2

58-74-2

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

614-019-00-2

salts of papaverine

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

614-020-00-8

physostigmine

200-332-8

57-47-6

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-021-00-3

salts of physostigmine

Acute Tox. 2 (*)
Acute Tox. 2 (*)

H330
H300

GHS06
Gef.

H330
H300

614-022-00-9

digitoxin

200-760-5

71-63-6

Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)

H331
H301
H373 (*)(*)

GHS06
GHS08
Gef.

H331
H301
H373 (*)(*)

614-023-00-4

ephedrine

206-080-5

299-42-3

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

614-024-00-X

salts of ephedrine

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

614-025-00-5

ouabain

211-139-3

630-60-4

Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)

H331
H301
H373 (*)(*)

GHS06
GHS08
Gef.

H331
H301
H373 (*)(*)

614-026-00-0

strophantin-K

234-239-9

11005-63-3

Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)

H331
H301
H373 (*)(*)

GHS06
GHS08
Gef.

H331
H301
H373 (*)(*)

614-027-00-6

bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(ß-D-glucopyranosyloxy)-8,14-dihydroxy-, (3ß, 6ß)-;
red squill;
scilliroside

208-077-4

507-60-8

Acute Tox. 2 (*)

H300

GHS06
Gef.

H300

614-028-00-1

reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;
2-ethylhexyl di-D-glucopyranoside

414-420-0

Eye Dam. 1

H318

GHS05
Gef.

H318

614-029-00-7

constitutional isomers of penta-O-allyl-ß-D-fructofuranosyl-a-D-glucopyranoside;
constitutional isomers of hexa-O-allyl-ß-D-fructofuranosyl-a-D-glucopyranoside;
constitutional isomers of hepta-O-allyl-ß-D-fructofuransoyl-a-D-glucopyranoside

419-640-0

68784-14-5

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

615-001-00-7

methyl isocyanate

210-866-3

624-83-9

Flam. Liq. 2
Repr. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Resp. Sens. 1
Skin Sens. 1
STOT SE 3
Skin Irrit. 2
Eye Dam. 1

H225
H361d***
H330
H311
H301
H334
H317
H335
H315
H318

GHS02
GHS06
GHS05
GHS08
Gef.

H225
H361d***
H330
H311
H301
H334
H317
H335
H315
H318

615-002-00-2

methyl isothiocyanate

209-132-5

556-61-6

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H314
H317
H400
H410

GHS06
GHS05
GHS09
Gef.

H331
H301
H314
H317
H410

615-003-00-8

thiocyanic acid

207-337-4

463-56-9

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Chronic 3

H332
H312
H302
H412

GHS07
Achtg.

H332
H312
H302
H412

EUH032

615-004-00-3

salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3

H332
H312
H302
H412

GHS07
Achtg.

H332
H312
H302
H412

EUH032

615-005-00-9

4,4'-methylenediphenyl diisocyanate;
diphenylmethane-4,4'-diisocyanate; [1]
2,2'-methylenediphenyl diisocyanate;
diphenylmethane-2,2'-diisocyanate; [2]
o-(p-isocyanatobenzyl)phenyl isocyanate;
diphenylmethane-2,4'-diisocyanate; [3]
methylenediphenyl diisocyanate [4]

202-966-0 [1]
219-799-4 [2]
227-534-9 [3]
247-714-0 [4]

101-68-8 [1]
2536-05-2 [2]
5873-54-1 [3]
26447-40-5 [4]

Carc. 2
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1

H351
H332
H373**
H319
H335
H315
H334
H317

GHS08
GHS07
Gef.

H351
H332
H373**
H319
H335
H315
H334
H317

Eye Irrit. 2; H319: C> 5 %
Skin Irrit. 2; H315: C> 5 %
Resp. Sens. 1; H334: C> 0,1 %
STOT SE 3; H335: C> 5 %

615-006-00-4

2-methyl-m-phenylene diisocyanate;
toluene-2,4-di-isocyanate; [1]
4-methyl-m-phenylene diisocyanate;
toluene-2,6-di-isocyanate; [2]
m-tolylidene diisocyanate;
toluene-diisocyanate [3]

202-039-0 [1]
209-544-5 [2]
247-722-4 [3]

91-08-7 [1]
584-84-9 [2]
26471-62-5 [3]

Carc. 2
Acute Tox. 2 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3

H351
H330
H319
H335
H315
H334
H317
H412

GHS06
GHS08
Gef.

H351
H330
H319
H335
H315
H334
H317
H412

Resp. Sens. 1; H334: C> 0,1 %

615-007-00-X

1,5-naphthylene diisocyanate

221-641-4

3173-72-6

Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Aquatic Chronic 3

H332
H319
H335
H315
H334
H412

GHS08
GHS07
Gef.

H332
H319
H335
H315
H334
H412

615-008-00-5

3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;
isophorone di-isocyanate

223-861-6

4098-71-9

Acute Tox. 3 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2

H331
H319
H335
H315
H334
H317
H411

GHS06
GHS08
GHS09
Gef.

H331
H319
H335
H315
H334
H317
H411

^(*)
Resp. Sens. 1; H334: C> 0,5 %
Skin Sens.1; H317: C> 0,5 %

615-009-00-0

4,4'-methylenedi(cyclohexyl isocyanate);
dicyclohexylmethane-4,4'-di-isocyanate

225-863-2

5124-30-1

Acute Tox. 3 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1

H331
H319
H335
H315
H334
H317

GHS06
GHS08
Gef.

H331
H319
H335
H315
H334
H317

^(*)
Resp. Sens. 1; H334: C> 0,5 %
Skin Sens. 1; H317: C> 0,5 %

615-010-00-6

2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]
2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]

241-001-8 [1]
239-714-4 [2]

16938-22-0 [1]
15646-96-5 [2]

Acute Tox. 3 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H331
H319
H335
H315
H334

GHS06
GHS08
Gef.

H331
H319
H335
H315
H334

^(*)
Resp. Sens. 1; H334: C> 0,5 %
Skin Sens. 1; H317: C> 0,5 %

615-011-00-1

hexamethylene-di-isocyanate

212-485-8

822-06-0

Acute Tox. 3 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1

H331
H319
H335
H315
H334
H317

GHS06
GHS08
Gef.

H331
H319
H335
H315
H334
H317

^(*)
Resp. Sens. 1; H334: C> 0,5 %
Skin Sens. 1; H317: C> 0,5 %

615-012-00-7

4-isocyanatosulphonyltoluene;
tosyl isocyanate

223-810-8

4083-64-1

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

EUH014

Eye Irrit.; H319: C> 5 %
STOT SE 3; H335: C> 5 %
Skin Irrit. 2; H315: C> 5 %

615-013-00-2

Cyanamid;
Carbamonitril

206-992-3

420-04-2

Carc. 2
Repr. 2
Acute Tox. 3
Acute Tox. 3
STOT RE 2
Skin Corr. 1
Skin Sens. 1
Eye Dam. 1
Aquatic Chronic 3

H351
H361fd
H311
H301
H373 (Schilddrüse)
H314
H317
H318
H412

GHS08
GHS06
GHS05
Gef.

H351
H361fd
H311
H301
H373 (Schilddrüse)
H314
H317
H412

615-014-00-8

tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate

7276-58-6

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

615-015-00-3

1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;
isobornyl thiocyanoacetate

204-081-5

115-31-1

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

615-016-00-9

potassium cyanate

209-676-3

590-28-3

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

615-017-00-4

calcium cyanamide

205-861-8

156-62-7

Acute Tox. 4 (*)
STOT SE 3
Eye Dam. 1

H302
H335
H318

GHS05
GHS07
Gef.

H302
H335
H318

615-018-00-X

2-(2-butoxyethoxy)ethyl thiocyanate

203-985-7

112-56-1

Flam. Liq. 3
Acute Tox. 3 (*)
Acute Tox. 3 (*)

H226
H311
H301

GHS02
GHS06
Gef.

H226
H311
H301

615-019-00-5

dicyclohexylcarbodiimide

208-704-1

538-75-0

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1

H311
H302
H318
H317

GHS06
GHS05
Gef.

H311
H302
H318
H317

615-020-00-0

methylene dithiocyanate

228-652-3

6317-18-6

Acute Tox. 2 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1

H330
H301
H314
H317
H400

GHS06
GHS05
GHS09
Gef.

H330
H301
H314
H317
H400

615-021-00-6

1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;
TGIC

219-514-3

2451-62-9

Muta. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H340
H331
H301
H373 (*)(*)
H318
H317
H412

GHS06
GHS08
GHS05
Gef.

H340
H331
H301
H373 (*)(*)
H318
H317
H412

615-022-00-1

methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate

410-550-7

79277-18-2

STOT RE 2 *
Resp. Sens. 1
Skin Sens. 1

H373**
H334
H317

GHS08
Gef.

H373**
H334
H317

EUH014

615-023-00-7

2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;
(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate

410-900-9

83056-32-0

Flam. Liq. 3
Muta. 2
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Resp. Sens. 1

H226
H341
H332
H373 (*)(*)
H318
H334

GHS02
GHS08
GHS05
GHS07
Gef.

H226
H341
H332
H373 (*)(*)
H318
H334

EUH014

615-024-00-2

2-phenylethylisocyanate

413-080-0

1943-82-4

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Skin Corr. 1a
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 2

H331
H302
H314
H334
H317
H411

GHS06
GHS08
GHS05
GHS09
Gef.

H331
H302
H314
H334
H317
H411

615-025-00-8

4,4'-ethylidenediphenyl dicyanate

405-740-1

47073-92-7

Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H332
H302
H373 (*)(*)
H318
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H332
H302
H373 (*)(*)
H318
H410

615-026-00-3

4,4'-methylenebis(2,6-dimethylphenyl cyanate)

405-790-4

101657-77-6

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

615-028-00-4

ethyl 2-(isocyanatosulfonyl)benzoate

410-220-2

77375-79-2

Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1

H302
H373**
H318
H334
H317

GHS05
GHS08
GHS07
Gef.

H302
H373**
H318
H334
H317

EUH014

615-029-00-X

2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane

411-280-2

Acute Tox. 2 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3

H330
H302
H314
H334
H317
H412

GHS06
GHS08
GHS05
Gef.

H330
H302
H314
H334
H317
H412

615-030-00-5

alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3

H332
H312
H302
H412

GHS07
Achtg.

H332
H312
H302
H412

615-031-00-0

thallium thiocyanate

222-571-7

3535-84-0

Acute Tox. 2 *
Acute Tox. 2 *
Acute Tox. 4 *
STOT RE 2
Aquatic Chronic 2

H330
H300
H312
H373**
H411

GHS06
GHS08
GHS09
Gef.

H330
H300
H312
H373**
H411

615-032-00-6

metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex

Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H332
H312
H302
H400
H410

GHS07
GHS09
Achtg.

H332
H312
H302
H410

615-033-00-1

reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0.097)

430-980-9

Aquatic Chronic 4

H413

615-034-00-7

reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)

430-750-8

Aquatic Chronic 4

H413

615-035-00-2

reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)

430-930-6

122886-55-9

Aquatic Chronic 4

H413

615-036-00-8

reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)

430-940-0

Aquatic Chronic 4

H413

615-037-00-3

reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)

430-950-5

Aquatic Chronic 4

H413

615-038-00-9

reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)

430-960-1

Aquatic Chronic 4

H413

615-039-00-4

reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)

430-970-4

Aquatic Chronic 4

H413

615-044-00-1

4-chlorophenylisocyanate

203-176-9

104-12-1

Acute Tox. 2 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H330
H302
H335
H315
H318
H334
H400
H410

GHS06
GHS05
GHS08
GHS09
Gef.

H330
H302
H335
H315
H318
H334
H410

615-045-00-7

4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)

420-530-1

Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4

H334
H317
H413

GHS08
Gef.

H334
H317
H413

616-001-00-X

N,N-dimethylformamide;
dimethyl formamide

200-679-5

68-12-2

Repr. 1B
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2

H360D (*)(*)(*)
H332
H312
H319

GHS08
GHS07
Gef.

H360D (*)(*)(*)
H332
H312
H319

616-002-00-5

2-fluoroacetamide

211-363-1

640-19-7

Acute Tox. 2 (*)
Acute Tox. 3 (*)

H300
H311

GHS06
Gef.

H300
H311

616-003-00-0

acrylamide;
prop-2-enamide

201-173-7

79-06-1

Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 3 (*)
STOT RE 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1

H350
H340
H361f (*)(*)(*)
H301
H372 (*)(*)
H332
H312
H319
H315
H317

GHS06
GHS08
Gef.

H350
H340
H361f (*)(*)(*)
H301
H372 (*)(*)
H332
H312
H319
H315
H317

616-004-00-6

allidochlor (ISO);
N,N-diallylchloroacetamide

202-270-7

93-71-0

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H312
H302
H319
H315
H411

GHS07
GHS09
Achtg.

H312
H302
H319
H315
H411

616-005-00-1

chlorthiamid (ISO);
2,6-dichloro (thiobenzamide)

217-637-7

1918-13-4

Acute Tox. 4 (*)

H302

GHS07
Achtg.

H302

616-006-00-7

Dichlofluanid (ISO);
N-[(Dichlorfluormethyl)thio]-N',N'-dimethyl-N-phenylsulfamid

214-118-7

1085-98-9

Acute Tox. 4
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1

H332
H319
H317
H400

GHS07
GHS09
Achtg.

H332
H319
H317
H400

M = 10

616-007-00-2

diphenamid (ISO);
N,N-dimethyl-2,2-diphenylacetamide

213-482-4

957-51-7

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

616-008-00-8

propachlor (ISO);
2-chloro-N-isopropylacetanilide;
a-chloro-N-isopropylacetanilide

217-638-2

1918-16-7

Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H319
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H319
H317
H410

616-009-00-3

propanil (ISO);
3',4'-dichloropropionanilide

211-914-6

709-98-8

Acute Tox. 4 *
Aquatic Acute 1

H302
H400

GHS07
GHS09
Achtg.

H302
H400

M=10

616-010-00-9

tosylchloramide sodium

204-854-7

127-65-1

Acute Tox. 4 (*)
Skin Corr. 1B
Resp. Sens. 1

H302
H314
H334

GHS08
GHS05
GHS07
Dg

H302
H314
H334

EUH031

616-011-00-4

N,N-Dimethylacetamid

204-826-4

127-19-5

Repr. 1B
Acute Tox. 4*
Acute Tox. 4*

H360D***
H332
H312

GHS08
GHS07
Gef.

H360D***
H332
H312

616-012-00-X

N-(dichlorofluoromethylthio)phthalimide;
N-(fluorodichloromethylthio)phthalimide

211-952-3

719-96-0

Skin Irrit. 2

H315

GHS07
Achtg.

H315

616-013-00-5

butyraldehyde oxime

203-792-8

110-69-0

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Irrit. 2

H311
H302
H319

GHS06
Gef.

H311
H302
H319

616-014-00-0

2-butanone oxime;
ethyl methyl ketoxime;
ethyl methyl ketone oxime

202-496-6

96-29-7

Carc. 2
Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1

H351
H312
H318
H317

GHS08
GHS05
GHS07
Gef.

H351
H312
H318
H317

616-015-00-6

alachlor (ISO);
2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide

240-110-8

15972-60-8

Carc. 2
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H302
H317
H410

M=10

616-016-00-1

1-(3,4-dichlorophenylimino) thiosemicarbazide

5836-73-7

Acute Tox. 2 (*)

H300

GHS06
Gef.

H300

616-017-00-7

cartap hydrochloride

239-309-2

15263-52-2

Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H312
H302
H400
H410

GHS07
GHS09
Achtg.

H312
H302
H410

616-018-00-2

N,N-diethyl-m-toluamide;
deet

205-149-7

134-62-3

Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3

H302
H319
H315
H412

GHS07
Achtg.

H302
H319
H315
H412

616-019-00-8

perfluidone (ISO);
1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide;

253-718-3

37924-13-3

Acute Tox. 4 (*)
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

616-020-00-3

tebuthiuron (ISO);
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea

251-793-7

34014-18-1

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

616-021-00-9

thiazafluron (ISO);
1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea

246-901-4

25366-23-8

Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

616-022-00-4

acetamide

200-473-5

60-35-5

Carc. 2

H351

GHS08
Achtg.

H351

616-023-00-X

N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide

401-980-6

Skin Irrit. 2
Skin Sens. 1

H315
H317

GHS07
Achtg.

H315
H317

616-024-00-5

2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide

402-260-4

54942-74-4

Aquatic Chronic 4

H413

616-025-00-0

valinamide

402-840-7

20108-78-5

Repr. 2
Eye Irrit. 2
Skin Sens. 1

H361f (*)(*)(*)
H319
H317

GHS08
Achtg.

H361f (*)(*)(*)
H319
H317

616-026-00-6

thioacetamide

200-541-4

62-55-5

Carc. 1B
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3

H350
H302
H319
H315
H412

GHS08
GHS07
Gef.

H350
H302
H319
H315
H412

616-027-00-1

tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate

403-760-5

Skin Sens. 1

H317

GHS07
Achtg.

H317

616-028-00-7

N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide

403-790-9

108673-51-4

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

616-029-00-2

N,N'-ethylenebis(vinylsulfonylacetamide)

404-790-1

66710-66-5

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

616-030-00-8

ethidimuron (ISO);
1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea

250-010-6

30043-49-3

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

616-031-00-3

dimethachlor (ISO);
2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide;

256-625-6

50563-36-5

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

616-032-00-9

diflufenican (ISO);
N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide

83164-33-4

Aquatic Chronic 3

H412

616-033-00-4

cyprofuram (ISO);
N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide

274-050-9

69581-33-5

Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1

H301
H312
H400
H410

GHS06
GHS09
Gef.

H301
H312
H410

616-034-00-X

pyracarbolid; (ISO);
3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide

246-419-4

24691-76-7

Aquatic Chronic 3

H412

616-035-00-5

cymoxanil (ISO);
2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide

261-043-0

57966-95-7

Repr. 2
Acute Tox. 4
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361fd
H302
H373 (Blut, Thymusdrüse)
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H361fd
H302
H373 (Blut, Thymusdrüse)
H317
H410

M = 1
M = 1

616-036-00-0

2-chloracetamide

201-174-2

79-07-2

Repr. 2
Acute Tox. 3 (*)
Skin Sens. 1

H361f (*)(*)(*)
H301
H317

GHS06
GHS08
Gef.

H361f (*)(*)(*)
H301
H317

Skin Sens. 1; H317: C> 0,1 %

616-037-00-6

Acetochlor (ISO); 2-Chlor-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamid

251-899-3

34256-82-1

Carc. 2
Repr. 2
Acute Tox. 4
STOT SE 3
STOT RE 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H361f
H332
H335
H373 (Nieren)
H315
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H361f
H332
H335
H373 (Nieren)
H315
H317
H410

M = 1 000
M = 100

616-038-00-1

(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride

406-010-5

88918-84-7

Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H318
H317
H411

GHS05
GHS07
GHS09
Gef.

H318
H317
H411

616-039-00-7

3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide

406-200-8

117827-06-2

Skin Sens. 1

H317

GHS07
Achtg.

H317

616-040-00-2

potassiumN-(4-toluenesulfonyl)-4-toluenesulfonamide

406-650-5

97888-41-0

Eye Dam. 1

H318

GHS05
Gef.

H318

616-041-00-8

3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide

406-840-8

101664-25-9

Aquatic Chronic 4

H413

616-042-00-3

N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide

407-070-5

142859-67-4

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

616-043-00-9

isoxaben (ISO);
N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide

407-190-8

82558-50-7

Aquatic Chronic 4

H413

616-044-00-4

N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide

402-510-2

Aquatic Chronic 2

H411

GHS09

H411

616-045-00-X

2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide

405-190-2

122371-93-1

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

616-046-00-5

N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide

406-390-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-047-00-0

reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C₁₆)alkylacetamide;
2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C₁₈)alkylacetamide

406-640-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

616-048-00-6

3'-trifluoromethylisobutyranilide

406-740-4

1939-27-1

STOT RE 2 (*)
Aquatic Chronic 2

H373 (*)(*)
H411

GHS08
GHS09
Achtg.

H373 (*)(*)
H411

616-049-00-1

2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide

408-150-2

99141-89-6

Aquatic Chronic 4

H413

616-050-00-7

lufenuron (ISO);
N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide

410-690-9

103055-07-8

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

616-051-00-2

reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;
2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene

411-070-0

Aquatic Chronic 4

H413

616-052-00-8

formamide

200-842-0

75-12-7

Repr. 1B

H360D (*)(*)(*)

GHS08
Gef.

H360D (*)(*)(*)

616-053-00-3

N-methylacetamide

201-182-6

79-16-3

Repr. 1B

H360D (*)(*)(*)

GHS08
Gef.

H360D (*)(*)(*)

616-054-00-9

iprodione (ISO);
3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide

253-178-9

36734-19-7

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

616-055-00-4

propyzamide (ISO);
3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide

245-951-4

23950-58-5

Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H400
H410

GHS08
GHS09
Achtg.

H351
H410

616-056-00-X

N-methylformamide

204-624-6

123-39-7

Repr. 1B
Acute Tox. 4 (*)

H360D (*)(*)(*)
H312

GHS08
GHS07
Dg

H360D (*)(*)(*)
H312

616-057-00-5

reaction mass of:N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;
methacrylamide;
2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;
N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide

412-790-8

Carc. 1B
Muta. 2
STOT RE 2 (*)

H350
H341
H373 (*)(*)

GHS08
Gef.

H350
H341
H373 (*)(*)

616-058-00-0

1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene

412-570-1

119462-56-5

STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H318
H317
H400
H410

GHS08
GHS05
GHS07
GHS09
Gef.

H373 (*)(*)
H318
H317
H410

616-059-00-6

4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide

412-650-6

121487-83-0

Aquatic Chronic 4

H413

616-060-00-1

Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)

413-770-1

Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H314
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H314
H317
H410

616-061-00-7

N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide

413-610-0

124172-53-8

Eye Irrit. 2
Aquatic Chronic 3

H319
H412

GHS07
Achtg.

H319
H412

616-062-00-2

N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide

411-590-8

70693-57-1

Skin Corr. 1B
Aquatic Chronic 3

H314
H412

GHS05
Gef.

H314
H412

616-063-00-8

3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione

411-920-0

106917-30-0

Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1a
Aquatic Acute 1
Aquatic Chronic 1

H331
H302
H373 (*)(*)
H314
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H331
H302
H373 (*)(*)
H314
H410

616-064-00-3

N -tert-butyl-3-methylpicolinamide

406-720-5

32998-95-1

Aquatic Chronic 3

H412

616-065-00-9

3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea

411-970-3

79881-89-3

Acute Tox. 4 (*)
STOT RE 2 (*)

H302
H373 (*)(*)

GHS08
GHS07
Achtg.

H302
H373 (*)(*)

616-066-00-4

5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone

405-100-1

115662-06-1

Repr. 2

H361f (*)(*)(*)

GHS08
Achtg.

H361f (*)(*)(*)

616-067-00-X

dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate

407-300-4

92683-20-0

Aquatic Chronic 4

H413

616-068-00-5

potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate

406-500-9

174393-75-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

616-069-00-0

1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide

406-210-2

110560-22-0

Aquatic Chronic 4

H413

616-070-00-6

reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;
3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;
3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea

406-530-2

Aquatic Chronic 4

H413

616-071-00-1

reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;
bis(N-octadecyl-N'-phenyleneureido)methylene;
bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)

406-550-1

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

616-072-00-7

1-(2-deoxy-5-O-trityl-ß-D-threopentofuranosyl)thymine

407-120-6

55612-11-8

Aquatic Chronic 4

H413

616-073-00-2

4'-ethoxy-2-benzimidazoleanilide

407-600-5

120187-29-3

Muta. 2
Aquatic Chronic 4

H341
H413

GHS08
Achtg.

H341
H413

616-074-00-8

N-butyl-2-(4-morpholinylcarbonyl)benzamide

407-730-2

104958-67-0

Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H319
H317
H412

GHS07
Achtg.

H319
H317
H412

616-075-00-3

D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)

408-120-9

65197-96-8

Acute Tox. 4 (*)
Eye Dam. 1

H302
H318

GHS05
GHS07
Gef.

H302
H318

616-076-00-9

tebufenozide (ISO);
N -tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide

412-850-3

112410-23-8

Aquatic Chronic 2

H411

GHS09

H411

616-077-00-4

reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;
potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate

411-310-4

Eye Dam. 1

H318

GHS05
Gef.

H318

616-078-00-X

2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide

411-330-3

104541-33-5

Aquatic Chronic 4

H413

616-079-00-5

1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate

411-700-4

140921-24-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

616-080-00-0

4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)

411-850-0

119018-29-0

Aquatic Chronic 3

H412

616-081-00-6

5-bromo-8-naphtholactam

413-480-5

24856-00-6

Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

616-082-00-1

N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide

413-200-1

129604-78-0

Skin Sens. 1

H317

GHS07
Achtg.

H317

616-083-00-7

[2-[(4-nitrophenyl)amino]ethyl]urea

410-700-1

27080-42-8

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

616-084-00-2

2,4-bis[N'-(4-methylphenyl)ureido]toluene

411-790-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-085-00-8

3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione

412-190-6

168900-02-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-086-00-3

2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene

412-250-1

102387-48-4

Aquatic Chronic 4

H413

616-087-00-9

reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;
7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate

412-260-6

52658-19-2

Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H319
H317
H411

GHS07
GHS09
Achtg.

H319
H317
H411

616-088-00-4

2-aminosulfonyl-N,N-dimethylnicotinamide

413-440-7

112006-75-4

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

616-089-00-X

5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran

415-360-8

41107-56-6

Muta. 2

H341

GHS08
Achtg.

H341

616-090-00-5

1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride

415-660-9

70918-74-0

Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2

H331
H311
H301
H373 (*)(*)
H411

GHS06
GHS08
GHS09
Gef.

H331
H311
H301
H373 (*)(*)
H411

616-091-00-0

1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione

423-400-0

59653-74-6

Muta. 1B
Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1

H340
H331
H302
H373 (*)(*)
H318
H317

GHS06
GHS08
GHS05
Gef.

H340
H331
H302
H373 (*)(*)
H318
H317

616-092-00-6

Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene withN,N-di-2-propenylformamide

404-035-6

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

616-093-00-1

Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride

406-620-1

129217-90-9

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

616-094-00-7

3,3-Dicyclohexyl-1'1'-methylenbis-(4,1-phenylen)diharnstoff

406-370-3

58890-25-8

Aquatic Chronic 4

H413

616-095-00-2

3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea

406-690-3

43136-14-7

Aquatic Chronic 4

H413

616-096-00-8

N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide

408-110-4

110483-07-3

Aquatic Chronic 4

H413

616-097-00-3

N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide

411-840-6

83372-55-8

Aquatic Chronic 4

H413

616-098-00-9

1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide

411-750-7

119126-15-7

Aquatic Chronic 2

H411

GHS09

H411

616-099-00-4

2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide

414-170-2

135937-20-1

Aquatic Chronic 4

H413

616-100-00-8

1,3-dimethyl-1,3-bis(trimethylsilyl)urea

414-180-7

10218-17-4

Acute Tox. 4 (*)
Skin Irrit. 2

H302
H315

GHS07
Achtg.

H302
H315

616-101-00-3

(S)-N -tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide

414-600-9

149182-72-9

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

616-102-00-9

reaction mass of: a-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-?-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);
1,2-(or 1,3-)bis[a-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-?-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;
1,2,3-tris[a-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-?-oxy-poly-(oxyethylene-co-oxypropylene)]propane]

415-870-0

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

616-103-00-4

(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide

415-030-3

120298-38-6

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

616-104-00-X

benalaxyl (ISO);
methylN-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate

275-728-7

71626-11-4

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-105-00-5

chlorotoluron (ISO);
3-(3-chloro-p-tolyl)-1,1-dimethylurea

239-592-2

15545-48-9

Carc. 2
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H361d (*)(*)(*)
H400
H410

GHS08
GHS09
Achtg.

H351
H361d (*)(*)(*)
H410

616-106-00-0

phenmedipham (ISO);
methyl 3-(3-methylcarbaniloyloxy)carbanilate

237-199-0

13684-63-4

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-107-00-6

cinidon ethyl (ISO);
ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate

142891-20-1

Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H351
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H317
H410

616-108-00-1

iodosulfuron-methyl-sodium;
sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide

144550-36-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-109-00-7

sulfosulfuron (ISO);
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea

141776-32-1

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-110-00-2

cyclanilide (ISO);
1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid

419-150-7

113136-77-9

Acute Tox. 4 (*)
Aquatic Chronic 2

H302
H411

GHS07
GHS09
Achtg.

H302
H411

616-111-00-8

fenhexamid (ISO);
N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid

422-530-5

126833-17-8

Aquatic Chronic 2

H411

GHS09

H411

616-112-00-3

oxasulfuron (ISO);
oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate

144651-06-9

STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1

H373 (*)(*)
H400
H410

GHS08
GHS09
Achtg.

H373 (*)(*)
H410

616-113-00-9

desmedipham (ISO);
ethyl 3-phenylcarbamoyloxyphenylcarbamate

237-198-5

13684-56-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M=10

616-114-00-4

dodecanamide,N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-

418-010-2

136897-58-0

Aquatic Chronic 4

H413

616-115-00-X

N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide

416-150-9

136450-06-1

Aquatic Chronic 4

H413

616-116-00-5

N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate

416-790-9

143052-96-4

Aquatic Chronic 4

H413

616-117-00-0

N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide

416-860-9

777891-21-1

Repr. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H361f (*)(*)(*)
H317
H400
H410

GHS08
GHS09
Achtg.

H361f (*)(*)(*)
H317
H410

616-118-00-6

N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride

417-950-0

65797-42-4

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

616-119-00-1

2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide

418-060-5

118020-93-2

Aquatic Chronic 4

H413

616-120-00-7

reaction mass of:N-(3-dimethylamino-4-methyl-phenyl)-benzamide;
N-(3-dimethylamino-2-methyl-phenyl)-benzamide;
N-(3-dimethylamino-3-methyl-phenyl)-benzamide

420-600-1

STOT RE 2 (*)
Aquatic Chronic 2

H373 (*)(*)
H411

GHS08
GHS09
Achtg.

H373 (*)(*)
H411

616-121-00-2

2,4-dihydroxy-N-(2-methoxyphenyl)benzamide

419-090-1

129205-19-2

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

616-122-00-8

methyl-neodecanamide

414-460-9

105726-67-8

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

616-123-00-3

N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide

414-740-0

96141-86-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-124-00-9

lithium bis(trifluoromethylsulfonyl)imide

415-300-0

90076-65-6

Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 2 *
Skin Corr. 1B
Aquatic Chronic 3

H311
H301
H373**
H314
H412

GHS06
GHS05
GHS08
Gef.

H311
H301
H373**
H314
H412

616-125-00-4

3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-ß-carboxamide

415-730-9

151338-11-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

410

616-126-00-X

1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide

423-960-6

139756-01-7

Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3

H302
H373**
H412

GHS08
GHS07
Achtg.

H302
H373**
H412

616-127-00-5

reaction mass of:N,N'-Ethane-1,2-diylbis(decanamide);
12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;
N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)

430-050-2

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

616-128-00-0

N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide

417-530-7

123590-00-1

Aquatic Chronic 4

H413

616-129-00-6

N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide

419-710-0

42774-15-2

Acute Tox. 4 (*)
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

616-130-00-1

N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide

421-780-2

150919-56-5

Aquatic Chronic 4

H413

616-131-00-7

1-aminocyclopentanecarboxamide

422-950-9

17193-28-1

STOT RE 1
Acute Tox. 4 *
Eye Dam. 1

H372**
H302
H318

GHS05
GHS08
GHS07
Gef.

H372**
H302
H318

616-132-00-2

N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide

423-250-6

130016-98-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-133-00-8

N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide

423-990-1

149118-66-1

Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H318
H410

616-134-00-3

3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide

401-820-5

793710-14-2

Aquatic Chronic 3

H412

616-135-00-9

(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide

430-230-0

136522-17-3

Acute Tox. 4 (*)
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

616-136-00-4

reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)

430-380-7

Aquatic Chronic 2

H411

GHS09

H411

616-137-00-X

4-dichloroacetyl-1-oxa-4-azaspiro[4,5]decane

401-130-4

71526-07-3

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

616-138-00-5

benzoic acid,N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide

431-600-4

112226-61-6

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

616-139-00-0

(3S,4aS,8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide

420-380-5

136465-81-1

Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3

H302
H318
H412

GHS05
GHS07
Gef.

H302
H318
H412

616-140-00-6

N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]

429-380-1

133336-92-2

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

616-141-00-1

zoxamide (ISO);
(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide

156052-68-5

Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H317
H400
H410

GHS07
GHS09
Achtg.

H317
H410

M=10

616-142-00-7

1,3-Bis(vinylsulfonylacetamido)propane

428-350-3

93629-90-4

Muta. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H341
H318
H317
H412

GHS08
GHS05
GHS07
Gef.

H341
H318
H317
H412

616-143-00-2

N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide

422-560-9

149591-38-8

Repr. 2
Eye Irrit. 2
Aquatic Chronic 4

H361f (*)(*)(*)
H319
H413

GHS08
Achtg.

H361f (*)(*)(*)
H319
H413

616-144-00-8

3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl] benzamide

431-130-1

Aquatic Chronic 4

H413

616-145-00-3

pethoxamide (ISO);
2-chloro-N-(2- ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide

106700-29-2

Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

M=100

616-146-00-9

N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4- dimethyl-3-oxopentanoic acidamide

431-330-7

142776-95-2

Aquatic Chronic 4

H413

616-147-00-4

1- methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide

424-160-1

139481-22-4

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

616-148-00-X

N-[6,9-dihydro-9-[[2- hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide

424-550-1

84245-12-5

Carc. 1B
Muta. 1B
Repr. 1B

H350
H340
H360FD

GHS08
Gef.

H350
H340
H360FD

616-150-00-0

(2R,3S )-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride

425-260-6

STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H373**
H318
H317
H411

GHS05
GHS08
GHS07
GHS09
Gef.

H373**
H318
H317
H411

616-151-00-6

N-(2-amino-4,6- dichloropyrimidin-5-yl)formamide

425-650-6

171887-03-9

Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3

H302
H318
H317
H412

GHS05
GHS07
Gef.

H302
H318
H317
H412

616-152-00-1

4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide

425-850-3

125971-96-2

Aquatic Chronic 4

H413

616-153-00-7

4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide

425-860-8

125971-57-5

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

616-154-00-2

3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide

431-110-0

Aquatic Chronic 4

H413

616-155-00-8

N,N,N',N'- tetracyclohexyl-1,3-benzenedicarboxamide

431-040-0

104560-40-9

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-156-00-3

6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino] acetanilide

430-500-8

204277-61-2

Aquatic Chronic 4

H413

616-157-00-9

3-amino-4-hydroxy-N-(3- isopropoxypropyl)benzenesulfonamide hydrochloride

427-780-9

114565-70-7

Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H318
H400
H410

GHS05
GHS07
GHS09
Gef.

H302
H318
H410

616-158-00-4

N-[4-cyano-3-trifluoromethylphenyl]methacrylamide

427-880-2

90357-53-2

STOT RE 2 *
Aquatic Chronic 2

H373**
H411

GHS08
GHS09
Achtg.

H373**
H411

616-160-00-5

2,2'- azobis[N-(2-hydroxyethyl)-2-methylpropionamide]

429-090-3

61551-69-7

Skin Sens. 1
Aquatic Chronic 3

H317
H412

GHS07
Achtg.

H317
H412

616-161-00-0

2,4-dichloro-5-hydroxyacetanilide

429-110-0

67669-19-6

Aquatic Chronic 3

H412

616-162-00-6

isostearic acid monoisopropanolamide

431-540-9

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

616-163-00-1

4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]

430-350-3

192463-88-0

Aquatic Chronic 4

H413

616-164-00-7

dimoxystrobin (ISO);
(E)-2-(methoxyimino)-N-methyl-2-[a-(2,5-xylyloxy)-o-tolyl] acetamide

149961-52-4

Carc. 2
Repr. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H361d***
H332
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H361d***
H332
H410

M=10

616-165-00-2

beflubutamid (ISO);
(RS)-N-benzyl-2-(a,a,a,4-tetrafluoro-m-tolyoxy)butyramide

113614-08-7

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M=100

616-166-00-8

cyazofamid (ISO);
4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide

120116-88-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M=10

616-167-00-3

N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide

418-290-6

168612-06-4

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

616-168-00-9

1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium

418-440-0

136997-71-2

Skin Sens. 1

H317

GHS07
Achtg.

H317

616-169-00-4

4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3- pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one

420-220-4

92771-56-7

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

616-170-00-X

(2R)-2-amino-2- phenylacetamide

420-370-0

6485-67-2

Eye Irrit. 2
Skin Sens. 1

H319
H317

GHS07
Achtg.

H319
H317

616-171-00-5

2-(para-chlorophenyl)glycineamide

420-830-0

102333-75-5

Eye Dam. 1
Skin Sens. 1

H318
H317

GHS05
GHS07
Gef.

H318
H317

616-172-00-0

N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl) acetamide;
(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl

423-840-3

14691-89-5

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

616-174-00-1

2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride

424-560-4

151257-01-1

Acute Tox. 4 *
Eye Irrit. 2

H302
H319

GHS07
Achtg.

H302
H319

616-175-00-7

2-(2-hexyldecyloxy) benzamide

431-230-3

202483-62-3

Aquatic Chronic 4

H413

616-176-00-2

3-N,N-bis(methoxyethyl) aminoacetanilide

432-530-7

24294-01-7

Acute Tox. 4 *
Aquatic Chronic 3

H302
H412

GHS07
Achtg.

H302
H412

616-177-00-8

(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5- dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;
N-[3-({4-[(2-{butyl[(4-methylphenyl) sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl] tetradecanamide

432-970-1

217324-98-6

Aquatic Chronic 4

H413

616-178-00-3

N-(5-(bis(2- methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide

434-500-9

52583-35-4

Aquatic Chronic 4

H413

616-179-00-9

2-chloro-N-(4-methylphenyl)acetamide

435-170-9

16634-82-5

Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H318
H317
H400
H410

GHS05
GHS07
GHS09
Gef.

H318
H317
H410

616-180-00-4

N,N-(dimethylamino)thioacetamide hydrochloride

435-470-1

27366-72-9

Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H360D***
H400
H410

GHS08
GHS09
Gef.

H360D***
H410

616-181-00-X

4'-methyldodecane-1-sulfonanilide

435-490-9

17417-32-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-182-00-5

N'-(1,3-dimethylbutylidene)-3-hydroxy-2- naphthohydrazide

435-860-1

214417-91-1

Skin Sens. 1
Aquatic Chronic 2

H317
H411

GHS07
GHS09
Achtg.

H317
H411

616-183-00-0

N-dodecyl-4-methoxybenzamide

442-340-6

1854-15-5

Aquatic Chronic 4

H413

616-184-00-6

3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide

442-560-2

105043-55-8

Aquatic Chronic 4

H413

616-186-00-7

N,N'-(2-chloro-1,4-phenylene)bis(3- oxobutaneamide)

443-010-4

53641-10-4

Aquatic Chronic 3

H412

616-188-00-8

2-(5,5-dimethyl-2,4- dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide

443-980-9

221215-20-9

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

616-189-00-3

N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl] acetamide

444-780-4

452962-97-9

Aquatic Chronic 4

H413

616-190-00-9

N-decyl-4- nitrobenzamide

445-880-0

64026-19-3

Aquatic Chronic 4

H413

616-191-00-4

2-ethyl-N-methyl-N -(3-methylphenyl)butanamide

446-190-2

406488-30-0

Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H302
H319
H315
H317
H411

GHS07
GHS09
Achtg.

H302
H319
H315
H317
H411

616-192-00-X

2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide

448-060-0

727678-39-9

Aquatic Chronic 4

H413

616-193-00-5

N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H- isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide

449-940-7

368450-39-9

Aquatic Chronic 4

H413

616-194-00-0

2,2-diethoxy-N,N-dimethylacetamide

449-950-1

34640-92-1

Eye Irrit. 2

H319

GHS07
Achtg.

H319

616-196-00-1

disodium salt of 1-hydroxy-4-(ß-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy) ethoxy)-N-dodecyl-2-naphthamide

419-990-4

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

616-197-00-7

reaction mass of: potassiumN-[3-(dimethyloxidoamino) propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;
N-[3-(dimethyloxidoamino) propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide

422-500-1

STOT RE 2 *

H373**

GHS08
Achtg.

H373**

616-198-00-2

1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene

423-300-7

Skin Sens. 1
Aquatic Chronic 4

H317
H413

GHS07
Achtg.

H317
H413

616-200-00-1

reaction mass of N,N'- ethane-1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N,N'-ethane-1,2- diylbis(12-hydroxyoctadecan amide)

432-430-3

Aquatic Chronic 4

H413

616-201-00-7

12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine

432-840-2

220926-97-6

Acute Tox. 4 *
Aquatic Chronic 4

H332
H413

GHS07
Achtg.

H332
H413

616-202-00-2

reaction mass of: 2,2'-[(3,3'- dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;
2-[[3,3'- dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3- oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl] azo]-N-(2-carboxylphenyl)-3-oxo-butanamide

434-330-5

Carc. 2
Skin Sens. 1
Aquatic Chronic 4

H351
H317
H413

GHS08
GHS07
Achtg.

H351
H317
H413

616-203-00-8

reaction mass of:N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl] acetamide;
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl] acetamide

442-280-0

Aquatic Chronic 4

H413

616-204-00-3

N,N''-(methylenedi-4,1-phenylene) bis[N'-octylurea]

451-060-3

122886-55-9

Aquatic Chronic 4

H413

616-205-00-9

Metazachlor (ISO);
2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide

266-583-0

67129-08-2

Skin Sens. 1B
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1

H317
H351
H400
H410

GHS07
GHS08
GHS09
Achtg.

H317
H351
H410

M = 100
M = 100

616-206-00-4

flufenoxuron (ISO);
1-(4-(2- cloro-a,a,a-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea

417-680-3

101463-69-8

Lact.

H362

GHS09

H362

M = 10000
M = 10000

Aquatic Acute 1

H400

Achtg.

Aquatic Chronic 1

H410

616-207-00-X

Polyhexamethylen-biguanid-hydrochlorid;
PHMB

32289-58-0
27083-27-8

Carc. 2
Acute Tox. 2
Acute Tox. 4
STOT RE 1
Eye Dam. 1
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1

H351
H330
H302
H372 (Atemwege) (Einatmen)
H318
H317
H400
H410

GHS08
GHS06
GHS05
GHS09
Gef.

H351
H330
H302
H372 (Atemwege) (Einatmen)
H318
H317
H410

M = 10
M = 10

616-208-00-5

N-ethyl-2-pyrrolidone;
1- ethylpyrrolidin-2-one

220-250-6

2687-91-4

Repr. 1B

H360D

GHS08
Gef.

H360D

616-209-00-0

amidosulfuron (ISO);
3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0

120923-37-7

Aquatic Acute 1

H400

GHS09

H410

M = 100
M = 100

Aquatic Chronic 1

H410

Achtg.

616-210-00-6

tebufenpyrad (ISO);
N-(4-tertbutylbenzyl)-
4-chloro-3-ethyl-1- methyl-1Hpyrazole-5-
carboxamide

119168-77-3

Acute Tox. 3

H301

GHS06

H301

M = 10
M = 10

Acute Tox. 4

H332

GHS08

H332

STOT RE 2

H373 (Magen-Darm-Trakt) (oral)

GHS09

H373 (Magen-Darm-Trakt) (oral)

Skin Sens. 1B

H317

Gef.

H317

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

616-211-00-1

proquinazid (ISO);
6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4

Carc. 2

H351

GHS08

H351

M = 1

Aquatic Acute 1

H400

GHS09

M = 10

Aquatic Chronic 1

H410

Achtg.

H410

616-212-00-7

3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate

259-627-5

55406-53-6

Acute Tox. 3
Acute Tox. 4
STOT RE 1
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H331
H302
H372 (Kehlkopf)
H318
H317
H400
H410

GHS06
GHS08
GHS05
GHS09
Gef.

H331
H302
H372 (Kehlkopf)
H318
H317
H410

M = 10
M = 1

616-213-00-2

Mandipropamid (ISO); 2-(4-Chlorphenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1- yloxy)acetamid

374726-62-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M = 1
M = 1

616-214-00-8

Metosulam (ISO); N-(2,6-Dichlor-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2- sulfonamid

139528-85-1

Carc. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H351
H373 (Augen, Nieren)
H400
H410

GHS08
GHS09
Achtg.

H351
H373 (Augen, Nieren)
H410

M = 1 000
M = 100

616-215-00-3

Dimethenamid-P (ISO); 2-Chlor-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamid

163515-14-8

Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H317
H400
H410

GHS07
GHS09
Achtg.

H302
H317
H410

M = 10
M = 10

616-216-00-9

Flonicamid (ISO);N-(Cyanomethyl)-4-(trifluormethyl)pyridin-3-carboxamid

158062-67-0

Acute Tox. 4

H302

GHS07
Achtg.

H302

616-217-00-4

Sulfoxaflor (ISO); [Methyl(oxo){1-[6-(trifluormethyl)-3-pyridyl]ethyl}-?6-sulfanyliden]cyanamid

946578-00-3

Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

M = 1
M = 1

616-218-00-X

Benzovindiflupyr (ISO);N-[9-(Dichlormethylen)-1,2,3,4-tetrahydro-1,4-methanonaphthalin-5-yl]-3-(difluormethyl)-1-methyl-1H-pyrazol-4-carbonsäureamid

1072957-71-1

Acute Tox. 3
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1

H331
H301
H400
H410

GHS06
GHS09
Gef.

H331
H301
H410

M = 100
M = 100

616-219-00-5

Fluopyram (ISO);N-{2-[3-Chlor-5-(trifluormethyl)pyridin-2-yl]ethyl}-2-(trifluormethyl)benzamid

658066-35-4

Aquatic Chronic 2

H411

GHS09

H411

616-220-00-0

Pencycuron (ISO); 1-[(4-Chlorphenyl)methyl]-1-cyclopentyl-3-phenylharnstoff

266-096-3

66063-05-6

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M = 1
M = 1

616-221-00-6

Hexaflumuron (ISO);
1-(3,5-Dichlor-4-(1,1,2,2-tetrafluorethoxy)phenyl)-3-(2,6-difluorbenzoyl) harnstoff

401-400-1

86479-06-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09 Achtg.

H410

M = 1 000
M = 10 000

616-222-00-1

Penthiopyrad (ISO);
(RS)-N-[2-(1,3-Dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluormethyl)pyrazol-4-carboxamid

183675-82-3

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

M = 1
M = 1

616-223-00-7

Carbetamid (ISO);
(R)-1-(Ethylcarbamoyl) ethylcarbanilat; (2R)-1-(ethylamino)-1-oxopropan-2-ylphenylcarbamat

240-286-6

16118-49-3

Carc. 2
Repr. 1B
Acute Tox. 4
Aquatic Chronic 2

H351
H360D
H302
H411

GHS08
GHS07
GHS09
Gef.

H351
H360D
H302
H411

617-001-00-2

di-tert-butyl peroxide

203-733-6

110-05-4

Org. Perox. E
Flam. Liq. 2
Muta. 2

H242
H225
H341

GHS02
GHS08
Gef.

H242
H225
H341

617-002-00-8

a,a-dimethylbenzyl hydroperoxide;
cumene hydroperoxide

201-254-7

80-15-9

Org. Perox. E
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Aquatic Chronic 2

H242
H331
H312
H302
H373 (*)(*)
H314
H411

GHS02
GHS06
GHS08
GHS05
GHS09
Gef.

H242
H331
H312
H302
H373 (*)(*)
H314
H411

Skin Corr. 1B; H314: C> 10 %
Skin Irrit. 2; H315: 3 % ≤ C < 10 %
Eye Dam. 1; H318: 3 % ≤ C < 10 %
Eye Irrit. 2; H319: 1 % ≤ C < 3 %
STOT SE 3; H335: C < 10 %

617-003-00-3

dilauroyl peroxide

203-326-3

105-74-8

Org. Perox. D

H242

GHS02
Gef.

H242

617-004-00-9

1,2,3,4-tetrahydro-1-naphthyl hydroperoxide

212-230-0

771-29-9

Org. Perox. D
Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1

H242
H302
H314
H400
H410

GHS02
GHS05
GHS07
GHS09
Gef.

H242
H302
H314
H410

STOT SE 3; H335: C> 5 %

617-006-00-X

bis(a,a-dimethylbenzyl) peroxide

201-279-3

80-43-3

Org. Perox. F
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2

H242
H319
H315
H411

GHS02
GHS07
GHS09
Achtg.

H242
H319
H315
H411

617-007-00-5

tert-butyl a,a-dimethylbenzyl peroxide

222-389-8

3457-61-2

Org. Perox. E Skin Irrit. 2
Aquatic Chronic 2

H242
H315
H411

GHS02
GHS07
GHS09
Achtg.

H242
H315
H411

617-008-00-0

dibenzoyl peroxide;
benzoyl peroxide

202-327-6

94-36-0

Org. Perox. B
Eye Irrit. 2
Skin Sens. 1

H241
H319
H317

GHS01
GHS02
GHS07
Gef.

H241
H319
H317

617-010-00-1

1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1’-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4]

201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4]

78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4]

Org. Perox. a
Skin Corr. 1B
Acute Tox. 4 *

H240
H314
H302

GHS01
GHS05
GHS07
Gef.

H240
H314
H302

STOT SE 3; H335: C> 5 %

617-010-01-9

1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]
1,1'-dioxybiscyclohexan-1-ol; [2]
cyclohexylidene hydroperoxide; [3]
cyclohexanone, peroxide [4]
[≤ 91 % solution]

201-091-1 [1]
219-306-2 [2]
220-279-4 [3]
235-527-7 [4]

78-18-2 [1]
2407-94-5 [2]
2699-11-8 [3]
12262-58-7 [4]

Org. Perox. C
Acute Tox. 4 (*)
Skin Corr. 1B

H242
H302
H314

GHS02
GHS05
GHS07
Gef.

H242
H302
H314

STOT SE 3; H335: C> 5 %

C T

617-012-00-2

8-p-menthyl hydroperoxide;
p-menthane hydroperoxide

201-281-4

80-47-7

Org. Perox. D
Skin Corr. 1B
Acute Tox. 4 (*)

H242
H314
H332

GHS02
GHS05
GHS07
Gef.

H242
H314
H332

STOT SE 3; H335: C> 5 %

617-013-00-8

O,O -tert-butylO-docosyl monoperoxyoxalate

404-300-6

116753-76-5

Org. Perox. C (*)(*)(*)(*)
Aquatic Acute 1
Aquatic Chronic 1

H242
H400
H410

GHS02
GHS09
Gef.

H242
H410

617-014-00-3

6-(nonylamino)-6-oxo-peroxyhexanoic acid

406-680-9

104788-63-8

Org. Perox. C (*)(*)(*)(*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1

H242
H318
H317
H400

GHS02
GHS05
GHS07
GHS09
Gef.

H242
H318
H317
H400

617-015-00-9

bis(4-methylbenzoyl)peroxide

407-950-9

895-85-2

Org. Perox. B (*)(*)(*)(*)
Aquatic Acute 1
Aquatic Chronic 1

H241
H400
H410

GHS01
GHS02
GHS09
Gef.

H241
H410

617-016-00-4

3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate

413-910-1

Org. Perox. C (*)(*)(*)(*)
Flam. Liq. 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H242
H226
H315
H400
H410

GHS02
GHS07
GHS09
Gef.

H242
H226
H315
H410

617-017-00-X

reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;
2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene

412-140-3

32144-25-5

Org. Perox. D
Aquatic Chronic 4

H242
H413

GHS02
Gef.

H242
H413

617-018-00-5

reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;
1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight

410-840-3

71566-50-2

Org. Perox. C (*)(*)(*)(*)
Aquatic Chronic 2

H242
H411

GHS02
GHS09
Gef.

H242
H411

617-019-00-0

6-(phthalimido)peroxyhexanoic acid

410-850-8

128275-31-0

Org. Perox. D
Eye Dam. 1
Aquatic Acute 1

H242
H318
H400

GHS02
GHS05
GHS09
DgGef.

H242
H318
H400

617-020-00-6

1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)

420-060-5

117663-11-3

Flam. Liq. 3
Org. Perox. D (*)(*)(*)(*)
Aquatic Chronic 2

H226
H242
H411

GHS02
GHS09
Gef.

H226
H242
H411

617-021-00-1

methylethylketone peroxide trimer

429-320-2

Org. Perox. B****
Asp. Tox. 1
Skin Irrit. 2
Skin Sens. 1

H241
H304
H315
H317

GHS01
GHS02
GHS08
GHS07
Gef.

H241
H304
H315
H317

617-022-00-7

reaction mass of: 1,2-dimethylpropylidene dihydroperoxide;
dimethyl 1,2-benzenedicarboxylate

442-480-8

Org. Perox. C
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2

H242
H302
H314
H317
H411

GHS02
GHS05
GHS07
GHS09
Gef.

H242
H302
H314
H317
H411

617-023-00-2

tert-Butylhydroperoxid

200-915-7

75-91-2

Muta. 2

H341

GHS08
Achtg.

H341

647-001-00-8

glucosidase, ß-

232-589-7

9001-22-3

Resp. Sens. 1

H334

GHS08
Gef.

H334

647-002-00-3

cellulase

232-734-4

9012-54-8

Resp. Sens. 1

H334

GHS08
Gef.

H334

647-003-00-9

cellobiohydrolase, exo-

253-465-9

37329-65-0

Resp. Sens. 1

H334

GHS08
Gef.

H334

647-004-00-4

cellulases with the exception of those specified elsewhere in this Annex

Resp. Sens. 1

H334

GHS08
Gef.

H334

647-005-00-X

bromelain, juice

232-572-4

9001-00-7

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

647-006-00-5

ficin

232-599-1

9001-33-6

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

647-007-00-0

papain

232-627-2

9001-73-4

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

647-008-00-6

pepsin A

232-629-3

9001-75-6

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

647-009-00-1

rennin

232-645-0

9001-98-3

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

647-010-00-7

trypsin

232-650-8

9002-07-7

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

647-011-00-2

chymotrypsin

232-671-2

9004-07-3

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

647-012-00-8

subtilisin

232-752-2

9014-01-1

STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1

H335
H315
H318
H334

GHS08
GHS05 GHS07
Gef.

H335
H315
H318
H334

647-013-00-3

proteinase, microbial neutral

232-966-6

9068-59-1

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

647-014-00-9

proteases with the exception of those specified elsewhere in this Annex

Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1

H319
H335
H315
H334

GHS08
GHS07
Gef.

H319
H335
H315
H334

647-015-00-4

amylase, a-

232-565-6

9000-90-2

Resp. Sens. 1

H334

GHS08
Gef.

H334

647-016-00-X

amylases with the exception of those specified elsewhere in this Annex

Resp. Sens. 1

H334

GHS08
Gef.

H334

647-017-00-5

laccase

420-150-4

80498-15-3

Resp. Sens. 1

H334

GHS08
Gef.

H334

648-001-00-0

Distillates (coal tar), benzole fraction;
Light Oil;
[a complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C₄to C₁₀ and distilling in the approximate range of 80^oC to 160^oC (175^oF to 320^oF).]

283-482-7

84650-02-2

Carc. 1B

H350

GHS08
Gef.

H350

648-002-00-6

Tar oils, brown-coal;
Light Oil;
[The distillate from lignite tar boiling in the range of approximately 80 °C to 250 °C (176 °F to 482 °F). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]

302-674-4

94114-40-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-003-00-1

Benzol forerunnings (coal);
Light Oil Redistillate, low boiling;
[The distillate from coke oven light oil having an approximate distillation range below 100 °C (212 °F). Composed primarily of C₄ to C₆ aliphatic hydrocarbons.]

266-023-5

65996-88-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-004-00-7

Distillates (coal tar), benzole fraction, BTX-rich;
Light Oil Redistillate, low boiling;
[a residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 °C to 200 °C (167 °F to 392 °F).]

309-984-9

101896-26-8

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-005-00-2

Aromatic hydrocarbons, C_6-10, C₈-rich;
Light Oil Redistillate, low boiling

292-697-5

90989-41-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-006-00-8

Solvent naphtha (coal), light;
Light Oil Redistillate, low boiling

287-498-5

85536-17-0

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-007-00-3

Solvent naphtha (coal), xylene-styrene cut;
Light Oil Redistillate, intermediate boiling

287-502-5

85536-20-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-008-00-9

Solvent naphtha (coal), coumarone-styrene contg.;
Light Oil Redistillate, intermediate boiling

287-500-4

85536-19-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-009-00-4

Naphtha (coal), distn. residues;
Light Oil Redistillate, high boiling;
[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]

292-636-2

90641-12-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-010-00-X

Aromatic hydrocarbons, C₈;
Light Oil Redistillate, high boiling

292-694-9

90989-38-1

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-012-00-0

Aromatic hydrocarbons, C_8-9, hydrocarbon resin polymn. by-product;
Light Oil Redistillate, high boiling;
[a complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₈ through C₉ and boiling in the range of approximately 120 °C to 215 °C (248 °F to 419 °F).]

295-281-1

91995-20-9

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-013-00-6

Aromatic hydrocarbons, C_9-12, benzene distn.;
Light Oil Redistillate, high boiling

295-551-9

92062-36-7

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-014-00-1

Extract residues (coal), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 °C to 160 °C (194 °F to 320 °F). It consists predominantly of benzene, toluene and xylenes.]

295-323-9

91995-61-8

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-015-00-7

Extract residues (coal tar), benzole fraction alk., acid ext.;
Light Oil Extract Residues, low boiling;
[a complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 °C to 195 °C (185 °F to 383 °F).]

309-868-8

101316-63-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-016-00-2

Extract residues (coal), benzole fraction acid;
Light Oil Extract Residues, low boiling;
[An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]

298-725-2

93821-38-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-017-00-8

Extract residues (coal), light oil alk., distn. overheads;
Light Oil Extract Residues, low boiling;
[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145 °C (293 °F). Composed primarily of C₇ and C₈aliphatic and aromatic hydrocarbons.]

292-625-2

90641-02-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-018-00-3

Extract residues (coal), light oil alk., acid ext., indene fraction;
Light Oil Extract Residues, intermediate boiling

309-867-2

101316-62-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-019-00-9

Extract residues (coal), light oil alk., indene naphtha fraction;
Light Oil Extract Residues, high boiling;
[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 °C to 180 °C (311 °F to 356 °F). Composed primarily of indene, indan and trimethylbenzenes.]

292-626-8

90641-03-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-020-00-4

Solvent naphtha (coal);
Light Oil Extract Residues, high boiling;
[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 °C to 210 °C (266 °F to 410 °F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]

266-013-0

65996-79-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-021-00-X

Distillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling;
[a distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F). May also include unsaturated hydrocarbons such as indene and coumarone.]

309-971-8

101794-90-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-022-00-5

Distillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling;
[This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, ando-,m- andp-cresol and boiling in the range of 140 °C to 215 °C (284 °F to 419 °F).]

292-609-5

90640-87-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-023-00-0

Distillates (coal tar), light oils; Carbolic Oil;
[a complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 °C to 210 °C (302 °F to 410 °F).]

283-483-2

84650-03-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-024-00-6

Tar oils, coal;
Carbolic Oil;
[The distillate from high temperature coal tar having an approximate distillation range of 130 °C to 250 °C (266 °F to 410 °F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]

266-016-7

65996-82-9

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-026-00-7

Extract residues (coal), light oil alk., acid ext.;
Carbolic Oil Extract Residue;
[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]

292-624-7

90641-01-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-027-00-2

Extract residues (coal), tar oil alk.;
Carbolic Oil Extract Residue;
[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]

266-021-4

65996-87-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-028-00-8

Extract oils (coal), light oil;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]

292-622-6

90640-99-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-029-00-3

Pyridine, alkyl derivs.;
Crude Tar bases;
[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 °C (302 °F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]

269-929-9

68391-11-7

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-030-00-9

Tar bases, coal, picoline fraction;
Distillate bases;
[Pyridine bases boiling in the range of approximately 125 °C to 160 °C (257 °F 320 °F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]

295-548-2

92062-33-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-031-00-4

Tar bases, coal, lutidine fraction;
Distillate bases

293-766-2

91082-52-9

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-032-00-X

Extract oils (coal), tar base, collidine fraction;
Distillate bases;
[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]

273-077-3

68937-63-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-033-00-5

Tar bases, coal, collidine fraction;
Distillate bases;
[The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]

295-543-5

92062-28-7

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-034-00-0

Tar bases, coal, aniline fraction;
Distillate bases;
[The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]

295-541-4

92062-27-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-035-00-6

Tar bases, coal, toluidine fraction;
Distillate bases

293-767-8

91082-53-0

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-036-00-1

Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;
Redistillates;
[a complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 °C to 190 °C (320 °F to 374 °F).]

295-292-1

91995-31-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-037-00-7

Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 °C to 270 °C (374 °F to 518 °F). Composed primarily of substituted dinuclear aromatics.]

295-295-8

91995-35-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-038-00-2

Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;
Redistillates;
[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 °C to 230 °C (428 °F to 446 °F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]

295-329-1

91995-66-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-039-00-8

Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;
Redistillates;
[a neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225 °C to 255 °C (437 °F to 491 °F). Composed primarily of substituted dinuclear aromatic hydrocarbons.]

310-170-0

122070-79-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-040-00-3

Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;
Redistillates;
[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 °C to 260 °C (464 °F to 500 °F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]

310-171-6

122070-80-8

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-041-00-9

Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;
Wash Oil Redistillate;
[a complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260^oC to 290^oC (500^oF to 554^oF).]

309-851-5

101316-45-4

Carc. 1B

H350

GHS08
Gef.

H350

648-042-00-4

Distillates (coal tar), upper, fluorene-rich;
Wash Oil Redistillate;
[a complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]

284-900-0

84989-11-7

Carc. 1B

H350

GHS08
Gef.

H350

648-043-00-X

Creosote oil, acenaphthene fraction, acenaphthene-free;
Wash Oil Redistillate;
[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]

292-606-9

90640-85-0

Carc. 1B

H350

GHS08
Gef.

H350

648-044-00-5

Distillates (coal tar), heavy oils;
Heavy Anthracene Oil;
[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240^oC to 400^oC (464^oF to 752^oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]

292-607-4

90640-86-1

Carc. 1B

H350

GHS08
Gef.

H350

648-045-00-0

Distillates (coal tar), upper;
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 220^oC to 450^oC (428^oF to 842^oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]

266-026-1

65996-91-0

Carc. 1B

H350

GHS08
Gef.

H350

648-046-00-6

Anthracene oil, acid ext.;
Anthracene Oil Extract Residue;
[a complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325^oC to 365^oC (617^oF to 689^oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]

295-274-3

91995-14-1

Carc. 1B

H350

GHS08
Gef.

H350

648-047-00-1

Distillates (coal tar);
Heavy Anthracene Oil;
[The distillate from coal tar having an approximate distillation range of 100^oC to 450^oC (212^oF to 842^oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]

266-027-7

65996-92-1

Carc. 1B

H350

GHS08
Gef.

H350

648-048-00-7

Distillates (coal tar), pitch, heavy oils;
Heavy Anthracene Oil;
[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300^oC to 470^oC (572^oF to 878^oF). The product may also contain heteroatoms.]

295-312-9

91995-51-6

Carc. 1B

H350

GHS08
Gef.

H350

648-049-00-2

Distillates (coal tar), pitch;
Heavy Anthracene Oil;
[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200^oC to greater than 400^oC (392^oF to greater than 752^oF).]

309-855-7

101316-49-8

Carc. 1B

H350

GHS08
Gef.

H350

648-050-00-8

Distillates (coal tar), heavy oils, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350^oC to 400^oC (662^oF to 752^oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]

295-304-5

91995-42-5

Carc. 1B

H350

GHS08
Gef.

H350

648-051-00-3

Distillates (coal tar), pitch, pyrene fraction;
Heavy Anthracene Oil Redistillate;
[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380^oC to 410^oC (7160 to 770^oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]

295-313-4

91995-52-7

Carc. 1B

H350

GHS08
Gef.

H350

648-052-00-9

Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;
Coal Tar Extract;
[a complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₁₂.]

308-296-6

97926-76-6

Carc. 1B

H350

GHS08
Gef.

H350

648-053-00-4

Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;
Coal Tar Extract;
[a complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₁₂.]

308-297-1

97926-77-7

Carc. 1B

H350

GHS08
Gef.

H350

648-054-00-X

Pitch;
Pitch

263-072-4

61789-60-4

Carc. 1B

H350

GHS08
Gef.

H350

648-055-00-5

pitch, coal tar, high-temp.;
[The residue from the distillation of high temperature coal tar. a black solid with an approximate softening point from 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]

266-028-2

65996-93-2

Carc. 1A

H350

GHS08

H350

M = 1000
M = 1000

Muta. 1B

H340

GHS09

H340

Repr. 1B

H360FD

Gef.

H360FD

Aquatic Acute 1

H400

Aquatic Chronic 1

H410

648-056-00-0

Pitch, coal tar, high-temp., heat-treated;
Pitch;
[The heat treated residue from the distillation of high temperature coal tar. a black solid with an approximate softening point from 80^oC to 180^oC (176^oF to 356^oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]

310-162-7

121575-60-8

Carc. 1B

H350

GHS08
Gef.

H350

648-057-00-6

Pitch, coal tar, high-temp., secondary;
Pitch Redistillate;
[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140^oC to 170^oC (284^oF to 392^oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]

302-650-3

94114-13-3

Carc. 1B

H350

GHS08
Gef.

H350

648-058-00-1

Residues (coal tar), pitch distn.;
Pitch Redistillate;
[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400^oC to 470^oC (752^oF to 846^oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]

295-507-9

92061-94-4

Carc. 1B

H350

GHS08
Gef.

H350

648-059-00-7

Tar, coal, high-temp., distn. and storage residues;
Coal Tar Solids Residue;
[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]

295-535-1

92062-20-9

Carc. 1B

H350

GHS08
Gef.

H350

648-060-00-2

Tar, coal, storage residues;
Coal Tar Solids Residue;
[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]

293-764-1

91082-50-7

Carc. 1B

H350

GHS08
Gef.

H350

648-061-00-8

Tar, coal, high-temp., residues;
Coal Tar Solids Residue;
[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]

309-726-5

100684-51-3

Carc. 1B

H350

GHS08
Gef.

H350

648-062-00-3

Tar, coal, high-temp., high-solids;
Coal Tar Solids Residue;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700^oC (1292^oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]

273-615-7

68990-61-4

Carc. 1B

H350

GHS08
Gef.

H350

648-063-00-9

Waste solids, coal-tar pitch coking;
Coal Tar Solids Residue;
[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]

295-549-8

92062-34-5

Carc. 1B

H350

GHS08
Gef.

H350

648-064-00-4

Extract residues (coal), brown;
Coal Tar Extract;
[The residue from extraction of dried coal.]

294-285-0

91697-23-3

Carc. 1B

H350

GHS08
Gef.

H350

648-065-00-X

Paraffin waxes (coal), brown-coal-high-temp. tar;
Coal Tar Extract;
[a complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C₁₂.]

295-454-1

92045-71-1

Carc. 1B

H350

GHS08
Gef.

H350

648-066-00-5

Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;
Coal Tar Extract;
[a complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C₁₂.]

295-455-7

92045-72-2

Carc. 1B

H350

GHS08
Gef.

H350

648-067-00-0

Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;
Coal Tar Extract;
[a complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₁₂.]

308-298-7

97926-78-8

Carc. 1B

H350

GHS08
Gef.

H350

648-068-00-6

Tar, coal, low-temp., distn. residues;
Tar Oil, intermediate boiling;
[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300^oC (572^oF). Composed primarily of aromatic compounds.]

309-887-1

101316-85-2

Carc. 1B

H350

GHS08
Gef.

H350

648-069-00-1

Pitch, coal tar, low-temp;
Pitch Residue;
[a complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40^oC to 180^oC (104^oF to 356^oF). Composed primarily of a complex mixture of hydrocarbons.]

292-651-4

90669-57-1

Carc. 1B

H350

GHS08
Gef.

H350

648-070-00-7

Pitch, coal tar, low-temp., oxidized;
Pitch Residue, oxidised;
[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70^oC to 180^oC (158^oF to 356^oF). Composed primarily of a complex mixture of hydrocarbons.]

292-654-0

90669-59-3

Carc. 1B

H350

GHS08
Gef.

H350

648-071-00-2

Pitch, coal tar, low-temp., heat-treated;
Pitch Residue, oxidised;
Pitch Residue, heat-treated;
[a complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50^oC to 140^oC (122^oF to 284^oF). Composed primarily of a complex mixture of aromatic compounds.]

292-653-5

90669-58-2

Carc. 1B

H350

GHS08
Gef.

H350

648-072-00-8

Distillates (coal-petroleum), condensed-ring arom;
Distillates;
[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220^oC to 450^oC (428^oF to 842^oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]

269-159-3

68188-48-7

Carc. 1B

H350

GHS08
Gef.

H350

648-073-00-3

Aromatic hydrocarbons, C_20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;
Pyrolysis Products;
[a complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₂₈ and having a softening point of 100^oC to 220^oC (212^oF to 428^oF) according to DIN 52025.]

309-956-6

101794-74-5

Carc. 1B

H350

GHS08
Gef.

H350

648-074-00-9

Aromatic hydrocarbons, C_20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;
Pyrolysis Products;
[a complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₂₈ and having a softening point of 100^oC to 220^oC (212^oF to 428^oF) according to DIN 52025.]

309-957-1

101794-75-6

Carc. 1B

H350

GHS08
Gef.

H350

648-075-00-4

Aromatic hydrocarbons, C_20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;
Pyrolysis Products;
[a complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₂₈ and having a softening point of 100^oC to 220^oC (212^oF to 428^oF) according to DIN 52025.]

309-958-7

101794-76-7

Carc. 1B

H350

GHS08
Gef.

H350

648-076-00-X

Pitch, coal tar-petroleum;
Pitch Residues;
[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. a solid with a softening point from 40^oC to 180^oC (140^oF to 356^oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]

269-109-0

68187-57-5

Carc. 1B

H350

GHS08
Gef.

H350

648-077-00-5

Phenanthrene, distn. residues;
Heavy Anthracene Oil Redistillate;
[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340^oC to 420^oC (644^oF to 788^oF). It consists predominantly of phenanthrene, anthracene and carbazole.]

310-169-5

122070-78-4

Carc. 1B

H350

GHS08
Gef.

H350

648-078-00-0

Distillates (coal tar), upper, fluorene-free;
Wash Oil Redistillate;
[a complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]

284-899-7

84989-10-6

Carc. 1B

H350

GHS08
Gef.

H350

648-079-00-6

Anthracene oil;
Anthracene oil;
[a complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300^oC ot 400^oC (572^oF to 752^oF). Composed primarily of phenanthrene, anthracene and carbazole.]

292-602-7

90640-80-5

Carc. 1B

H350

GHS08
Gef.

H350

648-080-00-1

Residues (coal tar), creosote oil distn.;
Wash Oil Redistillate;
[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 °C to 330 °C (518 °F to 626 °F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]

295-506-3

92061-93-3

Carc. 1B

H350

GHS08
Gef.

H350

648-081-00-7

Tar, coal;
Coal tar;
[The by-product from the destructive distillation of coal. Almost black semisolid. a complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]

232-361-7

8007-45-2

Carc. 1A

H350

GHS08
Gef.

H350

648-082-00-2

Tar, coal, high-temp.;
Coal tar;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700^oC (1292^oF)) destructive distillation of coal. a black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]

266-024-0

65996-89-6

Carc. 1A

H350

GHS08
Gef.

H350

648-083-00-8

Tar, coal, low-temp.;
Coal oil;
[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700^oC (1292^oF)) destructive distillation of coal. a black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]

266-025-6

65996-90-9

Carc. 1A

H350

GHS08
Gef.

H350

648-084-00-3

Distillates (coal), coke-oven light oil, naphthalene cut;
Naphthalene Oil;
[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 °C (298 °F).]

285-076-5

85029-51-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-085-00-9

Distillates (coal tar), naphthalene oils;
Naphthalene Oil;
[a complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 °C to 250 °C (392 °F to 482 °F).]

283-484-8

84650-04-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-086-00-4

Distillates (coal tar), naphthalene oils, naphthalene-low;
Naphthalene Oil Redistillate;
[a complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]

284-898-1

84989-09-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-087-00-X

Distillates (coal tar), naphthalene oil crystn. mother liquor;
Naphthalene Oil Redistillate;
[a complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]

295-310-8

91995-49-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-088-00-5

Extract residues (coal), naphthalene oil, alk.;
Naphthalene Oil Extract Residue;
[a complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]

310-166-9

121620-47-1

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-089-00-0

Extract residues (coal), naphthalene oil, alk., naphthalene-low;
Naphthalene Oil Extract Residue;
[a complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]

310-167-4

121620-48-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-090-00-6

Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;
Naphthalene Oil Extract Residue;
[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]

292-612-1

90640-90-7

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-091-00-1

Extract residues (coal), naphthalene oil alk., distn. overheads;
Naphthalene Oil Extract Residue;
[The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 °C to 220 °C (356 °F to 428 °F). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]

292-627-3

90641-04-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-092-00-7

Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;
Methylnaphthalene Oil;
[a distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 °C to 255 °C (437 °F to 491 °F).]

309-985-4

101896-27-9

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-093-00-2

Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;
Methylnaphthalene Oil;
[a distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 °C to 255 °C (455 °F to 491 °F).]

309-972-3

101794-91-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-094-00-8

Distillates (coal tar), naphthalene oils, acid exts.;
Methylnaphthalene Oil Extract Residue;
[a complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 °C to 255 °C (446 °F to 491 °F). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]

295-309-2

91995-48-1

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-095-00-3

Extract residues (coal), naphthalene oil alk., distn. residues;
Methylnaphthalene Oil Extract Residue;
[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 °C to 300 °C (428 °F to 572 °F). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]

292-628-9

90641-05-7

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-096-00-9

Extract oils (coal), acidic, tar-base free;
Methylnaphthalene Oil Extract Residue;
[The extract oil boiling in the range of approximately 220 °C to 265 °C (428 °F to 509 °F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]

284-901-6

84989-12-8

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-097-00-4

Distillates (coal tar), benzole fraction, distn. residues;
Wash Oil;
[a complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 °C to 300 °C (302 °F to 572 °F) or a semi-solid or solid with a melting point up to 70 °C (158 °F). It is composed primarily of naphthalene and alkyl naphthalenes.]

310-165-3

121620-46-0

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-098-00-X

Creosote oil, acenaphthene fraction;
Wash Oil;
[a complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 °C to 280 °C (464 °F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]

292-605-3

90640-84-9

Carc. 1B

H350

GHS08
Gef.

H350

648-099-00-5

Creosote oil;
[a complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392 °F to 617 °F).]

263-047-8

61789-28-4

Carc. 1B

H350

GHS08
Gef.

H350

648-100-00-9

Creosote oil, high-boiling distillate;
Wash Oil;
[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41 °F).]

274-565-9

70321-79-8

Carc. 1B

H350

GHS08
Gef.

H350

648-101-00-4

Creosote;
[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]

232-287-5

8001-58-9

Carc. 1B

H350

GHS08
Gef.

H350

648-102-00-X

Extract residues (coal), creosote oil acid;
Wash Oil Extract Residue;
[a complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 °C to 280 °C (482 °F to 536 °F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]

310-189-4

122384-77-4

Carc. 1B

H350

GHS08
Gef.

H350

648-103-00-5

Anthracene oil, anthracene paste;
Anthracene Oil Fraction;
[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]

292-603-2

90640-81-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-104-00-0

Anthracene oil, anthracene-low;
Anthracene Oil Fraction;
[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]

292-604-8

90640-82-7

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-105-00-6

Residues (coal tar), anthracene oil distn.;
Anthracene Oil Fraction;
[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 °C to 400 °C (644 °F to 752 °F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]

295-505-8

92061-92-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-106-00-1

Anthracene oil, anthracene paste, anthracene fraction;
Anthracene Oil Fraction;
[a complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 °C to 350 °C (626 °F to 662 °F). It contains chiefly anthracene, carbazole and phenanthrene.]

295-275-9

91995-15-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-107-00-7

Anthracene oil, anthracene paste, carbazole fraction;
Anthracene Oil Fraction;
[a complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 °C to 360 °C (662 °F to 680 °F). It contains chiefly anthracene, carbazole and phenanthrene.]

295-276-4

91995-16-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-108-00-2

Anthracene oil, anthracene paste, distn. lights;
Anthracene Oil Fraction;
[a complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 °C to 340 °C (554 °F to 644 °F). It contains chiefly trinuclear aromatics and their dihydro derivatives.]

295-278-5

91995-17-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-109-00-8

Tar oils, coal, low-temp.;
Tar Oil, high boiling;
[a distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 °C to 340 °C (320 °F to 644 °F).]

309-889-2

101316-87-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-110-00-3

Extract residues (coal), low temp. coal atar alk.;
[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]

310-191-5

122384-78-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-111-00-9

Phenols, ammonia liquor ext.;
Alkaline Extract;
[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 °C (1 292 °F)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.]

284-881-9

84988-93-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-112-00-4

Distillates (coal tar), light oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]

292-610-0

90640-88-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-113-00-X

Extracts, coal tar oil alk.;
Alkaline Extract;
[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]

266-017-2

65996-83-0

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-114-00-5

Distillates (coal tar), naphthalene oils, alk. exts.;
Alkaline Extract;
[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]

292-611-6

90640-89-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-115-00-0

Extract residues (coal), tar oil alk., carbonated, limed;
Crude Phenols;
[The product obtained by treatment of coal tar oil alkaline extract with CO₂ and CaO. Composed primarily of CaCO₃, Ca(OH)₂, Na₂CO₃ and other organic and inorganic impurities.]

292-629-4

90641-06-8

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-116-00-6

Tar acids, coal, crude;
Crude Phenols;
[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]

266-019-3

65996-85-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-117-00-1

Tar acids, brown-coal, crude;
Crude Phenols;
[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]

309-888-7

101316-86-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-118-00-7

Tar acids, brown-coal gasification;
Crude Phenols;
[a complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C_6-10 hydroxy aromatic phenols and their homologs.]

295-536-7

92062-22-1

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-119-00-2

Tar acids, distn. residues;
Distillate Phenols;
[a residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C₈ through C₁₀ with a softening point of 60 °C to 80 °C (140 °F to 176 °F).]

306-251-5

96690-55-0

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-120-00-8

Tar acids, methylphenol fraction;
Distillate Phenols;
[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]

284-892-9

84989-04-8

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-121-00-3

Tar acids, polyalkylphenol fraction;
Distillate Phenols;
[The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 °C to 320 °C (437 °F to 608 °F). Composed primarily of polyalkylphenols.]

284-893-4

84989-05-9

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-122-00-9

Tar acids, xylenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]

284-895-5

84989-06-0

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-123-00-4

Tar acids, ethylphenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]

284-891-3

84989-03-7

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-124-00-X

Tar acids, 3,5-xylenol fraction;
Distillate Phenols;
[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]

284-896-0

84989-07-1

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-125-00-5

Tar acids, residues, distillates, first-cut;
Distillate Phenols;
[The residue from the distillation in the range of 235 °C to 355 °C (481 °F to 697 °F) of light carbolic oil.]

270-713-1

68477-23-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-126-00-0

Tar acids, cresylic, residues;
Distillate Phenols;
[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. a black solid with a melting point approximately 80 °C (176 °F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]

271-418-0

68555-24-8

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-127-00-6

Phenols, C_9-11;
Distillate Phenols

293-435-2

91079-47-9

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-128-00-1

Tar acids, cresylic;
Distillate Phenols;
[a complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). It contains chiefly phenols and pyridine bases.]

295-540-9

92062-26-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-129-00-7

Tar acids, brown-coal, C₂-alkylphenol fraction;
Distillate Phenols;
[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Composed primarily ofm- andp-ethylphenol as well as cresols and xylenols.]

302-662-9

94114-29-1

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-130-00-2

Extract oils (coal), naphthalene oils;
Acid Extract;
[The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]

292-623-1

90641-00-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-131-00-8

Tar bases, quinoline derivs.;
Distillate bases

271-020-7

68513-87-1

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-132-00-3

Tar bases, coal, quinoline derivs. fraction;
Distillate bases

274-560-1

70321-67-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-133-00-9

Tar bases, coal, distn. residues;
Distillate bases;
[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]

295-544-0

92062-29-8

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-134-00-4

Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 120 °C (158 °F to 248 °F).]

309-745-9

100801-63-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-135-00-X

Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 °C to 120 °C (158 °F to 248 °F).]

309-748-5

100801-65-8

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-136-00-5

Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;
Heat Treatment Products;
[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 210 °C (158 °F to 410 °F).]

309-749-0

100801-66-9

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-137-00-0

Extract residues (coal), tar oil alk., naphthalene distn. residues;
Naphthalene Oil Extract Residue;
[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]

277-567-8

73665-18-6

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-138-00-6

Creosote oil, low-boiling distillate;
Wash Oil;
[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 °C (100 °F).]

274-566-4

70321-80-1

Carc. 1B

H350

GHS08
Gef.

H350

648-139-00-1

Tar acids, cresylic, sodium salts, caustic solns.;
Alkaline Extract

272-361-4

68815-21-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-140-00-7

Extract oils (coal), tar base;
Acid Extract;
[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]

266-020-9

65996-86-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-141-00-2

Tar bases, coal, crude;
Crude Tar bases;
[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]

266-018-8

65996-84-1

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-142-00-8

Residues (coal), liq. solvent extn.;
[a cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]

302-681-2

94114-46-2

Carc. 1B

H350

GHS08
Gef.

H350

648-143-00-3

Coal liquids, liq. solvent extn. soln.;
[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. a black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]

302-682-8

94114-47-3

Carc. 1B

H350

GHS08
Gef.

H350

648-144-00-9

Coal liquids, liq. solvent extn.;
[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. a black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]

302-683-3

94114-48-4

Carc. 1B

H350

GHS08
Gef.

H350

648-145-00-4

Tar brown-coal;
[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150^oC to 360^oC (302^oF to 680^oF).]

309-885-0

101316-83-0

Carc. 1A

H350

GHS08
Gef.

H350

648-146-00-X

Tar, brown-coal, low-temp.;
[a tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]

309-886-6

101316-84-1

Carc. 1A

H350

GHS08
Gef.

H350

648-147-00-5

Light oil (coal), coke-oven;
Crude benzole;
[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 °C (1 292 °F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]

266-012-5

65996-78-3

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-148-00-0

Distillates (coal), liq. solvent extn., primary;
[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C₄ through C₁₄.]

302-688-0

94114-52-0

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-149-00-6

Distillates (coal), solvent extn., hydrocracked;
[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C₄ through C₁₄. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]

302-689-6

94114-53-1

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-150-00-1

Naphtha (coal), solvent extn., hydrocracked;
[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C₄ to C₉. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]

302-690-1

94114-54-2

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-151-00-7

Gasoline, coal solvent extn., hydrocracked naphtha;
[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30^oC to 180^oC (86^oF to 356^oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C₄ through C₉.]

302-691-7

94114-55-3

Carc. 1B

H350

GHS08
Gef.

H350

648-152-00-2

Distillates (coal), solvent extn., hydrocracked middle;
[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 300 °C (356 °F to 572 °F. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C₉ through C₁₄. Nitrogen, sulfur and oxygen-containing compounds are also present.]

302-692-2

94114-56-4

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-153-00-8

Distillates (coal), solvent extn., hydrocracked hydrogenated middle;
[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 280 °C (356 °F to 536 °F). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C₉ through C₁₄.]

302-693-8

94114-57-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

648-154-00-3

Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;
[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180^oC to 225^oC (356^oF to 473^oF). Composed primarily of hydrogenated two-ringhydrocarbons and theiralkyl derivatives having carbon numbers predominantly in the range of C₁₀ through C₁₂.]

302-694-3

94114-58-6

Carc. 2

H351

GHS08
Achtg.

H350

648-155-00-9

Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;
[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200^oC to 280^oC (392^oF to 536^oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C₁₁ through C₁₄.]

302-695-9

94114-59-7

Carc. 2

H351

GHS08
Achtg.

H350

648-156-00-4

Light oil (coal), semi-coking process;
Fresh oil;
[The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700 °C (1 292 °F)) destructive distillation of coal. Composed primarily of C_6-10 hydrocarbons.]

292-635-7

90641-11-5

Carc. 1B
Muta. 1B

H350
H340

GHS08
Gef.

H350
H340

649-001-00-3

Extracts (petroleum), light naphthenic distillate solvent

265-102-1

64742-03-6

Carc. 1B

H350

GHS08
Gef.

H350

649-002-00-9

Extracts (petroleum), heavy paraffinic distillate solvent

265-103-7

64742-04-7

Carc. 1B

H350

GHS08
Gef.

H350

649-003-00-4

Extracts (petroleum), light paraffinic distillate solvent

265-104-2

64742-05-8

Carc. 1B

H350

GHS08
Gef.

H350

649-004-00-X

Extracts (petroleum), heavy naphthenic distillate solvent

265-111-0

64742-11-6

Carc. 1B

H350

GHS08
Gef.

H350

649-005-00-5

Extracts (petroleum), light vacuum gas oil solvent

295-341-7

91995-78-7

Carc. 1B

H350

GHS08
Gef.

H350

649-006-00-0

hydrocarbons C_26-55, arom-rich

307-753-7

97722-04-8

Carc. 1B

H350

GHS08
Gef.

H350

649-007-00-6

fatty acids, tall-oil, reaction products with iminodiethanol and boric acid

400-160-5

Skin Irrit. 2
Aquatic Chronic 2

H315
H411

GHS07
GHS09
Achtg.

H315
H411

649-008-00-1

Residues (petroleum), atm. tower;
Heavy Fuel oil;
[a complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C₂₀ and boiling above approximately 350^oC (662^oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

265-045-2

64741-45-3

Carc. 1B

H350

GHS08
Gef.

H350

649-009-00-7

Gas oils (petroleum), heavy vacuum;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₅₀ and boiling in the range of approximately 350^oC to 600^oC (662^oF to 1112^oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]

265-058-3

64741-57-7

Carc. 1B

H350

GHS08
Gef.

H350

649-010-00-2

Distillates (petroleum), heavy catalytic cracked;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₅ and boiling in the range of approximately 260^oC to 500^oC (500^oF to 932^oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

265-063-0

64741-61-3

Carc. 1B

H350

GHS08
Gef.

H350

649-011-00-8

Clarified oils (petroleum), catalytic cracked;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C₂₀ and boiling above approximately 350^oC (662^oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

265-064-6

64741-62-4

Carc. 1B

H350

GHS08
Gef.

H350

649-012-00-3

Residues (petroleum), hydrocracked;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C₂₀ and boiling above approximately 350^oC (662^oF).]

265-076-1

64741-75-9

Carc. 1B

H350

GHS08
Gef.

H350

649-013-00-9

Residues (petroleum), thermal cracked;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C₂₀ and boiling above approximately 350^oC (662^oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

265-081-9

64741-80-6

Carc. 1B

H350

GHS08
Gef.

H350

649-014-00-4

Distillates (petroleum), heavy thermal cracked;
Heavy Fuel oil;
[a complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₁₅through C₃₆ and boiling in the range of approximately 260^oC to 480^oC (500^oF to 896^oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

265-082-4

64741-81-7

Carc. 1B

H350

GHS08
Gef.

H350

649-015-00-X

Gas oils (petroleum), hydrotreated vacuum;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₃through C₅₀ and boiling in the range of approximately 230^oC to 600^oC (446^oF to 1112^oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

265-162-9

64742-59-2

Carc. 1B

H350

GHS08
Gef.

H350

649-016-00-5

Residues (petroleum), hydrodesulfurized atmospheric tower;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C₂₀ and boiling above approximately 350^oC (662^oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

265-181-2

64742-78-5

Carc. 1B

H350

GHS08
Gef.

H350

649-017-00-0

Gas oils (petroleum), hydrodesulfurized heavy vacuum;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and boiling in the range of approximately 350^oC to 600^oC (662^oF to 1112^oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

265-189-6

64742-86-5

Carc. 1B

H350

GHS08
Gef.

H350

649-018-00-6

Residues (petroleum), steam-cracked;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C₁₄ and boiling above approximately 260^oC (500^oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

265-193-8

64742-90-1

Carc. 1B

H350

GHS08
Gef.

H350

649-019-00-1

Residues (petroleum), atmospheric;
Heavy Fuel oil;
[a complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C₁₁ and boiling above approximately 200^oC (392^oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]

269-777-3

68333-22-2

Carc. 1B

H350

GHS08
Gef.

H350

649-020-00-7

Clarified oils (petroleum), hydrodesulfurized catalytic cracked;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C₂₀ and boiling above approximately 350^oC (662^oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]

269-782-0

68333-26-6

Carc. 1B

H350

GHS08
Gef.

H350

649-021-00-2

Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₁ through C₃₀ and boiling in the range of approximately 205^oC to 450^oC (401^oF to 842^oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]

269-783-6

68333-27-7

Carc. 1B

H350

GHS08
Gef.

H350

649-022-00-8

Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₅ and boiling in the range of approximately 260^oC to 500^oC (500^oF to 932^oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

269-784-1

68333-28-8

Carc. 1B

H350

GHS08
Gef.

H350

649-023-00-3

Fuel oil, residues-straight-run gas oils, high-sulfur;
Heavy Fuel oil

270-674-0

68476-32-4

Carc. 1B

H350

GHS08
Gef.

H350

649-024-00-9

Fuel oil, residual;
Heavy Fuel oil;
[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]

270-675-6

68476-33-5

Carc. 1B

H350

GHS08
Gef.

H350

649-025-00-4

Residues (petroleum), catalytic reformer fractionator residue distn.;
Heavy Fuel oil;
[a complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399^oC (750^oF).]

270-792-2

68478-13-7

Carc. 1B

H350

GHS08
Gef.

H350

649-026-00-X

Residues (petroleum), heavy coker gas oil and vacuum gas oil;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C₁₃ and boiling above approximately 230^oC (446^oF).]

270-796-4

68478-17-1

Carc. 1B

H350

GHS08
Gef.

H350

649-027-00-5

Residues (petroleum), heavy coker and light vacuum;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C₁₃ and boiling above approximately 230^oC (446^oF).]

270-983-0

68512-61-8

Carc. 1B

H350

GHS08
Gef.

H350

649-028-00-0

Residues (petroleum), light vacuum;
Heavy Fuel oil;
[a complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C₁₃ and boiling above approximately 230^oC (446^oF).]

270-984-6

68512-62-9

Carc. 1B

H350

GHS08
Gef.

H350

649-029-00-6

Residues (petroleum), steam-cracked light;
Heavy Fuel oil;
[a complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C₇ and boiling in the range of approximately 101^oC to 555^oC (214^oF to 1030^oF).]

271-013-9

68513-69-9

Carc. 1B

H350

GHS08
Gef.

H350

649-030-00-1

Fuel oil, No 6;
Heavy Fuel oil;
[a distillate oil having a minimum viscosity of 900 SUS at 37.7^oC (100^oF) to a maximum of 9000 SUS at 37.7^oC (100^oF).]

271-384-7

68553-00-4

Carc. 1B

H350

GHS08
Gef.

H350

649-031-00-7

Residues (petroleum), topping plant, low-sulfur;
Heavy Fuel oil;
[a low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]

271-763-7

68607-30-7

Carc. 1B

H350

GHS08
Gef.

H350

649-032-00-2

Gas oils (petroleum), heavy atmospheric;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₇ through C₃₅ and boiling in the range of approximately 121^oC to 510^oC (250^oF to 950^oF).]

272-184-2

68783-08-4

Carc. 1B

H350

GHS08
Gef.

H350

649-033-00-8

Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;
Heavy Fuel oil;
[a very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C₂₀ and boiling above approximately 350^oC (662^oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]

272-187-9

68783-13-1

Carc. 1B

H350

GHS08
Gef.

H350

649-034-00-3

Distillates (petroleum), petroleum residues vacuum;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]

273-263-4

68955-27-1

Carc. 1B

H350

GHS08
Gef.

H350

649-035-00-9

Residues (petroleum), steam-cracked, resinous;
Heavy Fuel oil;
[a complex residuum from the distillation of steam-cracked petroleum residues.]

273-272-3

68955-36-2

Carc. 1B

H350

GHS08
Gef.

H350

649-036-00-4

Distillates (petroleum), intermediate vacuum;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₄through C₄₂ and boiling in the range of approximately 250^oC to 545^oC (482^oF to 1013^oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

274-683-0

70592-76-6

Carc. 1B

H350

GHS08
Gef.

H350

649-037-00-X

Distillates (petroleum), light vacuum;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₁through C₃₅ and boiling in the range of approximately 250^oC to 545^oC (482^oF to 1013^oF).]

274-684-6

70592-77-7

Carc. 1B

H350

GHS08
Gef.

H350

649-038-00-5

Distillates (petroleum), vacuum;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C₁₅ through C₅₀and boiling in the range of approximately 270^oC to 600^oC (518^oF to 1112^oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

274-685-1

70592-78-8

Carc. 1B

H350

GHS08
Gef.

H350

649-039-00-0

Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C₁₈ to C₄₄ and boiling in the range of approximately 304^oC to 548^oC (579^oF to 1018^oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

285-555-9

85117-03-9

Carc. 1B

H350

GHS08
Gef.

H350

649-040-00-6

Residues (petroleum), steam-cracked, distillates;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]

292-657-7

90669-75-3

Carc. 1B

H350

GHS08
Gef.

H350

649-041-00-1

Residues (petroleum), vacuum, light;
Heavy Fuel oil;
[a complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C₂₄ and boiling above approximately 390^oC (734^oF).]

292-658-2

90669-76-4

Carc. 1B

H350

GHS08
Gef.

H350

649-042-00-7

Fuel oil, heavy, high-sulfur;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C₂₅ and boiling above approximately 400^oC (752^oF).]

295-396-7

92045-14-2

Carc. 1B

H350

GHS08
Gef.

H350

649-043-00-2

Residues (petroleum), catalytic cracking;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C₁₁ and boiling above approximately 200^oC (392^oF).]

295-511-0

92061-97-7

Carc. 1B

H350

GHS08
Gef.

H350

649-044-00-8

Distillates (petroleum), intermediate catalytic cracked, thermally degraded;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220^oC to 450^oC (428^oF to 842^oF). This stream is likely to contain organic sulfur compounds.]

295-990-6

92201-59-7

Carc. 1B

H350

GHS08
Gef.

H350

649-045-00-3

Residual oils (petroleum);
Heavy Fuel oil;
[a complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100^oC.]

298-754-0

93821-66-0

Carc. 1B

H350

GHS08
Gef.

H350

649-046-00-9

Residues, steam cracked, thermally treated;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180^oC (356^oF).]

308-733-0

98219-64-8

Carc. 1B

H350

GHS08
Gef.

H350

649-047-00-4

Distillates (petroleum), hydrodesulfurized full-range middle;
Heavy Fuel oil;
[a complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₂₅ and boiling in the range of approximately 150^oC to 400^oC (302^oF to 752^oF).]

309-863-0

101316-57-8

Carc. 1B

H350

GHS08
Gef.

H350

649-048-00-X

Residues (petroleum), catalytic reformer fractionator;
Heavy Fuel oil;
[a complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₀ through C₂₅ and boiling in the range of approximately 160^oC to 400^oC (320^oF to 725^oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]

265-069-3

64741-67-9

Carc. 1B

H350

GHS08
Gef.

H350

649-049-00-5

Petroleum;
Crude oil;
[a complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]

232-298-5

8002-05-9

Carc. 1B

H350

GHS08
Gef.

H350

649-050-00-0

Distillates (petroleum), light paraffinic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]

265-051-5

64741-50-0

Carc. 1A

H350

GHS08
Gef.

H350

649-051-00-6

Distillates (petroleum), heavy paraffinic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]

265-052-0

64741-51-1

Carc. 1A

H350

GHS08
Gef.

H350

649-052-00-1

Distillates (petroleum), light naphthenic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-053-6

64741-52-2

Carc. 1A

H350

GHS08
Gef.

H350

649-053-00-7

Distillates (petroleum), heavy naphthenic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-054-1

64741-53-3

Carc. 1A

H350

GHS08
Gef.

H350

649-054-00-2

Distillates (petroleum), acid-treated heavy naphthenic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-117-3

64742-18-3

Carc. 1A

H350

GHS08
Gef.

H350

649-055-00-8

Distillates (petroleum), acid-treated light naphthenic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-118-9

64742-19-4

Carc. 1A

H350

GHS08
Gef.

H350

649-056-00-3

Distillates (petroleum), acid-treated heavy paraffinic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil having a viscosity of a least 100 SUS at 100^oF (19cSt at 40^oC).]

265-119-4

64742-20-7

Carc. 1A

H350

GHS08
Gef.

H350

649-057-00-9

Distillates (petroleum), acid-treated light paraffinic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil having a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC).]

265-121-5

64742-21-8

Carc. 1A

H350

GHS08
Gef.

H350

649-058-00-4

Distillates (petroleum), chemically neutralized heavy paraffinic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains a relatively large proportion of aliphatic hydrocarbons.]

265-127-8

64742-27-4

Carc. 1A

H350

GHS08
Gef.

H350

649-059-00-X

Distillates (petroleum), chemically neutralized light paraffinic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil with a viscosity less than 100 SUS at 100^oF (19cSt at 40^oC).]

265-128-3

64742-28-5

Carc. 1A

H350

GHS08
Gef.

H350

649-060-00-5

Distillates (petroleum), chemically neutralized heavy naphthenic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-135-1

64742-34-3

Carc. 1A

H350

GHS08
Gef.

H350

649-061-00-0

Distillates (petroleum), chemically neutralized light naphthenic;
Unrefined or mildly refined baseoil;
[a complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS a 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-136-7

64742-35-4

Carc. 1A

H350

GHS08
Gef.

H350

649-062-00-6

Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C₃-rich acid-free;
Petroleum gas;
[a complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C₂ through C₄, predominantly C₃.]

270-755-0

68477-73-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-063-00-1

Gases (petroleum), catalytic cracker;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

270-756-6

68477-74-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-064-00-7

Gases (petroleum), catalytic cracker, C_1-5-rich;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C₁ through C₆, predominantly C₁ through C₅.]

270-757-1

68477-75-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-065-00-2

Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C_2-4-rich;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C₂ through C₆, predominantly C₂ through C₄.]

270-758-7

68477-76-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-066-00-8

Gases (petroleum), catalytic reformer, C_1-4-rich;
Petroleum gas;
[a complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C₁ through C₆, predominantly C₁ through C₄.]

270-760-8

68477-79-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-067-00-3

Gases (petroleum), C_3-5 olefinic-paraffinic alkylation feed;
Petroleum gas;
[a complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C₃ through C₅ which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]

270-765-5

68477-83-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-068-00-9

Gases (petroleum), C₄-rich;
Petroleum gas;
[a complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C₃ through C₅, predominantly C₄.]

270-767-6

68477-85-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-069-00-4

Gases (petroleum), deethanizer overheads;
Petroleum gas;
[a complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]

270-768-1

68477-86-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-070-00-X

Gases (petroleum), deisobutanizer tower overheads;
Petroleum gas;
[a complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₃ through C₄.]

270-769-7

68477-87-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-071-00-5

Gases (petroleum), depropanizer dry, propene-rich;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]

270-772-3

68477-90-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-072-00-0

Gases (petroleum), depropanizer overheads;
Petroleum gas;
[a complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₂ through C₄.]

270-773-9

68477-91-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-073-00-6

Gases (petroleum), gas recovery plant depropanizer overheads;
Petroleum gas;
[a complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C₁ through C₄, predominantly propane.]

270-777-0

68477-94-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-074-00-1

Gases (petroleum), Girbotol unit feed;
Petroleum gas;
[a complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₂ through C₄.]

270-778-6

68477-95-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-075-00-7

Gases (petroleum), isomerized naphtha fractionator, C₄-rich, hydrogen sulfide-free;
Petroleum gas

270-782-8

68477-99-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-076-00-2

Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;
Petroleum gas;
[a complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

270-802-5

68478-21-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-077-00-8

Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

270-803-0

68478-22-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-078-00-3

Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C₁through C₅.]

270-804-6

68478-24-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-079-00-9

Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₄.]

270-806-7

68478-26-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-080-00-4

Tail gas (petroleum), saturate gas plant mixed stream, C₄-rich;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C₃ through C₆, predominantly butane and isobutane.]

270-813-5

68478-32-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-081-00-X

Tail gas (petroleum), saturate gas recovery plant, C_1-2-rich;
Petroleum gas;
[a complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C₁through C₅, predominantly methane and ethane.]

270-814-0

68478-33-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-082-00-5

Tail gas (petroleum), vacuum residues thermal cracker;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

270-815-6

68478-34-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-083-00-0

Hydrocarbons, C_3-4-rich, petroleum distillate;
Petroleum gas;
[a complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C₃ through C₅, predominantly C₃ through C₄.]

270-990-9

68512-91-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-084-00-6

Gases (petroleum), full-range straight-run naphtha dehexanizer off;
petroleum gas;
[a complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂ through C₆.]

271-000-8

68513-15-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-085-00-1

Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;
Petroleum gas;
[a complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₄. It may also contain small amounts of hydrogen and hydrogen sulfide.]

271-001-3

68513-16-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-086-00-7

Gases (petroleum), light straight-run naphtha stabilizer off;
Petroleum gas;
[a complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₂ through C₆.]

271-002-9

68513-17-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-087-00-2

Residues (petroleum), alkylation splitter, C₄-rich;
Petroleum gas;
[a complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C₄ through C₅, predominantly butane and boiling in the range of approximately - 11.7 °C to 27.8 °C (11 °F to 82 °F).]

271-010-2

68513-66-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-088-00-8

Hydrocarbons, C_1-4;
Petroleum gas;
[a complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄ and boiling in the range of approximately minus 164 °C to minus 0.5 °C (- 263 °F to 31 °F).]

271-032-2

68514-31-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-089-00-3

Hydrocarbons, C_1-4, sweetened;
Petroleum gas;
[a complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄ and boiling in the range of approximately - 164 °C to - 0.5 °C (- 263 °F to 31 °F).]

271-038-5

68514-36-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-090-00-9

Hydrocarbons, C_1-3;
Petroleum gas;
[a complex combination of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₃ and boiling in the range of approximately minus 164 °C to minus 42 °C (- 263 °F to - 44 °F).]

271-259-7

68527-16-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-091-00-4

Hydrocarbons, C_1-4, debutanizer fraction;
Petroleum gas

271-261-8

68527-19-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-092-00-X

Gases (petroleum), C_1-5, wet;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

271-624-0

68602-83-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-093-00-5

Hydrocarbons, C_2-4;
Petroleum gas

271-734-9

68606-25-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-094-00-0

Hydrocarbons, C₃;
Petroleum gas

271-735-4

68606-26-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-095-00-6

Gases (petroleum), alkylation feed;
Petroleum gas;
[a complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₃ through C₄.]

271-737-5

68606-27-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-096-00-1

Gases (petroleum), depropanizer bottoms fractionation off;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]

271-742-2

68606-34-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-097-00-7

Gases (petroleum), refinery blend;
Petroleum gas;
[a complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

272-183-7

68783-07-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-098-00-2

Gases (petroleum), catalytic cracking;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₃through C₅.]

272-203-4

68783-64-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-099-00-8

Gases (petroleum), C_2-4, sweetened;
Petroleum gas;
[a complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C₂through C₄ and boiling in the range of approximately - 51 °C to - 34 °C (- 60 °F to - 30 °F).]

272-205-5

68783-65-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-100-00-1

Gases (petroleum), crude oil fractionation off;
Petroleum gas;
[a complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

272-871-7

68918-99-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-101-00-7

Gases (petroleum), dehexanizer off;
Petroleum gas;
[a complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

272-872-2

68919-00-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-102-00-2

Gases (petroleum), light straight run gasoline fractionation stabilizer off;
Petroleum gas;
[a complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

272-878-5

68919-05-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-103-00-8

Gases (petroleum), naphtha unifiner desulfurization stripper off;
Petroleum gas;
[a complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄.]

272-879-0

68919-06-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-104-00-3

Gases (petroleum), straight-run naphtha catalytic reforming off;
Petroleum gas;
[a complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]

272-882-7

68919-09-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-105-00-9

Gases (petroleum), fluidized catalytic cracker splitter overheads;
Petroleum gas;
[a complex combination of hydrocarbons produced by the fractionation of the charge to the C₃-C₄ splitter. It consists predominantly of C₃ hydrocarbons.]

272-893-7

68919-20-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-106-00-4

Gases (petroleum), straight-run stabilizer off;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄.]

272-883-2

68919-10-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-107-00-X

Gases (petroleum), catalytic cracked naphtha debutanizer;
Petroleum gas;
[a complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄.]

273-169-3

68952-76-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-108-00-5

Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;
Petroleum gas;
[a complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₄.]

273-170-9

68952-77-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-109-00-0

Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;
petroleum gas;
[a complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₆.]

273-175-6

68952-81-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-110-00-6

Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

273-176-1

68952-82-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-111-00-1

Gases (petroleum, light steam-cracked, butadiene conc.;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C₄.]

273-265-5

68955-28-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-112-00-7

Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;
Petroleum gas;
[a complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₂ through C₄.]

273-270-2

68955-34-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-113-00-2

Hydrocarbons, C₄;
Petroleum gas

289-339-5

87741-01-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-114-00-8

Alkanes, C_1-4, C₃-rich;
Petroleum gas

292-456-4

90622-55-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-115-00-3

Gases (petroleum), steam-cracker C₃-rich;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 °C to 0 °C (- 94 °F to 32 °F).]

295-404-9

92045-22-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-116-00-9

Hydrocarbons, C₄, steam-cracker distillate;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C₄, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10.4 °F to 41 °F).]

295-405-4

92045-23-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-117-00-4

Petroleum gases, liquefied, sweetened, C₄ fraction;
Petroleum gas;
[a complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C₄ saturated and unsaturated hydrocarbons.]

295-463-0

92045-80-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K S U

649-118-00-X

Hydrocarbons, C₄, 1,3-butadiene- and isobutene-free;
Petroleum gas

306-004-1

95465-89-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-119-00-5

Raffinates (petroleum), steam-cracked C₄ fraction cuprous ammonium acetate extn., C_3-5 and C_3-5 unsatd., butadiene-free;
Petroleum gas

307-769-4

97722-19-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-120-00-0

Gases (petroleum), amine system feed;
Refinery gas;
[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁through C₅ may also be present.]

270-746-1

68477-65-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-121-00-6

Gases (petroleum), benzene unit hydrodesulfurizer off;
Refinery gas;
[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆, including benzene, may also be present.]

270-747-7

68477-66-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-122-00-1

Gases (petroleum), benzene unit recycle, hydrogen-rich;
Refinery gas;
[a complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C₁ through C₆.]

270-748-2

68477-67-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-123-00-7

Gases (petroleum), blend oil, hydrogen-nitrogen-rich;
Refinery gas;
[a complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

270-749-8

68477-68-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-124-00-2

Gases (petroleum), catalytic reformed naphtha stripper overheads;
Refinery gas;
[a complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C₁through C₄.]

270-759-2

68477-77-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-125-00-8

Gases (petroleum), C_6-8 catalytic reformer recycle;
Refinery gas;
[a complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C₆-C₈ feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

270-761-3

68477-80-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-126-00-3

Gases (petroleum), C_6-8 catalytic reformer;
Refinery gas;
[a complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C₆-C₈feed. It consists of hydrocarbons having carbon numbers in the range of C₁ through C₅ and hydrogen.]

270-762-9

68477-81-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-127-00-9

Gases (petroleum), C_6-8 catalytic reformer recycle, hydrogen-rich;
Refinery gas

270-763-4

68477-82-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-128-00-4

Gases (petroleum), C₂-return stream;
Refinery gas;
[a complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]

270-766-0

68477-84-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-129-00-X

Gases (petroleum), dry sour, gas-concn.-unit-off;
Refinery gas;
[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₃.]

270-774-4

68477-92-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-130-00-5

Gases (petroleum), gas concn. reabsorber distn.;
Refinery gas;
[a complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C₁through C₃.]

270-776-5

68477-93-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-131-00-0

Gases (petroleum), hydrogen absorber off;
Refinery gas;
[a complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C₂ hydrocarbons.]

270-779-1

68477-96-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-132-00-6

Gases (petroleum), hydrogen-rich;
Refinery gas;
[a complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C₂ hydrocarbons.]

270-780-7

68477-97-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-133-00-1

Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;
Refinery gas;
[a complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

270-781-2

68477-98-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-134-00-7

Gases (petroleum), recycle, hydrogen-rich;
Refinery gas;
[a complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C₁ through C₅.]

270-783-3

68478-00-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-135-00-2

Gases (petroleum), reformer make-up, hydrogen-rich;
Refinery gas;
[a complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁through C₅.]

270-784-9

68478-01-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-136-00-8

Gases (petroleum), reforming hydrotreater;
Refinery gas;
[a complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C₃ through C₅.]

270-785-4

68478-02-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-137-00-3

Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;
Refinery gas;
[a complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₂through C₅.]

270-787-5

68478-03-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-138-00-9

Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;
Refinery gas;
[a complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

270-788-0

68478-04-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-139-00-4

Gases (petroleum), thermal cracking distn.;
Refinery gas;
[a complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

270-789-6

68478-05-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-140-00-X

Tail gas (petroleum), catalytic cracker refractionation absorber;
Refinery gas;
[a complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C₁through C₃.]

270-805-1

68478-25-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-141-00-5

Tail gas (petroleum), catalytic reformed naphtha separator;
Refinery gas;
[a complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

270-807-2

68478-27-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-142-00-0

Tail gas (petroleum), catalytic reformed naphtha stabilizer;
Refinery gas;
[a complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

270-808-8

68478-28-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-143-00-6

Tail gas (petroleum), cracked distillate hydrotreater separator;
Refinery gas;
[a complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

270-809-3

68478-29-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-144-00-1

Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;
Refinery gas;
[a complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁through C₆.]

270-810-9

68478-30-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-145-00-7

Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;
Refinery gas;
[a complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]

270-999-8

68513-14-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-146-00-2

Gases (petroleum), reformer effluent high-pressure flash drum off;
Refinery gas;
[a complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]

271-003-4

68513-18-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-147-00-8

Gases (petroleum), reformer effluent low-pressure flash drum off;
Refinery gas;
[a complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]

271-005-5

68513-19-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-148-00-3

Gases (petroleum), oil refinery gas distn. off;
Refinery gas;
[a complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C₁ through C₆ or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₂, hydrogen, nitrogen, and carbon monoxide.]

271-258-1

68527-15-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-149-00-9

Gases (petroleum), benzene unit hydrotreater depentanizer overheads;
Refinery gas;
[a complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆. It may contain trace amounts of benzene.]

271-623-5

68602-82-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-150-00-4

Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;
Refinery gas;
[a complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₃.]

271-625-6

68602-84-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-151-00-X

Petroleum products, refinery gases;
Refinery gas;
[a complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]

271-750-6

68607-11-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-152-00-5

Gases (petroleum), hydrocracking low-pressure separator;
Refinery gas;
[a complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C₁ through C₃.]

272-182-1

68783-06-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-153-00-0

Gases (petroleum), refinery;
Refinery gas;
[a complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₃.]

272-338-9

68814-67-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-154-00-6

Gases (petroleum), platformer products separator off;
Refinery gas;
[a complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₂ through C₄.]

272-343-6

68814-90-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-155-00-1

Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;
Refinery gas;
[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C₄ through C₅.]

272-775-5

68911-58-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-156-00-7

Gases (petroleum), hydrotreated sour kerosine flash drum;
Refinery gas;
[a complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C₂ through C₅.]

272-776-0

68911-59-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-157-00-2

Gases (petroleum), distillate unifiner desulfurization stripper off;
Refinery gas;
[a complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]

272-873-8

68919-01-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-158-00-8

Gases (petroleum), fluidized catalytic cracker fractionation off;
Refinery gas;
[a complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

272-874-3

68919-02-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-159-00-3

Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;
Refinery gas;
[a complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]

272-875-9

68919-03-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-160-00-9

Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;
Refinery gas;
[a complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

272-876-4

68919-04-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-161-00-4

Gases (petroleum), platformer stabilizer off, light ends fractionation;
Refinery gas;
[a complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]

272-880-6

68919-07-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-162-00-X

Gases (petroleum), preflash tower off, crude distn.;
Refinery gas;
[a complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

272-881-1

68919-08-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-163-00-5

Gases (petroleum), tar stripper off;
Refinery gas;
[a complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄.]

272-884-8

68919-11-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-164-00-0

Gases (petroleum), unifiner stripper off;
Refinery gas;
[a combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]

272-885-3

68919-12-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-165-00-6

Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;
Refinery gas;
[a complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]

273-173-5

68952-79-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-166-00-1

Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;
Refinery gas;
[a complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

273-174-0

68952-80-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-167-00-7

Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;
Refinery gas;
[a complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C₁through C₄.]

273-269-7

68955-33-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-168-00-2

Gases (petroleum), crude distn. and catalytic cracking;
Refinery gas;
[a complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

273-563-5

68989-88-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-169-00-8

Gases (petroleum), gas oil diethanolamine scrubber off;
Refinery gas;
[a complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C₁ through C₅.]

295-397-2

92045-15-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-170-00-3

Gases (petroleum), gas oil hydrodesulfurization effluent;
Refinery gas;
[a complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₃.]

295-398-8

92045-16-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-171-00-9

Gases (petroleum), gas oil hydrodesulfurization purge;
Refinery gas;
[a complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄.]

295-399-3

92045-17-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-172-00-4

Gases (petroleum), hydrogenator effluent flash drum off;
Refinery gas;
[a complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁through C₆.]

295-400-7

92045-18-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-173-00-X

Gases (petroleum), naphtha steam cracking high-pressure residual;
Refinery gas;
[a complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅ with which natural gas may also be mixed.]

295-401-2

92045-19-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-174-00-5

Gases (petroleum), residue visbaking off;
Refinery gas;
[a complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

295-402-8

92045-20-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-175-00-0

Foots oil (petroleum), acid-treated;
Foots oil;
[a complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C₂₀ through C₅₀.]

300-225-7

93924-31-3

Flam. Gas 1
Press. Gas
Carc. 1B

H220
H350
H340

GHS02
GHS04
GHS08
Gef.

H220
H350
H340

K U

649-176-00-6

Foots oil (petroleum), clay-treated;
Foots oil;
[a complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C₂₀ through C₅₀.]

300-226-2

93924-32-4

Flam. Gas 1
Press. Gas
Carc. 1B

H220
H350
H340

GHS02
GHS04
GHS08
Gef.

H220
H350
H340

K U

649-177-00-1

Gases (petroleum), C_3-4;
Petroleum gas;
[a complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C₃ through C₄, predominantly of propane and propylene, and boiling in the range of approximately - 51 °C to - 1 °C (- 60 °F to 30 °F.)]

268-629-5

68131-75-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-178-00-7

Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;
Petroleum gas;
[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C₁through C₄.]

269-617-2

68307-98-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-179-00-2

Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;
Petroleum gas;
[a complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C₁ through C₄.]

269-618-8

68307-99-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-180-00-8

Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;
Petroleum gas;
[a complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₄.]

269-619-3

68308-00-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-181-00-3

Tail gas (petroleum), cracked distillate hydrotreater stripper;
Petroleum gas;
[a complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

269-620-9

68308-01-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-182-00-9

Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[a complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₄.]

269-630-3

68308-10-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-183-00-4

Tail gas (petroleum), gas oil catalytic cracking absorber;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₅.]

269-623-5

68308-03-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-184-00-X

Tail gas (petroleum), gas recovery plant;
Petroleum gas;
[a complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₅.]

269-624-0

68308-04-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-185-00-5

Tail gas (petroleum), gas recovery plant deethanizer;
Petroleum gas;
[a complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄.]

269-625-6

68308-05-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-186-00-0

Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;
Petroleum gas;
[a complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

269-626-1

68308-06-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-187-00-6

Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;
Petroleum gas;
[a complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₆.]

269-627-7

68308-07-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-188-00-1

Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;
Petroleum gas;
[a complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

269-629-8

68308-09-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-189-00-7

Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄.]

269-631-9

68308-11-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-190-00-2

Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;
Petroleum gas;
[a complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₆.]

269-632-4

68308-12-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-191-00-8

Gases (petroleum), catalytic cracked overheads;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₃ through C₅ and boiling in the range of approximately - 48 °C to 32 °C (- 54 °F to 90 °F).]

270-071-2

68409-99-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-193-00-9

Alkanes, C_1-2;
Petroleum gas

270-651-5

68475-57-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-194-00-4

Alkanes, C_2-3;
Petroleum gas

270-652-0

68475-58-1

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-195-00-X

Alkanes, C_3-4;
petroleum gas

270-653-6

68475-59-2

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-196-00-5

Alkanes, C_4-5;
Petroleum gas

270-654-1

68475-60-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-197-00-0

Fuel gases;
Petroleum gas;
[a combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]

270-667-2

68476-26-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-198-00-6

Fuel gases, crude oil of distillates;
Petroleum gas;
[a complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C₁ through C₄ and boiling in the range of approximately - 217 °C to - 12 °C (- 423 °F to 10 °F).]

270-670-9

68476-29-9

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-199-00-1

Hydrocarbons, C_3-4;
Petroleum gas

270-681-9

68476-40-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-200-00-5

Hydrocarbons, C_4-5;
Petroleum gas

270-682-4

68476-42-6

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-201-00-0

Hydrocarbons, C_2-4, C₃-rich;
Petroleum gas

270-689-2

68476-49-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-202-00-6

Petroleum gases, liquefied;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₃ through C₇ and boiling in the range of approximately - 40 °C to 80 °C (- 40 °F to 176 °F).]

270-704-2

68476-85-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K S U

649-203-00-1

Petroleum gases, liquefied, sweetened;
Petroleum gas;
[a complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C₃ through C₇ and boiling in the range of approximately - 40 °C to 80 °C (- 40 °F to 176 °F).]

270-705-8

68476-86-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K S U

649-204-00-7

gases (petroleum), C_3-4, isobutane-rich;
Petroleum gas;
[a complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C₃ through C₆, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C₃ through C₄, predominantly isobutane.]

270-724-1

68477-33-8

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-205-00-2

Distillates (petroleum), C_3-6, piperylene-rich;
Petroleum gas;
[a complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C₃through C₆. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C₃ through C₆, predominantly piperylenes.]

270-726-2

68477-35-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-206-00-8

Gases (petroleum), butane splitter overheads;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₃ through C₄.]

270-750-3

68477-69-0

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-207-00-3

Gases (petroleum), C_2-3-;
Petroleum gas;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]

270-751-9

68477-70-3

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-208-00-9

Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C₄-rich acid-free;
Petroleum gas;
[a complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C₃ through C₅, predominantly C₄.]

270-752-4

68477-71-4

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-209-00-4

Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C_3-5-rich;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₃ through C₅.]

270-754-5

68477-72-5

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-210-00-X

Tail gas (petroleum), isomerized naphtha fractionation stabilizer;
Petroleum gas;
[a complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁through C₄.]

269-628-2

68308-08-7

Press. Gas
Flam. Gas 1
Carc. 1a
Muta. 1B

H220
H350
H340

GHS04
GHS02
GHS08
Gef.

H220
H350
H340

K U

649-211-00-5

Foots oil (petroleum), carbon-treated;
Foots oil;
[a complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C₁₂.]

308-126-0

97862-76-5

Carc. 1B

H350

GHS08
Gef.

H350

649-212-00-0

Distillates (petroleum), sweetened middle;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₂₀ and boiling in the range of approximately 150^oC to 345^oC (302^oF to 653^oF).]

265-088-7

64741-86-2

Carc. 1B

H350

GHS08
Gef.

H350

649-213-00-6

Gas oils (petroleum), solvent-refined;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₁₁ through C₂₅ and boiling in the range of approximately 205^oC to 400^oC (401^oF to 752^oF).]

265-092-9

64741-90-8

Carc. 1B

H350

GHS08
Gef.

H350

649-214-00-1

Distillates (petroleum), solvent-refined middle;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₉ through C₂₀ and boiling in the range of approximately 150^oC to 345^oC (302^oF to 653^oF).]

265-093-4

64741-91-9

Carc. 1B

H350

GHS08
Gef.

H350

649-215-00-7

Gas oils (petroleum), acid-treated;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₃ through C₂₅ and boiling in the range of approximately 230^oC to 400^oC (446^oF to 752^oF).]

265-112-6

64742-12-7

Carc. 1B

H350

GHS08
Gef.

H350

649-216-00-2

Distillates (petroleum), acid-treated middle;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₁ through C₂₀ and boiling in the range of approximately 205^oC to 345^oC (401^oF to 653^oF).]

265-113-1

64742-13-8

Carc. 1B

H350

GHS08
Gef.

H350

649-217-00-8

Distillates (petroleum), acid-treated light;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₁₆ and boiling in the range of approximately 150^oC to 290^oC (302^oF to 554^oF).]

265-114-7

64742-14-9

Carc. 1B

H350

GHS08
Gef.

H350

649-218-00-3

Gas oils (petroleum), chemically neutralized;
Gasoil - unspecified;
[a complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₃ through C₂₅ and boiling in the range of approximately 230^oC to 400^oC (446^oF to 752^oF).]

265-129-9

64742-29-6

Carc. 1B

H350

GHS08
Gef.

H350

649-219-00-9

Distillates (petroleum), chemically neutralized middle;
Gasoil - unspecified;
[a complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₁ through C₂₀ and boiling in the range of approximately 205^oC to 345^oC (401^oF to 653^oF).]

265-130-4

64742-30-9

Carc. 1B

H350

GHS08
Gef.

H350

649-220-00-4

Distillates (petroleum), clay-treated middle;
Gasoil - unspecified;
[a complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₂₀ and boiling in the range of approximately 150^oC to 345^oC (302^oF to 653^oF).]

265-139-3

64742-38-7

Carc. 1B

H350

GHS08
Gef.

H350

649-221-00-X

Distillates (petroleum), hydrotreated middle;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₁through C₂₅ and boiling in the range of approximately 205^oC to 400^oC (401^oF to 752^oF).]

265-148-2

64742-46-7

Carc. 1B

H350

GHS08
Gef.

H350

649-222-00-5

Gas oils (petroleum), hydrodesulfurized;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₃ through C₂₅ and boiling in the range of approximately 230^oC to 400^oC (446^oF to 752^oF).]

265-182-8

64742-79-6

Carc. 1B

H350

GHS08
Gef.

H350

649-223-00-0

Distillates (petroleum), hydrodesulfurized middle;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₁ through C₂₅ and boiling in the range of approximately 205^oC to 400^oC (401^oF to 752^oF).]

265-183-3

64742-80-9

Carc. 1B

H350

GHS08
Gef.

H350

649-224-00-6

Fuels, diesel;
Gasoil - unspecified;
[a complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₂₀ and boiling in the range of approximately 163^oC to 357^oC (325^oF to 675^oF).]

269-822-7

68334-30-5

Carc. 2

H351

GHS08
Achtg.

H351

649-225-00-1

Fuel oil, No 2;
Gasoil - unspecified;
[a distillate oil having a minimum viscosity of 32,6 SUS at 37,7^oC (100^oF) to a maximum of 37,9 SUS at 37,7^oC (100^oF).]

270-671-4

68476-30-2

Carc. 2

H351

GHS08
Achtg.

H351

649-226-00-7

Fuel oil, No 4;
Gasoil - unspecified;
[a distillate oil having a minimum viscosity of 45 SUS at 37,7^oC (100^oF) to a maximum of 125 SUS at 37,7^oC (100^oF).]

270-673-5

68476-31-3

Carc. 2

H351

GHS08
Achtg.

H351

649-227-00-2

Fuels, diesel, No 2;
Gasoil - unspecified;
[a distillate oil having a minimum viscosity of 32,6 SUS at 37,7^oC (100^oF).]

270-676-1

68476-34-6

Carc. 2

H351

GHS08
Achtg.

H351

649-228-00-8

Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;
Gasoil - unspecified;
[a complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343^oC to 399^oC (650^oF to 750^oF).]

270-719-4

68477-29-2

Carc. 1B

H350

GHS08
Gef.

H350

649-229-00-3

Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;
Gasoil - unspecified;
[a complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288^oC to 371^oC (550^oF to 700^oF).]

270-721-5

68477-30-5

Carc. 1B

H350

GHS08
Gef.

H350

649-230-00-9

Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;
Gasoil - unspecified;
[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288^oC (550^oF).]

270-722-0

68477-31-6

Carc. 1B

H350

GHS08
Gef.

H350

649-231-00-4

Distillates (petroleum), highly refined middle;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₀ through C₂₀.]

292-615-8

90640-93-0

Carc. 1B

H350

GHS08
Gef.

H350

649-232-00-X

Distillates (petroleum) catalytic reformer, heavy arom. conc.;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₀through C₁₆ and boiling in the range of approximately 200^oC to 300^oC (392^oF to 572^oF).]

295-294-2

91995-34-5

Carc. 1B

H350

GHS08
Gef.

H350

649-233-00-5

Gas oils, paraffinic;
Gasoil - unspecified;
[a distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190^oC to 330^oC (374^oF to 594^oF).]

300-227-8

93924-33-5

Carc. 1B

H350

GHS08
Gef.

H350

649-234-00-0

Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;
Gasoil - unspecified

307-035-3

97488-96-5

Carc. 1B

H350

GHS08
Gef.

H350

649-235-00-6

Hydrocarbons, C_16-20, hydrotreated middle distillate, distn. lights;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₆ through C₂₀ and boiling in the range of approximately 290^oC to 350^oC (554^oF to 662^oF). It produces a finished oil having a viscosity of 2cSt at 100^oC (212^oF).]

307-659-6

97675-85-9

Carc. 1B

H350

GHS08
Gef.

H350

649-236-00-1

Hydrocarbons, C_12-20, hydrotreated paraffinic, distn. lights;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₂through C₂₀ and boiling in the range of approximately 230^oC to 350^oC (446^oF to 662^oF). It produces a finished oil having a viscosity of 2cSt at 100^oC (212^oF).]

307-660-1

97675-86-0

Carc. 1B

H350

GHS08
Gef.

H350

649-237-00-7

Hydrocarbons, C_11-17, solvent-extd. light naphthenic;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40^oC (104^oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₁ through C₁₇ and boiling in the range of approximately 200^oC to 300^oC (392^oF to 572^oF).]

307-757-9

97722-08-2

Carc. 1B

H350

GHS08
Gef.

H350

649-238-00-2

Gas oils, hydrotreated;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₇ through C₂₇ and boiling in the range of approximately 330^oC to 340^oC (626^oF to 644^oF).]

308-128-1

97862-78-7

Carc. 1B

H350

GHS08
Gef.

H350

649-239-00-8

Distillates (petroleum), carbon-treated light paraffinic;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₂ through C₂₈.]

309-667-5

100683-97-4

Carc. 1B

H350

GHS08
Gef.

H350

649-240-00-3

Distillates (petroleum), intermediate paraffinic, carbon-treated;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₆ through C₃₆.]

309-668-0

100683-98-5

Carc. 1B

H350

GHS08
Gef.

H350

649-241-00-9

Distillates (petroleum), intermediate paraffinic, clay-treated;
Gasoil - unspecified;
[a complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₆ through C₃₆.]

309-669-6

100683-99-6

Carc. 1B

H350

GHS08
Gef.

H350

649-242-00-4

Alkanes, C_12-26-branched and linear

292-454-3

90622-53-0

Carc. 1B

H350

GHS08
Gef.

H350

649-243-00-X

Lubricating greases;
Grease;
[a complex combination of hydrocarbons having carbon numbers predominantly in the range of C₁₂ through C_50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]

278-011-7

74869-21-9

Carc. 1B

H350

GHS08
Gef.

H350

649-244-00-5

Slack wax (petroleum);
Slack wax;
[a complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₂₀.]

265-165-5

64742-61-6

Carc. 1B

H350

GHS08
Gef.

H350

649-245-00-0

Slack wax (petroleum), acid-treated;
Slack wax;
[a complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₂₀.]

292-659-8

90669-77-5

Carc. 1B

H350

GHS08
Gef.

H350

649-246-00-6

Slack wax (petroleum), clay-treated;
Slack wax;
[a complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C₂₀.]

292-660-3

90669-78-6

Carc. 1B

H350

GHS08
Gef.

H350

649-247-00-1

Slack wax (petroleum), hydrotreated;
Slack wax;
[a complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₂₀.]

295-523-6

92062-09-4

Carc. 1B

H350

GHS08
Gef.

H350

649-248-00-7

Slack wax (petroleum), low-melting;
Slack wax;
[a complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₁₂.]

295-524-1

92062-10-7

Carc. 1B

H350

GHS08
Gef.

H350

649-249-00-2

Slack wax (petroleum), low-melting, hydrotreated;
Slack wax;
[a complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]

295-525-7

92062-11-8

Carc. 1B

H350

GHS08
Gef.

H350

649-250-00-8

Slack wax (petroleum), low-melting, carbon-treated;
Slack wax;
[a complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₁₂.]

308-155-9

97863-04-2

Carc. 1B

H350

GHS08
Gef.

H350

649-251-00-3

Slack wax (petroleum), low-melting, clay-treated;
Slack wax;
[a complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₁₂.]

308-156-4

97863-05-3

Carc. 1B

H350

GHS08
Gef.

H350

649-252-00-9

Slack wax (petroleum), low-melting, silicic acid-treated;
Slack wax;
[a complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C₁₂.]

308-158-5

97863-06-4

Carc. 1B

H350

GHS08
Gef.

H350

649-253-00-4

Slack wax (petroleum), carbon-treated;
Slack wax;
[a complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]

309-723-9

100684-49-9

Carc. 1B

H350

GHS08
Gef.

H350

649-254-00-X

Petrolatum;
Petrolatum;
[a complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C_25.]

232-373-2

8009-03-8

Carc. 1B

H350

GHS08
Gef.

H350

649-255-00-5

Petrolatum (petroleum), oxidized;
Petrolatum;
[a complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]

265-206-7

64743-01-7

Carc. 1B

H350

GHS08
Gef.

H350

649-256-00-0

Petrolatum (petroleum), alumina-treated;
Petrolatum;
[a complex combination of hydrocarbons obtained when petrolatum is treated with Al₂O₃ to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C₂₅.]

285-098-5

85029-74-9

Carc. 1B

H350

GHS08
Gef.

H350

649-257-00-6

Petrolatum (petroleum), hydrotreated;
Petrolatum;
[a complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C₂₀.]

295-459-9

92045-77-7

Carc. 1B

H350

GHS08
Gef.

H350

649-258-00-1

Petrolatum (petroleum), carbon-treated;
Petrolatum;
[a complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C₂₀.]

308-149-6

97862-97-0

Carc. 1B

H350

GHS08
Gef.

H350

649-259-00-7

Petrolatum (petroleum), silicic acid-treated;
Petrolatum;
[a complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C₂₀.]

308-150-1

97862-98-1

Carc. 1B

H350

GHS08
Gef.

H350

649-260-00-2

Petrolatum (petroleum), clay-treated;
Petrolatum;
[a complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C₂₅.]

309-706-6

100684-33-1

Carc. 1B

H350

GHS08
Gef.

H350

649-261-00-8

Gasoline, natural;
Low boiling point naphtha;
[a complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₄ through C₈ and boiling in the range of approximately minus 20 °C to 120 °C (- 4 °F to 248 °F).]

232-349-1

8006-61-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-262-00-3

Naphtha;
Low boiling point naphtha;
[Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C₅ through C₆ and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]

232-443-2

8030-30-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-263-00-9

Ligroine;
Low boiling point naphtha;
[a complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 °C to 135 °C (58 °F to 275 °F).]

232-453-7

8032-32-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-264-00-4

Naphtha (petroleum), heavy straight-run;
Low boiling point naphtha;
[a complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₆ through C₁₂ and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]

265-041-0

64741-41-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-265-00-X

Naphtha (petroleum), full-range straight-run;
Low boiling point naphtha;
[a complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₁ and boiling in the range of approximately - 20 °C to 220 °C (- 4 °F to 428 °F).]

265-042-6

64741-42-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-266-00-5

Naphtha (petroleum), light straight-run;
Low boiling point naphtha;
[a complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₀ and boiling in the range of approximately - 20 °C to 180 °C (- 4 °F to 356 °F).]

265-046-8

64741-46-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-267-00-0

Solvent naphtha (petroleum), light aliph.;
Low boiling point naphtha;
[a complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₅ through C₁₀ and boiling in the range of approximately 35 °C to 160 °C (95 °F to 320 °F).]

265-192-2

64742-89-8

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-268-00-6

Distillates (petroleum), straight-run light;
Low boiling point naphtha;
[a complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂ through C₇ and boiling in the range of approximately - 88 °C to 99 °C (- 127 °F to 210 °F).]

270-077-5

68410-05-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-269-00-1

Gasoline, vapor-recovery;
Low boiling point naphtha;
[a complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₁ and boiling in the range of approximately - 20 °C to 196 °C (- 4 °F to 384 °F).]

271-025-4

68514-15-8

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-270-00-7

Gasoline, straight-run, topping-plant;
Low boiling point naphtha;
[a complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 °C to 193,3 °C (97 °F to 380 °F).]

271-727-0

68606-11-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-271-00-2

Naphtha (petroleum), unsweetened;
Low boiling point naphtha;
[a complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C₅ through C₁₂ and boiling in the range of approximately 0 °C to 230 °C (25 °F to 446 °F).]

272-186-3

68783-12-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-272-00-8

Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;
Low boiling point naphtha;
[a complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₃ through C₆.]

272-931-2

68921-08-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-273-00-3

Naphtha (petroleum), heavy straight run, arom.-contg.;
Low boiling point naphtha;
[a complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C₈ through C₁₂ and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]

309-945-6

101631-20-3

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-274-00-9

Naphtha (petroleum), full-range alkylate;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C₃ through C₅ It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₂ and boiling in the range of approximately 90 °C to 220 °C (194 °F to 428 °F).]

265-066-7

64741-64-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-275-00-4

Naphtha (petroleum), heavy alkylate;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C₃ to C₅. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C₉ through C₁₂ and boiling in the range of approximately 150 °C to 220 °C (302 °F to 428 °F).]

265-067-2

64741-65-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-276-00-X

Naphtha (petroleum), light alkylate;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C₃ through C₅. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₀ and boiling in the range of approximately 90 °C to 160 °C (194 °F to 320 °F).]

265-068-8

64741-66-8

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-277-00-5

Naphtha (petroleum), isomerization;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C₄ through C₆ hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]

265-073-5

64741-70-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-278-00-0

Naphtha (petroleum), solvent-refined light;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₅ through C₁₁ and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]

265-086-6

64741-84-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-279-00-6

Naphtha (petroleum), solvent-refined heavy;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₂ and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]

265-095-5

64741-92-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-280-00-1

Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C₆ through C₉.]

270-088-5

68410-71-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-281-00-7

Raffinates (petroleum), reformer, Lurgi unit-sepd.;
Low boiling point modified naphtha;
[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C₆ through C₈.]

270-349-3

68425-35-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-282-00-2

Naphtha (petroleum), full-range alkylate, butane-contg.;
Low boiling point modified naphta;
[a complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C₃ through C₅. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₂ with some butanes and boiling in the range of approximately 35 °C to 200 °C (95 °F to 428 °F).]

271-267-0

68527-27-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-283-00-8

Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]

295-315-5

91995-53-8

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-284-00-3

Naphtha (petroleum), C_4-12, butane-alkylate, isooctane-rich;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₂, rich in isooctane, and boiling in the range of approximately 35 °C to 210 °C (95 °F to 410 °F).]

295-430-0

92045-49-3

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-285-00-9

Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[a combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 °C to 99 °C (201 °F to 210 °F).]

295-436-3

92045-55-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-286-00-4

Naphtha (petroleum), isomerization, C₆-fraction;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 °C to 66 °C (140 °F to 151 °F).]

295-440-5

92045-58-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-287-00-X

Hydrocarbons, C_6-7, naphtha-cracking, solvent-refined;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C₆ through C₇ and boiling in the range of approximately 70 °C to 100 °C (158 °F to 212 °F).]

295-446-8

92045-64-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-288-00-5

Hydrocarbons, C₆-rich, hydrotreated light naphtha distillates, solvent-refined;
Low boiling point modified naphtha;
[a complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 °C to 70 °C (149 °F to 158 °F).]

309-871-4

101316-67-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-289-00-0

Naphtha (petroleum), heavy catalytic cracked;
Low boiling point cat-cracked naphtha;
[a complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₆ through C₁₂ and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]

265-055-7

64741-54-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-290-00-6

Naphtha (petroleum), light catalytic cracked;
Low boiling point cat-cracked naphtha;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₁ and boiling in the range of approximately - 20 °C to 190 °C (- 4 °F to 374 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]

265-056-2

64741-55-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-291-00-1

Hydrocarbons, C_3-11, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[a complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₃ through C₁₁ and boiling in a range approximately up to 204 °C (400 °F).]

270-686-6

68476-46-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-292-00-7

Naphtha (petroleum), catalytic cracked light distd.;
Low boiling point cat-cracked naphtha;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁ through C₅.]

272-185-8

68783-09-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-293-00-2

Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;
Low boiling point cat-cracked naphtha.;
[a complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]

295-311-3

91995-50-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-294-00-8

Naphtha (petroleum), heavy catalytic cracked, sweetened;
Low boiling point cat-cracked naphtha;
[a complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₆ through C₁₂ and boiling in the range of approximately 60 °C to 200 °C (140 °F to 392 °F).]

295-431-6

92045-50-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-295-00-3

Naphtha (petroleum), light catalytic cracked sweetened;
Low boiling point cat-cracked naphtha;
[a complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 °C to 210 °C (95 °F to 410 °F).]

295-441-0

92045-59-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-296-00-9

Hydrocarbons, C_8-12, catalytic-cracking, chem. neutralized;
Low boiling point cat-cracked naphtha;
[a complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C₈ through C₁₂ and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]

295-794-0

92128-94-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-297-00-4

Hydrocarbons, C_8-12, catalytic cracker distillates;
Low boiling point cat-cracked naphtha;
[a complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₈ through C₁₂ and boiling in the range of approximately 140 °C to 210 °C (284 °F to 410 °F).]

309-974-4

101794-97-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-298-00-X

Hydrocarbons, C_8-12, catalytic cracking, chem. neutralized, sweetened;
Low boiling point cat-cracked naphtha

309-987-5

101896-28-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-299-00-5

Naphtha (petroleum), light catalytic reformed;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₅ through C₁₁ and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]

265-065-1

64741-63-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-300-00-9

Naphtha (petroleum), heavy catalytic reformed;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₂ and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]

265-070-9

64741-68-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-301-00-4

Distillates (petroleum), catalytic reformed depentanizer;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₃through C₆ and boiling in the range of approximately - 49 °C to 63 °C (- 57 °F to 145 °F).]

270-660-4

68475-79-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-302-00-X

Hydrocarbons, C_2-6, C_6-8 catalytic reformer;
Low boiling point cat-reformed naphtha

270-687-1

68476-47-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-303-00-5

Residues (petroleum), C_6-8 catalytic reformer;
Low boiling point cat-reformed naphtha;
[a complex residuum from the catalytic reforming of C_6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂through C₆.]

270-794-3

68478-15-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-304-00-0

Naphtha (petroleum), light catalytic reformed, arom.-free;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₅ through C₈ and boiling in the range of approximately 35 °C to 120 °C (95 °F to 248 °F). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]

270-993-5

68513-03-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-305-00-6

Distillates (petroleum), catalytic reformed straight-run naphtha overheads;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₂ through C₆.]

271-008-1

68513-63-3

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-306-00-1

Petroleum products, hydrofiner-powerformer reformates;
Low boiling point cat-reformed naphtha;
[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 °C to 210 °C (80 °F to 410 °F).]

271-058-4

68514-79-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-307-00-7

Naphtha (petroleum), full-range reformed;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₅ through C₁₂ and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]

272-895-8

68919-37-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-308-00-2

Naphtha (petroleum), catalytic reformed;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₂ and boiling in the range of approximately 30 °C to 220 °C (90 °F to 430 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]

273-271-8

68955-35-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-309-00-8

Distillates (petroleum), catalytic reformed hydrotreated light, C_8-12 arom. fraction;
Low boiling point cat-reformed naphtha;
[a complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C₈ through C₁₀ and boiling in the range of approximately 160 °C to 180 °C (320 °F to 356 °F).]

285-509-8

85116-58-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-310-00-3

Aromatic hydrocarbons, C₈, catalytic reforming-derived;
Low boiling point cat-reformed naphtha

295-279-0

91995-18-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-311-00-9

Aromatic hydrocarbons, C_7-12, C₈-rich;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₇through C₁₂ (primarily C₈) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 °C to 200 °C (266 °F to 392 °F).]

297-401-8

93571-75-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-312-00-4

Gasoline, C_5-11, high-octane stabilised reformed;
Low boiling point cat-reformed naphtha;
[a complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C₅ through C₁₁ and boiling in the range of approximately 45 °C to 185 °C (113 °F to 365 °F).]

297-458-9

93572-29-3

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-313-00-X

Hydrocarbons, C_7-12, C_>9-arom.-rich, reforming heavy fraction;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C₇through C₁₂ and boiling in the range of approximately 120 °C to 210 °C (248 °F to 380 °F) and C₉ and higher aromatic hydrocarbons.]

297-465-7

93572-35-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-314-00-5

Hydrocarbons, C_5-11, nonaroms.-rich, reforming light fraction;
Low boiling point cat-reformed naphtha;
[a complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C₅through C₁₁ and boiling in the range of approximately 35 °C to 125 °C (94 °F to 257 °F), benzene and toluene.]

297-466-2

93572-36-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-315-00-0

Foots oil (petroleum), silicic acid-treated;
Foots oil;
[a complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C₁₂.]

308-127-6

97862-77-6

Carc. 1B

H350
H304

GHS08
Gef.

H350
H304

649-316-00-6

Naphtha (petroleum), light thermal cracked;
Low boiling point thermally cracked naphtha;
[a complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₄through C₈ and boiling in the range of approximately - 10 °C to 130 °C (14 °F to 266 °F).]

265-075-6

64741-74-8

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-317-00-1

Naphtha (petroleum), heavy thermal cracked;
Low boiling point thermally cracked naphtha;
[a complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₆through C₁₂ and boiling in the range of approximately 65 °C to 220 °C (148 °F to 428 °F).]

265-085-0

64741-83-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-318-00-7

Distillates (petroleum), heavy arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C_5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C₅. This stream may contain benzene.]

267-563-4

67891-79-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-319-00-2

Distillates (petroleum), light arom.;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C_5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C₅. This stream may contain benzene.]

267-565-5

67891-80-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-320-00-8

Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;
Low boiling point thermally cracked naphtha;
[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 °C (1 500 °F) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C₉ and boiling at approximately 204 °C (400 °F).]

270-344-6

68425-29-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-321-00-3

Aromatic hydrocarbons, C_6-8, naphtha-raffinate pyrolyzate-derived;
Low boiling point thermally cracked naphtha;
[a complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 °C (1 500 °F) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₆ through C₈, including benzene.]

270-658-3

68475-70-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-322-00-9

Distillates (petroleum), thermal cracked naphtha and gas oil;
Low boiling point thermally cracked naphtha;
[a complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C₅ and boiling in the range of approximately 33 °C to 60 °C (91 °F to 140 °F).]

271-631-9

68603-00-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-323-00-4

Distillates (petroleum), thermal cracked naphtha and gas oil, C₅-dimer-contg.;
Low boiling point thermally cracked naphtha;
[a complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C₅ with some dimerized C₅ olefins and boiling in the range of approximately 33 °C to 184 °C (91 °F to 363 °F).]

271-632-4

68603-01-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-324-00-X

Distillates (petroleum), thermal cracked naphtha and gas oil, extractive;
Low boiling point thermally cracked naphtha;
[a complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 °C to 40 °C (88 °F to 104 °F).]

271-634-5

68603-03-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-325-00-5

Distillates (petroleum), light thermal cracked, debutanized arom.;
Low boiling point thermally cracked naphtha;
[a complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]

273-266-0

68955-29-3

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-326-00-0

Naphtha (petroleum), light thermal cracked, sweetened;
Low boiling point thermally cracked naphtha;
[a complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 °C to 100 °C (68 °F to 212 °F).]

295-447-3

92045-65-3

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-327-00-6

Naphtha (petroleum), hydrotreated heavy;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C₆through C₁₃ and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]

265-150-3

64742-48-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-328-00-1

Naphtha (petroleum), hydrotreated light;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄through C₁₁ and boiling in the range of approximately minus 20 °C to 190 °C (- 4 °F to 374 °F).]

265-151-9

64742-49-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-329-00-7

Naphtha (petroleum), hydrodesulfurized light;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₁ and boiling in the range of approximately - 20 °C to 190 °C (- 4 °F to 374 °F).]

265-178-6

64742-73-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-330-00-2

naphtha (petroleum),
hydrodesulphurized
heavy;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]

265-185-4

64742-82-1

Carc. 1B

H350

GHS08

H350

Muta. 1B

H340

Gef.

H340

STOT RE 1

H372 (zentrales Nervensystem)

Asp. Tox. 1

H304

649-331-00-8

Distillates (petroleum), hydrotreated middle, intermediate boiling;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₅through C₁₀ and boiling in the range of approximately 127 °C to 188 °C (262 °F to 370 °F).]

270-092-7

68410-96-8

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-332-00-3

Distillates (petroleum), light distillate hydrotreating process, low-boiling;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₆through C₉ and boiling in the range of approximately 3 °C to 194 °C (37 °F to 382 °F).]

270-093-2

68410-97-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-333-00-9

Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₃through C₆ and boiling in the range of approximately - 49 °C to 68 °C (- 57 °F to 155 °F).]

270-094-8

68410-98-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-334-00-4

Solvent naphtha (petroleum), light arom., hydrotreated;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₈ through C₁₀ and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]

270-988-8

68512-78-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-335-00-X

Naphtha (petroleum), hydrodesulfurized thermal cracked light;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₅ to C₁₁and boiling in the range of approximately 23 °C to 195 °C (73 °F to 383 °F).]

285-511-9

85116-60-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-336-00-5

Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately - 20 °C to 190 °C (- 4 °F to 374 °F).]

285-512-4

85116-61-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-337-00-0

Naphtha (petroleum), heavy steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha

295-432-1

92045-51-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-338-00-6

Naphtha (petroleum), hydrodesulfurized full-range;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₁ and boiling in the range of approximately 30 °C to 250 °C (86 °F to 482 °F).]

295-433-7

92045-52-8

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-339-00-1

Naphtha (petroleum), hydrotreated light steam-cracked;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₅ through C₁₁ and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]

295-438-4

92045-57-3

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-340-00-7

Hydrocarbons, C_4-12, naphtha-cracking, hydrotreated;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₂ and boiling in the range of approximately 30 °C to 230 °C (86 °F to 446 °F).]

295-443-1

92045-61-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-341-00-2

Solvent naphtha (petroleum), hydrotreated light naphthenic;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C₆ through C₇ and boiling in the range of approximately 73 °C to 85 °C (163 °F to 185 °F).]

295-529-9

92062-15-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-342-00-8

Naphtha (petroleum), light steam-cracked, hydrogenated;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₀ and boiling in the range of approximately 50 °C to 200 °C (122 °F to 392 °F). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulfur and oxygenated compounds.]

296-942-7

93165-55-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-343-00-3

Hydrocarbons, C_6-11, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]

297-852-0

93763-33-8

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-344-00-9

Hydrocarbons, C_9-12, hydrotreated, dearomatized;
Low boiling point hydrogen treated naphtha;
[a complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]

297-853-6

93763-34-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-345-00-4

stoddard solvent;
Low boiling point
naphtha - unspecified;
[a colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 °C to 204,4 °C (300 °F to 400 °F).]

232-489-3

8052-41-3

Carc. 1B

H350

GHS08

H350

Muta. 1B

H340

Gef.

H340

STOT RE 1

H372 (zentrales Nervensystem)

Asp. Tox. 1

H304

649-346-00-X

Natural gas condensates (petroleum);
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C₂ to C₂₀. It is a liquid at atmospheric temperature and pressure.]

265-047-3

64741-47-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-347-00-5

Natural gas (petroleum), raw liq. mix;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C₂ through C₈.]

265-048-9

64741-48-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-348-00-0

Naphtha (petroleum), light hydrocracked;
Low boiling naphtha - unspecified;
[a complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₀, and boiling in the range of approximately - 20 °C to 180 °C (- 4 °F to 356 °F).]

265-071-4

64741-69-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-349-00-6

Naphtha (petroleum), heavy hydrocracked;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₆ through C₁₂, and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F).]

265-079-8

64741-78-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-350-00-1

Naphtha (petroleum), sweetened;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₂ and boiling in the range of approximately - 10 °C to 230 °C (14 °F to 446 °F).]

265-089-2

64741-87-3

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-351-00-7

Naphtha (petroleum), acid-treated;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₂ and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]

265-115-2

64742-15-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-352-00-2

Naphtha (petroleum), chemically neutralized heavy;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C₆ through C₁₂ and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]

265-122-0

64742-22-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-353-00-8

Naphtha (petroleum), chemically neutralized light;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₁ and boiling in the range of approximately - 20 °C to 190 °C (- 4 °F to 374 °F).]

265-123-6

64742-23-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-354-00-3

Naphtha (petroleum), catalytic dewaxed;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₅ through C₁₂ and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]

265-170-2

64742-66-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-355-00-9

Naphtha (petroleum), light steam-cracked;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₁ and boiling in the range of approximately minus 20 °C to 190 °C (- 4 °F to 374 °F). This stream is likely to contain 10 vol. % or more benzene.]

265-187-5

64742-83-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-356-00-4

Solvent naphtha (petroleum), light arom.;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₈ through C₁₀ and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]

265-199-0

64742-95-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-357-00-X

Aromatic hydrocarbons, C_6-10, acid-treated, neutralized;
Low boiling point naphtha - unspecified

268-618-5

68131-49-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-358-00-5

Distillates (petroleum), C_3-5, 2-methyl-2-butene-rich;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C₃ through C₅, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C₃ through C₅, predominantly 2-methyl-2-butene.]

270-725-7

68477-34-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-359-00-0

Distillates (petroleum), polymd. steam-cracked petroleum distillates, C_5-12fraction;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₅through C₁₂.]

270-735-1

68477-50-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-360-00-6

Distillates (petroleum), steam-cracked, C_5-12 fraction;
Low boiling point naphtha - unspecified;
[a complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₅through C₁₂.]

270-736-7

68477-53-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-361-00-1

Distillates (petroleum), steam-cracked, C_5-10 fraction, mixed with light steam-cracked petroleum naphtha C₅ fraction;
Low boiling point naphtha - unspecified

270-738-8

68477-55-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-362-00-7

Extracts (petroleum), cold-acid, C_4-6;
Low boiling point naphtha - unspecified;
[a complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C₃ through C₆, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C₄ through C₆, predominantly C₅.]

270-741-4

68477-61-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-363-00-2

Distillates (petroleum), depentanizer overheads;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₄ through C₆.]

270-771-8

68477-89-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-364-00-8

Residues (petroleum), butane splitter bottoms;
Low boiling point naphtha - unspecified;
[a complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]

270-791-7

68478-12-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-365-00-3

Residual oils (petroleum), deisobutanizer tower;
Low boiling point naphtha - unspecified;
[a complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C₄ through C₆.]

270-795-9

68478-16-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-366-00-9

Naphtha (petroleum), full-range coker;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₄through C₁₅ and boiling in the range of approximately 43 °C to 250 °C (110 °F-500 °F).]

270-991-4

68513-02-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-367-00-4

Naphtha (petroleum), steam-cracked middle arom.;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₇through C₁₂ and boiling in the range of approximately 130 °C to 220 °C (266 °F to 428 °F).]

271-138-9

68516-20-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-368-00-X

Naphtha (petroleum), clay-treated full-range straight-run;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₁ and boiling in the range of approximately - 20 °C to 220 °C (- 4 °F to 429 °F).]

271-262-3

68527-21-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-369-00-5

Naphtha (petroleum), clay-treated light straight-run;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₀ and boiling in the range of approximately 93 °C to 180 °C (200 °F to 356 °F).]

271-263-9

68527-22-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-370-00-0

Naphtha (petroleum), light steam-cracked arom.;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₇through C₉ and boiling in the range of approximately 110 °C to 165 °C (230 °F to 329 °F).]

271-264-4

68527-23-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-371-00-6

Naphtha (petroleum), light steam-cracked, debenzenized;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₂ and boiling in the range of approximately 80 °C to 218 °C (176 °F to 424 °F).]

271-266-5

68527-26-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-372-00-1

Naphtha (petroleum), arom.-contg.;
Low boiling point naphtha - unspecified

271-635-0

68603-08-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-373-00-7

Gasoline, pyrolysis, debutanizer bottoms;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C₅.]

271-726-5

68606-10-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-374-00-2

Naphtha (petroleum), light, sweetened;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C₃through C₆ and boiling in the range of approximately - 20 °C to 100 °C (- 4 °F to 212 °F).]

272-206-0

68783-66-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-375-00-8

Natural gas condensates;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂ through C₈.]

272-896-3

68919-39-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-376-00-3

Distillates (petroleum), naphtha unifiner stripper;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C₂ through C₆.]

272-932-8

68921-09-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-377-00-9

Naphtha (petroleum), catalytic reformed light, arom.-free fraction;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C₅ to C₈ and boiling in the range of approximately 66 °C to 121 °C (151 °F to 250 °F).]

285-510-3

85116-59-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-378-00-4

Gasoline;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C₃ and boiling in the range of 30 °C to 260 °C (86 °F to 500 °F).]

289-220-8

86290-81-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-379-00-X

Aromatic hydrocarbons, C_7-8, dealkylation products, distn. residues;
Low boiling point naphtha - unspecified

292-698-0

90989-42-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-380-00-5

Hydrocarbons, C_4-6, depentanizer lights, arom. hydrotreater;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₆, predominantly pentanes and pentenes, and boiling in the range of approximately 25 °C to 40 °C (77 °F to 104 °F).]

295-298-4

91995-38-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-381-00-0

Distillates (petroleum), heat-soaked steam-cracked naphtha, C₅-rich;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C₄ through C₆, predominantly C₅.]

295-302-4

91995-41-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-382-00-6

Extracts (petroleum), catalytic reformed light naphtha solvent;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₇ through C₈ and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]

295-331-2

91995-68-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-383-00-1

Naphtha (petroleum), hydrodesulfurized light, dearomatized;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C₇ paraffins and cycloparaffins boiling in a range of approximately 90 °C to 100 °C (194 °F to 212 °F).]

295-434-2

92045-53-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-384-00-7

Naphtha (petroleum), light, C₅-rich, sweetened;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₅, predominantly C₅, and boiling in the range of approximately minus 10 °C to 35 °C (14 °F to 95 °F).]

295-442-6

92045-60-8

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-385-00-2

Hydrocarbons, C_8-11, naphtha-cracking, toluene cut;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₈ through C₁₁ and boiling in the range of approximately 130 °C to 205 °C (266 °F to 401 °F).]

295-444-7

92045-62-0

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-386-00-8

Hydrocarbons, C_4-11, naphtha-cracking, arom.-free;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₄ through C₁₁ and boiling in the range of approximately 30 °C to 205 °C (86 °F to 401 °F).]

295-445-2

92045-63-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-387-00-3

Naphtha (petroleum), light heat-soaked, steam-cracked;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C₄ through C₆ and boiling in the range of approximately 0 °C to 80 °C (32 °F to 176 °F).]

296-028-8

92201-97-3

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-388-00-9

Distillates (petroleum), C₆-rich;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C₅ through C₇, rich in C₆, and boiling in the range of approximately 60 °C to 70 °C (140 °F to 158 °F).]

296-903-4

93165-19-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-389-00-4

Gasoline, pyrolysis, hydrogenated;
Low boiling point naphtha-unspecified;
[a distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 °C to 200 °C (68 °F to 392 °F).]

302-639-3

94114-03-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-390-00-X

Distillates (petroleum), steam-cracked, C_8-12 fraction, polymd., distn. lights;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by distillation of the polymerized C₈ through C₁₂ fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₈ through C₁₂.]

305-750-5

95009-23-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-391-00-5

Extracts (petroleum) heavy naphtha solvent, clay-treated;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₆ through C₁₀ and boiling in the range of approximately 80 °C to 180 °C (175 °F to 356 °F).]

308-261-5

97926-43-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-392-00-0

Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₂ and boiling in the range of approximately 95 °C to 200 °C (203 °F to 392 °F).]

308-713-1

98219-46-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-393-00-6

Naphtha (petroleum), light steam-cracked, thermally treated;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₅through C₆ and boiling in the range of approximately 35 °C to 80 °C (95 °F to 176 °F).]

308-714-7

98219-47-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-394-00-1

Distillates (petroleum), C_7-9, C₈-rich, hydrodesulfurized dearomatized;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C₇through C₉, predominantly C₈ paraffins and cycloparaffins, boiling in the range of approximately 120 °C to 130 °C (248 °F to 266 °F).]

309-862-5

101316-56-7

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-395-00-7

Hydrocarbons, C_6-8, hydrogenated sorption-dearomatized, toluene raffination;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₆through C₈ and boiling in the range of approximately 80 °C to 135 °C (176 °F to 275 °F).]

309-870-9

101316-66-9

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-396-00-2

Naphtha (petroleum), hydrodesulfurised full-range coker;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₅ to C₁₁ and boiling in the range of approximately 23 °C to 196 °C (73 °F to 385 °F).]

309-879-8

101316-76-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-397-00-8

Naphtha (petroleum), sweetened light;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₅ through C₈ and boiling in the range of approximately 20 °C to 130 °C (68 °F to 266 °F).]

309-976-5

101795-01-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-398-00-3

Hydrocarbons, C_3-6, C₅-rich, steam-cracked naphtha;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C₃ through C₆, predominantly C₅.]

310-012-0

102110-14-5

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-399-00-9

Hydrocarbons, C₅-rich, dicyclopentadiene-contg.;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C₅ and dicyclopentadiene and boiling in the range of approximately 30 °C to 170 °C (86 °F to 338 °F).]

310-013-6

102110-15-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-400-00-2

Residues (petroleum), steam-cracked light, arom.;
Low boiling point naphtha - unspecified;
[a complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C₅. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C₅ and boiling above approximately 40 °C (104 °F).]

310-057-6

102110-55-4

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-401-00-8

Hydrocarbons, C_>5, C_5-6-rich;
Low boiling point naphtha - unspecified

270-690-8

68476-50-6

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-402-00-3

Hydrocarbons, C₅-rich;
Low boiling point naphtha - unspecified

270-695-5

68476-55-1

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-403-00-9

Aromatic hydrocarbons, C_8-10;
Low boiling point naphtha - unspecified

292-695-4

90989-39-2

Carc. 1B
Muta. 1B
Asp. Tox. 1

H350
H340
H304

GHS08
Gef.

H350
H340
H304

649-404-00-4

Kerosine (petroleum);
Straight run kerosine;
[a complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₁₆ and boiling in the range of approximately 150^oC to 290^oC (320^oF to 554^oF).]

232-366-4

8008-20-6

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-405-00-X

solvent naphtha (petroleum), medium aliph.;
Straight run kerosine;
[a complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 °C to 220 °C (284 °F to 428 °F).]

265-191-7

64742-88-7

STOT RE 1

H372 (zentrales Nervensystem)

GHS08

H372 (zentrales Nervens ystem)

Asp. Tox. 1

H304

Gef.

H304

649-406-00-5

Solvent naphtha (petroleum) heavy aliph.;
Straight run kerosine;
[a complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₁₁ through C₁₆ and boiling in the range of approximately 190^oC to 290^oC (374^oF to 554^oF).]

265-200-4

64742-96-7

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-407-00-0

Kerosine (petroleum), straight-run wide-cut;
Straight run kerosine;
[a complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70^oC to 220^oC (158^oF to 428^oF).]

295-418-5

92045-37-9

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-408-00-6

Distillates (petroleum), steam-cracked;
Cracked kerosine;
[a complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₆ and boiling in the range of approximately 90^oC to 290^oC (190^oF to 554^oF).]

265-194-3

64742-91-2

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-409-00-1

Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C_8-10 fraction;
Cracked kerosine;
[a complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C₈ through C₁₀ and boiling in the range of approximately 129^oC to 194^oC (264^oF to 382^oF).]

270-728-3

68477-39-4

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-410-00-7

Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C_10-12 fraction;
Cracked kerosine;
[a complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C₁₀ through C₁₂.]

270-729-9

68477-40-7

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-411-00-2

Distillates (petroleum), steam-cracked, C_8-12 fraction;
Cracked kerosine;
[a complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₈ through C₁₂.]

270-737-2

68477-54-3

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-412-00-8

Kerosine (petroleum), hydrodesulfurized thermal cracked;
Cracked kerosine;
[a complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C₈ to C₁₆ and boiling in the range of approximately 120^oC to 283^oC (284^oF to 541^oF).]

285-507-7

85116-55-8

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-413-00-3

Aromtic hydrocarbons, C_>10, steam-cracking, hydrotreated;
Cracked kerosine;
[a complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C₁₀ and boiling in the range of approximately 150^oC to 320^oC (302^oF to 608^oF).]

292-621-0

90640-98-5

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-414-00-9

Naphtha (petroleum), steam-cracked, hydrotreated, C_9-10-arom.-rich;
Cracked kerosine;
[a complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C₉ through C₁₀ and boiling in the range of approximately 140^oC to 200^oC (284^oF to 392^oF).]

292-637-8

90641-13-7

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-415-00-4

Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;
Cracked kerosine;
[a complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100^oC to 250^oC (212^oF to 482^oF.]

309-866-7

101316-61-4

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-416-00-X

Distillates (petroleum), catalytic cracked heavy tar light;
Cracked kerosine;
[a complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100^oC to 250^oC (212^oF to 482^oF).]

309-938-8

101631-13-4

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-417-00-5

Solvent naphtha (petroleum), hydrocracked heavy arom.;
Cracked kerosine;
[a complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₁₆ and boiling in the range of approximately 235^oC to 290^oC (455^oF to 554^oF).]

309-881-9

101316-80-7

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-418-00-0

Distillates (petroleum), steam-cracked heavy tar light;
Cracked kerosine;
[a complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100^oC to 250^oC (212^oF to 482^oF).]

309-940-9

101631-15-6

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-419-00-6

Distillates (petroleum), alkylate;
Kerosine - unspecified;
[a complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C₃ through C₅. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C₁₁ through C₁₇ and boiling in the range of approximately 205^oC to 320^oC (401^oF to 608^oF).]

265-074-0

64741-73-7

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-420-00-1

Extracts (petroleum), heavy naphtha solvent;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₇ through C₁₂ and boiling in the range of approximately 90^oC to 220^oC (194^oF to 428^oF).]

265-099-7

64741-98-6

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-421-00-7

Distillates (petroleum), chemically neutralized light;
Kerosine - unspecified;
[a complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₁₆ and boiling in the range of approximately 150^oC to 290^oC (302^oF to 554^oF).]

265-132-5

64742-31-0

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-422-00-2

Distillates (petroleum), hydrotreated light;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉through C₁₆ and boiling in the range of approximately 150^oC to 290^oC (302^oF to 554^oF).]

265-149-8

64742-47-8

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-423-00-8

Kerosine (petroleum), hydrodesulfurized;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₁₆ and boiling in the range of approximately 150^oC to 290^oC (302^oF to 554^oF).]

265-184-9

64742-81-0

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-424-00-3

Solvent naphtha (petroleum), heavy arom.;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₉ through C₁₆ and boiling in the range of approximately 165^oC to 290^oC (330^oF to 554^oF).]

265-198-5

64742-94-5

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-425-00-9

Naphtha (petroleum), heavy coker;
Kerosine - unspecified;
[a complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₆ through C₁₅ and boiling in the range of approximately 157^oC to 288^oC (315^oF to 550^oF).]

269-778-9

68333-23-3

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-426-00-4

Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;
Kerosine - unspecified;
[a complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C₇ to C₁₃ and boiling in the range of approximately 98^oC to 218^oC (208^oF to 424^oF).]

285-508-2

85116-57-0

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-427-00-X

Kerosine (petroleum), sweetened;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₁₆ and boiling in the range of 130^oC to 290^oC (266^oF to 554^oF).]

294-799-5

91770-15-9

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-428-00-5

Kerosine (petroleum), solvent-refined sweetened;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150^oC to 260^oC (302^oF to 500^oF).]

295-416-4

92045-36-8

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-429-00-0

Hydrocarbons, C_9-16, hydrotreated, dearomatized;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]

297-854-1

93763-35-0

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-430-00-6

Kerosine (petroleum), solvent-refined hydrodesulfurized;
Kerosine - unspecified

307-033-2

97488-94-3

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-431-00-1

Distillates (petroleum), hydrodesulfurized full-range middle coker;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₈ through C₁₆ and boiling in the range of approximately 120^oC to 283^oC (248^oF to 541^oF).]

309-864-6

101316-58-9

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-432-00-7

Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₀through C₁₃ and boiling in the range of approximately 180^oC to 240^oC (356^oF to 464^oF).]

309-882-4

101316-81-8

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-433-00-2

Solvent naphtha (petroleum), hydrodesulfurized medium;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₀through C₁₃ and boiling in the range of approximately 175^oC to 220^oC (347^oF to 428^oF).]

309-884-5

101316-82-9

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-434-00-8

Kerosine (petroleum), hydrotreated;
Kerosine - unspecified;
[a complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C₁₂ through C₁₆ and boiling in the range of approximately 230^oC to 270^oC (446^oF to 518^oF).]

309-944-0

101631-19-0

Asp. Tox. 1

H304

GHS08
Gef.

H304

649-435-00-3

Distillates (petroleum), light catalytic cracked;
Cracked gasoil;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₂₅ and boiling in the range of approximately 150^oC to 400^oC (302^oF to 752^oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]

265-060-4

64741-59-9

Carc. 1B

H350

GHS08
Gef.

H350

649-436-00-9

Distillates (petroleum), intermediate catalytic cracked;
Cracked gasoil;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₁ through C₃₀ and boiling in the range of approximately 205^oC to 450^oC (401^oF to 842^oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]

265-062-5

64741-60-2

Carc. 1B

H350

GHS08
Gef.

H350

649-437-00-4

Distillates (petroleum), light hydrocracked;
Cracked gasoil;
[a complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₁₀ through C₁₈ and boiling in the range of approximately 160^oC to 320^oC (320^oF to 608^oF).]

265-078-2

64741-77-1

Carc. 2

H351

GHS08
Achtg.

H351

649-438-00-X

Distillates (petroleum), light thermal cracked;
Cracked gasoil;
[a complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C₁₀through C₂₂ and boiling in the range of approximately 160^oC to 370^oC (320^oF to 698^oF).]

265-084-5

64741-82-8

Carc. 1B

H350

GHS08
Gef.

H350

649-439-00-5

Distillates (petroleum), hydrodesulfurized light catalytic cracked;
Cracked gasoil;
[a complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C₉ through C₂₅ and boiling in the range of approximately 150^oC to 400^oC (302^oF to 752^oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]

269-781-5

68333-25-5

Carc. 1B

H350

GHS08
Gef.

H350

649-440-00-0

Distillates (petroleum), light steam-cracked naphtha;
Cracked gasoil;
[a complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₀ through C₁₈.]

270-662-5

68475-80-9

Carc. 1B

H350

GHS08
Gef.

H350

649-441-00-6

Distillates (petroleum), cracked steam-cracked petroleum distillates;
Cracked gasoil;
[a complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C₁₀ to low molecular weight polymers.]

270-727-8

68477-38-3

Carc. 1B

H350

GHS08
Gef.

H350

649-442-00-1

Gas oils (petroleum), steam-cracked;
Cracked gasoil;
[a complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C₉ and boiling in the range of from approximately 205^oC to 400^oC (400^oF to 752^oF).]

271-260-2

68527-18-4

Carc. 1B

H350

GHS08
Gef.

H350

649-443-00-7

Distillates (petroleum), hydrodesulfurized thermal cracked middle;
Cracked gasoil;
[a complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₁ to C₂₅ and boiling in the range of approximately 205^oC to 400^oC (401^oF to 752^oF).]

285-505-6

85116-53-6

Carc. 1B

H350

GHS08
Gef.

H350

649-444-00-2

Gas oils (petroleum), thermal-cracked, hydrodesulfurized;
Cracked gasoil

295-411-7

92045-29-9

Carc. 1B

H350

GHS08
Gef.

H350

649-445-00-8

Residues (petroleum), hydrogenated steam-cracked naphtha;
Cracked gasoil;
[a complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200^oC to 350^oC (32^oF to 662^oF).]

295-514-7

92062-00-5

Carc. 1B

H350

GHS08
Gef.

H350

649-446-00-3

Residues (petroleum), steam-cracked naphtha distn.;
Cracked gasoil;
[a complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147^oC to 300^oC (297^oF to 572^oF) and produces a finished oil having a viscosity of 18cSt at 50^oC.]

295-517-3

92062-04-9

Carc. 1B

H350

GHS08
Gef.

H350

649-447-00-9

Distillates (petroleum), light catalytic cracked, thermally degraded;
Cracked gasoil;
[a complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190^oC to 340^oC (374^oF to 644^oF). This stream is likely to contain organic sulfur compounds.]

295-991-1

92201-60-0

Carc. 1B

H350

GHS08
Gef.

H350

649-448-00-4

Residues (petroleum), steam-cracked heat-soaked naphtha;
Cracked gasoil;
[a complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150^oC to 350^oC (302^oF to 662^oF).]

297-905-8

93763-85-0

Carc. 1B

H350

GHS08
Gef.

H350

649-449-00-X

Hydrocarbons, C_16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;
Cracked gasoil;
[a complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₆ through C₂₀ and boiling in the range of approximately 360^oC to 500^oC (680^oF to 932^oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100^oC (212^oF).]

307-662-2

97675-88-2

Carc. 2

H351

GHS08
Achtg.

H351

649-450-00-5

Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;
Cracked gasoil;
[a complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₄ through C₂₀ and boiling in the range of approximately 270^oC to 370^oC (518^oF to 698^oF).]

308-278-8

97926-59-5

Carc. 1B

H350

GHS08
Gef.

H350

649-451-00-0

Distillates (petroleum), hydrodesulfurized middle coker;
Cracked gasoil;
[a complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C₁₂ through C₂₁ and boiling in the range of approximately 200^oC to 360^oC (392^oF to 680^oF).]

309-865-1

101316-59-0

Carc. 1B

H350

GHS08
Gef.

H350

649-452-00-6

Distillates (petroleum), heavy steam-cracked;
Cracked gasoil;
[a complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250^oC to 400^oC (482^oF to 752^oF).]

309-939-3

101631-14-5

Carc. 1B

H350

GHS08
Gef.

H350

649-453-00-1

Distillates (petroleum), heavy hydrocracked;
baseoil - unspecified;
[a complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C₁₅-C₃₉ and boiling in the range of approximately 260^oC to 600^oC (500^oF to 1112^oF).]

265-077-7

64741-76-0

Carc. 1B

H350

GHS08
Gef.

H350

649-454-00-7

Distillates (petroleum), solvent-refined heavy paraffinic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC).]

265-090-8

64741-88-4

Carc. 1B

H350

GHS08
Gef.

H350

649-455-00-2

Distillates (petroleum), solvent-refined light paraffinic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₁₅through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC).]

265-091-3

64741-89-5

Carc. 1B

H350

GHS08
Gef.

H350

649-456-00-8

Residual oils (petroleum), solvent deasphalted;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained as the solvent soluble fraction from C₃-C₄ solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C₂₅ and boiling above approximately 400^oC (752^oF).]

265-096-0

64741-95-3

Carc. 1B

H350

GHS08
Gef.

H350

649-457-00-3

Distillates (petroleum), solvent-refined heavy naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt a 40^oC). It contains relatively few normal paraffins.]

265-097-6

64741-96-4

Carc. 1B

H350

GHS08
Gef.

H350

649-458-00-9

Distillates (petroleum), solvent-refined light naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-098-1

64741-97-5

Carc. 1B

H350

GHS08
Gef.

H350

649-459-00-4

Residual oils (petroleum,) solvent-refined;
baseoil - unspecified;
[a complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C₂₅ and boiling above approximately 400^oC (752^oF).]

265-101-6

64742-01-4

Carc. 1B

H350

GHS08
Gef.

H350

649-460-00-X

Distillates (petroleum), clay-treated paraffinic;
baseoil - unspecified;
[a complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains a relatively large proportion of saturated hydrocarbons.]

265-137-2

64742-36-5

Carc. 1B

H350

GHS08
Gef.

H350

649-461-00-5

Distillates (petroleum), clay-treated light paraffinic;
baseoil - unspecified;
[a complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains a relatively large proportion of saturated hydrocarbons.]

265-138-8

64742-37-6

Carc. 1B

H350

GHS08
Gef.

H350

649-462-00-0

Residual oils (petroleum), clay-treated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C₂₅ and boiling above approximately 400^oC (752^oF).]

265-143-5

64742-41-2

Carc. 1B

H350

GHS08
Gef.

H350

649-463-00-6

Distillates (petroleum), clay-treated heavy naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-146-1

64742-44-5

Carc. 1B

H350

GHS08
Gef.

H350

649-464-00-1

Distillates (petroleum), clay-treated light naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-147-7

64742-45-6

Carc. 1B

H350

GHS08
Gef.

H350

649-465-00-7

Distillates (petroleum), hydrotreated heavy naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₅₀ and produces a finished oil of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-155-0

64742-52-5

Carc. 1B

H350

GHS08
Gef.

H350

649-466-00-2

Distillates (petroleum), hydrotreated light naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-156-6

64742-53-6

Carc. 1B

H350

GHS08
Gef.

H350

649-467-00-8

Distillates (petroleum), hydrotreated heavy paraffinic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₅₀ and produces a finished oil of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains a relatively large proportion of saturated hydrocarbons.]

265-157-1

64742-54-7

Carc. 1B

H350

GHS08
Gef.

H350

649-468-00-3

Distillates (petroleum), hydrotreated light paraffinic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains a relatively large proportion of saturated hydrocarbons.]

265-158-7

64742-55-8

Carc. 1B

H350

GHS08
Gef.

H350

649-469-00-9

Distillates (petroleum), solvent-dewaxed light paraffinic;
baseoil - unspecified;
[a complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC).]

265-159-2

64742-56-9

Carc. 1B

H350

GHS08
Gef.

H350

649-470-00-4

Residual oils (petroleum), hydrotreated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C₂₅ and boiling above approximately 400^oC (752^oF).]

265-160-8

64742-57-0

Carc. 1B

H350

GHS08
Gef.

H350

649-471-00-X

Residual oils (petroleum), solvent-dewaxed;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C₂₅ and boiling above approximately 400^oC (752^oF).]

265-166-0

64742-62-7

Carc. 1B

H350

GHS08
Gef.

H350

649-472-00-5

Distillates (petroleum), solvent-dewaxed heavy naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C_{20 .}through C₅₀ and produces a finished oil of not less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-167-6

64742-63-8

Carc. 1B

H350

GHS08
Gef.

H350

649-473-00-0

Distillates (petroleum), solvent-dewaxed light naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C₁₅ through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-168-1

64742-64-9

Carc. 1B

H350

GHS08
Gef.

H350

649-474-00-6

Distillates (petroleum), solvent-dewaxed heavy paraffinic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity not less than 100 SUS at 100^oF (19cSt at 40^oC).]

265-169-7

64742-65-0

Carc. 1B

H350

GHS08
Gef.

H350

649-475-00-1

Naphthenic oils (petroleum), catalytic dewaxed heavy;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-172-3

64742-68-3

Carc. 1B

H350

GHS08
Gef.

H350

649-476-00-7

Naphthenic oils (petroleum), catalytic dewaxed light;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil with a viscosity less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-173-9

64742-69-4

Carc. 1B

H350

GHS08
Gef.

H350

649-477-00-2

Paraffin oils (petroleum), catalytic dewaxed heavy;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC).]

265-174-4

64742-70-7

Carc. 1B

H350

GHS08
Gef.

H350

649-478-00-8

Paraffin oils (petroleum), catalytic dewaxed light;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC).]

265-176-5

64742-71-8

Carc. 1B

H350

GHS08
Gef.

H350

649-479-00-3

Naphthenic oils (petroleum), complex dewaxed heavy;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil having a viscosity of at least 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-179-1

64742-75-2

Carc. 1B

H350

GHS08
Gef.

H350

649-480-00-9

Naphthenic oils (petroleum), complex dewaxed light;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil having a viscosity less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

265-180-7

64742-76-3

Carc. 1B

H350

GHS08
Gef.

H350

649-481-00-4

Lubricating oils (petroleum), C_20-50, hydrotreated neutral oil-based, high-viscosity;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₅₀ and produces a finished oil having a viscosity of approximately 112cSt at 40^oC. It contains a relatively large proportion of saturated hydrocarbons.]

276-736-3

72623-85-9

Carc. 1B

H350

GHS08
Gef.

H350

649-482-00-X

Lubricating oils (petroleum), C_15-30, hydrotreated neutral oil-based;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀ and produces a finished oil having a viscosity of approximately 15cSt at 40^oC. It contains a relatively large proportion of saturated hydrocabons.]

276-737-9

72623-86-0

Carc. 1B

H350

GHS08
Gef.

H350

649-483-00-5

Lubricating oils (petroleum), C_20-50, hydrotreated neutral oil-based;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₅₀ and produces a finished oil with a viscosity of approximately 32cSt at 40^oC. It contains a relatively large proportion of saturated hydrocarbons.]

276-738-4

72623-87-1

Carc. 1B

H350

GHS08
Gef.

H350

649-484-00-0

Lubricating oils;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C₁₅ through C₅₀.]

278-012-2

74869-22-0

Carc. 1B

H350

GHS08
Gef.

H350

649-485-00-6

Distillates (petroleum), complex dewaxed heavy paraffinci;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

292-613-7

90640-91-8

Carc. 1B

H350

GHS08
Gef.

H350

649-486-00-1

Distillates (petroleum), complex dewaxed light paraffinic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₂ through C₃₀ and produces a finished oil with a viscosity of less than 100 SUS at 100^oF (19cSt at 40^oC). It contains relatively few normal paraffins.]

292-614-2

90640-92-9

Carc. 1B

H350

GHS08
Gef.

H350

649-487-00-7

Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀.]

292-616-3

90640-94-1

Carc. 1B

H350

GHS08
Gef.

H350

649-488-00-2

Hydrocarbons, C_20-50, solvent dewaxed heavy paraffinic, hydrotreated;
baseoil - unspecified;
[a complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀.]

292-617-9

90640-95-2

Carc. 1B

H350

GHS08
Gef.

H350

649-489-00-8

Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;
baseoil - unspecified;
[a complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀.]

292-618-4

90640-96-3

Carc. 1B

H350

GHS08
Gef.

H350

649-490-00-3

Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;
baseoil - unspecified;
[a complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀.]

292-620-5

90640-97-4

Carc. 1B

H350

GHS08
Gef.

H350

649-491-00-9

Residual oils (petroleum), hydrotreated solvent dewaxed;
baseoil - unspecified

292-656-1

90669-74-2

Carc. 1B

H350

GHS08
Gef.

H350

649-492-00-4

Residual oils (petroleum), catalytic dewaxed;
baseoil - unspecified

294-843-3

91770-57-9

Carc. 1B

H350

GHS08
Gef.

H350

649-493-00-X

Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₂₅ through C₃₉ and produces a finished oil with a viscosity of approximately 44 cSt at 50^oC.]

295-300-3

91995-39-0

Carc. 1B

H350

GHS08
Gef.

H350

649-494-00-5

Distillates (petroleum), dewaxed light paraffinic, hydrotreated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C₂₁ through C₂₉ and produces a finished oil with a viscosity of approximately 13 cSt at 50^oC.]

295-301-9

91995-40-3

Carc. 1B

H350

GHS08
Gef.

H350

649-495-00-0

Distillates (petroleum), hydrocracked solvent-refined, dewaxed;
baseoil - unspecified;
[a complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]

295-306-6

91995-45-8

Carc. 1B

H350

GHS08
Gef.

H350

649-496-00-6

Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C₁₅through C₃₀ and produces a finished oil with a viscosity of between 13-15cSt at 40^oC.]

295-316-0

91995-54-9

Carc. 1B

H350

GHS08
Gef.

H350

649-497-00-1

Lubricating oils (petroleum), C_17-35, solvent-extd., dewaxed, hydrotreated;
baseoil - unspecified

295-423-2

92045-42-6

Carc. 1B

H350

GHS08
Gef.

H350

649-498-00-7

Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;
baseoil - unspecified

295-424-8

92045-43-7

Carc. 1B

H350

GHS08
Gef.

H350

649-499-00-2

Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;
baseoil - unspecified;
[a complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380^oC (716^oF).]

295-499-7

92061-86-4

Carc. 1B

H350

GHS08
Gef.

H350

649-500-00-6

Paraffin oils (petroleum), solvent-refined dewaxed heavy;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50^oC.]

295-810-6

92129-09-4

Carc. 1B

H350

GHS08
Gef.

H350

649-501-00-1

Lubricating oils (petroleum), base oils, paraffinic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100^oF (23cSt at 40^oC).]

297-474-6

93572-43-1

Carc. 1B

H350

GHS08
Gef.

H350

649-502-00-7

Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;
baseoil - unspecified

297-857-8

93763-38-3

Carc. 1B

H350

GHS08
Gef.

H350

649-503-00-2

Hydrocarbons, C_20-50, residual oil hydrogenation vacuum distillate;
baseoil - unspecified

300-257-1

93924-61-9

Carc. 1B

H350

GHS08
Gef.

H350

649-504-00-8

Distillates (petroleum), solvent-refined hydrotreated heavy;
hydrogenated;
baseoil - unspecified

305-588-5

94733-08-1

Carc. 1B

H350

GHS08
Gef.

H350

649-505-00-3

Distillates (petroleum), solvent-refined hydrocracked light;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₈through C₂₇ and boiling in the range of approximately 370^oC to 450^oC (698^oF to 842^oF).]

305-589-0

94733-09-2

Carc. 1B

H350

GHS08
Gef.

H350

649-506-00-9

Lubricating oils (petroleum), C_18-40, solvent-dewaxed hydrocracked distillate-based;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₈ through C₄₀ and boiling in the range of approximately 370^oC to 550^oC (698^oF to 1022^oF).]

305-594-8

94733-15-0

Carc. 1B

H350

GHS08
Gef.

H350

649-507-00-4

Lubricating oils (petroleum), C_18-40, solvent-dewaxed hydrogenated raffinate-based;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₈ through C₄₀ and boiling in the range of approximately 370^oC to 550^oC (698^oF to 1022^oF).]

305-595-3

94733-16-1

Carc. 1B

H350

GHS08
Gef.

H350

649-508-00-X

Hydrocarbons, C_13-30, arom.-rich, solvent-extd. naphthenic distillate;
baseoil - unspecified

305-971-7

95371-04-3

Carc. 1B

H350

GHS08
Gef.

H350

649-509-00-5

Hydrocarbons, C_16-32, arom. rich, solvent-extd. naphthenic distillate;
baseoil - unspecified

305-972-2

95371-05-4

Carc. 1B

H350

GHS08
Gef.

H350

649-510-00-0

Hydrocarbons, C_37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;
baseoil - unspecified

305-974-3

95371-07-6

Carc. 1B

H350

GHS08
Gef.

H350

649-511-00-6

Hydrocarbons, C_37-65, hydrotreated deasphalted vacuum distn. residues;
baseoil - unspecified

305-975-9

95371-08-7

Carc. 1B

H350

GHS08
Gef.

H350

649-512-00-1

Distillates (petroleum), hydrocracked solvent-refined light;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₈through C₂₇ and boiling in the range of approximately 370^oC to 450^oC (698^oF to 842^oF.]

307-010-7

97488-73-8

Carc. 1B

H350

GHS08
Gef.

H350

649-513-00-7

Distillates (petroleum), solvent-refined hydrogenated heavy;
baseoil - unspecified;
[a complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₉through C₄₀ and boiling in the range of approximately 390^oC to 550^oC (734^oF to 1022^oF).]

307-011-2

97488-74-9

Carc. 1B

H350

GHS08
Gef.

H350

649-514-00-2

Lubricating oils (petroleum), C_18-27, hydrocracked solvent-dewaxed;
baseoil - unspecified

307-034-8

97488-95-4

Carc. 1B

H350

GHS08
Gef.

H350

649-515-00-8

Hydrocarbons, C_17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₇ through C₃₀ and boiling in the range of approximately 300^oC to 400^oC (572^oF to 752^oF). It produces a finished oil having a viscosity of 4cSt at approximately 100^oC (212^oF).]

307-661-7

97675-87-1

Carc. 1B

H350

GHS08
Gef.

H350

649-516-00-3

Hydrocarbons, C_17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100^oC (212^oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₇ through C₄₀ and boiling in the range of approximately 300^oC to 500^oC (592^oF to 932^oF).]

307-755-8

97722-06-0

Carc. 1B

H350

GHS08
Gef.

H350

649-517-00-9

Hydrocarbons, C_13-27, solvent-extd. light naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40^oC (104^oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₃ through C₂₇ and boiling in the range of approximately 240^oC to 400^oC (464^oF to 752^oF.]

307-758-4

97722-09-3

Carc. 1B

H350

GHS08
Gef.

H350

649-518-00-4

Hydrocarbons, C_14-29, solvent-extd. light naphthenic;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40^oC (104^oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₄ through C₂₉ and boiling in the range of approximately 250^oC to 425^oC (482^oF to 797^oF).]

307-760-5

97722-10-6

Carc. 1B

H350

GHS08
Gef.

H350

649-519-00-X

Hydrocarbons, C_27-42, dearomatized;
baseoil - unspecified

308-131-8

97862-81-2

Carc. 1B

H350

GHS08
Gef.

H350

649-520-00-5

Hydrocarbons, C_17-30, hydrotreated distillates, distn. lights;
baseoil - unspecified

308-132-3

97862-82-3

Carc. 1B

H350

GHS08
Gef.

H350

649-521-00-0

Hydrocarbons, C_27-45, naphthenic vacuum distn.;
baseoil - unspecified

308-133-9

97862-83-4

Carc. 1B

H350

GHS08
Gef.

H350

649-522-00-6

Hydrocarbons, C_27-45, dearomatized;
baseoil - unspecified

308-287-7

97926-68-6

Carc. 1B

H350

GHS08
Gef.

H350

649-523-00-1

Hydrocarbons, C_20-58, hydrotreated;
baseoil - unspecified

308-289-8

97926-70-0

Carc. 1B

H350

GHS08
Gef.

H350

649-524-00-7

Hydrocarbons, C_27-42, naphthenic;
baseoil - unspecified

308-290-3

97926-71-1

Carc. 1B

H350

GHS08
Gef.

H350

649-525-00-2

Residual oils (petroleum), carbon-treated solvent-dewaxed;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]

309-710-8

100684-37-5

Carc. 1B

H350

GHS08
Gef.

H350

649-526-00-8

Residual oils (petroleum), clay-treated solvent-dewaxed;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]

309-711-3

100684-38-6

Carc. 1B

H350

GHS08
Gef.

H350

649-527-00-3

Lubricating oils (petroleum), C_>25, solvent-extd., deasphalted, dewaxed, hydrogenated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C₂₅ and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100^oC (212^oF).]

309-874-0

101316-69-2

Carc. 1B

H350

GHS08
Gef.

H350

649-528-00-9

Lubricating oils (petroleum), C_17-32, solvent-extd., dewaxed, hydrogenated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₇through C₃₂ and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40^oC (104^oF.]

309-875-6

101316-70-5

Carc. 1B

H350

GHS08
Gef.

H350

649-529-00-4

Lubricating oils (petroleum), C_20-35, solvent-extd., dewaxed, hydrogenated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₀through C₃₅ and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40^oC (104^oF).]

309-876-1

101316-71-6

Carc. 1B

H350

GHS08
Gef.

H350

649-530-00-X

Lubricating oils (petroleum), C_24-50, solvent-extd., dewaxed, hydrogenated;
baseoil - unspecified;
[a complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₄through C₅₀ and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40^oC (104^oF).]

309-877-7

101316-72-7

Carc. 1B

H350

GHS08
Gef.

H350

649-531-00-5

Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;
Distillate aromatic extract (treated);
[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]

272-175-3

68783-00-6

Carc. 1B

H350

GHS08
Gef.

H350

649-532-00-0

Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀.]

272-180-0

68783-04-0

Carc. 1B

H350

GHS08
Gef.

H350

649-533-00-6

Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]

272-342-0

68814-89-1

Carc. 1B

H350

GHS08
Gef.

H350

649-534-00-1

Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀ and produces a finished oil of at least 19cSt at 40^oC (100 SUS at 100^oF).]

292-631-5

90641-07-9

Carc. 1B

H350

GHS08
Gef.

H350

649-535-00-7

Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₂₁ through C₃₃ and boiling in the range of approximately 350^oC to 480^oC (662^oF to 896^oF).

292-632-0

90641-08-0

Carc. 1B

H350

GHS08
Gef.

H350

649-536-00-2

Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₇ through C₂₆ and boiling in the range of approximately 280^oC to 400^oC (536^oF to 752^oF).]

292-633-6

90641-09-1

Carc. 1B

H350

GHS08
Gef.

H350

649-537-00-8

Extracts (petroleum), hydrotreated light paraffinic distillate solvent;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₆through C₃₆.]

295-335-4

91995-73-2

Carc. 1B

H350

GHS08
Gef.

H350

649-538-00-3

Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₃₀. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]

295-338-0

91995-75-4

Carc. 1B

H350

GHS08
Gef.

H350

649-539-00-9

Extracts (petroleum), light paraffinic distillate solvent, acid-treated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₆ through C₃₂.]

295-339-6

91995-76-5

Carc. 1B

H350

GHS08
Gef.

H350

649-540-00-4

Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₅through C₄₀ and produces a finished oil with a viscosity of greater than 10cSt at 40^oC.]

295-340-1

91995-77-6

Carc. 1B

H350

GHS08
Gef.

H350

649-541-00-X

Extracts (petroleum), light vacuum gas oil solvent, hydrotreated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₃ through C₃₀.]

295-342-2

91995-79-8

Carc. 1B

H350

GHS08
Gef.

H350

649-542-00-5

Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]

296-437-1

92704-08-0

Carc. 1B

H350

GHS08
Gef.

H350

649-543-00-0

Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₅₀ and produces a finished oil with a viscosity of greater than 19cSt at 40^oC.]

297-827-4

93763-10-1

Carc. 1B

H350

GHS08
Gef.

H350

649-544-00-6

Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C₁₅ through C₅₀ and produces a finished oil with a viscosity of greater than 19cSt at 40^oC.]

297-829-5

93763-11-2

Carc. 1B

H350

GHS08
Gef.

H350

649-545-00-1

Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₆ through C₃₂.]

309-672-2

100684-02-4

Carc. 1B

H350

GHS08
Gef.

H350

649-546-00-7

Extracts (petroleum), light paraffinic distillate solvent, clay-treated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₆ through C₃₂.]

309-673-8

100684-03-5

Carc. 1B

H350

GHS08
Gef.

H350

649-547-00-2

Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₃through C₃₀.]

309-674-3

100684-04-6

Carc. 1B

H350

GHS08
Gef.

H350

649-548-00-8

Extracts (petroleum), light vacuum gas oil solvent, clay-treated;
Distillate aromatic extract (treated);
[a complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C₁₃through C₃₀.]

309-675-9

100684-05-7

Carc. 1B

H350

GHS08
Gef.

H350

649-549-00-3

Foots oil (petroleum);
Foots oil;
[a complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C₂₀ through C₅₀.]

265-171-8

64742-67-2

Carc. 1B

H350

GHS08
Gef.

H350

649-550-00-9

Foots oil (petroleum), hydrotreated;
Foots oil

295-394-6

92045-12-0

Carc. 1B

H350

GHS08
Gef.

H350

650-002-00-6

turpentine, oil

232-350-7

8006-64-2

Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2

H226
H332
H312
H302
H304
H319
H315
H317
H411

GHS02
GHS08
GHS07
GHS09
Gef.

H226
H332
H312
H302
H304
H319
H315
H317
H411

650-003-00-1

fenson (ISO);
4-chlorophenyl benzenesulphonate;

201-274-6

80-38-6

Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 2

H302
H319
H411

GHS07
GHS09
Achtg.

H302
H319
H411

650-004-00-7

norbormide (ISO);
5-(a-hydroxy-a-2-pyridylbenzyl)-7-(a-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide

213-589-6

991-42-4

Acute Tox. 4 *

H302

GHS07
Achtg.

H302

650-005-00-2

(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone

201-501-9

83-79-4

Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1

H301
H319
H335
H315
H400
H410

GHS06
GHS09
Gef.

H301
H319
H335
H315
H410

650-006-00-8

benquinox (ISO);
p-benzoquinone 1-benzoylhydrazone 4-oxime

207-807-9

495-73-8

Acute Tox. 3 *
Acute Tox. 4 *

H301
H312

GHS06
Gef.

H301
H312

650-007-00-3

chlordimeform (ISO);
N₂-(4-chloro-o-tolyl)-N₁,N₁-dimethylformamidine

228-200-5

6164-98-3

Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H312
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H312
H302
H410

650-008-00-9

drazoxolon (ISO);
4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone

227-197-8

5707-69-7

Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1

H301
H400
H410

GHS06
GHS09
Gef.

H301
H410

650-009-00-4

chlordimeform hydrochloride;
N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;
N²-(4-chloro-o-tolyl)-N¹,N¹-dimethylformamidine hydorchloride

243-269-1

19750-95-9

Carc. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H351
H302
H400
H410

GHS08
GHS07
GHS09
Achtg.

H351
H302
H410

650-010-00-X

benzyl violet 4B;
a-[4-(4-dimethylamino-a-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate

216-901-9

1694-09-3

Carc. 2

H351

GHS08
Achtg.

H351

650-012-00-0

erionite

12510-42-8

Carc. 1A

H350

GHS08
Gef.

H350

650-013-00-6

asbestos

-
-
-
-
-
-
-

12001-28-4
132207-32-0
12172-73-5
77536-66-4
77536-68-6
77536-67-5
12001-29-5

Carc. 1a
STOT RE 1

H350
H372 **

GHS08
Gef.

H350
H372 **

650-014-00-1

diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate

401-770-4

Skin Corr. 1B
Acute Tox. 4 *

H314
H302

GHS05
GHS07
Gef.

H314
H302

650-015-00-7

rosin;
colophony

232-475-7
232-484-6
277-299-1

8050-09-7
8052-10-6
73138-82-6

Skin Sens. 1

H317

GHS07
Achtg.

H317

650-016-00-2

Mineral wool, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na₂O+K₂O+CaO+MgO+BaO) content greater than 18 % by weight]

Carc. 2

H351

GHS08
Achtg.

H351

AQR

650-017-00-8

Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na₂O+K₂O+CaO+MgO+BaO) content less or equal to 18 % by weight]

Carc. 1B

H350i

GHS08
Achtg.

H350i

650-018-00-3

Reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid

406-230-1

Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H226
H351
H314
H332
H317
H400
H410

GHS02
GHS08
GHS05 GHS07
GHS09
Gef.

H226
H351
H314
H332
H317
H410

650-031-00-4

bis(4-hydroxy-N-methylanilinium) sulphate

200-237-1

55-55-0

Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H302
H373 **
H317
H400
H410

GHS08
GHS07
GHS09
Achtg.

H302
H373 **
H317
H410

650-032-00-X

Cyproconazol (ISO); (2RS,3RS;2RS,3SR)-2-(4-Chlorphenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

94361-06-5

Repr. 1B
Acute Tox. 3
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1

H360D
H301
H373 (Leber)
H400
H410

GHS08
GHS06
GHS09
Gef.

H360D
H301
H373 (Leber)
H410

M = 10
M = 1

650-041-00-9

triasulfuron (ISO);
1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea

82097-50-5

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

650-042-00-4

reaction product of: polyethylene-polyamine-(C₁₆-C₁₈)-alkylamides with monothio-(C₂)-alkyl phosphonates

417-450-2

Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3

H319
H315
H317
H412

GHS07
Achtg.

H319
H315
H317
H412

650-043-00-X

reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate

420-310-3

Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1

H302
H400
H410

GHS07
GHS09
Achtg.

H302
H410

650-044-00-5

mixed linear and branched C_14-15 alcohols ethoxylated, reaction product with epichlorohydrin

420-480-9

158570-99-1

Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H317
H400
H410

GHS07
GHS09
Achtg.

H315
H317
H410

650-045-00-0

reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate

417-110-3

Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2

H225
H315
H318
H411

GHS02
GHS05
GHS09
Gef.

H225
H315
H318
H411

650-046-00-6

di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates

416-180-2

12222-04-7

Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2

H302
H373 **
H411

GHS08
GHS07
GHS09
Achtg.

H302
H373 **
H411

650-047-00-1

dibenzylphenylsulfonium hexafluoroantimonate

417-760-8

134164-24-2

STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2

H372 **
H302
H318
H317
H411

GHS08
GHS05 GHS07
GHS09
Gef.

H372 **
H302
H318
H317
H411

650-048-00-7

reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid

420-070-1

Org. Perox. D ****
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1a
Aquatic Acute 1

H242
H332
H312
H302
H314
H400

GHS02
GHS05 GHS07
GHS09
Gef.

H242
H332
H312
H302
H314
H400

650-049-00-2

2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl

417-960-5

Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1

H315
H318
H317
H400
H410

GHS05 GHS07
GHS09
Gef.

H315
H318
H317
H410

650-050-00-8

reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;
1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;
1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers

423-600-8

Aquatic Chronic 2

H411

GHS09

H411

650-055-00-5

silver sodium zirconium hydrogenphosphate

422-570-3

155925-27-2

Aquatic Acute 1
Aquatic Chronic 1

H400
H410

GHS09
Achtg.

H410

*) Umgerechnete Punktschätzung der akuten Toxizität gemäß der Tabelle 3.1.2 in Anhang I.

umwelt-online - Demo-Version

(Stand: 19.08.2020)

Alle vollständigen Texte in der aktuellen Fassung im Jahresabonnement
Nutzungsgebühr: 90.- € netto (Grundlizenz)

(derzeit ca. 7200 Titel s.Übersicht - keine Unterteilung in Fachbereiche)

Preise & Bestellung

Die Zugangskennung wird kurzfristig übermittelt

? Fragen ?
Abonnentenzugang/Volltextversion